<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:SMX="http://smxpublicltd.com/20251231"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="smx-20251231.xsd" xlink:type="simple"/>
    <context id="From2025-01-01to2025-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-07-152024-07-15_ifrs-full_PotentialOrdinaryShareTransactionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:PotentialOrdinaryShareTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-15</startDate>
            <endDate>2024-07-15</endDate>
        </period>
    </context>
    <context id="From2025-01-152025-01-15_ifrs-full_PotentialOrdinaryShareTransactionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:PotentialOrdinaryShareTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-15</startDate>
            <endDate>2025-01-15</endDate>
        </period>
    </context>
    <context id="From2025-06-162025-06-16_ifrs-full_PotentialOrdinaryShareTransactionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:PotentialOrdinaryShareTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-16</startDate>
            <endDate>2025-06-16</endDate>
        </period>
    </context>
    <context id="From2025-08-072025-08-07_ifrs-full_PotentialOrdinaryShareTransactionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:PotentialOrdinaryShareTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-07</startDate>
            <endDate>2025-08-07</endDate>
        </period>
    </context>
    <context id="From2025-10-232025-10-23_ifrs-full_PotentialOrdinaryShareTransactionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:PotentialOrdinaryShareTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-23</startDate>
            <endDate>2025-10-23</endDate>
        </period>
    </context>
    <context id="From2025-11-182025-11-18_ifrs-full_PotentialOrdinaryShareTransactionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:PotentialOrdinaryShareTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-18</startDate>
            <endDate>2025-11-18</endDate>
        </period>
    </context>
    <context id="From2026-02-172026-02-17_ifrs-full_PotentialOrdinaryShareTransactionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:PotentialOrdinaryShareTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-17</startDate>
            <endDate>2026-02-17</endDate>
        </period>
    </context>
    <context id="From2026-05-112026-05-11_ifrs-full_PotentialOrdinaryShareTransactionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:PotentialOrdinaryShareTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-11</startDate>
            <endDate>2026-05-11</endDate>
        </period>
    </context>
    <context id="From2026-06-012026-06-01_ifrs-full_PotentialOrdinaryShareTransactionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:PotentialOrdinaryShareTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-06-01</startDate>
            <endDate>2026-06-01</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_IssuedAndAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:IssuedAndAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_TransactionWithNonControllingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:TransactionWithNonControllingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_ForeignCurrencyTranslationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:ForeignCurrencyTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_NoncontrollingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_IssuedAndAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:IssuedAndAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TransactionWithNonControllingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:TransactionWithNonControllingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ForeignCurrencyTranslationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:ForeignCurrencyTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_NoncontrollingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_IssuedAndAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:IssuedAndAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ForeignCurrencyTranslationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:ForeignCurrencyTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_NoncontrollingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_IssuedAndAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:IssuedAndAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_TransactionWithNonControllingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:TransactionWithNonControllingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_ForeignCurrencyTranslationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:ForeignCurrencyTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_NoncontrollingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_IssuedAndAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:IssuedAndAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_TransactionWithNonControllingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:TransactionWithNonControllingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_ForeignCurrencyTranslationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:ForeignCurrencyTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_NoncontrollingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_IssuedAndAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:IssuedAndAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ForeignCurrencyTranslationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:ForeignCurrencyTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_IssuedAndAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:IssuedAndAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_TransactionWithNonControllingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:TransactionWithNonControllingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_ForeignCurrencyTranslationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:ForeignCurrencyTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_NoncontrollingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-07-26_ifrs-full_OrdinarySharesMember_custom_SecurityMattersPTYLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">SMX:SecurityMattersPTYLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-26</instant>
        </period>
    </context>
    <context id="From2022-07-262022-07-26_custom_LionheartMember_custom_BusinessCombinationAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">SMX:LionheartMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:BusinessCombinationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-26</startDate>
            <endDate>2022-07-26</endDate>
        </period>
    </context>
    <context id="AsOf2023-10-03_custom_TrueGoldConsortiumPtyLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:TrueGoldConsortiumPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-03</instant>
        </period>
    </context>
    <context id="From2023-10-032023-10-03_custom_TrueGoldConsortiumPtyLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:TrueGoldConsortiumPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-03</startDate>
            <endDate>2023-10-03</endDate>
        </period>
    </context>
    <context id="From2023-10-032023-10-03_custom_TrueGoldConsortiumPtyLtdMember18007828">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">SMX:TrueGoldConsortiumPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-03</startDate>
            <endDate>2023-10-03</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-07-31_custom_TrueGoldConsortiumPtyLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">SMX:TrueGoldConsortiumPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_ConvertibleSecuritiesFundingAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:ConvertibleSecuritiesFundingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_StandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_FundingAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:FundingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_StandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-07-152024-07-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
        </entity>
        <period>
            <startDate>2024-07-15</startDate>
            <endDate>2024-07-15</endDate>
        </period>
    </context>
    <context id="AsOf2024-07-15_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-15</instant>
        </period>
    </context>
    <context id="AsOf2024-07-14_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-14</instant>
        </period>
    </context>
    <context id="From2025-01-152025-01-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
        </entity>
        <period>
            <startDate>2025-01-15</startDate>
            <endDate>2025-01-15</endDate>
        </period>
    </context>
    <context id="AsOf2025-01-15_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-15</instant>
        </period>
    </context>
    <context id="AsOf2025-01-14_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-14</instant>
        </period>
    </context>
    <context id="From2025-06-162025-06-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
        </entity>
        <period>
            <startDate>2025-06-16</startDate>
            <endDate>2025-06-16</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-16_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-16</instant>
        </period>
    </context>
    <context id="AsOf2025-06-15_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-15</instant>
        </period>
    </context>
    <context id="From2025-08-072025-08-07">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
        </entity>
        <period>
            <startDate>2025-08-07</startDate>
            <endDate>2025-08-07</endDate>
        </period>
    </context>
    <context id="AsOf2025-08-07_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-08-07</instant>
        </period>
    </context>
    <context id="AsOf2025-08-06_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-08-06</instant>
        </period>
    </context>
    <context id="From2025-10-232025-10-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
        </entity>
        <period>
            <startDate>2025-10-23</startDate>
            <endDate>2025-10-23</endDate>
        </period>
    </context>
    <context id="AsOf2025-10-23_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-10-23</instant>
        </period>
    </context>
    <context id="AsOf2025-10-22_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-10-22</instant>
        </period>
    </context>
    <context id="From2025-11-182025-11-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
        </entity>
        <period>
            <startDate>2025-11-18</startDate>
            <endDate>2025-11-18</endDate>
        </period>
    </context>
    <context id="AsOf2025-11-18_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-11-18</instant>
        </period>
    </context>
    <context id="AsOf2025-11-17_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-11-17</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SecurityMattersSmxPlcMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">SMX:SecurityMattersSmxPlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_SecurityMattersSmxPlcMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">SMX:SecurityMattersSmxPlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SecurityMattersPTYLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">SMX:SecurityMattersPTYLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_SecurityMattersPTYLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">SMX:SecurityMattersPTYLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_LionheartIIICorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">SMX:LionheartIIICorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_LionheartIIICorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">SMX:LionheartIIICorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SMXIrelandLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">SMX:SMXIrelandLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_SMXIrelandLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">SMX:SMXIrelandLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SMXFashionAndLuxuryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">SMX:SMXFashionAndLuxuryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_SMXFashionAndLuxuryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">SMX:SMXFashionAndLuxuryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_TrueSilverSMXPlatformLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">SMX:TrueSilverSMXPlatformLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_TrueSilverSMXPlatformLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">SMX:TrueSilverSMXPlatformLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SMXIsraelLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">SMX:SMXIsraelLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_SMXIsraelLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">SMX:SMXIsraelLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SecurityMattersCanadaLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">SMX:SecurityMattersCanadaLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_SecurityMattersCanadaLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">SMX:SecurityMattersCanadaLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SMXBeveragesPtyLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">SMX:SMXBeveragesPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_SMXBeveragesPtyLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">SMX:SMXBeveragesPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SMXCircularEconomyPlatformPTELtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">SMX:SMXCircularEconomyPlatformPTELtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_SMXCircularEconomyPlatformPTELtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">SMX:SMXCircularEconomyPlatformPTELtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_TrueGoldConsortiumPtyLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">SMX:TrueGoldConsortiumPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_TrueGoldConsortiumPtyLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">SMX:TrueGoldConsortiumPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SMXCircularEconomyFZCOLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">SMX:SMXCircularEconomyFZCOLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_SMXCircularEconomyFZCOLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">SMX:SMXCircularEconomyFZCOLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_YahalomaTechnologiesIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">SMX:YahalomaTechnologiesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_YahalomaTechnologiesIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">SMX:YahalomaTechnologiesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_ComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_MachineryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_FurnitureAndOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">SMX:FurnitureAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LeaseholdImprovementsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_MachineryMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_FurnitureAndOfficeEquipmentMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">SMX:FurnitureAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_ComputerEquipmentMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_LeaseholdImprovementsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_MachineryMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_FurnitureAndOfficeEquipmentMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">SMX:FurnitureAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_ComputerEquipmentMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_LeaseholdImprovementsMember_custom_AccumulatedDepreciationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_MachineryMember_custom_AccumulatedDepreciationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_FurnitureAndOfficeEquipmentMember_custom_AccumulatedDepreciationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">SMX:FurnitureAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_ComputerEquipmentMember_custom_AccumulatedDepreciationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_AccumulatedDepreciationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LeaseholdImprovementsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_MachineryMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_FurnitureAndOfficeEquipmentMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">SMX:FurnitureAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_ComputerEquipmentMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LeaseholdImprovementsMember_custom_AccumulatedDepreciationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_MachineryMember_custom_AccumulatedDepreciationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_FurnitureAndOfficeEquipmentMember_custom_AccumulatedDepreciationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">SMX:FurnitureAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_ComputerEquipmentMember_custom_AccumulatedDepreciationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_AccumulatedDepreciationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LeaseholdImprovementsMember_custom_AccumulatedDepreciationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_MachineryMember_custom_AccumulatedDepreciationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_FurnitureAndOfficeEquipmentMember_custom_AccumulatedDepreciationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">SMX:FurnitureAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_ComputerEquipmentMember_custom_AccumulatedDepreciationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_AccumulatedDepreciationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_MachineryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_FurnitureAndOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">SMX:FurnitureAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_ComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LeaseholdImprovementsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_MachineryMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_FurnitureAndOfficeEquipmentMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">SMX:FurnitureAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_ComputerEquipmentMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_LeaseholdImprovementsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_MachineryMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_FurnitureAndOfficeEquipmentMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">SMX:FurnitureAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_ComputerEquipmentMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_LeaseholdImprovementsMember_custom_AccumulatedDepreciationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_MachineryMember_custom_AccumulatedDepreciationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_FurnitureAndOfficeEquipmentMember_custom_AccumulatedDepreciationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">SMX:FurnitureAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_ComputerEquipmentMember_custom_AccumulatedDepreciationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_AccumulatedDepreciationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LeaseholdImprovementsMember_custom_AccumulatedDepreciationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_MachineryMember_custom_AccumulatedDepreciationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_FurnitureAndOfficeEquipmentMember_custom_AccumulatedDepreciationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">SMX:FurnitureAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_ComputerEquipmentMember_custom_AccumulatedDepreciationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_AccumulatedDepreciationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_MachineryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_FurnitureAndOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">SMX:FurnitureAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_ComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_YahalomaTechnologiesIncMember18009937">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">SMX:YahalomaTechnologiesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_YahalomaTechnologiesIncMember18009937">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">SMX:YahalomaTechnologiesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_CapitalisedDevelopmentExpenditureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LicencesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_custom_TechnologyLicenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">SMX:TechnologyLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_CapitalisedDevelopmentExpenditureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LicencesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_custom_TechnologyLicenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">SMX:TechnologyLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_CapitalisedDevelopmentExpenditureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LicencesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_custom_TechnologyLicenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">SMX:TechnologyLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_AccumulatedDepreciationAmortisationMember_ifrs-full_CapitalisedDevelopmentExpenditureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_AccumulatedDepreciationAmortisationMember_ifrs-full_LicencesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_AccumulatedDepreciationAmortisationMember_custom_TechnologyLicenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">SMX:TechnologyLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_AccumulatedDepreciationAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_AccumulatedDepreciationAmortisationMember_ifrs-full_CapitalisedDevelopmentExpenditureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_AccumulatedDepreciationAmortisationMember_ifrs-full_LicencesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_AccumulatedDepreciationAmortisationMember_custom_TechnologyLicenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">SMX:TechnologyLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_AccumulatedDepreciationAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_AccumulatedDepreciationAmortisationMember_ifrs-full_CapitalisedDevelopmentExpenditureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_AccumulatedDepreciationAmortisationMember_ifrs-full_LicencesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_AccumulatedDepreciationAmortisationMember_custom_TechnologyLicenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">SMX:TechnologyLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_AccumulatedDepreciationAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_CapitalisedDevelopmentExpenditureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LicencesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_TechnologyLicenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">SMX:TechnologyLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_CapitalisedDevelopmentExpenditureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LicencesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_custom_TechnologyLicenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">SMX:TechnologyLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_CapitalisedDevelopmentExpenditureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LicencesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_custom_TechnologyLicenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">SMX:TechnologyLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_AccumulatedDepreciationAmortisationMember_ifrs-full_CapitalisedDevelopmentExpenditureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_AccumulatedDepreciationAmortisationMember_ifrs-full_LicencesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_AccumulatedDepreciationAmortisationMember_custom_TechnologyLicenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">SMX:TechnologyLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_AccumulatedDepreciationAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_AccumulatedDepreciationAmortisationMember_ifrs-full_CapitalisedDevelopmentExpenditureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_AccumulatedDepreciationAmortisationMember_ifrs-full_LicencesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_AccumulatedDepreciationAmortisationMember_custom_TechnologyLicenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">SMX:TechnologyLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_AccumulatedDepreciationAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">SMX:AccumulatedDepreciationAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_CapitalisedDevelopmentExpenditureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LicencesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_TechnologyLicenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">SMX:TechnologyLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_OtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_OtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-242024-01-25_custom_ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-24</startDate>
            <endDate>2024-01-25</endDate>
        </period>
    </context>
    <context id="AsOf2024-01-25_custom_ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-25</instant>
        </period>
    </context>
    <context id="AsOf2024-01-25_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-25</instant>
        </period>
    </context>
    <context id="AsOf2024-01-25_ifrs-full_OrdinarySharesMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-25</instant>
        </period>
    </context>
    <context id="From2024-01-242024-01-25_custom_ConvertibleNotesMember_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-24</startDate>
            <endDate>2024-01-25</endDate>
        </period>
    </context>
    <context id="From2024-01-242024-01-25_custom_ConvertibleNoteAgreementsMember_custom_BonusWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:BonusWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:ConvertibleNoteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-24</startDate>
            <endDate>2024-01-25</endDate>
        </period>
    </context>
    <context id="From2024-01-242024-01-25_custom_ConvertibleNoteAgreementsMember_custom_BonusWarrantsMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:BonusWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:ConvertibleNoteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-24</startDate>
            <endDate>2024-01-25</endDate>
        </period>
    </context>
    <context id="From2024-01-242024-01-25_custom_ConvertibleNoteAgreementsMember_custom_RedeemableWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:RedeemableWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:ConvertibleNoteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-24</startDate>
            <endDate>2024-01-25</endDate>
        </period>
    </context>
    <context id="From2024-01-242024-01-25_custom_ConvertibleNoteAgreementsMember_custom_RedeemableWarrantsMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:RedeemableWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:ConvertibleNoteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-24</startDate>
            <endDate>2024-01-25</endDate>
        </period>
    </context>
    <context id="AsOf2024-01-25_custom_ConvertibleNoteAgreementsMember_custom_RedeemableWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:RedeemableWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:ConvertibleNoteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-25</instant>
        </period>
    </context>
    <context id="AsOf2024-01-25_custom_ConvertibleNoteAgreementsMember_custom_RedeemableWarrantsMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:RedeemableWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:ConvertibleNoteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-25</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_RedeemableWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:RedeemableWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_RedeemableWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:RedeemableWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-09-062024-09-06_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-06</startDate>
            <endDate>2024-09-06</endDate>
        </period>
    </context>
    <context id="From2024-09-062024-09-06_custom_SecuritiesPurchaseAgreementMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-06</startDate>
            <endDate>2024-09-06</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-06_custom_SecuritiesPurchaseAgreementMember_custom_WarrantAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:WarrantAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-06</instant>
        </period>
    </context>
    <context id="AsOf2024-09-06_custom_SecuritiesPurchaseAgreementMember_custom_WarrantAMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:WarrantAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-06</instant>
        </period>
    </context>
    <context id="AsOf2024-09-06_custom_SecuritiesPurchaseAgreementMember_custom_WarrantBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:WarrantBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-06</instant>
        </period>
    </context>
    <context id="AsOf2024-09-06_custom_SecuritiesPurchaseAgreementMember_custom_WarrantBMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:WarrantBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-06</instant>
        </period>
    </context>
    <context id="AsOf2024-09-06_custom_SecuritiesPurchaseAgreementMember_custom_WarrantAMember_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:WarrantAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-06</instant>
        </period>
    </context>
    <context id="AsOf2024-09-06_custom_SecuritiesPurchaseAgreementMember_custom_WarrantAOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:WarrantAOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-06</instant>
        </period>
    </context>
    <context id="AsOf2024-09-06_custom_SecuritiesPurchaseAgreementMember_custom_WarrantAOneMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:WarrantAOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-06</instant>
        </period>
    </context>
    <context id="AsOf2024-09-06_custom_SecuritiesPurchaseAgreementMember_custom_WarrantBMember_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:WarrantBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-06</instant>
        </period>
    </context>
    <context id="AsOf2024-09-06_custom_SecuritiesPurchaseAgreementMember_custom_WarrantBMember_ifrs-full_OrdinarySharesMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:WarrantBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-06</instant>
        </period>
    </context>
    <context id="AsOf2024-09-06_custom_SecuritiesPurchaseAgreementMember_custom_WarrantBOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:WarrantBOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-06</instant>
        </period>
    </context>
    <context id="AsOf2024-09-06_custom_SecuritiesPurchaseAgreementMember_custom_WarrantBOneMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:WarrantBOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-06</instant>
        </period>
    </context>
    <context id="AsOf2024-09-06_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-06</instant>
        </period>
    </context>
    <context id="From2025-02-242025-02-24_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-24</startDate>
            <endDate>2025-02-24</endDate>
        </period>
    </context>
    <context id="AsOf2025-02-24_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-24</instant>
        </period>
    </context>
    <context id="From2025-08-242025-08-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
        </entity>
        <period>
            <startDate>2025-08-24</startDate>
            <endDate>2025-08-24</endDate>
        </period>
    </context>
    <context id="AsOf2025-08-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
        </entity>
        <period>
            <instant>2025-08-24</instant>
        </period>
    </context>
    <context id="From2025-10-282025-10-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
        </entity>
        <period>
            <startDate>2025-10-28</startDate>
            <endDate>2025-10-28</endDate>
        </period>
    </context>
    <context id="From2025-10-282025-10-28_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-28</startDate>
            <endDate>2025-10-28</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_ConversionOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:ConversionOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_ConversionOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:ConversionOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SecuritiesPurchaseAgreementMember_custom_ConversionOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:ConversionOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_SecuritiesPurchaseAgreementMember_custom_ConversionOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:ConversionOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_RestrictedShareUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-04-11_custom_AlphaAprilNoteMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">SMX:AlphaAprilNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-11</instant>
        </period>
    </context>
    <context id="From2024-04-112024-04-11_custom_AlphaAprilNoteMember_custom_SecuritiesPurchaseAgreementMember_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">SMX:AlphaAprilNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-11</startDate>
            <endDate>2024-04-11</endDate>
        </period>
    </context>
    <context id="From2024-04-112024-04-11_custom_AlphaAprilNoteMember_custom_SecuritiesPurchaseAgreementMember_ifrs-full_OrdinarySharesMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">SMX:AlphaAprilNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-11</startDate>
            <endDate>2024-04-11</endDate>
        </period>
    </context>
    <context id="From2024-04-112024-04-11_custom_AlphaAprilNoteMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">SMX:AlphaAprilNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-11</startDate>
            <endDate>2024-04-11</endDate>
        </period>
    </context>
    <context id="From2024-04-112024-04-11_custom_AlphaAprilNoteMember_custom_SecuritiesPurchaseAgreementMember_ifrs-full_TopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">SMX:AlphaAprilNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-11</startDate>
            <endDate>2024-04-11</endDate>
        </period>
    </context>
    <context id="From2024-04-112024-04-11_custom_SecuritiesPurchaseAgreementMember_ifrs-full_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-11</startDate>
            <endDate>2024-04-11</endDate>
        </period>
    </context>
    <context id="AsOf2024-04-11_custom_SecuritiesPurchaseAgreementMember_ifrs-full_WarrantsMember_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-11</instant>
        </period>
    </context>
    <context id="AsOf2024-04-11_custom_SecuritiesPurchaseAgreementMember_ifrs-full_WarrantsMember_ifrs-full_OrdinarySharesMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-11</instant>
        </period>
    </context>
    <context id="AsOf2024-04-11_custom_SecuritiesPurchaseAgreementMember_ifrs-full_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-11</instant>
        </period>
    </context>
    <context id="AsOf2024-04-11_custom_SecuritiesPurchaseAgreementMember_ifrs-full_WarrantsMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-11</instant>
        </period>
    </context>
    <context id="From2024-04-112024-04-11_custom_SecuritiesPurchaseAgreementMember_custom_AlphaAprilNoteMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">SMX:AlphaAprilNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-11</startDate>
            <endDate>2024-04-11</endDate>
        </period>
    </context>
    <context id="From2024-04-112024-04-11_custom_SecuritiesPurchaseAgreementMember_custom_ConversionOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:ConversionOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-11</startDate>
            <endDate>2024-04-11</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_OrdinarySharesMember_custom_InvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:InvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SecuritiesPurchaseAgreementMember_ifrs-full_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-04-11_custom_SecuritiesPurchaseAgreementMember_custom_AprilWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:AprilWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-11</instant>
        </period>
    </context>
    <context id="From2024-04-112024-04-11_custom_SecuritiesPurchaseAgreementMember_custom_AprilWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:AprilWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-11</startDate>
            <endDate>2024-04-11</endDate>
        </period>
    </context>
    <context id="From2025-04-022025-04-02">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
        </entity>
        <period>
            <startDate>2025-04-02</startDate>
            <endDate>2025-04-02</endDate>
        </period>
    </context>
    <context id="From2025-07-102025-07-10_custom_SeniorSecuredNoteDueMayThirtyOneTwentyTwentyFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">SMX:SeniorSecuredNoteDueMayThirtyOneTwentyTwentyFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-10</startDate>
            <endDate>2025-07-10</endDate>
        </period>
    </context>
    <context id="AsOf2025-07-10_custom_ConvertibleNoteDueDecemberThirtyOneTwentyTwentyFourMember_custom_TheEightHundredConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">SMX:TheEightHundredConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">SMX:ConvertibleNoteDueDecemberThirtyOneTwentyTwentyFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-10</instant>
        </period>
    </context>
    <context id="AsOf2025-07-10_custom_TheEightHundredConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">SMX:TheEightHundredConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-10</instant>
        </period>
    </context>
    <context id="AsOf2025-07-10_custom_NonConvertibleNoteDueDecemberThirtyOneTwentyTwentyFourMember_custom_TheFiveHundredNonConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">SMX:TheFiveHundredNonConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">SMX:NonConvertibleNoteDueDecemberThirtyOneTwentyTwentyFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-10</instant>
        </period>
    </context>
    <context id="AsOf2025-07-10_custom_TheFiveHundredNonConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">SMX:TheFiveHundredNonConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-10</instant>
        </period>
    </context>
    <context id="AsOf2025-07-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
        </entity>
        <period>
            <instant>2025-07-10</instant>
        </period>
    </context>
    <context id="From2025-07-102025-07-10_custom_TheEightHundredConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">SMX:TheEightHundredConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-10</startDate>
            <endDate>2025-07-10</endDate>
        </period>
    </context>
    <context id="AsOf2025-05-13_custom_ConvertiblePromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">SMX:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-13</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_ConvertiblePromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">SMX:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_ConvertiblePromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">SMX:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-07-192025-07-19_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-19</startDate>
            <endDate>2025-07-19</endDate>
        </period>
    </context>
    <context id="AsOf2025-07-19_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-19</instant>
        </period>
    </context>
    <context id="AsOf2024-07-19_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-19</instant>
        </period>
    </context>
    <context id="From2025-07-192025-07-19_custom_SecuritiesPurchaseAgreementMember_custom_JulyWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:JulyWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-19</startDate>
            <endDate>2025-07-19</endDate>
        </period>
    </context>
    <context id="From2025-07-192025-07-19_custom_SecuritiesPurchaseAgreementMember_custom_JulyWarrantsMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:JulyWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-19</startDate>
            <endDate>2025-07-19</endDate>
        </period>
    </context>
    <context id="AsOf2025-07-19_custom_SecuritiesPurchaseAgreementMember_custom_JulyWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:JulyWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-19</instant>
        </period>
    </context>
    <context id="From2025-07-192025-07-19_custom_SecuritiesPurchaseAgreementMember_custom_AlphaJulyNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">SMX:AlphaJulyNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-19</startDate>
            <endDate>2025-07-19</endDate>
        </period>
    </context>
    <context id="From2025-07-192025-07-19_custom_SecuritiesPurchaseAgreementMember_custom_ConversionOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:ConversionOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-19</startDate>
            <endDate>2025-07-19</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_SecuritiesPurchaseAgreementMember_custom_AlphaJulyNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">SMX:AlphaJulyNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_SecuritiesPurchaseAgreementMember_custom_ConversionOptionMember_custom_ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">SMX:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:ConversionOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SecuritiesPurchaseAgreementMember_custom_ConversionOptionMember_custom_ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">SMX:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:ConversionOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-08-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
        </entity>
        <period>
            <instant>2025-08-30</instant>
        </period>
    </context>
    <context id="From2025-08-302025-08-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
        </entity>
        <period>
            <startDate>2025-08-30</startDate>
            <endDate>2025-08-30</endDate>
        </period>
    </context>
    <context id="From2025-08-302025-08-30_custom_FebruaryTwentyEightTwoThousandAndTwentyFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">SMX:FebruaryTwentyEightTwoThousandAndTwentyFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-30</startDate>
            <endDate>2025-08-30</endDate>
        </period>
    </context>
    <context id="From2025-08-302025-08-30_custom_MarchTwentyThirtyTwoThousandAndTwentyFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">SMX:MarchTwentyThirtyTwoThousandAndTwentyFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-30</startDate>
            <endDate>2025-08-30</endDate>
        </period>
    </context>
    <context id="From2025-08-302025-08-30_custom_MayTwentyThirtyTwoThousandAndTwentyFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">SMX:MayTwentyThirtyTwoThousandAndTwentyFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-30</startDate>
            <endDate>2025-08-30</endDate>
        </period>
    </context>
    <context id="From2025-08-302025-08-30_custom_JuneTwentyThirtyTwoThousandAndTwentyFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">SMX:JuneTwentyThirtyTwoThousandAndTwentyFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-30</startDate>
            <endDate>2025-08-30</endDate>
        </period>
    </context>
    <context id="From2025-03-282025-03-28_custom_OneThousandAndEightHundredDiagonalLendingLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">SMX:OneThousandAndEightHundredDiagonalLendingLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-28</startDate>
            <endDate>2025-03-28</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_OneThousandAndEightHundredDiagonalLendingLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">SMX:OneThousandAndEightHundredDiagonalLendingLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_OneThousandAndEightHundredDiagonalLendingLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">SMX:OneThousandAndEightHundredDiagonalLendingLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_OneThousandAndEightHundredDiagonalLendingLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">SMX:OneThousandAndEightHundredDiagonalLendingLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_OneThousandAndEightHundredDiagonalLendingLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">SMX:OneThousandAndEightHundredDiagonalLendingLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-03-282025-03-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
        </entity>
        <period>
            <startDate>2025-03-28</startDate>
            <endDate>2025-03-28</endDate>
        </period>
    </context>
    <context id="AsOf2025-03-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
        </entity>
        <period>
            <instant>2025-03-28</instant>
        </period>
    </context>
    <context id="From2025-03-282025-03-28_custom_ConversionOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:ConversionOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-28</startDate>
            <endDate>2025-03-28</endDate>
        </period>
    </context>
    <context id="From2022-05-012022-05-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-05-09_custom_RBWMayAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWMayAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-09</instant>
        </period>
    </context>
    <context id="From2025-05-092025-05-09_custom_RBWMayAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWMayAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-09</startDate>
            <endDate>2025-05-09</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_RBWMayAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWMayAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-05-23_custom_RBWMayAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWMayAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-23</instant>
        </period>
    </context>
    <context id="From2025-05-232025-05-23_custom_RBWMayAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWMayAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-23</startDate>
            <endDate>2025-05-23</endDate>
        </period>
    </context>
    <context id="AsOf2025-05-27_custom_RBWMayAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWMayAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-27</instant>
        </period>
    </context>
    <context id="From2025-05-272025-05-27_custom_RBWMayAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWMayAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-27</startDate>
            <endDate>2025-05-27</endDate>
        </period>
    </context>
    <context id="AsOf2025-07-03_custom_RBWMayAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWMayAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-03</instant>
        </period>
    </context>
    <context id="From2025-07-032025-07-03_custom_RBWMayAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWMayAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-03</startDate>
            <endDate>2025-07-03</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_OrdinarySharesMember_custom_RBWMayAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWMayAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-08-01_custom_RBWAugustAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWAugustAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-08-01</instant>
        </period>
    </context>
    <context id="From2025-08-012025-08-01_custom_RBWAugustAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWAugustAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-01</startDate>
            <endDate>2025-08-01</endDate>
        </period>
    </context>
    <context id="From2025-08-012025-08-01_custom_ConvertibleLoanTrancheOneMember_custom_RBWAugustAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ConvertibleLoanTrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWAugustAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-01</startDate>
            <endDate>2025-08-01</endDate>
        </period>
    </context>
    <context id="From2025-08-012025-08-01_custom_ConvertibleLoanTrancheTwoMember_custom_RBWAugustAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ConvertibleLoanTrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWAugustAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-01</startDate>
            <endDate>2025-08-01</endDate>
        </period>
    </context>
    <context id="From2025-08-012025-08-01_custom_ConvertibleLoanTrancheThreeMember_custom_RBWAugustAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ConvertibleLoanTrancheThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWAugustAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-01</startDate>
            <endDate>2025-08-01</endDate>
        </period>
    </context>
    <context id="From2025-08-012025-08-01_custom_ConvertibleLoanTrancheFourMember_custom_RBWAugustAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ConvertibleLoanTrancheFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWAugustAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-01</startDate>
            <endDate>2025-08-01</endDate>
        </period>
    </context>
    <context id="From2025-08-012025-08-01_custom_ConvertibleLoanTrancheFiveMember_custom_RBWAugustAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ConvertibleLoanTrancheFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWAugustAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-01</startDate>
            <endDate>2025-08-01</endDate>
        </period>
    </context>
    <context id="AsOf2025-08-27_custom_RBWAugustAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWAugustAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-08-27</instant>
        </period>
    </context>
    <context id="From2025-08-272025-08-27_custom_RBWAugustAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWAugustAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-27</startDate>
            <endDate>2025-08-27</endDate>
        </period>
    </context>
    <context id="AsOf2025-09-12_custom_RBWAugustAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWAugustAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-12</instant>
        </period>
    </context>
    <context id="From2025-09-122025-09-12_custom_RBWAugustAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWAugustAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-12</startDate>
            <endDate>2025-09-12</endDate>
        </period>
    </context>
    <context id="AsOf2025-09-17_custom_RBWAugustAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWAugustAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-17</instant>
        </period>
    </context>
    <context id="From2025-09-172025-09-17_custom_RBWAugustAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWAugustAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-17</startDate>
            <endDate>2025-09-17</endDate>
        </period>
    </context>
    <context id="AsOf2025-10-02_custom_RBWAugustAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWAugustAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-10-02</instant>
        </period>
    </context>
    <context id="From2025-10-022025-10-02_custom_RBWAugustAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWAugustAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-02</startDate>
            <endDate>2025-10-02</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_OrdinarySharesMember_custom_RBWAugustAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWAugustAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_RBWMayAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWMayAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-01_custom_RBWDecemberAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWDecemberAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-01</instant>
        </period>
    </context>
    <context id="From2025-05-092025-05-09_custom_RBWDecemberAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWDecemberAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-09</startDate>
            <endDate>2025-05-09</endDate>
        </period>
    </context>
    <context id="From2025-12-012025-12-01_custom_RBWDecemberAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWDecemberAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-01</startDate>
            <endDate>2025-12-01</endDate>
        </period>
    </context>
    <context id="From2025-12-012025-12-01_custom_ConvertibleLoanTrancheMember_custom_RBWDecemberAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ConvertibleLoanTrancheMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWDecemberAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-01</startDate>
            <endDate>2025-12-01</endDate>
        </period>
    </context>
    <context id="From2025-12-032025-12-03_custom_ConvertibleLoanTrancheOneMember_custom_RBWDecemberAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ConvertibleLoanTrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWDecemberAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-03</startDate>
            <endDate>2025-12-03</endDate>
        </period>
    </context>
    <context id="From2025-12-292025-12-29_custom_ConvertibleLoanTrancheTwoMember_custom_RBWDecemberAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ConvertibleLoanTrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWDecemberAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-29</startDate>
            <endDate>2025-12-29</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-03_custom_RBWDecemberAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWDecemberAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-03</instant>
        </period>
    </context>
    <context id="From2025-12-032025-12-03_custom_RBWDecemberAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWDecemberAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-03</startDate>
            <endDate>2025-12-03</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-29_custom_RBWDecemberAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWDecemberAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-29</instant>
        </period>
    </context>
    <context id="From2025-12-292025-12-29_custom_RBWDecemberAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWDecemberAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-29</startDate>
            <endDate>2025-12-29</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_OrdinarySharesMember_custom_RBWDecemberAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWDecemberAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_RBWDecemberAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWDecemberAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_RBWDecemberAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWDecemberAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2022-08-012023-01-31_custom_BridgeLoanAgreementsMember_custom_ElevenLendersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:ElevenLendersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:BridgeLoanAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="From2022-08-012023-01-31_ifrs-full_TopOfRangeMember_custom_BridgeLoanAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:BridgeLoanAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-01-31_custom_BridgeLoanAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:BridgeLoanAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_BridgeLoanAgreementsMember_custom_BonusWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">SMX:BonusWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:BridgeLoanAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_BridgeLoanAgreementsMember_custom_BonusWarrantsMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">SMX:BonusWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:BridgeLoanAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">SMX:RedeemableWarrantsTypeOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:BridgeLoanAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeOneMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">SMX:RedeemableWarrantsTypeOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:BridgeLoanAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">SMX:RedeemableWarrantsTypeOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:BridgeLoanAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeOneMember_custom_ThirdAnniversaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">SMX:RedeemableWarrantsTypeOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">SMX:ThirdAnniversaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:BridgeLoanAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeOneMember_custom_ThirdAnniversaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">SMX:RedeemableWarrantsTypeOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">SMX:ThirdAnniversaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:BridgeLoanAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeOneMember_custom_ThirdAnniversaryMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">SMX:RedeemableWarrantsTypeOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">SMX:ThirdAnniversaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:BridgeLoanAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeOneMember_custom_FourthAnniversaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">SMX:RedeemableWarrantsTypeOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">SMX:FourthAnniversaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:BridgeLoanAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeOneMember_custom_FourthAnniversaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">SMX:RedeemableWarrantsTypeOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">SMX:FourthAnniversaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:BridgeLoanAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeOneMember_custom_FourthAnniversaryMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">SMX:RedeemableWarrantsTypeOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">SMX:FourthAnniversaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:BridgeLoanAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">SMX:RedeemableWarrantsTypeTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:BridgeLoanAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeTwoMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">SMX:RedeemableWarrantsTypeTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:BridgeLoanAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">SMX:RedeemableWarrantsTypeTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:BridgeLoanAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeTwoMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">SMX:RedeemableWarrantsTypeTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:BridgeLoanAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeTwoMember_custom_FirstAnniversaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">SMX:RedeemableWarrantsTypeTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">SMX:FirstAnniversaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:BridgeLoanAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeTwoMember_custom_FirstAnniversaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">SMX:RedeemableWarrantsTypeTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">SMX:FirstAnniversaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:BridgeLoanAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeTwoMember_custom_FirstAnniversaryMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">SMX:RedeemableWarrantsTypeTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">SMX:FirstAnniversaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:BridgeLoanAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeTwoMember_custom_SecondAnniversaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">SMX:RedeemableWarrantsTypeTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">SMX:SecondAnniversaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:BridgeLoanAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeTwoMember_custom_SecondAnniversaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">SMX:RedeemableWarrantsTypeTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">SMX:SecondAnniversaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:BridgeLoanAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeTwoMember_custom_SecondAnniversaryMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">SMX:RedeemableWarrantsTypeTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">SMX:SecondAnniversaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:BridgeLoanAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2023-12-312023-12-31_custom_BridgeLoanAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:BridgeLoanAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_BridgeLoanAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:BridgeLoanAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-12-312024-12-31_custom_BridgeLoanAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:BridgeLoanAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-31</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_BridgeLoanAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:BridgeLoanAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-06-272024-06-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
        </entity>
        <period>
            <startDate>2024-06-27</startDate>
            <endDate>2024-06-27</endDate>
        </period>
    </context>
    <context id="From2024-09-042024-09-04">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
        </entity>
        <period>
            <startDate>2024-09-04</startDate>
            <endDate>2024-09-04</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_InvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:InvestorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_InvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:InvestorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_BridgeLoanAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:BridgeLoanAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeOneMember_custom_MonteCarloSimulationModelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">SMX:RedeemableWarrantsTypeOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">SMX:MonteCarloSimulationModelMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:BridgeLoanAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeOneMember_custom_MonteCarloSimulationModelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">SMX:RedeemableWarrantsTypeOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">SMX:MonteCarloSimulationModelMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:BridgeLoanAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeTwoMember_custom_MonteCarloSimulationModelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">SMX:RedeemableWarrantsTypeTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">SMX:MonteCarloSimulationModelMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:BridgeLoanAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_ThreeValuationModelsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">SMX:ThreeValuationModelsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_ThreeValuationModelsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">SMX:ThreeValuationModelsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-04-192024-04-19_custom_StockPurchaseAgreementMember_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:StockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-19</startDate>
            <endDate>2024-04-19</endDate>
        </period>
    </context>
    <context id="AsOf2024-04-19_custom_StockPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:StockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-19</instant>
        </period>
    </context>
    <context id="AsOf2025-12-01_custom_StandbyEquityPurchaseAgreementMember_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-01</instant>
        </period>
    </context>
    <context id="From2025-12-012025-12-01_custom_StandbyEquityPurchaseAgreementMember_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-01</startDate>
            <endDate>2025-12-01</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-30_custom_StandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-30</instant>
        </period>
    </context>
    <context id="From2025-12-302025-12-30_custom_StandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-30</startDate>
            <endDate>2025-12-30</endDate>
        </period>
    </context>
    <context id="From2025-12-092025-12-09_custom_StandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-09</startDate>
            <endDate>2025-12-09</endDate>
        </period>
    </context>
    <context id="From2024-09-112024-09-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
        </entity>
        <period>
            <startDate>2024-09-11</startDate>
            <endDate>2024-09-11</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-11_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-11</instant>
        </period>
    </context>
    <context id="AsOf2024-09-11_ifrs-full_OrdinarySharesMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-11</instant>
        </period>
    </context>
    <context id="From2024-09-112024-09-11_custom_TwoSeriesACommonWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">SMX:TwoSeriesACommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-11</startDate>
            <endDate>2024-09-11</endDate>
        </period>
    </context>
    <context id="From2024-09-112024-09-11_custom_TwoSeriesACommonWarrantsMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">SMX:TwoSeriesACommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-11</startDate>
            <endDate>2024-09-11</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-11_custom_SeriesBCommonWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">SMX:SeriesBCommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-11</instant>
        </period>
    </context>
    <context id="AsOf2024-09-11_custom_SeriesBCommonWarrantsMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">SMX:SeriesBCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-11</instant>
        </period>
    </context>
    <context id="AsOf2024-09-11_custom_PreFundedUnitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:PreFundedUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-11</instant>
        </period>
    </context>
    <context id="AsOf2024-09-11_custom_PreFundedUnitMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:PreFundedUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-11</instant>
        </period>
    </context>
    <context id="From2024-09-112024-09-11_custom_PreFundedWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:PreFundedWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-11</startDate>
            <endDate>2024-09-11</endDate>
        </period>
    </context>
    <context id="From2024-09-112024-09-11_custom_PreFundedWarrantMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-11</startDate>
            <endDate>2024-09-11</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-11_custom_PreFundedWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:PreFundedWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-11</instant>
        </period>
    </context>
    <context id="AsOf2024-09-11_custom_PreFundedWarrantMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-11</instant>
        </period>
    </context>
    <context id="From2024-09-112024-09-11_custom_SeriesACommonWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">SMX:SeriesACommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-11</startDate>
            <endDate>2024-09-11</endDate>
        </period>
    </context>
    <context id="From2024-09-112024-09-11_custom_SeriesACommonWarrantsMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">SMX:SeriesACommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-11</startDate>
            <endDate>2024-09-11</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-11_custom_SeriesACommonWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">SMX:SeriesACommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-11</instant>
        </period>
    </context>
    <context id="AsOf2024-09-11_custom_SeriesACommonWarrantsMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">SMX:SeriesACommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-11</instant>
        </period>
    </context>
    <context id="From2024-09-112024-09-11_custom_SeriesBCommonWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">SMX:SeriesBCommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-11</startDate>
            <endDate>2024-09-11</endDate>
        </period>
    </context>
    <context id="From2024-09-112024-09-11_custom_SeriesBCommonWarrantsMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">SMX:SeriesBCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-11</startDate>
            <endDate>2024-09-11</endDate>
        </period>
    </context>
    <context id="From2024-10-282024-10-28_custom_SeriesACommonWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">SMX:SeriesACommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-28</startDate>
            <endDate>2024-10-28</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SeriesACommonWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">SMX:SeriesACommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SeriesACommonWarrantsMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">SMX:SeriesACommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SeriesACommonWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">SMX:SeriesACommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SeriesACommonWarrantsMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">SMX:SeriesACommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SeriesACommonWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">SMX:SeriesACommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_SeriesACommonWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">SMX:SeriesACommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_PlacementAgentAgreementtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:PlacementAgentAgreementtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-10-282024-10-28_custom_ThirdPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">SMX:ThirdPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-28</startDate>
            <endDate>2024-10-28</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_ThirdPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">SMX:ThirdPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_ThirdPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">SMX:ThirdPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-28_custom_LoanAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:LoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="From2024-12-282024-12-28_custom_LoanAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:LoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-28</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_LoanAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:LoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_LoanAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:LoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_custom_LoanAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:LoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_LoanAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:LoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_OfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_MotorVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_OfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_MotorVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_OfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_MotorVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_OfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_MotorVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_OfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_MotorVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_PreferenceSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:PreferenceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_DeferredSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">SMX:DeferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_NewDeferredSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">SMX:NewDeferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2026-02-172026-02-17_custom_NonadjustingEventsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">SMX:NonadjustingEventsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-17</startDate>
            <endDate>2026-02-17</endDate>
        </period>
    </context>
    <context id="From2026-05-112026-05-11_custom_NonadjustingEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">SMX:NonadjustingEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-11</startDate>
            <endDate>2026-05-11</endDate>
        </period>
    </context>
    <context id="From2026-06-012026-06-01_custom_NonadjustingEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">SMX:NonadjustingEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-06-01</startDate>
            <endDate>2026-06-01</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_PreferenceSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:PreferenceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_DeferredSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">SMX:DeferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_NewDeferredSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">SMX:NewDeferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-01-04_custom_ServiceProviderAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:ServiceProviderAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-04</instant>
        </period>
    </context>
    <context id="AsOf2024-01-04_custom_ServiceProviderAgreementsMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:ServiceProviderAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-04</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_ifrs-full_OrdinarySharesMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-21_ifrs-full_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-21</instant>
        </period>
    </context>
    <context id="AsOf2024-06-21_ifrs-full_WarrantsMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-21</instant>
        </period>
    </context>
    <context id="AsOf2024-06-21_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-21</instant>
        </period>
    </context>
    <context id="AsOf2024-06-21_ifrs-full_OrdinarySharesMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-21</instant>
        </period>
    </context>
    <context id="From2024-06-212024-06-21_ifrs-full_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-21</startDate>
            <endDate>2024-06-21</endDate>
        </period>
    </context>
    <context id="From2024-06-212024-06-21_ifrs-full_WarrantsMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-21</startDate>
            <endDate>2024-06-21</endDate>
        </period>
    </context>
    <context id="AsOf2024-02-01_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-01</instant>
        </period>
    </context>
    <context id="AsOf2024-02-01_ifrs-full_OrdinarySharesMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-01</instant>
        </period>
    </context>
    <context id="AsOf2024-02-20_custom_UnderwritingAgreementMember_custom_OrdinarySharesAndPrefundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">SMX:OrdinarySharesAndPrefundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-20</instant>
        </period>
    </context>
    <context id="AsOf2024-02-20_custom_UnderwritingAgreementMember_custom_OrdinarySharesAndPrefundedWarrantsMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">SMX:OrdinarySharesAndPrefundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-20</instant>
        </period>
    </context>
    <context id="From2024-02-202024-02-20_custom_UnderwritingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-20</startDate>
            <endDate>2024-02-20</endDate>
        </period>
    </context>
    <context id="From2024-02-202024-02-20_custom_UnderwritingAgreementMember_custom_PrefundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">SMX:PrefundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-20</startDate>
            <endDate>2024-02-20</endDate>
        </period>
    </context>
    <context id="From2024-02-202024-02-20_custom_AfterReverseStockSplitMember_custom_PrefundedWarrantsMember_custom_UnderwritingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">SMX:PrefundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-20</startDate>
            <endDate>2024-02-20</endDate>
        </period>
    </context>
    <context id="AsOf2024-02-20_custom_UnderwritingAgreementMember_custom_PrefundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">SMX:PrefundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-20</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_UnderwritingAgreementMember_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_UnderwritingAgreementMember_ifrs-full_OrdinarySharesMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_UnderwritingAgreementMember_custom_PrefundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">SMX:PrefundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_UnderwritingAgreementMember_custom_PrefundedWarrantsMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">SMX:PrefundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_UnderwritingAgreementMember_custom_PrefundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">SMX:PrefundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_AfterReverseStockSplitMember_custom_PrefundedWarrantsMember_custom_UnderwritingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">SMX:PrefundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-02-282024-02-28_custom_InvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:InvestorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-28</startDate>
            <endDate>2024-02-28</endDate>
        </period>
    </context>
    <context id="From2024-02-282024-02-28_custom_InvestorsMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:InvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-28</startDate>
            <endDate>2024-02-28</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_ConvertiblePromissoryNoteMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">SMX:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_InvestorsMember_custom_WarrantAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:InvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:WarrantAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_InvestorsMember_custom_WarrantAMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:InvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:WarrantAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-04-112024-04-11_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-11</startDate>
            <endDate>2024-04-11</endDate>
        </period>
    </context>
    <context id="From2024-04-112024-04-11_custom_SecuritiesPurchaseAgreementMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-11</startDate>
            <endDate>2024-04-11</endDate>
        </period>
    </context>
    <context id="From2024-04-112024-04-11_custom_SecuritiesPurchaseAgreementMember_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-11</startDate>
            <endDate>2024-04-11</endDate>
        </period>
    </context>
    <context id="From2024-04-112024-04-11_custom_SecuritiesPurchaseAgreementMember_ifrs-full_OrdinarySharesMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-11</startDate>
            <endDate>2024-04-11</endDate>
        </period>
    </context>
    <context id="From2023-09-062023-09-06_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-06</startDate>
            <endDate>2023-09-06</endDate>
        </period>
    </context>
    <context id="From2023-09-062023-09-06_custom_SecuritiesPurchaseAgreementMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-06</startDate>
            <endDate>2023-09-06</endDate>
        </period>
    </context>
    <context id="From2023-09-062023-09-06_custom_SecuritiesPurchaseAgreementMember_ifrs-full_BottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-06</startDate>
            <endDate>2023-09-06</endDate>
        </period>
    </context>
    <context id="From2023-09-062023-09-06_custom_SecuritiesPurchaseAgreementMember_ifrs-full_BottomOfRangeMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-06</startDate>
            <endDate>2023-09-06</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_OrdinarySharesMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_WarrantsMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_OrdinarySharesMember18019968">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_OrdinarySharesMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-04-30_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="AsOf2024-04-30_ifrs-full_OrdinarySharesMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="AsOf2024-04-24_custom_InvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:InvestorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-24</instant>
        </period>
    </context>
    <context id="AsOf2024-04-24_custom_InvestorsMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:InvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-24</instant>
        </period>
    </context>
    <context id="AsOf2025-04-24_custom_InvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:InvestorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-24</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_OrdinarySharesMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-27_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-27</instant>
        </period>
    </context>
    <context id="AsOf2024-06-27_ifrs-full_OrdinarySharesMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-27</instant>
        </period>
    </context>
    <context id="From2024-06-272024-06-27_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-27</startDate>
            <endDate>2024-06-27</endDate>
        </period>
    </context>
    <context id="AsOf2024-07-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
        </entity>
        <period>
            <instant>2024-07-10</instant>
        </period>
    </context>
    <context id="From2024-07-102024-07-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
        </entity>
        <period>
            <startDate>2024-07-10</startDate>
            <endDate>2024-07-10</endDate>
        </period>
    </context>
    <context id="From2024-07-102024-07-10_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-10</startDate>
            <endDate>2024-07-10</endDate>
        </period>
    </context>
    <context id="AsOf2024-07-10_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-10</instant>
        </period>
    </context>
    <context id="From2024-07-192024-07-19_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-19</startDate>
            <endDate>2024-07-19</endDate>
        </period>
    </context>
    <context id="From2024-07-192024-07-19_custom_SecuritiesPurchaseAgreementMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-19</startDate>
            <endDate>2024-07-19</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SecuritiesPurchaseAgreementMember_ifrs-full_WarrantsMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-09-11_custom_InvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:InvestorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-11</instant>
        </period>
    </context>
    <context id="AsOf2024-09-11_custom_InvestorsMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:InvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-11</instant>
        </period>
    </context>
    <context id="AsOf2024-09-11_custom_InvestorsMember_custom_PreFundedWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:InvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">SMX:PreFundedWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-11</instant>
        </period>
    </context>
    <context id="AsOf2024-09-11_custom_InvestorsMember_custom_PreFundedWarrantMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:InvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">SMX:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-11</instant>
        </period>
    </context>
    <context id="AsOf2024-09-11_custom_InvestorsMember_custom_SeriesACommonWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:InvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:SeriesACommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-11</instant>
        </period>
    </context>
    <context id="AsOf2024-09-11_custom_InvestorsMember_custom_SeriesACommonWarrantsMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:InvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:SeriesACommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-11</instant>
        </period>
    </context>
    <context id="AsOf2024-10-28_custom_InvestorsMember_custom_SeriesBCommonWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:InvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:SeriesBCommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-28</instant>
        </period>
    </context>
    <context id="AsOf2024-10-28_custom_InvestorsMember_custom_SeriesBCommonWarrantsMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:InvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:SeriesBCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-28</instant>
        </period>
    </context>
    <context id="AsOf2024-10-28_custom_InvestorsMember_custom_SeriesACommonWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:InvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:SeriesACommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-28</instant>
        </period>
    </context>
    <context id="AsOf2024-10-28_custom_InvestorsMember_custom_SeriesACommonWarrantsMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:InvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:SeriesACommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-28</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SeriesACommonWarrantsMember18020578">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:SeriesACommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SeriesACommonWarrantsMember_custom_AfterReverseStockSplitMember18020593">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:SeriesACommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_SeriesACommonWarrantsMember18020812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:SeriesACommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_SeriesACommonWarrantsMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">SMX:SeriesACommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
        </entity>
        <period>
            <instant>2024-09-16</instant>
        </period>
    </context>
    <context id="AsOf2024-09-16_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-16</instant>
        </period>
    </context>
    <context id="From2024-09-012024-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
        </entity>
        <period>
            <startDate>2024-09-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-09-012024-09-30_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_OrdinarySharesMember_custom_AlphaAprilNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">SMX:AlphaAprilNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_OrdinarySharesMember_custom_AlphaJulyNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">SMX:AlphaJulyNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_OrdinarySharesMember18020906">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_OrdinarySharesMember_custom_InvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:InvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_OrdinarySharesMember_custom_InvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:InvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_WarrantsMember_custom_UnderwritersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:UnderwritersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_WarrantsMember_custom_UnderwritersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:UnderwritersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_OrdinarySharesMember_custom_PromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">SMX:PromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_OrdinarySharesMember_custom_PromissoryNotesMember_custom_RBWAugustAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">SMX:PromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWAugustAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_OrdinarySharesMember_custom_PromissoryNotesMember_custom_RBWDecemberAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">SMX:PromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RBWDecemberAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_OrdinarySharesMember_custom_TargetSEPAAgreementMember_custom_InvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:InvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:TargetSEPAAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_OrdinarySharesMember_custom_TargetSEPAAgreementMember_custom_InvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:InvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:TargetSEPAAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SettlementAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SettlementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_OrdinarySharesMember_custom_SettlementAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SettlementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_OrdinarySharesMember_custom_SettlementAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:SettlementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-312024-01-31_custom_EmployeesDirectorsAndServiceProvidersMember_ifrs-full_RestrictedShareUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:EmployeesDirectorsAndServiceProvidersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-31</startDate>
            <endDate>2024-01-31</endDate>
        </period>
    </context>
    <context id="From2024-01-312024-01-31_custom_EmployeesDirectorsAndServiceProvidersMember_ifrs-full_RestrictedShareUnitsMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:EmployeesDirectorsAndServiceProvidersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-31</startDate>
            <endDate>2024-01-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_EmployeesDirectorsAndServiceProvidersMember_ifrs-full_RestrictedShareUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:EmployeesDirectorsAndServiceProvidersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-07-212024-07-21_custom_AdvisorMember_ifrs-full_RestrictedShareUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:AdvisorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-21</startDate>
            <endDate>2024-07-21</endDate>
        </period>
    </context>
    <context id="From2024-07-212024-07-21_custom_AdvisorMember_ifrs-full_RestrictedShareUnitsMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:AdvisorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-21</startDate>
            <endDate>2024-07-21</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_AdvisorMember_ifrs-full_RestrictedShareUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:AdvisorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-08-29_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:TwoThousandTwentyTwoIncentiveEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-29</instant>
        </period>
    </context>
    <context id="AsOf2024-08-29_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:TwoThousandTwentyTwoIncentiveEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-29</instant>
        </period>
    </context>
    <context id="From2024-08-292024-08-29_custom_EmployeesExecutiveOfficersAndDirectorsMember_ifrs-full_RestrictedShareUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:EmployeesExecutiveOfficersAndDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-29</startDate>
            <endDate>2024-08-29</endDate>
        </period>
    </context>
    <context id="From2024-08-292024-08-29_custom_EmployeesExecutiveOfficersAndDirectorsMember_ifrs-full_RestrictedShareUnitsMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:EmployeesExecutiveOfficersAndDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-29</startDate>
            <endDate>2024-08-29</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_EmployeesAndServiceProvidersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:EmployeesAndServiceProvidersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_EmployeesAndServiceProvidersMember_custom_AfterReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:EmployeesAndServiceProvidersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReservesWithinEquityAxis">SMX:AfterReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_BlackScholesPricingModelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">SMX:BlackScholesPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_RestrictedShareUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-02-24_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:TwoThousandTwentyTwoIncentiveEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-24</instant>
        </period>
    </context>
    <context id="From2025-02-242025-02-24_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_ExecutiveOfficersAndDirectorsCertainConsultantsAndAdvisorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:ExecutiveOfficersAndDirectorsCertainConsultantsAndAdvisorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:TwoThousandTwentyTwoIncentiveEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-24</startDate>
            <endDate>2025-02-24</endDate>
        </period>
    </context>
    <context id="From2025-02-242025-02-24_custom_DirectorsCertainConsultantsAndAdvisorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:DirectorsCertainConsultantsAndAdvisorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-24</startDate>
            <endDate>2025-02-24</endDate>
        </period>
    </context>
    <context id="From2025-02-242025-02-24_custom_BlackScholesPricingModelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">SMX:BlackScholesPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-24</startDate>
            <endDate>2025-02-24</endDate>
        </period>
    </context>
    <context id="AsOf2025-03-17_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:TwoThousandTwentyTwoIncentiveEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-17</instant>
        </period>
    </context>
    <context id="From2025-03-172025-03-17_custom_CertainConsultantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:CertainConsultantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-17</startDate>
            <endDate>2025-03-17</endDate>
        </period>
    </context>
    <context id="From2025-03-172025-03-17_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_DirectorsCertainConsultantsAndAdvisorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:DirectorsCertainConsultantsAndAdvisorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:TwoThousandTwentyTwoIncentiveEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-17</startDate>
            <endDate>2025-03-17</endDate>
        </period>
    </context>
    <context id="From2025-03-172025-03-17_custom_BlackScholesPricingModelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">SMX:BlackScholesPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-17</startDate>
            <endDate>2025-03-17</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-17_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:TwoThousandTwentyTwoIncentiveEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-17</instant>
        </period>
    </context>
    <context id="From2025-06-172025-06-17_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_ExecutiveOfficersAndDirectorsCertainConsultantsAndAdvisorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:ExecutiveOfficersAndDirectorsCertainConsultantsAndAdvisorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:TwoThousandTwentyTwoIncentiveEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-17</startDate>
            <endDate>2025-06-17</endDate>
        </period>
    </context>
    <context id="From2025-06-172025-06-17_custom_DirectorsCertainConsultantsAndAdvisorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:DirectorsCertainConsultantsAndAdvisorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-17</startDate>
            <endDate>2025-06-17</endDate>
        </period>
    </context>
    <context id="From2025-06-172025-06-17_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_DirectorsCertainConsultantsAndAdvisorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:DirectorsCertainConsultantsAndAdvisorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:TwoThousandTwentyTwoIncentiveEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-17</startDate>
            <endDate>2025-06-17</endDate>
        </period>
    </context>
    <context id="From2025-06-172025-06-17_custom_BlackScholesPricingModelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">SMX:BlackScholesPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-17</startDate>
            <endDate>2025-06-17</endDate>
        </period>
    </context>
    <context id="AsOf2025-07-03_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:TwoThousandTwentyTwoIncentiveEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-03</instant>
        </period>
    </context>
    <context id="From2025-07-032025-07-03_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_ExecutiveOfficersAndDirectorsCertainConsultantsAndAdvisorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:ExecutiveOfficersAndDirectorsCertainConsultantsAndAdvisorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:TwoThousandTwentyTwoIncentiveEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-03</startDate>
            <endDate>2025-07-03</endDate>
        </period>
    </context>
    <context id="From2025-07-032025-07-03_custom_DirectorsCertainConsultantsAndAdvisorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:DirectorsCertainConsultantsAndAdvisorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-03</startDate>
            <endDate>2025-07-03</endDate>
        </period>
    </context>
    <context id="From2025-07-032025-07-03_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_DirectorsCertainConsultantsAndAdvisorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:DirectorsCertainConsultantsAndAdvisorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:TwoThousandTwentyTwoIncentiveEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-03</startDate>
            <endDate>2025-07-03</endDate>
        </period>
    </context>
    <context id="From2025-07-032025-07-03_custom_BlackScholesPricingModelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">SMX:BlackScholesPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-03</startDate>
            <endDate>2025-07-03</endDate>
        </period>
    </context>
    <context id="AsOf2025-08-26_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:TwoThousandTwentyTwoIncentiveEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-08-26</instant>
        </period>
    </context>
    <context id="From2025-08-262025-08-26_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_ExecutiveOfficersAndDirectorsCertainConsultantsAndAdvisorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:ExecutiveOfficersAndDirectorsCertainConsultantsAndAdvisorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:TwoThousandTwentyTwoIncentiveEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-26</startDate>
            <endDate>2025-08-26</endDate>
        </period>
    </context>
    <context id="From2025-08-262025-08-26_custom_DirectorsCertainConsultantsAndAdvisorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:DirectorsCertainConsultantsAndAdvisorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-26</startDate>
            <endDate>2025-08-26</endDate>
        </period>
    </context>
    <context id="From2025-08-262025-08-26_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_DirectorsCertainConsultantsAndAdvisorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:DirectorsCertainConsultantsAndAdvisorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:TwoThousandTwentyTwoIncentiveEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-26</startDate>
            <endDate>2025-08-26</endDate>
        </period>
    </context>
    <context id="From2025-08-262025-08-26_custom_BlackScholesPricingModelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">SMX:BlackScholesPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-26</startDate>
            <endDate>2025-08-26</endDate>
        </period>
    </context>
    <context id="AsOf2025-09-04_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:TwoThousandTwentyTwoIncentiveEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-04</instant>
        </period>
    </context>
    <context id="From2025-09-042025-09-04_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_ExecutiveOfficersAndDirectorsCertainConsultantsAndAdvisorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:ExecutiveOfficersAndDirectorsCertainConsultantsAndAdvisorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:TwoThousandTwentyTwoIncentiveEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-04</startDate>
            <endDate>2025-09-04</endDate>
        </period>
    </context>
    <context id="From2025-09-042025-09-04_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_DirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:TwoThousandTwentyTwoIncentiveEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-04</startDate>
            <endDate>2025-09-04</endDate>
        </period>
    </context>
    <context id="From2025-09-042025-09-04_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_ExecutiveOfficersAndDirectorsCertainConsultantsEmployeesAndAdvisorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:ExecutiveOfficersAndDirectorsCertainConsultantsEmployeesAndAdvisorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:TwoThousandTwentyTwoIncentiveEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-04</startDate>
            <endDate>2025-09-04</endDate>
        </period>
    </context>
    <context id="From2025-09-042025-09-04_custom_BlackScholesPricingModelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">SMX:BlackScholesPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-04</startDate>
            <endDate>2025-09-04</endDate>
        </period>
    </context>
    <context id="AsOf2025-10-29_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:TwoThousandTwentyTwoIncentiveEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-10-29</instant>
        </period>
    </context>
    <context id="From2025-10-292025-10-29_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_ExecutiveOfficersAndDirectorsCertainConsultantsEmployeesAndAdvisorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:ExecutiveOfficersAndDirectorsCertainConsultantsEmployeesAndAdvisorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:TwoThousandTwentyTwoIncentiveEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-29</startDate>
            <endDate>2025-10-29</endDate>
        </period>
    </context>
    <context id="From2025-10-292025-10-29_custom_DirectorsCertainConsultantsAndAdvisorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:DirectorsCertainConsultantsAndAdvisorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-29</startDate>
            <endDate>2025-10-29</endDate>
        </period>
    </context>
    <context id="From2025-10-292025-10-29_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_DirectorsCertainConsultantsAndAdvisorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:DirectorsCertainConsultantsAndAdvisorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:TwoThousandTwentyTwoIncentiveEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-29</startDate>
            <endDate>2025-10-29</endDate>
        </period>
    </context>
    <context id="From2025-10-292025-10-29_custom_BlackScholesPricingModelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">SMX:BlackScholesPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-29</startDate>
            <endDate>2025-10-29</endDate>
        </period>
    </context>
    <context id="AsOf2025-11-21_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:TwoThousandTwentyTwoIncentiveEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-11-21</instant>
        </period>
    </context>
    <context id="From2025-11-212025-11-21_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_ExecutiveOfficersAndDirectorsCertainConsultantsEmployeesAndAdvisorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:ExecutiveOfficersAndDirectorsCertainConsultantsEmployeesAndAdvisorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:TwoThousandTwentyTwoIncentiveEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-21</startDate>
            <endDate>2025-11-21</endDate>
        </period>
    </context>
    <context id="From2025-11-212025-11-21_custom_DirectorsCertainConsultantsAndAdvisorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:DirectorsCertainConsultantsAndAdvisorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-21</startDate>
            <endDate>2025-11-21</endDate>
        </period>
    </context>
    <context id="From2025-11-212025-11-21_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_DirectorsCertainConsultantsAndAdvisorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:DirectorsCertainConsultantsAndAdvisorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:TwoThousandTwentyTwoIncentiveEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-21</startDate>
            <endDate>2025-11-21</endDate>
        </period>
    </context>
    <context id="From2025-11-212025-11-21_custom_BlackScholesPricingModelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">SMX:BlackScholesPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-21</startDate>
            <endDate>2025-11-21</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_RestrictedShareUnitsMember_custom_EmployeesDirectorsAndServiceProvidersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:EmployeesDirectorsAndServiceProvidersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_RestrictedShareUnitsMember_custom_EmployeesDirectorsAndServiceProvidersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:EmployeesDirectorsAndServiceProvidersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_RestrictedShareUnitsMember_custom_EmployeesDirectorsAndServiceProvidersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:EmployeesDirectorsAndServiceProvidersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_RestrictedShareUnitsMember_custom_EmployeesDirectorsAndServiceProvidersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:EmployeesDirectorsAndServiceProvidersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_GeneralAndAdministrativeExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">SMX:GeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_GeneralAndAdministrativeExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">SMX:GeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_GeneralAndAdministrativeExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">SMX:GeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_ResearchAndDevelopmentExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">SMX:ResearchAndDevelopmentExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_ResearchAndDevelopmentExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">SMX:ResearchAndDevelopmentExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ResearchAndDevelopmentExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">SMX:ResearchAndDevelopmentExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SellingAndMarketingExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">SMX:SellingAndMarketingExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_SellingAndMarketingExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">SMX:SellingAndMarketingExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_SellingAndMarketingExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">SMX:SellingAndMarketingExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2026-02-172026-02-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
        </entity>
        <period>
            <startDate>2026-02-17</startDate>
            <endDate>2026-02-17</endDate>
        </period>
    </context>
    <context id="From2026-05-112026-05-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
        </entity>
        <period>
            <startDate>2026-05-11</startDate>
            <endDate>2026-05-11</endDate>
        </period>
    </context>
    <context id="From2026-06-012026-06-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
        </entity>
        <period>
            <startDate>2026-06-01</startDate>
            <endDate>2026-06-01</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_DirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:DirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_DirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">SMX:DirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_JointVenturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_JointVenturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_RelatedPartiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_RelatedPartiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2015-01-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
        </entity>
        <period>
            <instant>2015-01-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-01-31_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-01-31_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="AsOf2023-01-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-01-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_TechnologyLicenseIntellectualPropertyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">SMX:TechnologyLicenseIntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_TechnologyLicenseIntellectualPropertyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">SMX:TechnologyLicenseIntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-01-12_custom_RAndITradingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">SMX:RAndITradingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-12</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_CreditRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_CreditRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_ShortTermLoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ShortTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_ShortTermLoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ShortTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_ConvertibleFeaturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ConvertibleFeaturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_ConvertibleFeaturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ConvertibleFeaturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_BridgeLoansMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:BridgeLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_BridgeLoansMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:BridgeLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_TradeAndOtherPayablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:TradeAndOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_TradeAndOtherPayablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:TradeAndOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_GovernmentGrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:GovernmentGrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_GovernmentGrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:GovernmentGrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_NotLaterThanOneYearMember_custom_TradeAndOtherPayablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_TradeAndOtherPayablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_custom_TradeAndOtherPayablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_custom_TradeAndOtherPayablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_custom_TradeAndOtherPayablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanFiveYearsMember_custom_TradeAndOtherPayablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_NotLaterThanOneYearMember_custom_ShortTermLoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ShortTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_ShortTermLoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ShortTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_custom_ShortTermLoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ShortTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_custom_ShortTermLoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ShortTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_custom_ShortTermLoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ShortTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanFiveYearsMember_custom_ShortTermLoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ShortTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_NotLaterThanOneYearMember_custom_BridgeLoansMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:BridgeLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_BridgeLoansMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:BridgeLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_custom_BridgeLoansMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:BridgeLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_custom_BridgeLoansMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:BridgeLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_custom_BridgeLoansMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:BridgeLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanFiveYearsMember_custom_BridgeLoansMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:BridgeLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_NotLaterThanOneYearMember_custom_GovernmentGrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:GovernmentGrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_GovernmentGrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:GovernmentGrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_custom_GovernmentGrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:GovernmentGrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_custom_GovernmentGrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:GovernmentGrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_custom_GovernmentGrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:GovernmentGrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanFiveYearsMember_custom_GovernmentGrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:GovernmentGrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_NotLaterThanOneYearMember_ifrs-full_LeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_ifrs-full_LeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_ifrs-full_LeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_ifrs-full_LeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_ifrs-full_LeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_NotLaterThanOneYearMember_custom_ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_custom_ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_custom_ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_custom_ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanFiveYearsMember_custom_ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_NotLaterThanOneYearMember_custom_FinancialDerivativesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:FinancialDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_FinancialDerivativesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:FinancialDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_custom_FinancialDerivativesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:FinancialDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_custom_FinancialDerivativesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:FinancialDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_custom_FinancialDerivativesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:FinancialDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanFiveYearsMember_custom_FinancialDerivativesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:FinancialDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_FinancialDerivativesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:FinancialDerivativesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_NotLaterThanOneYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_NotLaterThanOneYearMember_custom_TradeAndOtherPayablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_TradeAndOtherPayablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_custom_TradeAndOtherPayablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_custom_TradeAndOtherPayablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_custom_TradeAndOtherPayablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanFiveYearsMember_custom_TradeAndOtherPayablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_NotLaterThanOneYearMember_custom_ShortTermLoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ShortTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_ShortTermLoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ShortTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_custom_ShortTermLoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ShortTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_custom_ShortTermLoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ShortTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_custom_ShortTermLoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ShortTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanFiveYearsMember_custom_ShortTermLoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ShortTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_NotLaterThanOneYearMember_custom_BridgeLoansMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:BridgeLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_BridgeLoansMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:BridgeLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_custom_BridgeLoansMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:BridgeLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_custom_BridgeLoansMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:BridgeLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_custom_BridgeLoansMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:BridgeLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanFiveYearsMember_custom_BridgeLoansMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:BridgeLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_NotLaterThanOneYearMember_custom_GovernmentGrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:GovernmentGrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_GovernmentGrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:GovernmentGrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_custom_GovernmentGrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:GovernmentGrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_custom_GovernmentGrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:GovernmentGrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_custom_GovernmentGrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:GovernmentGrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanFiveYearsMember_custom_GovernmentGrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:GovernmentGrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_NotLaterThanOneYearMember_ifrs-full_LeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_ifrs-full_LeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_ifrs-full_LeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_ifrs-full_LeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_ifrs-full_LeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_NotLaterThanOneYearMember_custom_ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_custom_ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_custom_ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_custom_ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanFiveYearsMember_custom_ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_NotLaterThanOneYearMember_custom_FinancialDerivativesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:FinancialDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_FinancialDerivativesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:FinancialDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_custom_FinancialDerivativesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:FinancialDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_custom_FinancialDerivativesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:FinancialDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_custom_FinancialDerivativesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:FinancialDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanFiveYearsMember_custom_FinancialDerivativesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:FinancialDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_FinancialDerivativesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">SMX:FinancialDerivativesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_NotLaterThanOneYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_Level1OfFairValueHierarchyMember_ifrs-full_DerivativesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">ifrs-full:DerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_Level2OfFairValueHierarchyMember_ifrs-full_DerivativesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">ifrs-full:DerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_ifrs-full_DerivativesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">ifrs-full:DerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_DerivativesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">ifrs-full:DerivativesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_Level1OfFairValueHierarchyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_Level2OfFairValueHierarchyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_Level3OfFairValueHierarchyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_Level1OfFairValueHierarchyMember_ifrs-full_DerivativesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">ifrs-full:DerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_Level2OfFairValueHierarchyMember_ifrs-full_DerivativesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">ifrs-full:DerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_ifrs-full_DerivativesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">ifrs-full:DerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_DerivativesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">ifrs-full:DerivativesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_Level1OfFairValueHierarchyMember_ifrs-full_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_Level2OfFairValueHierarchyMember_ifrs-full_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_ifrs-full_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_WarrantsMember18031281">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_Level1OfFairValueHierarchyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_Level2OfFairValueHierarchyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_Level3OfFairValueHierarchyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2026-02-052026-02-05_custom_NonadjustingEventMember_ifrs-full_BottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">SMX:NonadjustingEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-05</startDate>
            <endDate>2026-02-05</endDate>
        </period>
    </context>
    <context id="From2026-02-052026-02-05_custom_NonadjustingEventMember_ifrs-full_TopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">SMX:NonadjustingEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-05</startDate>
            <endDate>2026-02-05</endDate>
        </period>
    </context>
    <context id="From2025-12-092025-12-09">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
        </entity>
        <period>
            <startDate>2025-12-09</startDate>
            <endDate>2025-12-09</endDate>
        </period>
    </context>
    <context id="AsOf2026-02-05_custom_NonadjustingEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">SMX:NonadjustingEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-05</instant>
        </period>
    </context>
    <context id="From2026-02-052026-02-05_custom_NonadjustingEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">SMX:NonadjustingEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-05</startDate>
            <endDate>2026-02-05</endDate>
        </period>
    </context>
    <context id="AsOf2026-02-17_custom_NonadjustingEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">SMX:NonadjustingEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-17</instant>
        </period>
    </context>
    <context id="AsOf2026-02-16_custom_NonadjustingEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">SMX:NonadjustingEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-16</instant>
        </period>
    </context>
    <context id="AsOf2026-02-17_custom_NonadjustingEventMember_ifrs-full_BottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">SMX:NonadjustingEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-17</instant>
        </period>
    </context>
    <context id="AsOf2026-02-17_custom_NonadjustingEventMember_ifrs-full_TopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">SMX:NonadjustingEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-17</instant>
        </period>
    </context>
    <context id="AsOf2026-01-30_custom_NonadjustingEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">SMX:NonadjustingEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-30</instant>
        </period>
    </context>
    <context id="From2026-01-302026-01-30_custom_NonadjustingEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">SMX:NonadjustingEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-30</startDate>
            <endDate>2026-01-30</endDate>
        </period>
    </context>
    <context id="From2026-05-102026-05-10_custom_NonadjustingEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">SMX:NonadjustingEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-10</startDate>
            <endDate>2026-05-10</endDate>
        </period>
    </context>
    <context id="AsOf2026-05-10_custom_NonadjustingEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">SMX:NonadjustingEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-10</instant>
        </period>
    </context>
    <context id="AsOf2026-05-11_custom_NonadjustingEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">SMX:NonadjustingEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-11</instant>
        </period>
    </context>
    <context id="From2026-05-312026-05-31_custom_NonadjustingEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">SMX:NonadjustingEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-31</startDate>
            <endDate>2026-05-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-05-31_custom_NonadjustingEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">SMX:NonadjustingEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-31</instant>
        </period>
    </context>
    <context id="AsOf2026-06-01_custom_NonadjustingEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940674</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">SMX:NonadjustingEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-01</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="AUD">
        <measure>iso4217:AUD</measure>
    </unit>
    <unit id="ILS">
        <measure>iso4217:ILS</measure>
    </unit>
    <unit id="Euro">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="EuroPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:EUR</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="SGD">
        <measure>iso4217:SGD</measure>
    </unit>
    <unit id="AED">
        <measure>iso4217:AED</measure>
    </unit>
    <dei:DocumentType contextRef="From2025-01-01to2025-12-31" id="Fact000025">6-K</dei:DocumentType>
    <dei:EntityFileNumber contextRef="From2025-01-01to2025-12-31" id="Fact000026">001-41639</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2025-01-01to2025-12-31" id="Fact000027">SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</dei:EntityRegistrantName>
    <dei:EntityAddressAddressLine1 contextRef="From2025-01-01to2025-12-31" id="Fact000028">Mespil Business Centre</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2025-01-01to2025-12-31" id="Fact000029">Mespil House</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3 contextRef="From2025-01-01to2025-12-31" id="Fact000030">Sussex Road</dei:EntityAddressAddressLine3>
    <dei:EntityAddressCityOrTown contextRef="From2025-01-01to2025-12-31" id="Fact000031">Dublin</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode contextRef="From2025-01-01to2025-12-31" id="Fact000032">4</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry contextRef="From2025-01-01to2025-12-31" id="Fact000033">IE</dei:EntityAddressCountry>
    <dei:AmendmentFlag contextRef="From2025-01-01to2025-12-31" id="Fact000003">false</dei:AmendmentFlag>
    <dei:DocumentPeriodEndDate contextRef="From2025-01-01to2025-12-31" id="Fact000004">2025-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="From2025-01-01to2025-12-31" id="Fact000005">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="From2025-01-01to2025-12-31" id="Fact000006">2026</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="From2025-01-01to2025-12-31" id="Fact000007">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="From2025-01-01to2025-12-31" id="Fact000008">0001940674</dei:EntityCentralIndexKey>
    <ifrs-full:ShorttermBorrowings
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0080"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:ImpairmentAndAmortization
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0151"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:ListingExpenses
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0153"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:ListingExpenses
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0154"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:GainsOnDisposalsOfInvestmentProperties
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0169"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:GainsOnDisposalsOfInvestmentProperties
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0170"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0173"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0174"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0181"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0182"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0183"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-12-31_custom_IssuedAndAdditionalPaidInCapitalMember"
      id="xdx2ixbrl0248"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-12-31_custom_TransactionWithNonControllingInterestMember"
      id="xdx2ixbrl0249"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-12-31_custom_ForeignCurrencyTranslationMember"
      id="xdx2ixbrl0250"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2025-01-012025-12-31_custom_IssuedAndAdditionalPaidInCapitalMember"
      id="xdx2ixbrl0256"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2025-01-012025-12-31_custom_TransactionWithNonControllingInterestMember"
      id="xdx2ixbrl0257"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0259"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2025-01-012025-12-31_custom_IssuedAndAdditionalPaidInCapitalMember"
      id="xdx2ixbrl0264"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2025-01-012025-12-31_custom_TransactionWithNonControllingInterestMember"
      id="xdx2ixbrl0265"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2025-01-012025-12-31_custom_TransactionWithNonControllingInterestMember"
      id="xdx2ixbrl0273"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2025-01-012025-12-31_custom_ForeignCurrencyTranslationMember"
      id="xdx2ixbrl0274"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0275"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments
      contextRef="From2025-01-012025-12-31_custom_TransactionWithNonControllingInterestMember"
      id="xdx2ixbrl0281"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments
      contextRef="From2025-01-012025-12-31_custom_ForeignCurrencyTranslationMember"
      id="xdx2ixbrl0282"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments
      contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0283"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments
      contextRef="From2025-01-012025-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0285"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:IncreaseDecreaseThroughConversionOfShortTermLoan
      contextRef="From2025-01-012025-12-31_custom_TransactionWithNonControllingInterestMember"
      id="xdx2ixbrl0289"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:IncreaseDecreaseThroughConversionOfShortTermLoan
      contextRef="From2025-01-012025-12-31_custom_ForeignCurrencyTranslationMember"
      id="xdx2ixbrl0290"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:IncreaseDecreaseThroughConversionOfShortTermLoan
      contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0291"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:IncreaseDecreaseThroughConversionOfShortTermLoan
      contextRef="From2025-01-012025-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0293"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:EquityIssuanceToInvestors
      contextRef="From2025-01-012025-12-31_custom_TransactionWithNonControllingInterestMember"
      id="xdx2ixbrl0297"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:EquityIssuanceToInvestors
      contextRef="From2025-01-012025-12-31_custom_ForeignCurrencyTranslationMember"
      id="xdx2ixbrl0298"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:EquityIssuanceToInvestors
      contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0299"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:EquityIssuanceToInvestors
      contextRef="From2025-01-012025-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0301"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="From2025-01-012025-12-31_custom_TransactionWithNonControllingInterestMember"
      id="xdx2ixbrl0305"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="From2025-01-012025-12-31_custom_ForeignCurrencyTranslationMember"
      id="xdx2ixbrl0306"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0307"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="From2025-01-012025-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0309"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_custom_TransactionWithNonControllingInterestMember"
      id="xdx2ixbrl0321"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2024-01-012024-12-31_custom_IssuedAndAdditionalPaidInCapitalMember"
      id="xdx2ixbrl0328"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2024-01-012024-12-31_custom_TransactionWithNonControllingInterestMember"
      id="xdx2ixbrl0329"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2024-01-012024-12-31_custom_ForeignCurrencyTranslationMember"
      id="xdx2ixbrl0330"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2024-01-012024-12-31_custom_IssuedAndAdditionalPaidInCapitalMember"
      id="xdx2ixbrl0336"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2024-01-012024-12-31_custom_TransactionWithNonControllingInterestMember"
      id="xdx2ixbrl0337"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0339"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2024-01-012024-12-31_custom_IssuedAndAdditionalPaidInCapitalMember"
      id="xdx2ixbrl0344"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2024-01-012024-12-31_custom_TransactionWithNonControllingInterestMember"
      id="xdx2ixbrl0345"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="From2024-01-012024-12-31_custom_TransactionWithNonControllingInterestMember"
      id="xdx2ixbrl0353"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="From2024-01-012024-12-31_custom_ForeignCurrencyTranslationMember"
      id="xdx2ixbrl0354"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0355"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="From2024-01-012024-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0357"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2024-01-012024-12-31_custom_TransactionWithNonControllingInterestMember"
      id="xdx2ixbrl0361"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2024-01-012024-12-31_custom_ForeignCurrencyTranslationMember"
      id="xdx2ixbrl0362"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0363"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2024-01-012024-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0365"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments
      contextRef="From2024-01-012024-12-31_custom_TransactionWithNonControllingInterestMember"
      id="xdx2ixbrl0369"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments
      contextRef="From2024-01-012024-12-31_custom_ForeignCurrencyTranslationMember"
      id="xdx2ixbrl0370"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments
      contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0371"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments
      contextRef="From2024-01-012024-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0373"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:IncreaseDecreaseThroughConversionOfBridgeLoanIntoOrdinarySharesWarrants
      contextRef="From2024-01-012024-12-31_custom_TransactionWithNonControllingInterestMember"
      id="xdx2ixbrl0377"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:IncreaseDecreaseThroughConversionOfBridgeLoanIntoOrdinarySharesWarrants
      contextRef="From2024-01-012024-12-31_custom_ForeignCurrencyTranslationMember"
      id="xdx2ixbrl0378"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:IncreaseDecreaseThroughConversionOfBridgeLoanIntoOrdinarySharesWarrants
      contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0379"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:IncreaseDecreaseThroughConversionOfBridgeLoanIntoOrdinarySharesWarrants
      contextRef="From2024-01-012024-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0381"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:IncreaseDecreaseThroughConversionOfPrePaidAdvancedIntoOrdinaryShares
      contextRef="From2024-01-012024-12-31_custom_TransactionWithNonControllingInterestMember"
      id="xdx2ixbrl0385"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:IncreaseDecreaseThroughConversionOfPrePaidAdvancedIntoOrdinaryShares
      contextRef="From2024-01-012024-12-31_custom_ForeignCurrencyTranslationMember"
      id="xdx2ixbrl0386"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:IncreaseDecreaseThroughConversionOfPrePaidAdvancedIntoOrdinaryShares
      contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0387"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:IncreaseDecreaseThroughConversionOfPrePaidAdvancedIntoOrdinaryShares
      contextRef="From2024-01-012024-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0389"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:IssuanceOfSharesOfInvestmentUnits
      contextRef="From2024-01-012024-12-31_custom_TransactionWithNonControllingInterestMember"
      id="xdx2ixbrl0393"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:IssuanceOfSharesOfInvestmentUnits
      contextRef="From2024-01-012024-12-31_custom_ForeignCurrencyTranslationMember"
      id="xdx2ixbrl0394"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:IssuanceOfSharesOfInvestmentUnits
      contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0395"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:IssuanceOfSharesOfInvestmentUnits
      contextRef="From2024-01-012024-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0397"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:ExerciseOfWarrantsIntoOrdinarySharesNet
      contextRef="From2024-01-012024-12-31_custom_TransactionWithNonControllingInterestMember"
      id="xdx2ixbrl0401"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:ExerciseOfWarrantsIntoOrdinarySharesNet
      contextRef="From2024-01-012024-12-31_custom_ForeignCurrencyTranslationMember"
      id="xdx2ixbrl0402"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:ExerciseOfWarrantsIntoOrdinarySharesNet
      contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0403"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:ExerciseOfWarrantsIntoOrdinarySharesNet
      contextRef="From2024-01-012024-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0405"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:StockIssuedDuringPeriodValueOfTransactionWithNonControllingInterests
      contextRef="From2024-01-012024-12-31_custom_ForeignCurrencyTranslationMember"
      id="xdx2ixbrl0410"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:StockIssuedDuringPeriodValueOfTransactionWithNonControllingInterests
      contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0411"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:StockIssuedDuringPeriodValueOfTransactionWithNonControllingInterests
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0414"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="AsOf2022-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0428"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="AsOf2022-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0435"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2023-01-012023-12-31_custom_IssuedAndAdditionalPaidInCapitalMember"
      id="xdx2ixbrl0438"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2023-01-012023-12-31_custom_ForeignCurrencyTranslationMember"
      id="xdx2ixbrl0439"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2023-01-012023-12-31_custom_IssuedAndAdditionalPaidInCapitalMember"
      id="xdx2ixbrl0445"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0447"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2023-01-012023-12-31_custom_IssuedAndAdditionalPaidInCapitalMember"
      id="xdx2ixbrl0452"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="From2023-01-012023-12-31_custom_ForeignCurrencyTranslationMember"
      id="xdx2ixbrl0460"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0461"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0463"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2023-01-012023-12-31_custom_ForeignCurrencyTranslationMember"
      id="xdx2ixbrl0467"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0468"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0470"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2023-01-012023-12-31_custom_ForeignCurrencyTranslationMember"
      id="xdx2ixbrl0474"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0475"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0477"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments
      contextRef="From2023-01-012023-12-31_custom_ForeignCurrencyTranslationMember"
      id="xdx2ixbrl0481"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments
      contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0482"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments
      contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0484"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="From2023-01-012023-12-31_custom_ForeignCurrencyTranslationMember"
      id="xdx2ixbrl0488"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0489"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0491"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:IncreaseDecreaseIssuanceOfSharesAndWarrants
      contextRef="From2023-01-012023-12-31_custom_ForeignCurrencyTranslationMember"
      id="xdx2ixbrl0495"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:IncreaseDecreaseIssuanceOfSharesAndWarrants
      contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0496"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:IncreaseDecreaseIssuanceOfSharesAndWarrants
      contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0498"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:ConversionOfWarrantsToOrdinaryShares
      contextRef="From2023-01-012023-12-31_custom_ForeignCurrencyTranslationMember"
      id="xdx2ixbrl0502"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:ConversionOfWarrantsToOrdinaryShares
      contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0503"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:ConversionOfWarrantsToOrdinaryShares
      contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0505"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:ExerciseOfWarrantsNet
      contextRef="From2023-01-012023-12-31_custom_ForeignCurrencyTranslationMember"
      id="xdx2ixbrl0509"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:ExerciseOfWarrantsNet
      contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0510"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:ExerciseOfWarrantsNet
      contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0512"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:IssuanceOfWarrantsAfterReset
      contextRef="From2023-01-012023-12-31_custom_ForeignCurrencyTranslationMember"
      id="xdx2ixbrl0516"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:IssuanceOfWarrantsAfterReset
      contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0517"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:IssuanceOfWarrantsAfterReset
      contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0519"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_custom_IssuedAndAdditionalPaidInCapitalMember"
      id="xdx2ixbrl0522"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_custom_ForeignCurrencyTranslationMember"
      id="xdx2ixbrl0523"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0524"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      id="xdx2ixbrl0525"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:AdjustmentsForIssuanceOfRestrictedShares
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0556"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:AdjustmentsForIssuanceOfRestrictedShares
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0557"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0569"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForImpairmentLossRecognisedInProfitOrLossGoodwill
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0573"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0583"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0584"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForFinanceIncomeCost
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0597"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:RemeasurementOfInvestmentInAssociatedCompany
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0599"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:RemeasurementOfInvestmentInAssociatedCompany
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0600"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForInterestExpense
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0604"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForInterestExpense
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0605"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0607"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0608"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:IssuanceCostDueToInducementWarrantExercisePrice
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0615"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:IssuanceCostDueToInducementWarrantExercisePrice
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0617"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:IssuanceOfOrdinarySharesDueToCommitmentFacilityFee
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0621"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:ListingCosts
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0623"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:ListingCosts
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0624"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0635"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:CapitalizedDevelopmentCostClassifiedAsInvestingActivities
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0639"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0643"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:RepaymentsOfCurrentBorrowings
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0652"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:RepaymentsOfCurrentBorrowings
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0653"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:RepaymentOfConvertibleNotes
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0656"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:RepaymentOfConvertibleNotes
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0657"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:RepaymentOfPrepaidAdvancesadvancePaymentForEquityNet
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0667"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:ProceedsFromIssuanceOfShares
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0671"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:ExerciseOfWarrantsAndPrefundedWarrantsOrdinaryShares
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0675"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromCurrentBorrowings
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0683"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromCurrentBorrowings
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0685"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:ProceedsFromIssuanceOfBridgeLoansAndWarrants
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0687"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:ProceedsFromIssuanceOfBridgeLoansAndWarrants
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0688"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromIssuingOtherEquityInstruments
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0691"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromIssuingOtherEquityInstruments
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0692"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:ExerciseOfCashlessOptionsIntoOrdinaryShares
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0731"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:ExerciseOfWarrantsAndPrefundedWarrantsIntoOrdinaryShares
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0735"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:SharesIssuanceCost
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0739"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:SharesIssuanceCost
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0741"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:OtherCurrentReceivableInConnectionToExerciseOfWarrant
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0743"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:OtherCurrentReceivableInConnectionToExerciseOfWarrant
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0745"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:RemeasurementOfInvestment
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0747"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:RemeasurementOfInvestment
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0748"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:IssuanceOfWarrants
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0752"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:IssuanceOfWarrants
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0753"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2024-01-012024-12-31_custom_SMXCircularEconomyFZCOLtdMember"
      id="xdx2ixbrl0820"
      unitRef="Pure"
      xsi:nil="true"/>
    <SMX:ReceivableInRespectOfExerciseOfWarrants
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0961"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_LeaseholdImprovementsMember_ifrs-full_GrossCarryingAmountMember"
      id="xdx2ixbrl0993"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_MachineryMember_ifrs-full_GrossCarryingAmountMember"
      id="xdx2ixbrl0995"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_custom_FurnitureAndOfficeEquipmentMember_ifrs-full_GrossCarryingAmountMember"
      id="xdx2ixbrl0997"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_ComputerEquipmentMember_ifrs-full_GrossCarryingAmountMember"
      id="xdx2ixbrl0999"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember"
      id="xdx2ixbrl1001"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_LeaseholdImprovementsMember_ifrs-full_GrossCarryingAmountMember"
      id="xdx2ixbrl1093"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_custom_FurnitureAndOfficeEquipmentMember_ifrs-full_GrossCarryingAmountMember"
      id="xdx2ixbrl1097"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_ComputerEquipmentMember_ifrs-full_GrossCarryingAmountMember"
      id="xdx2ixbrl1099"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_ComputerEquipmentMember_ifrs-full_GrossCarryingAmountMember"
      id="xdx2ixbrl1119"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_LeaseholdImprovementsMember_custom_AccumulatedDepreciationMember"
      id="xdx2ixbrl1153"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_custom_FurnitureAndOfficeEquipmentMember_custom_AccumulatedDepreciationMember"
      id="xdx2ixbrl1157"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_ComputerEquipmentMember_custom_AccumulatedDepreciationMember"
      id="xdx2ixbrl1159"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_custom_TechnologyLicenseMember"
      id="xdx2ixbrl1201"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_CapitalisedDevelopmentExpenditureMember"
      id="xdx2ixbrl1204"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LicencesMember"
      id="xdx2ixbrl1205"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_custom_TechnologyLicenseMember"
      id="xdx2ixbrl1206"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember"
      id="xdx2ixbrl1207"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_custom_AccumulatedDepreciationAmortisationMember_ifrs-full_LicencesMember"
      id="xdx2ixbrl1225"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_custom_AccumulatedDepreciationAmortisationMember_custom_TechnologyLicenseMember"
      id="xdx2ixbrl1226"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_custom_AccumulatedDepreciationAmortisationMember_custom_TechnologyLicenseMember"
      id="xdx2ixbrl1231"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LicencesMember"
      id="xdx2ixbrl1255"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_custom_TechnologyLicenseMember"
      id="xdx2ixbrl1256"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_custom_TechnologyLicenseMember"
      id="xdx2ixbrl1261"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2023-12-31_custom_AccumulatedDepreciationAmortisationMember_ifrs-full_LicencesMember"
      id="xdx2ixbrl1275"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2023-12-31_custom_AccumulatedDepreciationAmortisationMember_custom_TechnologyLicenseMember"
      id="xdx2ixbrl1276"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2023-12-31_custom_AccumulatedDepreciationAmortisationMember_ifrs-full_LicencesMember"
      id="xdx2ixbrl1280"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2023-12-31_custom_AccumulatedDepreciationAmortisationMember_custom_TechnologyLicenseMember"
      id="xdx2ixbrl1281"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_custom_AccumulatedDepreciationAmortisationMember_ifrs-full_LicencesMember"
      id="xdx2ixbrl1290"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_custom_AccumulatedDepreciationAmortisationMember_custom_TechnologyLicenseMember"
      id="xdx2ixbrl1291"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_custom_AccumulatedDepreciationAmortisationMember_ifrs-full_LicencesMember"
      id="xdx2ixbrl1295"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_custom_AccumulatedDepreciationAmortisationMember_custom_TechnologyLicenseMember"
      id="xdx2ixbrl1296"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-09-06_custom_SecuritiesPurchaseAgreementMember_custom_WarrantAMember_custom_AfterReverseStockSplitMember"
      id="xdx2ixbrl1379"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-09-06_custom_SecuritiesPurchaseAgreementMember_custom_WarrantBMember_custom_AfterReverseStockSplitMember"
      id="xdx2ixbrl1381"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-09-06_custom_SecuritiesPurchaseAgreementMember_custom_WarrantBMember_ifrs-full_OrdinarySharesMember_custom_AfterReverseStockSplitMember"
      id="xdx2ixbrl1390"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-04-11_custom_SecuritiesPurchaseAgreementMember_ifrs-full_WarrantsMember_ifrs-full_OrdinarySharesMember_custom_AfterReverseStockSplitMember"
      id="xdx2ixbrl1465"
      unitRef="Shares"
      xsi:nil="true"/>
    <SMX:ReverseStockSplitAmount
      contextRef="From2025-07-102025-07-10_custom_TheEightHundredConvertibleNoteMember"
      id="xdx2ixbrl1521"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:WarrantsToPurchaseOrdinaryShares
      contextRef="From2025-07-192025-07-19_custom_SecuritiesPurchaseAgreementMember_custom_JulyWarrantsMember_custom_AfterReverseStockSplitMember"
      id="xdx2ixbrl1545"
      unitRef="Shares"
      xsi:nil="true"/>
    <SMX:WarrantsToPurchaseShares
      contextRef="From2025-01-012025-12-31_custom_BridgeLoanAgreementsMember_custom_BonusWarrantsMember_custom_AfterReverseStockSplitMember"
      id="xdx2ixbrl1886"
      unitRef="Shares"
      xsi:nil="true"/>
    <SMX:WarrantsToPurchaseShares
      contextRef="From2025-01-012025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeOneMember_custom_AfterReverseStockSplitMember"
      id="xdx2ixbrl1894"
      unitRef="Shares"
      xsi:nil="true"/>
    <SMX:WarrantsToPurchaseShares
      contextRef="From2024-01-012024-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeTwoMember_custom_AfterReverseStockSplitMember"
      id="xdx2ixbrl1908"
      unitRef="Shares"
      xsi:nil="true"/>
    <SMX:FairValueOfBonusWarrants
      contextRef="AsOf2025-12-31_custom_BridgeLoanAgreementsMember"
      id="xdx2ixbrl1940"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FairValueOfBonusWarrants
      contextRef="AsOf2024-12-31_custom_BridgeLoanAgreementsMember"
      id="xdx2ixbrl1942"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:RightofuseAssetsEffectofForeignExchange
      contextRef="From2024-01-012024-12-31_ifrs-full_MotorVehiclesMember"
      id="xdx2ixbrl2178"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:RightofuseAssetsEffectofForeignExchange
      contextRef="From2025-01-012025-12-31_ifrs-full_MotorVehiclesMember"
      id="xdx2ixbrl2194"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:NumberOfSharesIssuedAndOutstanding
      contextRef="AsOf2025-12-31_ifrs-full_PreferenceSharesMember"
      id="xdx2ixbrl2254"
      unitRef="Shares"
      xsi:nil="true"/>
    <SMX:NumberOfSharesIssuedAndOutstanding
      contextRef="AsOf2024-12-31_ifrs-full_PreferenceSharesMember"
      id="xdx2ixbrl2258"
      unitRef="Shares"
      xsi:nil="true"/>
    <SMX:NumberOfSharesIssuedAndOutstanding
      contextRef="AsOf2025-12-31_custom_NewDeferredSharesMember"
      id="xdx2ixbrl2274"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="AsOf2024-12-31_custom_NewDeferredSharesMember"
      id="xdx2ixbrl2276"
      unitRef="Shares"
      xsi:nil="true"/>
    <SMX:NumberOfSharesIssuedAndOutstanding
      contextRef="AsOf2024-12-31_custom_NewDeferredSharesMember"
      id="xdx2ixbrl2278"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-01-04_custom_ServiceProviderAgreementsMember_custom_AfterReverseStockSplitMember"
      id="xdx2ixbrl2315"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-03-31_ifrs-full_OrdinarySharesMember_custom_AfterReverseStockSplitMember"
      id="xdx2ixbrl2317"
      unitRef="Shares"
      xsi:nil="true"/>
    <SMX:WarrantsExercised
      contextRef="AsOf2024-06-21_ifrs-full_WarrantsMember_custom_AfterReverseStockSplitMember"
      id="xdx2ixbrl2322"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-06-21_ifrs-full_OrdinarySharesMember_custom_AfterReverseStockSplitMember"
      id="xdx2ixbrl2326"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-02-01_ifrs-full_OrdinarySharesMember_custom_AfterReverseStockSplitMember"
      id="xdx2ixbrl2334"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-02-20_custom_UnderwritingAgreementMember_custom_OrdinarySharesAndPrefundedWarrantsMember_custom_AfterReverseStockSplitMember"
      id="xdx2ixbrl2338"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-12-31_custom_UnderwritingAgreementMember_custom_PrefundedWarrantsMember_custom_AfterReverseStockSplitMember"
      id="xdx2ixbrl2367"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-12-31_custom_ConvertiblePromissoryNoteMember_custom_AfterReverseStockSplitMember"
      id="xdx2ixbrl2384"
      unitRef="Shares"
      xsi:nil="true"/>
    <SMX:WarrantsExercised
      contextRef="AsOf2024-12-31_custom_InvestorsMember_custom_WarrantAMember_custom_AfterReverseStockSplitMember"
      id="xdx2ixbrl2388"
      unitRef="Shares"
      xsi:nil="true"/>
    <SMX:NumberOfWarrantsIssued
      contextRef="From2024-04-112024-04-11_custom_SecuritiesPurchaseAgreementMember_custom_AfterReverseStockSplitMember"
      id="xdx2ixbrl2392"
      unitRef="Shares"
      xsi:nil="true"/>
    <SMX:NumberOfWarrantsIssued
      contextRef="From2024-04-112024-04-11_custom_SecuritiesPurchaseAgreementMember_ifrs-full_OrdinarySharesMember_custom_AfterReverseStockSplitMember"
      id="xdx2ixbrl2402"
      unitRef="Shares"
      xsi:nil="true"/>
    <SMX:NumberOfWarrantsIssued
      contextRef="From2024-01-012024-12-31_ifrs-full_WarrantsMember_custom_AfterReverseStockSplitMember"
      id="xdx2ixbrl2420"
      unitRef="Shares"
      xsi:nil="true"/>
    <SMX:NumberOfSharesConverted
      contextRef="AsOf2024-12-31_ifrs-full_OrdinarySharesMember_custom_AfterReverseStockSplitMember"
      id="xdx2ixbrl2424"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-12-31_ifrs-full_OrdinarySharesMember_custom_AfterReverseStockSplitMember"
      id="xdx2ixbrl2428"
      unitRef="Shares"
      xsi:nil="true"/>
    <SMX:NumberOfSharesConverted
      contextRef="AsOf2024-04-30_ifrs-full_OrdinarySharesMember_custom_AfterReverseStockSplitMember"
      id="xdx2ixbrl2432"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-04-30_ifrs-full_OrdinarySharesMember_custom_AfterReverseStockSplitMember"
      id="xdx2ixbrl2436"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-04-24_custom_InvestorsMember_custom_AfterReverseStockSplitMember"
      id="xdx2ixbrl2440"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-06-30_ifrs-full_OrdinarySharesMember_custom_AfterReverseStockSplitMember"
      id="xdx2ixbrl2448"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfSharesIssuedAndFullyPaid
      contextRef="AsOf2024-06-27_ifrs-full_OrdinarySharesMember_custom_AfterReverseStockSplitMember"
      id="xdx2ixbrl2454"
      unitRef="Shares"
      xsi:nil="true"/>
    <SMX:NumberOfWarrantsIssued
      contextRef="From2024-06-272024-06-27_custom_AfterReverseStockSplitMember"
      id="xdx2ixbrl2458"
      unitRef="Shares"
      xsi:nil="true"/>
    <SMX:IssueOfConvertibleShares
      contextRef="From2024-07-102024-07-10_custom_AfterReverseStockSplitMember"
      id="xdx2ixbrl2467"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-07-10_custom_AfterReverseStockSplitMember"
      id="xdx2ixbrl2469"
      unitRef="Shares"
      xsi:nil="true"/>
    <SMX:NumberOfWarrantsIssued
      contextRef="From2024-07-192024-07-19_custom_SecuritiesPurchaseAgreementMember_custom_AfterReverseStockSplitMember"
      id="xdx2ixbrl2473"
      unitRef="Shares"
      xsi:nil="true"/>
    <SMX:NumberOfSharesConverted
      contextRef="AsOf2024-12-31_custom_SecuritiesPurchaseAgreementMember_ifrs-full_WarrantsMember_custom_AfterReverseStockSplitMember"
      id="xdx2ixbrl2483"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-09-16_custom_AfterReverseStockSplitMember"
      id="xdx2ixbrl2521"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="From2024-09-012024-09-30_custom_AfterReverseStockSplitMember"
      id="xdx2ixbrl2525"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="From2024-01-312024-01-31_custom_EmployeesDirectorsAndServiceProvidersMember_ifrs-full_RestrictedShareUnitsMember_custom_AfterReverseStockSplitMember"
      id="xdx2ixbrl2567"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="From2024-07-212024-07-21_custom_AdvisorMember_ifrs-full_RestrictedShareUnitsMember_custom_AfterReverseStockSplitMember"
      id="xdx2ixbrl2575"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="From2024-08-292024-08-29_custom_EmployeesExecutiveOfficersAndDirectorsMember_ifrs-full_RestrictedShareUnitsMember_custom_AfterReverseStockSplitMember"
      id="xdx2ixbrl2587"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="AsOf2024-12-31_ifrs-full_RestrictedShareUnitsMember_custom_EmployeesDirectorsAndServiceProvidersMember"
      id="xdx2ixbrl2787"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="AsOf2023-12-31_ifrs-full_RestrictedShareUnitsMember_custom_EmployeesDirectorsAndServiceProvidersMember"
      id="xdx2ixbrl2789"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_EmployeesDirectorsAndServiceProvidersMember_ifrs-full_RestrictedShareUnitsMember"
      id="xdx2ixbrl2801"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="AsOf2025-12-31_ifrs-full_RestrictedShareUnitsMember_custom_EmployeesDirectorsAndServiceProvidersMember"
      id="xdx2ixbrl2803"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="AsOf2024-12-31_ifrs-full_RestrictedShareUnitsMember_custom_EmployeesDirectorsAndServiceProvidersMember"
      id="xdx2ixbrl2805"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl2810"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl2812"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl2814"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl2816"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl2822"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl2824"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl2830"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl2832"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl2838"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl2840"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <SMX:BusinessDevelopmentExpenses
      contextRef="From2024-01-012024-12-31_custom_SellingAndMarketingExpensesMember"
      id="xdx2ixbrl2948"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:BusinessDevelopmentExpenses
      contextRef="From2023-01-012023-12-31_custom_SellingAndMarketingExpensesMember"
      id="xdx2ixbrl2949"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:OtherExpenseByNature
      contextRef="From2023-01-012023-12-31_custom_SellingAndMarketingExpensesMember"
      id="xdx2ixbrl2961"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl2990"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl2991"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl2992"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:WeightedAverageShares
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl3028"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl3030"
      unitRef="Shares"
      xsi:nil="true"/>
    <SMX:RevaluationOfFinancialLiabilitiesAtFairValue
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl3062"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:KeyManagementPersonnelCompensationPaymentsForLegalServices
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl3065"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLoss
      contextRef="AsOf2025-12-31_custom_ShortTermLoanMember"
      id="xdx2ixbrl3169"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:NetForeignExchangeLoss
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl3238"
      unitRef="Euro"
      xsi:nil="true"/>
    <ifrs-full:NetForeignExchangeLoss
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl3249"
      unitRef="AED"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_TradeAndOtherPayablesMember"
      id="xdx2ixbrl3254"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_custom_TradeAndOtherPayablesMember"
      id="xdx2ixbrl3255"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_custom_TradeAndOtherPayablesMember"
      id="xdx2ixbrl3256"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_custom_TradeAndOtherPayablesMember"
      id="xdx2ixbrl3257"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanFiveYearsMember_custom_TradeAndOtherPayablesMember"
      id="xdx2ixbrl3258"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_NotLaterThanOneYearMember_custom_ShortTermLoanMember"
      id="xdx2ixbrl3261"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_ShortTermLoanMember"
      id="xdx2ixbrl3262"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_custom_ShortTermLoanMember"
      id="xdx2ixbrl3263"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_custom_ShortTermLoanMember"
      id="xdx2ixbrl3264"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_custom_ShortTermLoanMember"
      id="xdx2ixbrl3265"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanFiveYearsMember_custom_ShortTermLoanMember"
      id="xdx2ixbrl3266"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_custom_ShortTermLoanMember"
      id="xdx2ixbrl3267"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_BridgeLoansMember"
      id="xdx2ixbrl3270"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_custom_BridgeLoansMember"
      id="xdx2ixbrl3271"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_custom_BridgeLoansMember"
      id="xdx2ixbrl3272"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_custom_BridgeLoansMember"
      id="xdx2ixbrl3273"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanFiveYearsMember_custom_BridgeLoansMember"
      id="xdx2ixbrl3274"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_GovernmentGrantsMember"
      id="xdx2ixbrl3278"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_custom_GovernmentGrantsMember"
      id="xdx2ixbrl3279"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_custom_GovernmentGrantsMember"
      id="xdx2ixbrl3280"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_custom_GovernmentGrantsMember"
      id="xdx2ixbrl3281"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanFiveYearsMember_custom_GovernmentGrantsMember"
      id="xdx2ixbrl3282"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_ConvertibleNotesMember"
      id="xdx2ixbrl3294"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_custom_ConvertibleNotesMember"
      id="xdx2ixbrl3295"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_custom_ConvertibleNotesMember"
      id="xdx2ixbrl3296"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_custom_ConvertibleNotesMember"
      id="xdx2ixbrl3297"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanFiveYearsMember_custom_ConvertibleNotesMember"
      id="xdx2ixbrl3298"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_FinancialDerivativesMember"
      id="xdx2ixbrl3302"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_custom_FinancialDerivativesMember"
      id="xdx2ixbrl3303"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_custom_FinancialDerivativesMember"
      id="xdx2ixbrl3304"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_custom_FinancialDerivativesMember"
      id="xdx2ixbrl3305"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanFiveYearsMember_custom_FinancialDerivativesMember"
      id="xdx2ixbrl3306"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_TradeAndOtherPayablesMember"
      id="xdx2ixbrl3318"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_custom_TradeAndOtherPayablesMember"
      id="xdx2ixbrl3319"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_custom_TradeAndOtherPayablesMember"
      id="xdx2ixbrl3320"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_custom_TradeAndOtherPayablesMember"
      id="xdx2ixbrl3321"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanFiveYearsMember_custom_TradeAndOtherPayablesMember"
      id="xdx2ixbrl3322"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_ShortTermLoanMember"
      id="xdx2ixbrl3326"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_custom_ShortTermLoanMember"
      id="xdx2ixbrl3327"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_custom_ShortTermLoanMember"
      id="xdx2ixbrl3328"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_custom_ShortTermLoanMember"
      id="xdx2ixbrl3329"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanFiveYearsMember_custom_ShortTermLoanMember"
      id="xdx2ixbrl3330"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_BridgeLoansMember"
      id="xdx2ixbrl3334"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_custom_BridgeLoansMember"
      id="xdx2ixbrl3335"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_custom_BridgeLoansMember"
      id="xdx2ixbrl3336"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_custom_BridgeLoansMember"
      id="xdx2ixbrl3337"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanFiveYearsMember_custom_BridgeLoansMember"
      id="xdx2ixbrl3338"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_GovernmentGrantsMember"
      id="xdx2ixbrl3342"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_custom_GovernmentGrantsMember"
      id="xdx2ixbrl3343"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_custom_GovernmentGrantsMember"
      id="xdx2ixbrl3344"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_custom_GovernmentGrantsMember"
      id="xdx2ixbrl3345"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanFiveYearsMember_custom_GovernmentGrantsMember"
      id="xdx2ixbrl3346"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_ConvertibleNotesMember"
      id="xdx2ixbrl3358"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_custom_ConvertibleNotesMember"
      id="xdx2ixbrl3359"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_custom_ConvertibleNotesMember"
      id="xdx2ixbrl3360"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_custom_ConvertibleNotesMember"
      id="xdx2ixbrl3361"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanFiveYearsMember_custom_ConvertibleNotesMember"
      id="xdx2ixbrl3362"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_FinancialDerivativesMember"
      id="xdx2ixbrl3366"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_custom_FinancialDerivativesMember"
      id="xdx2ixbrl3367"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_custom_FinancialDerivativesMember"
      id="xdx2ixbrl3368"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_custom_FinancialDerivativesMember"
      id="xdx2ixbrl3369"
      unitRef="USD"
      xsi:nil="true"/>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanFiveYearsMember_custom_FinancialDerivativesMember"
      id="xdx2ixbrl3370"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_Level1OfFairValueHierarchyMember_ifrs-full_DerivativesMember"
      id="xdx2ixbrl3385"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_Level2OfFairValueHierarchyMember_ifrs-full_DerivativesMember"
      id="xdx2ixbrl3386"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_Level1OfFairValueHierarchyMember"
      id="xdx2ixbrl3390"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_Level2OfFairValueHierarchyMember"
      id="xdx2ixbrl3391"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_Level1OfFairValueHierarchyMember_ifrs-full_DerivativesMember"
      id="xdx2ixbrl3395"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_Level2OfFairValueHierarchyMember_ifrs-full_DerivativesMember"
      id="xdx2ixbrl3396"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_Level2OfFairValueHierarchyMember_ifrs-full_WarrantsMember"
      id="xdx2ixbrl3401"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_ifrs-full_WarrantsMember"
      id="xdx2ixbrl3402"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_Level2OfFairValueHierarchyMember"
      id="xdx2ixbrl3406"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000038"
      unitRef="USD">12201000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000039"
      unitRef="USD">2343000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:OtherCurrentAssets
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000041"
      unitRef="USD">587000</ifrs-full:OtherCurrentAssets>
    <ifrs-full:OtherCurrentAssets
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000042"
      unitRef="USD">1993000</ifrs-full:OtherCurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000044"
      unitRef="USD">12788000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000045"
      unitRef="USD">4336000</ifrs-full:CurrentAssets>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000050"
      unitRef="USD">7916000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000051"
      unitRef="USD">12328000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000053"
      unitRef="USD">20120000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000054"
      unitRef="USD">26144000</ifrs-full:Goodwill>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000056"
      unitRef="USD">165000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000057"
      unitRef="USD">268000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000059"
      unitRef="USD">336000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000060"
      unitRef="USD">348000</ifrs-full:RightofuseAssets>
    <ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000062"
      unitRef="USD">114000</ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000063"
      unitRef="USD">105000</ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000065"
      unitRef="USD">28651000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000066"
      unitRef="USD">39193000</ifrs-full:NoncurrentAssets>
    <ifrs-full:Assets
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000068"
      unitRef="USD">41439000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000069"
      unitRef="USD">43529000</ifrs-full:Assets>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000074"
      unitRef="USD">8720000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000075"
      unitRef="USD">9432000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <ifrs-full:OtherCurrentPayables
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000077"
      unitRef="USD">4217000</ifrs-full:OtherCurrentPayables>
    <ifrs-full:OtherCurrentPayables
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000078"
      unitRef="USD">4350000</ifrs-full:OtherCurrentPayables>
    <ifrs-full:ShorttermBorrowings
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000081"
      unitRef="USD">1000000</ifrs-full:ShorttermBorrowings>
    <SMX:ConvertibleNote
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000083"
      unitRef="USD">8295000</SMX:ConvertibleNote>
    <SMX:ConvertibleNote
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000084"
      unitRef="USD">3651000</SMX:ConvertibleNote>
    <ifrs-full:CurrentWarrantLiability
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000086"
      unitRef="USD">5000</ifrs-full:CurrentWarrantLiability>
    <ifrs-full:CurrentWarrantLiability
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000087"
      unitRef="USD">1384000</ifrs-full:CurrentWarrantLiability>
    <SMX:BridgeLoansLiabilities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000089"
      unitRef="USD">453000</SMX:BridgeLoansLiabilities>
    <SMX:BridgeLoansLiabilities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000090"
      unitRef="USD">902000</SMX:BridgeLoansLiabilities>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000092"
      unitRef="USD">42000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000093"
      unitRef="USD">81000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000095"
      unitRef="USD">21732000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000096"
      unitRef="USD">20800000</ifrs-full:CurrentLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000101"
      unitRef="USD">382000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000102"
      unitRef="USD">337000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000104"
      unitRef="USD">382000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000105"
      unitRef="USD">337000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:Liabilities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000107"
      unitRef="USD">22114000</ifrs-full:Liabilities>
    <ifrs-full:Liabilities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000108"
      unitRef="USD">21137000</ifrs-full:Liabilities>
    <SMX:IssuedCapitalAndAdditionalPaidInCapital
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000113"
      unitRef="USD">264629000</SMX:IssuedCapitalAndAdditionalPaidInCapital>
    <SMX:IssuedCapitalAndAdditionalPaidInCapital
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000114"
      unitRef="USD">89976000</SMX:IssuedCapitalAndAdditionalPaidInCapital>
    <ifrs-full:ReserveOfExchangeDifferencesOnTranslation
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000116"
      unitRef="USD">-4827000</ifrs-full:ReserveOfExchangeDifferencesOnTranslation>
    <ifrs-full:ReserveOfExchangeDifferencesOnTranslation
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000117"
      unitRef="USD">-1797000</ifrs-full:ReserveOfExchangeDifferencesOnTranslation>
    <SMX:TransactionWithNoncontrollingInterestReserve
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000119"
      unitRef="USD">258000</SMX:TransactionWithNoncontrollingInterestReserve>
    <SMX:TransactionWithNoncontrollingInterestReserve
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000120"
      unitRef="USD">258000</SMX:TransactionWithNoncontrollingInterestReserve>
    <ifrs-full:RetainedEarnings
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000122"
      unitRef="USD">-251204000</ifrs-full:RetainedEarnings>
    <ifrs-full:RetainedEarnings
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000123"
      unitRef="USD">-82026000</ifrs-full:RetainedEarnings>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000125"
      unitRef="USD">8856000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000126"
      unitRef="USD">6411000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:NoncontrollingInterests
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000128"
      unitRef="USD">10469000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:NoncontrollingInterests
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000129"
      unitRef="USD">15981000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000131"
      unitRef="USD">19325000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000132"
      unitRef="USD">22392000</ifrs-full:Equity>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000134"
      unitRef="USD">41439000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000135"
      unitRef="USD">43529000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000137"
      unitRef="USD">120099000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000138"
      unitRef="USD">12729000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000139"
      unitRef="USD">16567000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000141"
      unitRef="USD">11228000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000142"
      unitRef="USD">3059000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000143"
      unitRef="USD">2711000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:SalesAndMarketingExpense
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000145"
      unitRef="USD">4112000</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:SalesAndMarketingExpense
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000146"
      unitRef="USD">992000</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:SalesAndMarketingExpense
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000147"
      unitRef="USD">661000</ifrs-full:SalesAndMarketingExpense>
    <SMX:ImpairmentAndAmortization
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000149"
      unitRef="USD">10850000</SMX:ImpairmentAndAmortization>
    <SMX:ImpairmentAndAmortization
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000150"
      unitRef="USD">11085000</SMX:ImpairmentAndAmortization>
    <SMX:ListingExpenses
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000155"
      unitRef="USD">16802000</SMX:ListingExpenses>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000157"
      unitRef="USD">-146289000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000158"
      unitRef="USD">-27865000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000159"
      unitRef="USD">-36741000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:FinanceCosts
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000161"
      unitRef="USD">40703000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000162"
      unitRef="USD">13493000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000163"
      unitRef="USD">7891000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceIncome
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000165"
      unitRef="USD">12402000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000166"
      unitRef="USD">5957000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000167"
      unitRef="USD">1580000</ifrs-full:FinanceIncome>
    <ifrs-full:GainsOnDisposalsOfInvestmentProperties
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000171"
      unitRef="USD">22164000</ifrs-full:GainsOnDisposalsOfInvestmentProperties>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000175"
      unitRef="USD">-101000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000177"
      unitRef="USD">-174590000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000178"
      unitRef="USD">-35401000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000179"
      unitRef="USD">-20989000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000185"
      unitRef="USD">-174590000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000186"
      unitRef="USD">-35401000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000187"
      unitRef="USD">-20989000</ifrs-full:ProfitLoss>
    <SMX:OtherComprehensiveIncomeLoss
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000189"
      unitRef="USD">-3130000</SMX:OtherComprehensiveIncomeLoss>
    <SMX:OtherComprehensiveIncomeLoss
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000190"
      unitRef="USD">-1265000</SMX:OtherComprehensiveIncomeLoss>
    <SMX:OtherComprehensiveIncomeLoss
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000191"
      unitRef="USD">-283000</SMX:OtherComprehensiveIncomeLoss>
    <SMX:ComprehensiveIncomeLoss
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000193"
      unitRef="USD">-177720000</SMX:ComprehensiveIncomeLoss>
    <SMX:ComprehensiveIncomeLoss
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000194"
      unitRef="USD">-36666000</SMX:ComprehensiveIncomeLoss>
    <SMX:ComprehensiveIncomeLoss
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000195"
      unitRef="USD">-21272000</SMX:ComprehensiveIncomeLoss>
    <SMX:EquityHoldersOfCompany
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000201"
      unitRef="USD">-169178000</SMX:EquityHoldersOfCompany>
    <SMX:EquityHoldersOfCompany
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000202"
      unitRef="USD">-31092000</SMX:EquityHoldersOfCompany>
    <SMX:EquityHoldersOfCompany
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000203"
      unitRef="USD">-20914000</SMX:EquityHoldersOfCompany>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000205"
      unitRef="USD">-5412000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000206"
      unitRef="USD">-4309000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000207"
      unitRef="USD">-75000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact000209"
      unitRef="USDPShares">-37</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact000211"
      unitRef="USDPShares">-37</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact000213"
      unitRef="USDPShares">-138537</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact000215"
      unitRef="USDPShares">-138537</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact000217"
      unitRef="USDPShares">-9272541</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact000219"
      unitRef="USDPShares">-9272541</ifrs-full:DilutedEarningsLossPerShare>
    <SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding
      contextRef="From2024-07-152024-07-15_ifrs-full_PotentialOrdinaryShareTransactionsMember"
      id="Fact000222">1-for-75</SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding>
    <SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding
      contextRef="From2025-01-152025-01-15_ifrs-full_PotentialOrdinaryShareTransactionsMember"
      id="Fact000224">1-for-28.5</SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding>
    <SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding
      contextRef="From2025-06-162025-06-16_ifrs-full_PotentialOrdinaryShareTransactionsMember"
      id="Fact000226">1-for-4.1</SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding>
    <SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding
      contextRef="From2025-08-072025-08-07_ifrs-full_PotentialOrdinaryShareTransactionsMember"
      id="Fact000228">1-for-7</SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding>
    <SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding
      contextRef="From2025-10-232025-10-23_ifrs-full_PotentialOrdinaryShareTransactionsMember"
      id="Fact000230">1-for-10.89958</SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding>
    <SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding
      contextRef="From2025-11-182025-11-18_ifrs-full_PotentialOrdinaryShareTransactionsMember"
      id="Fact000232">1-for-8,</SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding>
    <SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding
      contextRef="From2026-02-172026-02-17_ifrs-full_PotentialOrdinaryShareTransactionsMember"
      id="Fact000234">1:4.8828125</SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding>
    <SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding
      contextRef="From2026-05-112026-05-11_ifrs-full_PotentialOrdinaryShareTransactionsMember"
      id="Fact000236">1-for-20</SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding>
    <SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding
      contextRef="From2026-06-012026-06-01_ifrs-full_PotentialOrdinaryShareTransactionsMember"
      id="Fact000238">1-for-2.285</SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_custom_IssuedAndAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000240"
      unitRef="USD">89976000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_custom_TransactionWithNonControllingInterestMember"
      decimals="-3"
      id="Fact000241"
      unitRef="USD">258000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_custom_ForeignCurrencyTranslationMember"
      decimals="-3"
      id="Fact000242"
      unitRef="USD">-1797000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      id="Fact000243"
      unitRef="USD">-82026000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000244"
      unitRef="USD">6411000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000245"
      unitRef="USD">15981000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000246"
      unitRef="USD">22392000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      id="Fact000251"
      unitRef="USD">-169178000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000252"
      unitRef="USD">-169178000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000253"
      unitRef="USD">-5412000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000254"
      unitRef="USD">-174590000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2025-01-012025-12-31_custom_ForeignCurrencyTranslationMember"
      decimals="-3"
      id="Fact000258"
      unitRef="USD">-3030000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2025-01-012025-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000260"
      unitRef="USD">-3030000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2025-01-012025-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000261"
      unitRef="USD">-100000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000262"
      unitRef="USD">-3130000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2025-01-012025-12-31_custom_ForeignCurrencyTranslationMember"
      decimals="-3"
      id="Fact000266"
      unitRef="USD">-3030000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      id="Fact000267"
      unitRef="USD">-169178000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2025-01-012025-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000268"
      unitRef="USD">-172208000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2025-01-012025-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000269"
      unitRef="USD">-5512000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000270"
      unitRef="USD">-177720000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2025-01-012025-12-31_custom_IssuedAndAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000272"
      unitRef="USD">114205000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2025-01-012025-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000276"
      unitRef="USD">114205000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000278"
      unitRef="USD">114205000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments
      contextRef="From2025-01-012025-12-31_custom_IssuedAndAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000280"
      unitRef="USD">43146000</ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments>
    <ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments
      contextRef="From2025-01-012025-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000284"
      unitRef="USD">43146000</ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments>
    <ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000286"
      unitRef="USD">43146000</ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments>
    <SMX:IncreaseDecreaseThroughConversionOfShortTermLoan
      contextRef="From2025-01-012025-12-31_custom_IssuedAndAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000288"
      unitRef="USD">4134000</SMX:IncreaseDecreaseThroughConversionOfShortTermLoan>
    <SMX:IncreaseDecreaseThroughConversionOfShortTermLoan
      contextRef="From2025-01-012025-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000292"
      unitRef="USD">4134000</SMX:IncreaseDecreaseThroughConversionOfShortTermLoan>
    <SMX:IncreaseDecreaseThroughConversionOfShortTermLoan
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000294"
      unitRef="USD">4134000</SMX:IncreaseDecreaseThroughConversionOfShortTermLoan>
    <SMX:EquityIssuanceToInvestors
      contextRef="From2025-01-012025-12-31_custom_IssuedAndAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000296"
      unitRef="USD">10529000</SMX:EquityIssuanceToInvestors>
    <SMX:EquityIssuanceToInvestors
      contextRef="From2025-01-012025-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000300"
      unitRef="USD">10529000</SMX:EquityIssuanceToInvestors>
    <SMX:EquityIssuanceToInvestors
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000302"
      unitRef="USD">10529000</SMX:EquityIssuanceToInvestors>
    <ifrs-full:IssueOfEquity
      contextRef="From2025-01-012025-12-31_custom_IssuedAndAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000304"
      unitRef="USD">2639000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="From2025-01-012025-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000308"
      unitRef="USD">2639000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000310"
      unitRef="USD">2639000</ifrs-full:IssueOfEquity>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31_custom_IssuedAndAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000312"
      unitRef="USD">264629000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31_custom_TransactionWithNonControllingInterestMember"
      decimals="-3"
      id="Fact000313"
      unitRef="USD">258000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31_custom_ForeignCurrencyTranslationMember"
      decimals="-3"
      id="Fact000314"
      unitRef="USD">-4827000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      id="Fact000315"
      unitRef="USD">-251204000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000316"
      unitRef="USD">8856000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000317"
      unitRef="USD">10469000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000318"
      unitRef="USD">19325000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_custom_IssuedAndAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000320"
      unitRef="USD">62901000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_custom_ForeignCurrencyTranslationMember"
      decimals="-3"
      id="Fact000322"
      unitRef="USD">-491000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      id="Fact000323"
      unitRef="USD">-50934000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000324"
      unitRef="USD">11476000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000325"
      unitRef="USD">20768000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000326"
      unitRef="USD">32244000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      id="Fact000331"
      unitRef="USD">-31092000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2024-01-012024-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000332"
      unitRef="USD">-31092000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2024-01-012024-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000333"
      unitRef="USD">-4309000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000334"
      unitRef="USD">-35401000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2024-01-012024-12-31_custom_ForeignCurrencyTranslationMember"
      decimals="-3"
      id="Fact000338"
      unitRef="USD">-1306000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2024-01-012024-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000340"
      unitRef="USD">-1306000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2024-01-012024-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000341"
      unitRef="USD">41000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000342"
      unitRef="USD">-1265000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2024-01-012024-12-31_custom_ForeignCurrencyTranslationMember"
      decimals="-3"
      id="Fact000346"
      unitRef="USD">-1306000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      id="Fact000347"
      unitRef="USD">-31092000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2024-01-012024-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000348"
      unitRef="USD">-32398000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2024-01-012024-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000349"
      unitRef="USD">-4268000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000350"
      unitRef="USD">-36666000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:IssueOfEquity
      contextRef="From2024-01-012024-12-31_custom_IssuedAndAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000352"
      unitRef="USD">1684000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="From2024-01-012024-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000356"
      unitRef="USD">1684000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000358"
      unitRef="USD">1684000</ifrs-full:IssueOfEquity>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2024-01-012024-12-31_custom_IssuedAndAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000360"
      unitRef="USD">3657000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2024-01-012024-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000364"
      unitRef="USD">3657000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000366"
      unitRef="USD">3657000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments
      contextRef="From2024-01-012024-12-31_custom_IssuedAndAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000368"
      unitRef="USD">7529000</ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments>
    <ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments
      contextRef="From2024-01-012024-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000372"
      unitRef="USD">7529000</ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments>
    <ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000374"
      unitRef="USD">7529000</ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments>
    <SMX:IncreaseDecreaseThroughConversionOfBridgeLoanIntoOrdinarySharesWarrants
      contextRef="From2024-01-012024-12-31_custom_IssuedAndAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000376"
      unitRef="USD">128000</SMX:IncreaseDecreaseThroughConversionOfBridgeLoanIntoOrdinarySharesWarrants>
    <SMX:IncreaseDecreaseThroughConversionOfBridgeLoanIntoOrdinarySharesWarrants
      contextRef="From2024-01-012024-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000380"
      unitRef="USD">128000</SMX:IncreaseDecreaseThroughConversionOfBridgeLoanIntoOrdinarySharesWarrants>
    <SMX:IncreaseDecreaseThroughConversionOfBridgeLoanIntoOrdinarySharesWarrants
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000382"
      unitRef="USD">128000</SMX:IncreaseDecreaseThroughConversionOfBridgeLoanIntoOrdinarySharesWarrants>
    <SMX:IncreaseDecreaseThroughConversionOfPrePaidAdvancedIntoOrdinaryShares
      contextRef="From2024-01-012024-12-31_custom_IssuedAndAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000384"
      unitRef="USD">527000</SMX:IncreaseDecreaseThroughConversionOfPrePaidAdvancedIntoOrdinaryShares>
    <SMX:IncreaseDecreaseThroughConversionOfPrePaidAdvancedIntoOrdinaryShares
      contextRef="From2024-01-012024-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000388"
      unitRef="USD">527000</SMX:IncreaseDecreaseThroughConversionOfPrePaidAdvancedIntoOrdinaryShares>
    <SMX:IncreaseDecreaseThroughConversionOfPrePaidAdvancedIntoOrdinaryShares
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000390"
      unitRef="USD">527000</SMX:IncreaseDecreaseThroughConversionOfPrePaidAdvancedIntoOrdinaryShares>
    <SMX:IssuanceOfSharesOfInvestmentUnits
      contextRef="From2024-01-012024-12-31_custom_IssuedAndAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000392"
      unitRef="USD">2699000</SMX:IssuanceOfSharesOfInvestmentUnits>
    <SMX:IssuanceOfSharesOfInvestmentUnits
      contextRef="From2024-01-012024-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000396"
      unitRef="USD">2699000</SMX:IssuanceOfSharesOfInvestmentUnits>
    <SMX:IssuanceOfSharesOfInvestmentUnits
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000398"
      unitRef="USD">2699000</SMX:IssuanceOfSharesOfInvestmentUnits>
    <SMX:ExerciseOfWarrantsIntoOrdinarySharesNet
      contextRef="From2024-01-012024-12-31_custom_IssuedAndAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000400"
      unitRef="USD">10590000</SMX:ExerciseOfWarrantsIntoOrdinarySharesNet>
    <SMX:ExerciseOfWarrantsIntoOrdinarySharesNet
      contextRef="From2024-01-012024-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000404"
      unitRef="USD">10590000</SMX:ExerciseOfWarrantsIntoOrdinarySharesNet>
    <SMX:ExerciseOfWarrantsIntoOrdinarySharesNet
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000406"
      unitRef="USD">10590000</SMX:ExerciseOfWarrantsIntoOrdinarySharesNet>
    <SMX:StockIssuedDuringPeriodValueOfTransactionWithNonControllingInterests
      contextRef="From2024-01-012024-12-31_custom_IssuedAndAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000408"
      unitRef="USD">261000</SMX:StockIssuedDuringPeriodValueOfTransactionWithNonControllingInterests>
    <SMX:StockIssuedDuringPeriodValueOfTransactionWithNonControllingInterests
      contextRef="From2024-01-012024-12-31_custom_TransactionWithNonControllingInterestMember"
      decimals="-3"
      id="Fact000409"
      unitRef="USD">258000</SMX:StockIssuedDuringPeriodValueOfTransactionWithNonControllingInterests>
    <SMX:StockIssuedDuringPeriodValueOfTransactionWithNonControllingInterests
      contextRef="From2024-01-012024-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000412"
      unitRef="USD">519000</SMX:StockIssuedDuringPeriodValueOfTransactionWithNonControllingInterests>
    <SMX:StockIssuedDuringPeriodValueOfTransactionWithNonControllingInterests
      contextRef="From2024-01-012024-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000413"
      unitRef="USD">-519000</SMX:StockIssuedDuringPeriodValueOfTransactionWithNonControllingInterests>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_custom_IssuedAndAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000416"
      unitRef="USD">89976000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_custom_TransactionWithNonControllingInterestMember"
      decimals="-3"
      id="Fact000417"
      unitRef="USD">258000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_custom_ForeignCurrencyTranslationMember"
      decimals="-3"
      id="Fact000418"
      unitRef="USD">-1797000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      id="Fact000419"
      unitRef="USD">-82026000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000420"
      unitRef="USD">6411000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000421"
      unitRef="USD">15981000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000422"
      unitRef="USD">22392000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-12-31_custom_IssuedAndAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000424"
      unitRef="USD">32713000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-12-31_custom_ForeignCurrencyTranslationMember"
      decimals="-3"
      id="Fact000425"
      unitRef="USD">-537000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      id="Fact000426"
      unitRef="USD">-30020000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000427"
      unitRef="USD">2156000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000429"
      unitRef="USD">2156000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-12-31_custom_IssuedAndAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000431"
      unitRef="USD">32713000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-12-31_custom_ForeignCurrencyTranslationMember"
      decimals="-3"
      id="Fact000432"
      unitRef="USD">-537000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      id="Fact000433"
      unitRef="USD">-30020000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000434"
      unitRef="USD">2156000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000436"
      unitRef="USD">2156000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      id="Fact000440"
      unitRef="USD">-20914000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000441"
      unitRef="USD">-20914000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000442"
      unitRef="USD">-75000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000443"
      unitRef="USD">-20989000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2023-01-012023-12-31_custom_ForeignCurrencyTranslationMember"
      decimals="-3"
      id="Fact000446"
      unitRef="USD">46000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000448"
      unitRef="USD">46000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000449"
      unitRef="USD">17000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000450"
      unitRef="USD">63000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2023-01-012023-12-31_custom_ForeignCurrencyTranslationMember"
      decimals="-3"
      id="Fact000453"
      unitRef="USD">46000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      id="Fact000454"
      unitRef="USD">-20914000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000455"
      unitRef="USD">-20868000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000456"
      unitRef="USD">-58000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000457"
      unitRef="USD">-20926000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:IssueOfEquity
      contextRef="From2023-01-012023-12-31_custom_IssuedAndAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000459"
      unitRef="USD">4896000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000462"
      unitRef="USD">4896000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000464"
      unitRef="USD">4896000</ifrs-full:IssueOfEquity>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2023-01-012023-12-31_custom_IssuedAndAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000466"
      unitRef="USD">11460000</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000469"
      unitRef="USD">11460000</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000471"
      unitRef="USD">11460000</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2023-01-012023-12-31_custom_IssuedAndAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000473"
      unitRef="USD">3269000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000476"
      unitRef="USD">3269000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000478"
      unitRef="USD">3269000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments
      contextRef="From2023-01-012023-12-31_custom_IssuedAndAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000480"
      unitRef="USD">5955000</ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments>
    <ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments
      contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000483"
      unitRef="USD">5955000</ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments>
    <ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000485"
      unitRef="USD">5955000</ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="From2023-01-012023-12-31_custom_IssuedAndAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000487"
      unitRef="USD">10000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000490"
      unitRef="USD">10000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000492"
      unitRef="USD">10000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <SMX:IncreaseDecreaseIssuanceOfSharesAndWarrants
      contextRef="From2023-01-012023-12-31_custom_IssuedAndAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000494"
      unitRef="USD">1837000</SMX:IncreaseDecreaseIssuanceOfSharesAndWarrants>
    <SMX:IncreaseDecreaseIssuanceOfSharesAndWarrants
      contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000497"
      unitRef="USD">1837000</SMX:IncreaseDecreaseIssuanceOfSharesAndWarrants>
    <SMX:IncreaseDecreaseIssuanceOfSharesAndWarrants
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000499"
      unitRef="USD">1837000</SMX:IncreaseDecreaseIssuanceOfSharesAndWarrants>
    <SMX:ConversionOfWarrantsToOrdinaryShares
      contextRef="From2023-01-012023-12-31_custom_IssuedAndAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000501"
      unitRef="USD">1008000</SMX:ConversionOfWarrantsToOrdinaryShares>
    <SMX:ConversionOfWarrantsToOrdinaryShares
      contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000504"
      unitRef="USD">1008000</SMX:ConversionOfWarrantsToOrdinaryShares>
    <SMX:ConversionOfWarrantsToOrdinaryShares
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000506"
      unitRef="USD">1008000</SMX:ConversionOfWarrantsToOrdinaryShares>
    <SMX:ExerciseOfWarrantsNet
      contextRef="From2023-01-012023-12-31_custom_IssuedAndAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000508"
      unitRef="USD">888000</SMX:ExerciseOfWarrantsNet>
    <SMX:ExerciseOfWarrantsNet
      contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000511"
      unitRef="USD">888000</SMX:ExerciseOfWarrantsNet>
    <SMX:ExerciseOfWarrantsNet
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000513"
      unitRef="USD">888000</SMX:ExerciseOfWarrantsNet>
    <SMX:IssuanceOfWarrantsAfterReset
      contextRef="From2023-01-012023-12-31_custom_IssuedAndAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000515"
      unitRef="USD">865000</SMX:IssuanceOfWarrantsAfterReset>
    <SMX:IssuanceOfWarrantsAfterReset
      contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000518"
      unitRef="USD">865000</SMX:IssuanceOfWarrantsAfterReset>
    <SMX:IssuanceOfWarrantsAfterReset
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000520"
      unitRef="USD">865000</SMX:IssuanceOfWarrantsAfterReset>
    <ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000526"
      unitRef="USD">20826000</ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests>
    <ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000527"
      unitRef="USD">20826000</ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_custom_IssuedAndAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000529"
      unitRef="USD">62901000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_custom_ForeignCurrencyTranslationMember"
      decimals="-3"
      id="Fact000530"
      unitRef="USD">-491000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      id="Fact000531"
      unitRef="USD">-50934000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000532"
      unitRef="USD">11476000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000533"
      unitRef="USD">20768000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000534"
      unitRef="USD">32244000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_custom_IssuedAndAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000536"
      unitRef="USD">62901000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_custom_ForeignCurrencyTranslationMember"
      decimals="-3"
      id="Fact000537"
      unitRef="USD">-491000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      id="Fact000538"
      unitRef="USD">-50934000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000539"
      unitRef="USD">11476000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000540"
      unitRef="USD">20768000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000541"
      unitRef="USD">32244000</ifrs-full:Equity>
    <SMX:IncomeLossBeforeTax
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000547"
      unitRef="USD">-174590000</SMX:IncomeLossBeforeTax>
    <SMX:IncomeLossBeforeTax
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000548"
      unitRef="USD">-35401000</SMX:IncomeLossBeforeTax>
    <SMX:IncomeLossBeforeTax
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000549"
      unitRef="USD">-20914000</SMX:IncomeLossBeforeTax>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000551"
      unitRef="USD">114205000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000552"
      unitRef="USD">3657000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000553"
      unitRef="USD">3269000</ifrs-full:AdjustmentsForSharebasedPayments>
    <SMX:AdjustmentsForIssuanceOfRestrictedShares
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000555"
      unitRef="USD">7811000</SMX:AdjustmentsForIssuanceOfRestrictedShares>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000559"
      unitRef="USD">3450000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000560"
      unitRef="USD">2273000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000561"
      unitRef="USD">225000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000563"
      unitRef="USD">1239000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000564"
      unitRef="USD">140000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000565"
      unitRef="USD">2938000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000567"
      unitRef="USD">1542000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000568"
      unitRef="USD">2197000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdjustmentsForImpairmentLossRecognisedInProfitOrLossGoodwill
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000571"
      unitRef="USD">6025000</ifrs-full:AdjustmentsForImpairmentLossRecognisedInProfitOrLossGoodwill>
    <ifrs-full:AdjustmentsForImpairmentLossRecognisedInProfitOrLossGoodwill
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000572"
      unitRef="USD">6813000</ifrs-full:AdjustmentsForImpairmentLossRecognisedInProfitOrLossGoodwill>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000575"
      unitRef="USD">-862000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000576"
      unitRef="USD">-2780000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000577"
      unitRef="USD">2074000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInOtherOperatingPayables
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000579"
      unitRef="USD">-440000</ifrs-full:AdjustmentsForIncreaseDecreaseInOtherOperatingPayables>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInOtherOperatingPayables
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000580"
      unitRef="USD">1761000</ifrs-full:AdjustmentsForIncreaseDecreaseInOtherOperatingPayables>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInOtherOperatingPayables
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000581"
      unitRef="USD">-235000</ifrs-full:AdjustmentsForIncreaseDecreaseInOtherOperatingPayables>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000585"
      unitRef="USD">19000</ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000587"
      unitRef="USD">-1500000</ifrs-full:AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000588"
      unitRef="USD">1890000</ifrs-full:AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000589"
      unitRef="USD">1496000</ifrs-full:AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities>
    <SMX:AdjustmentsForIncreaseDecreaseInInterestExpenses
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000591"
      unitRef="USD">18812000</SMX:AdjustmentsForIncreaseDecreaseInInterestExpenses>
    <SMX:AdjustmentsForIncreaseDecreaseInInterestExpenses
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000592"
      unitRef="USD">6818000</SMX:AdjustmentsForIncreaseDecreaseInInterestExpenses>
    <SMX:AdjustmentsForIncreaseDecreaseInInterestExpenses
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000593"
      unitRef="USD">3899000</SMX:AdjustmentsForIncreaseDecreaseInInterestExpenses>
    <ifrs-full:AdjustmentsForFinanceIncomeCost
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000595"
      unitRef="USD">-44000</ifrs-full:AdjustmentsForFinanceIncomeCost>
    <ifrs-full:AdjustmentsForFinanceIncomeCost
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000596"
      unitRef="USD">-435000</ifrs-full:AdjustmentsForFinanceIncomeCost>
    <SMX:RemeasurementOfInvestmentInAssociatedCompany
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000601"
      unitRef="USD">22164000</SMX:RemeasurementOfInvestmentInAssociatedCompany>
    <ifrs-full:AdjustmentsForInterestExpense
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000603"
      unitRef="USD">3634000</ifrs-full:AdjustmentsForInterestExpense>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000609"
      unitRef="USD">-101000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <SMX:IssuanceOfOptionsToUnderwriters
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000611"
      unitRef="USD">990000</SMX:IssuanceOfOptionsToUnderwriters>
    <SMX:IssuanceOfOptionsToUnderwriters
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000612"
      unitRef="USD">238000</SMX:IssuanceOfOptionsToUnderwriters>
    <SMX:IssuanceOfOptionsToUnderwriters
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000613"
      unitRef="USD">11000</SMX:IssuanceOfOptionsToUnderwriters>
    <SMX:IssuanceCostDueToInducementWarrantExercisePrice
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000616"
      unitRef="USD">184000</SMX:IssuanceCostDueToInducementWarrantExercisePrice>
    <SMX:IssuanceOfOrdinarySharesDueToCommitmentFacilityFee
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000619"
      unitRef="USD">2639000</SMX:IssuanceOfOrdinarySharesDueToCommitmentFacilityFee>
    <SMX:IssuanceOfOrdinarySharesDueToCommitmentFacilityFee
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000620"
      unitRef="USD">460000</SMX:IssuanceOfOrdinarySharesDueToCommitmentFacilityFee>
    <SMX:ListingCosts
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000625"
      unitRef="USD">16802000</SMX:ListingCosts>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000627"
      unitRef="USD">-17001000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000628"
      unitRef="USD">-11314000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000629"
      unitRef="USD">-12479000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000636"
      unitRef="USD">21000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000637"
      unitRef="USD">60000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <SMX:CapitalizedDevelopmentCostClassifiedAsInvestingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000640"
      unitRef="USD">169000</SMX:CapitalizedDevelopmentCostClassifiedAsInvestingActivities>
    <SMX:CapitalizedDevelopmentCostClassifiedAsInvestingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000641"
      unitRef="USD">976000</SMX:CapitalizedDevelopmentCostClassifiedAsInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000644"
      unitRef="USD">-190000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000645"
      unitRef="USD">-1036000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:RepaymentsOfCurrentBorrowings
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000651"
      unitRef="USD">500000</ifrs-full:RepaymentsOfCurrentBorrowings>
    <SMX:RepaymentOfConvertibleNotes
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000655"
      unitRef="USD">563000</SMX:RepaymentOfConvertibleNotes>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000659"
      unitRef="USD">53000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000660"
      unitRef="USD">80000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000661"
      unitRef="USD">42000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000663"
      unitRef="USD">370000</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000664"
      unitRef="USD">34000</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000665"
      unitRef="USD">30000</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <SMX:RepaymentOfPrepaidAdvancesadvancePaymentForEquityNet
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000668"
      unitRef="USD">423000</SMX:RepaymentOfPrepaidAdvancesadvancePaymentForEquityNet>
    <SMX:RepaymentOfPrepaidAdvancesadvancePaymentForEquityNet
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000669"
      unitRef="USD">-2679000</SMX:RepaymentOfPrepaidAdvancesadvancePaymentForEquityNet>
    <SMX:ProceedsFromIssuanceOfShares
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000672"
      unitRef="USD">6945000</SMX:ProceedsFromIssuanceOfShares>
    <SMX:ProceedsFromIssuanceOfShares
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000673"
      unitRef="USD">2630000</SMX:ProceedsFromIssuanceOfShares>
    <SMX:ExerciseOfWarrantsAndPrefundedWarrantsOrdinaryShares
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000676"
      unitRef="USD">2399000</SMX:ExerciseOfWarrantsAndPrefundedWarrantsOrdinaryShares>
    <SMX:ExerciseOfWarrantsAndPrefundedWarrantsOrdinaryShares
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000677"
      unitRef="USD">642000</SMX:ExerciseOfWarrantsAndPrefundedWarrantsOrdinaryShares>
    <ifrs-full:ProceedsFromIssueOfBondsNotesAndDebentures
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000679"
      unitRef="USD">31231000</ifrs-full:ProceedsFromIssueOfBondsNotesAndDebentures>
    <ifrs-full:ProceedsFromIssueOfBondsNotesAndDebentures
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000680"
      unitRef="USD">3303000</ifrs-full:ProceedsFromIssueOfBondsNotesAndDebentures>
    <ifrs-full:ProceedsFromIssueOfBondsNotesAndDebentures
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000681"
      unitRef="USD">2606000</ifrs-full:ProceedsFromIssueOfBondsNotesAndDebentures>
    <ifrs-full:ProceedsFromCurrentBorrowings
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000684"
      unitRef="USD">1000000</ifrs-full:ProceedsFromCurrentBorrowings>
    <SMX:ProceedsFromIssuanceOfBridgeLoansAndWarrants
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000689"
      unitRef="USD">550000</SMX:ProceedsFromIssuanceOfBridgeLoansAndWarrants>
    <ifrs-full:ProceedsFromIssuingOtherEquityInstruments
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000693"
      unitRef="USD">2919000</ifrs-full:ProceedsFromIssuingOtherEquityInstruments>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000695"
      unitRef="USD">29745000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000696"
      unitRef="USD">13110000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000697"
      unitRef="USD">11954000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000699"
      unitRef="USD">12744000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000700"
      unitRef="USD">1606000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000701"
      unitRef="USD">-1561000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000703"
      unitRef="USD">2343000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000704"
      unitRef="USD">168000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000705"
      unitRef="USD">1398000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000707"
      unitRef="USD">-2886000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000708"
      unitRef="USD">569000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000709"
      unitRef="USD">331000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000711"
      unitRef="USD">12201000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000712"
      unitRef="USD">2343000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000713"
      unitRef="USD">168000</ifrs-full:CashAndCashEquivalents>
    <SMX:ConversionOfLiabilityToOrdinaryShares
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000719"
      unitRef="USD">4134000</SMX:ConversionOfLiabilityToOrdinaryShares>
    <SMX:ConversionOfLiabilityToOrdinaryShares
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000720"
      unitRef="USD">645000</SMX:ConversionOfLiabilityToOrdinaryShares>
    <SMX:ConversionOfLiabilityToOrdinaryShares
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000721"
      unitRef="USD">5330000</SMX:ConversionOfLiabilityToOrdinaryShares>
    <SMX:ConversionOfBridgeLoansIntoOrdinarySharesAndWarrants
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000723"
      unitRef="USD">6000</SMX:ConversionOfBridgeLoansIntoOrdinarySharesAndWarrants>
    <SMX:ConversionOfBridgeLoansIntoOrdinarySharesAndWarrants
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000724"
      unitRef="USD">128000</SMX:ConversionOfBridgeLoansIntoOrdinarySharesAndWarrants>
    <SMX:ConversionOfBridgeLoansIntoOrdinarySharesAndWarrants
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000725"
      unitRef="USD">5192000</SMX:ConversionOfBridgeLoansIntoOrdinarySharesAndWarrants>
    <SMX:ConversionOfConvertibleNotesAndWarrantsIntoOrdinaryShares
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000727"
      unitRef="USD">43146000</SMX:ConversionOfConvertibleNotesAndWarrantsIntoOrdinaryShares>
    <SMX:ConversionOfConvertibleNotesAndWarrantsIntoOrdinaryShares
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000728"
      unitRef="USD">8530000</SMX:ConversionOfConvertibleNotesAndWarrantsIntoOrdinaryShares>
    <SMX:ConversionOfConvertibleNotesAndWarrantsIntoOrdinaryShares
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000729"
      unitRef="USD">175000</SMX:ConversionOfConvertibleNotesAndWarrantsIntoOrdinaryShares>
    <SMX:ExerciseOfCashlessOptionsIntoOrdinaryShares
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000732"
      unitRef="USD">314000</SMX:ExerciseOfCashlessOptionsIntoOrdinaryShares>
    <SMX:ExerciseOfCashlessOptionsIntoOrdinaryShares
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000733"
      unitRef="USD">2925000</SMX:ExerciseOfCashlessOptionsIntoOrdinaryShares>
    <SMX:ExerciseOfWarrantsAndPrefundedWarrantsIntoOrdinaryShares
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000736"
      unitRef="USD">4824000</SMX:ExerciseOfWarrantsAndPrefundedWarrantsIntoOrdinaryShares>
    <SMX:ExerciseOfWarrantsAndPrefundedWarrantsIntoOrdinaryShares
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000737"
      unitRef="USD">1008000</SMX:ExerciseOfWarrantsAndPrefundedWarrantsIntoOrdinaryShares>
    <SMX:SharesIssuanceCost
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000740"
      unitRef="USD">152000</SMX:SharesIssuanceCost>
    <SMX:OtherCurrentReceivableInConnectionToExerciseOfWarrant
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000744"
      unitRef="USD">1510000</SMX:OtherCurrentReceivableInConnectionToExerciseOfWarrant>
    <SMX:RemeasurementOfInvestment
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000749"
      unitRef="USD">-22164000</SMX:RemeasurementOfInvestment>
    <SMX:IssuanceOfWarrants
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000751"
      unitRef="USD">-1728000</SMX:IssuanceOfWarrants>
    <ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000755">&lt;p id="xdx_808_eifrs-full--DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_zCA8TMFTzHC6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
1 - &lt;span id="xdx_825_zsuARoLU4Bt7"&gt;GENERAL&lt;/span&gt;:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SMX
    (Security Matters) Public Limited Company (&#x201c;Security Matters&#x201d; or the &#x201c;Company&#x201d; and together with its subsidiaries,
    the &#x201c;Group&#x201d; or the &#x201c;consolidated entity&#x201d;) was incorporated on July 1, 2022 under the laws of Ireland with
    registered number 722009 and its registered office at Mespil Business Center, Mespil House, Sussex Road, Dublin 4, Ireland, D04 T4A6.
    The Company was incorporated in 2022 as part of the Business Combination (see Note 1.B). &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group provides one solution to solve both authentication and track challenges in order to uphold supply chain integrity and provide quality
assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader and
an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process
(or any other marked good along a supply chain) to the end producer. Its proprietary marker system embeds a permanent or removable (depending
on the needs of the customer) mark on solid, liquid or gaseous objects or materials. Each marker is comprised of a combination of marker
codes such that each marker is designed to be unique and unable to be duplicated. The marker system is coupled with an innovative patented
reader that responds to signals from the marker and, together with a patented algorithm, captures the details of the product retrieved
and stored on a blockchain digital ledger. Each marker can be stored, either locally on the reader and on private servers, cloud servers
or on a blockchain ledger, to protect data integrity and custody.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company continues to expand its strategic focus across multiple high-growth sectors, including advanced materials, precious metals, and
circular economy solutions. This includes expansion into key global markets such as Europe, Asia (e.g Japan, Korea, Singapore) and the
Middle East (e.g. UAE), development of digital asset capabilities including tokenization of materials, and integration of complementary
technologies to deliver end-to-end solutions to clients. The Company is also advancing applications across industries including automotive,
electronics, and critical minerals, positioning its platform as a comprehensive infrastructure layer for supply chain traceability and
circularity&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is developing capabilities for the tokenization of physical materials, enabling the creation of digital assets backed by verified
physical provenance, including applications in metals and other high-value materials.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;B.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    March 7, 2023 (the &#x201c;Closing Date&#x201d;) the Company completed its SPAC transaction (the &#x201c;Business Combination&#x201d;)
    with Lionheart III Corp (&#x201c;Lionheart&#x201d;), following that Lionheart and Security Matters PTY Ltd. (formerly named Security
    Matters Limited, which was incorporated in May 2018 under Australian law) became the Company&#x2019;s wholly-owned subsidiaries and
    the Company listed its ordinary shares and public warrants on the NASDAQ stock market under the tickers SMX and SMXWW, respectively.
    On July 26, 2022, Security Matters PTY Ltd. and Lionheart, a publicly traded special purpose acquisition company (SPAC), entered
    into a business combination agreement (the &#x201c;BCA&#x201d;) and accompanying scheme implementation deed (&#x201c;SID&#x201d;). Under
    the BCA, the existing Lionheart stockholders received the Company&#x2019;s shares and warrants in exchange for their existing Lionheart
    shares and warrants and all shares existed in Security Matters PTY Ltd. were cancelled in return for the Company&#x2019;s shares and
    resulting in Security Matters PTY Ltd. becoming a wholly owned subsidiary of the Company. Security Matters PTY Ltd. shareholders
    received consideration of &lt;span id="xdx_901_eifrs-full--NumberOfSharesIssued_iI_pid_c20220726__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--CounterpartiesAxis__custom--SecurityMattersPTYLtdMember_zv8aBSgD13b8" title="Number of shares issued"&gt;1&lt;/span&gt; ordinary share per &lt;span id="xdx_90A_ecustom--ShareIssuedPricePerShare_iI_pid_c20220726__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--CounterpartiesAxis__custom--SecurityMattersPTYLtdMember_zKTi2HxDYU39" title="Share price"&gt;10.3624&lt;/span&gt; Security Matters PTY Ltd. shares, having an implied value of $&lt;span id="xdx_906_eifrs-full--ParValuePerShare_iI_pid_c20220726__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--CounterpartiesAxis__custom--SecurityMattersPTYLtdMember_znEIVDKAl6w7" title="Par value per share"&gt;10.00&lt;/span&gt; per ordinary
    share and the Company became the holder of all of the issued shares in Security Matters PTY Ltd. and Lionheart, with Security Matters
    PTY Ltd. being delisted from the Australian Stock Exchange.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Business Combination resulted in &lt;span id="xdx_906_ecustom--RedemptionPercentageOfBusinessCombination_pid_dp_uPure_c20220726__20220726__ifrs-full--BusinessCombinationsAxis__custom--LionheartMember__ifrs-full--TypesOfContractsAxis__custom--BusinessCombinationAgreementMember_zlzHrcDbEK07" title="Redemption percentage of business combination"&gt;97.58&lt;/span&gt;% redemption by Lionheart&#x2019;s public shareholders which resulted in leaving $&lt;span id="xdx_90E_ecustom--RemainingFundsInTrustAccount_pn3n3_c20220726__20220726__ifrs-full--BusinessCombinationsAxis__custom--LionheartMember__ifrs-full--TypesOfContractsAxis__custom--BusinessCombinationAgreementMember_z9kNZzpKZafc" title="Remaining funds in trust account"&gt;3,061&lt;/span&gt; of funds
remaining in the trust account.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -14.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    October 3, 2023, the Company signed an agreement with True Gold Consortium Pty Ltd.&#x2019;s (&#x201c;TrueGold&#x201d;) shareholders
    to acquire an additional &lt;span id="xdx_90C_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_c20231003__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TrueGoldConsortiumPtyLtdMember_zlPaGLIt1ZNi" title="Percentage of interests acquired additional"&gt;7.5&lt;/span&gt;% which increased the Company&#x2019;s holdings to &lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20231003__20231003__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TrueGoldConsortiumPtyLtdMember_zftU8j3ckl9l"&gt;51.9&lt;/span&gt;% in TrueGold and resulted in the Company&#x2019;s
    gaining control over TrueGold. On July 10, 2024, the Company&#x2019;s ownership percentage in TrueGold increased from &lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20231003__20231003__ifrs-full--BusinessCombinationsAxis__custom--TrueGoldConsortiumPtyLtdMember_zVouAoWZkmB2" title="Percentage of holding interests"&gt;51.9&lt;/span&gt;% to &lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20240701__20240731__ifrs-full--BusinessCombinationsAxis__custom--TrueGoldConsortiumPtyLtdMember_zcgHGHE1egH6" title="Percentage of holding interests"&gt;52.9&lt;/span&gt;%
    as part of the LOI agreement with PMB.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -14.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;D.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
                                            of December 31, 2025, the Company incurred accumulated losses of $&lt;span id="xdx_908_eifrs-full--RetainedEarningsProfitLossForReportingPeriod_iNI_pn6n6_di_c20251231_zD7N0NxDY8ul" title="Accumulated losses"&gt;251&lt;/span&gt; million and continued
                                            to incurred operating losses and negative cash flows from operating activities during to
                                            date of these financial statements. The Company has not yet generated revenues and is required
                                            to obtain additional financing in order to continue to operate. The Company continues to actively manage its capital structure through a combination of equity financing, strategic partnerships, and access
to committed capital facilities. These initiatives are designed to support the Company&#x2019;s transition toward large-scale commercialization.
While additional funding will be required to support long-term growth, management believes that the Company&#x2019;s current strategy and
access to capital provide a reasonable basis to continue operations. The accompanying consolidated
                                            financial statements have been prepared assuming that the Company will continue as a going
                                            concern.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 85%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
1 &#x2013; GENERAL (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the period, the Company entered into convertible securities funding agreements up to $&lt;span id="xdx_902_ecustom--DebtIssued_iI_pn5n6_c20251231__ifrs-full--TypesOfContractsAxis__custom--ConvertibleSecuritiesFundingAgreementsMember_zSUC5Gs67aU3" title="Debt issued"&gt;42.8&lt;/span&gt;
million of principal amount before 20% Original Issuance Discount (&#x201c;OID&#x201d;) and a Standby Equity Purchase Agreement of
$&lt;span id="xdx_909_ecustom--DebtIssued_iI_pn5n6_c20251231__ifrs-full--TypesOfContractsAxis__custom--StandbyEquityPurchaseAgreementMember_zjOrnY4GF20a" title="Debt issued"&gt;100&lt;/span&gt;
million (hereafter &#x201c;SEPA&#x201d;) in addition to cash repayment of bridge loans, short term loan and convertible note in the
amount of $&lt;span id="xdx_90D_eifrs-full--ShorttermBorrowings_iI_pn3n3_c20251231__ifrs-full--TypesOfContractsAxis__custom--FundingAgreementsMember_zUEN2OV2C7Gc" title="Short term loan"&gt;1,433&lt;/span&gt;.
The Company plans to continue the issuance of shares and warrants and secure convertible notes and other funding sources such as the
increase of the SEPA by additional $&lt;span id="xdx_904_eifrs-full--ShareIssueRelatedCost_pn6n6_c20250101__20251231__ifrs-full--TypesOfContractsAxis__custom--StandbyEquityPurchaseAgreementMember_z1UgfpFtScA1" title="Issuance of shares and warrants"&gt;150&lt;/span&gt;
million (see note 26.2). While future funding remains subject to market conditions, the Company continues to actively pursue
multiple financing pathways, including equity facilities, strategic investors, and capital markets initiatives, to support its
operational and commercialization objectives. There are no assurances, however, that the Company will be able to obtain an adequate
level of financial resources that are required for the Company&#x2019;s long-term business plan. Considering the above, the
Company&#x2019;s dependency on external funding for its operations raises a substantial doubt about the Company&#x2019;s ability to
continue to operate as a going concern. The consolidated financial statements do not include any adjustments that might result from
the outcome of these uncertainties.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;E.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Company operates primarily with 9 wholly owned subsidiaries and 2 majority owned subsidiaries, all of which have been consolidated
    in these consolidated financial statements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_897_eifrs-full--DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_zgohH0K346r" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: -14.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&#160;&lt;span id="xdx_8B3_zKYQpcj1yPp1" style="display: none"&gt;SCHEDULE
OF COMPANIES SUBSIDIARIES&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 97%; margin-left: 0.25in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Controlled entity&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Country of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Incorporation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Percentage&lt;br/&gt; Owned&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;br/&gt; 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Percentage&lt;br/&gt; Owned&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;br/&gt; 2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;Security Matters (SMX) PLC&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; width: 14%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersSmxPlcMember_zBr6LN5hQqvb"&gt;Ireland&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersSmxPlcMember_zUXgK5uv3vU2"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersSmxPlcMember_zKi39G28Ffg1"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Security Matters PTY Ltd. &lt;br/&gt; (Formerly - Security Matters Limited)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersPTYLtdMember_zDZ55wgYs5B2"&gt;Australia&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersPTYLtdMember_zK9hluTnwaD7"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersPTYLtdMember_z6QkeDMBfa1d"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Lionheart III Corp&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--LionheartIIICorpMember_zCPrRcgHo3kk"&gt;USA&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--LionheartIIICorpMember_zruaSNV8xIJi"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--LionheartIIICorpMember_zCgOuWSw4rlf"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;SMX (Security Matters) Ireland Limited&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIrelandLimitedMember_zqwBe0hmO6hf"&gt;Ireland&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIrelandLimitedMember_zPD6puUD7Ts1"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIrelandLimitedMember_zsQs1iGYVXZ2"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;SMX Fashion and Luxury&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXFashionAndLuxuryMember_zQG7wmKn2k6e"&gt;France&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXFashionAndLuxuryMember_z51w51PDbQ45"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXFashionAndLuxuryMember_zGXCK89DSr9l"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;TrueSilver SMX Platform Ltd.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TrueSilverSMXPlatformLtdMember_zIkLGFNW5d67"&gt;Canada&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TrueSilverSMXPlatformLtdMember_zSjcG5eJ4cq8"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TrueSilverSMXPlatformLtdMember_zZINfuIwMoje"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;SMX (Security Matters) Israel Ltd. &lt;br/&gt; (Formerly - Security Matters Ltd.)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIsraelLtdMember_zLgdWQNdbF0b"&gt;Israel&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIsraelLtdMember_zeJbAgUa67oe"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIsraelLtdMember_zUUmdPk1IqGh"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Security Matters Canada Ltd.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersCanadaLtdMember_zq35iIcLHGec"&gt;Canada&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersCanadaLtdMember_zpHf9kMSmkJh"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersCanadaLtdMember_zU5VUytxxid4"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;SMX Beverages Pty Ltd.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXBeveragesPtyLtdMember_zNE20bEgS0j4"&gt;Australia&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXBeveragesPtyLtdMember_z8rZ9oZo0M82"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXBeveragesPtyLtdMember_zVIQLmrGYSeb"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;SMX Circular Economy Platform PTE, Ltd.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXCircularEconomyPlatformPTELtdMember_zMx3eK7tQfjk"&gt;Singapore&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXCircularEconomyPlatformPTELtdMember_z2igwrV4dgL4"&gt;70&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXCircularEconomyPlatformPTELtdMember_zwoO09W49b3"&gt;70&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;True Gold Consortium Pty Ltd.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TrueGoldConsortiumPtyLtdMember_zrfQ5nr7qqkc"&gt;Australia&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TrueGoldConsortiumPtyLtdMember_zwwOvc4hPBRj"&gt;52.9&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TrueGoldConsortiumPtyLtdMember_z8F7KKiWvso7"&gt;52.9&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;SMX Circular Economy FZCO *&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXCircularEconomyFZCOLtdMember_fKg_____zLzUMzVX4xZd"&gt;UAE&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXCircularEconomyFZCOLtdMember_fKg_____zFzNfth0cHAi"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXCircularEconomyFZCOLtdMember_fKg_____zGxIM1cEh6sl"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0820"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
addition, the Company&#x2019;s has the following investments in associated company:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 97%; margin-left: 0.25in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Entity&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Country of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Incorporation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Percentage Owned&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;br/&gt; 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Percentage Owned&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;br/&gt; 2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: justify"&gt;Yahaloma Technologies Inc.&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--YahalomaTechnologiesIncMember_zg5Yaf42RHde"&gt;Canada&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--YahalomaTechnologiesIncMember_zcQ6e8e2Cknk"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--YahalomaTechnologiesIncMember_zo53zVaksphe"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
proportion of ownership interest is equal to the proportion of voting power held.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 14.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F04_zEdeZq2xKdVl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F18_zSzBYYDeFNBl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    March 26, 2025, the Company established a fully owned entity incorporated in Dubai Multi Commodities Centre Authority, United Arab
    Emirates. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;*&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;The Company&#x2019;s Irish structure supports its intellectual property strategy, enhancing protection, licensing efficiency, and future
revenue generation from its technology portfolio&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AE_zgivlT7mKJDi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 85%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
1 &#x2013; GENERAL (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;F.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    July 15, 2024, the Company&#x2019;s Ordinary Shares began trading on the Nasdaq Capital Market post-reverse stock split of 75:1 under
    the symbol &#x201c;SMX,&#x201d; with a new CUSIP number of G8267K208 and ISIN code IE000IG23NR9. Approved by shareholders and Board
    of Directors on June 11, 2024. This &lt;span id="xdx_90A_ecustom--ReverseStockSplitRatioDescription_c20240715__20240715_zyI6OVzZ7CGc" title="Reverse stock split"&gt;reverse split consolidated every 75 shares into one new ordinary share and was aimed at meeting
    Nasdaq&#x2019;s minimum bid price requirement of $&lt;span id="xdx_901_ecustom--MinimumBidPrice_iI_pid_c20240715__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zOd8DrJ6mHB3" title="Minimum bid price"&gt;1.00&lt;/span&gt; per share&lt;/span&gt;, reducing the number of outstanding shares from approximately &lt;span id="xdx_90F_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_c20240714__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zQxsTvbx1y9k" title="Number of outstanding shares"&gt;44.8&lt;/span&gt;
    million to approximately &lt;span id="xdx_90A_eifrs-full--NumberOfSharesOutstanding_iI_pn3n3_c20240715__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zcZbUCjggEp7" title="Number of outstanding shares"&gt;597&lt;/span&gt; thousand. Fractional shares resulting from the split were aggregated and sold at market prices. Additionally,
    the par value of the Ordinary Shares increased from $&lt;span id="xdx_906_eifrs-full--ParValuePerShare_iI_pid_c20240714__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z8qlRucq7ag8" title="Par value per share"&gt;0.0022&lt;/span&gt; to $&lt;span id="xdx_902_eifrs-full--ParValuePerShare_iI_pid_c20240715__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z1VbxBzXwRJ5" title="Par value per share"&gt;0.165&lt;/span&gt;. The Company&#x2019;s options, warrants, and convertible securities
    were adjusted proportionately, and the Public Limited Company Constitution was amended to reflect these changes. All share, options
    and warrants amount in these December 31, 2025, financial statements are presented post this reverse stock split. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;G.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            January 15, 2025, the Company&#x2019;s Ordinary Shares began trading on the Nasdaq Capital
                                            Market post-reverse stock split of 28.5:1 under the symbol &#x201c;SMX,&#x201d; with a new
                                            CUSIP number of G8267K158 and ISIN code IE000WZ90ZV5. Approved by shareholders and Board
                                            of Directors on December 10, 2024. This &lt;span id="xdx_90B_ecustom--ReverseStockSplitRatioDescription_c20250115__20250115_zA19byBlxqI7" title="Reverse stock split"&gt;reverse split consolidated every 28.5 shares into
                                            one new ordinary share and was aimed at meeting Nasdaq&#x2019;s minimum bid price requirement
                                            of $&lt;span id="xdx_90D_ecustom--MinimumBidPrice_iI_pid_c20250115__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zutJvfdU1h8d" title="Minimum bid price"&gt;1.00&lt;/span&gt; per share&lt;/span&gt;, reducing the number of outstanding shares from approximately &lt;span id="xdx_900_eifrs-full--NumberOfSharesOutstanding_iI_pn3n3_c20250114__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z5sbcUFWvDlf" title="Number of outstanding shares"&gt;33,155&lt;/span&gt; thousand
                                            to approximately &lt;span id="xdx_902_eifrs-full--NumberOfSharesOutstanding_iI_pn3n3_c20250115__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zRE69QdwCcj" title="Number of outstanding shares"&gt;1,163&lt;/span&gt; thousand. Fractional shares resulting from the split were aggregated
                                            and sold at market prices. Additionally, the par value of the Ordinary Shares increased from
                                            $&lt;span id="xdx_901_eifrs-full--ParValuePerShare_iI_pid_c20250114__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zdzHz0E65nx8" title="Par value per share"&gt;0.165&lt;/span&gt; to $&lt;span id="xdx_90E_eifrs-full--ParValuePerShare_iI_pid_c20250115__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zXGreQBIyEik" title="Par value per share"&gt;4.70250014886352&lt;/span&gt;. The Company&#x2019;s options, warrants, and convertible securities
                                            were adjusted proportionately, and the Public Limited Company Constitution was amended to
                                            reflect these changes. All share, options and warrants amount in these December 31, 2025,
                                            financial statements are presented post this reverse stock split.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;H.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    June 16, 2025, the Company&#x2019;s Ordinary Shares began trading on the Nasdaq Capital Market post-reverse stock split of 4.1:1 under
    the symbol &#x201c;SMX,&#x201d; with a new CUSIP number of G8267K 166 and the new ISIN code IE000B8AU702. Approved by shareholders
    and Board of Directors on April 15, 2025, this &lt;span id="xdx_90F_ecustom--ReverseStockSplitRatioDescription_c20250616__20250616_zrNb4LS9qtA3" title="Reverse stock split"&gt;reverse split consolidated every 4.1 shares into one new ordinary share and was aimed
    at meeting Nasdaq&#x2019;s minimum bid price requirement of $&lt;span id="xdx_908_ecustom--MinimumBidPrice_iI_pid_c20250616__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z2MeveppJn1j" title="Minimum bid price"&gt;1.00&lt;/span&gt; per share&lt;/span&gt;, reducing the number of outstanding shares from approximately
    &lt;span id="xdx_902_eifrs-full--NumberOfSharesOutstanding_iI_pn6n6_c20250615__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zmLZyE4QcsZf" title="Number of outstanding shares"&gt;4&lt;/span&gt; million to approximately &lt;span id="xdx_90D_eifrs-full--NumberOfSharesOutstanding_iI_pn6n6_c20250616__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zSVv9UsoMp1" title="Number of outstanding shares"&gt;1&lt;/span&gt; million. Fractional shares resulting from the split were aggregated and sold at market prices. Additionally,
    the par value of the ordinary shares will be increased from $&lt;span id="xdx_908_eifrs-full--ParValuePerShare_iI_pid_c20250615__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zDAeSb1YshT6" title="Par value per share"&gt;0.00000000000001&lt;/span&gt; to $&lt;span id="xdx_90A_eifrs-full--ParValuePerShare_iI_pid_c20250616__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zsVpTIiautwi" title="Par value per share"&gt;0.000000000000041&lt;/span&gt;. The Company&#x2019;s options,
    warrants, and convertible securities were adjusted proportionately, and the Public Limited Company Constitution was amended to reflect
    these changes. The Basic and diluted loss per share attributable to shareholders amount in these December 31, 2025, financial statements
    are presented post this reverse stock split.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;I.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            August 7, 2025, the Company&#x2019;s Ordinary Shares began trading on the Nasdaq Capital Market
                                            post- reverse stock split of 7:1 under the symbol &#x201c;SMX,&#x201d; with a new CUSIP number
                                            of G8267K2174 and the new ISIN code IE000TB5RTG4. Approved by shareholders and Board of Directors
                                            on July 10, 2025, this &lt;span id="xdx_904_ecustom--ReverseStockSplitRatioDescription_c20250807__20250807_zqBwLdBHned3" title="Reverse stock split"&gt;reverse split consolidated every 7.0 shares into one new ordinary
                                            share and was aimed at meeting Nasdaq&#x2019;s minimum bid price requirement of $&lt;span id="xdx_908_ecustom--MinimumBidPrice_iI_pid_c20250807__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zs9XPf7WUPkd" title="Minimum bid price"&gt;1.00&lt;/span&gt; per
                                            share&lt;/span&gt;, reducing the number of outstanding shares from approximately &lt;span id="xdx_90E_eifrs-full--NumberOfSharesOutstanding_iI_pn6n6_c20250806__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zjAxFsRSyh67" title="Number of outstanding shares"&gt;9&lt;/span&gt; million to approximately
                                            &lt;span id="xdx_90D_eifrs-full--NumberOfSharesOutstanding_iI_pn6n6_c20250807__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zoOugiIGmEYf" title="Number of outstanding shares"&gt;1&lt;/span&gt; million. Fractional shares resulting from the split were aggregated and sold at market
                                            prices. Additionally, the par value of the ordinary shares will be increased from $&lt;span id="xdx_908_eifrs-full--ParValuePerShare_iI_pid_c20250806__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zRUDR0hS1c0l" title="Par value per share"&gt;0.00000000000041&lt;/span&gt;
                                            to $&lt;span id="xdx_90B_eifrs-full--ParValuePerShare_iI_pid_c20250807__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zVkwZarp5aei" title="Par value per share"&gt;0.000000000000287&lt;/span&gt;. The Company&#x2019;s options, warrants, and convertible securities
                                            were adjusted proportionately, and the Public Limited Company Constitution was amended to
                                            reflect these changes. The Basic and diluted loss per share attributable to shareholders
                                            amount in these December 31, 2025, financial statements are presented post this reverse stock
                                            split.&lt;/span&gt;&lt;/p&gt;
                                                                     &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
1 &#x2013; GENERAL (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;J.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    October 23, 2025, the Company&#x2019;s Ordinary Shares began trading on the Nasdaq Capital Market post-reverse stock split of 10.89958:1
    under the symbol &#x201c;SMX,&#x201d; with a new CUSIP number of G8267K182 and the new ISIN code IE000UPDVNX9. Approved by shareholders
    and Board of Directors on July 10, 2025, this &lt;span id="xdx_904_ecustom--ReverseStockSplitRatioDescription_c20251023__20251023_zTCjqdTGKnP4" title="Reverse stock split"&gt;reverse split consolidated every 10.89958 shares into one new ordinary share and was
    aimed at meeting Nasdaq&#x2019;s minimum bid price requirement of $&lt;span id="xdx_908_ecustom--MinimumBidPrice_iI_pid_c20251023__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z7lZb3WnACt2" title="Minimum bid price"&gt;1.00&lt;/span&gt; per share&lt;/span&gt;, reducing the number of outstanding shares from
    approximately &lt;span id="xdx_907_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_c20251022__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zzUlvo86ooxf" title="Number of outstanding shares"&gt;15.5&lt;/span&gt; million to approximately &lt;span id="xdx_908_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_c20251023__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zyS6pqBPf7sd" title="Number of outstanding shares"&gt;1.4&lt;/span&gt; million. Fractional shares resulting from the split were aggregated and sold at market
    prices. Additionally, the par value of the ordinary shares will be increased from $&lt;span id="xdx_90F_eifrs-full--ParValuePerShare_iI_pid_c20251022__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zdiPZ0m805X5" title="Par value per share"&gt;0.000000000000287&lt;/span&gt; to $&lt;span id="xdx_907_eifrs-full--ParValuePerShare_iI_pid_c20251023__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zr4vmz9CC7a9" title="Par value per share"&gt;0.00000000000312817946&lt;/span&gt;.
    The Company&#x2019;s options, warrants, and convertible securities were adjusted proportionately, and the Public Limited Company Constitution
    was amended to reflect these changes. The Basic and diluted loss per share attributable to shareholders amount in these December
    31, 2025, financial statements are presented post this reverse stock split.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;K.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    November 18, 2025, the Company&#x2019;s Ordinary Shares began trading on the Nasdaq Capital Market post-reverse stock split of 8:1
    under the symbol &#x201c;SMX,&#x201d; with a new CUSIP number of G8267K307 and the new ISIN code IE000UPDVNX9. Approved by shareholders
    and Board of Directors on July 10, 2025, this &lt;span id="xdx_90C_ecustom--ReverseStockSplitRatioDescription_c20251118__20251118_zAGyHd9L7oJ3" title="Reverse stock split"&gt;reverse split consolidated every 8 shares into one new ordinary share and was aimed
    at meeting Nasdaq&#x2019;s minimum bid price requirement of $&lt;span id="xdx_905_ecustom--MinimumBidPrice_iI_pid_c20251118__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zDJHmAWfSrT" title="Minimum bid price"&gt;1.00&lt;/span&gt; per share&lt;/span&gt;, reducing the number of outstanding shares from approximately
    &lt;span id="xdx_90D_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_c20251117__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zbVCdlMiDxRj" title="Number of outstanding shares"&gt;8.4&lt;/span&gt; million to approximately &lt;span id="xdx_903_eifrs-full--NumberOfSharesOutstanding_iI_pn4n6_c20251118__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zp1jZx42OICf" title="Number of outstanding shares"&gt;1.05&lt;/span&gt; million. Fractional shares resulting from the split were aggregated and sold at market prices.
    Additionally, the par value of the ordinary shares will be increased from $&lt;span id="xdx_90B_eifrs-full--ParValuePerShare_iI_pid_c20251117__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zcWzL1Dhms7c" title="Par value per share"&gt;0.00000000000312817946&lt;/span&gt; to $&lt;span id="xdx_903_eifrs-full--ParValuePerShare_iI_pid_c20251118__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zBeaVcZ8ahI2" title="Par value per share"&gt;0.00000000002502543568&lt;/span&gt; per
    share. The Company&#x2019;s options, warrants, and convertible securities were adjusted proportionately, and the Public Limited Company
    Constitution was amended to reflect these changes. The Basic and diluted loss per share attributable to shareholders amount in these
    December 31, 2025, financial statements are presented post this reverse stock split. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2022-07-26_ifrs-full_OrdinarySharesMember_custom_SecurityMattersPTYLtdMember"
      decimals="INF"
      id="Fact000757"
      unitRef="Shares">1</ifrs-full:NumberOfSharesIssued>
    <SMX:ShareIssuedPricePerShare
      contextRef="AsOf2022-07-26_ifrs-full_OrdinarySharesMember_custom_SecurityMattersPTYLtdMember"
      decimals="INF"
      id="Fact000759"
      unitRef="USDPShares">10.3624</SMX:ShareIssuedPricePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2022-07-26_ifrs-full_OrdinarySharesMember_custom_SecurityMattersPTYLtdMember"
      decimals="INF"
      id="Fact000761"
      unitRef="USDPShares">10.00</ifrs-full:ParValuePerShare>
    <SMX:RedemptionPercentageOfBusinessCombination
      contextRef="From2022-07-262022-07-26_custom_LionheartMember_custom_BusinessCombinationAgreementMember"
      decimals="INF"
      id="Fact000763"
      unitRef="Pure">0.9758</SMX:RedemptionPercentageOfBusinessCombination>
    <SMX:RemainingFundsInTrustAccount
      contextRef="From2022-07-262022-07-26_custom_LionheartMember_custom_BusinessCombinationAgreementMember"
      decimals="-3"
      id="Fact000765"
      unitRef="USD">3061000</SMX:RemainingFundsInTrustAccount>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2023-10-03_custom_TrueGoldConsortiumPtyLtdMember"
      decimals="INF"
      id="Fact000767"
      unitRef="Pure">0.075</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2023-10-032023-10-03_custom_TrueGoldConsortiumPtyLtdMember"
      decimals="INF"
      id="Fact000768"
      unitRef="Pure">0.519</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2023-10-032023-10-03_custom_TrueGoldConsortiumPtyLtdMember18007828"
      decimals="INF"
      id="Fact000770"
      unitRef="Pure">0.519</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2024-07-012024-07-31_custom_TrueGoldConsortiumPtyLtdMember"
      decimals="INF"
      id="Fact000772"
      unitRef="Pure">0.529</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:RetainedEarningsProfitLossForReportingPeriod
      contextRef="AsOf2025-12-31"
      decimals="-6"
      id="Fact000774"
      unitRef="USD">-251000000</ifrs-full:RetainedEarningsProfitLossForReportingPeriod>
    <SMX:DebtIssued
      contextRef="AsOf2025-12-31_custom_ConvertibleSecuritiesFundingAgreementsMember"
      decimals="-5"
      id="Fact000776"
      unitRef="USD">42800000</SMX:DebtIssued>
    <SMX:DebtIssued
      contextRef="AsOf2025-12-31_custom_StandbyEquityPurchaseAgreementMember"
      decimals="-5"
      id="Fact000778"
      unitRef="USD">100000000</SMX:DebtIssued>
    <ifrs-full:ShorttermBorrowings
      contextRef="AsOf2025-12-31_custom_FundingAgreementsMember"
      decimals="-3"
      id="Fact000780"
      unitRef="USD">1433000</ifrs-full:ShorttermBorrowings>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2025-01-012025-12-31_custom_StandbyEquityPurchaseAgreementMember"
      decimals="-6"
      id="Fact000782"
      unitRef="USD">150000000</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000784">&lt;p id="xdx_897_eifrs-full--DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_zgohH0K346r" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: -14.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&#160;&lt;span id="xdx_8B3_zKYQpcj1yPp1" style="display: none"&gt;SCHEDULE
OF COMPANIES SUBSIDIARIES&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 97%; margin-left: 0.25in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Controlled entity&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Country of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Incorporation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Percentage&lt;br/&gt; Owned&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;br/&gt; 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Percentage&lt;br/&gt; Owned&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;br/&gt; 2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;Security Matters (SMX) PLC&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; width: 14%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersSmxPlcMember_zBr6LN5hQqvb"&gt;Ireland&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersSmxPlcMember_zUXgK5uv3vU2"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersSmxPlcMember_zKi39G28Ffg1"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Security Matters PTY Ltd. &lt;br/&gt; (Formerly - Security Matters Limited)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersPTYLtdMember_zDZ55wgYs5B2"&gt;Australia&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersPTYLtdMember_zK9hluTnwaD7"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersPTYLtdMember_z6QkeDMBfa1d"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Lionheart III Corp&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--LionheartIIICorpMember_zCPrRcgHo3kk"&gt;USA&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--LionheartIIICorpMember_zruaSNV8xIJi"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--LionheartIIICorpMember_zCgOuWSw4rlf"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;SMX (Security Matters) Ireland Limited&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIrelandLimitedMember_zqwBe0hmO6hf"&gt;Ireland&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIrelandLimitedMember_zPD6puUD7Ts1"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIrelandLimitedMember_zsQs1iGYVXZ2"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;SMX Fashion and Luxury&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXFashionAndLuxuryMember_zQG7wmKn2k6e"&gt;France&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXFashionAndLuxuryMember_z51w51PDbQ45"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXFashionAndLuxuryMember_zGXCK89DSr9l"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;TrueSilver SMX Platform Ltd.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TrueSilverSMXPlatformLtdMember_zIkLGFNW5d67"&gt;Canada&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TrueSilverSMXPlatformLtdMember_zSjcG5eJ4cq8"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TrueSilverSMXPlatformLtdMember_zZINfuIwMoje"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;SMX (Security Matters) Israel Ltd. &lt;br/&gt; (Formerly - Security Matters Ltd.)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIsraelLtdMember_zLgdWQNdbF0b"&gt;Israel&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIsraelLtdMember_zeJbAgUa67oe"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIsraelLtdMember_zUUmdPk1IqGh"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Security Matters Canada Ltd.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersCanadaLtdMember_zq35iIcLHGec"&gt;Canada&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersCanadaLtdMember_zpHf9kMSmkJh"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersCanadaLtdMember_zU5VUytxxid4"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;SMX Beverages Pty Ltd.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXBeveragesPtyLtdMember_zNE20bEgS0j4"&gt;Australia&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXBeveragesPtyLtdMember_z8rZ9oZo0M82"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXBeveragesPtyLtdMember_zVIQLmrGYSeb"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;SMX Circular Economy Platform PTE, Ltd.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXCircularEconomyPlatformPTELtdMember_zMx3eK7tQfjk"&gt;Singapore&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXCircularEconomyPlatformPTELtdMember_z2igwrV4dgL4"&gt;70&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXCircularEconomyPlatformPTELtdMember_zwoO09W49b3"&gt;70&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;True Gold Consortium Pty Ltd.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TrueGoldConsortiumPtyLtdMember_zrfQ5nr7qqkc"&gt;Australia&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TrueGoldConsortiumPtyLtdMember_zwwOvc4hPBRj"&gt;52.9&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TrueGoldConsortiumPtyLtdMember_z8F7KKiWvso7"&gt;52.9&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;SMX Circular Economy FZCO *&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXCircularEconomyFZCOLtdMember_fKg_____zLzUMzVX4xZd"&gt;UAE&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXCircularEconomyFZCOLtdMember_fKg_____zFzNfth0cHAi"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXCircularEconomyFZCOLtdMember_fKg_____zGxIM1cEh6sl"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0820"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
addition, the Company&#x2019;s has the following investments in associated company:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 97%; margin-left: 0.25in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Entity&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Country of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Incorporation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Percentage Owned&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;br/&gt; 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Percentage Owned&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;br/&gt; 2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: justify"&gt;Yahaloma Technologies Inc.&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--YahalomaTechnologiesIncMember_zg5Yaf42RHde"&gt;Canada&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--YahalomaTechnologiesIncMember_zcQ6e8e2Cknk"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--YahalomaTechnologiesIncMember_zo53zVaksphe"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
proportion of ownership interest is equal to the proportion of voting power held.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 14.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F04_zEdeZq2xKdVl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F18_zSzBYYDeFNBl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    March 26, 2025, the Company established a fully owned entity incorporated in Dubai Multi Commodities Centre Authority, United Arab
    Emirates. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;*&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;The Company&#x2019;s Irish structure supports its intellectual property strategy, enhancing protection, licensing efficiency, and future
revenue generation from its technology portfolio&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory>
    <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_SecurityMattersSmxPlcMember"
      id="Fact000785">Ireland</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2025-01-012025-12-31_custom_SecurityMattersSmxPlcMember"
      decimals="INF"
      id="Fact000786"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2024-01-012024-12-31_custom_SecurityMattersSmxPlcMember"
      decimals="INF"
      id="Fact000787"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_SecurityMattersPTYLtdMember"
      id="Fact000788">Australia</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2025-01-012025-12-31_custom_SecurityMattersPTYLtdMember"
      decimals="INF"
      id="Fact000789"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2024-01-012024-12-31_custom_SecurityMattersPTYLtdMember"
      decimals="INF"
      id="Fact000790"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_LionheartIIICorpMember"
      id="Fact000791">USA</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2025-01-012025-12-31_custom_LionheartIIICorpMember"
      decimals="INF"
      id="Fact000792"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2024-01-012024-12-31_custom_LionheartIIICorpMember"
      decimals="INF"
      id="Fact000793"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_SMXIrelandLimitedMember"
      id="Fact000794">Ireland</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2025-01-012025-12-31_custom_SMXIrelandLimitedMember"
      decimals="INF"
      id="Fact000795"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2024-01-012024-12-31_custom_SMXIrelandLimitedMember"
      decimals="INF"
      id="Fact000796"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_SMXFashionAndLuxuryMember"
      id="Fact000797">France</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2025-01-012025-12-31_custom_SMXFashionAndLuxuryMember"
      decimals="INF"
      id="Fact000798"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2024-01-012024-12-31_custom_SMXFashionAndLuxuryMember"
      decimals="INF"
      id="Fact000799"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_TrueSilverSMXPlatformLtdMember"
      id="Fact000800">Canada</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2025-01-012025-12-31_custom_TrueSilverSMXPlatformLtdMember"
      decimals="INF"
      id="Fact000801"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2024-01-012024-12-31_custom_TrueSilverSMXPlatformLtdMember"
      decimals="INF"
      id="Fact000802"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_SMXIsraelLtdMember"
      id="Fact000803">Israel</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2025-01-012025-12-31_custom_SMXIsraelLtdMember"
      decimals="INF"
      id="Fact000804"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2024-01-012024-12-31_custom_SMXIsraelLtdMember"
      decimals="INF"
      id="Fact000805"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_SecurityMattersCanadaLtdMember"
      id="Fact000806">Canada</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2025-01-012025-12-31_custom_SecurityMattersCanadaLtdMember"
      decimals="INF"
      id="Fact000807"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2024-01-012024-12-31_custom_SecurityMattersCanadaLtdMember"
      decimals="INF"
      id="Fact000808"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_SMXBeveragesPtyLtdMember"
      id="Fact000809">Australia</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2025-01-012025-12-31_custom_SMXBeveragesPtyLtdMember"
      decimals="INF"
      id="Fact000810"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2024-01-012024-12-31_custom_SMXBeveragesPtyLtdMember"
      decimals="INF"
      id="Fact000811"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_SMXCircularEconomyPlatformPTELtdMember"
      id="Fact000812">Singapore</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2025-01-012025-12-31_custom_SMXCircularEconomyPlatformPTELtdMember"
      decimals="INF"
      id="Fact000813"
      unitRef="Pure">0.70</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2024-01-012024-12-31_custom_SMXCircularEconomyPlatformPTELtdMember"
      decimals="INF"
      id="Fact000814"
      unitRef="Pure">0.70</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_TrueGoldConsortiumPtyLtdMember"
      id="Fact000815">Australia</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2025-01-012025-12-31_custom_TrueGoldConsortiumPtyLtdMember"
      decimals="INF"
      id="Fact000816"
      unitRef="Pure">0.529</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2024-01-012024-12-31_custom_TrueGoldConsortiumPtyLtdMember"
      decimals="INF"
      id="Fact000817"
      unitRef="Pure">0.529</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_SMXCircularEconomyFZCOLtdMember"
      id="Fact000818">UAE</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2025-01-012025-12-31_custom_SMXCircularEconomyFZCOLtdMember"
      decimals="INF"
      id="Fact000819"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_YahalomaTechnologiesIncMember"
      id="Fact000821">Canada</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2025-01-012025-12-31_custom_YahalomaTechnologiesIncMember"
      decimals="INF"
      id="Fact000822"
      unitRef="Pure">0.50</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2024-01-012024-12-31_custom_YahalomaTechnologiesIncMember"
      decimals="INF"
      id="Fact000823"
      unitRef="Pure">0.50</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <SMX:ReverseStockSplitRatioDescription contextRef="From2024-07-152024-07-15" id="Fact000826">reverse split consolidated every 75 shares into one new ordinary share and was aimed at meeting
    Nasdaq&#x2019;s minimum bid price requirement of $1.00 per share</SMX:ReverseStockSplitRatioDescription>
    <SMX:MinimumBidPrice
      contextRef="AsOf2024-07-15_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact000828"
      unitRef="USDPShares">1.00</SMX:MinimumBidPrice>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2024-07-14_ifrs-full_OrdinarySharesMember"
      decimals="-5"
      id="Fact000830"
      unitRef="Shares">44800000</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2024-07-15_ifrs-full_OrdinarySharesMember"
      decimals="-3"
      id="Fact000832"
      unitRef="Shares">597000</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2024-07-14_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact000834"
      unitRef="USDPShares">0.0022</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2024-07-15_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact000836"
      unitRef="USDPShares">0.165</ifrs-full:ParValuePerShare>
    <SMX:ReverseStockSplitRatioDescription contextRef="From2025-01-152025-01-15" id="Fact000838">reverse split consolidated every 28.5 shares into
                                            one new ordinary share and was aimed at meeting Nasdaq&#x2019;s minimum bid price requirement
                                            of $1.00 per share</SMX:ReverseStockSplitRatioDescription>
    <SMX:MinimumBidPrice
      contextRef="AsOf2025-01-15_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact000840"
      unitRef="USDPShares">1.00</SMX:MinimumBidPrice>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2025-01-14_ifrs-full_OrdinarySharesMember"
      decimals="-3"
      id="Fact000842"
      unitRef="Shares">33155000</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2025-01-15_ifrs-full_OrdinarySharesMember"
      decimals="-3"
      id="Fact000844"
      unitRef="Shares">1163000</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2025-01-14_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact000846"
      unitRef="USDPShares">0.165</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2025-01-15_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact000848"
      unitRef="USDPShares">4.70250014886352</ifrs-full:ParValuePerShare>
    <SMX:ReverseStockSplitRatioDescription contextRef="From2025-06-162025-06-16" id="Fact000850">reverse split consolidated every 4.1 shares into one new ordinary share and was aimed
    at meeting Nasdaq&#x2019;s minimum bid price requirement of $1.00 per share</SMX:ReverseStockSplitRatioDescription>
    <SMX:MinimumBidPrice
      contextRef="AsOf2025-06-16_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact000852"
      unitRef="USDPShares">1.00</SMX:MinimumBidPrice>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2025-06-15_ifrs-full_OrdinarySharesMember"
      decimals="-6"
      id="Fact000854"
      unitRef="Shares">4000000</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2025-06-16_ifrs-full_OrdinarySharesMember"
      decimals="-6"
      id="Fact000856"
      unitRef="Shares">1000000</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2025-06-15_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact000858"
      unitRef="USDPShares">0.00000000000001</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2025-06-16_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact000860"
      unitRef="USDPShares">0.000000000000041</ifrs-full:ParValuePerShare>
    <SMX:ReverseStockSplitRatioDescription contextRef="From2025-08-072025-08-07" id="Fact000862">reverse split consolidated every 7.0 shares into one new ordinary
                                            share and was aimed at meeting Nasdaq&#x2019;s minimum bid price requirement of $1.00 per
                                            share</SMX:ReverseStockSplitRatioDescription>
    <SMX:MinimumBidPrice
      contextRef="AsOf2025-08-07_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact000864"
      unitRef="USDPShares">1.00</SMX:MinimumBidPrice>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2025-08-06_ifrs-full_OrdinarySharesMember"
      decimals="-6"
      id="Fact000866"
      unitRef="Shares">9000000</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2025-08-07_ifrs-full_OrdinarySharesMember"
      decimals="-6"
      id="Fact000868"
      unitRef="Shares">1000000</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2025-08-06_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact000870"
      unitRef="USDPShares">0.00000000000041</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2025-08-07_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact000872"
      unitRef="USDPShares">0.000000000000287</ifrs-full:ParValuePerShare>
    <SMX:ReverseStockSplitRatioDescription contextRef="From2025-10-232025-10-23" id="Fact000874">reverse split consolidated every 10.89958 shares into one new ordinary share and was
    aimed at meeting Nasdaq&#x2019;s minimum bid price requirement of $1.00 per share</SMX:ReverseStockSplitRatioDescription>
    <SMX:MinimumBidPrice
      contextRef="AsOf2025-10-23_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact000876"
      unitRef="USDPShares">1.00</SMX:MinimumBidPrice>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2025-10-22_ifrs-full_OrdinarySharesMember"
      decimals="-5"
      id="Fact000878"
      unitRef="Shares">15500000</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2025-10-23_ifrs-full_OrdinarySharesMember"
      decimals="-5"
      id="Fact000880"
      unitRef="Shares">1400000</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2025-10-22_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact000882"
      unitRef="USDPShares">0.000000000000287</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2025-10-23_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact000884"
      unitRef="USDPShares">0.00000000000312817946</ifrs-full:ParValuePerShare>
    <SMX:ReverseStockSplitRatioDescription contextRef="From2025-11-182025-11-18" id="Fact000886">reverse split consolidated every 8 shares into one new ordinary share and was aimed
    at meeting Nasdaq&#x2019;s minimum bid price requirement of $1.00 per share</SMX:ReverseStockSplitRatioDescription>
    <SMX:MinimumBidPrice
      contextRef="AsOf2025-11-18_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact000888"
      unitRef="USDPShares">1.00</SMX:MinimumBidPrice>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2025-11-17_ifrs-full_OrdinarySharesMember"
      decimals="-5"
      id="Fact000890"
      unitRef="Shares">8400000</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2025-11-18_ifrs-full_OrdinarySharesMember"
      decimals="-4"
      id="Fact000892"
      unitRef="Shares">1050000.00</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2025-11-17_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact000894"
      unitRef="USDPShares">0.00000000000312817946</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2025-11-18_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact000896"
      unitRef="USDPShares">0.00000000002502543568</ifrs-full:ParValuePerShare>
    <SMX:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000898">&lt;p id="xdx_80E_ecustom--DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_zA2sltrxGnRf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2 - &lt;span id="xdx_825_zyQxhuejHrY3"&gt;SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
significant accounting policies followed in the preparation of the financial statements, on a consistent basis, are:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_ecustom--DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory_zVcNVrxQQ44e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_868_z0TmrVU6Gst4"&gt;Basis
of preparation&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
financial statements have been prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International
Accounting Standards Board (&#x201c;IASB&#x201d;). The financial statements have been prepared under the historical cost convention except
for certain financial liabilities which are measured at fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_ecustom--PrinciplesOfConsolidationExplanatory_zL0IIIx6WpT6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_860_z2YBZbFSEY34"&gt;Principles
of consolidation&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Subsidiaries
are all those entities over which the Company has control. The Company controls an entity when it is exposed to, or has rights to, variable
returns from its involvement with the entity and has the ability to affect those returns through its power to direct the activities of
the entity. Subsidiaries are fully consolidated from the date on which control is obtained by the Company and until the date that control
is lost.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intercompany
transactions between entities in the consolidated entity are eliminated. Unrealized losses are also eliminated unless the transaction
provides evidence of the impairment of the asset transferred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eifrs-full--DescriptionOfAccountingPolicyForInvestmentInAssociates_ziGHtbwd6p35" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_861_zPi8tX7ogFSg"&gt;Investments
in associated companies&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Investments
in associated companies are accounted under the equity method and are initially recognized at cost. The investment&#x2019;s cost includes
transaction costs. The consolidated financial statements include the Group&#x2019;s share in net income or loss, in other comprehensive
income or loss, and in the net assets of associated companies accounted by the equity method from the date when significant influence
or joint control materialized, until the date on which the conditions for significant influence or joint control are no longer met.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Losses
of an associate in amounts which exceed its equity are recognized by the Company to the extent of its investment in the associate plus
any losses that the Company may incur as a result of a guarantee or other financial support provided in respect of the associate.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_eifrs-full--DescriptionOfAccountingPolicyForRepurchaseAndReverseRepurchaseAgreementsExplanatory_zGfEzJbmwUb9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Reverse
acquisition transaction&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
result of the merger between the Company and Security Matters PTY Ltd. as described in Note 1.B is that legally the Company owns the
entire share capital of Security Matters PTY Ltd.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accordingly,
for financial reporting purposes, Security Matters PTY Ltd. (the legal subsidiary) is the accounting acquirer, and the Company (the legal
parent) is the accounting acquiree. The consolidated financial statements prepared following the reverse acquisition are issued under
the name of the Company, but they are a continuation of the financial statements of Security Matters PTY Ltd. and reflect the fair values
of the assets and liabilities of the Company (the acquiree for accounting purposes), together with a deemed issuance of shares by Security
Matters PTY Ltd. at fair value based on the quoted opening share price of the Company in its first trading day following the closing
of the business combination transaction ($&lt;span id="xdx_909_ecustom--FairValueBasedOnQuotedOpeningSharePrice_pn3n3_c20250101__20251231_z94RhYu7KRc5" title="Fair value based on quoted opening share price"&gt;11,599&lt;/span&gt;), and a recapitalization of its equity. This deemed issuance of shares is in fact both
an equity transaction under IAS 32 (receiving the net assets of the Company) and an equity-settled share-based payment transaction under
IFRS 2 (receiving the listing status of the Company). The difference, in the amount of $&lt;span id="xdx_906_ecustom--FairValueOfEquityTransaction_pn3n3_c20250101__20251231_zMdxoUedsjkl" title="Fair value of equity transaction"&gt;16,802&lt;/span&gt;, between the fair value of the shares
deemed to have been issued by Security Matters PTY Ltd. and the fair value of the Company&#x2019;s identifiable net assets represent a
payment for the service of obtaining a stock exchange listing for its shares and it is therefore expensed immediately to profit or loss
at the closing date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is initially consolidated in the financial statements from the closing date of the Business Combination. Substantially all of
the assets and liabilities of the Company were comprised of marketable securities held in a trust account ($&lt;span id="xdx_90D_ecustom--MarketableSecuritiesHeldInTrustAccount_iI_pn3n3_c20251231_zhPz6eJVwLkh" title="Marketable securities held in trust account"&gt;4,921&lt;/span&gt;) and trade and other
payables and warrants ($&lt;span id="xdx_90C_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20251231_zrCVxFWG9c2"&gt;10,127&lt;/span&gt;) respectively, with fair values that were equivalent to their carrying amounts. Below are the implications
of the accounting treatment on the financial statements:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    assets and liabilities of Security Matters PTY Ltd. have been recognized and measured in these consolidated financial statements
    at their pre-combination carrying amounts.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    retained earnings and other equity balances recognized in those consolidated financial statements are the retained earnings and other
    equity balances of Security Matters PTY Ltd. immediately before the Business Combination.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    amount recognized as issued equity instruments in these consolidated financial statements has been determined by adding to the issued
    equity of Security Matters PTY Ltd. immediately before the Business Combination the fair value of the deemed issuance of shares,
    as described above. However, the equity structure (the number and type of shares issued) reflects the equity structure of the Company,
    including the shares issued by the Company through recapitalization. Accordingly, the equity structure of Security Matters PTY Ltd.
    (issued capital and addition paid in capital) in comparative periods is restated using the exchange ratio established in the Business
    Combination to reflect the number and par value of shares of the Company issued in the reverse acquisition transaction. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    statement of comprehensive loss reflects that of Security Matters PTY Ltd. for the full period together with the post-acquisition
    results of the Company from the Closing Date. Loss per share of Security Matters PTY Ltd. for periods prior to the acquisition date
    is restated such the denominator of the historical loss per share calculation is adjusted by multiplying the weighted-average shares
    used in each historically reported loss per share calculation by the exchange ratio established in the Business Combination.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eifrs-full--DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_zOpQqGV0lfid" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86B_zLzscRrh040k"&gt;Foreign
currency&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
consolidated financial statements are prepared in US Dollars, which is the functional and presentation currency of the Company. The functional
currency of Lionheart III Corp is US Dollar. The functional currency of SMX Fashion and Luxury is EURO. The functional currency of True
Silver SMX Platform is Canadian Dollars. The functional currency of SMX (Security Matters) Ireland Limited is US Dollar. The functional
currency of SMX Circular Economy Platform PTE, Ltd. is Singapore Dollar. The functional currency of Security Matters Pty Ltd. is Australian
Dollar. The functional currency of Security Matters Ltd. (Israel) is New Israeli Shekel. The functional currency of Security Matters
Canada Ltd. is Canadian Dollar. The functional currency of SMX Beverages Pty Ltd. is Australian Dollar. The functional currency of True
Gold is Australian Dollar. The functional currency of SMX Circular Economy FZCO is Emirati Dirham.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Transactions
and balances in foreign currencies are converted into US Dollars in accordance with the principles set forth by International Accounting
Standard (IAS) 21 (&#x201c;The Effects of Changes in Foreign Exchange Rates&#x201d;). Accordingly, transactions and balances have been
converted as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -14.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Assets
    and liabilities &#x2013; at the rate of exchange applicable at the reporting date.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expense
    items &#x2013; at annual average rate at the statements of financial position date. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Share
    capital, capital reserve and other capital movement items were at the rate of exchange as of the date of recognition of those items.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    accumulated deficit was based on the opening balance for the beginning of the reporting period in addition to the movements mentioned
    above.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exchange
                                            gains and losses from the aforementioned conversion are recognized in the statement of other
                                            comprehensive losses in the Foreign Currency Translation Reserve.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eifrs-full--DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_zmvoK7po3Py6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_864_z06wk3g40v4f"&gt;Issue
of a unit of financial instruments&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
issue of a unit of financial instruments such as a financial liability (e.g., a loan) and free-standing derivative (e.g. warrants) involves
the allocation of the proceeds received (before issuance costs) to financial derivatives and other financial instruments measured at
fair value in each period and to financial liabilities that are measured at amortized cost, with residual allocated to equity instruments.
Issuance costs are allocated to each component pro rata to the amounts determined for each component in the unit.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eifrs-full--DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_z6EqTf29TAE6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86F_zDC2EMt7taQ1"&gt;Fair
value measurement&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
value is the price that would be received when selling an asset or paid to transfer a liability in an orderly transaction between market
participants at the measurement date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value measurement is based on the presumption that the transaction to sell the asset or transfer the liability takes place either:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
    the principal market for the asset or liability; or&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;B.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
    the absence of a principal market, in the most advantageous market for the asset or liability.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
principal or the most advantageous market must be accessible to the Group.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or
liability, assuming that market participants act in their economic best interest.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
fair value measurement of a non-financial asset takes into account a market participant&#x2019;s ability to generate economic benefits
by using the asset in its highest and best use or by selling it to another market participant that would use the asset in its highest
and best use.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair
value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eifrs-full--DescriptionOfAccountingPolicyForFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory_zXMa2MEXQXH6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_868_z2wZ0Q7EjUDe"&gt;Classification
of financial instruments by fair value hierarchy&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
financial instruments presented in the statements of financial position at fair value are grouped into classes with similar characteristics
using the following fair value hierarchy which is determined based on the source of input used in measuring fair value:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Quoted
    prices (unadjusted) in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    2&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Inputs
    other than quoted prices included within Level 1 that are observable either directly or indirectly.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Inputs
    that are not based on observable market data (valuation techniques which use inputs that are not based on observable market data).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eifrs-full--DescriptionOfAccountingPolicyForFinancialAssetsExplanatory_zph0AKkxcSr9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_868_zxRk25zyWt3d"&gt;Financial
assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group classifies its financial assets into one of the following categories, depending on the purpose for which the asset was acquired.
The Group&#x2019;s accounting policy for each category is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
receivables: These assets are non-derivative financial assets with fixed or determinable payments that are not quoted in an active market.
They arise principally through the provision of goods and services, but also incorporate other types of contractual monetary asset. These
assets are carried at amortized cost less any provision for impairment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group has no financial assets classified at fair value through profit or loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eifrs-full--DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory_z2fkRNGLVNO7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_866_zfdQ0vFi3B69"&gt;Financial
liabilities&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;financial
liabilities measured at amortized cost:&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
liabilities are initially recognized at fair value less transaction costs that are directly attributable to the issue of financial liability.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;After
initial recognition, the Group measures all financial liabilities at amortized cost using the effective interest rate method, which ensures
that any interest expense over the period is at a constant interest rate on the balance of the liability carried in the statement of
financial position, except for financial liabilities which are measured at fair value through profit or loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;measured
at fair value through profit or loss:&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
financial liabilities comprise of derivatives that are options which are to be settled in equity instruments but nevertheless do not
meet the definitions of equity instruments. The Group measures those financial liabilities at fair value. Transaction costs are recognized
in profit or loss. After initial recognition, changes in fair value are recognized in profit or loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eifrs-full--DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_zoywYPKO4Hf4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_865_zfXXXuVjUcMj"&gt;Impairment
of non-financial assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
assets and goodwill that have an indefinite useful life are not subject to amortization and are tested annually for impairment, or more
frequently if events or changes in circumstances indicate that they might be impaired. Other non-financial assets are reviewed for impairment
whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. An impairment loss is recognized
for the amount by which the asset&#x2019;s carrying amount exceeds its recoverable amount. Recoverable amount is the higher of an asset&#x2019;s
fair value less costs of disposal and value-in-use. The value-in-use is the present value of the estimated future cash flows relating
to the asset using a pre-tax discount rate specific to the asset or cash-generating unit to which the asset belongs. Assets that do not
have independent cash flows are grouped together to form a cash-generating unit.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eifrs-full--DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_z0kOpYLYWAe5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_863_zK4TxxZ7xgBd"&gt;Property,
plant and equipment&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Items
of property, plant and equipment are initially recognized at cost. Cost includes directly attributable costs and the estimated present
value of any future costs of dismantling and removing items. Depreciation is computed by the straight-line method, based on the estimated
useful lives of the assets, as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_ecustom--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentDepreciationRateExplanatory_zNlCMb5gJrnh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B7_zNFvRHxuSBX1" style="display: none"&gt;SCHEDULE OF DEPRECIATION RATES OF PROPERTY, PLANT AND EQUIPMENT&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: justify"&gt;Computers&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--DepreciationRatePropertyPlantAndEquipment_pid_dp_uPure_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zd3v06BL3Tl2"&gt;33&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Machines and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--DepreciationRatePropertyPlantAndEquipment_pid_dp_uPure_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_zJqNWAbNaW57"&gt;20&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Furniture and office equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--DepreciationRatePropertyPlantAndEquipment_pid_dp_uPure_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember_zKfaHdrq7Yvh"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Leasehold improvements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--DepreciationRatePropertyPlantAndEquipment_pid_dp_uPure_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zCTeb9ETAbOb"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AA_zMUOPbJzK1u2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Leasehold
improvements are depreciated over the term of the expected lease including optional extension, or the estimated useful lives of the improvements,
whichever is shorter.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eifrs-full--DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_zMtk0eBw36Xe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_869_zR4iSMb7fIo2"&gt;Reimbursement
of research and development expenses&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Reimbursements
in proof of concept (POC) agreements of expenditures on research and development in order to achieve commercial agreement once this activity
is successful, are offset in profit or loss against the related expenses (research and development expenses). Any IP generated from this
activity remains at the ownership of the Group.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_ecustom--DescriptionOfAccountingPolicyForRightOfUseAssetsExplanatory_zNOrEtdeJq4l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86C_zcxdocpkCtvc"&gt;Right-of-use
assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
leases are accounted for by recognizing a right-of-use asset and a lease liability, excluding leases where the lease term is 12 months
or less, or where the underlying asset is of low-value. These leases expenditures are recognized on a straight-line basis over the lease
term. A right-of-use asset is recognized at the commencement date of a lease. The right-of-use asset is measured at cost, which comprises
the initial amount of the lease liability, adjusted for, as applicable, any lease payments made at or before the commencement date net
of any lease incentives received.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Right-of-use
assets are depreciated on a straight-line basis over the unexpired period of the lease or the estimated useful life of the asset, whichever
is the shorter. Where the Group expects to obtain ownership of the leased asset at the end of the lease term, the depreciation is over
its estimated useful life. Right-of-use assets are subject to impairment or adjusted for any remeasurement of lease liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eifrs-full--DescriptionOfAccountingPolicyForLeasesExplanatory_z2im3e9UgLV1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_863_zy1M5gfvJMD8"&gt;Lease
liabilities&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
leases are accounted for by recognizing a right-of-use asset and a lease liability. Lease liabilities are measured at the present value
of the contractual payments due to the lessor over the lease term, with the discount rate determined by reference to the rate implicit
in the lease unless (as is typically the case) this is not readily determinable, in which case the Group&#x2019;s incremental borrowing
rate on commencement of the lease is used. Variable lease payments are only included in the measurement of the lease liability if they
depend on an index or rate. In such cases, the initial measurement of the lease liability assumes the variable element will remain unchanged
throughout the lease term. Other variable lease payments are expensed in the period to which they relate.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
initial recognition, the carrying value of the lease liability also includes:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;amounts
    expected to be payable under any residual value guarantee.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
    exercise price of any purchase option granted in favor of the Group if it is reasonably certain to exercise that option.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;any
    penalties payable for terminating the lease, if the term of the lease has been estimated on the basis of termination option being
    exercised.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Subsequent
to initial measurement lease liabilities increase as a result of interest charged at a constant rate on the balance outstanding and are
reduced for lease payments made. Lease liabilities are remeasured when there is a change in future lease payments arising from a change
in an index or rate or when there is a change in the assessment of the term of any lease the remeasurement being recognized in front
of the right of use assets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_eifrs-full--DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_zPzpjW7BRTf8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86D_zEzjyqQsyWWa"&gt;Capitalized
technology development costs&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expenditures
on research activities are recognized in profit or loss as incurred. Expenditures on internally developed products are mainly employee
salaries and legal fees for filing of patents and are capitalized when the Group demonstrates all the following criteria:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    technical feasibility of completing the intangible asset so that it will be available for use or sale.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    intention to complete the intangible asset and use or sell it.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;c.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    ability to use or sell the intangible asset.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;d.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    probability of the intangible asset to generate future economic benefits. Among other things, the Group considers the existence of
    a market for the output of the intangible asset or the intangible asset itself or, if it is to be used internally, the usefulness
    of the intangible asset.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;e.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;f.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    ability to measure reliably the expenditures attributable to the intangible asset during its development.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
recognition criteria above are considered by the Group at each stage of development to determine when the criteria have been initially
met in full.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
technical feasibility criteria is determined to be met when a the milestone of initial marking and reading capabilities is satisfied.
The milestone&#x2019;s identification occurs only following a detailed broad mapping of the raw material characteristics and establishing
the formula for the chemical marker architecture to be embedded into the raw material based on industry standards and regulations. The
result is the initial evidence that the x-ray algorithm of the designated reader is in a stage that can identify the marker and convey
information. At this stage, the Group believes that the technical feasibility of completing the development for use is probable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group notes that technical feasibility has been established and the achieved technology is ready for the next stage which consists of
performing a proof-of-concept pilot with an industry partner, in order to adapt the technology for the relevant industry and adjust the
development to meet the industry&#x2019;s needs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 85%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Capitalized
technology development costs (Cont.) &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Currently,
the Group&#x2019;s capitalized development activities focus on:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Development
    of marker architecture to be embedded topically or in-situ (application) for each material/product within the optimal industrial
    manufacturing phase, based on industry standards and regulations.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Semi
    Industrial scale &#x2013; technology implementation in semi-industrial production.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Development
    of a digital platform to support the end-to-end traceability from raw material to final product to recycling.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group&#x2019;s management has the full intention to complete the development of the technology and ultimately to sell it. This intention
is demonstrated by initiating partnerships with industry market leaders and continuing the development into the next phase. The Group&#x2019;s
intention is also reflected in the Group&#x2019;s approved budget.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group&#x2019;s management intends to concentrate its future sales and marketing efforts in the U.S. and Asia Pacific markets, including,
but not limited to, recruitment of sales and marketing personnel. It plans to advance successful proof-of-concept pilots performed with
industry leading partners, and further advance its innovative technology and commercialization efforts and collaborations in the segments
relevant to its technology.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group&#x2019;s business model targets leading brands and manufacturers in order to create a new market standard for circular economy solutions,
brand authentication and supply chain integrity. The Company is currently in the transition phase from technology validation to commercial deployment. Revenue generation
is expected to scale as proof-of-concept programs and strategic partnerships convert into commercial agreements, particularly within large
enterprise and government-led ecosystems. The Group&#x2019;s technology is applicable for multiple industries such as gold, fashion,
electronics and circular economy &#x2013; plastic and rubber. The Group is able to provide an adaptive solution for multiple market segments,
based on a unified technology solution, through collaborative relationships with leading market companies which provide it with access
to various potential entities to sell its solution. This is part of the Group&#x2019;s strategy to create strategic partnerships with
market leaders across its main segments of activity. The Group believes that this close collaboration with market leaders, and developing
a product that meets their requests, suggest that there is a strong potential market for its development.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Adequate
technical and financial resources are available to complete the development; the development will be completed by the Group&#x2019;s technology
team which consists of professional experienced scientists and engineers, with a track record in the industrial sector and with financial
resources successfully raised through the issuance of ordinary shares and loans. The Group has already accomplished its core technology
development and is currently focused on development of specific adjustments for different market segments. This stage is focused and
short-termed, therefore, management believes that limited financial resources are required for completing the development and that there
is high probability for commencing commercial agreements following the successful proof-of-concept pilots. The Company is focused on establishing industry-wide adoption through collaboration with leading partners, with the objective of creating
standardized solutions across multiple sectors including plastics, metals, and supply chain authentication.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group has financial systems in place that allow it to maintain records in sufficient detail that enable it to measure reliably the expenditures
attributable to the intangible asset during its development.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Development
expenditures not satisfying all the above criteria are recognized in the consolidated statement of comprehensive income as incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Subsequent
measurement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
subsequent periods, capitalized development expenditures are measured at cost less accumulated amortization and accumulated impairment
losses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;An
asset is ready for its intended use, when the developed technology becomes operational and the Group completes an initial customization.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Capitalized
technology development costs (Cont.) &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
assets with a finite useful life are amortized over their estimated useful lives and reviewed for impairment whenever there is an indication
that the asset may be impaired. The amortization period and the amortization method for intangible assets are reviewed at least at each
year end.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
carrying amount of these assets is reviewed whenever events or changes in circumstances indicate that the carrying value of an asset
may not be recoverable. If the asset is considered to be impaired, the amount of any impairment is measured as the difference between
the carrying value and the fair value of the impaired asset. An expenditure incurred in development activities, including the Group&#x2019;s
software development is capitalized only where it clearly increases the economic benefits to be derived from the asset to which it relates,
the expenditure will lead to new or substantially improved products, the products are technically and commercially feasible and the Group
has sufficient resources to complete the development and reach the stage for which the product is ready for use.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
other expenditure, including those incurred in order to maintain an intangible assets current level of performance, is expensed as incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eifrs-full--DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_zIwWCXW6IqEa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_867_zO6219ni7F34"&gt;Share-based
compensation&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group measures the share-based expense and the cost of equity-settled transactions with employees and service providers by reference
to the fair value of the equity instruments at the date at which they are granted. The Group selected the Black-Scholes model as the
Group&#x2019;s option pricing model to estimate the fair value of the Group&#x2019;s options awards. The model is based on share price,
grant date and on assumptions regarding expected volatility, expected life of the options, expected dividend, and a no risk interest
rate. As for granted options which are settled in equity instruments, the fair value of the options at the grant date is charged to the
statement of comprehensive loss over the vesting period. Non-market vesting conditions are taken into account by adjusting the number
of equity instruments expected to vest at each reporting date so that, ultimately, the cumulative amount recognized over the vesting
period is based on the number of options that eventually vest.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_ecustom--DescriptionOfAccountingPolicyNewStandardsInterpretationsAndAmendmentsAdoptedExplanatory_zgg8NAQDjpPj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_865_zNQpem8EfGLb"&gt;New
standards, interpretations and amendments not yet effective&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
are a number of standards, amendments to standards, and interpretations which have been issued by the IASB that are effective in future
accounting periods that the Group has decided not to adopt early.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following amendments are effective for the annual reporting period beginning January 1, 2026:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;Amendments
to the Classification and Measurement of Financial Instruments (Amendment s to IFRS 9 Financial Instruments and IFRS 7 Financial Instruments:
Disclosures)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;Contracts
Referencing Nature -dependent Electricity (Amendments to IFRS 9 and IFRS 7)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following standards and amendments are effective for the annual reporting period beginning January 1, 2027:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
IFRS 18 Presentation and Disclosure in Financial Statements&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;IFRS
19 Subsidiaries without Public Accountability: Disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group is currently assessing the effect of these new accounting standards and amendments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;IFRS
18 Presentation and Disclosure in Financial Statements, which was issued by the IASB in April 2024 supersedes IAS 1 and will result in
major consequential amendments to IFRS Accounting Standards including IAS 8 Basis of Preparation of Financial Statements (renamed from
Accounting Policies, Changes in Accounting Estimates and Errors). Even though IFRS 18 will not have any effect on the recognition and
measurement of items in the consolidated financial statements, it is expected to have a significant effect on the presentation and disclosure
of certain items. These changes include categorisation and sub-totals in the statement of profit or loss, aggregation/disaggregation
and labelling of information, and disclosure of management-defined performance measures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group does not expect to be eligible to apply IFRS 19.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;The
significant accounting judgments, estimates and assumptions followed in the preparation of the financial statements, on a consistent
basis, are:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
the process of applying the significant accounting policies, the Group has made the following judgments which have the most significant
effect on the amounts recognized in the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of the consolidated financial statements requires management to make estimates and assumptions that have an effect on the
application of the accounting policies and on the reported amounts of assets, liabilities and expenses. Changes in accounting estimates
are reported in the period of the change in estimate. The key assumptions made in the financial statements are discussed below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_ecustom--DescriptionOfAccountingPolicyForShareBasedCompensationExplanatory_zC4FnAncuHwh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_860_zWSsK5mTYxWc"&gt;Share
based compensation&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group has a share-based remuneration scheme for employees. The fair value of share options is estimated by using the Black-Scholes model,
which was derived to model the value of the firm&#x2019;s equity over time. The simulation model was designed to take into account the
unique terms and conditions of the performance shares and share options, as well as the capital structure of the firm and the volatility
of its assets, on the date of grant based on certain assumptions. Those conditions are described in the share-based compensation note
and include, among others, the dividend growth rate, expected share price volatility and expected life of the options. The fair value
of the equity settled options granted is charged to the statement of profit or loss over the vesting period of each tranche and the credit
is taken to equity, based on the consolidated entity&#x2019;s estimate of shares that will eventually vest.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eifrs-full--DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory_zJ8z4SV41ey1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86E_zhQgs5aeirle"&gt;Intangible
assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group capitalizes costs for its developed projects when specific criteria are met. Initial capitalization of costs is based on management&#x2019;s
judgement that technological and economic feasibility is achievable, usually when a product development project has reached a defined
milestone according to an established project management model. The management makes assumptions regarding the expected future economic
benefit to be derived from the intangible asset and therefore whether the capitalized costs are expected to be recovered.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;This
amount of capitalized costs includes significant investment in the development of marking and reading capabilities in the subject material.
Prior to being marketed, the Group will obtain a proof-of-concept pilot with an industry leading partner. The innovative nature of the
product gives rise to some judgement as to whether the proof-of-concept will be successful such that it will lead to obtaining commercial
contracts with customers. See also note 6.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
bases its estimates on historical experience, assumptions, and information currently available and deemed to be reasonable at the time
the consolidated financial statements are prepared. However, actual amounts may differ from the estimated amounts as more detailed information
becomes available. Estimates and assumptions are reviewed on an ongoing basis and, if necessary, changes are recognized in the period
in which the estimate is revised.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eifrs-full--DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory_zLLFcJWVVHv" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_864_zeGoBG6QUy0b"&gt;Impairment
of goodwill and intangible assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group reviews goodwill for impairment at least once a year or more frequently if events or changes in circumstances indicate that there
is impairment. Goodwill is tested for impairment by assessing the recoverable amount of the cash-generating unit to which the goodwill
has been allocated. This requires management to make an estimate of the projected future cash flows from the continuing use of the cash-generating
unit to which the goodwill is allocated and also to choose a suitable discount rate for those cash flows. See more information in note
6.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
carrying values of the long-lived intangible assets are reviewed for impairment whenever events or changes in circumstances indicate
that the carrying amount of an asset may no longer be recoverable. If any indication exists, then the asset&#x2019;s recoverable amount
is estimated. Determining the recoverable amount is subjective and requires management to estimate project future cash flows, among other
factors. Future events and changing market conditions may impact on the assumptions as to prices, costs or other factors that may result
in changes to the estimates of future cash flows. If the Group concludes that a definite or indefinite long-lived intangible asset is
impaired, the Group recognize a loss in an amount equal to the excess of the carrying value of the asset over its fair value at the date
of impairment. The fair value at the date of the impairment becomes the new cost basis and will result in a lower depreciation expense
than for periods before the asset&#x2019;s impairment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_ecustom--DescriptionOfAccountingPolicyForFinancialLiabilitiesAtFairValueExplanatory_zAp0IcVFY1w4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_868_zrMpRGXlDXz1"&gt;Financial
liabilities at fair value&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of financial liabilities at fair value was estimated by using a Black Scholes model and Monte-Carlo simulation approach, which
was aimed to model the value of the Group&#x2019;s assets over time. The simulation approach was designed to take into account the terms
and conditions of the financial liabilities, which are described in notes 8, 9 and 11, as well as the capital structure of the Group
and the volatility of its assets. The valuation was performed based on management&#x2019;s assumptions and projections.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85C_zbF1c367bp68" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

</SMX:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory>
    <SMX:DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000900">&lt;p id="xdx_84A_ecustom--DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory_zVcNVrxQQ44e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_868_z0TmrVU6Gst4"&gt;Basis
of preparation&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
financial statements have been prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International
Accounting Standards Board (&#x201c;IASB&#x201d;). The financial statements have been prepared under the historical cost convention except
for certain financial liabilities which are measured at fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</SMX:DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory>
    <SMX:PrinciplesOfConsolidationExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000902">&lt;p id="xdx_84C_ecustom--PrinciplesOfConsolidationExplanatory_zL0IIIx6WpT6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_860_z2YBZbFSEY34"&gt;Principles
of consolidation&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Subsidiaries
are all those entities over which the Company has control. The Company controls an entity when it is exposed to, or has rights to, variable
returns from its involvement with the entity and has the ability to affect those returns through its power to direct the activities of
the entity. Subsidiaries are fully consolidated from the date on which control is obtained by the Company and until the date that control
is lost.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intercompany
transactions between entities in the consolidated entity are eliminated. Unrealized losses are also eliminated unless the transaction
provides evidence of the impairment of the asset transferred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</SMX:PrinciplesOfConsolidationExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForInvestmentInAssociates contextRef="From2025-01-01to2025-12-31" id="Fact000904">&lt;p id="xdx_844_eifrs-full--DescriptionOfAccountingPolicyForInvestmentInAssociates_ziGHtbwd6p35" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_861_zPi8tX7ogFSg"&gt;Investments
in associated companies&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Investments
in associated companies are accounted under the equity method and are initially recognized at cost. The investment&#x2019;s cost includes
transaction costs. The consolidated financial statements include the Group&#x2019;s share in net income or loss, in other comprehensive
income or loss, and in the net assets of associated companies accounted by the equity method from the date when significant influence
or joint control materialized, until the date on which the conditions for significant influence or joint control are no longer met.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Losses
of an associate in amounts which exceed its equity are recognized by the Company to the extent of its investment in the associate plus
any losses that the Company may incur as a result of a guarantee or other financial support provided in respect of the associate.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForInvestmentInAssociates>
    <ifrs-full:DescriptionOfAccountingPolicyForRepurchaseAndReverseRepurchaseAgreementsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000906">&lt;p id="xdx_841_eifrs-full--DescriptionOfAccountingPolicyForRepurchaseAndReverseRepurchaseAgreementsExplanatory_zGfEzJbmwUb9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Reverse
acquisition transaction&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
result of the merger between the Company and Security Matters PTY Ltd. as described in Note 1.B is that legally the Company owns the
entire share capital of Security Matters PTY Ltd.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accordingly,
for financial reporting purposes, Security Matters PTY Ltd. (the legal subsidiary) is the accounting acquirer, and the Company (the legal
parent) is the accounting acquiree. The consolidated financial statements prepared following the reverse acquisition are issued under
the name of the Company, but they are a continuation of the financial statements of Security Matters PTY Ltd. and reflect the fair values
of the assets and liabilities of the Company (the acquiree for accounting purposes), together with a deemed issuance of shares by Security
Matters PTY Ltd. at fair value based on the quoted opening share price of the Company in its first trading day following the closing
of the business combination transaction ($&lt;span id="xdx_909_ecustom--FairValueBasedOnQuotedOpeningSharePrice_pn3n3_c20250101__20251231_z94RhYu7KRc5" title="Fair value based on quoted opening share price"&gt;11,599&lt;/span&gt;), and a recapitalization of its equity. This deemed issuance of shares is in fact both
an equity transaction under IAS 32 (receiving the net assets of the Company) and an equity-settled share-based payment transaction under
IFRS 2 (receiving the listing status of the Company). The difference, in the amount of $&lt;span id="xdx_906_ecustom--FairValueOfEquityTransaction_pn3n3_c20250101__20251231_zMdxoUedsjkl" title="Fair value of equity transaction"&gt;16,802&lt;/span&gt;, between the fair value of the shares
deemed to have been issued by Security Matters PTY Ltd. and the fair value of the Company&#x2019;s identifiable net assets represent a
payment for the service of obtaining a stock exchange listing for its shares and it is therefore expensed immediately to profit or loss
at the closing date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is initially consolidated in the financial statements from the closing date of the Business Combination. Substantially all of
the assets and liabilities of the Company were comprised of marketable securities held in a trust account ($&lt;span id="xdx_90D_ecustom--MarketableSecuritiesHeldInTrustAccount_iI_pn3n3_c20251231_zhPz6eJVwLkh" title="Marketable securities held in trust account"&gt;4,921&lt;/span&gt;) and trade and other
payables and warrants ($&lt;span id="xdx_90C_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20251231_zrCVxFWG9c2"&gt;10,127&lt;/span&gt;) respectively, with fair values that were equivalent to their carrying amounts. Below are the implications
of the accounting treatment on the financial statements:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    assets and liabilities of Security Matters PTY Ltd. have been recognized and measured in these consolidated financial statements
    at their pre-combination carrying amounts.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    retained earnings and other equity balances recognized in those consolidated financial statements are the retained earnings and other
    equity balances of Security Matters PTY Ltd. immediately before the Business Combination.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    amount recognized as issued equity instruments in these consolidated financial statements has been determined by adding to the issued
    equity of Security Matters PTY Ltd. immediately before the Business Combination the fair value of the deemed issuance of shares,
    as described above. However, the equity structure (the number and type of shares issued) reflects the equity structure of the Company,
    including the shares issued by the Company through recapitalization. Accordingly, the equity structure of Security Matters PTY Ltd.
    (issued capital and addition paid in capital) in comparative periods is restated using the exchange ratio established in the Business
    Combination to reflect the number and par value of shares of the Company issued in the reverse acquisition transaction. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    statement of comprehensive loss reflects that of Security Matters PTY Ltd. for the full period together with the post-acquisition
    results of the Company from the Closing Date. Loss per share of Security Matters PTY Ltd. for periods prior to the acquisition date
    is restated such the denominator of the historical loss per share calculation is adjusted by multiplying the weighted-average shares
    used in each historically reported loss per share calculation by the exchange ratio established in the Business Combination.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForRepurchaseAndReverseRepurchaseAgreementsExplanatory>
    <SMX:FairValueBasedOnQuotedOpeningSharePrice
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000908"
      unitRef="USD">11599000</SMX:FairValueBasedOnQuotedOpeningSharePrice>
    <SMX:FairValueOfEquityTransaction
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000910"
      unitRef="USD">16802000</SMX:FairValueOfEquityTransaction>
    <SMX:MarketableSecuritiesHeldInTrustAccount
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000912"
      unitRef="USD">4921000</SMX:MarketableSecuritiesHeldInTrustAccount>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000913"
      unitRef="USD">10127000</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000915">&lt;p id="xdx_843_eifrs-full--DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_zOpQqGV0lfid" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86B_zLzscRrh040k"&gt;Foreign
currency&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
consolidated financial statements are prepared in US Dollars, which is the functional and presentation currency of the Company. The functional
currency of Lionheart III Corp is US Dollar. The functional currency of SMX Fashion and Luxury is EURO. The functional currency of True
Silver SMX Platform is Canadian Dollars. The functional currency of SMX (Security Matters) Ireland Limited is US Dollar. The functional
currency of SMX Circular Economy Platform PTE, Ltd. is Singapore Dollar. The functional currency of Security Matters Pty Ltd. is Australian
Dollar. The functional currency of Security Matters Ltd. (Israel) is New Israeli Shekel. The functional currency of Security Matters
Canada Ltd. is Canadian Dollar. The functional currency of SMX Beverages Pty Ltd. is Australian Dollar. The functional currency of True
Gold is Australian Dollar. The functional currency of SMX Circular Economy FZCO is Emirati Dirham.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Transactions
and balances in foreign currencies are converted into US Dollars in accordance with the principles set forth by International Accounting
Standard (IAS) 21 (&#x201c;The Effects of Changes in Foreign Exchange Rates&#x201d;). Accordingly, transactions and balances have been
converted as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -14.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Assets
    and liabilities &#x2013; at the rate of exchange applicable at the reporting date.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expense
    items &#x2013; at annual average rate at the statements of financial position date. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Share
    capital, capital reserve and other capital movement items were at the rate of exchange as of the date of recognition of those items.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    accumulated deficit was based on the opening balance for the beginning of the reporting period in addition to the movements mentioned
    above.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exchange
                                            gains and losses from the aforementioned conversion are recognized in the statement of other
                                            comprehensive losses in the Foreign Currency Translation Reserve.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000917">&lt;p id="xdx_84C_eifrs-full--DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_zmvoK7po3Py6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_864_z06wk3g40v4f"&gt;Issue
of a unit of financial instruments&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
issue of a unit of financial instruments such as a financial liability (e.g., a loan) and free-standing derivative (e.g. warrants) involves
the allocation of the proceeds received (before issuance costs) to financial derivatives and other financial instruments measured at
fair value in each period and to financial liabilities that are measured at amortized cost, with residual allocated to equity instruments.
Issuance costs are allocated to each component pro rata to the amounts determined for each component in the unit.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000919">&lt;p id="xdx_84A_eifrs-full--DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_z6EqTf29TAE6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86F_zDC2EMt7taQ1"&gt;Fair
value measurement&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
value is the price that would be received when selling an asset or paid to transfer a liability in an orderly transaction between market
participants at the measurement date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value measurement is based on the presumption that the transaction to sell the asset or transfer the liability takes place either:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
    the principal market for the asset or liability; or&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;B.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
    the absence of a principal market, in the most advantageous market for the asset or liability.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
principal or the most advantageous market must be accessible to the Group.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or
liability, assuming that market participants act in their economic best interest.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
fair value measurement of a non-financial asset takes into account a market participant&#x2019;s ability to generate economic benefits
by using the asset in its highest and best use or by selling it to another market participant that would use the asset in its highest
and best use.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair
value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000921">&lt;p id="xdx_843_eifrs-full--DescriptionOfAccountingPolicyForFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory_zXMa2MEXQXH6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_868_z2wZ0Q7EjUDe"&gt;Classification
of financial instruments by fair value hierarchy&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
financial instruments presented in the statements of financial position at fair value are grouped into classes with similar characteristics
using the following fair value hierarchy which is determined based on the source of input used in measuring fair value:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Quoted
    prices (unadjusted) in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    2&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Inputs
    other than quoted prices included within Level 1 that are observable either directly or indirectly.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Inputs
    that are not based on observable market data (valuation techniques which use inputs that are not based on observable market data).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForFinancialAssetsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000923">&lt;p id="xdx_84D_eifrs-full--DescriptionOfAccountingPolicyForFinancialAssetsExplanatory_zph0AKkxcSr9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_868_zxRk25zyWt3d"&gt;Financial
assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group classifies its financial assets into one of the following categories, depending on the purpose for which the asset was acquired.
The Group&#x2019;s accounting policy for each category is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
receivables: These assets are non-derivative financial assets with fixed or determinable payments that are not quoted in an active market.
They arise principally through the provision of goods and services, but also incorporate other types of contractual monetary asset. These
assets are carried at amortized cost less any provision for impairment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group has no financial assets classified at fair value through profit or loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForFinancialAssetsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000925">&lt;p id="xdx_842_eifrs-full--DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory_z2fkRNGLVNO7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_866_zfdQ0vFi3B69"&gt;Financial
liabilities&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;financial
liabilities measured at amortized cost:&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
liabilities are initially recognized at fair value less transaction costs that are directly attributable to the issue of financial liability.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;After
initial recognition, the Group measures all financial liabilities at amortized cost using the effective interest rate method, which ensures
that any interest expense over the period is at a constant interest rate on the balance of the liability carried in the statement of
financial position, except for financial liabilities which are measured at fair value through profit or loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;measured
at fair value through profit or loss:&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
financial liabilities comprise of derivatives that are options which are to be settled in equity instruments but nevertheless do not
meet the definitions of equity instruments. The Group measures those financial liabilities at fair value. Transaction costs are recognized
in profit or loss. After initial recognition, changes in fair value are recognized in profit or loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000927">&lt;p id="xdx_84D_eifrs-full--DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_zoywYPKO4Hf4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_865_zfXXXuVjUcMj"&gt;Impairment
of non-financial assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
assets and goodwill that have an indefinite useful life are not subject to amortization and are tested annually for impairment, or more
frequently if events or changes in circumstances indicate that they might be impaired. Other non-financial assets are reviewed for impairment
whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. An impairment loss is recognized
for the amount by which the asset&#x2019;s carrying amount exceeds its recoverable amount. Recoverable amount is the higher of an asset&#x2019;s
fair value less costs of disposal and value-in-use. The value-in-use is the present value of the estimated future cash flows relating
to the asset using a pre-tax discount rate specific to the asset or cash-generating unit to which the asset belongs. Assets that do not
have independent cash flows are grouped together to form a cash-generating unit.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000929">&lt;p id="xdx_843_eifrs-full--DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_z0kOpYLYWAe5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_863_zK4TxxZ7xgBd"&gt;Property,
plant and equipment&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Items
of property, plant and equipment are initially recognized at cost. Cost includes directly attributable costs and the estimated present
value of any future costs of dismantling and removing items. Depreciation is computed by the straight-line method, based on the estimated
useful lives of the assets, as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_ecustom--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentDepreciationRateExplanatory_zNlCMb5gJrnh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B7_zNFvRHxuSBX1" style="display: none"&gt;SCHEDULE OF DEPRECIATION RATES OF PROPERTY, PLANT AND EQUIPMENT&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: justify"&gt;Computers&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--DepreciationRatePropertyPlantAndEquipment_pid_dp_uPure_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zd3v06BL3Tl2"&gt;33&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Machines and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--DepreciationRatePropertyPlantAndEquipment_pid_dp_uPure_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_zJqNWAbNaW57"&gt;20&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Furniture and office equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--DepreciationRatePropertyPlantAndEquipment_pid_dp_uPure_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember_zKfaHdrq7Yvh"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Leasehold improvements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--DepreciationRatePropertyPlantAndEquipment_pid_dp_uPure_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zCTeb9ETAbOb"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AA_zMUOPbJzK1u2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Leasehold
improvements are depreciated over the term of the expected lease including optional extension, or the estimated useful lives of the improvements,
whichever is shorter.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory>
    <SMX:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentDepreciationRateExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000931">&lt;p id="xdx_890_ecustom--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentDepreciationRateExplanatory_zNlCMb5gJrnh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B7_zNFvRHxuSBX1" style="display: none"&gt;SCHEDULE OF DEPRECIATION RATES OF PROPERTY, PLANT AND EQUIPMENT&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: justify"&gt;Computers&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--DepreciationRatePropertyPlantAndEquipment_pid_dp_uPure_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zd3v06BL3Tl2"&gt;33&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Machines and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--DepreciationRatePropertyPlantAndEquipment_pid_dp_uPure_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_zJqNWAbNaW57"&gt;20&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Furniture and office equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--DepreciationRatePropertyPlantAndEquipment_pid_dp_uPure_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember_zKfaHdrq7Yvh"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Leasehold improvements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--DepreciationRatePropertyPlantAndEquipment_pid_dp_uPure_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zCTeb9ETAbOb"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</SMX:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentDepreciationRateExplanatory>
    <ifrs-full:DepreciationRatePropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_ComputerEquipmentMember"
      decimals="INF"
      id="Fact000932"
      unitRef="Pure">0.33</ifrs-full:DepreciationRatePropertyPlantAndEquipment>
    <ifrs-full:DepreciationRatePropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_MachineryMember"
      decimals="INF"
      id="Fact000933"
      unitRef="Pure">0.20</ifrs-full:DepreciationRatePropertyPlantAndEquipment>
    <ifrs-full:DepreciationRatePropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_custom_FurnitureAndOfficeEquipmentMember"
      decimals="INF"
      id="Fact000934"
      unitRef="Pure">0.10</ifrs-full:DepreciationRatePropertyPlantAndEquipment>
    <ifrs-full:DepreciationRatePropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_LeaseholdImprovementsMember"
      decimals="INF"
      id="Fact000935"
      unitRef="Pure">0.08</ifrs-full:DepreciationRatePropertyPlantAndEquipment>
    <ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000937">&lt;p id="xdx_842_eifrs-full--DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_zMtk0eBw36Xe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_869_zR4iSMb7fIo2"&gt;Reimbursement
of research and development expenses&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Reimbursements
in proof of concept (POC) agreements of expenditures on research and development in order to achieve commercial agreement once this activity
is successful, are offset in profit or loss against the related expenses (research and development expenses). Any IP generated from this
activity remains at the ownership of the Group.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory>
    <SMX:DescriptionOfAccountingPolicyForRightOfUseAssetsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000939">&lt;p id="xdx_84E_ecustom--DescriptionOfAccountingPolicyForRightOfUseAssetsExplanatory_zNOrEtdeJq4l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86C_zcxdocpkCtvc"&gt;Right-of-use
assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
leases are accounted for by recognizing a right-of-use asset and a lease liability, excluding leases where the lease term is 12 months
or less, or where the underlying asset is of low-value. These leases expenditures are recognized on a straight-line basis over the lease
term. A right-of-use asset is recognized at the commencement date of a lease. The right-of-use asset is measured at cost, which comprises
the initial amount of the lease liability, adjusted for, as applicable, any lease payments made at or before the commencement date net
of any lease incentives received.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Right-of-use
assets are depreciated on a straight-line basis over the unexpired period of the lease or the estimated useful life of the asset, whichever
is the shorter. Where the Group expects to obtain ownership of the leased asset at the end of the lease term, the depreciation is over
its estimated useful life. Right-of-use assets are subject to impairment or adjusted for any remeasurement of lease liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</SMX:DescriptionOfAccountingPolicyForRightOfUseAssetsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000941">&lt;p id="xdx_844_eifrs-full--DescriptionOfAccountingPolicyForLeasesExplanatory_z2im3e9UgLV1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_863_zy1M5gfvJMD8"&gt;Lease
liabilities&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
leases are accounted for by recognizing a right-of-use asset and a lease liability. Lease liabilities are measured at the present value
of the contractual payments due to the lessor over the lease term, with the discount rate determined by reference to the rate implicit
in the lease unless (as is typically the case) this is not readily determinable, in which case the Group&#x2019;s incremental borrowing
rate on commencement of the lease is used. Variable lease payments are only included in the measurement of the lease liability if they
depend on an index or rate. In such cases, the initial measurement of the lease liability assumes the variable element will remain unchanged
throughout the lease term. Other variable lease payments are expensed in the period to which they relate.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
initial recognition, the carrying value of the lease liability also includes:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;amounts
    expected to be payable under any residual value guarantee.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
    exercise price of any purchase option granted in favor of the Group if it is reasonably certain to exercise that option.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;any
    penalties payable for terminating the lease, if the term of the lease has been estimated on the basis of termination option being
    exercised.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Subsequent
to initial measurement lease liabilities increase as a result of interest charged at a constant rate on the balance outstanding and are
reduced for lease payments made. Lease liabilities are remeasured when there is a change in future lease payments arising from a change
in an index or rate or when there is a change in the assessment of the term of any lease the remeasurement being recognized in front
of the right of use assets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000943">&lt;p id="xdx_841_eifrs-full--DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_zPzpjW7BRTf8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86D_zEzjyqQsyWWa"&gt;Capitalized
technology development costs&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expenditures
on research activities are recognized in profit or loss as incurred. Expenditures on internally developed products are mainly employee
salaries and legal fees for filing of patents and are capitalized when the Group demonstrates all the following criteria:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    technical feasibility of completing the intangible asset so that it will be available for use or sale.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    intention to complete the intangible asset and use or sell it.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;c.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    ability to use or sell the intangible asset.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;d.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    probability of the intangible asset to generate future economic benefits. Among other things, the Group considers the existence of
    a market for the output of the intangible asset or the intangible asset itself or, if it is to be used internally, the usefulness
    of the intangible asset.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;e.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;f.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    ability to measure reliably the expenditures attributable to the intangible asset during its development.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
recognition criteria above are considered by the Group at each stage of development to determine when the criteria have been initially
met in full.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
technical feasibility criteria is determined to be met when a the milestone of initial marking and reading capabilities is satisfied.
The milestone&#x2019;s identification occurs only following a detailed broad mapping of the raw material characteristics and establishing
the formula for the chemical marker architecture to be embedded into the raw material based on industry standards and regulations. The
result is the initial evidence that the x-ray algorithm of the designated reader is in a stage that can identify the marker and convey
information. At this stage, the Group believes that the technical feasibility of completing the development for use is probable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group notes that technical feasibility has been established and the achieved technology is ready for the next stage which consists of
performing a proof-of-concept pilot with an industry partner, in order to adapt the technology for the relevant industry and adjust the
development to meet the industry&#x2019;s needs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 85%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Capitalized
technology development costs (Cont.) &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Currently,
the Group&#x2019;s capitalized development activities focus on:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Development
    of marker architecture to be embedded topically or in-situ (application) for each material/product within the optimal industrial
    manufacturing phase, based on industry standards and regulations.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Semi
    Industrial scale &#x2013; technology implementation in semi-industrial production.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Development
    of a digital platform to support the end-to-end traceability from raw material to final product to recycling.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group&#x2019;s management has the full intention to complete the development of the technology and ultimately to sell it. This intention
is demonstrated by initiating partnerships with industry market leaders and continuing the development into the next phase. The Group&#x2019;s
intention is also reflected in the Group&#x2019;s approved budget.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group&#x2019;s management intends to concentrate its future sales and marketing efforts in the U.S. and Asia Pacific markets, including,
but not limited to, recruitment of sales and marketing personnel. It plans to advance successful proof-of-concept pilots performed with
industry leading partners, and further advance its innovative technology and commercialization efforts and collaborations in the segments
relevant to its technology.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group&#x2019;s business model targets leading brands and manufacturers in order to create a new market standard for circular economy solutions,
brand authentication and supply chain integrity. The Company is currently in the transition phase from technology validation to commercial deployment. Revenue generation
is expected to scale as proof-of-concept programs and strategic partnerships convert into commercial agreements, particularly within large
enterprise and government-led ecosystems. The Group&#x2019;s technology is applicable for multiple industries such as gold, fashion,
electronics and circular economy &#x2013; plastic and rubber. The Group is able to provide an adaptive solution for multiple market segments,
based on a unified technology solution, through collaborative relationships with leading market companies which provide it with access
to various potential entities to sell its solution. This is part of the Group&#x2019;s strategy to create strategic partnerships with
market leaders across its main segments of activity. The Group believes that this close collaboration with market leaders, and developing
a product that meets their requests, suggest that there is a strong potential market for its development.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Adequate
technical and financial resources are available to complete the development; the development will be completed by the Group&#x2019;s technology
team which consists of professional experienced scientists and engineers, with a track record in the industrial sector and with financial
resources successfully raised through the issuance of ordinary shares and loans. The Group has already accomplished its core technology
development and is currently focused on development of specific adjustments for different market segments. This stage is focused and
short-termed, therefore, management believes that limited financial resources are required for completing the development and that there
is high probability for commencing commercial agreements following the successful proof-of-concept pilots. The Company is focused on establishing industry-wide adoption through collaboration with leading partners, with the objective of creating
standardized solutions across multiple sectors including plastics, metals, and supply chain authentication.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group has financial systems in place that allow it to maintain records in sufficient detail that enable it to measure reliably the expenditures
attributable to the intangible asset during its development.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Development
expenditures not satisfying all the above criteria are recognized in the consolidated statement of comprehensive income as incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Subsequent
measurement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
subsequent periods, capitalized development expenditures are measured at cost less accumulated amortization and accumulated impairment
losses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;An
asset is ready for its intended use, when the developed technology becomes operational and the Group completes an initial customization.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Capitalized
technology development costs (Cont.) &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
assets with a finite useful life are amortized over their estimated useful lives and reviewed for impairment whenever there is an indication
that the asset may be impaired. The amortization period and the amortization method for intangible assets are reviewed at least at each
year end.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
carrying amount of these assets is reviewed whenever events or changes in circumstances indicate that the carrying value of an asset
may not be recoverable. If the asset is considered to be impaired, the amount of any impairment is measured as the difference between
the carrying value and the fair value of the impaired asset. An expenditure incurred in development activities, including the Group&#x2019;s
software development is capitalized only where it clearly increases the economic benefits to be derived from the asset to which it relates,
the expenditure will lead to new or substantially improved products, the products are technically and commercially feasible and the Group
has sufficient resources to complete the development and reach the stage for which the product is ready for use.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
other expenditure, including those incurred in order to maintain an intangible assets current level of performance, is expensed as incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000945">&lt;p id="xdx_849_eifrs-full--DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_zIwWCXW6IqEa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_867_zO6219ni7F34"&gt;Share-based
compensation&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group measures the share-based expense and the cost of equity-settled transactions with employees and service providers by reference
to the fair value of the equity instruments at the date at which they are granted. The Group selected the Black-Scholes model as the
Group&#x2019;s option pricing model to estimate the fair value of the Group&#x2019;s options awards. The model is based on share price,
grant date and on assumptions regarding expected volatility, expected life of the options, expected dividend, and a no risk interest
rate. As for granted options which are settled in equity instruments, the fair value of the options at the grant date is charged to the
statement of comprehensive loss over the vesting period. Non-market vesting conditions are taken into account by adjusting the number
of equity instruments expected to vest at each reporting date so that, ultimately, the cumulative amount recognized over the vesting
period is based on the number of options that eventually vest.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory>
    <SMX:DescriptionOfAccountingPolicyNewStandardsInterpretationsAndAmendmentsAdoptedExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000947">&lt;p id="xdx_84E_ecustom--DescriptionOfAccountingPolicyNewStandardsInterpretationsAndAmendmentsAdoptedExplanatory_zgg8NAQDjpPj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_865_zNQpem8EfGLb"&gt;New
standards, interpretations and amendments not yet effective&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
are a number of standards, amendments to standards, and interpretations which have been issued by the IASB that are effective in future
accounting periods that the Group has decided not to adopt early.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following amendments are effective for the annual reporting period beginning January 1, 2026:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;Amendments
to the Classification and Measurement of Financial Instruments (Amendment s to IFRS 9 Financial Instruments and IFRS 7 Financial Instruments:
Disclosures)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;Contracts
Referencing Nature -dependent Electricity (Amendments to IFRS 9 and IFRS 7)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following standards and amendments are effective for the annual reporting period beginning January 1, 2027:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
IFRS 18 Presentation and Disclosure in Financial Statements&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;IFRS
19 Subsidiaries without Public Accountability: Disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group is currently assessing the effect of these new accounting standards and amendments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;IFRS
18 Presentation and Disclosure in Financial Statements, which was issued by the IASB in April 2024 supersedes IAS 1 and will result in
major consequential amendments to IFRS Accounting Standards including IAS 8 Basis of Preparation of Financial Statements (renamed from
Accounting Policies, Changes in Accounting Estimates and Errors). Even though IFRS 18 will not have any effect on the recognition and
measurement of items in the consolidated financial statements, it is expected to have a significant effect on the presentation and disclosure
of certain items. These changes include categorisation and sub-totals in the statement of profit or loss, aggregation/disaggregation
and labelling of information, and disclosure of management-defined performance measures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group does not expect to be eligible to apply IFRS 19.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;The
significant accounting judgments, estimates and assumptions followed in the preparation of the financial statements, on a consistent
basis, are:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
the process of applying the significant accounting policies, the Group has made the following judgments which have the most significant
effect on the amounts recognized in the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of the consolidated financial statements requires management to make estimates and assumptions that have an effect on the
application of the accounting policies and on the reported amounts of assets, liabilities and expenses. Changes in accounting estimates
are reported in the period of the change in estimate. The key assumptions made in the financial statements are discussed below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</SMX:DescriptionOfAccountingPolicyNewStandardsInterpretationsAndAmendmentsAdoptedExplanatory>
    <SMX:DescriptionOfAccountingPolicyForShareBasedCompensationExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000949">&lt;p id="xdx_848_ecustom--DescriptionOfAccountingPolicyForShareBasedCompensationExplanatory_zC4FnAncuHwh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_860_zWSsK5mTYxWc"&gt;Share
based compensation&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group has a share-based remuneration scheme for employees. The fair value of share options is estimated by using the Black-Scholes model,
which was derived to model the value of the firm&#x2019;s equity over time. The simulation model was designed to take into account the
unique terms and conditions of the performance shares and share options, as well as the capital structure of the firm and the volatility
of its assets, on the date of grant based on certain assumptions. Those conditions are described in the share-based compensation note
and include, among others, the dividend growth rate, expected share price volatility and expected life of the options. The fair value
of the equity settled options granted is charged to the statement of profit or loss over the vesting period of each tranche and the credit
is taken to equity, based on the consolidated entity&#x2019;s estimate of shares that will eventually vest.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</SMX:DescriptionOfAccountingPolicyForShareBasedCompensationExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000951">&lt;p id="xdx_844_eifrs-full--DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory_zJ8z4SV41ey1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86E_zhQgs5aeirle"&gt;Intangible
assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group capitalizes costs for its developed projects when specific criteria are met. Initial capitalization of costs is based on management&#x2019;s
judgement that technological and economic feasibility is achievable, usually when a product development project has reached a defined
milestone according to an established project management model. The management makes assumptions regarding the expected future economic
benefit to be derived from the intangible asset and therefore whether the capitalized costs are expected to be recovered.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;This
amount of capitalized costs includes significant investment in the development of marking and reading capabilities in the subject material.
Prior to being marketed, the Group will obtain a proof-of-concept pilot with an industry leading partner. The innovative nature of the
product gives rise to some judgement as to whether the proof-of-concept will be successful such that it will lead to obtaining commercial
contracts with customers. See also note 6.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
bases its estimates on historical experience, assumptions, and information currently available and deemed to be reasonable at the time
the consolidated financial statements are prepared. However, actual amounts may differ from the estimated amounts as more detailed information
becomes available. Estimates and assumptions are reviewed on an ongoing basis and, if necessary, changes are recognized in the period
in which the estimate is revised.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000953">&lt;p id="xdx_846_eifrs-full--DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory_zLLFcJWVVHv" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_864_zeGoBG6QUy0b"&gt;Impairment
of goodwill and intangible assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group reviews goodwill for impairment at least once a year or more frequently if events or changes in circumstances indicate that there
is impairment. Goodwill is tested for impairment by assessing the recoverable amount of the cash-generating unit to which the goodwill
has been allocated. This requires management to make an estimate of the projected future cash flows from the continuing use of the cash-generating
unit to which the goodwill is allocated and also to choose a suitable discount rate for those cash flows. See more information in note
6.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
carrying values of the long-lived intangible assets are reviewed for impairment whenever events or changes in circumstances indicate
that the carrying amount of an asset may no longer be recoverable. If any indication exists, then the asset&#x2019;s recoverable amount
is estimated. Determining the recoverable amount is subjective and requires management to estimate project future cash flows, among other
factors. Future events and changing market conditions may impact on the assumptions as to prices, costs or other factors that may result
in changes to the estimates of future cash flows. If the Group concludes that a definite or indefinite long-lived intangible asset is
impaired, the Group recognize a loss in an amount equal to the excess of the carrying value of the asset over its fair value at the date
of impairment. The fair value at the date of the impairment becomes the new cost basis and will result in a lower depreciation expense
than for periods before the asset&#x2019;s impairment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory>
    <SMX:DescriptionOfAccountingPolicyForFinancialLiabilitiesAtFairValueExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000955">&lt;p id="xdx_84B_ecustom--DescriptionOfAccountingPolicyForFinancialLiabilitiesAtFairValueExplanatory_zAp0IcVFY1w4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_868_zrMpRGXlDXz1"&gt;Financial
liabilities at fair value&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of financial liabilities at fair value was estimated by using a Black Scholes model and Monte-Carlo simulation approach, which
was aimed to model the value of the Group&#x2019;s assets over time. The simulation approach was designed to take into account the terms
and conditions of the financial liabilities, which are described in notes 8, 9 and 11, as well as the capital structure of the Group
and the volatility of its assets. The valuation was performed based on management&#x2019;s assumptions and projections.&lt;/span&gt;&lt;/p&gt;

</SMX:DescriptionOfAccountingPolicyForFinancialLiabilitiesAtFairValueExplanatory>
    <ifrs-full:DisclosureOfOtherCurrentAssetsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000957">&lt;p id="xdx_801_eifrs-full--DisclosureOfOtherCurrentAssetsExplanatory_z8vfAHvvQBte" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
3 - &lt;span id="xdx_82E_zaEF29pWuVIc"&gt;OTHER CURRENT RECEIVABLES&lt;/span&gt;:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_ecustom--DisclosureOfDetailedInformationAboutOtherCurrentAssetsExplanatory_zPGUi2PxZ5fk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;span id="xdx_8BD_zS82AbTVOT5a" style="display: none"&gt;SCHEDULE OF OTHER CURRENT RECEIVABLES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20251231_z6nhcJFL2J7d" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20241231_zpfyRKBakNO8" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--ReceivableInRespectOfExerciseOfWarrants_iI_maTAORzn6p_zX1xO1JuQSc2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: justify"&gt;Receivable in respect of exercise of warrants&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0961"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,510&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--CurrentValueAddedTaxReceivables_iI_maTAORzn6p_zjGeDuKeomh9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Tax authorities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;364&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;305&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--CurrentPrepaymentsAndOtherCurrentAssets_iI_maTAORzn6p_zW39LY7Hh0ob" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Prepaid expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;198&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;102&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--ProofOfConceptReceivablesCurrent_iI_maTAORzn6p_zA1zEJlYvL19" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Proof of concept receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;46&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--OtherCurrentFinancialAssets_iI_maTAORzn6p_zANAzjed0993" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;17&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;30&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--OtherCurrentAssets_iTI_mtTAORzn6p_zsnDRqhdzJB8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 1pt"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;587&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;1,993&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_zFFCYJlFsNof" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfOtherCurrentAssetsExplanatory>
    <SMX:DisclosureOfDetailedInformationAboutOtherCurrentAssetsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000959">&lt;p id="xdx_892_ecustom--DisclosureOfDetailedInformationAboutOtherCurrentAssetsExplanatory_zPGUi2PxZ5fk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;span id="xdx_8BD_zS82AbTVOT5a" style="display: none"&gt;SCHEDULE OF OTHER CURRENT RECEIVABLES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20251231_z6nhcJFL2J7d" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20241231_zpfyRKBakNO8" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--ReceivableInRespectOfExerciseOfWarrants_iI_maTAORzn6p_zX1xO1JuQSc2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: justify"&gt;Receivable in respect of exercise of warrants&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0961"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,510&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--CurrentValueAddedTaxReceivables_iI_maTAORzn6p_zjGeDuKeomh9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Tax authorities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;364&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;305&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--CurrentPrepaymentsAndOtherCurrentAssets_iI_maTAORzn6p_zW39LY7Hh0ob" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Prepaid expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;198&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;102&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--ProofOfConceptReceivablesCurrent_iI_maTAORzn6p_zA1zEJlYvL19" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Proof of concept receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;46&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--OtherCurrentFinancialAssets_iI_maTAORzn6p_zANAzjed0993" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;17&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;30&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--OtherCurrentAssets_iTI_mtTAORzn6p_zsnDRqhdzJB8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 1pt"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;587&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;1,993&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</SMX:DisclosureOfDetailedInformationAboutOtherCurrentAssetsExplanatory>
    <SMX:ReceivableInRespectOfExerciseOfWarrants
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000962"
      unitRef="USD">1510000</SMX:ReceivableInRespectOfExerciseOfWarrants>
    <ifrs-full:CurrentValueAddedTaxReceivables
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000964"
      unitRef="USD">364000</ifrs-full:CurrentValueAddedTaxReceivables>
    <ifrs-full:CurrentValueAddedTaxReceivables
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000965"
      unitRef="USD">305000</ifrs-full:CurrentValueAddedTaxReceivables>
    <ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000967"
      unitRef="USD">198000</ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets>
    <ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000968"
      unitRef="USD">102000</ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets>
    <SMX:ProofOfConceptReceivablesCurrent
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000970"
      unitRef="USD">8000</SMX:ProofOfConceptReceivablesCurrent>
    <SMX:ProofOfConceptReceivablesCurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000971"
      unitRef="USD">46000</SMX:ProofOfConceptReceivablesCurrent>
    <ifrs-full:OtherCurrentFinancialAssets
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000973"
      unitRef="USD">17000</ifrs-full:OtherCurrentFinancialAssets>
    <ifrs-full:OtherCurrentFinancialAssets
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000974"
      unitRef="USD">30000</ifrs-full:OtherCurrentFinancialAssets>
    <ifrs-full:OtherCurrentAssets
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000976"
      unitRef="USD">587000</ifrs-full:OtherCurrentAssets>
    <ifrs-full:OtherCurrentAssets
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000977"
      unitRef="USD">1993000</ifrs-full:OtherCurrentAssets>
    <ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000979">&lt;p id="xdx_806_eifrs-full--DisclosureOfPropertyPlantAndEquipmentExplanatory_zYrBscoOxpJf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
4 - &lt;span id="xdx_82A_zObtUuquz0yd"&gt;PROPERTY, PLANT AND EQUIPMENT, NET&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_eifrs-full--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_zIzsqrKPC8Xd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;span id="xdx_8B6_zM1iqrkyCiwe" style="display: none"&gt;SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Leasehold&lt;br/&gt; improvements&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Machines&lt;br/&gt; and&lt;br/&gt; Equipment&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Furniture&lt;br/&gt; and Office&lt;br/&gt; Equipment&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Computers&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="18" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 35%; font-weight: bold"&gt;At January 1, 2025&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_znmsrIBUf7Jf" style="width: 9%; text-align: right" title="Property and equipment, net"&gt;76&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zB0BNjdCQaH8" style="width: 9%; text-align: right" title="Property and equipment, net"&gt;1,162&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQA9FGjS8qM1" style="width: 9%; text-align: right" title="Property and equipment, net"&gt;70&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zpQzuGPEFh4f" style="width: 9%; text-align: right" title="Property and equipment, net"&gt;102&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z6mXLI0JtKB9" style="width: 9%; text-align: right" title="Property and equipment, net"&gt;1,410&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z2BVaiPiSEbl" style="text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0993"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zTEWYtd4H6Q1" style="text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0995"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zExx42T9bV87" style="text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0997"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zuBHEbCU2ZJ6" style="text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0999"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zGB7r0oTC3Q7" style="text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1001"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zSTiyIRYwd4e" style="text-align: right" title="Depreciation"&gt;10&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zeHLE9p6IGMj" style="text-align: right" title="Depreciation"&gt;118&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zwWRUO764fWh" style="text-align: right" title="Depreciation"&gt;8&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zJTMUb8NWCEc" style="text-align: right" title="Depreciation"&gt;4&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zhH2afLYBQD8" style="text-align: right" title="Depreciation"&gt;140&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Currency translation adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zzthPCqQhwji" style="border-bottom: Black 1pt solid; text-align: right" title="Currency translation adjustments"&gt;10&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z4kK9DBC2pS1" style="border-bottom: Black 1pt solid; text-align: right" title="Currency translation adjustments"&gt;167&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zd910qA4xq05" style="border-bottom: Black 1pt solid; text-align: right" title="Currency translation adjustments"&gt;10&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLtTLMqmZgE7" style="border-bottom: Black 1pt solid; text-align: right" title="Currency translation adjustments"&gt;15&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zwYZyEYgtDzi" style="border-bottom: Black 1pt solid; text-align: right" title="Currency translation adjustments"&gt;202&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;At December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zc54qZJXxfz5" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, net"&gt;86&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z4FzlJrCJmwb" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, net"&gt;1,329&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zU6heef1IyZ3" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, net"&gt;80&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zAaMazhrpHEh" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, net"&gt;117&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zcwNMOTkHsNb" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, net"&gt;1,612&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Accumulated depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;At January 1, 2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zLNOknlnoNJ2" style="text-align: right" title="Property and equipment, net"&gt;33&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z3oE6r6SyRU7" style="text-align: right" title="Property and equipment, net"&gt;965&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zvmUfuguV913" style="text-align: right" title="Property and equipment, net"&gt;46&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zQGyBYqE3jwk" style="text-align: right" title="Property and equipment, net"&gt;98&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zdkLldroTTml" style="text-align: right" title="Property and equipment, net"&gt;1,142&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z0ruvKato4y1" style="text-align: right" title="Depreciation"&gt;10&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zC5XZAqOYlwi" style="text-align: right" title="Depreciation"&gt;118&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zncEyz50Bixi" style="text-align: right" title="Depreciation"&gt;8&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zz8bOxdL9Xq4" style="text-align: right" title="Depreciation"&gt;4&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zoVyEailB772" style="text-align: right" title="Depreciation"&gt;140&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Currency translation adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zbqg5kfqtkE6" style="border-bottom: Black 1pt solid; text-align: right" title="Currency translation adjustments"&gt;5&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zk7PHXpOn996" style="border-bottom: Black 1pt solid; text-align: right" title="Currency translation adjustments"&gt;140&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z90kZkL4XhXc" style="border-bottom: Black 1pt solid; text-align: right" title="Currency translation adjustments"&gt;6&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z23sPcVjKYJ1" style="border-bottom: Black 1pt solid; text-align: right" title="Currency translation adjustments"&gt;14&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zKh51sQUGw86" style="border-bottom: Black 1pt solid; text-align: right" title="Currency translation adjustments"&gt;165&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;At December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zQaD3pp8fFac" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, net"&gt;48&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zjjkoxgHF5Re" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, net"&gt;1,223&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_znLVuyLbJIj6" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, net"&gt;60&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zwuP6XIp26sk" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, net"&gt;116&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zvgSuLz1JFSc" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, net"&gt;1,447&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Net book value at December 31, 2025&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_z2uqUi0UjNw2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Property and equipment, net"&gt;38&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_zq8VPnmQH6ig" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Property and equipment, net"&gt;106&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember_zmc1y2hsSPm5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Property and equipment, net"&gt;20&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zGBy5ghEEm73" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Property and equipment, net"&gt;1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231_zaY48dcoCK9c" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Property and equipment, net"&gt;165&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="vertical-align: bottom; width: 85%; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;SMX (SECURITY MATTERS)
                                            PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/p&gt;
                                          &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt; &lt;b&gt;&lt;/b&gt;&lt;/p&gt;
                                          &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;(US$ in thousands except share and per share data)&lt;/b&gt; &lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: justify; width: 15%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
4 - PROPERTY, PLANT AND EQUIPMENT, NET (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Leasehold&lt;br/&gt; improvements&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Machines&lt;br/&gt; and&lt;br/&gt; Equipment&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Furniture&lt;br/&gt; and Office&lt;br/&gt; Equipment&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Computers&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="18" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 35%; font-weight: bold"&gt;At January 1, 2024&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z32EAsnL3rDj" style="width: 9%; text-align: right" title="Property and equipment, net"&gt;75&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z97VzHSGbZ4l" style="width: 9%; text-align: right" title="Property and equipment, net"&gt;1,146&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z8IG6pGPzOF8" style="width: 9%; text-align: right" title="Property and equipment, net"&gt;69&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ztYZCEIbIwal" style="width: 9%; text-align: right" title="Property and equipment, net"&gt;102&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zqiP3pRrKzIg" style="width: 9%; text-align: right" title="Property and equipment, net"&gt;1,392&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zIElfWF5Fxv5" style="text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1093"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z6NiNG5rmOE8" style="text-align: right" title="Additions"&gt;21&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zgR2VDwZz5b5" style="text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1097"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zssc5zbfEXch" style="text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1099"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zncqWd2W04E1" style="text-align: right" title="Additions"&gt;21&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zrxXZTPyg1d" style="text-align: right" title="Depreciation"&gt;9&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zsuFV3iqYWU6" style="text-align: right" title="Depreciation"&gt;135&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zPxIl5CObHxc" style="text-align: right" title="Depreciation"&gt;9&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zSsj7ZO7oPwa" style="text-align: right" title="Depreciation"&gt;10&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zYQNUXMEXsAf" style="text-align: right" title="Depreciation"&gt;163&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Currency translation adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zSNjzoYVsRs5" style="border-bottom: Black 1pt solid; text-align: right" title="Currency translation adjustments"&gt;1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zardrQP5qoD2" style="border-bottom: Black 1pt solid; text-align: right" title="Currency translation adjustments"&gt;(5&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zRykoD40S9Ve" style="border-bottom: Black 1pt solid; text-align: right" title="Currency translation adjustments"&gt;1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z6tPe1qhEoH9" style="border-bottom: Black 1pt solid; text-align: right" title="Currency translation adjustments"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1119"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zyxudubcGYV5" style="border-bottom: Black 1pt solid; text-align: right" title="Currency translation adjustments"&gt;(3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;At December 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zdD6G9vcZvC1" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, net"&gt;76&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z7ymYMpMpYzl" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, net"&gt;1,162&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zwZEeyD53nbl" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, net"&gt;70&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zbHeHKMlZJpj" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, net"&gt;102&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zDsnfGKnhfb7" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, net"&gt;1,410&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Accumulated depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;At January 1, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zBZLokMN6xC6" style="text-align: right" title="Property and equipment, beginning balance"&gt;24&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zUUraf5iuFbh" style="text-align: right" title="Property and equipment, beginning balance"&gt;832&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zOk2JtjQlVHl" style="text-align: right" title="Property and equipment, beginning balance"&gt;37&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zm5qIBX2oWIi" style="text-align: right" title="Property and equipment, beginning balance"&gt;88&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z2CAfA7kBOAa" style="text-align: right" title="Property and equipment, beginning balance"&gt;981&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zde6al02g9ni" style="text-align: right" title="Depreciation"&gt;9&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zaqob8lfjUwf" style="text-align: right" title="Depreciation"&gt;135&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zNwzJR8BFCaj" style="text-align: right" title="Depreciation"&gt;9&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z8A1yAnqILYc" style="text-align: right" title="Depreciation"&gt;10&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zFcHA8ZTFnX2" style="text-align: right" title="Depreciation"&gt;163&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Currency translation adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zkmwPWjBAxod" style="border-bottom: Black 1pt solid; text-align: right" title="Currency translation adjustments"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1153"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zo3rFOJhoelg" style="border-bottom: Black 1pt solid; text-align: right" title="Currency translation adjustments"&gt;(2&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zXHBP7dfYof1" style="border-bottom: Black 1pt solid; text-align: right" title="Currency translation adjustments"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1157"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zCLu6qoYQ84k" style="border-bottom: Black 1pt solid; text-align: right" title="Currency translation adjustments"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1159"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zkV8p7DSVTB6" style="border-bottom: Black 1pt solid; text-align: right" title="Currency translation adjustments"&gt;(2&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;At December 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zIhFbH3dDgLf" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, net"&gt;33&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_ztIiU4gifZjh" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, net"&gt;965&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zy9F2kk4Dknl" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, net"&gt;46&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zH99xFFdtxL9" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, net"&gt;98&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zWiHBPcEIv6l" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, net"&gt;1,142&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Net book value at December 31, 2024&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zFc9uWVr6Nok" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Property and equipment, ending balance"&gt;43&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_zmGgKYv9v50j" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Property and equipment, ending balance"&gt;197&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember_z66Zh4MBmZzb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Property and equipment, ending balance"&gt;24&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zWBk3eFqY1r5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Property and equipment, ending balance"&gt;4&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20240101__20241231_zuuj5dHd9SLg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Property and equipment, ending balance"&gt;268&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zFG2Rsq9tukd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000981">&lt;p id="xdx_892_eifrs-full--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_zIzsqrKPC8Xd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;span id="xdx_8B6_zM1iqrkyCiwe" style="display: none"&gt;SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Leasehold&lt;br/&gt; improvements&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Machines&lt;br/&gt; and&lt;br/&gt; Equipment&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Furniture&lt;br/&gt; and Office&lt;br/&gt; Equipment&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Computers&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="18" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 35%; font-weight: bold"&gt;At January 1, 2025&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_znmsrIBUf7Jf" style="width: 9%; text-align: right" title="Property and equipment, net"&gt;76&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zB0BNjdCQaH8" style="width: 9%; text-align: right" title="Property and equipment, net"&gt;1,162&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQA9FGjS8qM1" style="width: 9%; text-align: right" title="Property and equipment, net"&gt;70&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zpQzuGPEFh4f" style="width: 9%; text-align: right" title="Property and equipment, net"&gt;102&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z6mXLI0JtKB9" style="width: 9%; text-align: right" title="Property and equipment, net"&gt;1,410&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z2BVaiPiSEbl" style="text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0993"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zTEWYtd4H6Q1" style="text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0995"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zExx42T9bV87" style="text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0997"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zuBHEbCU2ZJ6" style="text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0999"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zGB7r0oTC3Q7" style="text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1001"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zSTiyIRYwd4e" style="text-align: right" title="Depreciation"&gt;10&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zeHLE9p6IGMj" style="text-align: right" title="Depreciation"&gt;118&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zwWRUO764fWh" style="text-align: right" title="Depreciation"&gt;8&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zJTMUb8NWCEc" style="text-align: right" title="Depreciation"&gt;4&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zhH2afLYBQD8" style="text-align: right" title="Depreciation"&gt;140&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Currency translation adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zzthPCqQhwji" style="border-bottom: Black 1pt solid; text-align: right" title="Currency translation adjustments"&gt;10&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z4kK9DBC2pS1" style="border-bottom: Black 1pt solid; text-align: right" title="Currency translation adjustments"&gt;167&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zd910qA4xq05" style="border-bottom: Black 1pt solid; text-align: right" title="Currency translation adjustments"&gt;10&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLtTLMqmZgE7" style="border-bottom: Black 1pt solid; text-align: right" title="Currency translation adjustments"&gt;15&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zwYZyEYgtDzi" style="border-bottom: Black 1pt solid; text-align: right" title="Currency translation adjustments"&gt;202&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;At December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zc54qZJXxfz5" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, net"&gt;86&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z4FzlJrCJmwb" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, net"&gt;1,329&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zU6heef1IyZ3" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, net"&gt;80&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zAaMazhrpHEh" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, net"&gt;117&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zcwNMOTkHsNb" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, net"&gt;1,612&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Accumulated depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;At January 1, 2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zLNOknlnoNJ2" style="text-align: right" title="Property and equipment, net"&gt;33&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z3oE6r6SyRU7" style="text-align: right" title="Property and equipment, net"&gt;965&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zvmUfuguV913" style="text-align: right" title="Property and equipment, net"&gt;46&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zQGyBYqE3jwk" style="text-align: right" title="Property and equipment, net"&gt;98&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zdkLldroTTml" style="text-align: right" title="Property and equipment, net"&gt;1,142&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z0ruvKato4y1" style="text-align: right" title="Depreciation"&gt;10&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zC5XZAqOYlwi" style="text-align: right" title="Depreciation"&gt;118&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zncEyz50Bixi" style="text-align: right" title="Depreciation"&gt;8&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zz8bOxdL9Xq4" style="text-align: right" title="Depreciation"&gt;4&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zoVyEailB772" style="text-align: right" title="Depreciation"&gt;140&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Currency translation adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zbqg5kfqtkE6" style="border-bottom: Black 1pt solid; text-align: right" title="Currency translation adjustments"&gt;5&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zk7PHXpOn996" style="border-bottom: Black 1pt solid; text-align: right" title="Currency translation adjustments"&gt;140&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z90kZkL4XhXc" style="border-bottom: Black 1pt solid; text-align: right" title="Currency translation adjustments"&gt;6&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z23sPcVjKYJ1" style="border-bottom: Black 1pt solid; text-align: right" title="Currency translation adjustments"&gt;14&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zKh51sQUGw86" style="border-bottom: Black 1pt solid; text-align: right" title="Currency translation adjustments"&gt;165&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;At December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zQaD3pp8fFac" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, net"&gt;48&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zjjkoxgHF5Re" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, net"&gt;1,223&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_znLVuyLbJIj6" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, net"&gt;60&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zwuP6XIp26sk" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, net"&gt;116&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zvgSuLz1JFSc" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, net"&gt;1,447&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Net book value at December 31, 2025&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_z2uqUi0UjNw2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Property and equipment, net"&gt;38&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_zq8VPnmQH6ig" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Property and equipment, net"&gt;106&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember_zmc1y2hsSPm5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Property and equipment, net"&gt;20&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zGBy5ghEEm73" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Property and equipment, net"&gt;1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231_zaY48dcoCK9c" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Property and equipment, net"&gt;165&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="vertical-align: bottom; width: 85%; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;SMX (SECURITY MATTERS)
                                            PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/p&gt;
                                          &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt; &lt;b&gt;&lt;/b&gt;&lt;/p&gt;
                                          &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;(US$ in thousands except share and per share data)&lt;/b&gt; &lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: justify; width: 15%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
4 - PROPERTY, PLANT AND EQUIPMENT, NET (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Leasehold&lt;br/&gt; improvements&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Machines&lt;br/&gt; and&lt;br/&gt; Equipment&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Furniture&lt;br/&gt; and Office&lt;br/&gt; Equipment&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Computers&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="18" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 35%; font-weight: bold"&gt;At January 1, 2024&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z32EAsnL3rDj" style="width: 9%; text-align: right" title="Property and equipment, net"&gt;75&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z97VzHSGbZ4l" style="width: 9%; text-align: right" title="Property and equipment, net"&gt;1,146&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z8IG6pGPzOF8" style="width: 9%; text-align: right" title="Property and equipment, net"&gt;69&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ztYZCEIbIwal" style="width: 9%; text-align: right" title="Property and equipment, net"&gt;102&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zqiP3pRrKzIg" style="width: 9%; text-align: right" title="Property and equipment, net"&gt;1,392&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zIElfWF5Fxv5" style="text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1093"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z6NiNG5rmOE8" style="text-align: right" title="Additions"&gt;21&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zgR2VDwZz5b5" style="text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1097"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zssc5zbfEXch" style="text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1099"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zncqWd2W04E1" style="text-align: right" title="Additions"&gt;21&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zrxXZTPyg1d" style="text-align: right" title="Depreciation"&gt;9&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zsuFV3iqYWU6" style="text-align: right" title="Depreciation"&gt;135&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zPxIl5CObHxc" style="text-align: right" title="Depreciation"&gt;9&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zSsj7ZO7oPwa" style="text-align: right" title="Depreciation"&gt;10&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zYQNUXMEXsAf" style="text-align: right" title="Depreciation"&gt;163&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Currency translation adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zSNjzoYVsRs5" style="border-bottom: Black 1pt solid; text-align: right" title="Currency translation adjustments"&gt;1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zardrQP5qoD2" style="border-bottom: Black 1pt solid; text-align: right" title="Currency translation adjustments"&gt;(5&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zRykoD40S9Ve" style="border-bottom: Black 1pt solid; text-align: right" title="Currency translation adjustments"&gt;1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z6tPe1qhEoH9" style="border-bottom: Black 1pt solid; text-align: right" title="Currency translation adjustments"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1119"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zyxudubcGYV5" style="border-bottom: Black 1pt solid; text-align: right" title="Currency translation adjustments"&gt;(3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;At December 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zdD6G9vcZvC1" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, net"&gt;76&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z7ymYMpMpYzl" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, net"&gt;1,162&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zwZEeyD53nbl" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, net"&gt;70&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zbHeHKMlZJpj" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, net"&gt;102&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zDsnfGKnhfb7" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, net"&gt;1,410&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Accumulated depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;At January 1, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zBZLokMN6xC6" style="text-align: right" title="Property and equipment, beginning balance"&gt;24&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zUUraf5iuFbh" style="text-align: right" title="Property and equipment, beginning balance"&gt;832&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zOk2JtjQlVHl" style="text-align: right" title="Property and equipment, beginning balance"&gt;37&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zm5qIBX2oWIi" style="text-align: right" title="Property and equipment, beginning balance"&gt;88&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z2CAfA7kBOAa" style="text-align: right" title="Property and equipment, beginning balance"&gt;981&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zde6al02g9ni" style="text-align: right" title="Depreciation"&gt;9&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zaqob8lfjUwf" style="text-align: right" title="Depreciation"&gt;135&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zNwzJR8BFCaj" style="text-align: right" title="Depreciation"&gt;9&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z8A1yAnqILYc" style="text-align: right" title="Depreciation"&gt;10&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zFcHA8ZTFnX2" style="text-align: right" title="Depreciation"&gt;163&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Currency translation adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zkmwPWjBAxod" style="border-bottom: Black 1pt solid; text-align: right" title="Currency translation adjustments"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1153"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zo3rFOJhoelg" style="border-bottom: Black 1pt solid; text-align: right" title="Currency translation adjustments"&gt;(2&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zXHBP7dfYof1" style="border-bottom: Black 1pt solid; text-align: right" title="Currency translation adjustments"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1157"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zCLu6qoYQ84k" style="border-bottom: Black 1pt solid; text-align: right" title="Currency translation adjustments"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1159"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zkV8p7DSVTB6" style="border-bottom: Black 1pt solid; text-align: right" title="Currency translation adjustments"&gt;(2&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;At December 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zIhFbH3dDgLf" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, net"&gt;33&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_ztIiU4gifZjh" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, net"&gt;965&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zy9F2kk4Dknl" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, net"&gt;46&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zH99xFFdtxL9" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, net"&gt;98&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zWiHBPcEIv6l" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, net"&gt;1,142&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Net book value at December 31, 2024&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zFc9uWVr6Nok" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Property and equipment, ending balance"&gt;43&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_zmGgKYv9v50j" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Property and equipment, ending balance"&gt;197&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember_z66Zh4MBmZzb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Property and equipment, ending balance"&gt;24&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zWBk3eFqY1r5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Property and equipment, ending balance"&gt;4&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20240101__20241231_zuuj5dHd9SLg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Property and equipment, ending balance"&gt;268&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_ifrs-full_LeaseholdImprovementsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact000983"
      unitRef="USD">76000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_ifrs-full_MachineryMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact000985"
      unitRef="USD">1162000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_custom_FurnitureAndOfficeEquipmentMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact000987"
      unitRef="USD">70000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_ifrs-full_ComputerEquipmentMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact000989"
      unitRef="USD">102000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact000991"
      unitRef="USD">1410000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_LeaseholdImprovementsMember_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001003"
      unitRef="USD">10000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_MachineryMember_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001005"
      unitRef="USD">118000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_custom_FurnitureAndOfficeEquipmentMember_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001007"
      unitRef="USD">8000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_ComputerEquipmentMember_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001009"
      unitRef="USD">4000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001011"
      unitRef="USD">140000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_LeaseholdImprovementsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact001013"
      unitRef="USD">10000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_MachineryMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact001015"
      unitRef="USD">167000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_custom_FurnitureAndOfficeEquipmentMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact001017"
      unitRef="USD">10000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_ComputerEquipmentMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact001019"
      unitRef="USD">15000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact001021"
      unitRef="USD">202000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_ifrs-full_LeaseholdImprovementsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact001023"
      unitRef="USD">86000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_ifrs-full_MachineryMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact001025"
      unitRef="USD">1329000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_custom_FurnitureAndOfficeEquipmentMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact001027"
      unitRef="USD">80000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_ifrs-full_ComputerEquipmentMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact001029"
      unitRef="USD">117000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact001031"
      unitRef="USD">1612000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_ifrs-full_LeaseholdImprovementsMember_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001033"
      unitRef="USD">33000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_ifrs-full_MachineryMember_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001035"
      unitRef="USD">965000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_custom_FurnitureAndOfficeEquipmentMember_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001037"
      unitRef="USD">46000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_ifrs-full_ComputerEquipmentMember_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001039"
      unitRef="USD">98000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001041"
      unitRef="USD">1142000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_LeaseholdImprovementsMember_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001043"
      unitRef="USD">10000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_MachineryMember_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001045"
      unitRef="USD">118000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_custom_FurnitureAndOfficeEquipmentMember_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001047"
      unitRef="USD">8000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_ComputerEquipmentMember_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001049"
      unitRef="USD">4000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001051"
      unitRef="USD">140000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_LeaseholdImprovementsMember_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001053"
      unitRef="USD">5000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_MachineryMember_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001055"
      unitRef="USD">140000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_custom_FurnitureAndOfficeEquipmentMember_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001057"
      unitRef="USD">6000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_ComputerEquipmentMember_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001059"
      unitRef="USD">14000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001061"
      unitRef="USD">165000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_ifrs-full_LeaseholdImprovementsMember_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001063"
      unitRef="USD">48000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_ifrs-full_MachineryMember_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001065"
      unitRef="USD">1223000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_custom_FurnitureAndOfficeEquipmentMember_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001067"
      unitRef="USD">60000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_ifrs-full_ComputerEquipmentMember_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001069"
      unitRef="USD">116000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001071"
      unitRef="USD">1447000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact001073"
      unitRef="USD">38000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_ifrs-full_MachineryMember"
      decimals="-3"
      id="Fact001075"
      unitRef="USD">106000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_custom_FurnitureAndOfficeEquipmentMember"
      decimals="-3"
      id="Fact001077"
      unitRef="USD">20000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_ifrs-full_ComputerEquipmentMember"
      decimals="-3"
      id="Fact001079"
      unitRef="USD">1000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact001081"
      unitRef="USD">165000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-12-31_ifrs-full_LeaseholdImprovementsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact001083"
      unitRef="USD">75000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-12-31_ifrs-full_MachineryMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact001085"
      unitRef="USD">1146000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-12-31_custom_FurnitureAndOfficeEquipmentMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact001087"
      unitRef="USD">69000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-12-31_ifrs-full_ComputerEquipmentMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact001089"
      unitRef="USD">102000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact001091"
      unitRef="USD">1392000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_MachineryMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact001095"
      unitRef="USD">21000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact001101"
      unitRef="USD">21000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_LeaseholdImprovementsMember_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001103"
      unitRef="USD">9000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_MachineryMember_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001105"
      unitRef="USD">135000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_custom_FurnitureAndOfficeEquipmentMember_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001107"
      unitRef="USD">9000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_ComputerEquipmentMember_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001109"
      unitRef="USD">10000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001111"
      unitRef="USD">163000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_LeaseholdImprovementsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact001113"
      unitRef="USD">1000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_MachineryMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact001115"
      unitRef="USD">-5000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_custom_FurnitureAndOfficeEquipmentMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact001117"
      unitRef="USD">1000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact001121"
      unitRef="USD">-3000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_ifrs-full_LeaseholdImprovementsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact001123"
      unitRef="USD">76000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_ifrs-full_MachineryMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact001125"
      unitRef="USD">1162000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_custom_FurnitureAndOfficeEquipmentMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact001127"
      unitRef="USD">70000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_ifrs-full_ComputerEquipmentMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact001129"
      unitRef="USD">102000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact001131"
      unitRef="USD">1410000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-12-31_ifrs-full_LeaseholdImprovementsMember_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001133"
      unitRef="USD">24000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-12-31_ifrs-full_MachineryMember_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001135"
      unitRef="USD">832000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-12-31_custom_FurnitureAndOfficeEquipmentMember_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001137"
      unitRef="USD">37000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-12-31_ifrs-full_ComputerEquipmentMember_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001139"
      unitRef="USD">88000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-12-31_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001141"
      unitRef="USD">981000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_LeaseholdImprovementsMember_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001143"
      unitRef="USD">9000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_MachineryMember_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001145"
      unitRef="USD">135000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_custom_FurnitureAndOfficeEquipmentMember_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001147"
      unitRef="USD">9000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_ComputerEquipmentMember_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001149"
      unitRef="USD">10000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001151"
      unitRef="USD">163000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_MachineryMember_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001155"
      unitRef="USD">-2000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001161"
      unitRef="USD">-2000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_ifrs-full_LeaseholdImprovementsMember_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001163"
      unitRef="USD">33000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_ifrs-full_MachineryMember_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001165"
      unitRef="USD">965000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_custom_FurnitureAndOfficeEquipmentMember_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001167"
      unitRef="USD">46000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_ifrs-full_ComputerEquipmentMember_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001169"
      unitRef="USD">98000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_custom_AccumulatedDepreciationMember"
      decimals="-3"
      id="Fact001171"
      unitRef="USD">1142000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact001173"
      unitRef="USD">43000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_ifrs-full_MachineryMember"
      decimals="-3"
      id="Fact001175"
      unitRef="USD">197000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_custom_FurnitureAndOfficeEquipmentMember"
      decimals="-3"
      id="Fact001177"
      unitRef="USD">24000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_ifrs-full_ComputerEquipmentMember"
      decimals="-3"
      id="Fact001179"
      unitRef="USD">4000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001181"
      unitRef="USD">268000</ifrs-full:PropertyPlantAndEquipment>
    <SMX:DisclosureOfInvestmentInAssociatedCompaniesExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001183">&lt;p id="xdx_803_ecustom--DisclosureOfInvestmentInAssociatedCompaniesExplanatory_zYvY4kFI4Gxl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
5 - &lt;span id="xdx_82B_zr66SPEBnnog"&gt;INVESTMENTS IN ASSOCIATED COMPANY&lt;/span&gt;:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_eifrs-full--DisclosureOfSignificantInvestmentsInAssociatesExplanatory_zm43RoiJTOVd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;span id="xdx_8B2_zIF38Ciu9iCf" style="display: none"&gt;SCHEDULE OF INVESTMENTS IN ASSOCIATED COMPANIES&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Entity&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Country of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Incorporation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Percentage Owned&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31, 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Percentage Owned&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31, 2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: justify"&gt;Yahaloma Technologies Inc.&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_eifrs-full--CountryOfIncorporation_c20250101__20251231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--YahalomaTechnologiesIncMember_zKfyaw21DNvi"&gt;Canada&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestInAssociate_pid_dp_uPure_c20250101__20251231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--YahalomaTechnologiesIncMember_zdnHKMstk8p7"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestInAssociate_pid_dp_uPure_c20240101__20241231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--YahalomaTechnologiesIncMember_zVh09nGJ7zRb"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_z9SnCU34zmk5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
proportion of ownership interest is equal to the proportion of voting power held.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Yahaloma
Technologies Inc&lt;/span&gt;&lt;b&gt;.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 30, 2019, Security Matters Ltd. signed an agreement with Trifecta Industries Inc. (&#x201c;Trifecta&#x201d;) for the commercialization
of Security Matters Ltd.&#x2019;s trace technology in the diamonds and precious stone industry.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
the terms of the agreement, Security Matters Ltd. and Trifecta established a new entity &#x2013; Yahaloma Technologies Inc. (&#x201c;Yahaloma&#x201d;),
which is equally held by Security Matters Limited and Trifecta.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Yahaloma
has the exclusive rights and responsibility to commercialize the Group&#x2019;s intellectual property in the area of diamonds or precious
stone. Management has assessed the transaction and reached the conclusion that the new entity is jointly controlled by Security Matters
Limited and Trifecta. Management has further determined that the contractual arrangement provides the parties to the joint arrangement
with rights to the net assets of the arrangement. The contractual arrangement establishes each party&#x2019;s share in the profit or loss
relating to the activities of the arrangement. The arrangement is a joint venture and the Company&#x2019;s interests in this joint venture
is accounted for using the equity method of accounting.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</SMX:DisclosureOfInvestmentInAssociatedCompaniesExplanatory>
    <ifrs-full:DisclosureOfSignificantInvestmentsInAssociatesExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001185">&lt;p id="xdx_890_eifrs-full--DisclosureOfSignificantInvestmentsInAssociatesExplanatory_zm43RoiJTOVd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;span id="xdx_8B2_zIF38Ciu9iCf" style="display: none"&gt;SCHEDULE OF INVESTMENTS IN ASSOCIATED COMPANIES&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Entity&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Country of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Incorporation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Percentage Owned&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31, 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Percentage Owned&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31, 2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: justify"&gt;Yahaloma Technologies Inc.&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_eifrs-full--CountryOfIncorporation_c20250101__20251231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--YahalomaTechnologiesIncMember_zKfyaw21DNvi"&gt;Canada&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestInAssociate_pid_dp_uPure_c20250101__20251231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--YahalomaTechnologiesIncMember_zdnHKMstk8p7"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestInAssociate_pid_dp_uPure_c20240101__20241231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--YahalomaTechnologiesIncMember_zVh09nGJ7zRb"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ifrs-full:DisclosureOfSignificantInvestmentsInAssociatesExplanatory>
    <ifrs-full:CountryOfIncorporation
      contextRef="From2025-01-012025-12-31_custom_YahalomaTechnologiesIncMember18009937"
      id="Fact001186">Canada</ifrs-full:CountryOfIncorporation>
    <ifrs-full:ProportionOfOwnershipInterestInAssociate
      contextRef="From2025-01-012025-12-31_custom_YahalomaTechnologiesIncMember18009937"
      decimals="INF"
      id="Fact001187"
      unitRef="Pure">0.50</ifrs-full:ProportionOfOwnershipInterestInAssociate>
    <ifrs-full:ProportionOfOwnershipInterestInAssociate
      contextRef="From2024-01-012024-12-31_custom_YahalomaTechnologiesIncMember18009937"
      decimals="INF"
      id="Fact001188"
      unitRef="Pure">0.50</ifrs-full:ProportionOfOwnershipInterestInAssociate>
    <ifrs-full:DisclosureOfIntangibleAssetsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001190">&lt;p id="xdx_800_eifrs-full--DisclosureOfIntangibleAssetsExplanatory_zu2ANSSLKIz7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
6 - &lt;span id="xdx_826_zI6wJS47BAs1"&gt;INTANGIBLE ASSETS, NET AND GOODWILL&lt;/span&gt;:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_eifrs-full--DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_zuGNS9JNNyN4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span style="display: none"&gt;&lt;span id="xdx_8BC_zn6ZvZ83wT49"&gt;SUMMARY OF INTANGIBLE ASSETS NET&lt;/span&gt;&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BC_ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full--CapitalisedDevelopmentExpenditureMember_zryy5uSdbRWf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Capitalization of development costs&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B2_ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full--LicencesMember_zALD5KxvETvl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Purchased license&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B2_ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis_custom--TechnologyLicenseMember_zzTreDdWIetb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Core Technology License&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B1_zC0R7xh3V1E7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;COST&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsOtherThanGoodwillGross_iS_pn3n3_z4jJIUQdMKUe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 44%; font-weight: bold"&gt;As of January 1, 2025&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;5,266&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;782&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;10,449&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;16,497&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_iN_pn3n3_di_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zsTNiFWD2kDb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Currency translation adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;194&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;58&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1201"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;252&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zSSOelKE7TS" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Capitalized development cost&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1204"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1205"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1206"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1207"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_437_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsOtherThanGoodwillGross_iE_pn3n3_zCwhtMgrWL8e" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;As of December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;5,460&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;840&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;10,449&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;16,749&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Accumulated amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_438_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iS_pn3n3_zzdPAMRvQQl1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;As of January 1, 2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,788&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;75&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,306&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,169&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ziKKYNe7A9q7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;534&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;103&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,612&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,249&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_pn3n3_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_zYFCikZr2kY5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Impairment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,542&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1225"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1226"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,542&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_iN_pn3n3_di_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_zJHGPuhmuwrb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Currency translation adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(121&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(6&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1231"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(127&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_437_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iE_pn3n3_zsuG8rK5yDq2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;As of December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,743&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;172&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,918&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;8,833&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20250101__20251231_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn3n3_zORFQ0QsNOAl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Net book value as of December 31, 2025&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;717&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;668&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;6,531&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;7,916&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Capitalization of development costs&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Purchased license&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Core Technology License&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;COST&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_433_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsOtherThanGoodwillGross_iS_pn3n3_znxOOkHbgith" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 44%; font-weight: bold"&gt;As of January 1, 2024&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;5,342&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;819&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;10,449&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;16,610&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_433_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsOtherThanGoodwillGross_iS_pn3n3_z3UJmYQnLmo7" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cost,
    beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,342&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;819&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,449&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,610&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zsAajePlhJfc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Capitalized development cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;169&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1255"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1256"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;169&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_iN_pn3n3_di_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z402JuT2Pur1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Currency translation adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(245&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(37&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1261"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(282&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsOtherThanGoodwillGross_iE_pn3n3_ztP0H9nxjlFc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;As of December 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;5,266&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;782&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;10,449&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;16,497&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_437_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsOtherThanGoodwillGross_iE_pn3n3_zMurssZQVHu5" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cost,
    ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;5,266&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;782&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;10,449&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;16,497&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Accumulated amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43D_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iS_pn3n3_zqjbuNG6GJj7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;As of January 1, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;124&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1275"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1276"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;124&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_434_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iS_pn3n3_z6zRVBvMmET4" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accumulated
    amortization, beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;124&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1280"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1281"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;124&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_zlzXVvLnnFPb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;694&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;75&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,306&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,075&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_z0R3Adtac7uh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Impairment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,197&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1290"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1291"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,197&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_iN_pn3n3_di_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_z2JwE15AVNJc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Currency translation adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(227&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1295"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1296"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(227&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_438_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iE_pn3n3_zJt9vqZFOKRc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;As of December 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,788&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;75&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,306&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,169&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_433_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iE_pn3n3_zDnn5x91pcc" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accumulated
    amortization, ending balances&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,788&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;75&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,306&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,169&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43C_c20240101__20241231_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn3n3_znYpk2TUF092" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Net book value as of December 31, 2024&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;2,478&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;707&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;9,143&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;12,328&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_432_c20240101__20241231_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn3n3_zKzvZGL2N7G9" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Net book value&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;2,478&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;707&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;9,143&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;12,328&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A4_zrcz1J4YYGpl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
assets as of December 31, 2025 and 2024 consist of capitalized development costs of the Group&#x2019;s technology, the cost of the exclusive
license intellectual property and core technology license raised from the TrueGold business combination that reflects the existence of
underlying technology that has value through its continued use or re-use in many products or many generations of a singular product (that
is, a product family). &lt;span id="xdx_90B_eifrs-full--DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill_c20250101__20251231_z5KuoAKlqPzj" title="Usefull life of intangible assets"&gt;The capitalized development costs and purchased license are amortized in accordance with its useful life of 5.5
years. The Core Technology License is amortized in accordance with its useful life of 4 years&lt;/span&gt;. The Company commenced amortization of
both the capitalized development costs and purchased licenses and core technology as of July 1, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
6 - INTANGIBLE ASSETS, NET AND GOODWILL (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Goodwill
and impairment&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group is required to test, on an annual basis, whether goodwill has suffered any impairment. The recoverable amount is determined based
on value in use calculations. The use of this method requires an estimation of future cash flows and the determination of a discount
rate in order to calculate the present value of the cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
2025 and 2024, the Group did not meet its revenue forecast. This had an adverse impact on the projected value in use of the operation and
consequently resulted in an impairment to goodwill of $&lt;span id="xdx_900_eifrs-full--ImpairmentLossRecognisedInProfitOrLossGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--OtherIntangibleAssetsMember_zKZKaRT0aGq8" title="Impairment on goodwill"&gt;6,024&lt;/span&gt; and $&lt;span id="xdx_908_eifrs-full--ImpairmentLossRecognisedInProfitOrLossGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--OtherIntangibleAssetsMember_zxcGLLEMyOBj" title="Impairment on goodwill"&gt;6,813&lt;/span&gt; for the years ended December 31, 2025, and 2024 respectively.
The (pre-tax) discount rate used to measure the CGU&#x2019;s value in use was &lt;span id="xdx_909_ecustom--PretaxDiscountRate_pid_dp_uPure_c20250101__20251231_zKYS0yYI9cge" title="Pre-tax discount rate"&gt;30.0&lt;/span&gt;% and &lt;span id="xdx_904_ecustom--PretaxDiscountRate_pid_dp_uPure_c20240101__20241231_z6wYboDjomoa" title="Pre-tax discount rate"&gt;29.6&lt;/span&gt;% for the years ended December 31, 2025, and
2024 respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
carrying amount of goodwill is $&lt;span id="xdx_908_eifrs-full--Goodwill_iI_pn3n3_c20251231_zcKAX4JFB3aa" title="Goodwill"&gt;20,120&lt;/span&gt; and $&lt;span id="xdx_907_eifrs-full--Goodwill_iI_pn3n3_c20241231_zC6KFYOImww5" title="Goodwill"&gt;26,144&lt;/span&gt; for the years ended December 31, 2025, and 2024 respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
recoverable amount has been determined using value in use calculations based on cash flow projections derived from Company approved
budgets, reflecting management&#x2019;s expectation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfIntangibleAssetsExplanatory>
    <ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001192">&lt;p id="xdx_89C_eifrs-full--DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_zuGNS9JNNyN4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span style="display: none"&gt;&lt;span id="xdx_8BC_zn6ZvZ83wT49"&gt;SUMMARY OF INTANGIBLE ASSETS NET&lt;/span&gt;&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BC_ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full--CapitalisedDevelopmentExpenditureMember_zryy5uSdbRWf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Capitalization of development costs&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B2_ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full--LicencesMember_zALD5KxvETvl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Purchased license&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B2_ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis_custom--TechnologyLicenseMember_zzTreDdWIetb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Core Technology License&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B1_zC0R7xh3V1E7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;COST&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsOtherThanGoodwillGross_iS_pn3n3_z4jJIUQdMKUe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 44%; font-weight: bold"&gt;As of January 1, 2025&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;5,266&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;782&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;10,449&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;16,497&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_iN_pn3n3_di_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zsTNiFWD2kDb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Currency translation adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;194&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;58&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1201"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;252&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zSSOelKE7TS" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Capitalized development cost&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1204"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1205"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1206"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1207"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_437_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsOtherThanGoodwillGross_iE_pn3n3_zCwhtMgrWL8e" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;As of December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;5,460&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;840&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;10,449&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;16,749&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Accumulated amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_438_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iS_pn3n3_zzdPAMRvQQl1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;As of January 1, 2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,788&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;75&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,306&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,169&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ziKKYNe7A9q7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;534&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;103&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,612&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,249&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_pn3n3_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_zYFCikZr2kY5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Impairment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,542&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1225"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1226"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,542&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_iN_pn3n3_di_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_zJHGPuhmuwrb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Currency translation adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(121&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(6&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1231"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(127&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_437_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iE_pn3n3_zsuG8rK5yDq2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;As of December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,743&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;172&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,918&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;8,833&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20250101__20251231_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn3n3_zORFQ0QsNOAl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Net book value as of December 31, 2025&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;717&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;668&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;6,531&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;7,916&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Capitalization of development costs&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Purchased license&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Core Technology License&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;COST&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_433_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsOtherThanGoodwillGross_iS_pn3n3_znxOOkHbgith" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 44%; font-weight: bold"&gt;As of January 1, 2024&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;5,342&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;819&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;10,449&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;16,610&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_433_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsOtherThanGoodwillGross_iS_pn3n3_z3UJmYQnLmo7" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cost,
    beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,342&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;819&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,449&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,610&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zsAajePlhJfc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Capitalized development cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;169&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1255"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1256"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;169&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_iN_pn3n3_di_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z402JuT2Pur1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Currency translation adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(245&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(37&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1261"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(282&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsOtherThanGoodwillGross_iE_pn3n3_ztP0H9nxjlFc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;As of December 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;5,266&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;782&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;10,449&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;16,497&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_437_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsOtherThanGoodwillGross_iE_pn3n3_zMurssZQVHu5" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cost,
    ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;5,266&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;782&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;10,449&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;16,497&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Accumulated amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43D_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iS_pn3n3_zqjbuNG6GJj7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;As of January 1, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;124&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1275"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1276"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;124&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_434_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iS_pn3n3_z6zRVBvMmET4" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accumulated
    amortization, beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;124&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1280"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1281"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;124&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_zlzXVvLnnFPb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;694&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;75&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,306&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,075&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_z0R3Adtac7uh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Impairment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,197&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1290"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1291"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,197&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_iN_pn3n3_di_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_z2JwE15AVNJc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Currency translation adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(227&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1295"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1296"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(227&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_438_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iE_pn3n3_zJt9vqZFOKRc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;As of December 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,788&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;75&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,306&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,169&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_433_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iE_pn3n3_zDnn5x91pcc" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accumulated
    amortization, ending balances&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,788&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;75&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,306&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,169&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43C_c20240101__20241231_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn3n3_znYpk2TUF092" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Net book value as of December 31, 2024&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;2,478&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;707&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;9,143&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;12,328&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_432_c20240101__20241231_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn3n3_zKzvZGL2N7G9" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Net book value&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;2,478&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;707&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;9,143&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;12,328&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory>
    <SMX:IntangibleAssetsOtherThanGoodwillGross
      contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_CapitalisedDevelopmentExpenditureMember"
      decimals="-3"
      id="Fact001194"
      unitRef="USD">5266000</SMX:IntangibleAssetsOtherThanGoodwillGross>
    <SMX:IntangibleAssetsOtherThanGoodwillGross
      contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LicencesMember"
      decimals="-3"
      id="Fact001195"
      unitRef="USD">782000</SMX:IntangibleAssetsOtherThanGoodwillGross>
    <SMX:IntangibleAssetsOtherThanGoodwillGross
      contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_custom_TechnologyLicenseMember"
      decimals="-3"
      id="Fact001196"
      unitRef="USD">10449000</SMX:IntangibleAssetsOtherThanGoodwillGross>
    <SMX:IntangibleAssetsOtherThanGoodwillGross
      contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact001197"
      unitRef="USD">16497000</SMX:IntangibleAssetsOtherThanGoodwillGross>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_CapitalisedDevelopmentExpenditureMember"
      decimals="-3"
      id="Fact001199"
      unitRef="USD">-194000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LicencesMember"
      decimals="-3"
      id="Fact001200"
      unitRef="USD">-58000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact001202"
      unitRef="USD">-252000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <SMX:IntangibleAssetsOtherThanGoodwillGross
      contextRef="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_CapitalisedDevelopmentExpenditureMember"
      decimals="-3"
      id="Fact001209"
      unitRef="USD">5460000</SMX:IntangibleAssetsOtherThanGoodwillGross>
    <SMX:IntangibleAssetsOtherThanGoodwillGross
      contextRef="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LicencesMember"
      decimals="-3"
      id="Fact001210"
      unitRef="USD">840000</SMX:IntangibleAssetsOtherThanGoodwillGross>
    <SMX:IntangibleAssetsOtherThanGoodwillGross
      contextRef="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_custom_TechnologyLicenseMember"
      decimals="-3"
      id="Fact001211"
      unitRef="USD">10449000</SMX:IntangibleAssetsOtherThanGoodwillGross>
    <SMX:IntangibleAssetsOtherThanGoodwillGross
      contextRef="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact001212"
      unitRef="USD">16749000</SMX:IntangibleAssetsOtherThanGoodwillGross>
    <SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-12-31_custom_AccumulatedDepreciationAmortisationMember_ifrs-full_CapitalisedDevelopmentExpenditureMember"
      decimals="-3"
      id="Fact001214"
      unitRef="USD">2788000</SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill>
    <SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-12-31_custom_AccumulatedDepreciationAmortisationMember_ifrs-full_LicencesMember"
      decimals="-3"
      id="Fact001215"
      unitRef="USD">75000</SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill>
    <SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-12-31_custom_AccumulatedDepreciationAmortisationMember_custom_TechnologyLicenseMember"
      decimals="-3"
      id="Fact001216"
      unitRef="USD">1306000</SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill>
    <SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-12-31_custom_AccumulatedDepreciationAmortisationMember"
      decimals="-3"
      id="Fact001217"
      unitRef="USD">4169000</SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_custom_AccumulatedDepreciationAmortisationMember_ifrs-full_CapitalisedDevelopmentExpenditureMember"
      decimals="-3"
      id="Fact001219"
      unitRef="USD">534000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_custom_AccumulatedDepreciationAmortisationMember_ifrs-full_LicencesMember"
      decimals="-3"
      id="Fact001220"
      unitRef="USD">103000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_custom_AccumulatedDepreciationAmortisationMember_custom_TechnologyLicenseMember"
      decimals="-3"
      id="Fact001221"
      unitRef="USD">2612000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_custom_AccumulatedDepreciationAmortisationMember"
      decimals="-3"
      id="Fact001222"
      unitRef="USD">3249000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_custom_AccumulatedDepreciationAmortisationMember_ifrs-full_CapitalisedDevelopmentExpenditureMember"
      decimals="-3"
      id="Fact001224"
      unitRef="USD">1542000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_custom_AccumulatedDepreciationAmortisationMember"
      decimals="-3"
      id="Fact001227"
      unitRef="USD">1542000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_custom_AccumulatedDepreciationAmortisationMember_ifrs-full_CapitalisedDevelopmentExpenditureMember"
      decimals="-3"
      id="Fact001229"
      unitRef="USD">121000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_custom_AccumulatedDepreciationAmortisationMember_ifrs-full_LicencesMember"
      decimals="-3"
      id="Fact001230"
      unitRef="USD">6000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_custom_AccumulatedDepreciationAmortisationMember"
      decimals="-3"
      id="Fact001232"
      unitRef="USD">127000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2025-12-31_custom_AccumulatedDepreciationAmortisationMember_ifrs-full_CapitalisedDevelopmentExpenditureMember"
      decimals="-3"
      id="Fact001234"
      unitRef="USD">4743000</SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill>
    <SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2025-12-31_custom_AccumulatedDepreciationAmortisationMember_ifrs-full_LicencesMember"
      decimals="-3"
      id="Fact001235"
      unitRef="USD">172000</SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill>
    <SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2025-12-31_custom_AccumulatedDepreciationAmortisationMember_custom_TechnologyLicenseMember"
      decimals="-3"
      id="Fact001236"
      unitRef="USD">3918000</SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill>
    <SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2025-12-31_custom_AccumulatedDepreciationAmortisationMember"
      decimals="-3"
      id="Fact001237"
      unitRef="USD">8833000</SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2025-12-31_ifrs-full_CapitalisedDevelopmentExpenditureMember"
      decimals="-3"
      id="Fact001239"
      unitRef="USD">717000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2025-12-31_ifrs-full_LicencesMember"
      decimals="-3"
      id="Fact001240"
      unitRef="USD">668000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2025-12-31_custom_TechnologyLicenseMember"
      decimals="-3"
      id="Fact001241"
      unitRef="USD">6531000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact001242"
      unitRef="USD">7916000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <SMX:IntangibleAssetsOtherThanGoodwillGross
      contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_CapitalisedDevelopmentExpenditureMember"
      decimals="-3"
      id="Fact001244"
      unitRef="USD">5342000</SMX:IntangibleAssetsOtherThanGoodwillGross>
    <SMX:IntangibleAssetsOtherThanGoodwillGross
      contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LicencesMember"
      decimals="-3"
      id="Fact001245"
      unitRef="USD">819000</SMX:IntangibleAssetsOtherThanGoodwillGross>
    <SMX:IntangibleAssetsOtherThanGoodwillGross
      contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_custom_TechnologyLicenseMember"
      decimals="-3"
      id="Fact001246"
      unitRef="USD">10449000</SMX:IntangibleAssetsOtherThanGoodwillGross>
    <SMX:IntangibleAssetsOtherThanGoodwillGross
      contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact001247"
      unitRef="USD">16610000</SMX:IntangibleAssetsOtherThanGoodwillGross>
    <SMX:IntangibleAssetsOtherThanGoodwillGross
      contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_CapitalisedDevelopmentExpenditureMember"
      decimals="-3"
      id="Fact001249"
      unitRef="USD">5342000</SMX:IntangibleAssetsOtherThanGoodwillGross>
    <SMX:IntangibleAssetsOtherThanGoodwillGross
      contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LicencesMember"
      decimals="-3"
      id="Fact001250"
      unitRef="USD">819000</SMX:IntangibleAssetsOtherThanGoodwillGross>
    <SMX:IntangibleAssetsOtherThanGoodwillGross
      contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_custom_TechnologyLicenseMember"
      decimals="-3"
      id="Fact001251"
      unitRef="USD">10449000</SMX:IntangibleAssetsOtherThanGoodwillGross>
    <SMX:IntangibleAssetsOtherThanGoodwillGross
      contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact001252"
      unitRef="USD">16610000</SMX:IntangibleAssetsOtherThanGoodwillGross>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_CapitalisedDevelopmentExpenditureMember"
      decimals="-3"
      id="Fact001254"
      unitRef="USD">169000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact001257"
      unitRef="USD">169000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_CapitalisedDevelopmentExpenditureMember"
      decimals="-3"
      id="Fact001259"
      unitRef="USD">245000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LicencesMember"
      decimals="-3"
      id="Fact001260"
      unitRef="USD">37000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact001262"
      unitRef="USD">282000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <SMX:IntangibleAssetsOtherThanGoodwillGross
      contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_CapitalisedDevelopmentExpenditureMember"
      decimals="-3"
      id="Fact001264"
      unitRef="USD">5266000</SMX:IntangibleAssetsOtherThanGoodwillGross>
    <SMX:IntangibleAssetsOtherThanGoodwillGross
      contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LicencesMember"
      decimals="-3"
      id="Fact001265"
      unitRef="USD">782000</SMX:IntangibleAssetsOtherThanGoodwillGross>
    <SMX:IntangibleAssetsOtherThanGoodwillGross
      contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_custom_TechnologyLicenseMember"
      decimals="-3"
      id="Fact001266"
      unitRef="USD">10449000</SMX:IntangibleAssetsOtherThanGoodwillGross>
    <SMX:IntangibleAssetsOtherThanGoodwillGross
      contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact001267"
      unitRef="USD">16497000</SMX:IntangibleAssetsOtherThanGoodwillGross>
    <SMX:IntangibleAssetsOtherThanGoodwillGross
      contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_CapitalisedDevelopmentExpenditureMember"
      decimals="-3"
      id="Fact001269"
      unitRef="USD">5266000</SMX:IntangibleAssetsOtherThanGoodwillGross>
    <SMX:IntangibleAssetsOtherThanGoodwillGross
      contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LicencesMember"
      decimals="-3"
      id="Fact001270"
      unitRef="USD">782000</SMX:IntangibleAssetsOtherThanGoodwillGross>
    <SMX:IntangibleAssetsOtherThanGoodwillGross
      contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_custom_TechnologyLicenseMember"
      decimals="-3"
      id="Fact001271"
      unitRef="USD">10449000</SMX:IntangibleAssetsOtherThanGoodwillGross>
    <SMX:IntangibleAssetsOtherThanGoodwillGross
      contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact001272"
      unitRef="USD">16497000</SMX:IntangibleAssetsOtherThanGoodwillGross>
    <SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2023-12-31_custom_AccumulatedDepreciationAmortisationMember_ifrs-full_CapitalisedDevelopmentExpenditureMember"
      decimals="-3"
      id="Fact001274"
      unitRef="USD">124000</SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill>
    <SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2023-12-31_custom_AccumulatedDepreciationAmortisationMember"
      decimals="-3"
      id="Fact001277"
      unitRef="USD">124000</SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill>
    <SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2023-12-31_custom_AccumulatedDepreciationAmortisationMember_ifrs-full_CapitalisedDevelopmentExpenditureMember"
      decimals="-3"
      id="Fact001279"
      unitRef="USD">124000</SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill>
    <SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2023-12-31_custom_AccumulatedDepreciationAmortisationMember"
      decimals="-3"
      id="Fact001282"
      unitRef="USD">124000</SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_custom_AccumulatedDepreciationAmortisationMember_ifrs-full_CapitalisedDevelopmentExpenditureMember"
      decimals="-3"
      id="Fact001284"
      unitRef="USD">694000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_custom_AccumulatedDepreciationAmortisationMember_ifrs-full_LicencesMember"
      decimals="-3"
      id="Fact001285"
      unitRef="USD">75000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_custom_AccumulatedDepreciationAmortisationMember_custom_TechnologyLicenseMember"
      decimals="-3"
      id="Fact001286"
      unitRef="USD">1306000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_custom_AccumulatedDepreciationAmortisationMember"
      decimals="-3"
      id="Fact001287"
      unitRef="USD">2075000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_custom_AccumulatedDepreciationAmortisationMember_ifrs-full_CapitalisedDevelopmentExpenditureMember"
      decimals="-3"
      id="Fact001289"
      unitRef="USD">2197000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_custom_AccumulatedDepreciationAmortisationMember"
      decimals="-3"
      id="Fact001292"
      unitRef="USD">2197000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_custom_AccumulatedDepreciationAmortisationMember_ifrs-full_CapitalisedDevelopmentExpenditureMember"
      decimals="-3"
      id="Fact001294"
      unitRef="USD">227000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_custom_AccumulatedDepreciationAmortisationMember"
      decimals="-3"
      id="Fact001297"
      unitRef="USD">227000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-12-31_custom_AccumulatedDepreciationAmortisationMember_ifrs-full_CapitalisedDevelopmentExpenditureMember"
      decimals="-3"
      id="Fact001299"
      unitRef="USD">2788000</SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill>
    <SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-12-31_custom_AccumulatedDepreciationAmortisationMember_ifrs-full_LicencesMember"
      decimals="-3"
      id="Fact001300"
      unitRef="USD">75000</SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill>
    <SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-12-31_custom_AccumulatedDepreciationAmortisationMember_custom_TechnologyLicenseMember"
      decimals="-3"
      id="Fact001301"
      unitRef="USD">1306000</SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill>
    <SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-12-31_custom_AccumulatedDepreciationAmortisationMember"
      decimals="-3"
      id="Fact001302"
      unitRef="USD">4169000</SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill>
    <SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-12-31_custom_AccumulatedDepreciationAmortisationMember_ifrs-full_CapitalisedDevelopmentExpenditureMember"
      decimals="-3"
      id="Fact001304"
      unitRef="USD">2788000</SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill>
    <SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-12-31_custom_AccumulatedDepreciationAmortisationMember_ifrs-full_LicencesMember"
      decimals="-3"
      id="Fact001305"
      unitRef="USD">75000</SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill>
    <SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-12-31_custom_AccumulatedDepreciationAmortisationMember_custom_TechnologyLicenseMember"
      decimals="-3"
      id="Fact001306"
      unitRef="USD">1306000</SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill>
    <SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-12-31_custom_AccumulatedDepreciationAmortisationMember"
      decimals="-3"
      id="Fact001307"
      unitRef="USD">4169000</SMX:AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-12-31_ifrs-full_CapitalisedDevelopmentExpenditureMember"
      decimals="-3"
      id="Fact001309"
      unitRef="USD">2478000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-12-31_ifrs-full_LicencesMember"
      decimals="-3"
      id="Fact001310"
      unitRef="USD">707000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-12-31_custom_TechnologyLicenseMember"
      decimals="-3"
      id="Fact001311"
      unitRef="USD">9143000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001312"
      unitRef="USD">12328000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-12-31_ifrs-full_CapitalisedDevelopmentExpenditureMember"
      decimals="-3"
      id="Fact001314"
      unitRef="USD">2478000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-12-31_ifrs-full_LicencesMember"
      decimals="-3"
      id="Fact001315"
      unitRef="USD">707000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-12-31_custom_TechnologyLicenseMember"
      decimals="-3"
      id="Fact001316"
      unitRef="USD">9143000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001317"
      unitRef="USD">12328000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill contextRef="From2025-01-01to2025-12-31" id="Fact001319">The capitalized development costs and purchased license are amortized in accordance with its useful life of 5.5
years. The Core Technology License is amortized in accordance with its useful life of 4 years</ifrs-full:DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossGoodwill
      contextRef="From2025-01-012025-12-31_ifrs-full_OtherIntangibleAssetsMember"
      decimals="-3"
      id="Fact001321"
      unitRef="USD">6024000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossGoodwill
      contextRef="From2024-01-012024-12-31_ifrs-full_OtherIntangibleAssetsMember"
      decimals="-3"
      id="Fact001323"
      unitRef="USD">6813000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossGoodwill>
    <SMX:PretaxDiscountRate
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact001325"
      unitRef="Pure">0.300</SMX:PretaxDiscountRate>
    <SMX:PretaxDiscountRate
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact001327"
      unitRef="Pure">0.296</SMX:PretaxDiscountRate>
    <ifrs-full:Goodwill
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact001329"
      unitRef="USD">20120000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001331"
      unitRef="USD">26144000</ifrs-full:Goodwill>
    <ifrs-full:DisclosureOfFinancialInstrumentsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001333">&lt;p id="xdx_80E_eifrs-full--DisclosureOfFinancialInstrumentsExplanatory_zrjZ7mvUh0y9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
7 - &lt;span id="xdx_82B_z2V2lRBfcnDc"&gt;CONVERTIBLE NOTES&lt;/span&gt;:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            January 25, 2023, the Company received an amount of $&lt;span id="xdx_90E_eifrs-full--IssueOfConvertibleInstruments_pn3n3_c20240124__20240125__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_z7xVnY0TT1m4"&gt;250&lt;/span&gt; in consideration for issuance of
                                            a convertible note (the &#x201c;LP Convertible Note&#x201d;) and two types of warrants, to
                                            Lee Pinkerton (&#x201c;&lt;b&gt;LP&lt;/b&gt;&#x201d;). The LP Convertible Note&#x2019;s principal amount
                                            is $&lt;span id="xdx_905_eifrs-full--NotionalAmount_iI_pn3n3_c20240125__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_zHlJTi1E9ZV7"&gt;250&lt;/span&gt; and the maturity date is the earlier of &lt;span id="xdx_908_eifrs-full--BorrowingsMaturity_c20240124__20240125__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_zLhu82zZtvyg"&gt;December 31, 2024&lt;/span&gt;, and the date of any change
                                            in control (excluding the Business Combination). As of December 31, 2025, the company did
                                            not settle the full principal amount and all accrued interest. Based on Management&#x2019;s
                                            projections, the Company expects to satisfy this obligation by December 31, 2026. The Convertible
                                            Note has an interest rate of &lt;span id="xdx_904_eifrs-full--BorrowingsInterestRate_iI_pid_dp_uPure_c20240125__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_zZrh8Si1Z29b"&gt;15&lt;/span&gt;% per annum and shall be converted into ordinary shares at
                                            LP&#x2019;s discretion, at a fixed conversion price of $&lt;span id="xdx_904_ecustom--FixedConversionPrice_iI_pid_c20240125__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zSFXLR9DiHOa" title="Fixed conversion price"&gt;470,250&lt;/span&gt; ($&lt;span id="xdx_902_ecustom--FixedConversionPrice_iI_pid_c20240125__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_ztT6ivVshdsj" title="Fixed conversion price"&gt;5,746,196,840&lt;/span&gt; after reverse
                                            stock splits) per ordinary share. In addition, the Company has the right to satisfy the payment
                                            of the principal amount of the LP Convertible Note through the issuance of the Company&#x2019;s
                                            ordinary shares at a &lt;span id="xdx_905_ecustom--DiscountRate_pid_dp_uPure_c20240124__20240125__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zYvpQa8cDSyc"&gt;20&lt;/span&gt;% discount to the 20 trading day VWAP preceding the maturity date.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 14.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
part of the LP Convertible Note transaction, the LP was granted two types of warrants:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 14.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(i)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Bonus
                                            Warrants &#x2013; &lt;span id="xdx_90A_ecustom--WarrantsToPurchaseOrdinaryShares_pid_c20240124__20240125__ifrs-full--TypesOfContractsAxis__custom--ConvertibleNoteAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--BonusWarrantsMember_zLqcY8E8MlUi"&gt;0.27&lt;/span&gt; warrants to purchase ordinary shares (nil after reverse stock splits)
                                            of the Company at an exercise price of $&lt;span id="xdx_90E_ecustom--ExercisePriceOfWarrants_pid_c20240124__20240125__ifrs-full--TypesOfContractsAxis__custom--ConvertibleNoteAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--BonusWarrantsMember_zmiZWnXeGuMg" title="Exercise price"&gt;540,787&lt;/span&gt; ($&lt;span id="xdx_900_ecustom--ExercisePriceOfWarrants_pid_c20240124__20240125__ifrs-full--TypesOfContractsAxis__custom--ConvertibleNoteAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--BonusWarrantsMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zH9zmKV60zB8" title="Exercise price"&gt;6,608,126,366&lt;/span&gt; after reverse stock splits)
                                            per share.&lt;br/&gt;
                                            The Bonus Warrants term is five years commencing upon the Business Combination.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(ii)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redeemable
                                            Warrants &lt;span id="xdx_901_ecustom--WarrantsToPurchaseOrdinaryShares_pid_c20240124__20240125__ifrs-full--TypesOfContractsAxis__custom--ConvertibleNoteAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zizrYgdDEBTe"&gt;0.26&lt;/span&gt; warrants to purchase ordinary shares (nil after reverse stock splits) of the
                                            Company at a purchase price of $&lt;span id="xdx_904_ecustom--SharePurchasePrice_pid_c20240124__20240125__ifrs-full--TypesOfContractsAxis__custom--ConvertibleNoteAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zuVDHNl2TGua" title="Share purchase price"&gt;540,787&lt;/span&gt; ($&lt;span id="xdx_902_ecustom--SharePurchasePrice_pid_c20240124__20240125__ifrs-full--TypesOfContractsAxis__custom--ConvertibleNoteAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zveKbDc29pBi" title="Share purchase price"&gt;6,608,126,366&lt;/span&gt; after reverse stock splits) per share.
                                            The Redeemable Warrants term is &lt;span id="xdx_90C_ecustom--WarrantsTerm_dc_c20240124__20240125__ifrs-full--TypesOfContractsAxis__custom--ConvertibleNoteAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_z9ZcybyVsNb9" title="Warrants term"&gt;five years&lt;/span&gt; commencing upon the Business Combination. &lt;span id="xdx_90A_ecustom--PercentageOfRedeemableOnNoncumulativeBasis_pid_dp_uPure_c20240124__20240125__ifrs-full--TypesOfContractsAxis__custom--ConvertibleNoteAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zmjswVlFTeSc" title="Percentage of redeemable on non-cumulative basis"&gt;50&lt;/span&gt;%
                                            of the Redeemable Warrants shall be redeemable on a non-cumulative basis at the option of
                                            the holder, according to a schedule for $&lt;span id="xdx_90D_eifrs-full--ParValuePerShare_iI_pid_c20240125__ifrs-full--TypesOfContractsAxis__custom--ConvertibleNoteAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zxJr5v9NFVt5"&gt;235,125&lt;/span&gt; ($&lt;span id="xdx_901_eifrs-full--ParValuePerShare_iI_pid_c20240125__ifrs-full--TypesOfContractsAxis__custom--ConvertibleNoteAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zCpgvpx6kQug"&gt;2,873,098,420&lt;/span&gt; after reverse stock splits)
                                            per warrant. The LP has the option to decide that the Company will satisfy any or each redemption
                                            through the issuance of ordinary shares of the Company based upon a&lt;span id="xdx_906_ecustom--DiscountRate_pid_dp_uPure_c20240124__20240125__ifrs-full--TypesOfContractsAxis__custom--ConvertibleNoteAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zxCLMECagdji"&gt; 20&lt;/span&gt;% discount to the 20-trading
                                            day VWAP preceding each such anniversary.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 18.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
7 - CONVERTIBLE NOTES (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
LP Convertible Note is recorded in accordance with its fair value. The Redeemable Warrants are accounted as a derivative financial liability
measured at fair value through profit or loss. Management utilized a third-party appraiser to assist them in valuing the LP Convertible
Note and Redeemable Warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the Redeemable Warrants was calculated using the Monte-Carlo simulation model. As of December 31, 2025 and 2024, the expected
volatility that was used was &lt;span id="xdx_904_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zfWKQIDkZ341"&gt;359.7&lt;/span&gt;% and &lt;span id="xdx_907_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zYQJ5WD4hUci"&gt;53.94&lt;/span&gt;%, respectively, and the risk-free interest rate used was &lt;span id="xdx_907_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zItQ25X82yAd"&gt;4.67&lt;/span&gt;% and &lt;span id="xdx_901_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zWPyxjryNQM3"&gt;4.27&lt;/span&gt;%, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 18.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2025, and 2024 the fair value of the Redeemable Warrants was $&lt;span id="xdx_90B_ecustom--FairValueOfRedeemableWarrants_iI_pn3n3_c20251231_z2bL7w13e5zd" title="Fair value of redeemable warrants"&gt;32&lt;/span&gt; and $&lt;span id="xdx_90B_ecustom--FairValueOfRedeemableWarrants_iI_pn3n3_c20241231_zlosIibQFool" title="Fair value of redeemable warrants"&gt;55&lt;/span&gt;,&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 18.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
order to calculate the fair value of the LP Convertible Note, the Company discounted the payment schedule by a discount rate of &lt;span id="xdx_90C_ecustom--DiscountRate_pid_dp_uPure_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_zj9RuG7fRzyd"&gt;30&lt;/span&gt;%.
as of December 31, 2025, and a discount rate of &lt;span id="xdx_907_ecustom--DiscountRate_pid_dp_uPure_c20240101__20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_z8phPjkUonN6"&gt;22.9&lt;/span&gt;% as of December 31, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2025, and 2024 the fair value of the LP Convertible Note was $&lt;span id="xdx_904_ecustom--FairValueOfConvertibleNotes_iI_pn3n3_c20251231_zAMUvKJdgxoi" title="Fair value of convertible notes"&gt;333&lt;/span&gt; and $&lt;span id="xdx_90B_ecustom--FairValueOfConvertibleNotes_iI_pn3n3_c20241231_zw9mwR3MHDJ3" title="Fair value of convertible notes"&gt;336&lt;/span&gt;, respectively. All of the principal and accrued
interest under the LP Convertible Note is due and owing as of the date of the authorization of these financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;B.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            September 6, 2023, the Company entered into a Securities Purchase Agreement to issued and
                                            sold to an institutional investor, Generating Alpha Ltd. (&#x201c;Alpha&#x201d;), a convertible
                                            promissory note (the &#x201c;&lt;b&gt;Alpha September 2023 Note&lt;/b&gt;&#x201d;) with a fixed conversion
                                            price of $&lt;span id="xdx_90C_ecustom--ConversionPrice_pid_c20240906__20240906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zlKFGnzo3Thf" title="Conversion price"&gt;3,501&lt;/span&gt; ($&lt;span id="xdx_90E_ecustom--ConversionPrice_pid_c20240906__20240906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zNFoOcCtBJ5j" title="Conversion price"&gt;42,780,298&lt;/span&gt; after reverse stock splits), &lt;span id="xdx_90D_eifrs-full--NumberOfSharesIssued_iI_pid_c20240906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--WarrantAMember_zkXhl0stYich"&gt;1,838&lt;/span&gt; warrants A&#x2019;s (&lt;span id="xdx_90B_eifrs-full--NumberOfSharesIssued_iI_pid_dxL_c20240906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--WarrantAMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_z45m12dP7i96" title="::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1379"&gt;nil &lt;/span&gt;&lt;/span&gt;after
                                            reverse stock splits) and &lt;span id="xdx_903_eifrs-full--NumberOfSharesIssued_iI_pid_c20240906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--WarrantBMember_z1PWZaLEDsf8"&gt;1,225&lt;/span&gt; warrants B&#x2019;s (&lt;span id="xdx_902_eifrs-full--NumberOfSharesIssued_iI_pid_dxL_c20240906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--WarrantBMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zaD5gHtQrKwj" title="::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1381"&gt;nil&lt;/span&gt;&lt;/span&gt; after reverse stock splits), for
                                            gross proceeds of approximately $&lt;span id="xdx_906_eifrs-full--ProceedsFromIssuingShares_pn3n3_c20240906__20240906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zIx5qSvhwP2l"&gt;2,574&lt;/span&gt;, before deducting fees and other offering expenses
                                            payable by the Company to their service providers. The warrant A&#x2019;s were exercisable
                                            into &lt;span id="xdx_904_eifrs-full--NumberOfSharesIssued_iI_pid_c20240906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--WarrantAMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zmATz3AitbHc"&gt;1,838&lt;/span&gt; (&lt;span id="xdx_90D_eifrs-full--NumberOfSharesIssued_iI_pid_c20240906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--WarrantAMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zP0E0jFV0KDi"&gt;nil&lt;/span&gt; after reverse stock splits) ordinary shares at an exercise price of $&lt;span id="xdx_90F_ecustom--WarrantsExercisePricePerShare_iI_pid_c20240906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--WarrantAOneMember_zP6gbpvfu6c9" title="Warrants exercise price per share"&gt;4.7025&lt;/span&gt;
                                            ($&lt;span id="xdx_901_ecustom--WarrantsExercisePricePerShare_iI_pid_c20240906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--WarrantAOneMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zXZvYTR8IPd9" title="Warrants exercise price per share"&gt;57,462&lt;/span&gt; after reverse stock splits) per share subject to customary adjustments and may be
                                            exercised at any time until the five year anniversary. The warrant B&#x2019;s were exercisable
                                            into &lt;span id="xdx_907_eifrs-full--NumberOfSharesIssued_iI_pid_c20240906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--WarrantBMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z6S8lLxCxs96"&gt;1,225&lt;/span&gt; (&lt;span id="xdx_903_eifrs-full--NumberOfSharesIssued_iI_pid_dxL_c20240906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--WarrantBMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zTz1gkOY7SP2" title="::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1390"&gt;nil&lt;/span&gt;&lt;/span&gt; after reverse stock splits) ordinary shares at an exercise price of $&lt;span id="xdx_905_ecustom--WarrantsExercisePricePerShare_iI_pid_c20240906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--WarrantBOneMember_zRiSg0AmiuBd" title="Warrants exercise price per share"&gt;3,501&lt;/span&gt;
                                            ($&lt;span id="xdx_90A_ecustom--WarrantsExercisePricePerShare_iI_pid_c20240906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--WarrantBOneMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zsosjgK3HS8g" title="Warrants exercise price per share"&gt;42,780,298&lt;/span&gt; after reverse stock splits) per share, subject to customary adjustments and
                                            may be exercised at any time until the five-year anniversary. The warrant A&#x2019;s and the
                                            warrant B&#x2019;s meet the fixed-for-fixed criterion of IAS 32, resulting in being classified
                                            as equity. The Alpha September 2023 Note is in the principal amount of $&lt;span id="xdx_90C_eifrs-full--NetDebt_iI_pn3n3_c20240906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_z0SoUPiblMJ2" title="Principal amount"&gt;4,290&lt;/span&gt;. The actual
                                            amount loaned by the investor is $&lt;span id="xdx_90A_eifrs-full--BorrowingCostsIncurred_pn3n3_c20240906__20240906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zuTRDtfA4ca3" title="Actual loan amount"&gt;2,574&lt;/span&gt; after a &lt;span id="xdx_903_ecustom--OriginalIssueDiscount_iI_pid_dp_c20240906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zoLvP11nNDe7" title="Original issue discount"&gt;40&lt;/span&gt;% original issue discount. The maturity
                                            date of the Alpha September 2023 Note is the 12-month anniversary of the Effective Date,
                                            and is the date upon which the principal amount, as well as any accrued and unpaid interest
                                            and other fees, shall be due and payable. Interest accrues in the amount of &lt;span id="xdx_90C_ecustom--InterestAccruedPercent_iI_pid_dp_c20240906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zp1xilqVeNKe" title="Interest accrued percent"&gt;12&lt;/span&gt;% per year
                                            and shall be payable on the maturity date or upon acceleration or by prepayment or otherwise.
                                            The investor has the right, at any time, to convert all or any portion of the then outstanding
                                            and unpaid principal amount and interest (including any costs, fees and charges) into the
                                            Company&#x2019;s ordinary shares, at a fixed conversion price of $&lt;span id="xdx_902_ecustom--ConversionPrice_pid_c20240906__20240906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zORjy37qUos9" title="Conversion price"&gt;3,501&lt;/span&gt; ($&lt;span id="xdx_902_ecustom--ConversionPrice_pid_c20240906__20240906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zlcCXBuzKqH8" title="Conversion price"&gt;42,780,298&lt;/span&gt; after
                                            reverse stock splits) per share. &lt;span id="xdx_901_eifrs-full--DescriptionOfConversionOfDebtToEquity_pid_c20240906__20240906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zKjKlWutBDp"&gt;Any such conversion is subject to customary conversion limitations
                                            set forth in the Purchase Agreement, so the investor beneficially owns less than 4.99% of
                                            the Company&#x2019;s ordinary shares. Additionally, the Company has the right to convert in
                                            whole or in part the Alpha September 2023 Note into ordinary shares; provided that in no
                                            case shall the Company so convert the Alpha September 2023 Note if the result of the issuance
                                            of Ordinary Shares thereby would result in the beneficial ownership of the investor of ordinary
                                            shares in excess of 4.99%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt; text-indent: -14.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt; text-indent: -14.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt; text-indent: -14.2pt"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt; text-indent: -14.2pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt; text-indent: -14.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
7 - CONVERTIBLE NOTES (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt; text-indent: -14.2pt"&gt;&#160;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt; text-indent: -14.2pt"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Alpha September 2023 Note was recognized in accordance with the amortized cost method.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt; text-indent: -14.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2024, the investor converted all of the principal amount of the Alpha September 2023 Note into Ordinary Shares and exercised
all warrant A&#x2019;s and B&#x2019;s into Ordinary Shares of the Company.&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt; text-indent: -14.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt; text-indent: -14.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            February 24, 2024, the Company issued to Steven Wallitt (&#x201c;&lt;b&gt;SW&lt;/b&gt;&#x201d;) a convertible
                                            security with a face value of $&lt;span id="xdx_901_eifrs-full--IssueOfConvertibleInstruments_pn3n3_c20250224__20250224__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zTHaQrSeiDT4" title="Aggregate amount of convertible instruments issued"&gt;407&lt;/span&gt; in consideration of $&lt;span id="xdx_903_eifrs-full--ProceedsFromIssuingShares_pn3n3_c20250224__20250224__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_z5Yob055JE3b" title="Net proceeds from private placement"&gt;350&lt;/span&gt;, bearing &lt;span id="xdx_903_eifrs-full--BorrowingsInterestRate_iI_pid_dp_uPure_c20250224__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zN8eBJAA8Cpb" title="Interest rate"&gt;0&lt;/span&gt;% interest and maturing
                                            in &lt;span id="xdx_907_eifrs-full--BorrowingsMaturity_dtM_c20250224__20250224__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zxyw8IJEK4Zi" title="Borrowings maturity date"&gt;6&lt;/span&gt; month. The note shall be repaid solely by way of conversion into the Company&#x2019;s
                                            ordinary shares. The conversion price was determined according to the closing price of the
                                            Company&#x2019;s share on the day prior to the conversion date, with no floor price. SW ranks
                                            senior but is subordinated to ClearThink Asset Management (&#x201c;CTAM&#x201d;), the Company
                                            advisors, in case of any new debt issuance, including subordinated debt or redeemable preferred
                                            stock, except for instruments already negotiated with CTAM. In such cases, the Company is
                                            obligated to direct at least &lt;span id="xdx_907_ecustom--RepaymentOfDebtRate_iI_pid_dp_uPure_c20250224__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_z29R7kC2MB2h" title="Repayment of debt, rate"&gt;15&lt;/span&gt;% of the net proceeds from any new debt to repay the convertible
                                            security, unless SW waives this requirement.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt; text-align: justify; text-indent: -14.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 24, 2024, the Company extended the previous convertible security &lt;span id="xdx_90D_eifrs-full--BorrowingsMaturity_c20250824__20250824_zRXpHltp1NWk" title="Maturity date"&gt;maturity date to February 24, 2025&lt;/span&gt;. In addition, SW will have
the right to convert at his option all or a portion of the face value amount including OID or a maximum of $&lt;span id="xdx_907_eifrs-full--NotionalAmount_iI_pn3n3_c20250824_zDv9AQTbvgl" title="Face value"&gt;407&lt;/span&gt; into ordinary shares
at a conversion price under exactly the same terms of a new qualified financing for at least $&lt;span id="xdx_90B_eifrs-full--IssuedCapitalOrdinaryShares_iI_pn5n6_c20250824_zeJ9psazwdR7" title="Issued capital ordinary shares"&gt;1.5&lt;/span&gt; million from any source.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accordingly,
following a private placement transaction on October 28, 2024, the Company adjusted the conversion price to $&lt;span id="xdx_90C_ecustom--ConversionPricePerShare_pid_c20251028__20251028_zmqZRkDgWD14" title="Conversion of per share"&gt;0.49&lt;/span&gt; ($&lt;span id="xdx_907_ecustom--ConversionPricePerShare_pid_c20251028__20251028__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_z8zxCHo284C2" title="Conversion of per share"&gt;170,645&lt;/span&gt; after reverse
stock splits).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2025, the convertible security remains outstanding. Based on the Company&#x2019;s assessment, the expected repayment date
is December 31, 2026.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Based
on conversion terms under this agreement Investors have the right to convert the outstanding principal into ordinary shares at any time.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
convertible security is accounted in accordance with the amortized cost model, and amounted to $&lt;span id="xdx_90B_ecustom--ConversionPriceValue_pn3n3_c20250101__20251231__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zaeMOAKLwX56" title="Conversion price, value"&gt;483&lt;/span&gt; and $&lt;span id="xdx_900_ecustom--ConversionPriceValue_pn3n3_c20240101__20241231__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zPL2zb2mDJAh" title="Conversion price, value"&gt;370&lt;/span&gt; as of December 31, 2025,
and December 31, 2024, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
conversion option was accounted as a derivative financial liability and measured at fair value through profit or loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the conversion option was estimated using a Monte Carlo valuation model. As of December 31, 2025, and December 31, 2024,
the fair value amounted to $&lt;span id="xdx_90F_ecustom--FairValueOfConvertibleNotes_iI_pn3n3_c20251231__ifrs-full--ComponentsOfEquityAxis__custom--ConversionOptionMember_zhfu4ER11tu1" title="Fair value of convertible notes"&gt;124&lt;/span&gt; and $&lt;span id="xdx_90D_ecustom--FairValueOfConvertibleNotes_iI_pn3n3_c20241231__ifrs-full--ComponentsOfEquityAxis__custom--ConversionOptionMember_zPCv7mzdR4D" title="Fair value of convertible notes"&gt;95&lt;/span&gt;, respectively, based on volatility assumptions of &lt;span id="xdx_901_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20250101__20251231__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--ConversionOptionMember_z0lHNpr8uKld"&gt;202.8&lt;/span&gt;% and &lt;span id="xdx_90D_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20240101__20241231__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--ConversionOptionMember_z28Cv24MBRbb"&gt;39.78&lt;/span&gt;% and risk-free interest rates
of &lt;span id="xdx_903_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20250101__20251231__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--ConversionOptionMember_zV88FoaXNKyj"&gt;3.48&lt;/span&gt;% and &lt;span id="xdx_907_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20240101__20241231__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--ConversionOptionMember_zDykrF3ZX6Fc"&gt;4.37&lt;/span&gt;%, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of the date of these financial statements the principal and accrued interest payments according to the SW convertible security agreement
are due and owing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended December 31, 2025, a total of &lt;span id="xdx_90C_eifrs-full--NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_pid_uShares_c20250101__20251231_zXLEi8VTLDVb" title="RSU granted shares"&gt;58,238&lt;/span&gt; RSU were granted to investor Steven Wallit. Financing expenses in the amount of $&lt;span id="xdx_909_eifrs-full--FinanceCosts_c20250101__20251231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zFtWNIgipPjj" title="Financing expenses"&gt;3,466&lt;/span&gt;
were recognized in connection with the issuance of these RSUs. No settlement agreement was reached with the SW&#x2019;s investor; accordingly,
the expense was not offset against the existing liability.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
7 - CONVERTIBLE NOTES (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;D.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            April 11, 2024, the Company entered into Securities Purchase Agreements for the issuance
                                            of promissory note and warrants to Alpha, as follows:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt; text-align: justify; text-indent: -14.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Unsecured
                                            note (the &#x201c;&lt;b&gt;Alpha April Note&lt;/b&gt;&#x201d;) in the principal amount of $&lt;span id="xdx_905_eifrs-full--Borrowings_iI_pn3n3_c20240411__ifrs-full--BorrowingsByNameAxis__custom--AlphaAprilNoteMember__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zqzfrDZf8Vqi"&gt;2,250&lt;/span&gt;. The Alpha
                                            April Note carries an original issue discount (OID) of &lt;span id="xdx_90E_ecustom--OriginalIssueDiscount_iI_pid_dp_uPure_c20240411__ifrs-full--BorrowingsByNameAxis__custom--AlphaAprilNoteMember__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zl9r8yI8hiWg"&gt;10&lt;/span&gt;%, bears &lt;span id="xdx_908_eifrs-full--BorrowingsInterestRate_iI_pid_dp_uPure_c20240411__ifrs-full--BorrowingsByNameAxis__custom--AlphaAprilNoteMember__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_z92TNjN0QdLj"&gt;12&lt;/span&gt;% interest per year,
                                            and its maturity date is in 12 months from issue date. Alpha has the right to convert the
                                            outstanding principal and interest into Ordinary Shares at $&lt;span id="xdx_903_ecustom--SharePriceShareOptionsGranted2019_pid_c20240411__20240411__ifrs-full--BorrowingsByNameAxis__custom--AlphaAprilNoteMember__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zJvnNOExGAMc" title="Exercise price"&gt;513&lt;/span&gt; ($&lt;span id="xdx_90D_ecustom--SharePriceShareOptionsGranted2019_pid_c20240411__20240411__ifrs-full--BorrowingsByNameAxis__custom--AlphaAprilNoteMember__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_znkwbfsa3pU9" title="Exercise price"&gt;6,268,578&lt;/span&gt; after reverse
                                            stock splits) per share, with certain adjustments. If the Company is no longer restricted
                                            from variable rate transactions, the investor may convert at a &lt;span id="xdx_906_ecustom--DiscountRate_pid_dp_uPure_c20240411__20240411__ifrs-full--BorrowingsByNameAxis__custom--AlphaAprilNoteMember__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zSEhoQA0Lz7d"&gt;15&lt;/span&gt;% discount based on the
                                            lowest weighted average price during the 15 trading days before conversion. Any such conversion
                                            is subject to customary conversion limitations set forth in the Alpha April Note, so the
                                            investor beneficially owns less than &lt;span id="xdx_90A_ecustom--BeneficiallyOwnsRate_pid_dp_uPure_c20240411__20240411__ifrs-full--BorrowingsByNameAxis__custom--AlphaAprilNoteMember__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zyJwYJt0HPh1" title="Beneficially owns rate"&gt;4.99&lt;/span&gt;% of the Company&#x2019;s Ordinary Shares. Additionally,
                                            the Company has the right to convert in whole or in part the Alpha April Note into Ordinary
                                            Shares; provided that in no case shall the Company so convert the Alpha April Note if the
                                            result of the issuance of Ordinary Shares thereby would result in the beneficial ownership
                                            of the investor of Ordinary Shares in excess of &lt;span id="xdx_908_ecustom--ConversionOfHoldingSharesRate_pid_dp_uPure_c20240411__20240411__ifrs-full--BorrowingsByNameAxis__custom--AlphaAprilNoteMember__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zPK5TMFsUPy2" title="Conversion of shares rate"&gt;4.99&lt;/span&gt;%. A daily fee of $&lt;span id="xdx_90A_ecustom--ConversionOfSharesDailyFee_iI_pn3n3_c20240411__ifrs-full--BorrowingsByNameAxis__custom--AlphaAprilNoteMember__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zED3nUnPdm5l" title="Conversion of shares daily fee"&gt;2&lt;/span&gt; is applied if the
                                            Company fails to deliver shares upon conversion. &lt;span id="xdx_90C_ecustom--OutstandingPrincipalAndInterestDescription_c20240411__20240411__ifrs-full--BorrowingsByNameAxis__custom--AlphaAprilNoteMember__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zkmHn9aAlso" title="Outstanding principal and interest description"&gt;If an event of default occurs, the Alpha
                                            April Note&#x2019;s outstanding principal and interest increase by 120%, or 500% in specific
                                            default situations, with default interest at the lesser of 24.5% or the maximum legal rate&lt;/span&gt;.
                                            The Alpha April Note also includes restrictions against variable security transactions.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
                                                                                                                                                    &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;2.&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;A
                                            &lt;span id="xdx_907_ecustom--WarrantTerm_dtY_c20240411__20240411__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__ifrs-full--WarrantsMember_zdUX2mpMkzi6" title="Warrant, term"&gt;5.5&lt;/span&gt;-year warrant to purchase &lt;span id="xdx_90C_eifrs-full--NumberOfSharesIssued_iI_pid_c20240411__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__ifrs-full--WarrantsMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zjFgIPvsZtHf" title="Number of warrant shares issued"&gt;5,532&lt;/span&gt; Ordinary Shares (&lt;span id="xdx_90A_eifrs-full--NumberOfSharesIssued_iI_pid_dxL_c20240411__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__ifrs-full--WarrantsMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_z1X02lNcZT27" title="Number of warrant shares issued::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1465"&gt;nil&lt;/span&gt;&lt;/span&gt; after reverse stock splits) at $&lt;span id="xdx_909_eifrs-full--ParValuePerShare_iI_pid_c20240411__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__ifrs-full--WarrantsMember_zN25v0DbXKee" title="Warrant, per shares"&gt;336&lt;/span&gt;
                                            ($&lt;span id="xdx_905_eifrs-full--ParValuePerShare_iI_pid_c20240411__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__ifrs-full--WarrantsMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zKECK1lBSoE7" title="Warrant, per shares"&gt;4,105,736&lt;/span&gt; after reverse stock splits) per share, with anti-dilution protections. (&#x201c;the
                                            April Warrants&#x201d;). There is a &lt;span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20240411__20240411__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__ifrs-full--WarrantsMember_zpKLqtIA4szf" title="Ownership limit, rate"&gt;4.99&lt;/span&gt;% ownership limit on the exercise of this warrant,
                                            and the Company must pay a &#x201c;Buy-In&#x201d; amount if shares are not delivered timely.
                                            Alpha may elect to choose cashless exercise mechanism.&lt;/td&gt;&lt;/tr&gt;
                                                                                                                                                    &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
                                                                                                                                                    &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;3.&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Inducement
offers which amends the Company&#x2019;s existing warrants B&#x2019;s held by Alpha issued in September 2023 to a reduced exercise price
of $&lt;span id="xdx_90C_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20240411__20240411__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--BorrowingsByNameAxis__custom--AlphaAprilNoteMember_z6kxiG6HSNr6" title="Exercise price of share"&gt;4.7025&lt;/span&gt; ($&lt;span id="xdx_900_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20240411__20240411__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--BorrowingsByNameAxis__custom--AlphaAprilNoteMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zaioMS08mpoc" title="Exercise price of share"&gt;57,462&lt;/span&gt; after reverse stock splits) per share. Alpha immediately exercised these warrants B&#x2019;s in full.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
                                                                                                                                                    &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Alpha April Note is a financial liability which is measured in accordance with the amortized cost method and its conversion option is
a derivative financial liability measured at fair value through profit or loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of April 11, 2024, the Alpha April Note amounted to $&lt;span id="xdx_90B_eifrs-full--CurrentDerivativeFinancialLiabilities_iI_pn3n3_c20240411__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__ifrs-full--WarrantsMember_zBtTIRGtmL4g" title="Warrant, fair value"&gt;220&lt;/span&gt;, and the Conversion Option fair value amounted to $&lt;span id="xdx_902_ecustom--ConversionPriceValue_pn3n3_c20240411__20240411__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--ConversionOptionMember_zBTHFRkK2Ma" title="Conversion price, value"&gt;656&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of April 11, 2024, the fair value of the conversion option was calculated by estimating the Alpha April Note using Monte Carlo model
with expected volatility of &lt;span id="xdx_903_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20240411__20240411__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__ifrs-full--WarrantsMember_zCDOUifJNaIe"&gt;52.08&lt;/span&gt;% and the risk-free interest rate used is &lt;span id="xdx_90E_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20240411__20240411__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__ifrs-full--WarrantsMember_zbixT4bVK0Z5"&gt;5.17&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
2024, the investor converted approximately $&lt;span id="xdx_900_ecustom--NumberOfValueConverted_iI_pn3n3_c20241231_zH26vai73d95" title="Number of value converted"&gt;2,110&lt;/span&gt; of the principal amount and accrued interest into &lt;span id="xdx_901_ecustom--NumberOfWarrantsIssued_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OrdinarySharesMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InvestorsMember_zgibUA73FA6f" title="Number of warrants"&gt;467,424&lt;/span&gt; (38 after reverse stock splits)
ordinary shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2024, the Alpha April Note amounted to $&lt;span id="xdx_903_eifrs-full--CurrentDerivativeFinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__ifrs-full--WarrantsMember_z4IBipq2EDcc" title="Warrant, fair value"&gt;72&lt;/span&gt; and the Conversion Option fair value amounted to $&lt;span id="xdx_907_ecustom--ConversionPriceValue_pn3n3_c20240101__20241231__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--ConversionOptionMember_zI4el6inedRh" title="Conversion price, value"&gt;48&lt;/span&gt;. As of December 31, 2024,
the fair value of the Conversion Option was calculated by estimating the Alpha April Note using Monte Carlo model with expected volatility
of &lt;span id="xdx_906_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20240101__20241231__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--ConversionOptionMember_zf0Mii7XMTci"&gt;39.78&lt;/span&gt;% and the risk-free interest rate used is &lt;span id="xdx_907_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20240101__20241231__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--ConversionOptionMember_zWqugCIHgFP2"&gt;4.37&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
April Warrants were classified as a derivative financial liability measured at fair value through profit or loss. After initial recognition,
at each cut off, the April Warrants will be measured in accordance with their fair value and all changes in fair value will be recognized
through profit or loss. As of April 11, 2024, the April Warrants&#x2019; fair value amounted to $&lt;span id="xdx_907_eifrs-full--CurrentDerivativeFinancialLiabilities_iI_pn3n3_c20240411__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--AprilWarrantsMember_zsUTSsnrVmSf" title="Warrant, fair value"&gt;1,090&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of April 11, 2024, the fair value of the April Warrants was calculated using the Black-Scholes model with expected volatility of &lt;span id="xdx_903_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20240411__20240411__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--AprilWarrantsMember_zkrj0dvDeP4e"&gt;73.43&lt;/span&gt;%
and the risk-free interest rate used is &lt;span id="xdx_903_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20240411__20240411__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--AprilWarrantsMember_zSTSJaCbp5R9"&gt;4.61&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2024, Alpha exercised all the April Warrants into Ordinary Shares of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
addition, during 2025, Alpha exercised its embedded conversion option with respect to the remaining balance of the Alpha April Note,
converting it into &lt;span id="xdx_901_ecustom--FairValueOfConvertibleConversionShares_pid_c20250101__20251231_z10QQWTrXe22" title="Fair value of convertible conversion shares"&gt;16&lt;/span&gt; ordinary shares of the Company, with a fair value at the conversion date of $&lt;span id="xdx_904_ecustom--FairValueOfConvertibleConversionValue_pn3n3_c20250101__20251231_zPA8yh5IdD62" title="Fair value of convertible conversion"&gt;842&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;b&gt;NOTE 7 - CONVERTIBLE NOTES (CONT.):&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 2, 2025, the Company entered into a settlement agreement with Alpha, pursuant to which it issued &lt;span id="xdx_906_ecustom--FairValueOfConvertibleConversionShares_pid_c20250402__20250402_zf9anEvCxfw9" title="Fair value of convertible conversion shares"&gt;33&lt;/span&gt; ordinary shares to Alpha, with
a fair value at the issuance date of $&lt;span id="xdx_90A_ecustom--FairValueOfConvertibleConversionValue_pn3n3_c20250402__20250402_zIEq2VFasnD9" title="Fair value of convertible conversion"&gt;787&lt;/span&gt;. As of December 31, 2025, the entire outstanding balance of the Alpha April Note had been converted
into ordinary shares of the Company, and accordingly, no further liability to Alpha remains in respect of this note.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;E.
On July 10, 2024, the Company entered into a Letter of Intent with PMB Partners, LP (&#x201c;&lt;b&gt;PMB&lt;/b&gt;&#x201d;), as part of the Company&#x2019;s
ongoing efforts to satisfy its existing liabilities while conserving cash. Although the Letter of Intent was binding, the Letter of Intent
provided that the Company and PMB negotiate in good faith the drafting and execution of the exchange of a $&lt;span id="xdx_901_eifrs-full--IssueOfConvertibleInstruments_pn3n3_c20250710__20250710__ifrs-full--BorrowingsByNameAxis__custom--SeniorSecuredNoteDueMayThirtyOneTwentyTwentyFourMember_zcq8ijr1HcT1"&gt;1,000&lt;/span&gt; senior secured note
(originally due May 31, 2024) for a $&lt;span id="xdx_906_ecustom--PromissoryNote_iI_pn3n3_c20250710__ifrs-full--CreationDateAxis__custom--ConvertibleNoteDueDecemberThirtyOneTwentyTwentyFourMember__ifrs-full--BorrowingsByNameAxis__custom--TheEightHundredConvertibleNoteMember_zIOB0cxjs96k"&gt;800&lt;/span&gt; Convertible Note due December 31, 2024 (&#x201c;the $&lt;span id="xdx_90F_ecustom--PromissoryNote_iI_pn3n3_c20250710__ifrs-full--BorrowingsByNameAxis__custom--TheEightHundredConvertibleNoteMember_zW7J2YHwwme9"&gt;800&lt;/span&gt; Convertible Note&#x201d;), and a $&lt;span id="xdx_906_ecustom--PromissoryNote_iI_pn3n3_c20250710__ifrs-full--CreationDateAxis__custom--NonConvertibleNoteDueDecemberThirtyOneTwentyTwentyFourMember__ifrs-full--BorrowingsByNameAxis__custom--TheFiveHundredNonConvertibleNoteMember_zRJkpDyKCcn1" title="Promissory note"&gt;500&lt;/span&gt;
non-convertible promissory note due December 31, 2024 (&#x201c;the $&lt;span id="xdx_90C_ecustom--PromissoryNote_iI_pn3n3_c20250710__ifrs-full--BorrowingsByNameAxis__custom--TheFiveHundredNonConvertibleNoteMember_z6KzfddQpUG6" title="Promissory note"&gt;500&lt;/span&gt; Non-Convertible Promissory Note&#x201d; and, together with the
$&lt;span id="xdx_905_ecustom--PromissoryNote_iI_pn3n3_c20250710__ifrs-full--BorrowingsByNameAxis__custom--TheEightHundredConvertibleNoteMember_zryE3EH24sc1"&gt;800&lt;/span&gt; Convertible Note, the &#x201c;Senior Promissory Notes&#x201d;) and other ancillary documents, contracts, or agreements to give effect
to the terms of the Letter of Intent not otherwise satisfied at or as of the Effective Date (the &#x201c;Definitive Agreements&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Definitive Agreements, consisting of a Subscription Agreement, a Notes Exchange Agreement, a Share Exchange Agreement, the $&lt;span id="xdx_905_ecustom--PromissoryNote_iI_pn3n3_c20250710__ifrs-full--BorrowingsByNameAxis__custom--TheEightHundredConvertibleNoteMember_zrhKwYjQ9jhe"&gt;800&lt;/span&gt; Convertible
Note and the $&lt;span id="xdx_907_ecustom--PromissoryNote_iI_pn3n3_c20250710__ifrs-full--CreationDateAxis__custom--NonConvertibleNoteDueDecemberThirtyOneTwentyTwentyFourMember__ifrs-full--BorrowingsByNameAxis__custom--TheFiveHundredNonConvertibleNoteMember_zK6BiBXFVMbi" title="Promissory note"&gt;500&lt;/span&gt; Non-Convertible Promissory Note, with terms consistent with the Letter of Intent, were all dated as of September 4,
2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Senior Promissory Notes carry an annual interest of &lt;span id="xdx_909_ecustom--ConvertiblePromissoryNoteInterestRate_iI_pid_dp_uPure_c20250710_zzdadaQfo75c" title="Convertible promissory note interest rate"&gt;15&lt;/span&gt;%. PMB has the right to convert the $&lt;span id="xdx_906_ecustom--PromissoryNote_iI_pn3n3_c20250710__ifrs-full--BorrowingsByNameAxis__custom--TheEightHundredConvertibleNoteMember_zarbOshOQM1b"&gt;800&lt;/span&gt; Convertible Note and accumulated interest
into &lt;span id="xdx_90D_ecustom--IssueOfConvertibleShares_pid_c20250710__20250710__ifrs-full--BorrowingsByNameAxis__custom--TheEightHundredConvertibleNoteMember_zvfXayXfLlQ5" title="Issue of convertible shares"&gt;2,673&lt;/span&gt; (&lt;span id="xdx_90B_ecustom--ReverseStockSplitAmount_dxL_c20250710__20250710__ifrs-full--BorrowingsByNameAxis__custom--TheEightHundredConvertibleNoteMember_zpLe8y7oouH6" title="Reverse stock split amount::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1521"&gt;nil&lt;/span&gt;&lt;/span&gt; after reverse stock splits) ordinary shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
$&lt;span id="xdx_90C_ecustom--PromissoryNote_iI_pn3n3_c20250710__ifrs-full--BorrowingsByNameAxis__custom--TheEightHundredConvertibleNoteMember_zHUwyZPTe6ch"&gt;800&lt;/span&gt; Convertible Note is a financial liability which measured on the initial day at fair value recognized financial expenses or income
through profit and loss. In the subsequent measurement the $&lt;span id="xdx_90C_ecustom--PromissoryNote_iI_pn3n3_c20250710__ifrs-full--BorrowingsByNameAxis__custom--TheEightHundredConvertibleNoteMember_zacokhAERyDk"&gt;800&lt;/span&gt; Convertible Note is with accordance with the amortized cost method.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
conversion option meets the conditions for equity classification according to IAS 32 and recorded as equity instrument.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
$&lt;span id="xdx_90D_ecustom--PromissoryNote_iI_pn3n3_c20250710__ifrs-full--BorrowingsByNameAxis__custom--TheFiveHundredNonConvertibleNoteMember_zpkqMH8mEbje" title="Promissory note"&gt;500&lt;/span&gt; Non-Convertible Promissory Note is a liability which measured on the initial day at fair value recognized financial expenses or
income through profit and loss. In the subsequent measurement, the $&lt;span id="xdx_900_ecustom--PromissoryNote_iI_pn3n3_c20250710__ifrs-full--BorrowingsByNameAxis__custom--TheFiveHundredNonConvertibleNoteMember_ze7LOxoBcqy3" title="Promissory note"&gt;500&lt;/span&gt; Non-Convertible Promissory Note measured in accordance with the
amortized cost method.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
May 13, 2025, the parties executed an amendment, under which the maturity date of both notes was extended to November 30, 2025, the annual
interest rate was increased to 18%, and the principal balance of each note was adjusted to include accrued and unpaid interest up to
the date of the amendment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with IFRS 9, the quantitative and qualitative effects of the amendment were assessed, and it was determined that the modification
was non-substantial. Accordingly, the amortized cost of the liabilities was adjusted to reflect the revised contractual cash flows, discounted
at the original effective interest rate, with the resulting difference recognized as finance expenses in profit or loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
amortized cost including interest of the convertible promissory note in the principal amount of $&lt;span id="xdx_909_ecustom--PromissoryNote_iI_pn3n3_c20250513__ifrs-full--BorrowingsByNameAxis__custom--ConvertiblePromissoryNoteMember_zTuJq9CK6r06" title="Promissory note"&gt;800&lt;/span&gt; and the promissory note in the principal
amount of $&lt;span id="xdx_900_eifrs-full--Borrowings_iI_pn3n3_c20250513__ifrs-full--BorrowingsByNameAxis__custom--ConvertiblePromissoryNoteMember_z4kYQLMvLjub" title="Borrowed amount"&gt;500&lt;/span&gt;, in aggregate, was $&lt;span id="xdx_90C_eifrs-full--Borrowings_iI_pn3n3_c20251231__ifrs-full--BorrowingsByNameAxis__custom--ConvertiblePromissoryNoteMember_zc6MqzTts0qc" title="Borrowed amount"&gt;1,572&lt;/span&gt; as of December 31, 2025, and $&lt;span id="xdx_90B_eifrs-full--Borrowings_iI_pn3n3_c20241231__ifrs-full--BorrowingsByNameAxis__custom--ConvertiblePromissoryNoteMember_zQ3OQ0wnSACl" title="Borrowed amount"&gt;1,359&lt;/span&gt; as of December 31, 2024, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
2025, a total of 58,254 ordinary shares were granted to PMB&#x2019;s investor. Finance expenses in the amount of $3,679 were recognized.
As no settlement agreement was reached with PMB&#x2019;s investor, the recognized finance expense was recorded against issued capital
and additional paid-in capital and was not offset against the related financial liability.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
of the principal and accrued interest under the PMB Convertible Notes, is due and owing as of the date of these financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;F.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;On July 19, 2024 the Company entered into Securities Purchase Agreement issued and sold
                                                                                                                                                                                                                                      to Alpha, a promissory note (the &#x201c;&lt;b&gt;Alpha July Note&lt;/b&gt;&#x201d;) and warrants (the &#x201c;July Warrants&#x201d;), for gross
                                                                                                                                                                                                                                      proceeds of $&lt;span id="xdx_90D_ecustom--ProceedsFromIssuancePromissoryNoteAndWarrant_pn2n3_c20250719__20250719__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zktzCoTVo1He" title="Proceeds from issuance promissory note and warrant"&gt;747.5&lt;/span&gt;,
                                                                                                                                                                                                                                      before deducting fees and other offering expenses payable by the Company. The Alpha July Note is in the principal amount of $&lt;span id="xdx_90B_eifrs-full--Borrowings_iI_pn3n3_c20250719__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zHcOyduElFfg"&gt;1,150&lt;/span&gt;
                                                                                                                                                                                                                                      (the &#x201c;Principal Amount&#x201d;) and carries an original issue discount of &lt;span id="xdx_902_ecustom--OriginalIssueDiscount_iI_pid_dp_uPure_c20240719__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zOrKaXmEkPI1"&gt;35&lt;/span&gt;%.
                                                                                                                                                                                                                                      The maturity date of the Alpha July Note is the 12-month anniversary of the issuance date. &lt;span id="xdx_901_eifrs-full--DescriptionOfConversionOfDebtToEquity_c20250719__20250719__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_gIFDOCODTE-VGJ_zeFiA8VmG9d7"&gt;The
                                                                                                                                                                                                                                      Alpha has the right, at any time, to convert all or any portion of the outstanding and unpaid principal amount and interest
                                                                                                                                                                                                                                      (including any costs, fees and charges) into the Company&#x2019;s Ordinary Shares, at a conversion price equal to &lt;/span&gt;&lt;span id="xdx_C04_gIFDOCODTE-VGJ_zmaB7RVW8Wqh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
                                                                                                                                                                                                                                      lesser of $174 ($2,126,184 after reverse stock splits) or 80% of the lowest volume weighted average price of the Company&#x2019;s
                                                                                                                                                                                                                                      ordinary shares during the twenty trading days prior to the conversion, subject to&lt;/span&gt;&lt;span id="xdx_C0B_gIFDOCODTE-VGJ_zjp1c3255yPg"&gt;
                                                                                                                                                                                                                                      customary adjustments as provided in the Alpha July Note including for fundamental transactions (the &#x201c;Conversion
                                                                                                                                                                                                                                      option&#x201d;) Any such conversion is subject to customary conversion limitations set forth in the Alpha July Note so the Alpha
                                                                                                                                                                                                                                      beneficially owns less than 4.99% of the Company&#x2019;s Ordinary Shares. Any principal amount on the Alpha July Note which is not
                                                                                                                                                                                                                                      paid when due shall bear interest at the rate of the lesser of (i) 24.5% per annum and (ii) the maximum amount permitted by law
                                                                                                                                                                                                                                      during the Event of Default. Upon the occurrence of any Event of Default, the principal amount then outstanding plus accrued
                                                                                                                                                                                                                                      interest (including any costs, fees and charges) increases to 120% of such amount through the date of full repayment, as well as all
                                                                                                                                                                                                                                      costs of collection&lt;/span&gt;. According to the purchase agreement, the Company issued to the Alpha the July Warrants, to purchase up
                                                                                                                                                                                                                                      to &lt;span id="xdx_909_ecustom--WarrantsToPurchaseOrdinaryShares_pid_c20250719__20250719__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--JulyWarrantsMember_zC8TDsoy4yy4"&gt;7,317&lt;/span&gt;
                                                                                                                                                                                                                                      (&lt;span id="xdx_90B_ecustom--WarrantsToPurchaseOrdinaryShares_pid_dxL_c20250719__20250719__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--JulyWarrantsMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zjbvyHw4Ojol" title="Warrants to purchase ordinary shares::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1545"&gt;nil&lt;/span&gt;&lt;/span&gt;
                                                                                                                                                                                                                                      after reverse stock splits) Ordinary Shares, with an exercise price of $&lt;span id="xdx_905_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20250719__20250719__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--JulyWarrantsMember_zpx8XQ2x1kkd"&gt;178&lt;/span&gt;
                                                                                                                                                                                                                                      ($&lt;span id="xdx_905_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20250719__20250719__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--JulyWarrantsMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zpMhr4LX4euh"&gt;2,175,062&lt;/span&gt;
                                                                                                                                                                                                                                      after reverse stock splits) per share, subject to customary adjustments and certain price-based anti-dilution protections, and may
                                                                                                                                                                                                                                      be exercised at any time for &lt;span id="xdx_906_ecustom--WarrantTerm_dtY_c20250719__20250719__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--JulyWarrantsMember_z5PXLxXwqryl"&gt;5.5&lt;/span&gt;
                                                                                                                                                                                                                                      years from issuance.&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span title="Description of conversion of debt to equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span title="Description of conversion of debt to equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 81%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
7 - CONVERTIBLE NOTES (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
July Warrants also may be exercised pursuant to a cashless or net exercise provision. The exercise of the July Warrants is subject to
a beneficial ownership limitation of &lt;span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20250719__20250719__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--JulyWarrantsMember_z2jtcFtqaJTc" title="Ownership limit, rate"&gt;4.99&lt;/span&gt;% of the number of Ordinary Shares outstanding immediately after giving effect to such exercise.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
July Warrants were classified as a derivative financial liability measured at fair value through profit or loss. After initial recognition,
at each cut-off, the July Warrants will be measured in accordance with its fair value and all changes in fair value will be recognized
through profit or loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of July 19, 2024, the July Warrants fair value amounted to $&lt;span id="xdx_900_eifrs-full--CurrentDerivativeFinancialLiabilities_iI_pn3n3_c20250719__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--JulyWarrantsMember_zHyP98JcvLR9" title="Warrant, fair value"&gt;741&lt;/span&gt;. The July Warrants were calculated using Black-Scholes model with expected
volatility of &lt;span id="xdx_90C_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20250719__20250719__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--JulyWarrantsMember_zPaHcLEwOJgi"&gt;59.6&lt;/span&gt;% and the risk-free interest rate used is &lt;span id="xdx_901_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20250719__20250719__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--JulyWarrantsMember_zIcjH1dcVkFj"&gt;4.16&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2024, all of the July Warrants were converted into ordinary shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Alpha July Note is a financial liability which will be measured in accordance with the amortized cost method, and its conversion option
is a derivative financial liability measured at fair value through profit or loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As of July 19, 2024, the Alpha July Note amounted to $&lt;span id="xdx_904_ecustom--ConversionPriceValue_pn3n3_c20250719__20250719__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--BorrowingsByNameAxis__custom--AlphaJulyNoteMember_zGny3mBcuIGj" title="Conversion price, value"&gt;0&lt;/span&gt;, and the Conversion Option fair value amounted to $&lt;span id="xdx_90C_ecustom--ConversionPriceValue_pn3n3_c20250719__20250719__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--ConversionOptionMember_z4Gw2HpCCypc" title="Conversion price, value"&gt;753&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of July 19, 2024, the fair value of the conversion option was calculated by estimating the Alpha July Note using Monte Carlo model with
expected volatility of &lt;span id="xdx_902_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20250719__20250719__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--ConversionOptionMember_zgzHxWkPyc26"&gt;61.67&lt;/span&gt;% and the risk-free interest rate used is &lt;span id="xdx_90E_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20250719__20250719__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--ConversionOptionMember_zwdAjR7uTuN6"&gt;4.85&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2024, the Alpha July Note amounted to $&lt;span id="xdx_907_ecustom--ConversionPriceValue_pn3n3_c20240101__20241231__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--BorrowingsByNameAxis__custom--AlphaJulyNoteMember_zanJFTQqIRQ1" title="Conversion price, value"&gt;520&lt;/span&gt;, and the Conversion Option fair value amounted to $&lt;span id="xdx_90C_ecustom--ConversionPriceValue_pn3n3_c20240101__20241231__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--ConversionOptionMember__ifrs-full--BorrowingsByNameAxis__custom--ConvertibleNotesMember_zfAu92k2wXJh" title="Conversion price, value"&gt;527&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As of December 31,
2024, the fair value of the Conversion Option was calculated by estimating the Alpha July Note using the Monte Carlo model with expected
volatility of &lt;span id="xdx_905_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20240101__20241231__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--ConversionOptionMember__ifrs-full--BorrowingsByNameAxis__custom--ConvertibleNotesMember_z6zXZnp4NSdk"&gt;58.7&lt;/span&gt;% and the risk-free interest rate used is &lt;span id="xdx_903_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20250101__20251231__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--ConversionOptionMember__ifrs-full--BorrowingsByNameAxis__custom--ConvertibleNotesMember_zYsgGKFMzTui"&gt;4.28&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
2025, the Alpha July Note and the accrued interest were fully converted into ordinary shares (see Note 15. B-1).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;G.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 30, 2024, the Company entered into a Securities Purchase Agreement with 1800 Diagonal Lending LLC (&#x201c;&lt;b&gt;1800 Diagonal August&lt;/b&gt;&#x201d;),
to issue and sell a promissory note, for gross proceeds to the Company of $194.5, before deducting fees and other offering expenses payable
by the Company (&#x201c;the 1800 Diagonal August Promissory Note&#x201d;). The 1800 Diagonal August Promissory Note is in the principal
amount of $&lt;span id="xdx_900_eifrs-full--NotionalAmount_iI_pn2n3_c20250830_zuval07K6fqe"&gt;223.7&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
which includes an original issue discount of $&lt;span id="xdx_902_eifrs-full--PaymentsForDebtIssueCosts_pn2n3_c20250830__20250830_zHPc8evsAmo2"&gt;29.2&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.
A one-time interest charge of 10%, or $&lt;span id="xdx_906_eifrs-full--InterestPayable_iI_pn2n3_c20250830_zTbuN9NOhXv3"&gt;22.4&lt;/span&gt;&lt;/span&gt;
&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;was applied to the principal. The maturity date of the 1800
Diagonal August Promissory Note is &lt;span id="xdx_90A_eifrs-full--BorrowingsMaturity_c20250830__20250830_zfZFEDNJID12"&gt;June 30, 2025&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.
The accrued, unpaid interest and outstanding principal, subject to adjustment, shall be paid in five payments as follows: (1) on February
28, 2025, $&lt;span id="xdx_90D_ecustom--PaymentsOnUnpaidInterestAndPrincipleAmount_pn3n3_c20250830__20250830__ifrs-full--CreationDateAxis__custom--FebruaryTwentyEightTwoThousandAndTwentyFiveMember_zUl2lAZSjc61"&gt;123&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;;
(2) on March 30, 2025, $&lt;span id="xdx_90A_ecustom--PaymentsOnUnpaidInterestAndPrincipleAmount_pn2n3_c20250830__20250830__ifrs-full--CreationDateAxis__custom--MarchTwentyThirtyTwoThousandAndTwentyFiveMember_zSSIbbaoDz4f"&gt;30.7&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;;
(3) on April 30, 2025, $&lt;span id="xdx_909_ecustom--PaymentsOnUnpaidInterestAndPrincipleAmount_pn2n3_c20250830__20250830__ifrs-full--CreationDateAxis__custom--MayTwentyThirtyTwoThousandAndTwentyFiveMember_zSzxobd9wxKd"&gt;30.7&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;;
(4) on May 30, 2025, $&lt;span id="xdx_90C_ecustom--PaymentsOnUnpaidInterestAndPrincipleAmount_pn2n3_c20250830__20250830__ifrs-full--CreationDateAxis__custom--MayTwentyThirtyTwoThousandAndTwentyFiveMember_zFRM04teaAhd"&gt;30.7&lt;/span&gt;&lt;/span&gt;
&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and (5) on June 30, 2025, $&lt;span id="xdx_904_ecustom--PaymentsOnUnpaidInterestAndPrincipleAmount_pn2n3_c20250830__20250830__ifrs-full--CreationDateAxis__custom--JuneTwentyThirtyTwoThousandAndTwentyFiveMember_znBjCkSV7eQ5" title="Payments on unpaid interest and principle amount"&gt;30.7&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
7 - CONVERTIBLE NOTES (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;The 1800 Diagonal August Promissory Note contains customary Events of Default for transactions similar to the transactions contemplated by the Purchase Agreement and the Note.&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In the event of an Event of Default, (i) the 1800 Diagonal August Promissory Note shall become immediately due and payable, (ii) &lt;span id="xdx_90A_eifrs-full--DescriptionOfConversionOfDebtToEquity_c20250830__20250830_zCBthejUFFAl" title="Conversion of debt"&gt;the principal and interest balance of the note shall be increased by 150% and (ii) the 1800 Diagonal August Promissory Note may be converted into Ordinary Shares of the Company at the sole discretion of the 1800 Diagonal August. The conversion price shall equal the lowest closing bid price of the Ordinary Shares during the prior ten trading day period multiplied by 75% (representing a 25% discount). Any such conversion is subject to customary conversion limitations set forth in the 1800 Diagonal August Promissory Note so the 1800 Diagonal August beneficially owns less than 4.99% of the Company&#x2019;s Ordinary Shares. The 1800 Diagonal August shall be entitled to deduct $1.5 from the conversion amount in each Notice of Conversion to cover Holder&#x2019;s deposit fees associated with each Notice of Conversion&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Purchase Agreement contains customary representations and warranties made by each of the Company and the 1800 Diagonal August. The Company
is subject to customary indemnification terms in favour of the 1800 Diagonal August and its affiliates and certain other parties. The
Company paid a placement agent approximately $&lt;span id="xdx_901_eifrs-full--ProfessionalFeesExpense_pn3n3_c20250830__20250830_zfFCmCpYS2P6" title="Fee expense"&gt;18 &lt;/span&gt;in cash fees in relation to the transactions contemplated by the Purchase Agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
1800 Diagonal August Promissory Note was accounted as financial liability in accordance with the amortized cost method using the effective
interest rate of &lt;span id="xdx_90F_ecustom--EffectiveInterestRate_pid_dp_c20250328__20250328__ifrs-full--CounterpartiesAxis__custom--OneThousandAndEightHundredDiagonalLendingLLCMember_z19y7oBOAPb3" title="Effective interest rate"&gt;674&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2024, the carrying amount of the host straight debt component was $ &lt;span id="xdx_908_eifrs-full--NetDebt_iI_pn3n3_c20241231__ifrs-full--CounterpartiesAxis__custom--OneThousandAndEightHundredDiagonalLendingLLCMember_zHaVeLoYF4S8" title="Debt"&gt;147&lt;/span&gt; and the fair value of the embedded conversion
option was $ &lt;span id="xdx_90F_ecustom--FairValueOfEmbeddedConversionOption_pn3n3_c20240101__20241231__ifrs-full--CounterpartiesAxis__custom--OneThousandAndEightHundredDiagonalLendingLLCMember_z3IqifyMVE8a" title="Fair value of the embedded conversion option"&gt;121&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
convertible feature was accounted as derivative financial liability and measured at fair value through profit and loss. Management utilized
a third-party appraiser to assist them in valuing the convertible feature fair value using the monte Carlo simulation with expected volatility
of&lt;span id="xdx_902_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20240101__20241231__ifrs-full--CounterpartiesAxis__custom--OneThousandAndEightHundredDiagonalLendingLLCMember_zJiLQZsohINd" title="Expected volatility"&gt; 43&lt;/span&gt;% and the risk-free interest rate used is&lt;span id="xdx_90B_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20240101__20241231__ifrs-full--CounterpartiesAxis__custom--OneThousandAndEightHundredDiagonalLendingLLCMember_zKDgb4Of2Gci" title="Risk free interest rate"&gt; 4.89&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_ecustom--ConvertibleFeatureDescription_c20240101__20241231__ifrs-full--CounterpartiesAxis__custom--OneThousandAndEightHundredDiagonalLendingLLCMember_zpCK4DilbQR8" title="Convertible feature description"&gt;According
to the agreement, the loan conversion will only occur in the event of default. For the purpose of estimating the convertible feature
the third-party appraiser has assumed, based on Moody&#x2019;s rate methodology, the is a 43.6% probability that a default event will
occur. Therefore, the value of the Convertible feature is only 43.6% of the Convertible feature valuation&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
1800 Diagonal August Promissory Note was fully repaid in cash during 2025 for an aggregate amount of approximately $&lt;span id="xdx_904_eifrs-full--RepaymentsOfCurrentBorrowings_pn3n3_c20250101__20251231__ifrs-full--CounterpartiesAxis__custom--OneThousandAndEightHundredDiagonalLendingLLCMember_zBaaNVLlYdF2" title="Aggregate amount"&gt;246&lt;/span&gt; (comprising the
original principal amount of $&lt;span id="xdx_901_eifrs-full--NotionalAmount_iI_pp2n3_c20251231__ifrs-full--CounterpartiesAxis__custom--OneThousandAndEightHundredDiagonalLendingLLCMember_zSGt0oPd5Lhh" title="Notional amount"&gt;223.7 &lt;/span&gt;and interest of $&lt;span id="xdx_909_eifrs-full--NotionalAmount_iI_pp2n3_c20241231__ifrs-full--CounterpartiesAxis__custom--OneThousandAndEightHundredDiagonalLendingLLCMember_zWpjiJLv9sIe" title="Notional amount"&gt;22.4&lt;/span&gt;$).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;H.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            March 28, 2025, the Company entered into an agreement with 1800 Diagonal (&#x201c;&lt;b&gt;1800
                                            Diagonal March&lt;/b&gt;&#x201d;), pursuant to which it issued a promissory note with a par value
                                            of $ &lt;span id="xdx_908_ecustom--ProceedsFromIssueOfBondsNotesAndDebenture_pn5n6_c20250328__20250328_zEKnbPPxmGQf" title="Gross proceeds"&gt;295.5&lt;/span&gt; in consideration for net cash proceeds of approximately $&lt;span id="xdx_90E_eifrs-full--ProceedsFromIssueOfRegulatoryCapitalFinancialLiabilities_pn5n6_c20250328__20250328_zLAIZZrNjk1k" title="Net proceeds"&gt;250&lt;/span&gt;, after deduction
                                            of issuance expenses of approximately $&lt;span id="xdx_900_eifrs-full--ShareIssueRelatedCost_pn5n6_c20250328__20250328_ziLq7QTOpKGd" title="Share issue expense"&gt;7&lt;/span&gt;.&lt;span id="xdx_904_ecustom--DescriptionOfRepayableInSevenInstalments_pn5n6_c20250328__20250328_zymuaf4Ap6ii" title="Description of repayable in seven instalments"&gt;The note bears interest at an annual rate of 12%
                                            and is repayable in seven instalments between September 2025 and March 2026, as follows:
                                            (1) $ 163 on September 30, 2025; (2)-(7) $ 27.2 on each month-end from October 2025 to March
                                            2026.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
note contains customary default provisions for similar transactions, under which, in the event of default: (i) it becomes immediately
due and payable; (ii) the outstanding principal and interest increase by &lt;span id="xdx_909_ecustom--OutstandingPrincipalAndInterestIncreasePercentage_pid_dp_c20250328__20250328_zduAGfCcamvg" title="Outstanding principal and interest increase percentage"&gt;150&lt;/span&gt;%; and (iii) it may be converted, at the sole discretion
of 1800 Diagonal March, into ordinary shares of the Company. In this regard, the conversion price is the lowest closing price of the
Company&#x2019;s shares during the ten trading days preceding the conversion request, less a&lt;span id="xdx_90C_ecustom--DiscountRate_pid_dp_c20250328__20250328_zwbG9BqJeUw6" title="Outstanding principal and interest increase percentage"&gt; 25&lt;/span&gt;% discount. Conversion is subject to an
ownership limitation of &lt;span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20250328__20250328_zHkxUkCDCv51" title="Subsidiaries, percentage owned"&gt;4.99&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
agreement also includes customary representations, undertakings, and indemnities in favour of 1800 Diagonal March, its subsidiaries,
and related entities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
accounting purposes, the promissory note is a compound financial instrument, bifurcated on initial recognition into: (i) a host straight
debt component, classified as a financial liability measured at amortized cost, with an effective interest rate at initial recognition
of &lt;span id="xdx_90C_ecustom--EffectiveInterestRate_pid_dp_c20250328__20250328_zkMimQrOzsT1" title="Effective interest rate"&gt;107.46&lt;/span&gt;%; and&lt;br/&gt;
(ii) an embedded conversion option, classified as a derivative financial liability measured at fair value through profit or loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
7 - CONVERTIBLE NOTES (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of March 28, 2025, the carrying amount of the host straight debt component was $&lt;span id="xdx_90E_eifrs-full--NetDebt_iI_pn3n3_c20250328_zf1arf5IiCV" title="Debt"&gt;204&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the embedded conversion option at initial recognition was estimated at $ &lt;span id="xdx_907_ecustom--ConversionPriceValue_pn3n3_c20250328__20250328__ifrs-full--ComponentsOfEquityAxis__custom--ConversionOptionMember_zcqq5lLw2fDh" title="Conversion price, value"&gt;47&lt;/span&gt;, as determined by management with the assistance
of an independent appraiser using a Monte Carlo simulation, incorporating an expected volatility of &lt;span id="xdx_906_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20250328__20250328__ifrs-full--ComponentsOfEquityAxis__custom--ConversionOptionMember_zvN1ADjJV4o1"&gt;60.37&lt;/span&gt;% and a risk-free interest rate
of &lt;span id="xdx_90F_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20250328__20250328__ifrs-full--ComponentsOfEquityAxis__custom--ConversionOptionMember_zmQGkH9Sx5c7"&gt;4.04&lt;/span&gt;%. As conversion is permitted only upon an event of default, the appraiser estimated the probability of such an event at &lt;span id="xdx_909_ecustom--ConversionPricePercentage_pid_dp_uPure_c20250328__20250328__ifrs-full--ComponentsOfEquityAxis__custom--ConversionOptionMember_z6YH3Psdaeb" title="Conversion price percentage"&gt;8.962&lt;/span&gt;%,
and the fair value was calculated accordingly as this percentage of the full conversion value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
2025, the promissory note was fully repaid in cash for an aggregate amount of approximately &lt;span id="xdx_908_eifrs-full--IssueOfConvertibleInstruments_pn3n3_uUSD_c20220501__20220531_zR6cCjgSKxUl" title="Aggregate amount"&gt;$317&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;I.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            May 9, 2025, the Company entered into an agreement with RBW Capital &lt;b&gt;(&#x201c;RBW May&#x201d;)&lt;/b&gt;,
                                            pursuant to which it issued a promissory note with a par value of $&lt;span id="xdx_90A_ecustom--PromissoryNote_iI_pn3n3_c20250509__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_z8zU46GFN29k" title="Issuance of promissory note"&gt;6,875&lt;/span&gt; in consideration
                                            for total cash proceeds of $&lt;span id="xdx_904_ecustom--ProceedsFromIssuanceOfPromissoryNote_pn3n3_c20250509__20250509__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_zC1y1L9IQI1f" title="Cash proceeds"&gt;5,500&lt;/span&gt; (before deduction of issuance expenses), reflecting an
                                            original issue discount (&#x201c;OID&#x201d;) of $&lt;span id="xdx_90F_eifrs-full--NotionalAmount_iI_pn3n3_c20250509__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_zia4cEvVBn8g" title="Original issue amount"&gt;1,375&lt;/span&gt;, or &lt;span id="xdx_907_ecustom--OriginalIssueDiscount_iI_pid_dp_c20250509__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_z6hmsTcGsI9g" title="Original issue discount"&gt;20&lt;/span&gt;% of the par value. The proceeds
                                            were received in instalments in accordance with the terms of the agreement, including $&lt;span id="xdx_90F_ecustom--ProceedsFromReceivedForInstalments_pn3n3_c20250509__20250509__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_ztptG5IrmmY" title="Proceeds from instalments"&gt;1,375&lt;/span&gt;
                                            upon signing of the agreement, $&lt;span id="xdx_90F_ecustom--ProceedsFromReceivedForInstalments_pn3n3_c20250509__20250509__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_zLzXBqVvonc6" title="Proceeds from instalments"&gt;1,375&lt;/span&gt; near the time of submitting the draft prospectus (Registration
                                            Statement) to the SEC, and additional amounts of $&lt;span id="xdx_90B_ecustom--PaymentsForAdditionalAmount_pn3n3_c20250509__20250509__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_zAeb7sKTaNo2" title="Additional amounts"&gt;625&lt;/span&gt; and $&lt;span id="xdx_90D_ecustom--PaymentsForAdditionalAmount_pn3n3_c20250101__20251231__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_zGAjERsOqFMg" title="Additional amounts"&gt;2,125&lt;/span&gt;, no later than the effective
                                            date of the Form F-1.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;According
to the agreement the issuance expenses amounted to:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(i)
Cash placement agent fee of $&lt;span id="xdx_906_eifrs-full--BrokerageFeeExpense_pn3n3_c20250509__20250509__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_zMLXpntMQHgl" title="Cash placement agent fee"&gt;640&lt;/span&gt; and legal expenses of $&lt;span id="xdx_90B_eifrs-full--AdministrativeExpense_pn3n3_c20250509__20250509__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_zCo4CXpxcgoa" title="Legal expenses"&gt;220&lt;/span&gt;, and&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(ii)
Warrants, at a rate of &lt;span id="xdx_902_ecustom--PercentageOfWarrantsRate_pid_dp_uPure_c20250509__20250509__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_z9uyFmEQs1r9" title="Percentage of warrants rate"&gt;5&lt;/span&gt;% of the number of shares that will actually be issued within each funding round. The warrants are exercisable
at a price of $&lt;span id="xdx_90E_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20250509__20250509__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_zS9JjyZLgOZf" title="Exercise price of share"&gt;4,497&lt;/span&gt; per share, for a period of &lt;span id="xdx_904_ecustom--WarrantTerm_dtY_c20250509__20250509__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_zd7t47GFbm5j" title="Warrant, term"&gt;5&lt;/span&gt; years from the date of grant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
warrants granted to the underwriters are classified as equity-settled share-based payments under IFRS 2 and are measured at fair value
at the grant date. the Company has allocated the underwriting costs incurred in proportion to the allocation of proceeds. Accordingly,
the total fair value recognized against additional paid in capital and amounted to $&lt;span id="xdx_907_eifrs-full--CurrentDerivativeFinancialLiabilities_iI_pn3n3_c20250509__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_zo06Nybezdyk" title="Warrant, fair value"&gt;2,718&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
contractual maturity date for repayment of the principal is May 8, 2026.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
the terms of the note, no interest applies unless an event of default occurs. The note includes customary default provisions for similar
transactions, under which, in the event of default: &lt;span id="xdx_90C_ecustom--OutstandingPrincipalAndInterestDescription_c20250509__20250509__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_z8ymHBE7DtQ" title="Outstanding principal and interest description"&gt;(i) the principal amount increases automatically by 20%; (ii) default interest of
20% per annum applies; and (iii) all outstanding debt may be declared immediately due and payable.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
principal is convertible at the Company&#x2019;s option at any time, at a conversion price equal to the higher of $ &lt;span id="xdx_905_ecustom--ConversionPrice_pid_uUSDPShares_c20250509__20250509__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_zzFuqvc9a4Gk" title="Conversion price"&gt;0.32&lt;/span&gt; per share or
the lowest closing price of the Company&#x2019;s shares during the seven trading days preceding the conversion request.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Conversion
is subject to an ownership limitation of &lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20250509__20250509__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_zpmvOPrq8d29" title="Ownership limit, rate"&gt;4.99&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
accounting purposes, each instalment of proceeds received under the agreement is treated as a separate compound financial instrument,
bifurcated on initial recognition into: (i) a host straight debt component, classified as a financial liability measured at amortized
cost; and (ii) an embedded conversion option, classified as a derivative financial liability measured at fair value through profit or
loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
2025, all four scheduled instalments had been received, and accordingly, four host straight debt components were recognized, together
with four corresponding embedded conversion options.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
this regard, management with the assistance of an independent appraiser estimated the fair value of each embedded conversion option using
a Monte Carlo simulation as follow:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Tranche
1 &#x2013; As of May 9, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
host straight debt component was measured at approximately $&lt;span id="xdx_90B_eifrs-full--NetDebt_iI_pn3n3_c20250509__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_zGw3hNjV2MS7" title="Debt"&gt;825&lt;/span&gt;,&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the conversion feature was estimated at approximately $&lt;span id="xdx_90D_ecustom--ConversionPriceValue_pn3n3_c20250509__20250509__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_ztTQgPbq4rYg" title="Conversion price, value"&gt;550&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
key assumptions used in the valuation were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
                                            Period: &lt;span id="xdx_903_ecustom--DescriptionOfFairValueAssumptionsValuationsOfExpectedTerm_dtY_c20250509__20250509__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_zycwFYcjaXn4" title="Excepted period"&gt;1 &lt;/span&gt;year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
7 - CONVERTIBLE NOTES (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
                                            Volatility: &lt;span id="xdx_900_ecustom--DescriptionOfFairValueAssumptionsValuationsOfExpectedVolatility_pid_dp_uPure_c20250509__20250509__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_zsTTvBV18Ukg" title="Excepted volatility"&gt;62.03&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Risk-Free
                                            Interest Rate: &lt;span id="xdx_900_ecustom--DescriptionOfFairValueAssumptionsValuationsOfRiskFreeInterestRate_pid_dp_uPure_c20250509__20250509__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_zAt4d46IfF5j" title="Risk-free interest rate"&gt;4.05&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
                                            Dividend Yield: &lt;span id="xdx_906_ecustom--DescriptionOfFairValueAssumptionsValuationsOfExpectedDividendYieldPercentage_pid_dp_uPure_c20250509__20250509__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_zjzskwOy2qT4" title="Expected dividend yield"&gt;0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Tranche
2 &#x2013; As of May 23, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
host straight debt component was measured at approximately $&lt;span id="xdx_907_eifrs-full--NetDebt_iI_pn3n3_c20250523__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_z4BBig84dn3l" title="Debt"&gt;836&lt;/span&gt;,&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the conversion feature was estimated at approximately $&lt;span id="xdx_909_ecustom--ConversionPriceValue_pn3n3_c20250523__20250523__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_zPl40Q9nUkoh" title="Conversion price, value"&gt;539&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
key assumptions used in the valuation were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
                                            Period: &lt;span id="xdx_90B_ecustom--DescriptionOfFairValueAssumptionsValuationsOfExpectedTerm_dtY_c20250523__20250523__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_zlMp9fT0g1Je" title="Excepted period"&gt;0.96&lt;/span&gt; year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
                                            Volatility: &lt;span id="xdx_909_ecustom--DescriptionOfFairValueAssumptionsValuationsOfExpectedVolatility_pid_dp_uPure_c20250523__20250523__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_zXK6J1V1Sno5" title="Excepted volatility"&gt;62.13&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Risk-Free
                                            Interest Rate: &lt;span id="xdx_903_ecustom--DescriptionOfFairValueAssumptionsValuationsOfRiskFreeInterestRate_pid_dp_uPure_c20250523__20250523__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_zQCrUGbj7aH" title="Risk-free interest rate"&gt;4.15&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
                                            Dividend Yield: &lt;span id="xdx_902_ecustom--DescriptionOfFairValueAssumptionsValuationsOfExpectedDividendYieldPercentage_pid_dp_uPure_c20250523__20250523__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_zsw4t2bBToh4" title="Expected dividend yield"&gt;0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Tranche
3 &#x2013; As of June 27, 2025&lt;/span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The host straight debt component was measured at approximately $&lt;span id="xdx_907_eifrs-full--NetDebt_iI_pn3n3_c20250527__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_z98E0MQJD0G9" title="Debt"&gt;404&lt;/span&gt;,&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the conversion feature was estimated at approximately $&lt;span id="xdx_90E_ecustom--ConversionPriceValue_pn3n3_c20250527__20250527__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_zR46xJoeB5rb" title="Conversion price, value"&gt;221&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
key assumptions used in the valuation were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
                                            Period: &lt;span id="xdx_907_ecustom--DescriptionOfFairValueAssumptionsValuationsOfExpectedTerm_dtY_c20250527__20250527__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_z91iv668viQj" title="Excepted period"&gt;0.85&lt;/span&gt; year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
                                            Volatility: &lt;span id="xdx_900_ecustom--DescriptionOfFairValueAssumptionsValuationsOfExpectedVolatility_pid_dp_uPure_c20250527__20250527__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_zNaqEoTzaSDa" title="Excepted volatility"&gt;47.84&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Risk-Free
                                            Interest Rate: &lt;span id="xdx_900_ecustom--DescriptionOfFairValueAssumptionsValuationsOfRiskFreeInterestRate_pid_dp_uPure_c20250527__20250527__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_zgr27BCU9hT4" title="Risk-free interest rate"&gt;4.06&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
                                            Dividend Yield: &lt;span id="xdx_905_ecustom--DescriptionOfFairValueAssumptionsValuationsOfExpectedDividendYieldPercentage_pid_dp_uPure_c20250527__20250527__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_zKNPhQY4qaIk" title="Expected dividend yield"&gt;0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Tranche
4 &#x2013; As of July 3, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
host straight debt component was measured at approximately $&lt;span id="xdx_901_eifrs-full--NetDebt_iI_pn3n3_c20250703__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_zpYs4f7TmI7h" title="Debt"&gt;1,372&lt;/span&gt;,&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the conversion feature was estimated at approximately $&lt;span id="xdx_900_ecustom--ConversionPriceValue_pn3n3_c20250703__20250703__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_zD7OqGiH7ssi" title="Conversion price, value"&gt;753&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
key assumptions used in the valuation were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
                                            Period: &lt;span id="xdx_909_ecustom--DescriptionOfFairValueAssumptionsValuationsOfExpectedTerm_dtY_c20250703__20250703__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_zBdVCvfTZ1ac" title="Excepted period"&gt;0.85&lt;/span&gt; year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
                                            Volatility: &lt;span id="xdx_90B_ecustom--DescriptionOfFairValueAssumptionsValuationsOfExpectedVolatility_pid_dp_uPure_c20250703__20250703__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_z3JNRsK5Gqdh" title="Excepted volatility"&gt;47.84&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Risk-Free
                                            Interest Rate: &lt;span id="xdx_903_ecustom--DescriptionOfFairValueAssumptionsValuationsOfRiskFreeInterestRate_pid_dp_uPure_c20250703__20250703__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_zAoJ9bASUZg" title="Risk-free interest rate"&gt;4.06&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
                                            Dividend Yield: &lt;span id="xdx_909_ecustom--DescriptionOfFairValueAssumptionsValuationsOfExpectedDividendYieldPercentage_pid_dp_uPure_c20250703__20250703__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_zhc5s818r3Dk" title="Expected dividend yield"&gt;0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2025, the RBW May notes were fully converted into &lt;span id="xdx_902_eifrs-full--NumberOfSharesIssued_iI_c20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_z9Tk8lIhZKMg" title="Number of shares issued"&gt;1,949&lt;/span&gt; ordinary shares of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;J.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            August 1, 2025, the Company entered into an agreement with RBW Capital (&#x201c;&lt;b&gt;RBW August&lt;/b&gt;&#x201d;),
                                            pursuant to which a Convertible Loan Agreement with two primary investors, Target Capital
                                            1 LLC and Secure Net Capital LLC (collectively, the &#x201c;Investors&#x201d;), pursuant to
                                            which the Company issued a promissory note with a par value of $&lt;span id="xdx_90C_ecustom--PromissoryNote_iI_pn3n3_c20250801__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_zbpWBa74TTw5" title="Issuance of promissory note"&gt;15,000&lt;/span&gt;, following an amendment
                                            to the agreement dated September 9, 2025. In consideration for total cash proceeds of $&lt;span id="xdx_900_ecustom--ProceedsFromIssuanceOfPromissoryNote_pn3n3_c20250801__20250801__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_za3PWHrJZEUj" title="Cash proceeds"&gt;12,000&lt;/span&gt;.
                                            (before deduction of placement agent fee and legal expenses in total amount of $&lt;span id="xdx_90D_eifrs-full--BrokerageFeeExpense_pn3n3_c20250801__20250801__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_z0ojWdjbrkfd" title="Cash placement agent fee"&gt;&lt;span id="xdx_909_eifrs-full--AdministrativeExpense_pn3n3_c20250801__20250801__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_zRYYWWEEtFJ" title="Legal expenses"&gt;1,145&lt;/span&gt;&lt;/span&gt;), reflecting
                                            an original issue discount (&#x201c;OID&#x201d;) of $&lt;span id="xdx_908_eifrs-full--NotionalAmount_iI_pn3n3_c20250801__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_zePX0yj0plsf" title="Original issue amount"&gt;3,000&lt;/span&gt;, or &lt;span id="xdx_90D_ecustom--OriginalIssueDiscount_iI_pid_dp_c20250801__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_z8PiDUdH9pQd" title="Original issue discount"&gt;20&lt;/span&gt;% of the par value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
the terms of the note, no interest applies unless an event of default occurs. The note includes customary default provisions for similar
transactions, under which, in the event of default: &lt;span id="xdx_904_ecustom--OutstandingPrincipalAndInterestDescription_c20250801__20250801__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_zwK8ozFquxY7" title="Outstanding principal and interest description"&gt;(i) the principal amount increases automatically by 20%; (ii) default interest of
20% per annum applies; and (iii) all outstanding debt may be declared immediately due and payable.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company retains the right to prepay the outstanding balance at any time without penalty, providing flexibility to mitigate future dilution
should alternative financing become available.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;To
prevent a change in control, a Beneficial Ownership Limitation was established, restricting any Investor from owning more than &lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20250509__20250509__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_zz7FRuSrRBGh" title="Ownership limit, rate"&gt;4.99&lt;/span&gt;%
of the Company&#x2019;s outstanding ordinary shares at any given time.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the Convertible Loan Agreement, the loan proceeds were disbursed in five tranches: $&lt;span id="xdx_90B_ecustom--ProceedsFromLoan_pn3n3_c20250801__20250801__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleLoanTrancheOneMember__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_zbvMQV4Mai2k" title="Proceeds from loan"&gt;5,000&lt;/span&gt;, $&lt;span id="xdx_906_ecustom--ProceedsFromLoan_pn3n3_c20250801__20250801__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleLoanTrancheTwoMember__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_z9PErHKBTYK5" title="Proceeds from loan"&gt;1,000&lt;/span&gt;, $&lt;span id="xdx_903_ecustom--ProceedsFromLoan_pn3n3_c20250801__20250801__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleLoanTrancheThreeMember__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_zOt5yrzXpct2" title="Proceeds from loan"&gt;2,000&lt;/span&gt;, $&lt;span id="xdx_904_ecustom--ProceedsFromLoan_pn3n3_c20250801__20250801__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleLoanTrancheFourMember__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_zCBhkQ89ZG1k" title="Proceeds from loan"&gt;1,000&lt;/span&gt; and $&lt;span id="xdx_905_ecustom--ProceedsFromLoan_pn3n3_c20250801__20250801__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleLoanTrancheFiveMember__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_zsUKa0N5B5w" title="Proceeds from loan"&gt;3,000&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
7 - CONVERTIBLE NOTES (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Investors may convert the outstanding principal into ordinary shares at any time, at a conversion price equal to the higher of :&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
&lt;span id="xdx_905_eifrs-full--DescriptionOfConversionOfDebtToEquity_c20250801__20250801__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_zW5Me5fuhyFd" title="Description of conversion of debt to equity"&gt;85% of the lowest daily Volume Weighted Average Price (&#x201c;VWAP&#x201d;) during the seven trading days immediately preceding the conversion
date, representing a 15% discount to market price.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
A floor price of $&lt;span id="xdx_906_ecustom--FloorPricePricePerShare_iI_pid_c20250801__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_zBhoriRmiGg" title="Floor price"&gt;954&lt;/span&gt; per share was established to protect the Company and existing shareholders from excessive dilution, such that the
conversion price cannot fall below this threshold.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
accounting purposes, each instalment of proceeds received under the agreement is treated as a separate compound financial instrument,
bifurcated on initial recognition into: (i) a host straight debt component, classified as a financial liability measured at amortized
cost; and (ii) an embedded conversion option, classified as a derivative financial liability measured at fair value through profit or
loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
2025, all five scheduled instalments had been received, and accordingly, five host straight debt components were recognized, together
with five corresponding embedded conversion options.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
this regard, management with the assistance of an independent appraiser estimated the fair value of each embedded conversion option using
a Monte Carlo simulation as follow:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Tranche
1 &#x2013; As of August 1, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
host straight debt component was measured at approximately $&lt;span id="xdx_904_eifrs-full--NetDebt_iI_pn3n3_c20250801__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_zVkzQ0x0vPqi" title="Debt"&gt;3,113&lt;/span&gt;,&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the conversion feature was estimated at approximately $&lt;span id="xdx_907_ecustom--ConversionPriceValue_pn3n3_c20250801__20250801__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_z8D7v5ZmXI5a" title="Conversion price, value"&gt;1,887&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
key assumptions used in the valuation were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
                                            Period: &lt;span id="xdx_904_ecustom--DescriptionOfFairValueAssumptionsValuationsOfExpectedTerm_dtY_c20250801__20250801__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_zsgfwGlubBF1" title="Excepted period"&gt;1&lt;/span&gt; year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
                                            Volatility: &lt;span id="xdx_903_ecustom--DescriptionOfFairValueAssumptionsValuationsOfExpectedVolatility_pid_dp_uPure_c20250801__20250801__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_z8b8cfqa3UG3" title="Excepted volatility"&gt;156.54&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Risk-Free
                                            Interest Rate: &lt;span id="xdx_907_ecustom--DescriptionOfFairValueAssumptionsValuationsOfRiskFreeInterestRate_pid_dp_uPure_c20250801__20250801__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_zKnPcVi8qwV5" title="Risk-free interest rate"&gt;3.87&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
                                            Dividend Yield: &lt;span id="xdx_904_ecustom--DescriptionOfFairValueAssumptionsValuationsOfExpectedDividendYieldPercentage_pid_dp_uPure_c20250801__20250801__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_zdtO5lunck6c" title="Expected dividend yield"&gt;0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Tranche
2 &#x2013; As of August 27, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
host straight debt component was measured at approximately $&lt;span id="xdx_909_eifrs-full--NetDebt_iI_pn3n3_c20250827__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_zekBlIuQzL47" title="Debt"&gt;768&lt;/span&gt;,&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the conversion feature was estimated at approximately $&lt;span id="xdx_907_ecustom--ConversionPriceValue_pn3n3_c20250827__20250827__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_z7IDJlARCMZ8" title="Conversion price, value"&gt;232&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
key assumptions used in the valuation were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
                                            Period: &lt;span id="xdx_90C_ecustom--DescriptionOfFairValueAssumptionsValuationsOfExpectedTerm_dtY_c20250827__20250827__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_zJ43H94lkcVd" title="Excepted period"&gt;0.93&lt;/span&gt; year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
                                            Volatility: &lt;span id="xdx_905_ecustom--DescriptionOfFairValueAssumptionsValuationsOfExpectedVolatility_pid_dp_uPure_c20250827__20250827__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_zFTn9KVDvkfb" title="Excepted volatility"&gt;151.55&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Risk-Free
                                            Interest Rate: &lt;span id="xdx_906_ecustom--DescriptionOfFairValueAssumptionsValuationsOfRiskFreeInterestRate_pid_dp_uPure_c20250827__20250827__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_zidrZmzKAaqa" title="Risk-free interest rate"&gt;3.86&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
                                            Dividend Yield: &lt;span id="xdx_90B_ecustom--DescriptionOfFairValueAssumptionsValuationsOfExpectedDividendYieldPercentage_pid_dp_uPure_c20250827__20250827__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_zhGSIVptkCud" title="Expected dividend yield"&gt;0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Tranche
3 &#x2013; As of September 12, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
host straight debt component was measured at approximately $&lt;span id="xdx_90A_eifrs-full--NetDebt_iI_pn3n3_c20250912__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_zi1rcV3kQcal" title="Debt"&gt;1,811&lt;/span&gt;,&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the conversion feature was estimated at approximately $&lt;span id="xdx_909_ecustom--ConversionPriceValue_pn3n3_c20250912__20250912__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_zP1EJyQmZvB4" title="Conversion price, value"&gt;189&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
key assumptions used in the valuation were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
                                            Period: &lt;span id="xdx_906_ecustom--DescriptionOfFairValueAssumptionsValuationsOfExpectedTerm_dtY_c20250912__20250912__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_zyNu3J2CoVF5" title="Excepted period"&gt;0.89&lt;/span&gt; year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
                                            Volatility: &lt;span id="xdx_908_ecustom--DescriptionOfFairValueAssumptionsValuationsOfExpectedVolatility_pid_dp_uPure_c20250912__20250912__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_zHmjxwXs3jui" title="Excepted volatility"&gt;161.65&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Risk-Free
                                            Interest Rate: &lt;span id="xdx_905_ecustom--DescriptionOfFairValueAssumptionsValuationsOfRiskFreeInterestRate_pid_dp_uPure_c20250912__20250912__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_zftam9GbUsUl" title="Risk-free interest rate"&gt;3.7&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
                                            Dividend Yield: &lt;span id="xdx_90F_ecustom--DescriptionOfFairValueAssumptionsValuationsOfExpectedDividendYieldPercentage_pid_dp_uPure_c20250912__20250912__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_zfkLXGq0Zdu5" title="Expected dividend yield"&gt;0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
7 - CONVERTIBLE NOTES (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Tranche
4 &#x2013; As of September 17, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
host straight debt component was measured at approximately $&lt;span id="xdx_90D_eifrs-full--NetDebt_iI_pn3n3_c20250917__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_z6G0ricao553" title="Debt"&gt;901&lt;/span&gt;,&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the conversion feature was estimated at approximately $&lt;span id="xdx_90A_ecustom--ConversionPriceValue_pn3n3_c20250917__20250917__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_zwmdAgzLgl6l" title="Conversion price, value"&gt;99&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
key assumptions used in the valuation were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
                                            Period: &lt;span id="xdx_90A_ecustom--DescriptionOfFairValueAssumptionsValuationsOfExpectedTerm_dtY_c20250917__20250917__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_zyZYA047YeMk" title="Excepted period"&gt;0.87&lt;/span&gt; year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
                                            Volatility: &lt;span id="xdx_909_ecustom--DescriptionOfFairValueAssumptionsValuationsOfExpectedVolatility_pid_dp_uPure_c20250917__20250917__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_zQJpDk3iGFp4" title="Excepted volatility"&gt;148.9&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Risk-Free
                                            Interest Rate: &lt;span id="xdx_901_ecustom--DescriptionOfFairValueAssumptionsValuationsOfRiskFreeInterestRate_pid_dp_uPure_c20250917__20250917__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_z1WhLLzaVuie" title="Risk-free interest rate"&gt;3.65&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
                                            Dividend Yield: &lt;span id="xdx_908_ecustom--DescriptionOfFairValueAssumptionsValuationsOfExpectedDividendYieldPercentage_pid_dp_uPure_c20250917__20250917__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_zDsf0ce1uVs6" title="Expected dividend yield"&gt;0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Tranche
5 &#x2013; As of October 2, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
host straight debt component was measured at approximately $&lt;span id="xdx_90D_eifrs-full--NetDebt_iI_pn3n3_c20251002__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_zK0E0TVx9A4b" title="Debt"&gt;2,656&lt;/span&gt;,&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the conversion feature was estimated at approximately $&lt;span id="xdx_908_ecustom--ConversionPriceValue_pn3n3_c20251002__20251002__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_zYqsgpCR3uBa" title="Conversion price, value"&gt;344&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
key assumptions used in the valuation were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
                                            Period: &lt;span id="xdx_906_ecustom--DescriptionOfFairValueAssumptionsValuationsOfExpectedTerm_dtY_c20251002__20251002__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_zu4rgxtEkEuc" title="Excepted period"&gt;0.83&lt;/span&gt; year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
                                            Volatility: &lt;span id="xdx_905_ecustom--DescriptionOfFairValueAssumptionsValuationsOfExpectedVolatility_pid_dp_uPure_c20251002__20251002__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_zeskJkMqAO79" title="Excepted volatility"&gt;151.81&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Risk-Free
                                            Interest Rate: &lt;span id="xdx_90F_ecustom--DescriptionOfFairValueAssumptionsValuationsOfRiskFreeInterestRate_pid_dp_uPure_c20251002__20251002__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_zNApoMNNlp31" title="Risk-free interest rate"&gt;3.68&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
                                            Dividend Yield: &lt;span id="xdx_90C_ecustom--DescriptionOfFairValueAssumptionsValuationsOfExpectedDividendYieldPercentage_pid_dp_uPure_c20251002__20251002__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_znFkavILpAJ2" title="Expected dividend yield"&gt;0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
2025, a principal amount in the amount of $&lt;span id="xdx_90E_ecustom--NumberOfValueConverted_iI_pn3n3_c20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_zAkaOfc4dbrk" title="Number of value converted"&gt;13,750&lt;/span&gt; was converted into &lt;span id="xdx_908_eifrs-full--NumberOfSharesIssued_iI_c20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_zAcS9pHg838g" title="Number of shares issued"&gt;66,794&lt;/span&gt; ordinary shares of the company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
addition, as part of the RBW December, the Company and the relevant parties agreed that a principal amount of $&lt;span id="xdx_90E_eifrs-full--NetDebt_iI_pn3n3_c20251231__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_zCNGqlFe2hF2" title="Principal amount"&gt;1,250&lt;/span&gt; which was not converted
as part of the RBW August agreement would be offset against the proceeds of the new RBW December agreement (See note 7.E).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
this context, it should be noted that a modification of terms occurred following an agreement reached with the same lenders. In light
of the fact that the modification was entered into with the same investors/lenders, the Company was required to assess whether the modification
constituted a &#x201c;substantial modification&#x201d; in accordance with IFRS 9. Based on the valuation expert&#x2019;s determination that
the modification was indeed substantial, the Company derecognized the original debt from its books at its carrying amount as of the modification
date and recognized the new debt at its fair value as of that date. Any difference between the carrying amount of the original debt and
the fair value of the new debt was recognized immediately as a finance loss in the amount of $&lt;span id="xdx_90F_eifrs-full--FinanceCosts_pn3n3_c20250101__20251231__ifrs-full--TypesOfContractsAxis__custom--RBWMayAgreementMember_zsrzhJRpIPFi" title="Financing expenses"&gt;249&lt;/span&gt;, and all costs associated with the
amendment were recognized as an immediate expense.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2025, the Company had no remaining obligations in respect of this liability.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;K.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            December 1, 2025, the Company entered into an agreement with RBW Capital &lt;b&gt;(&#x201c;RBW December&#x201d;)&lt;/b&gt;,
                                            pursuant to which the Company issued a promissory note with a par value of $&lt;span id="xdx_90E_ecustom--PromissoryNote_iI_pn3n3_c20251201__ifrs-full--TypesOfContractsAxis__custom--RBWDecemberAgreementMember_zdgWMTbdVY2b" title="Issuance of promissory note"&gt;20,625&lt;/span&gt;, following
                                            an amendment to the agreement dated December 9, 2025. In consideration for total cash proceeds
                                            of $&lt;span id="xdx_90F_ecustom--ProceedsFromIssuanceOfPromissoryNote_pn3n3_c20250509__20250509__ifrs-full--TypesOfContractsAxis__custom--RBWDecemberAgreementMember_zgun61Y7ovO7" title="Cash proceeds"&gt;16,500&lt;/span&gt; (before deduction of placement agent fee, legal expenses in total amount of $&lt;span id="xdx_902_eifrs-full--BrokerageFeeExpense_pn3n3_c20251201__20251201__ifrs-full--TypesOfContractsAxis__custom--RBWDecemberAgreementMember_zGjoX7bZq8Ne" title="Cash placement agent fee"&gt;&lt;span id="xdx_903_eifrs-full--AdministrativeExpense_pn3n3_c20251201__20251201__ifrs-full--TypesOfContractsAxis__custom--RBWDecemberAgreementMember_zdgITRe8w3p4" title="Legal expenses"&gt;1,460&lt;/span&gt;&lt;/span&gt;),
                                            reflecting an original issue discount (&#x201c;OID&#x201d;) of $&lt;span id="xdx_90E_eifrs-full--NotionalAmount_iI_pn3n3_c20251201__ifrs-full--TypesOfContractsAxis__custom--RBWDecemberAgreementMember_zKsmw77Aljo6" title="Original issue amount"&gt;4,125&lt;/span&gt;, or &lt;span id="xdx_904_ecustom--OriginalIssueDiscount_iI_pid_dp_c20251201__ifrs-full--TypesOfContractsAxis__custom--RBWDecemberAgreementMember_z0AZft5f7tta" title="Original issue discount"&gt;20&lt;/span&gt;% of the par value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
the terms of the note, no interest applies unless an event of default occurs. The note includes customary default provisions for similar
transactions, under which, in the event of default: &lt;span id="xdx_904_ecustom--OutstandingPrincipalAndInterestDescription_c20251201__20251201__ifrs-full--TypesOfContractsAxis__custom--RBWDecemberAgreementMember_zQdToXbTF3Il" title="Outstanding principal and interest description"&gt;(i) the principal amount increases automatically by 20%; (ii) default interest of
20% per annum applies; and (iii) all outstanding debt may be declared immediately due and payable.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company retains the right to prepay the outstanding balance at any time without penalty, providing flexibility to mitigate future dilution
should alternative financing become available.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;To
prevent a change in control, a Beneficial Ownership Limitation was established, restricting any Investor from owning more than &lt;span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20251201__20251201__ifrs-full--TypesOfContractsAxis__custom--RBWDecemberAgreementMember_zyY1lNx5g93" title="Ownership limit, rate"&gt;4.99&lt;/span&gt;%
of the Company&#x2019;s outstanding ordinary shares at any given time.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
7 - CONVERTIBLE NOTES (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
investor is entitled to convert the Note into ordinary shares of the Company at any time, at a conversion price equal to the greater
of the following two amounts:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
&lt;span id="xdx_90D_eifrs-full--DescriptionOfConversionOfDebtToEquity_c20251201__20251201__ifrs-full--TypesOfContractsAxis__custom--RBWDecemberAgreementMember_zwo3bvvySh3a" title="Description of conversion of debt to equity"&gt;The conversion price is set at 85% of the lowest daily Volume Weighted Average Price (&#x201c;VWAP&#x201d;) during the five trading days
immediately preceding conversion, representing a 15% discount to market price.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
A floor price of $&lt;span id="xdx_908_ecustom--FloorPricePricePerShare_iI_pid_c20251201__ifrs-full--TypesOfContractsAxis__custom--RBWDecemberAgreementMember_zkpt04KrlEl4" title="Floor price"&gt;1.5&lt;/span&gt; per share was established to protect the Company and existing shareholders from excessive dilution, such that the
conversion price cannot fall below this threshold.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
loan proceeds in an aggregate amount of $&lt;span id="xdx_907_ecustom--ProceedsFromLoan_pn3n3_c20251201__20251201__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleLoanTrancheMember__ifrs-full--TypesOfContractsAxis__custom--RBWDecemberAgreementMember_zRjslg9GBMPf" title="Proceeds from loan"&gt;16,500&lt;/span&gt;, were received in two separate tranches, as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December
                                            3, 2025 &#x2013;$&lt;span id="xdx_909_ecustom--ProceedsFromLoan_pn3n3_c20251203__20251203__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleLoanTrancheOneMember__ifrs-full--TypesOfContractsAxis__custom--RBWDecemberAgreementMember_zhZZjZxC6bUf" title="Proceeds from loan"&gt;5,750&lt;/span&gt; thousand&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December
                                            29, 2025 &#x2013;$&lt;span id="xdx_906_ecustom--ProceedsFromLoan_pn3n3_c20251229__20251229__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleLoanTrancheTwoMember__ifrs-full--TypesOfContractsAxis__custom--RBWDecemberAgreementMember_zhXr8BPDW25j" title="Proceeds from loan"&gt;10,750&lt;/span&gt; thousand&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
accounting purposes, each instalment of proceeds received under the agreement is treated as a separate compound financial instrument,
bifurcated on initial recognition into: (i) a host straight debt component, classified as a financial liability measured at amortized
cost; and (ii) an embedded conversion option, classified as a derivative financial liability measured at fair value through profit or
loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
2025, the two scheduled instalments had been received, and accordingly, two host straight debt components were recognized, together with
two corresponding embedded conversion options.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
this regard, management with the assistance of an independent appraiser estimated the fair value of each embedded conversion option using
a Monte Carlo simulation as follow:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Tranche
1 &#x2013; As of December 3, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
host straight debt component was measured at approximately $&lt;span id="xdx_90D_eifrs-full--NetDebt_iI_pn3n3_c20251203__ifrs-full--TypesOfContractsAxis__custom--RBWDecemberAgreementMember_zZeGX7kmxSnf" title="Debt"&gt;2,507&lt;/span&gt;,&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the conversion feature was estimated at approximately $&lt;span id="xdx_90F_ecustom--ConversionPriceValue_pn3n3_c20251203__20251203__ifrs-full--TypesOfContractsAxis__custom--RBWDecemberAgreementMember_zNmw9HkoYTl2" title="Conversion price, value"&gt;3,243&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
key assumptions used in the valuation were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
                                            Period: &lt;span id="xdx_903_ecustom--DescriptionOfFairValueAssumptionsValuationsOfExpectedTerm_dtY_c20251203__20251203__ifrs-full--TypesOfContractsAxis__custom--RBWDecemberAgreementMember_zRsWqYSFS8Zk" title="Excepted period"&gt;0.5&lt;/span&gt; year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
                                            Volatility: &lt;span id="xdx_90B_ecustom--DescriptionOfFairValueAssumptionsValuationsOfExpectedVolatility_pid_dp_uPure_c20251203__20251203__ifrs-full--TypesOfContractsAxis__custom--RBWDecemberAgreementMember_zXIzaGBTmGr7" title="Excepted volatility"&gt;202.47&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Risk-Free
                                            Interest Rate: &lt;span id="xdx_90F_ecustom--DescriptionOfFairValueAssumptionsValuationsOfRiskFreeInterestRate_pid_dp_uPure_c20251203__20251203__ifrs-full--TypesOfContractsAxis__custom--RBWDecemberAgreementMember_zsOFBpzPlxQh" title="Risk-free interest rate"&gt;3.68&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
                                            Dividend Yield: &lt;span id="xdx_90F_ecustom--DescriptionOfFairValueAssumptionsValuationsOfExpectedDividendYieldPercentage_pid_dp_uPure_c20251203__20251203__ifrs-full--TypesOfContractsAxis__custom--RBWDecemberAgreementMember_zd7BPg7ZKtkl" title="Expected dividend yield"&gt;0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Tranche
2 &#x2013; As of December 29, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
host straight debt component was measured at approximately $&lt;span id="xdx_907_eifrs-full--NetDebt_iI_pn3n3_c20251229__ifrs-full--TypesOfContractsAxis__custom--RBWDecemberAgreementMember_ztA3lM4nKut1" title="Debt"&gt;4,450&lt;/span&gt;,&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the conversion feature was estimated at approximately $&lt;span id="xdx_906_ecustom--ConversionPriceValue_pn3n3_c20251229__20251229__ifrs-full--TypesOfContractsAxis__custom--RBWDecemberAgreementMember_zKnPXaevAhe8" title="Conversion price, value"&gt;6,300&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
key assumptions used in the valuation were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
                                            Period: &lt;span id="xdx_904_ecustom--DescriptionOfFairValueAssumptionsValuationsOfExpectedTerm_dtY_c20251229__20251229__ifrs-full--TypesOfContractsAxis__custom--RBWDecemberAgreementMember_zBTkCe3HwUs" title="Excepted period"&gt;0.43&lt;/span&gt; year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
                                            Volatility: &lt;span id="xdx_900_ecustom--DescriptionOfFairValueAssumptionsValuationsOfExpectedVolatility_pid_dp_uPure_c20251229__20251229__ifrs-full--TypesOfContractsAxis__custom--RBWDecemberAgreementMember_z1Lkp8n4f5n3" title="Excepted volatility"&gt;244.64&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Risk-Free
                                            Interest Rate: &lt;span id="xdx_90B_ecustom--DescriptionOfFairValueAssumptionsValuationsOfRiskFreeInterestRate_pid_dp_uPure_c20251229__20251229__ifrs-full--TypesOfContractsAxis__custom--RBWDecemberAgreementMember_zD3ghg2fqC05" title="Risk-free interest rate"&gt;3.62&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
                                            Dividend Yield: &lt;span id="xdx_900_ecustom--DescriptionOfFairValueAssumptionsValuationsOfExpectedDividendYieldPercentage_pid_dp_uPure_c20251229__20251229__ifrs-full--TypesOfContractsAxis__custom--RBWDecemberAgreementMember_z97ATevri3N2" title="Expected dividend yield"&gt;0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
December 2025 the company converted principal amount of the RBW December notes of $&lt;span id="xdx_903_ecustom--NumberOfValueConverted_iI_pn3n3_c20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--TypesOfContractsAxis__custom--RBWDecemberAgreementMember_zivvloYwGS96" title="Number of value converted"&gt;11,984&lt;/span&gt; into &lt;span id="xdx_909_eifrs-full--NumberOfSharesIssued_iI_c20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--TypesOfContractsAxis__custom--RBWDecemberAgreementMember_zFYIAeEClOp4" title="Number of shares issued"&gt;168,853&lt;/span&gt; ordinary shares of the company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
remaining principal amount as of December 31, 2025, was totalled to $&lt;span id="xdx_90B_ecustom--ConvertedDebtRemainingPrincipalAmount_iI_pn3n3_c20251231__ifrs-full--TypesOfContractsAxis__custom--RBWDecemberAgreementMember_zYZAut7Kc3t3" title="Converted debt remaining principal"&gt;8,641&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2025, the host straight debt component was measured at approximately $&lt;span id="xdx_90D_eifrs-full--NetDebt_iI_pn3n3_c20251231__ifrs-full--TypesOfContractsAxis__custom--RBWDecemberAgreementMember_zJ6umIXjCZYd" title="Debt"&gt;2,668&lt;/span&gt; and the fair value of the conversion feature
was estimated at approximately $&lt;span id="xdx_900_ecustom--ConversionPriceValue_pn3n3_c20250101__20251231__ifrs-full--TypesOfContractsAxis__custom--RBWDecemberAgreementMember_zHQ8gQ9gaNJ9" title="Conversion price, value"&gt;3,083&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
purposes of the aggregate fair value measurement as of December 31, 2025, the conversion feature was valued using the following assumptions:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
                                            Period: &lt;span id="xdx_906_ecustom--DescriptionOfFairValueAssumptionsValuationsOfExpectedTerm_dtY_c20250101__20251231__ifrs-full--TypesOfContractsAxis__custom--RBWDecemberAgreementMember_z82VmmEXYqWd" title="Excepted period"&gt;0.43&lt;/span&gt; year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
                                            Volatility: &lt;span id="xdx_904_ecustom--DescriptionOfFairValueAssumptionsValuationsOfExpectedVolatility_pid_dp_uPure_c20250101__20251231__ifrs-full--TypesOfContractsAxis__custom--RBWDecemberAgreementMember_zcPQJt5fm2k8" title="Excepted volatility"&gt;262.92&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Risk-Free
                                            Interest Rate: &lt;span id="xdx_90D_ecustom--DescriptionOfFairValueAssumptionsValuationsOfRiskFreeInterestRate_pid_dp_uPure_c20250101__20251231__ifrs-full--TypesOfContractsAxis__custom--RBWDecemberAgreementMember_zo15DwZlxEGf" title="Risk-free interest rate"&gt;3.61&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
                                            Dividend Yield: &lt;span id="xdx_90D_ecustom--DescriptionOfFairValueAssumptionsValuationsOfExpectedDividendYieldPercentage_pid_dp_uPure_c20250101__20251231__ifrs-full--TypesOfContractsAxis__custom--RBWDecemberAgreementMember_z8KHy1B7o7k9" title="Expected dividend yield"&gt;0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfFinancialInstrumentsExplanatory>
    <ifrs-full:IssueOfConvertibleInstruments
      contextRef="From2024-01-242024-01-25_custom_ConvertibleNotesMember"
      decimals="-3"
      id="Fact001334"
      unitRef="USD">250000</ifrs-full:IssueOfConvertibleInstruments>
    <ifrs-full:NotionalAmount
      contextRef="AsOf2024-01-25_custom_ConvertibleNotesMember"
      decimals="-3"
      id="Fact001335"
      unitRef="USD">250000</ifrs-full:NotionalAmount>
    <ifrs-full:BorrowingsMaturity
      contextRef="From2024-01-242024-01-25_custom_ConvertibleNotesMember"
      id="Fact001336">December 31, 2024</ifrs-full:BorrowingsMaturity>
    <ifrs-full:BorrowingsInterestRate
      contextRef="AsOf2024-01-25_custom_ConvertibleNotesMember"
      decimals="INF"
      id="Fact001337"
      unitRef="Pure">0.15</ifrs-full:BorrowingsInterestRate>
    <SMX:FixedConversionPrice
      contextRef="AsOf2024-01-25_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact001339"
      unitRef="USDPShares">470250</SMX:FixedConversionPrice>
    <SMX:FixedConversionPrice
      contextRef="AsOf2024-01-25_ifrs-full_OrdinarySharesMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact001341"
      unitRef="USDPShares">5746196840</SMX:FixedConversionPrice>
    <SMX:DiscountRate
      contextRef="From2024-01-242024-01-25_custom_ConvertibleNotesMember_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact001342"
      unitRef="Pure">0.20</SMX:DiscountRate>
    <SMX:WarrantsToPurchaseOrdinaryShares
      contextRef="From2024-01-242024-01-25_custom_ConvertibleNoteAgreementsMember_custom_BonusWarrantsMember"
      decimals="INF"
      id="Fact001343"
      unitRef="Shares">0.27</SMX:WarrantsToPurchaseOrdinaryShares>
    <SMX:ExercisePriceOfWarrants
      contextRef="From2024-01-242024-01-25_custom_ConvertibleNoteAgreementsMember_custom_BonusWarrantsMember"
      decimals="INF"
      id="Fact001345"
      unitRef="USDPShares">540787</SMX:ExercisePriceOfWarrants>
    <SMX:ExercisePriceOfWarrants
      contextRef="From2024-01-242024-01-25_custom_ConvertibleNoteAgreementsMember_custom_BonusWarrantsMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact001347"
      unitRef="USDPShares">6608126366</SMX:ExercisePriceOfWarrants>
    <SMX:WarrantsToPurchaseOrdinaryShares
      contextRef="From2024-01-242024-01-25_custom_ConvertibleNoteAgreementsMember_custom_RedeemableWarrantsMember"
      decimals="INF"
      id="Fact001348"
      unitRef="Shares">0.26</SMX:WarrantsToPurchaseOrdinaryShares>
    <SMX:SharePurchasePrice
      contextRef="From2024-01-242024-01-25_custom_ConvertibleNoteAgreementsMember_custom_RedeemableWarrantsMember"
      decimals="INF"
      id="Fact001350"
      unitRef="USDPShares">540787</SMX:SharePurchasePrice>
    <SMX:SharePurchasePrice
      contextRef="From2024-01-242024-01-25_custom_ConvertibleNoteAgreementsMember_custom_RedeemableWarrantsMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact001352"
      unitRef="USDPShares">6608126366</SMX:SharePurchasePrice>
    <SMX:WarrantsTerm
      contextRef="From2024-01-242024-01-25_custom_ConvertibleNoteAgreementsMember_custom_RedeemableWarrantsMember"
      id="Fact001354">P5Y</SMX:WarrantsTerm>
    <SMX:PercentageOfRedeemableOnNoncumulativeBasis
      contextRef="From2024-01-242024-01-25_custom_ConvertibleNoteAgreementsMember_custom_RedeemableWarrantsMember"
      decimals="INF"
      id="Fact001356"
      unitRef="Pure">0.50</SMX:PercentageOfRedeemableOnNoncumulativeBasis>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2024-01-25_custom_ConvertibleNoteAgreementsMember_custom_RedeemableWarrantsMember"
      decimals="INF"
      id="Fact001357"
      unitRef="USDPShares">235125</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2024-01-25_custom_ConvertibleNoteAgreementsMember_custom_RedeemableWarrantsMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact001358"
      unitRef="USDPShares">2873098420</ifrs-full:ParValuePerShare>
    <SMX:DiscountRate
      contextRef="From2024-01-242024-01-25_custom_ConvertibleNoteAgreementsMember_custom_RedeemableWarrantsMember"
      decimals="INF"
      id="Fact001359"
      unitRef="Pure">0.20</SMX:DiscountRate>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2025-01-012025-12-31_custom_RedeemableWarrantsMember"
      decimals="INF"
      id="Fact001360"
      unitRef="Pure">3.597</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2024-01-012024-12-31_custom_RedeemableWarrantsMember"
      decimals="INF"
      id="Fact001361"
      unitRef="Pure">0.5394</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2025-01-012025-12-31_custom_RedeemableWarrantsMember"
      decimals="INF"
      id="Fact001362"
      unitRef="Pure">0.0467</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2024-01-012024-12-31_custom_RedeemableWarrantsMember"
      decimals="INF"
      id="Fact001363"
      unitRef="Pure">0.0427</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <SMX:FairValueOfRedeemableWarrants
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact001365"
      unitRef="USD">32000</SMX:FairValueOfRedeemableWarrants>
    <SMX:FairValueOfRedeemableWarrants
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001367"
      unitRef="USD">55000</SMX:FairValueOfRedeemableWarrants>
    <SMX:DiscountRate
      contextRef="From2025-01-012025-12-31_custom_ConvertibleNotesMember"
      decimals="INF"
      id="Fact001368"
      unitRef="Pure">0.30</SMX:DiscountRate>
    <SMX:DiscountRate
      contextRef="From2024-01-012024-12-31_custom_ConvertibleNotesMember"
      decimals="INF"
      id="Fact001369"
      unitRef="Pure">0.229</SMX:DiscountRate>
    <SMX:FairValueOfConvertibleNotes
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact001371"
      unitRef="USD">333000</SMX:FairValueOfConvertibleNotes>
    <SMX:FairValueOfConvertibleNotes
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001373"
      unitRef="USD">336000</SMX:FairValueOfConvertibleNotes>
    <SMX:ConversionPrice
      contextRef="From2024-09-062024-09-06_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact001375"
      unitRef="USDPShares">3501</SMX:ConversionPrice>
    <SMX:ConversionPrice
      contextRef="From2024-09-062024-09-06_custom_SecuritiesPurchaseAgreementMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact001377"
      unitRef="USDPShares">42780298</SMX:ConversionPrice>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-09-06_custom_SecuritiesPurchaseAgreementMember_custom_WarrantAMember"
      decimals="INF"
      id="Fact001378"
      unitRef="Shares">1838</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-09-06_custom_SecuritiesPurchaseAgreementMember_custom_WarrantBMember"
      decimals="INF"
      id="Fact001380"
      unitRef="Shares">1225</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="From2024-09-062024-09-06_custom_SecuritiesPurchaseAgreementMember"
      decimals="-3"
      id="Fact001382"
      unitRef="USD">2574000</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-09-06_custom_SecuritiesPurchaseAgreementMember_custom_WarrantAMember_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact001383"
      unitRef="Shares">1838</ifrs-full:NumberOfSharesIssued>
    <SMX:WarrantsExercisePricePerShare
      contextRef="AsOf2024-09-06_custom_SecuritiesPurchaseAgreementMember_custom_WarrantAOneMember"
      decimals="INF"
      id="Fact001386"
      unitRef="USDPShares">4.7025</SMX:WarrantsExercisePricePerShare>
    <SMX:WarrantsExercisePricePerShare
      contextRef="AsOf2024-09-06_custom_SecuritiesPurchaseAgreementMember_custom_WarrantAOneMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact001388"
      unitRef="USDPShares">57462</SMX:WarrantsExercisePricePerShare>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-09-06_custom_SecuritiesPurchaseAgreementMember_custom_WarrantBMember_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact001389"
      unitRef="Shares">1225</ifrs-full:NumberOfSharesIssued>
    <SMX:WarrantsExercisePricePerShare
      contextRef="AsOf2024-09-06_custom_SecuritiesPurchaseAgreementMember_custom_WarrantBOneMember"
      decimals="INF"
      id="Fact001392"
      unitRef="USDPShares">3501</SMX:WarrantsExercisePricePerShare>
    <SMX:WarrantsExercisePricePerShare
      contextRef="AsOf2024-09-06_custom_SecuritiesPurchaseAgreementMember_custom_WarrantBOneMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact001394"
      unitRef="USDPShares">42780298</SMX:WarrantsExercisePricePerShare>
    <ifrs-full:NetDebt
      contextRef="AsOf2024-09-06_custom_SecuritiesPurchaseAgreementMember"
      decimals="-3"
      id="Fact001396"
      unitRef="USD">4290000</ifrs-full:NetDebt>
    <ifrs-full:BorrowingCostsIncurred
      contextRef="From2024-09-062024-09-06_custom_SecuritiesPurchaseAgreementMember"
      decimals="-3"
      id="Fact001398"
      unitRef="USD">2574000</ifrs-full:BorrowingCostsIncurred>
    <SMX:OriginalIssueDiscount
      contextRef="AsOf2024-09-06_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact001400"
      unitRef="Pure">0.40</SMX:OriginalIssueDiscount>
    <SMX:InterestAccruedPercent
      contextRef="AsOf2024-09-06_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact001402"
      unitRef="Pure">0.12</SMX:InterestAccruedPercent>
    <SMX:ConversionPrice
      contextRef="From2024-09-062024-09-06_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact001404"
      unitRef="USDPShares">3501</SMX:ConversionPrice>
    <SMX:ConversionPrice
      contextRef="From2024-09-062024-09-06_custom_SecuritiesPurchaseAgreementMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact001406"
      unitRef="USDPShares">42780298</SMX:ConversionPrice>
    <ifrs-full:DescriptionOfConversionOfDebtToEquity
      contextRef="From2024-09-062024-09-06_custom_SecuritiesPurchaseAgreementMember"
      id="Fact001407">Any such conversion is subject to customary conversion limitations
                                            set forth in the Purchase Agreement, so the investor beneficially owns less than 4.99% of
                                            the Company&#x2019;s ordinary shares. Additionally, the Company has the right to convert in
                                            whole or in part the Alpha September 2023 Note into ordinary shares; provided that in no
                                            case shall the Company so convert the Alpha September 2023 Note if the result of the issuance
                                            of Ordinary Shares thereby would result in the beneficial ownership of the investor of ordinary
                                            shares in excess of 4.99%</ifrs-full:DescriptionOfConversionOfDebtToEquity>
    <ifrs-full:IssueOfConvertibleInstruments
      contextRef="From2025-02-242025-02-24_custom_SecuritiesPurchaseAgreementMember"
      decimals="-3"
      id="Fact001409"
      unitRef="USD">407000</ifrs-full:IssueOfConvertibleInstruments>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="From2025-02-242025-02-24_custom_SecuritiesPurchaseAgreementMember"
      decimals="-3"
      id="Fact001411"
      unitRef="USD">350000</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:BorrowingsInterestRate
      contextRef="AsOf2025-02-24_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact001413"
      unitRef="Pure">0</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:BorrowingsMaturity
      contextRef="From2025-02-242025-02-24_custom_SecuritiesPurchaseAgreementMember"
      id="Fact001415">6</ifrs-full:BorrowingsMaturity>
    <SMX:RepaymentOfDebtRate
      contextRef="AsOf2025-02-24_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact001417"
      unitRef="Pure">0.15</SMX:RepaymentOfDebtRate>
    <ifrs-full:BorrowingsMaturity contextRef="From2025-08-242025-08-24" id="Fact001419">maturity date to February 24, 2025</ifrs-full:BorrowingsMaturity>
    <ifrs-full:NotionalAmount
      contextRef="AsOf2025-08-24"
      decimals="-3"
      id="Fact001421"
      unitRef="USD">407000</ifrs-full:NotionalAmount>
    <ifrs-full:IssuedCapitalOrdinaryShares
      contextRef="AsOf2025-08-24"
      decimals="-5"
      id="Fact001423"
      unitRef="USD">1500000</ifrs-full:IssuedCapitalOrdinaryShares>
    <SMX:ConversionPricePerShare
      contextRef="From2025-10-282025-10-28"
      decimals="INF"
      id="Fact001425"
      unitRef="USDPShares">0.49</SMX:ConversionPricePerShare>
    <SMX:ConversionPricePerShare
      contextRef="From2025-10-282025-10-28_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact001427"
      unitRef="USDPShares">170645</SMX:ConversionPricePerShare>
    <SMX:ConversionPriceValue
      contextRef="From2025-01-012025-12-31_custom_SecuritiesPurchaseAgreementMember"
      decimals="-3"
      id="Fact001429"
      unitRef="USD">483000</SMX:ConversionPriceValue>
    <SMX:ConversionPriceValue
      contextRef="From2024-01-012024-12-31_custom_SecuritiesPurchaseAgreementMember"
      decimals="-3"
      id="Fact001431"
      unitRef="USD">370000</SMX:ConversionPriceValue>
    <SMX:FairValueOfConvertibleNotes
      contextRef="AsOf2025-12-31_custom_ConversionOptionMember"
      decimals="-3"
      id="Fact001433"
      unitRef="USD">124000</SMX:FairValueOfConvertibleNotes>
    <SMX:FairValueOfConvertibleNotes
      contextRef="AsOf2024-12-31_custom_ConversionOptionMember"
      decimals="-3"
      id="Fact001435"
      unitRef="USD">95000</SMX:FairValueOfConvertibleNotes>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2025-01-012025-12-31_custom_SecuritiesPurchaseAgreementMember_custom_ConversionOptionMember"
      decimals="INF"
      id="Fact001436"
      unitRef="Pure">2.028</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2024-01-012024-12-31_custom_SecuritiesPurchaseAgreementMember_custom_ConversionOptionMember"
      decimals="INF"
      id="Fact001437"
      unitRef="Pure">0.3978</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2025-01-012025-12-31_custom_SecuritiesPurchaseAgreementMember_custom_ConversionOptionMember"
      decimals="INF"
      id="Fact001438"
      unitRef="Pure">0.0348</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2024-01-012024-12-31_custom_SecuritiesPurchaseAgreementMember_custom_ConversionOptionMember"
      decimals="INF"
      id="Fact001439"
      unitRef="Pure">0.0437</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact001441"
      unitRef="Shares">58238</ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:FinanceCosts
      contextRef="From2025-01-012025-12-31_ifrs-full_RestrictedShareUnitsMember"
      decimals="0"
      id="Fact001443"
      unitRef="USD">3466</ifrs-full:FinanceCosts>
    <ifrs-full:Borrowings
      contextRef="AsOf2024-04-11_custom_AlphaAprilNoteMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="-3"
      id="Fact001444"
      unitRef="USD">2250000</ifrs-full:Borrowings>
    <SMX:OriginalIssueDiscount
      contextRef="AsOf2024-04-11_custom_AlphaAprilNoteMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact001445"
      unitRef="Pure">0.10</SMX:OriginalIssueDiscount>
    <ifrs-full:BorrowingsInterestRate
      contextRef="AsOf2024-04-11_custom_AlphaAprilNoteMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact001446"
      unitRef="Pure">0.12</ifrs-full:BorrowingsInterestRate>
    <SMX:SharePriceShareOptionsGranted2019
      contextRef="From2024-04-112024-04-11_custom_AlphaAprilNoteMember_custom_SecuritiesPurchaseAgreementMember_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact001448"
      unitRef="USDPShares">513</SMX:SharePriceShareOptionsGranted2019>
    <SMX:SharePriceShareOptionsGranted2019
      contextRef="From2024-04-112024-04-11_custom_AlphaAprilNoteMember_custom_SecuritiesPurchaseAgreementMember_ifrs-full_OrdinarySharesMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact001450"
      unitRef="USDPShares">6268578</SMX:SharePriceShareOptionsGranted2019>
    <SMX:DiscountRate
      contextRef="From2024-04-112024-04-11_custom_AlphaAprilNoteMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact001451"
      unitRef="Pure">0.15</SMX:DiscountRate>
    <SMX:BeneficiallyOwnsRate
      contextRef="From2024-04-112024-04-11_custom_AlphaAprilNoteMember_custom_SecuritiesPurchaseAgreementMember_ifrs-full_TopOfRangeMember"
      decimals="INF"
      id="Fact001453"
      unitRef="Pure">0.0499</SMX:BeneficiallyOwnsRate>
    <SMX:ConversionOfHoldingSharesRate
      contextRef="From2024-04-112024-04-11_custom_AlphaAprilNoteMember_custom_SecuritiesPurchaseAgreementMember_ifrs-full_TopOfRangeMember"
      decimals="INF"
      id="Fact001455"
      unitRef="Pure">0.0499</SMX:ConversionOfHoldingSharesRate>
    <SMX:ConversionOfSharesDailyFee
      contextRef="AsOf2024-04-11_custom_AlphaAprilNoteMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="-3"
      id="Fact001457"
      unitRef="USD">2000</SMX:ConversionOfSharesDailyFee>
    <SMX:OutstandingPrincipalAndInterestDescription
      contextRef="From2024-04-112024-04-11_custom_AlphaAprilNoteMember_custom_SecuritiesPurchaseAgreementMember"
      id="Fact001459">If an event of default occurs, the Alpha
                                            April Note&#x2019;s outstanding principal and interest increase by 120%, or 500% in specific
                                            default situations, with default interest at the lesser of 24.5% or the maximum legal rate</SMX:OutstandingPrincipalAndInterestDescription>
    <SMX:WarrantTerm
      contextRef="From2024-04-112024-04-11_custom_SecuritiesPurchaseAgreementMember_ifrs-full_WarrantsMember"
      id="Fact001461">P5Y6M</SMX:WarrantTerm>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-04-11_custom_SecuritiesPurchaseAgreementMember_ifrs-full_WarrantsMember_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact001463"
      unitRef="Shares">5532</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2024-04-11_custom_SecuritiesPurchaseAgreementMember_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact001467"
      unitRef="USDPShares">336</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2024-04-11_custom_SecuritiesPurchaseAgreementMember_ifrs-full_WarrantsMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact001469"
      unitRef="USDPShares">4105736</ifrs-full:ParValuePerShare>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2024-04-112024-04-11_custom_SecuritiesPurchaseAgreementMember_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact001471"
      unitRef="Pure">0.0499</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2024-04-112024-04-11_custom_AlphaAprilNoteMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact001473"
      unitRef="USDPShares">4.7025</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2024-04-112024-04-11_custom_SecuritiesPurchaseAgreementMember_custom_AlphaAprilNoteMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact001475"
      unitRef="USDPShares">57462</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:CurrentDerivativeFinancialLiabilities
      contextRef="AsOf2024-04-11_custom_SecuritiesPurchaseAgreementMember_ifrs-full_WarrantsMember"
      decimals="-3"
      id="Fact001477"
      unitRef="USD">220000</ifrs-full:CurrentDerivativeFinancialLiabilities>
    <SMX:ConversionPriceValue
      contextRef="From2024-04-112024-04-11_custom_SecuritiesPurchaseAgreementMember_custom_ConversionOptionMember"
      decimals="-3"
      id="Fact001479"
      unitRef="USD">656000</SMX:ConversionPriceValue>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2024-04-112024-04-11_custom_SecuritiesPurchaseAgreementMember_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact001480"
      unitRef="Pure">0.5208</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2024-04-112024-04-11_custom_SecuritiesPurchaseAgreementMember_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact001481"
      unitRef="Pure">0.0517</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <SMX:NumberOfValueConverted
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001483"
      unitRef="USD">2110000</SMX:NumberOfValueConverted>
    <SMX:NumberOfWarrantsIssued
      contextRef="From2024-01-012024-12-31_ifrs-full_OrdinarySharesMember_custom_InvestorsMember"
      decimals="INF"
      id="Fact001485"
      unitRef="Shares">467424</SMX:NumberOfWarrantsIssued>
    <ifrs-full:CurrentDerivativeFinancialLiabilities
      contextRef="AsOf2024-12-31_custom_SecuritiesPurchaseAgreementMember_ifrs-full_WarrantsMember"
      decimals="-3"
      id="Fact001487"
      unitRef="USD">72000</ifrs-full:CurrentDerivativeFinancialLiabilities>
    <SMX:ConversionPriceValue
      contextRef="From2024-01-012024-12-31_custom_SecuritiesPurchaseAgreementMember_custom_ConversionOptionMember"
      decimals="-3"
      id="Fact001489"
      unitRef="USD">48000</SMX:ConversionPriceValue>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2024-01-012024-12-31_custom_SecuritiesPurchaseAgreementMember_custom_ConversionOptionMember"
      decimals="INF"
      id="Fact001490"
      unitRef="Pure">0.3978</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2024-01-012024-12-31_custom_SecuritiesPurchaseAgreementMember_custom_ConversionOptionMember"
      decimals="INF"
      id="Fact001491"
      unitRef="Pure">0.0437</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:CurrentDerivativeFinancialLiabilities
      contextRef="AsOf2024-04-11_custom_SecuritiesPurchaseAgreementMember_custom_AprilWarrantsMember"
      decimals="-3"
      id="Fact001493"
      unitRef="USD">1090000</ifrs-full:CurrentDerivativeFinancialLiabilities>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2024-04-112024-04-11_custom_SecuritiesPurchaseAgreementMember_custom_AprilWarrantsMember"
      decimals="INF"
      id="Fact001494"
      unitRef="Pure">0.7343</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2024-04-112024-04-11_custom_SecuritiesPurchaseAgreementMember_custom_AprilWarrantsMember"
      decimals="INF"
      id="Fact001495"
      unitRef="Pure">0.0461</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <SMX:FairValueOfConvertibleConversionShares
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact001497"
      unitRef="Shares">16</SMX:FairValueOfConvertibleConversionShares>
    <SMX:FairValueOfConvertibleConversionValue
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001499"
      unitRef="USD">842000</SMX:FairValueOfConvertibleConversionValue>
    <SMX:FairValueOfConvertibleConversionShares
      contextRef="From2025-04-022025-04-02"
      decimals="INF"
      id="Fact001501"
      unitRef="Shares">33</SMX:FairValueOfConvertibleConversionShares>
    <SMX:FairValueOfConvertibleConversionValue
      contextRef="From2025-04-022025-04-02"
      decimals="-3"
      id="Fact001503"
      unitRef="USD">787000</SMX:FairValueOfConvertibleConversionValue>
    <ifrs-full:IssueOfConvertibleInstruments
      contextRef="From2025-07-102025-07-10_custom_SeniorSecuredNoteDueMayThirtyOneTwentyTwentyFourMember"
      decimals="-3"
      id="Fact001504"
      unitRef="USD">1000000</ifrs-full:IssueOfConvertibleInstruments>
    <SMX:PromissoryNote
      contextRef="AsOf2025-07-10_custom_ConvertibleNoteDueDecemberThirtyOneTwentyTwentyFourMember_custom_TheEightHundredConvertibleNoteMember"
      decimals="-3"
      id="Fact001505"
      unitRef="USD">800000</SMX:PromissoryNote>
    <SMX:PromissoryNote
      contextRef="AsOf2025-07-10_custom_TheEightHundredConvertibleNoteMember"
      decimals="-3"
      id="Fact001506"
      unitRef="USD">800000</SMX:PromissoryNote>
    <SMX:PromissoryNote
      contextRef="AsOf2025-07-10_custom_NonConvertibleNoteDueDecemberThirtyOneTwentyTwentyFourMember_custom_TheFiveHundredNonConvertibleNoteMember"
      decimals="-3"
      id="Fact001508"
      unitRef="USD">500000</SMX:PromissoryNote>
    <SMX:PromissoryNote
      contextRef="AsOf2025-07-10_custom_TheFiveHundredNonConvertibleNoteMember"
      decimals="-3"
      id="Fact001510"
      unitRef="USD">500000</SMX:PromissoryNote>
    <SMX:PromissoryNote
      contextRef="AsOf2025-07-10_custom_TheEightHundredConvertibleNoteMember"
      decimals="-3"
      id="Fact001511"
      unitRef="USD">800000</SMX:PromissoryNote>
    <SMX:PromissoryNote
      contextRef="AsOf2025-07-10_custom_TheEightHundredConvertibleNoteMember"
      decimals="-3"
      id="Fact001512"
      unitRef="USD">800000</SMX:PromissoryNote>
    <SMX:PromissoryNote
      contextRef="AsOf2025-07-10_custom_NonConvertibleNoteDueDecemberThirtyOneTwentyTwentyFourMember_custom_TheFiveHundredNonConvertibleNoteMember"
      decimals="-3"
      id="Fact001514"
      unitRef="USD">500000</SMX:PromissoryNote>
    <SMX:ConvertiblePromissoryNoteInterestRate
      contextRef="AsOf2025-07-10"
      decimals="INF"
      id="Fact001516"
      unitRef="Pure">0.15</SMX:ConvertiblePromissoryNoteInterestRate>
    <SMX:PromissoryNote
      contextRef="AsOf2025-07-10_custom_TheEightHundredConvertibleNoteMember"
      decimals="-3"
      id="Fact001517"
      unitRef="USD">800000</SMX:PromissoryNote>
    <SMX:IssueOfConvertibleShares
      contextRef="From2025-07-102025-07-10_custom_TheEightHundredConvertibleNoteMember"
      decimals="INF"
      id="Fact001519"
      unitRef="Shares">2673</SMX:IssueOfConvertibleShares>
    <SMX:PromissoryNote
      contextRef="AsOf2025-07-10_custom_TheEightHundredConvertibleNoteMember"
      decimals="-3"
      id="Fact001522"
      unitRef="USD">800000</SMX:PromissoryNote>
    <SMX:PromissoryNote
      contextRef="AsOf2025-07-10_custom_TheEightHundredConvertibleNoteMember"
      decimals="-3"
      id="Fact001523"
      unitRef="USD">800000</SMX:PromissoryNote>
    <SMX:PromissoryNote
      contextRef="AsOf2025-07-10_custom_TheFiveHundredNonConvertibleNoteMember"
      decimals="-3"
      id="Fact001525"
      unitRef="USD">500000</SMX:PromissoryNote>
    <SMX:PromissoryNote
      contextRef="AsOf2025-07-10_custom_TheFiveHundredNonConvertibleNoteMember"
      decimals="-3"
      id="Fact001527"
      unitRef="USD">500000</SMX:PromissoryNote>
    <SMX:PromissoryNote
      contextRef="AsOf2025-05-13_custom_ConvertiblePromissoryNoteMember"
      decimals="-3"
      id="Fact001529"
      unitRef="USD">800000</SMX:PromissoryNote>
    <ifrs-full:Borrowings
      contextRef="AsOf2025-05-13_custom_ConvertiblePromissoryNoteMember"
      decimals="-3"
      id="Fact001531"
      unitRef="USD">500000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="AsOf2025-12-31_custom_ConvertiblePromissoryNoteMember"
      decimals="-3"
      id="Fact001533"
      unitRef="USD">1572000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="AsOf2024-12-31_custom_ConvertiblePromissoryNoteMember"
      decimals="-3"
      id="Fact001535"
      unitRef="USD">1359000</ifrs-full:Borrowings>
    <SMX:ProceedsFromIssuancePromissoryNoteAndWarrant
      contextRef="From2025-07-192025-07-19_custom_SecuritiesPurchaseAgreementMember"
      decimals="-2"
      id="Fact001537"
      unitRef="USD">747500</SMX:ProceedsFromIssuancePromissoryNoteAndWarrant>
    <ifrs-full:Borrowings
      contextRef="AsOf2025-07-19_custom_SecuritiesPurchaseAgreementMember"
      decimals="-3"
      id="Fact001538"
      unitRef="USD">1150000</ifrs-full:Borrowings>
    <SMX:OriginalIssueDiscount
      contextRef="AsOf2024-07-19_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact001539"
      unitRef="Pure">0.35</SMX:OriginalIssueDiscount>
    <ifrs-full:DescriptionOfConversionOfDebtToEquity
      contextRef="From2025-07-192025-07-19_custom_SecuritiesPurchaseAgreementMember"
      id="Fact001542">The
                                                                                                                                                                                                                                      Alpha has the right, at any time, to convert all or any portion of the outstanding and unpaid principal amount and interest
                                                                                                                                                                                                                                      (including any costs, fees and charges) into the Company&#x2019;s Ordinary Shares, at a conversion price equal tothe
                                                                                                                                                                                                                                      lesser of $174 ($2,126,184 after reverse stock splits) or 80% of the lowest volume weighted average price of the Company&#x2019;s
                                                                                                                                                                                                                                      ordinary shares during the twenty trading days prior to the conversion, subject to
                                                                                                                                                                                                                                      customary adjustments as provided in the Alpha July Note including for fundamental transactions (the &#x201c;Conversion
                                                                                                                                                                                                                                      option&#x201d;) Any such conversion is subject to customary conversion limitations set forth in the Alpha July Note so the Alpha
                                                                                                                                                                                                                                      beneficially owns less than 4.99% of the Company&#x2019;s Ordinary Shares. Any principal amount on the Alpha July Note which is not
                                                                                                                                                                                                                                      paid when due shall bear interest at the rate of the lesser of (i) 24.5% per annum and (ii) the maximum amount permitted by law
                                                                                                                                                                                                                                      during the Event of Default. Upon the occurrence of any Event of Default, the principal amount then outstanding plus accrued
                                                                                                                                                                                                                                      interest (including any costs, fees and charges) increases to 120% of such amount through the date of full repayment, as well as all
                                                                                                                                                                                                                                      costs of collection</ifrs-full:DescriptionOfConversionOfDebtToEquity>
    <SMX:WarrantsToPurchaseOrdinaryShares
      contextRef="From2025-07-192025-07-19_custom_SecuritiesPurchaseAgreementMember_custom_JulyWarrantsMember"
      decimals="INF"
      id="Fact001543"
      unitRef="Shares">7317</SMX:WarrantsToPurchaseOrdinaryShares>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2025-07-192025-07-19_custom_SecuritiesPurchaseAgreementMember_custom_JulyWarrantsMember"
      decimals="INF"
      id="Fact001546"
      unitRef="USDPShares">178</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2025-07-192025-07-19_custom_SecuritiesPurchaseAgreementMember_custom_JulyWarrantsMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact001547"
      unitRef="USDPShares">2175062</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <SMX:WarrantTerm
      contextRef="From2025-07-192025-07-19_custom_SecuritiesPurchaseAgreementMember_custom_JulyWarrantsMember"
      id="Fact001548">P5Y6M</SMX:WarrantTerm>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2025-07-192025-07-19_custom_SecuritiesPurchaseAgreementMember_custom_JulyWarrantsMember"
      decimals="INF"
      id="Fact001550"
      unitRef="Pure">0.0499</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:CurrentDerivativeFinancialLiabilities
      contextRef="AsOf2025-07-19_custom_SecuritiesPurchaseAgreementMember_custom_JulyWarrantsMember"
      decimals="-3"
      id="Fact001552"
      unitRef="USD">741000</ifrs-full:CurrentDerivativeFinancialLiabilities>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2025-07-192025-07-19_custom_SecuritiesPurchaseAgreementMember_custom_JulyWarrantsMember"
      decimals="INF"
      id="Fact001553"
      unitRef="Pure">0.596</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2025-07-192025-07-19_custom_SecuritiesPurchaseAgreementMember_custom_JulyWarrantsMember"
      decimals="INF"
      id="Fact001554"
      unitRef="Pure">0.0416</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <SMX:ConversionPriceValue
      contextRef="From2025-07-192025-07-19_custom_SecuritiesPurchaseAgreementMember_custom_AlphaJulyNoteMember"
      decimals="-3"
      id="Fact001556"
      unitRef="USD">0</SMX:ConversionPriceValue>
    <SMX:ConversionPriceValue
      contextRef="From2025-07-192025-07-19_custom_SecuritiesPurchaseAgreementMember_custom_ConversionOptionMember"
      decimals="-3"
      id="Fact001558"
      unitRef="USD">753000</SMX:ConversionPriceValue>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2025-07-192025-07-19_custom_SecuritiesPurchaseAgreementMember_custom_ConversionOptionMember"
      decimals="INF"
      id="Fact001559"
      unitRef="Pure">0.6167</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2025-07-192025-07-19_custom_SecuritiesPurchaseAgreementMember_custom_ConversionOptionMember"
      decimals="INF"
      id="Fact001560"
      unitRef="Pure">0.0485</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <SMX:ConversionPriceValue
      contextRef="From2024-01-012024-12-31_custom_SecuritiesPurchaseAgreementMember_custom_AlphaJulyNoteMember"
      decimals="-3"
      id="Fact001562"
      unitRef="USD">520000</SMX:ConversionPriceValue>
    <SMX:ConversionPriceValue
      contextRef="From2024-01-012024-12-31_custom_SecuritiesPurchaseAgreementMember_custom_ConversionOptionMember_custom_ConvertibleNotesMember"
      decimals="-3"
      id="Fact001564"
      unitRef="USD">527000</SMX:ConversionPriceValue>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2024-01-012024-12-31_custom_SecuritiesPurchaseAgreementMember_custom_ConversionOptionMember_custom_ConvertibleNotesMember"
      decimals="INF"
      id="Fact001565"
      unitRef="Pure">0.587</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2025-01-012025-12-31_custom_SecuritiesPurchaseAgreementMember_custom_ConversionOptionMember_custom_ConvertibleNotesMember"
      decimals="INF"
      id="Fact001566"
      unitRef="Pure">0.0428</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:NotionalAmount
      contextRef="AsOf2025-08-30"
      decimals="-2"
      id="Fact001567"
      unitRef="USD">223700</ifrs-full:NotionalAmount>
    <ifrs-full:PaymentsForDebtIssueCosts
      contextRef="From2025-08-302025-08-30"
      decimals="-2"
      id="Fact001568"
      unitRef="USD">29200</ifrs-full:PaymentsForDebtIssueCosts>
    <ifrs-full:InterestPayable
      contextRef="AsOf2025-08-30"
      decimals="-2"
      id="Fact001569"
      unitRef="USD">22400</ifrs-full:InterestPayable>
    <ifrs-full:BorrowingsMaturity contextRef="From2025-08-302025-08-30" id="Fact001570">June 30, 2025</ifrs-full:BorrowingsMaturity>
    <SMX:PaymentsOnUnpaidInterestAndPrincipleAmount
      contextRef="From2025-08-302025-08-30_custom_FebruaryTwentyEightTwoThousandAndTwentyFiveMember"
      decimals="-3"
      id="Fact001571"
      unitRef="USD">123000</SMX:PaymentsOnUnpaidInterestAndPrincipleAmount>
    <SMX:PaymentsOnUnpaidInterestAndPrincipleAmount
      contextRef="From2025-08-302025-08-30_custom_MarchTwentyThirtyTwoThousandAndTwentyFiveMember"
      decimals="-2"
      id="Fact001572"
      unitRef="USD">30700</SMX:PaymentsOnUnpaidInterestAndPrincipleAmount>
    <SMX:PaymentsOnUnpaidInterestAndPrincipleAmount
      contextRef="From2025-08-302025-08-30_custom_MayTwentyThirtyTwoThousandAndTwentyFiveMember"
      decimals="-2"
      id="Fact001573"
      unitRef="USD">30700</SMX:PaymentsOnUnpaidInterestAndPrincipleAmount>
    <SMX:PaymentsOnUnpaidInterestAndPrincipleAmount
      contextRef="From2025-08-302025-08-30_custom_MayTwentyThirtyTwoThousandAndTwentyFiveMember"
      decimals="-2"
      id="Fact001574"
      unitRef="USD">30700</SMX:PaymentsOnUnpaidInterestAndPrincipleAmount>
    <SMX:PaymentsOnUnpaidInterestAndPrincipleAmount
      contextRef="From2025-08-302025-08-30_custom_JuneTwentyThirtyTwoThousandAndTwentyFiveMember"
      decimals="-2"
      id="Fact001576"
      unitRef="USD">30700</SMX:PaymentsOnUnpaidInterestAndPrincipleAmount>
    <ifrs-full:DescriptionOfConversionOfDebtToEquity contextRef="From2025-08-302025-08-30" id="Fact001578">the principal and interest balance of the note shall be increased by 150% and (ii) the 1800 Diagonal August Promissory Note may be converted into Ordinary Shares of the Company at the sole discretion of the 1800 Diagonal August. The conversion price shall equal the lowest closing bid price of the Ordinary Shares during the prior ten trading day period multiplied by 75% (representing a 25% discount). Any such conversion is subject to customary conversion limitations set forth in the 1800 Diagonal August Promissory Note so the 1800 Diagonal August beneficially owns less than 4.99% of the Company&#x2019;s Ordinary Shares. The 1800 Diagonal August shall be entitled to deduct $1.5 from the conversion amount in each Notice of Conversion to cover Holder&#x2019;s deposit fees associated with each Notice of Conversion</ifrs-full:DescriptionOfConversionOfDebtToEquity>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2025-08-302025-08-30"
      decimals="-3"
      id="Fact001580"
      unitRef="USD">18000</ifrs-full:ProfessionalFeesExpense>
    <SMX:EffectiveInterestRate
      contextRef="From2025-03-282025-03-28_custom_OneThousandAndEightHundredDiagonalLendingLLCMember"
      decimals="INF"
      id="Fact001582"
      unitRef="Pure">6.74</SMX:EffectiveInterestRate>
    <ifrs-full:NetDebt
      contextRef="AsOf2024-12-31_custom_OneThousandAndEightHundredDiagonalLendingLLCMember"
      decimals="-3"
      id="Fact001584"
      unitRef="USD">147000</ifrs-full:NetDebt>
    <SMX:FairValueOfEmbeddedConversionOption
      contextRef="From2024-01-012024-12-31_custom_OneThousandAndEightHundredDiagonalLendingLLCMember"
      decimals="-3"
      id="Fact001586"
      unitRef="USD">121000</SMX:FairValueOfEmbeddedConversionOption>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2024-01-012024-12-31_custom_OneThousandAndEightHundredDiagonalLendingLLCMember"
      decimals="INF"
      id="Fact001588"
      unitRef="Pure">0.43</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2024-01-012024-12-31_custom_OneThousandAndEightHundredDiagonalLendingLLCMember"
      decimals="INF"
      id="Fact001590"
      unitRef="Pure">0.0489</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <SMX:ConvertibleFeatureDescription
      contextRef="From2024-01-012024-12-31_custom_OneThousandAndEightHundredDiagonalLendingLLCMember"
      id="Fact001592">According
to the agreement, the loan conversion will only occur in the event of default. For the purpose of estimating the convertible feature
the third-party appraiser has assumed, based on Moody&#x2019;s rate methodology, the is a 43.6% probability that a default event will
occur. Therefore, the value of the Convertible feature is only 43.6% of the Convertible feature valuation</SMX:ConvertibleFeatureDescription>
    <ifrs-full:RepaymentsOfCurrentBorrowings
      contextRef="From2025-01-012025-12-31_custom_OneThousandAndEightHundredDiagonalLendingLLCMember"
      decimals="-3"
      id="Fact001594"
      unitRef="USD">246000</ifrs-full:RepaymentsOfCurrentBorrowings>
    <ifrs-full:NotionalAmount
      contextRef="AsOf2025-12-31_custom_OneThousandAndEightHundredDiagonalLendingLLCMember"
      decimals="2"
      id="Fact001596"
      unitRef="USD">223700</ifrs-full:NotionalAmount>
    <ifrs-full:NotionalAmount
      contextRef="AsOf2024-12-31_custom_OneThousandAndEightHundredDiagonalLendingLLCMember"
      decimals="2"
      id="Fact001598"
      unitRef="USD">22400</ifrs-full:NotionalAmount>
    <SMX:ProceedsFromIssueOfBondsNotesAndDebenture
      contextRef="From2025-03-282025-03-28"
      decimals="-5"
      id="Fact001600"
      unitRef="USD">295500000</SMX:ProceedsFromIssueOfBondsNotesAndDebenture>
    <ifrs-full:ProceedsFromIssueOfRegulatoryCapitalFinancialLiabilities
      contextRef="From2025-03-282025-03-28"
      decimals="-5"
      id="Fact001602"
      unitRef="USD">250000000</ifrs-full:ProceedsFromIssueOfRegulatoryCapitalFinancialLiabilities>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2025-03-282025-03-28"
      decimals="-5"
      id="Fact001604"
      unitRef="USD">7000000</ifrs-full:ShareIssueRelatedCost>
    <SMX:DescriptionOfRepayableInSevenInstalments contextRef="From2025-03-282025-03-28" id="Fact001606">The note bears interest at an annual rate of 12%
                                            and is repayable in seven instalments between September 2025 and March 2026, as follows:
                                            (1) $ 163 on September 30, 2025; (2)-(7) $ 27.2 on each month-end from October 2025 to March
                                            2026.</SMX:DescriptionOfRepayableInSevenInstalments>
    <SMX:OutstandingPrincipalAndInterestIncreasePercentage
      contextRef="From2025-03-282025-03-28"
      decimals="INF"
      id="Fact001608"
      unitRef="Pure">1.50</SMX:OutstandingPrincipalAndInterestIncreasePercentage>
    <SMX:DiscountRate
      contextRef="From2025-03-282025-03-28"
      decimals="INF"
      id="Fact001610"
      unitRef="Pure">0.25</SMX:DiscountRate>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2025-03-282025-03-28"
      decimals="INF"
      id="Fact001612"
      unitRef="Pure">0.0499</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <SMX:EffectiveInterestRate
      contextRef="From2025-03-282025-03-28"
      decimals="INF"
      id="Fact001614"
      unitRef="Pure">1.0746</SMX:EffectiveInterestRate>
    <ifrs-full:NetDebt
      contextRef="AsOf2025-03-28"
      decimals="-3"
      id="Fact001616"
      unitRef="USD">204000</ifrs-full:NetDebt>
    <SMX:ConversionPriceValue
      contextRef="From2025-03-282025-03-28_custom_ConversionOptionMember"
      decimals="-3"
      id="Fact001618"
      unitRef="USD">47000</SMX:ConversionPriceValue>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2025-03-282025-03-28_custom_ConversionOptionMember"
      decimals="INF"
      id="Fact001619"
      unitRef="Pure">0.6037</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2025-03-282025-03-28_custom_ConversionOptionMember"
      decimals="INF"
      id="Fact001620"
      unitRef="Pure">0.0404</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <SMX:ConversionPricePercentage
      contextRef="From2025-03-282025-03-28_custom_ConversionOptionMember"
      decimals="INF"
      id="Fact001622"
      unitRef="Pure">0.08962</SMX:ConversionPricePercentage>
    <ifrs-full:IssueOfConvertibleInstruments
      contextRef="From2022-05-012022-05-31"
      decimals="-3"
      id="Fact001624"
      unitRef="USD">317000</ifrs-full:IssueOfConvertibleInstruments>
    <SMX:PromissoryNote
      contextRef="AsOf2025-05-09_custom_RBWMayAgreementMember"
      decimals="-3"
      id="Fact001626"
      unitRef="USD">6875000</SMX:PromissoryNote>
    <SMX:ProceedsFromIssuanceOfPromissoryNote
      contextRef="From2025-05-092025-05-09_custom_RBWMayAgreementMember"
      decimals="-3"
      id="Fact001628"
      unitRef="USD">5500000</SMX:ProceedsFromIssuanceOfPromissoryNote>
    <ifrs-full:NotionalAmount
      contextRef="AsOf2025-05-09_custom_RBWMayAgreementMember"
      decimals="-3"
      id="Fact001630"
      unitRef="USD">1375000</ifrs-full:NotionalAmount>
    <SMX:OriginalIssueDiscount
      contextRef="AsOf2025-05-09_custom_RBWMayAgreementMember"
      decimals="INF"
      id="Fact001632"
      unitRef="Pure">0.20</SMX:OriginalIssueDiscount>
    <SMX:ProceedsFromReceivedForInstalments
      contextRef="From2025-05-092025-05-09_custom_RBWMayAgreementMember"
      decimals="-3"
      id="Fact001634"
      unitRef="USD">1375000</SMX:ProceedsFromReceivedForInstalments>
    <SMX:ProceedsFromReceivedForInstalments
      contextRef="From2025-05-092025-05-09_custom_RBWMayAgreementMember"
      decimals="-3"
      id="Fact001636"
      unitRef="USD">1375000</SMX:ProceedsFromReceivedForInstalments>
    <SMX:PaymentsForAdditionalAmount
      contextRef="From2025-05-092025-05-09_custom_RBWMayAgreementMember"
      decimals="-3"
      id="Fact001638"
      unitRef="USD">625000</SMX:PaymentsForAdditionalAmount>
    <SMX:PaymentsForAdditionalAmount
      contextRef="From2025-01-012025-12-31_custom_RBWMayAgreementMember"
      decimals="-3"
      id="Fact001640"
      unitRef="USD">2125000</SMX:PaymentsForAdditionalAmount>
    <ifrs-full:BrokerageFeeExpense
      contextRef="From2025-05-092025-05-09_custom_RBWMayAgreementMember"
      decimals="-3"
      id="Fact001642"
      unitRef="USD">640000</ifrs-full:BrokerageFeeExpense>
    <ifrs-full:AdministrativeExpense
      contextRef="From2025-05-092025-05-09_custom_RBWMayAgreementMember"
      decimals="-3"
      id="Fact001644"
      unitRef="USD">220000</ifrs-full:AdministrativeExpense>
    <SMX:PercentageOfWarrantsRate
      contextRef="From2025-05-092025-05-09_custom_RBWMayAgreementMember"
      decimals="INF"
      id="Fact001646"
      unitRef="Pure">0.05</SMX:PercentageOfWarrantsRate>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2025-05-092025-05-09_custom_RBWMayAgreementMember"
      decimals="INF"
      id="Fact001648"
      unitRef="USDPShares">4497</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <SMX:WarrantTerm
      contextRef="From2025-05-092025-05-09_custom_RBWMayAgreementMember"
      id="Fact001650">P5Y</SMX:WarrantTerm>
    <ifrs-full:CurrentDerivativeFinancialLiabilities
      contextRef="AsOf2025-05-09_custom_RBWMayAgreementMember"
      decimals="-3"
      id="Fact001652"
      unitRef="USD">2718000</ifrs-full:CurrentDerivativeFinancialLiabilities>
    <SMX:OutstandingPrincipalAndInterestDescription
      contextRef="From2025-05-092025-05-09_custom_RBWMayAgreementMember"
      id="Fact001654">(i) the principal amount increases automatically by 20%; (ii) default interest of
20% per annum applies; and (iii) all outstanding debt may be declared immediately due and payable.</SMX:OutstandingPrincipalAndInterestDescription>
    <SMX:ConversionPrice
      contextRef="From2025-05-092025-05-09_custom_RBWMayAgreementMember"
      decimals="INF"
      id="Fact001656"
      unitRef="USDPShares">0.32</SMX:ConversionPrice>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2025-05-092025-05-09_custom_RBWMayAgreementMember"
      decimals="INF"
      id="Fact001658"
      unitRef="Pure">0.0499</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:NetDebt
      contextRef="AsOf2025-05-09_custom_RBWMayAgreementMember"
      decimals="-3"
      id="Fact001660"
      unitRef="USD">825000</ifrs-full:NetDebt>
    <SMX:ConversionPriceValue
      contextRef="From2025-05-092025-05-09_custom_RBWMayAgreementMember"
      decimals="-3"
      id="Fact001662"
      unitRef="USD">550000</SMX:ConversionPriceValue>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedTerm
      contextRef="From2025-05-092025-05-09_custom_RBWMayAgreementMember"
      id="Fact001664">P1Y</SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedTerm>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedVolatility
      contextRef="From2025-05-092025-05-09_custom_RBWMayAgreementMember"
      decimals="INF"
      id="Fact001666"
      unitRef="Pure">0.6203</SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedVolatility>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfRiskFreeInterestRate
      contextRef="From2025-05-092025-05-09_custom_RBWMayAgreementMember"
      decimals="INF"
      id="Fact001668"
      unitRef="Pure">0.0405</SMX:DescriptionOfFairValueAssumptionsValuationsOfRiskFreeInterestRate>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedDividendYieldPercentage
      contextRef="From2025-05-092025-05-09_custom_RBWMayAgreementMember"
      decimals="INF"
      id="Fact001670"
      unitRef="Pure">0</SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedDividendYieldPercentage>
    <ifrs-full:NetDebt
      contextRef="AsOf2025-05-23_custom_RBWMayAgreementMember"
      decimals="-3"
      id="Fact001672"
      unitRef="USD">836000</ifrs-full:NetDebt>
    <SMX:ConversionPriceValue
      contextRef="From2025-05-232025-05-23_custom_RBWMayAgreementMember"
      decimals="-3"
      id="Fact001674"
      unitRef="USD">539000</SMX:ConversionPriceValue>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedTerm
      contextRef="From2025-05-232025-05-23_custom_RBWMayAgreementMember"
      id="Fact001676">P0Y11M15D</SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedTerm>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedVolatility
      contextRef="From2025-05-232025-05-23_custom_RBWMayAgreementMember"
      decimals="INF"
      id="Fact001678"
      unitRef="Pure">0.6213</SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedVolatility>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfRiskFreeInterestRate
      contextRef="From2025-05-232025-05-23_custom_RBWMayAgreementMember"
      decimals="INF"
      id="Fact001680"
      unitRef="Pure">0.0415</SMX:DescriptionOfFairValueAssumptionsValuationsOfRiskFreeInterestRate>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedDividendYieldPercentage
      contextRef="From2025-05-232025-05-23_custom_RBWMayAgreementMember"
      decimals="INF"
      id="Fact001682"
      unitRef="Pure">0</SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedDividendYieldPercentage>
    <ifrs-full:NetDebt
      contextRef="AsOf2025-05-27_custom_RBWMayAgreementMember"
      decimals="-3"
      id="Fact001684"
      unitRef="USD">404000</ifrs-full:NetDebt>
    <SMX:ConversionPriceValue
      contextRef="From2025-05-272025-05-27_custom_RBWMayAgreementMember"
      decimals="-3"
      id="Fact001686"
      unitRef="USD">221000</SMX:ConversionPriceValue>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedTerm
      contextRef="From2025-05-272025-05-27_custom_RBWMayAgreementMember"
      id="Fact001688">P0Y10M6D</SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedTerm>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedVolatility
      contextRef="From2025-05-272025-05-27_custom_RBWMayAgreementMember"
      decimals="INF"
      id="Fact001690"
      unitRef="Pure">0.4784</SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedVolatility>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfRiskFreeInterestRate
      contextRef="From2025-05-272025-05-27_custom_RBWMayAgreementMember"
      decimals="INF"
      id="Fact001692"
      unitRef="Pure">0.0406</SMX:DescriptionOfFairValueAssumptionsValuationsOfRiskFreeInterestRate>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedDividendYieldPercentage
      contextRef="From2025-05-272025-05-27_custom_RBWMayAgreementMember"
      decimals="INF"
      id="Fact001694"
      unitRef="Pure">0</SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedDividendYieldPercentage>
    <ifrs-full:NetDebt
      contextRef="AsOf2025-07-03_custom_RBWMayAgreementMember"
      decimals="-3"
      id="Fact001696"
      unitRef="USD">1372000</ifrs-full:NetDebt>
    <SMX:ConversionPriceValue
      contextRef="From2025-07-032025-07-03_custom_RBWMayAgreementMember"
      decimals="-3"
      id="Fact001698"
      unitRef="USD">753000</SMX:ConversionPriceValue>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedTerm
      contextRef="From2025-07-032025-07-03_custom_RBWMayAgreementMember"
      id="Fact001700">P0Y10M6D</SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedTerm>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedVolatility
      contextRef="From2025-07-032025-07-03_custom_RBWMayAgreementMember"
      decimals="INF"
      id="Fact001702"
      unitRef="Pure">0.4784</SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedVolatility>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfRiskFreeInterestRate
      contextRef="From2025-07-032025-07-03_custom_RBWMayAgreementMember"
      decimals="INF"
      id="Fact001704"
      unitRef="Pure">0.0406</SMX:DescriptionOfFairValueAssumptionsValuationsOfRiskFreeInterestRate>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedDividendYieldPercentage
      contextRef="From2025-07-032025-07-03_custom_RBWMayAgreementMember"
      decimals="INF"
      id="Fact001706"
      unitRef="Pure">0</SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedDividendYieldPercentage>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-12-31_ifrs-full_OrdinarySharesMember_custom_RBWMayAgreementMember"
      decimals="INF"
      id="Fact001708"
      unitRef="Shares">1949</ifrs-full:NumberOfSharesIssued>
    <SMX:PromissoryNote
      contextRef="AsOf2025-08-01_custom_RBWAugustAgreementMember"
      decimals="-3"
      id="Fact001710"
      unitRef="USD">15000000</SMX:PromissoryNote>
    <SMX:ProceedsFromIssuanceOfPromissoryNote
      contextRef="From2025-08-012025-08-01_custom_RBWAugustAgreementMember"
      decimals="-3"
      id="Fact001712"
      unitRef="USD">12000000</SMX:ProceedsFromIssuanceOfPromissoryNote>
    <ifrs-full:BrokerageFeeExpense
      contextRef="From2025-08-012025-08-01_custom_RBWAugustAgreementMember"
      decimals="-3"
      id="Fact001714"
      unitRef="USD">1145000</ifrs-full:BrokerageFeeExpense>
    <ifrs-full:AdministrativeExpense
      contextRef="From2025-08-012025-08-01_custom_RBWAugustAgreementMember"
      decimals="-3"
      id="Fact001716"
      unitRef="USD">1145000</ifrs-full:AdministrativeExpense>
    <ifrs-full:NotionalAmount
      contextRef="AsOf2025-08-01_custom_RBWAugustAgreementMember"
      decimals="-3"
      id="Fact001718"
      unitRef="USD">3000000</ifrs-full:NotionalAmount>
    <SMX:OriginalIssueDiscount
      contextRef="AsOf2025-08-01_custom_RBWAugustAgreementMember"
      decimals="INF"
      id="Fact001720"
      unitRef="Pure">0.20</SMX:OriginalIssueDiscount>
    <SMX:OutstandingPrincipalAndInterestDescription
      contextRef="From2025-08-012025-08-01_custom_RBWAugustAgreementMember"
      id="Fact001722">(i) the principal amount increases automatically by 20%; (ii) default interest of
20% per annum applies; and (iii) all outstanding debt may be declared immediately due and payable.</SMX:OutstandingPrincipalAndInterestDescription>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2025-05-092025-05-09_custom_RBWMayAgreementMember"
      decimals="INF"
      id="Fact001724"
      unitRef="Pure">0.0499</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <SMX:ProceedsFromLoan
      contextRef="From2025-08-012025-08-01_custom_ConvertibleLoanTrancheOneMember_custom_RBWAugustAgreementMember"
      decimals="-3"
      id="Fact001726"
      unitRef="USD">5000000</SMX:ProceedsFromLoan>
    <SMX:ProceedsFromLoan
      contextRef="From2025-08-012025-08-01_custom_ConvertibleLoanTrancheTwoMember_custom_RBWAugustAgreementMember"
      decimals="-3"
      id="Fact001728"
      unitRef="USD">1000000</SMX:ProceedsFromLoan>
    <SMX:ProceedsFromLoan
      contextRef="From2025-08-012025-08-01_custom_ConvertibleLoanTrancheThreeMember_custom_RBWAugustAgreementMember"
      decimals="-3"
      id="Fact001730"
      unitRef="USD">2000000</SMX:ProceedsFromLoan>
    <SMX:ProceedsFromLoan
      contextRef="From2025-08-012025-08-01_custom_ConvertibleLoanTrancheFourMember_custom_RBWAugustAgreementMember"
      decimals="-3"
      id="Fact001732"
      unitRef="USD">1000000</SMX:ProceedsFromLoan>
    <SMX:ProceedsFromLoan
      contextRef="From2025-08-012025-08-01_custom_ConvertibleLoanTrancheFiveMember_custom_RBWAugustAgreementMember"
      decimals="-3"
      id="Fact001734"
      unitRef="USD">3000000</SMX:ProceedsFromLoan>
    <ifrs-full:DescriptionOfConversionOfDebtToEquity
      contextRef="From2025-08-012025-08-01_custom_RBWAugustAgreementMember"
      id="Fact001736">85% of the lowest daily Volume Weighted Average Price (&#x201c;VWAP&#x201d;) during the seven trading days immediately preceding the conversion
date, representing a 15% discount to market price.</ifrs-full:DescriptionOfConversionOfDebtToEquity>
    <SMX:FloorPricePricePerShare
      contextRef="AsOf2025-08-01_custom_RBWAugustAgreementMember"
      decimals="INF"
      id="Fact001738"
      unitRef="USDPShares">954</SMX:FloorPricePricePerShare>
    <ifrs-full:NetDebt
      contextRef="AsOf2025-08-01_custom_RBWAugustAgreementMember"
      decimals="-3"
      id="Fact001740"
      unitRef="USD">3113000</ifrs-full:NetDebt>
    <SMX:ConversionPriceValue
      contextRef="From2025-08-012025-08-01_custom_RBWAugustAgreementMember"
      decimals="-3"
      id="Fact001742"
      unitRef="USD">1887000</SMX:ConversionPriceValue>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedTerm
      contextRef="From2025-08-012025-08-01_custom_RBWAugustAgreementMember"
      id="Fact001744">P1Y</SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedTerm>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedVolatility
      contextRef="From2025-08-012025-08-01_custom_RBWAugustAgreementMember"
      decimals="INF"
      id="Fact001746"
      unitRef="Pure">1.5654</SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedVolatility>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfRiskFreeInterestRate
      contextRef="From2025-08-012025-08-01_custom_RBWAugustAgreementMember"
      decimals="INF"
      id="Fact001748"
      unitRef="Pure">0.0387</SMX:DescriptionOfFairValueAssumptionsValuationsOfRiskFreeInterestRate>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedDividendYieldPercentage
      contextRef="From2025-08-012025-08-01_custom_RBWAugustAgreementMember"
      decimals="INF"
      id="Fact001750"
      unitRef="Pure">0</SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedDividendYieldPercentage>
    <ifrs-full:NetDebt
      contextRef="AsOf2025-08-27_custom_RBWAugustAgreementMember"
      decimals="-3"
      id="Fact001752"
      unitRef="USD">768000</ifrs-full:NetDebt>
    <SMX:ConversionPriceValue
      contextRef="From2025-08-272025-08-27_custom_RBWAugustAgreementMember"
      decimals="-3"
      id="Fact001754"
      unitRef="USD">232000</SMX:ConversionPriceValue>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedTerm
      contextRef="From2025-08-272025-08-27_custom_RBWAugustAgreementMember"
      id="Fact001756">P0Y11M4D</SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedTerm>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedVolatility
      contextRef="From2025-08-272025-08-27_custom_RBWAugustAgreementMember"
      decimals="INF"
      id="Fact001758"
      unitRef="Pure">1.5155</SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedVolatility>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfRiskFreeInterestRate
      contextRef="From2025-08-272025-08-27_custom_RBWAugustAgreementMember"
      decimals="INF"
      id="Fact001760"
      unitRef="Pure">0.0386</SMX:DescriptionOfFairValueAssumptionsValuationsOfRiskFreeInterestRate>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedDividendYieldPercentage
      contextRef="From2025-08-272025-08-27_custom_RBWAugustAgreementMember"
      decimals="INF"
      id="Fact001762"
      unitRef="Pure">0</SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedDividendYieldPercentage>
    <ifrs-full:NetDebt
      contextRef="AsOf2025-09-12_custom_RBWAugustAgreementMember"
      decimals="-3"
      id="Fact001764"
      unitRef="USD">1811000</ifrs-full:NetDebt>
    <SMX:ConversionPriceValue
      contextRef="From2025-09-122025-09-12_custom_RBWAugustAgreementMember"
      decimals="-3"
      id="Fact001766"
      unitRef="USD">189000</SMX:ConversionPriceValue>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedTerm
      contextRef="From2025-09-122025-09-12_custom_RBWAugustAgreementMember"
      id="Fact001768">P0Y10M20D</SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedTerm>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedVolatility
      contextRef="From2025-09-122025-09-12_custom_RBWAugustAgreementMember"
      decimals="INF"
      id="Fact001770"
      unitRef="Pure">1.6165</SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedVolatility>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfRiskFreeInterestRate
      contextRef="From2025-09-122025-09-12_custom_RBWAugustAgreementMember"
      decimals="INF"
      id="Fact001772"
      unitRef="Pure">0.037</SMX:DescriptionOfFairValueAssumptionsValuationsOfRiskFreeInterestRate>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedDividendYieldPercentage
      contextRef="From2025-09-122025-09-12_custom_RBWAugustAgreementMember"
      decimals="INF"
      id="Fact001774"
      unitRef="Pure">0</SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedDividendYieldPercentage>
    <ifrs-full:NetDebt
      contextRef="AsOf2025-09-17_custom_RBWAugustAgreementMember"
      decimals="-3"
      id="Fact001776"
      unitRef="USD">901000</ifrs-full:NetDebt>
    <SMX:ConversionPriceValue
      contextRef="From2025-09-172025-09-17_custom_RBWAugustAgreementMember"
      decimals="-3"
      id="Fact001778"
      unitRef="USD">99000</SMX:ConversionPriceValue>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedTerm
      contextRef="From2025-09-172025-09-17_custom_RBWAugustAgreementMember"
      id="Fact001780">P0Y10M13D</SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedTerm>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedVolatility
      contextRef="From2025-09-172025-09-17_custom_RBWAugustAgreementMember"
      decimals="INF"
      id="Fact001782"
      unitRef="Pure">1.489</SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedVolatility>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfRiskFreeInterestRate
      contextRef="From2025-09-172025-09-17_custom_RBWAugustAgreementMember"
      decimals="INF"
      id="Fact001784"
      unitRef="Pure">0.0365</SMX:DescriptionOfFairValueAssumptionsValuationsOfRiskFreeInterestRate>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedDividendYieldPercentage
      contextRef="From2025-09-172025-09-17_custom_RBWAugustAgreementMember"
      decimals="INF"
      id="Fact001786"
      unitRef="Pure">0</SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedDividendYieldPercentage>
    <ifrs-full:NetDebt
      contextRef="AsOf2025-10-02_custom_RBWAugustAgreementMember"
      decimals="-3"
      id="Fact001788"
      unitRef="USD">2656000</ifrs-full:NetDebt>
    <SMX:ConversionPriceValue
      contextRef="From2025-10-022025-10-02_custom_RBWAugustAgreementMember"
      decimals="-3"
      id="Fact001790"
      unitRef="USD">344000</SMX:ConversionPriceValue>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedTerm
      contextRef="From2025-10-022025-10-02_custom_RBWAugustAgreementMember"
      id="Fact001792">P0Y9M29D</SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedTerm>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedVolatility
      contextRef="From2025-10-022025-10-02_custom_RBWAugustAgreementMember"
      decimals="INF"
      id="Fact001794"
      unitRef="Pure">1.5181</SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedVolatility>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfRiskFreeInterestRate
      contextRef="From2025-10-022025-10-02_custom_RBWAugustAgreementMember"
      decimals="INF"
      id="Fact001796"
      unitRef="Pure">0.0368</SMX:DescriptionOfFairValueAssumptionsValuationsOfRiskFreeInterestRate>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedDividendYieldPercentage
      contextRef="From2025-10-022025-10-02_custom_RBWAugustAgreementMember"
      decimals="INF"
      id="Fact001798"
      unitRef="Pure">0</SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedDividendYieldPercentage>
    <SMX:NumberOfValueConverted
      contextRef="AsOf2025-12-31_ifrs-full_OrdinarySharesMember_custom_RBWMayAgreementMember"
      decimals="-3"
      id="Fact001800"
      unitRef="USD">13750000</SMX:NumberOfValueConverted>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-12-31_ifrs-full_OrdinarySharesMember_custom_RBWAugustAgreementMember"
      decimals="INF"
      id="Fact001802"
      unitRef="Shares">66794</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NetDebt
      contextRef="AsOf2025-12-31_custom_RBWMayAgreementMember"
      decimals="-3"
      id="Fact001804"
      unitRef="USD">1250000</ifrs-full:NetDebt>
    <ifrs-full:FinanceCosts
      contextRef="From2025-01-012025-12-31_custom_RBWMayAgreementMember"
      decimals="-3"
      id="Fact001806"
      unitRef="USD">249000</ifrs-full:FinanceCosts>
    <SMX:PromissoryNote
      contextRef="AsOf2025-12-01_custom_RBWDecemberAgreementMember"
      decimals="-3"
      id="Fact001808"
      unitRef="USD">20625000</SMX:PromissoryNote>
    <SMX:ProceedsFromIssuanceOfPromissoryNote
      contextRef="From2025-05-092025-05-09_custom_RBWDecemberAgreementMember"
      decimals="-3"
      id="Fact001810"
      unitRef="USD">16500000</SMX:ProceedsFromIssuanceOfPromissoryNote>
    <ifrs-full:BrokerageFeeExpense
      contextRef="From2025-12-012025-12-01_custom_RBWDecemberAgreementMember"
      decimals="-3"
      id="Fact001812"
      unitRef="USD">1460000</ifrs-full:BrokerageFeeExpense>
    <ifrs-full:AdministrativeExpense
      contextRef="From2025-12-012025-12-01_custom_RBWDecemberAgreementMember"
      decimals="-3"
      id="Fact001814"
      unitRef="USD">1460000</ifrs-full:AdministrativeExpense>
    <ifrs-full:NotionalAmount
      contextRef="AsOf2025-12-01_custom_RBWDecemberAgreementMember"
      decimals="-3"
      id="Fact001816"
      unitRef="USD">4125000</ifrs-full:NotionalAmount>
    <SMX:OriginalIssueDiscount
      contextRef="AsOf2025-12-01_custom_RBWDecemberAgreementMember"
      decimals="INF"
      id="Fact001818"
      unitRef="Pure">0.20</SMX:OriginalIssueDiscount>
    <SMX:OutstandingPrincipalAndInterestDescription
      contextRef="From2025-12-012025-12-01_custom_RBWDecemberAgreementMember"
      id="Fact001820">(i) the principal amount increases automatically by 20%; (ii) default interest of
20% per annum applies; and (iii) all outstanding debt may be declared immediately due and payable.</SMX:OutstandingPrincipalAndInterestDescription>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2025-12-012025-12-01_custom_RBWDecemberAgreementMember"
      decimals="INF"
      id="Fact001822"
      unitRef="Pure">0.0499</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:DescriptionOfConversionOfDebtToEquity
      contextRef="From2025-12-012025-12-01_custom_RBWDecemberAgreementMember"
      id="Fact001824">The conversion price is set at 85% of the lowest daily Volume Weighted Average Price (&#x201c;VWAP&#x201d;) during the five trading days
immediately preceding conversion, representing a 15% discount to market price.</ifrs-full:DescriptionOfConversionOfDebtToEquity>
    <SMX:FloorPricePricePerShare
      contextRef="AsOf2025-12-01_custom_RBWDecemberAgreementMember"
      decimals="INF"
      id="Fact001826"
      unitRef="USDPShares">1.5</SMX:FloorPricePricePerShare>
    <SMX:ProceedsFromLoan
      contextRef="From2025-12-012025-12-01_custom_ConvertibleLoanTrancheMember_custom_RBWDecemberAgreementMember"
      decimals="-3"
      id="Fact001828"
      unitRef="USD">16500000</SMX:ProceedsFromLoan>
    <SMX:ProceedsFromLoan
      contextRef="From2025-12-032025-12-03_custom_ConvertibleLoanTrancheOneMember_custom_RBWDecemberAgreementMember"
      decimals="-3"
      id="Fact001830"
      unitRef="USD">5750000</SMX:ProceedsFromLoan>
    <SMX:ProceedsFromLoan
      contextRef="From2025-12-292025-12-29_custom_ConvertibleLoanTrancheTwoMember_custom_RBWDecemberAgreementMember"
      decimals="-3"
      id="Fact001832"
      unitRef="USD">10750000</SMX:ProceedsFromLoan>
    <ifrs-full:NetDebt
      contextRef="AsOf2025-12-03_custom_RBWDecemberAgreementMember"
      decimals="-3"
      id="Fact001834"
      unitRef="USD">2507000</ifrs-full:NetDebt>
    <SMX:ConversionPriceValue
      contextRef="From2025-12-032025-12-03_custom_RBWDecemberAgreementMember"
      decimals="-3"
      id="Fact001836"
      unitRef="USD">3243000</SMX:ConversionPriceValue>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedTerm
      contextRef="From2025-12-032025-12-03_custom_RBWDecemberAgreementMember"
      id="Fact001838">P0Y6M</SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedTerm>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedVolatility
      contextRef="From2025-12-032025-12-03_custom_RBWDecemberAgreementMember"
      decimals="INF"
      id="Fact001840"
      unitRef="Pure">2.0247</SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedVolatility>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfRiskFreeInterestRate
      contextRef="From2025-12-032025-12-03_custom_RBWDecemberAgreementMember"
      decimals="INF"
      id="Fact001842"
      unitRef="Pure">0.0368</SMX:DescriptionOfFairValueAssumptionsValuationsOfRiskFreeInterestRate>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedDividendYieldPercentage
      contextRef="From2025-12-032025-12-03_custom_RBWDecemberAgreementMember"
      decimals="INF"
      id="Fact001844"
      unitRef="Pure">0</SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedDividendYieldPercentage>
    <ifrs-full:NetDebt
      contextRef="AsOf2025-12-29_custom_RBWDecemberAgreementMember"
      decimals="-3"
      id="Fact001846"
      unitRef="USD">4450000</ifrs-full:NetDebt>
    <SMX:ConversionPriceValue
      contextRef="From2025-12-292025-12-29_custom_RBWDecemberAgreementMember"
      decimals="-3"
      id="Fact001848"
      unitRef="USD">6300000</SMX:ConversionPriceValue>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedTerm
      contextRef="From2025-12-292025-12-29_custom_RBWDecemberAgreementMember"
      id="Fact001850">P0Y5M4D</SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedTerm>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedVolatility
      contextRef="From2025-12-292025-12-29_custom_RBWDecemberAgreementMember"
      decimals="INF"
      id="Fact001852"
      unitRef="Pure">2.4464</SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedVolatility>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfRiskFreeInterestRate
      contextRef="From2025-12-292025-12-29_custom_RBWDecemberAgreementMember"
      decimals="INF"
      id="Fact001854"
      unitRef="Pure">0.0362</SMX:DescriptionOfFairValueAssumptionsValuationsOfRiskFreeInterestRate>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedDividendYieldPercentage
      contextRef="From2025-12-292025-12-29_custom_RBWDecemberAgreementMember"
      decimals="INF"
      id="Fact001856"
      unitRef="Pure">0</SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedDividendYieldPercentage>
    <SMX:NumberOfValueConverted
      contextRef="AsOf2025-12-31_ifrs-full_OrdinarySharesMember_custom_RBWDecemberAgreementMember"
      decimals="-3"
      id="Fact001858"
      unitRef="USD">11984000</SMX:NumberOfValueConverted>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-12-31_ifrs-full_OrdinarySharesMember_custom_RBWDecemberAgreementMember"
      decimals="INF"
      id="Fact001860"
      unitRef="Shares">168853</ifrs-full:NumberOfSharesIssued>
    <SMX:ConvertedDebtRemainingPrincipalAmount
      contextRef="AsOf2025-12-31_custom_RBWDecemberAgreementMember"
      decimals="-3"
      id="Fact001862"
      unitRef="USD">8641000</SMX:ConvertedDebtRemainingPrincipalAmount>
    <ifrs-full:NetDebt
      contextRef="AsOf2025-12-31_custom_RBWDecemberAgreementMember"
      decimals="-3"
      id="Fact001864"
      unitRef="USD">2668000</ifrs-full:NetDebt>
    <SMX:ConversionPriceValue
      contextRef="From2025-01-012025-12-31_custom_RBWDecemberAgreementMember"
      decimals="-3"
      id="Fact001866"
      unitRef="USD">3083000</SMX:ConversionPriceValue>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedTerm
      contextRef="From2025-01-012025-12-31_custom_RBWDecemberAgreementMember"
      id="Fact001868">P0Y5M4D</SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedTerm>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedVolatility
      contextRef="From2025-01-012025-12-31_custom_RBWDecemberAgreementMember"
      decimals="INF"
      id="Fact001870"
      unitRef="Pure">2.6292</SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedVolatility>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfRiskFreeInterestRate
      contextRef="From2025-01-012025-12-31_custom_RBWDecemberAgreementMember"
      decimals="INF"
      id="Fact001872"
      unitRef="Pure">0.0361</SMX:DescriptionOfFairValueAssumptionsValuationsOfRiskFreeInterestRate>
    <SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedDividendYieldPercentage
      contextRef="From2025-01-012025-12-31_custom_RBWDecemberAgreementMember"
      decimals="INF"
      id="Fact001874"
      unitRef="Pure">0</SMX:DescriptionOfFairValueAssumptionsValuationsOfExpectedDividendYieldPercentage>
    <ifrs-full:DisclosureOfDebtSecuritiesExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001876">&lt;p id="xdx_804_eifrs-full--DisclosureOfDebtSecuritiesExplanatory_zlZcy01s9YH8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
8 - &lt;span id="xdx_82A_zPyTRQoYiuh8"&gt;BRIDGE LOANS LIABILITIES&lt;/span&gt;:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Between
                                            August 2022 to January 2023, Security Matters PTY Ltd. entered into bridge loan agreements
                                            (the &lt;b&gt;&#x201c;Bridge Loans&#x201d;&lt;/b&gt;) with eleven lenders, which previously lent Security
                                            Matters PTY Ltd. an aggregate amount of $&lt;span id="xdx_907_ecustom--ProceedsFromLoansAndWarrants_pn3n3_c20220801__20230131__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ElevenLendersMember_zeqiOOkgQHN7" title="Proceeds from loans and warrants"&gt;3,860&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.25pt; text-align: justify; text-indent: -35.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Part
of the lender received also bonus warrants and redeemable warrants as described below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Bridge Loans have a maturity date of up to&lt;span id="xdx_908_eifrs-full--BorrowingsMaturity_c20220801__20230131__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zyALuICQt2za" title="Borrowings maturity"&gt; two years&lt;/span&gt; and bear an interest rate of &lt;span id="xdx_908_eifrs-full--BorrowingsInterestRate_iI_pid_dp_uPure_c20230131__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zbToItKBKDPa" title="Interest rate"&gt;10&lt;/span&gt;% per annum.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
part of the Bridge Loans agreements, some of the lenders were granted two types of warrants:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(i)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Bonus
                                            Warrants &#x2013; &lt;span id="xdx_909_ecustom--WarrantsToPurchaseShares_pid_c20250101__20251231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--BonusWarrantsMember_zBr9HBQMOxle" title="Warrants to purchase, shares"&gt;0.32&lt;/span&gt; warrants (&lt;span id="xdx_908_ecustom--WarrantsToPurchaseShares_pid_dxL_c20250101__20251231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--BonusWarrantsMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zd1eBK3tCmc2" title="Warrants to purchase, shares::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1886"&gt;nil&lt;/span&gt;&lt;/span&gt; after reverse stock splits) to purchase ordinary shares
                                            of the Company at an exercise price of $&lt;span id="xdx_908_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20250101__20251231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--BonusWarrantsMember_z5vn5Gbkp3Kd" title="Exercise price of share"&gt;540,787&lt;/span&gt; ($&lt;span id="xdx_90F_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20250101__20251231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--BonusWarrantsMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zcxcH5vQwu0e" title="Exercise price of share"&gt;6,608,126,366&lt;/span&gt; after reverse stock splits)
                                            per share and a first priority security interest in the shares of Security Matters PTY&#x2019;s
                                            interest in TrueGold Consortium Pty Ltd. (&#x201c;&lt;b&gt;Bonus Warrants&lt;/b&gt;&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Bonus Warrants term is five years commencing upon the BCA.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 54.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(ii)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redeemable
                                            Warrants Type 1 &#x2013; &lt;span id="xdx_908_ecustom--WarrantsToPurchaseShares_pid_c20250101__20251231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeOneMember_zWy35JySziTj" title="Warrants to purchase shares"&gt;0.13&lt;/span&gt; warrants (&lt;span id="xdx_90B_ecustom--WarrantsToPurchaseShares_pid_dxL_c20250101__20251231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeOneMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zhm7CPpDTyp1" title="Warrants to purchase shares::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1894"&gt;nil&lt;/span&gt;&lt;/span&gt; after reverse stock splits) to purchase ordinary
                                            shares of SMX PLC at a purchase price of $&lt;span id="xdx_90B_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20250101__20251231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeOneMember_zQQ33QJ6pLR7"&gt;540,787&lt;/span&gt; ($&lt;span id="xdx_903_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20250101__20251231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeOneMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zV8mo2BHxCwk"&gt;6,608,126,366&lt;/span&gt; after reverse stock splits)
                                            per share. The Redeemable Warrants Type 1 term is &lt;span id="xdx_900_eifrs-full--BorrowingsMaturity_c20250101__20251231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeOneMember_zrNa81f1g4rh"&gt;five years&lt;/span&gt; commencing upon the BCA. (&#x201c;&lt;b&gt;Redeemable
                                            Warrants Type 1&lt;/b&gt;&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20251231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeOneMember_ztN8atGFb4bf"&gt;50.00&lt;/span&gt;%
                                            of the Redeemable Warrants Type 1 shall be redeemable on a non-cumulative basis at the option
                                            of the holder, during the 30 days following the Business Combination for $&lt;span id="xdx_908_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20250101__20251231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeOneMember_zzEXChutMXBi"&gt;235,125&lt;/span&gt; ($&lt;span id="xdx_90A_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20250101__20251231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeOneMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zxLHwOYiWdP8"&gt;2,873,098,420&lt;/span&gt;
                                            after reverse stock splits) per warrant.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20251231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeOneMember__ifrs-full--CreationDateAxis__custom--ThirdAnniversaryMember_zPPLOzPMFQme"&gt;25.00&lt;/span&gt;%
                                            of the Redeemable Warrants Type 1 shall be redeemable on a non-cumulative basis at the option
                                            of the holder for the 30 days following the third anniversary of the Business Combination
                                            for $&lt;span id="xdx_909_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20250101__20251231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeOneMember__ifrs-full--CreationDateAxis__custom--ThirdAnniversaryMember_zvXWeTOSXhM5"&gt;235,125&lt;/span&gt; ($&lt;span id="xdx_909_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20250101__20251231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeOneMember__ifrs-full--CreationDateAxis__custom--ThirdAnniversaryMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zAZaleprKnvi"&gt;2,873,098,420&lt;/span&gt; after reverse stock splits) per warrant.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20251231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeOneMember__ifrs-full--CreationDateAxis__custom--FourthAnniversaryMember_zlmAq5y1Zjo1"&gt;25.00&lt;/span&gt;%
                                            of the Redeemable Warrants Type 1 shall be redeemable on a non-cumulative basis at the option
                                            of the holder for the 30 days following the fourth anniversary of the Business Combination
                                            for $&lt;span id="xdx_901_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20250101__20251231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeOneMember__ifrs-full--CreationDateAxis__custom--FourthAnniversaryMember_zVwGmxxa7UGl"&gt;235,125&lt;/span&gt; ($&lt;span id="xdx_907_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20250101__20251231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeOneMember__ifrs-full--CreationDateAxis__custom--FourthAnniversaryMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_z5xHkPTf6VS7"&gt;2,873,098,420&lt;/span&gt; after reverse stock splits) per warrant.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(iii)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redeemable
                                            Warrants Type 2 &#x2013; &lt;span id="xdx_900_ecustom--WarrantsToPurchaseShares_pid_c20250101__20251231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeTwoMember_zeHX2Lj0rxbf"&gt;0.53&lt;/span&gt; warrants (&lt;span id="xdx_90B_ecustom--WarrantsToPurchaseShares_pid_dxL_c20240101__20241231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeTwoMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_z1V7RK7OMYX6" title="::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1908"&gt;nil&lt;/span&gt;&lt;/span&gt; after reverse stock splits) to purchase ordinary
                                            shares of SMX at a purchase price of $&lt;span id="xdx_901_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20240101__20241231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeTwoMember_zPHi3NtYsrEf"&gt;540,787&lt;/span&gt; ($&lt;span id="xdx_905_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20250101__20251231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeTwoMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_znFOzMmI29Il"&gt;6,608,126,366&lt;/span&gt; after reverse stock splits)
                                            per share. The Redeemable Warrants Type 2 term is &lt;span id="xdx_90B_eifrs-full--BorrowingsMaturity_c20240101__20241231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeTwoMember_zitLrx5E1sZ6"&gt;five years&lt;/span&gt; commencing upon the SPAC transaction
                                            (&#x201c;&lt;b&gt;Redeemable Warrants Type 2&lt;/b&gt;&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20251231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeTwoMember__ifrs-full--CreationDateAxis__custom--FirstAnniversaryMember_zUDWZl8sWRRl"&gt;50.00&lt;/span&gt;%
                                            of the Redeemable Warrants Type 2 shall be redeemable on a non-cumulative basis at the option
                                            of the holder, during the 30 days following the first anniversary of the Business Combination
                                            for $&lt;span id="xdx_90D_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20250101__20251231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeTwoMember__ifrs-full--CreationDateAxis__custom--FirstAnniversaryMember_ztMPnJOi2Ru8"&gt;235,125&lt;/span&gt; ($&lt;span id="xdx_905_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20250101__20251231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeTwoMember__ifrs-full--CreationDateAxis__custom--FirstAnniversaryMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zrW0dZtj4Yfa"&gt;2,873,098,420&lt;/span&gt; after reverse stock splits) per warrant.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20251231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeTwoMember__ifrs-full--CreationDateAxis__custom--SecondAnniversaryMember_zMpWEXAmJZVk"&gt;50.00&lt;/span&gt;%
                                            of the Redeemable Warrants Type 2 shall be redeemable on a non-cumulative basis at the option
                                            of the holder, during the 30 days following the second anniversary of the Business Combination
                                            for $&lt;span id="xdx_900_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20250101__20251231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeTwoMember__ifrs-full--CreationDateAxis__custom--SecondAnniversaryMember_zwZ4Kc15bvia"&gt;235,125&lt;/span&gt; ($&lt;span id="xdx_90E_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20250101__20251231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeTwoMember__ifrs-full--CreationDateAxis__custom--SecondAnniversaryMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zzKm9T8IGXmc"&gt;2,873,098,420&lt;/span&gt; after reverse stock splits) per warrant.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eifrs-full--DescriptionOfApproachUsedToDetermineDiscountRates_c20250101__20251231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeTwoMember_zzM3l1wfwXC6"&gt;Each
investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of the
Company based upon a 20% discount to the 20-trading day VWAP preceding each such anniversary.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
loan components were accounted in accordance with the amortized cost method.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Bridge loans conversions
and repayments:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
                                            2023 the company converted principal amount of $&lt;span id="xdx_908_eifrs-full--IssueOfConvertibleInstruments_pn3n3_c20231231__20231231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zQ1TPucEIQLb" title="Aggregate amount of convertible instruments issued"&gt;1,350&lt;/span&gt; and redeemable warrants at the amount
                                            of $&lt;span id="xdx_90F_ecustom--RedeemableWarrants_iI_pn3n3_c20231231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_z1JTsqdNYu1" title="Redeemable warrants"&gt;1,000&lt;/span&gt; into ordinary shares.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
                                            2023 the company converted principal amount of $&lt;span id="xdx_906_eifrs-full--IssueOfConvertibleInstruments_pn3n3_c20241231__20241231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zgWr9LOUgT2b" title="Aggregate amount of convertible instruments issued"&gt;750 &lt;/span&gt;and redeemable warrants at the amount
                                            of $&lt;span id="xdx_906_ecustom--RedeemableWarrants_iI_pn3n3_c20241231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zR41XDT3Gfwl" title="Redeemable warrants"&gt;1,450&lt;/span&gt; into cashless warrants which converted during 2024 into ordinary shares.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
8 - BRIDGE LOANS LIABILITIES (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            June 27, 2024, the Company converted $&lt;span id="xdx_909_eifrs-full--IssueOfConvertibleInstruments_pn3n3_c20240627__20240627_zErqInO6uoU7"&gt;119&lt;/span&gt; of principal amount into ordinary shares warrants&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            September 4, 2024, the Company converted $&lt;span id="xdx_90D_eifrs-full--IssueOfConvertibleInstruments_pn3n3_c20240904__20240904_zELRGBeNbks8"&gt;1,300&lt;/span&gt; of principal amount and accumulated interest
                                            into Senior Promissory Note (see note 7.E).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
                                            2025, the company repaid cash amount of $&lt;span id="xdx_90F_ecustom--RepaymentsOfDebtAmount_pn3n3_c20250101__20251231_zZ1stD97h4K4" title="Repaid cash amount"&gt;370&lt;/span&gt; of principal amount and accumulated interest.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
                                            2025, a total of &lt;span id="xdx_90D_eifrs-full--NumberOfSharesIssued_iI_pid_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InvestorsMember_zCCSxgwRiowd" title="Number of shares issued"&gt;2,333&lt;/span&gt; ordinary shares were issued to the investors, accordingly Finance
                                            expenses of approximately $&lt;span id="xdx_902_eifrs-full--FinanceCosts_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InvestorsMember_zcVHW4CIEdo8" title="Finance expenses"&gt;198&lt;/span&gt; were recognized against share capital and share premium.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2025, and December 31, 2024, the principal and the accumulated interest of the bridge loans were amounted to $&lt;span id="xdx_907_eifrs-full--LoansPayableInDefault_iI_pn3n3_c20251231_zSjEQnSYhtu5" title="Bridge loans"&gt;453&lt;/span&gt; and
$&lt;span id="xdx_902_eifrs-full--LoansPayableInDefault_iI_pn3n3_c20241231_zmRV2TyZharl" title="Bridge loans"&gt;728&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
warrants were classified as a derivative financial liability and are re-measured each reporting date, with changes in fair value recognized
in finance expense (income), net.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
valuing the Bonus Warrants using the Black Scholes model.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2025, and 2024, the fair value of the Bonus Warrants was &lt;span id="xdx_907_ecustom--FairValueOfBonusWarrants_iI_dxL_c20251231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zJHPJYkHUVCh" title="Fair value of bonus warrants::XDX::-"&gt;&lt;span id="xdx_908_ecustom--FairValueOfBonusWarrants_iI_dxL_c20241231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zVSiLomnKUB" title="Fair value of bonus warrants::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1940"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1942"&gt;nil&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
utilized a third-party appraiser to valuing the Redeemable Warrants Type 1. The fair value of the Redeemable Warrants Type 1 was calculated
using the Monte-Carlo simulation model.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2025 and 2024, the fair value of the Redeemable Warrants Type 1 was $&lt;span id="xdx_906_ecustom--FairValueOfWarrants_pn3n3_c20250101__20251231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeOneMember__ifrs-full--MeasurementAxis__custom--MonteCarloSimulationModelMember_zwkwuLiI3qR9" title="Fair value of warrants"&gt;30&lt;/span&gt; and $&lt;span id="xdx_908_ecustom--FairValueOfWarrants_pn3n3_c20240101__20241231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeOneMember__ifrs-full--MeasurementAxis__custom--MonteCarloSimulationModelMember_zHrSxJ8fdLb9" title="Fair value of warrants"&gt;34&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
utilized a third-party appraiser to valuing the Redeemable Warrants Type 2. The fair value of the Redeemable Warrants Type 2 was calculated
using Monte-Carlo simulation model.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2025 the redeemable warrants type 2 was expired&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2024, the fair value of the Redeemable Warrants Type 2 amounted to $&lt;span id="xdx_905_ecustom--FairValueOfWarrants_pn3n3_c20240101__20241231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeTwoMember__ifrs-full--MeasurementAxis__custom--MonteCarloSimulationModelMember_z2ABSm2fzAZ5" title="Fair value of warrants"&gt;140&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
main assumptions used in the three valuation models as of December 31, 2024 described above were:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;risk
                                            free rate &lt;span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20240101__20241231__ifrs-full--MeasurementAxis__custom--ThreeValuationModelsMember_zeTlFth7N4Q9"&gt;4.27&lt;/span&gt;%;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;volatility
                                            of assets &lt;span id="xdx_90B_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20240101__20241231__ifrs-full--MeasurementAxis__custom--ThreeValuationModelsMember_zZygSKvf7C0h"&gt;53.94&lt;/span&gt;%;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;expected
                                            terms of the warrants &lt;span id="xdx_909_ecustom--DescriptionOfExpectedTermWarrants_dtY_c20240101__20241231__ifrs-full--MeasurementAxis__custom--ThreeValuationModelsMember_zhpxjSGxM7C8" title="Term warrants"&gt;3.18&lt;/span&gt; years.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
main assumptions used in the three valuation models as of December 31, 2025, described above were:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;risk
                                            free rate &lt;span id="xdx_90B_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20250101__20251231__ifrs-full--MeasurementAxis__custom--ThreeValuationModelsMember_zCki133yx7L8"&gt;4.67&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;volatility
                                            of assets &lt;span id="xdx_90B_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20250101__20251231__ifrs-full--MeasurementAxis__custom--ThreeValuationModelsMember_zLXvLKRRRgB7"&gt;359.7&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;expected
                                            terms of the warrants &lt;span id="xdx_90A_ecustom--DescriptionOfExpectedTermWarrants_dtY_c20250101__20251231__ifrs-full--MeasurementAxis__custom--ThreeValuationModelsMember_zvANPaLHBvsf" title="Term warrants"&gt;2.18&lt;/span&gt; years.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfDebtSecuritiesExplanatory>
    <SMX:ProceedsFromLoansAndWarrants
      contextRef="From2022-08-012023-01-31_custom_BridgeLoanAgreementsMember_custom_ElevenLendersMember"
      decimals="-3"
      id="Fact001878"
      unitRef="USD">3860000</SMX:ProceedsFromLoansAndWarrants>
    <ifrs-full:BorrowingsMaturity
      contextRef="From2022-08-012023-01-31_ifrs-full_TopOfRangeMember_custom_BridgeLoanAgreementsMember"
      id="Fact001880">two years</ifrs-full:BorrowingsMaturity>
    <ifrs-full:BorrowingsInterestRate
      contextRef="AsOf2023-01-31_custom_BridgeLoanAgreementsMember"
      decimals="INF"
      id="Fact001882"
      unitRef="Pure">0.10</ifrs-full:BorrowingsInterestRate>
    <SMX:WarrantsToPurchaseShares
      contextRef="From2025-01-012025-12-31_custom_BridgeLoanAgreementsMember_custom_BonusWarrantsMember"
      decimals="INF"
      id="Fact001884"
      unitRef="Shares">0.32</SMX:WarrantsToPurchaseShares>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2025-01-012025-12-31_custom_BridgeLoanAgreementsMember_custom_BonusWarrantsMember"
      decimals="INF"
      id="Fact001888"
      unitRef="USDPShares">540787</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2025-01-012025-12-31_custom_BridgeLoanAgreementsMember_custom_BonusWarrantsMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact001890"
      unitRef="USDPShares">6608126366</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <SMX:WarrantsToPurchaseShares
      contextRef="From2025-01-012025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeOneMember"
      decimals="INF"
      id="Fact001892"
      unitRef="Shares">0.13</SMX:WarrantsToPurchaseShares>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="From2025-01-012025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeOneMember"
      decimals="INF"
      id="Fact001895"
      unitRef="USDPShares">540787</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="From2025-01-012025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeOneMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact001896"
      unitRef="USDPShares">6608126366</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:BorrowingsMaturity
      contextRef="From2025-01-012025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeOneMember"
      id="Fact001897">five years</ifrs-full:BorrowingsMaturity>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeOneMember"
      decimals="INF"
      id="Fact001898"
      unitRef="Pure">0.5000</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2025-01-012025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeOneMember"
      decimals="INF"
      id="Fact001899"
      unitRef="USDPShares">235125</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2025-01-012025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeOneMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact001900"
      unitRef="USDPShares">2873098420</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeOneMember_custom_ThirdAnniversaryMember"
      decimals="INF"
      id="Fact001901"
      unitRef="Pure">0.2500</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2025-01-012025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeOneMember_custom_ThirdAnniversaryMember"
      decimals="INF"
      id="Fact001902"
      unitRef="USDPShares">235125</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2025-01-012025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeOneMember_custom_ThirdAnniversaryMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact001903"
      unitRef="USDPShares">2873098420</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeOneMember_custom_FourthAnniversaryMember"
      decimals="INF"
      id="Fact001904"
      unitRef="Pure">0.2500</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2025-01-012025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeOneMember_custom_FourthAnniversaryMember"
      decimals="INF"
      id="Fact001905"
      unitRef="USDPShares">235125</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2025-01-012025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeOneMember_custom_FourthAnniversaryMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact001906"
      unitRef="USDPShares">2873098420</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <SMX:WarrantsToPurchaseShares
      contextRef="From2025-01-012025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeTwoMember"
      decimals="INF"
      id="Fact001907"
      unitRef="Shares">0.53</SMX:WarrantsToPurchaseShares>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="From2024-01-012024-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeTwoMember"
      decimals="INF"
      id="Fact001909"
      unitRef="USDPShares">540787</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="From2025-01-012025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeTwoMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact001910"
      unitRef="USDPShares">6608126366</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:BorrowingsMaturity
      contextRef="From2024-01-012024-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeTwoMember"
      id="Fact001911">five years</ifrs-full:BorrowingsMaturity>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeTwoMember_custom_FirstAnniversaryMember"
      decimals="INF"
      id="Fact001912"
      unitRef="Pure">0.5000</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2025-01-012025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeTwoMember_custom_FirstAnniversaryMember"
      decimals="INF"
      id="Fact001913"
      unitRef="USDPShares">235125</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2025-01-012025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeTwoMember_custom_FirstAnniversaryMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact001914"
      unitRef="USDPShares">2873098420</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeTwoMember_custom_SecondAnniversaryMember"
      decimals="INF"
      id="Fact001915"
      unitRef="Pure">0.5000</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2025-01-012025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeTwoMember_custom_SecondAnniversaryMember"
      decimals="INF"
      id="Fact001916"
      unitRef="USDPShares">235125</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2025-01-012025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeTwoMember_custom_SecondAnniversaryMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact001917"
      unitRef="USDPShares">2873098420</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:DescriptionOfApproachUsedToDetermineDiscountRates
      contextRef="From2025-01-012025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeTwoMember"
      id="Fact001918">Each
investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of the
Company based upon a 20% discount to the 20-trading day VWAP preceding each such anniversary.</ifrs-full:DescriptionOfApproachUsedToDetermineDiscountRates>
    <ifrs-full:IssueOfConvertibleInstruments
      contextRef="From2023-12-312023-12-31_custom_BridgeLoanAgreementsMember"
      decimals="-3"
      id="Fact001920"
      unitRef="USD">1350000</ifrs-full:IssueOfConvertibleInstruments>
    <SMX:RedeemableWarrants
      contextRef="AsOf2023-12-31_custom_BridgeLoanAgreementsMember"
      decimals="-3"
      id="Fact001922"
      unitRef="USD">1000000</SMX:RedeemableWarrants>
    <ifrs-full:IssueOfConvertibleInstruments
      contextRef="From2024-12-312024-12-31_custom_BridgeLoanAgreementsMember"
      decimals="-3"
      id="Fact001924"
      unitRef="USD">750000</ifrs-full:IssueOfConvertibleInstruments>
    <SMX:RedeemableWarrants
      contextRef="AsOf2024-12-31_custom_BridgeLoanAgreementsMember"
      decimals="-3"
      id="Fact001926"
      unitRef="USD">1450000</SMX:RedeemableWarrants>
    <ifrs-full:IssueOfConvertibleInstruments
      contextRef="From2024-06-272024-06-27"
      decimals="-3"
      id="Fact001927"
      unitRef="USD">119000</ifrs-full:IssueOfConvertibleInstruments>
    <ifrs-full:IssueOfConvertibleInstruments
      contextRef="From2024-09-042024-09-04"
      decimals="-3"
      id="Fact001928"
      unitRef="USD">1300000</ifrs-full:IssueOfConvertibleInstruments>
    <SMX:RepaymentsOfDebtAmount
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001930"
      unitRef="USD">370000</SMX:RepaymentsOfDebtAmount>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-12-31_custom_InvestorsMember"
      decimals="INF"
      id="Fact001932"
      unitRef="Shares">2333</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:FinanceCosts
      contextRef="From2025-01-012025-12-31_custom_InvestorsMember"
      decimals="-3"
      id="Fact001934"
      unitRef="USD">198000</ifrs-full:FinanceCosts>
    <ifrs-full:LoansPayableInDefault
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact001936"
      unitRef="USD">453000</ifrs-full:LoansPayableInDefault>
    <ifrs-full:LoansPayableInDefault
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001938"
      unitRef="USD">728000</ifrs-full:LoansPayableInDefault>
    <SMX:FairValueOfWarrants
      contextRef="From2025-01-012025-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeOneMember_custom_MonteCarloSimulationModelMember"
      decimals="-3"
      id="Fact001944"
      unitRef="USD">30000</SMX:FairValueOfWarrants>
    <SMX:FairValueOfWarrants
      contextRef="From2024-01-012024-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeOneMember_custom_MonteCarloSimulationModelMember"
      decimals="-3"
      id="Fact001946"
      unitRef="USD">34000</SMX:FairValueOfWarrants>
    <SMX:FairValueOfWarrants
      contextRef="From2024-01-012024-12-31_custom_BridgeLoanAgreementsMember_custom_RedeemableWarrantsTypeTwoMember_custom_MonteCarloSimulationModelMember"
      decimals="-3"
      id="Fact001948"
      unitRef="USD">140000</SMX:FairValueOfWarrants>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2024-01-012024-12-31_custom_ThreeValuationModelsMember"
      decimals="INF"
      id="Fact001949"
      unitRef="Pure">0.0427</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2024-01-012024-12-31_custom_ThreeValuationModelsMember"
      decimals="INF"
      id="Fact001950"
      unitRef="Pure">0.5394</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <SMX:DescriptionOfExpectedTermWarrants
      contextRef="From2024-01-012024-12-31_custom_ThreeValuationModelsMember"
      id="Fact001952">P3Y2M4D</SMX:DescriptionOfExpectedTermWarrants>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2025-01-012025-12-31_custom_ThreeValuationModelsMember"
      decimals="INF"
      id="Fact001953"
      unitRef="Pure">0.0467</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2025-01-012025-12-31_custom_ThreeValuationModelsMember"
      decimals="INF"
      id="Fact001954"
      unitRef="Pure">3.597</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <SMX:DescriptionOfExpectedTermWarrants
      contextRef="From2025-01-012025-12-31_custom_ThreeValuationModelsMember"
      id="Fact001956">P2Y2M4D</SMX:DescriptionOfExpectedTermWarrants>
    <SMX:DisclosureOfSPACreditLineExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001958">&lt;p id="xdx_80D_ecustom--DisclosureOfSPACreditLineExplanatory_zqwTo6jyqmD" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
9 &#x2013; ALPHA &lt;span id="xdx_825_zAE5pqAj3gFg"&gt;SPA&lt;/span&gt;: &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 19, 2024, the Company entered into a Stock Purchase Agreement (&#x201c;SPA&#x201d;) with Alpha, committing Alpha to&lt;span id="xdx_903_ecustom--PurchasePriceDescription_c20240419__20240419__ifrs-full--TypesOfContractsAxis__custom--StockPurchaseAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zuursCdzDDll" title="Purchase price description"&gt; purchase up to
$&lt;span id="xdx_905_eifrs-full--NotionalAmount_iI_pn6n6_c20240419__ifrs-full--TypesOfContractsAxis__custom--StockPurchaseAgreementMember_zDRgT2jSB0Il"&gt;30&lt;/span&gt; million of the Company&#x2019;s ordinary shares, subject to the SPA&#x2019;s terms. The Company may direct Alpha to purchase ordinary
shares at its discretion after a three-month period, with a minimum purchase (&#x201c;Put&#x201d;) of $20 and a maximum of $833 in any
30-day period, subject to certain pricing conditions based on market price. The Company has the right to terminate the SPA at no cost
or penalty upon five trading days&#x2019; prior written notice to Alpha, provided that there are no outstanding Put notices for which
ordinary shares need to be issued and the Company has paid all amounts owed to Alpha pursuant to the SPA and any indebtedness the Company
otherwise owes to Alpha or its affiliates.&lt;/span&gt; As of December 31, 2024, no withdrawal was carried out from this credit line. On May 9, 2025,
the Company terminated the SPA without having made any withdrawals up to that date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</SMX:DisclosureOfSPACreditLineExplanatory>
    <SMX:PurchasePriceDescription
      contextRef="From2024-04-192024-04-19_custom_StockPurchaseAgreementMember_ifrs-full_OrdinarySharesMember"
      id="Fact001960">purchase up to
$30 million of the Company&#x2019;s ordinary shares, subject to the SPA&#x2019;s terms. The Company may direct Alpha to purchase ordinary
shares at its discretion after a three-month period, with a minimum purchase (&#x201c;Put&#x201d;) of $20 and a maximum of $833 in any
30-day period, subject to certain pricing conditions based on market price. The Company has the right to terminate the SPA at no cost
or penalty upon five trading days&#x2019; prior written notice to Alpha, provided that there are no outstanding Put notices for which
ordinary shares need to be issued and the Company has paid all amounts owed to Alpha pursuant to the SPA and any indebtedness the Company
otherwise owes to Alpha or its affiliates.</SMX:PurchasePriceDescription>
    <ifrs-full:NotionalAmount
      contextRef="AsOf2024-04-19_custom_StockPurchaseAgreementMember"
      decimals="-6"
      id="Fact001961"
      unitRef="USD">30000000</ifrs-full:NotionalAmount>
    <SMX:DisclosureOfTargetSEPAExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001963">&lt;p id="xdx_805_ecustom--DisclosureOfTargetSEPAExplanatory_zSrrsAfaVE8c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
10 &#x2013; &lt;span id="xdx_825_zqAa8BTw0bm1"&gt;TARGET SEPA&lt;/span&gt;:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 1, 2025, the Company entered into a Standby Equity Purchase Agreement as amended on December 9, 2025 (the &#x201c;SEPA&#x201d;)
with the Selling Stockholders Target Capital 1 LLC (the &#x201c;SEPA Investor&#x201d;), in which the SEPA Investor has committed to purchase
from the Company up to $&lt;span id="xdx_902_eifrs-full--NotionalAmount_iI_pn6n6_c20251201__ifrs-full--TypesOfContractsAxis__custom--StandbyEquityPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OrdinarySharesMember_zLhFbs4DfFJ7" title="Investor committed to purchase amount"&gt;100&lt;/span&gt; million of the Company&#x2019;s Ordinary Shares in an equity line of credit (the &#x201c;Equity Line&#x201d;),
subject to the terms and conditions specified in the SEPA;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
consideration for the SEPA Investor commitment to purchase Ordinary Shares upon the terms and subject to the conditions set forth in
the SEPA, the Company agreed to pay to the SEPA Investor a facility fee (the &#x201c;Facility Fee&#x201d;) equal to &lt;span id="xdx_903_ecustom--PercentageOfCommitmentAmount_pid_dcp_c20251201__20251201__ifrs-full--TypesOfContractsAxis__custom--StandbyEquityPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OrdinarySharesMember_zQPBRumOXK6i" title="Percentage of commitment amount"&gt;two&lt;/span&gt; percent of the
commitment amount of $&lt;span id="xdx_902_eifrs-full--NotionalAmount_iI_pn6n6_c20251201__ifrs-full--TypesOfContractsAxis__custom--StandbyEquityPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OrdinarySharesMember_zLGg7fyhf3Eh" title="Investor committed to purchase amount"&gt;100&lt;/span&gt; million. To satisfy the Facility Fee, the Company shall issue or cause to be issued or transferred to the SEPA
Investor that number of additional Ordinary Shares (or pre-funded warrants representing such shares) equal to $&lt;span id="xdx_90C_eifrs-full--IssuedCapitalOrdinaryShares_iI_pn6n6_c20251201__ifrs-full--TypesOfContractsAxis__custom--StandbyEquityPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OrdinarySharesMember_z35xWBCYf9Pe" title="Number of ordinary shares at a cost value issued"&gt;2&lt;/span&gt; million divided by the
lesser of the most recent closing price of the Ordinary Shares on (i) the effective date of the SEPA, and (ii) the lowest 1-Trading Day
VWAP of the Ordinary Shares of the five Trading Days immediately preceding the date the SEPA Form F-1 is declared effective. On December
30, 2025, The Company issued to the SEPA Investor &lt;span id="xdx_901_eifrs-full--NumberOfSharesIssued_iI_pid_c20251230__ifrs-full--TypesOfContractsAxis__custom--StandbyEquityPurchaseAgreementMember_zImzIxjabZYd" title="Number of ordinary shares issued"&gt;10,505&lt;/span&gt; ordinary shares at a cost value of $&lt;span id="xdx_90C_eifrs-full--IssuedCapitalOrdinaryShares_iI_pn3n3_c20251230__ifrs-full--TypesOfContractsAxis__custom--StandbyEquityPurchaseAgreementMember_zt5MegQJu0A4" title="Number of ordinary shares at a cost value issued"&gt;2,639&lt;/span&gt; equals to the spot price of the number
of shares issued as determined on their issuance date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Subject
to the terms and conditions of the SEPA, &lt;span id="xdx_904_ecustom--DescriptionOfInvestorsTermsAndConditions_c20251230__20251230__ifrs-full--TypesOfContractsAxis__custom--StandbyEquityPurchaseAgreementMember_zcAeiaAH31Oh" title="Investors terms and conditions description"&gt;the Company has the right from time to time at its discretion until the first day of the month
following the 36-month period after the date of the SEPA (or earlier in the event the SEPA Investor shall have made payment of $100 million
in Advances), to direct the SEPA Investor to purchase a specified amount of ordinary shares (each such sale, an &#x201c;Advance&#x201d;)
by delivering written notice to the SEPA Investor (each, an &#x201c;Advance Notice&#x201d;). While there is no mandatory minimum amount
for any Advance, it may not exceed the lesser of (i) an amount equal to one hundred percent (100%) of the average of the Daily Traded
Amount (as defined in the SEPA) during the five consecutive Trading Days immediately preceding an Advance Notice, (ii) 30% of the Daily
Traded Amount (as defined in the SEPA) and (iii) $1 million, and may not exceed 4.99% of the issued and outstanding Ordinary Shares.
The Ordinary Shares purchased pursuant to an Advance will be purchased at a price equal to 94% of the lowest VWAP of the Ordinary Shares
during the three Trading Days following the applicable notice date. The Company may also deliver intraday purchase notices to the Investor,
and the Ordinary Shares purchased pursuant to an intraday Advance will be purchased at a price equal to 98% of the lowest traded price
of the Ordinary Shares during the intraday pricing period, as determined pursuant to the terms of the SEPA.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has the right to control the timing and amount of any sales of ordinary shares to the SEPA Investor under the Equity Line. Actual
sales of the Ordinary Shares under the Equity Line will depend on a variety of factors to be determined by the Company from time to time,
which may include, among other things, market conditions, the trading price of the Ordinary Shares and determinations by the Company
as to the appropriate sources of funding for its business and operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the SEPA, the SEPA Investor may offer, sell or otherwise distribute all or a portion of the ordinary shares purchased under the SEPA,
either publicly or through private transactions, at prevailing market prices or at negotiated prices. The Company will not receive any
proceeds from the sale of ordinary shares by the SEPA Investor pursuant to the SEPA. However, the Company may receive up to $&lt;span id="xdx_90C_eifrs-full--ProceedsFromIssuingShares_pn6n6_c20251230__20251230__ifrs-full--TypesOfContractsAxis__custom--StandbyEquityPurchaseAgreementMember_zT9FhXSHoAL2" title="Gross proceeds"&gt;100&lt;/span&gt; million
in aggregate gross proceeds from sales of ordinary shares to the SEPA Investor that the Company may, in its sole discretion, elect to
make from time to time pursuant to the SEPA and in accordance with the terms and conditions thereof.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
10 &#x2013; TARGET SEPA (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company intends to use the net proceeds from the sale of the SEPA for working capital and general corporate purposes, to pay down certain
outstanding indebtedness and other liabilities of the Company. Initially, the Company intended to acquire bitcoin or another cryptocurrency
subject to the mutual consent of the parties, which should serve as a reserve asset for the Company, and for so long as the SEPA remain
outstanding, shall be used to secure amounts outstanding under the SEPA. After payment of expenses and certain liabilities, generally,
&lt;span id="xdx_90F_ecustom--PercentageOfNetProceedsUsedToPurchaseCryptoAssets_pid_dp_uPure_c20251230__20251230__ifrs-full--TypesOfContractsAxis__custom--StandbyEquityPurchaseAgreementMember_z3pML6Yh0B04" title="Net proceeds"&gt;50&lt;/span&gt;% of net proceeds to the Company under the SEPA and the Equity Line will be used to purchase the crypto assets. However, on December
9, 2025, &lt;span id="xdx_904_ecustom--DescriptionOfPurchaseObligationOfCryptoAssets_pid_c20251209__20251209__ifrs-full--TypesOfContractsAxis__custom--StandbyEquityPurchaseAgreementMember_zISzBxZ98Gr9" title="Description of purchase obligation of crypto assets"&gt;the agreement was amended and the Company&#x2019;s obligation to acquire bitcoin or another cryptocurrency with a portion of
the proceeds under the SEPA terms was amended. If at the time the Company delivers any purchase notice the price of the ordinary shares
on the trading market is at or above $10.0, the Company is not required to use the proceeds of such purchase notice to acquire bitcoin
or another cryptocurrency.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2025, &lt;span id="xdx_908_ecustom--WithdrawalOfStandbyEquityPurchase_iI_do_c20251231__ifrs-full--TypesOfContractsAxis__custom--StandbyEquityPurchaseAgreementMember_zIM9PsIKIkNc" title="Withdrawal of SEPA"&gt;no&lt;/span&gt; withdrawal was carried out from Target SEPA.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</SMX:DisclosureOfTargetSEPAExplanatory>
    <ifrs-full:NotionalAmount
      contextRef="AsOf2025-12-01_custom_StandbyEquityPurchaseAgreementMember_ifrs-full_OrdinarySharesMember"
      decimals="-6"
      id="Fact001965"
      unitRef="USD">100000000</ifrs-full:NotionalAmount>
    <SMX:PercentageOfCommitmentAmount
      contextRef="From2025-12-012025-12-01_custom_StandbyEquityPurchaseAgreementMember_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact001967"
      unitRef="Pure">2</SMX:PercentageOfCommitmentAmount>
    <ifrs-full:NotionalAmount
      contextRef="AsOf2025-12-01_custom_StandbyEquityPurchaseAgreementMember_ifrs-full_OrdinarySharesMember"
      decimals="-6"
      id="Fact001969"
      unitRef="USD">100000000</ifrs-full:NotionalAmount>
    <ifrs-full:IssuedCapitalOrdinaryShares
      contextRef="AsOf2025-12-01_custom_StandbyEquityPurchaseAgreementMember_ifrs-full_OrdinarySharesMember"
      decimals="-6"
      id="Fact001971"
      unitRef="USD">2000000</ifrs-full:IssuedCapitalOrdinaryShares>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-12-30_custom_StandbyEquityPurchaseAgreementMember"
      decimals="INF"
      id="Fact001973"
      unitRef="Shares">10505</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:IssuedCapitalOrdinaryShares
      contextRef="AsOf2025-12-30_custom_StandbyEquityPurchaseAgreementMember"
      decimals="-3"
      id="Fact001975"
      unitRef="USD">2639000</ifrs-full:IssuedCapitalOrdinaryShares>
    <SMX:DescriptionOfInvestorsTermsAndConditions
      contextRef="From2025-12-302025-12-30_custom_StandbyEquityPurchaseAgreementMember"
      id="Fact001977">the Company has the right from time to time at its discretion until the first day of the month
following the 36-month period after the date of the SEPA (or earlier in the event the SEPA Investor shall have made payment of $100 million
in Advances), to direct the SEPA Investor to purchase a specified amount of ordinary shares (each such sale, an &#x201c;Advance&#x201d;)
by delivering written notice to the SEPA Investor (each, an &#x201c;Advance Notice&#x201d;). While there is no mandatory minimum amount
for any Advance, it may not exceed the lesser of (i) an amount equal to one hundred percent (100%) of the average of the Daily Traded
Amount (as defined in the SEPA) during the five consecutive Trading Days immediately preceding an Advance Notice, (ii) 30% of the Daily
Traded Amount (as defined in the SEPA) and (iii) $1 million, and may not exceed 4.99% of the issued and outstanding Ordinary Shares.
The Ordinary Shares purchased pursuant to an Advance will be purchased at a price equal to 94% of the lowest VWAP of the Ordinary Shares
during the three Trading Days following the applicable notice date. The Company may also deliver intraday purchase notices to the Investor,
and the Ordinary Shares purchased pursuant to an intraday Advance will be purchased at a price equal to 98% of the lowest traded price
of the Ordinary Shares during the intraday pricing period, as determined pursuant to the terms of the SEPA.</SMX:DescriptionOfInvestorsTermsAndConditions>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="From2025-12-302025-12-30_custom_StandbyEquityPurchaseAgreementMember"
      decimals="-6"
      id="Fact001979"
      unitRef="USD">100000000</ifrs-full:ProceedsFromIssuingShares>
    <SMX:PercentageOfNetProceedsUsedToPurchaseCryptoAssets
      contextRef="From2025-12-302025-12-30_custom_StandbyEquityPurchaseAgreementMember"
      decimals="INF"
      id="Fact001981"
      unitRef="Pure">0.50</SMX:PercentageOfNetProceedsUsedToPurchaseCryptoAssets>
    <SMX:DescriptionOfPurchaseObligationOfCryptoAssets
      contextRef="From2025-12-092025-12-09_custom_StandbyEquityPurchaseAgreementMember"
      id="Fact001983">the agreement was amended and the Company&#x2019;s obligation to acquire bitcoin or another cryptocurrency with a portion of
the proceeds under the SEPA terms was amended. If at the time the Company delivers any purchase notice the price of the ordinary shares
on the trading market is at or above $10.0, the Company is not required to use the proceeds of such purchase notice to acquire bitcoin
or another cryptocurrency.</SMX:DescriptionOfPurchaseObligationOfCryptoAssets>
    <SMX:WithdrawalOfStandbyEquityPurchase
      contextRef="AsOf2025-12-31_custom_StandbyEquityPurchaseAgreementMember"
      decimals="0"
      id="Fact001985"
      unitRef="USD">0</SMX:WithdrawalOfStandbyEquityPurchase>
    <ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001987">&lt;p id="xdx_804_eifrs-full--DisclosureOfDerivativeFinancialInstrumentsExplanatory_zdwbz3cm99jd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
11 &#x2013; &lt;span id="xdx_82B_zysTowgStU1i"&gt;WARRANTS &#x2013; DERIVATIVE FINANCIAL LIABILITY&lt;/span&gt;&lt;/b&gt;:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 11, 2024, the Company entered into a AEGIS Private Placement transaction (the &#x201c;AEGIS Private Placement&#x201d;), pursuant
to a Securities Purchase Agreement and a Registration Rights Agreement with certain institutional investors (the &#x201c;Purchasers&#x201d;
), which under certain circumstances could result in an aggregate gross proceeds of up to $&lt;span id="xdx_907_ecustom--ProceedFromIssuanceOfPrivatePlacement_pn3n6_c20240911__20240911_zugoJqpr6w8j" title="Proceeds from issuance of private placement"&gt;5.350&lt;/span&gt; million, before deducting fees to the
placement agents and other expenses payable by the Company in connection with the Private before deducting fees to the placement agents
Placement. &lt;span id="xdx_902_ecustom--GrossProceedsOnEscrowAndPayablePercentage_pid_dp_uPure_c20240911__20240911_zJ9ubZ3JcVwa" title="Gross proceeds on escrow and payable percentage"&gt;20&lt;/span&gt;% of the gross proceeds, or $&lt;span id="xdx_90D_ecustom--ProceedsFromEscrowOfWarrants_pn3n3_c20240911__20240911_zZMoNnK97795" title="Gross proceeds from escrow"&gt;1,072&lt;/span&gt; was held in escrow and repaid to the Purchasers pursuant to certain circumstances during
the terms of the Series A Common Warrants issued in the AEGIS Private Placement. The Company was unable to satisfy certain of the specified
circumstances and did not receive the $&lt;span id="xdx_907_ecustom--AdjustmentsOfEscrowWarrants_pn3n3_c20240911__20240911_zjLqwXNZfM66" title="Adjustments of escrow"&gt;1,072&lt;/span&gt; from Escrow and adjustments were made to the Warrants issued as described below. As such,
the Company received gross proceeds of $&lt;span id="xdx_904_eifrs-full--FinanceCosts_pn3n3_c20240911__20240911_zhdrLKOwoBk5" title="Transaction costs"&gt;4,278&lt;/span&gt; excluding transaction costs. Aegis Capital Corp. (&#x201c;Aegis&#x201d;), acted as the lead
placement agent and ClearThink Securities acted as a co-placement agent for the AEGIS Private Placement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
offering consisted of the sale of &lt;span id="xdx_90E_eifrs-full--NumberOfSharesIssuedButNotFullyPaid_iI_pid_c20240911__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zGxF5wgknyyh" title="Sale of Common shares"&gt;187,719&lt;/span&gt; (&lt;span id="xdx_904_eifrs-full--NumberOfSharesIssuedButNotFullyPaid_iI_pid_c20240911__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zikiX5b2e0yb" title="Sale of Common shares"&gt;15&lt;/span&gt; after reverse stock splits) Common Units, each consisting of one Ordinary Share or Pre-Funded
Warrant, two Series A Common Warrants each to purchase one Ordinary Share per warrant at an exercise price of $&lt;span id="xdx_906_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_uUSDPShares_c20240911__20240911__ifrs-full--ClassesOfShareCapitalAxis__custom--TwoSeriesACommonWarrantsMember_zcTBpXG8Dygi" title="Exercise price"&gt;28.5&lt;/span&gt; ($&lt;span id="xdx_904_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_uUSDPShares_c20240911__20240911__ifrs-full--ClassesOfShareCapitalAxis__custom--TwoSeriesACommonWarrantsMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zoPRafH7qoRb" title="Exercise price"&gt;348,254&lt;/span&gt; after reverse
stock splits) , subject to adjustment, and one Series B Common Warrants to purchase such number of Ordinary Shares as determined in the
Series B Warrant. The public offering price per Common Unit was $&lt;span id="xdx_901_eifrs-full--ParValuePerShare_iI_pid_uUSDPShares_c20240911__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesBCommonWarrantsMember_z3G2u99yqqp1" title="Public offering price per share"&gt;28.5&lt;/span&gt; ($&lt;span id="xdx_901_eifrs-full--ParValuePerShare_iI_pid_uUSDPShares_c20240911__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesBCommonWarrantsMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_z1CGs0LZgKc" title="Public offering price per share"&gt;348,254&lt;/span&gt; after reverse stock splits) (or $&lt;span id="xdx_90B_eifrs-full--ParValuePerShare_iI_pid_uUSDPShares_c20240911__ifrs-full--ComponentsOfEquityAxis__custom--PreFundedUnitMember_zHXBpNGxjhH3" title="Public offering price per share"&gt;28.49&lt;/span&gt;) ($&lt;span id="xdx_901_eifrs-full--ParValuePerShare_iI_pid_uUSDPShares_c20240911__ifrs-full--ComponentsOfEquityAxis__custom--PreFundedUnitMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zPQofGsI9pna" title="Public offering price per share"&gt;348,132&lt;/span&gt; after
reverse stock splits) for each Pre-Funded Unit, which is equal to the public offering price per Common Unit to be sold in the offering
minus an exercise price of $&lt;span id="xdx_903_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_uUSDPShares_c20240911__20240911__ifrs-full--ComponentsOfEquityAxis__custom--PreFundedWarrantMember_zXvzXBvQYmD9" title="Exercise price"&gt;0.00285&lt;/span&gt; ($&lt;span id="xdx_906_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_uUSDPShares_c20240911__20240911__ifrs-full--ComponentsOfEquityAxis__custom--PreFundedWarrantMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zqE7qEJ50eH1" title="Exercise price"&gt;34.8&lt;/span&gt; after reverse stock splits) per Pre-Funded Warrant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Pre-Funded Warrants were immediately exercisable and may be exercised at any time until exercised in full. For each Pre-Funded Unit sold
in the offering, the number of Common Units in the offering will be decreased on a one-for-one basis. During the offering the company
issued &lt;span id="xdx_902_eifrs-full--NumberOfSharesIssued_iI_pid_c20240911__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zWe7Lh4Tm80d" title="Shares issued"&gt;55,789&lt;/span&gt; (&lt;span id="xdx_90D_eifrs-full--NumberOfSharesIssued_iI_pid_c20240911__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zWvzI4tbu13b" title="Shares issued"&gt;5&lt;/span&gt; after reverse stock splits) ordinary shares and &lt;span id="xdx_905_eifrs-full--NumberOfSharesIssued_iI_pid_c20240911__ifrs-full--ComponentsOfEquityAxis__custom--PreFundedWarrantMember_zxLyMZyFcgV9" title="Shares issued"&gt;131,930&lt;/span&gt; (&lt;span id="xdx_90A_eifrs-full--NumberOfSharesIssued_iI_pid_c20240911__ifrs-full--ComponentsOfEquityAxis__custom--PreFundedWarrantMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zAr0GhGWMepa" title="Shares issued"&gt;11&lt;/span&gt; after reverse stock splits) Pre-Funded Warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
initial exercise price of each Series A Common Warrant is $&lt;span id="xdx_904_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_uUSDPShares_c20240911__20240911__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesACommonWarrantsMember_zF5ah5dxIisl" title="Exercise price"&gt;1&lt;/span&gt; ($&lt;span id="xdx_908_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_uUSDPShares_c20240911__20240911__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesACommonWarrantsMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_z2gic5WgDKAb" title="Exercise price"&gt;12,219&lt;/span&gt; after reverse stock splits) per Ordinary Share. The Series A Common
Warrants are exercisable immediately subject to registration and expire by March 12, 3030. Post-adjustment, the number of securities
issuable under the Series A Common Warrants in the aggregate is &lt;span id="xdx_905_eifrs-full--NumberOfSharesIssued_iI_pid_c20240911__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesACommonWarrantsMember_zZIz16ucw7F7" title="Number of shares issued"&gt;766,210&lt;/span&gt; (&lt;span id="xdx_904_eifrs-full--NumberOfSharesIssued_iI_pid_c20240911__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesACommonWarrantsMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zv9aksvEDQEh" title="Number of shares issued"&gt;63&lt;/span&gt; after reverse stock splits). The post-adjustment exercise
price of each Series A Common Warrant is $&lt;span id="xdx_905_ecustom--AdjustmentOfExercisePrice_pid_uUSDPShares_c20240911__20240911__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesACommonWarrantsMember_zqxSDnVXzzQi" title="Adjustment of exercise price"&gt;13.9&lt;/span&gt; ($&lt;span id="xdx_907_ecustom--AdjustmentOfExercisePrice_pid_uUSDPShares_c20240911__20240911__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesACommonWarrantsMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zsiiOOkVbvZa" title="Adjustment of exercise price"&gt;169,850&lt;/span&gt; after reverse stock splits)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
11 &#x2013; WARRANTS &#x2013; DERIVATIVE FINANCIAL LIABILITY (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
initial exercise price of each Series B Common Warrant is $&lt;span id="xdx_909_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_uUSDPShares_c20240911__20240911__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesBCommonWarrantsMember_zxCXZUuX0MRa" title="Exercise price"&gt;0.00285&lt;/span&gt; ($&lt;span id="xdx_90D_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_uUSDPShares_c20240911__20240911__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesBCommonWarrantsMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zZqD1lFEBo6h" title="Exercise price"&gt;34.8&lt;/span&gt; after reverse stock splits) per Ordinary Share. The number
of Ordinary Shares issuable under the Series B Warrant, if any, is subject to adjustment to be determined pursuant to the trading price
of the Ordinary Shares following the effectiveness of a resale registration statement that the Company has undertaken to file on behalf
the Purchasers. Post-adjustment, the number of securities issuable under the Series B Common Warrant is &lt;span id="xdx_90A_eifrs-full--NumberOfSharesIssued_iI_pid_c20240911__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesBCommonWarrantsMember_zGF7tZ06kWRa" title="Number of shares issued"&gt;195,381&lt;/span&gt; (&lt;span id="xdx_90C_eifrs-full--NumberOfSharesIssued_iI_pid_c20240911__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesBCommonWarrantsMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zOpqyn8JSn6b" title="Number of shares issued"&gt;16&lt;/span&gt; after reverse stock
splits).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Pre-Funded Warrants, Series B Common Warrants and Series A Common Warrant meets the definition of a derivative financial liability and
measured at fair value through profit and loss on initial recognition and subsequent.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2024, all the Pre-Funded warrants and all the Series B Common Warrants were exercised into ordinary shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of October 28, 2024, the fair value of the Series A Common Warrant was $&lt;span id="xdx_90F_ecustom--FairValueOfWarrants_pn3n3_c20241028__20241028__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesACommonWarrantsMember_zGVLcwpKW8V4" title="Fair value of warrants"&gt;5,845&lt;/span&gt; which is recognized on a systematic basis over the period
the time-value of Warrant A decays, on a straight-line basis &#x2013; the Company expects this period to be approximately five years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
utilized a third-party appraiser to assist them in valuing the Series A Common Warrant by using the Black-Scholes model.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
key inputs that were used to estimate the fair value as of October 28, 2024, were:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;risk-free
                                            interest rate &lt;span id="xdx_90C_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20241028__20241028__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesACommonWarrantsMember_zOwB1BhooEmg" title="Risk-free interest rate"&gt;4.11&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;expected
                                            volatility &lt;span id="xdx_909_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20241028__20241028__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesACommonWarrantsMember_zcYbXCC0kul8" title="Expected volatility"&gt;59.1&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;expected
                                            dividend yield of &lt;span id="xdx_905_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20241028__20241028__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesACommonWarrantsMember_zkUsFG4cXjY7" title="Expected dividend yield"&gt;0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;expected
                                            term of warrants &#x2013; &lt;span id="xdx_901_ecustom--DescriptionOfExpectedTermWarrants_dtYp_c20241028__20241028__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesACommonWarrantsMember_z30VK0gUopF9" title="Expected term of warrants"&gt;5.4&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
2024, &lt;span id="xdx_905_eifrs-full--NumberOfSharesIssued_iI_pid_c20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesACommonWarrantsMember_zXL9gQFOORN5" title="Number of shares issued"&gt;277,439&lt;/span&gt; (&lt;span id="xdx_901_eifrs-full--NumberOfSharesIssued_iI_pid_c20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesACommonWarrantsMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zS0J1MkH7BZf" title="Number of shares issued"&gt;23&lt;/span&gt; after reverse stock splits) Series A Common Warrants were exercised into ordinary shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
remaining &lt;span id="xdx_90D_eifrs-full--NumberOfSharesIssued_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesACommonWarrantsMember_zWHuXvkZQV06" title="Number of shares issued and outstanding"&gt;488,762&lt;/span&gt; (&lt;span id="xdx_90E_eifrs-full--NumberOfSharesIssued_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesACommonWarrantsMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zUFS4vDZ2LR" title="Number of shares issued and outstanding"&gt;40&lt;/span&gt; after reverse stock splits) Series A Common Warrants have been valued at the fair value as of December 31, 2025
and 2024 and amounted to $&lt;span id="xdx_90E_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesACommonWarrantsMember_zoXkwvJz4Pxi" title="Derivative financial liabilities"&gt;5&lt;/span&gt; and $&lt;span id="xdx_900_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesACommonWarrantsMember_z0HtnSSVvXc1" title="Derivative financial liabilities"&gt;1,322&lt;/span&gt; respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
key inputs that were used to estimate the fair value as of December 31, 2025, were:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;risk-free
                                            interest rate &lt;span id="xdx_90A_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesACommonWarrantsMember_zT99CYg2Qqn5" title="Risk-free interest rate"&gt;3.658&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;expected
                                            volatility &lt;span id="xdx_90C_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesACommonWarrantsMember_zG9WgUp60ARd" title="Expected volatility"&gt;168.55&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;expected
                                            dividend yield of &lt;span id="xdx_90D_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesACommonWarrantsMember_z3SyYIdEtjM5" title="Expected dividend yield"&gt;0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;expected
                                            term of warrants &#x2013; &lt;span id="xdx_90C_ecustom--DescriptionOfExpectedTermWarrants_dtYp_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesACommonWarrantsMember_zVv2mScdLn1f" title="Expected term of warrants"&gt;4.2&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
key inputs that were used to estimate the fair value as of December 31, 2024, were:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;risk-free
                                            interest rate &lt;span id="xdx_90A_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesACommonWarrantsMember_zVUGRgCaQnD2" title="Risk-free interest rate"&gt;4.38&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;expected
                                            volatility &lt;span id="xdx_908_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesACommonWarrantsMember_z0ycI8SjVcne" title="Expected volatility"&gt;58.9&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;expected
                                            dividend yield of &lt;span id="xdx_90B_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesACommonWarrantsMember_z5X1CFB8LEnd" title="Expected dividend yield"&gt;0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;expected
                                            term of warrants &#x2013; &lt;span id="xdx_90D_ecustom--DescriptionOfExpectedTermWarrants_dtYp_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesACommonWarrantsMember_zk2gIWIGG8Rc" title="Expected term of warrants"&gt;5.2&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company also entered into a Placement Agent Agreement with Aegis as the lead placement agent, The Company agreed to pay Aegis a cash
placement fee equal to &lt;span id="xdx_90E_ecustom--CashPlacementFeePercentage_pid_dp_uPure_c20250101__20251231__ifrs-full--TypesOfContractsAxis__custom--PlacementAgentAgreementtMember_zjvpyUnGnqK9" title="Cash placement fee percentage"&gt;10.0&lt;/span&gt;% of the gross cash proceeds received in the AEGIS Private Placement, a &lt;span id="xdx_90E_ecustom--GrossProceedsOnCashProceedsPercentage_pid_dp_uPure_c20250101__20251231__ifrs-full--TypesOfContractsAxis__custom--PlacementAgentAgreementtMember_zRYwaWOfxlMf" title="Gross proceeds on cash proceeds percentage"&gt;3&lt;/span&gt;% commission of the proceeds from
any cash exercise of the Warrants, and to pay ClearThink Securities a cash placement fee equal to &lt;span id="xdx_90F_ecustom--CashPlacementFeePercentage_pid_dp_uPure_c20250101__20251231_zLESg84MakH3" title="Cash placement fee percentage"&gt;2.0&lt;/span&gt;% of the gross cash proceeds received
in the AEGIS Private Placement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
transaction cost amounted to $&lt;span id="xdx_90B_ecustom--TransactionCost_pn3n3_c20250101__20251231_zIJJ9Hruq3D4" title="Transaction cost"&gt;1,113&lt;/span&gt; and allocated to the financial instruments issued that measured at fair value through profit and
loss and recorded as expenses incurred. The placement agent fee includes liable to pay &lt;span id="xdx_908_ecustom--CashPlacementFeePercentage_pid_dp_uPure_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesACommonWarrantsMember_zHZhTcVjPkw9" title="Cash placement fee percentage"&gt;3&lt;/span&gt;% of the proceeds from the cash exercise of Series
A Common Warrants (&#x201c;the &lt;span id="xdx_902_ecustom--GrossProceedsOnCashProceedsPercentage_pid_dp_uPure_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesACommonWarrantsMember_zb44LnqmEmpk" title="Gross proceeds on cash proceeds percentage"&gt;3&lt;/span&gt;% Provision&#x201d;). The &lt;span id="xdx_90D_ecustom--ProvisionForFairValueOfFinancialLiabilityPercentage_pid_dp_uPure_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesACommonWarrantsMember_znH3AfHx3LTf" title="Provision for fair value of financial liability percentage"&gt;3&lt;/span&gt;% Provision accounted for financial liability at fair value through profit and
loss on initial recognition and subsequent.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
11 &#x2013; WARRANTS &#x2013; DERIVATIVE FINANCIAL LIABILITY (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
utilized a third-party appraiser to assist them in valuing the &lt;span id="xdx_90E_ecustom--ProvisionForFairValueOfFinancialLiabilityPercentage_pid_dp_uPure_c20241028__20241028__ifrs-full--CounterpartiesAxis__custom--ThirdPartyMember_zV6nUbRG3bO" title="Provision for fair value of financial liability percentage"&gt;3&lt;/span&gt;% Provision by using the Black-Scholes model. The key inputs that were
used to estimate the fair value as of October 28, 2024, were:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;risk-free
                                            interest rate &lt;span id="xdx_907_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20241028__20241028__ifrs-full--CounterpartiesAxis__custom--ThirdPartyMember_zXEhGTnPnxSf" title="Risk-free interest rate"&gt;4.11&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;expected
                                            volatility &lt;span id="xdx_903_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20241028__20241028__ifrs-full--CounterpartiesAxis__custom--ThirdPartyMember_zEXPgYQbt6u" title="Expected volatility"&gt;59.1&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;expected
                                            dividend yield of &lt;span id="xdx_90C_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20241028__20241028__ifrs-full--CounterpartiesAxis__custom--ThirdPartyMember_zScG10nwna4e" title="Expected dividend yield"&gt;0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;expected
                                            term of warrants &#x2013; &lt;span id="xdx_90D_ecustom--DescriptionOfExpectedTermWarrants_dtYp_c20241028__20241028__ifrs-full--CounterpartiesAxis__custom--ThirdPartyMember_zzAxJxRt7JZc" title="Expected term of warrants"&gt;5.4&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of October 28, 2024, the fair value of the &lt;span id="xdx_901_ecustom--ProvisionForFairValueOfFinancialLiabilityPercentage_pid_dp_uPure_c20241028__20241028__ifrs-full--CounterpartiesAxis__custom--ThirdPartyMember_zriipEm572Gc" title="Provision for fair value of financial liability percentage"&gt;3&lt;/span&gt;% provision was $&lt;span id="xdx_90A_ecustom--FairValueOfWarrants_pn3n3_c20241028__20241028__ifrs-full--CounterpartiesAxis__custom--ThirdPartyMember_zrhNSIQ6LFPc" title="Fair value of warrants"&gt;76&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
key inputs that were used to estimate the fair value as of December 31, 2025, were:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;risk-free
                                            interest rate &lt;span id="xdx_909_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20250101__20251231__ifrs-full--CounterpartiesAxis__custom--ThirdPartyMember_zBgh14oP8pxa" title="Risk-free interest rate"&gt;3.658&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;expected
                                            volatility &lt;span id="xdx_903_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20250101__20251231__ifrs-full--CounterpartiesAxis__custom--ThirdPartyMember_zVjVIRATlULd" title="Expected volatility"&gt;168.55&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;expected
                                            dividend yield of &lt;span id="xdx_909_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20250101__20251231__ifrs-full--CounterpartiesAxis__custom--ThirdPartyMember_zK589LvSY455" title="Expected dividend yield"&gt;0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;expected
                                            term of warrants &#x2013; &lt;span id="xdx_907_ecustom--DescriptionOfExpectedTermWarrants_dtYp_c20250101__20251231__ifrs-full--CounterpartiesAxis__custom--ThirdPartyMember_zN0NMTP78uHe" title="Expected term of warrants"&gt;4.2&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
key inputs that were used to estimate the fair value as of December 31, 2024, were:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;risk-free
                                            interest rate &lt;span id="xdx_905_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20240101__20241231__ifrs-full--CounterpartiesAxis__custom--ThirdPartyMember_znryXwLZbB9b" title="Risk-free interest rate"&gt;4.38&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;expected
                                            volatility &lt;span id="xdx_90C_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20240101__20241231__ifrs-full--CounterpartiesAxis__custom--ThirdPartyMember_zq1aFBGueaxl" title="Expected volatility"&gt;58.9&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;expected
                                            dividend yield of &lt;span id="xdx_90F_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20240101__20241231__ifrs-full--CounterpartiesAxis__custom--ThirdPartyMember_zHQTpNdGoXrk" title="Expected dividend yield"&gt;0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;expected
                                            term of warrants &#x2013; &lt;span id="xdx_902_ecustom--DescriptionOfExpectedTermWarrants_dtYp_c20240101__20241231__ifrs-full--CounterpartiesAxis__custom--ThirdPartyMember_zOgWTleOAA9j" title="Expected term of warrants"&gt;5.2&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2025, and December 31, 2024, the fair value of the &lt;span id="xdx_908_ecustom--ProvisionForFairValueOfFinancialLiabilityPercentage_pid_dp_uPure_c20250101__20251231__ifrs-full--CounterpartiesAxis__custom--ThirdPartyMember_zXPFl9QSC8W6" title="Provision for fair value of financial liability percentage"&gt;&lt;span id="xdx_90E_ecustom--ProvisionForFairValueOfFinancialLiabilityPercentage_pid_dp_uPure_c20240101__20241231__ifrs-full--CounterpartiesAxis__custom--ThirdPartyMember_zKOEBAp9Qxs7" title="Provision for fair value of financial liability percentage"&gt;3&lt;/span&gt;&lt;/span&gt;% provision was $&lt;span id="xdx_904_ecustom--FairValueOfWarrants_pp5n6_c20250101__20251231__ifrs-full--CounterpartiesAxis__custom--ThirdPartyMember_zDvRKHwFRHx8" title="Fair value of warrants"&gt;0.01&lt;/span&gt; and $&lt;span id="xdx_904_ecustom--FairValueOfWarrants_pn3n3_c20240101__20241231__ifrs-full--CounterpartiesAxis__custom--ThirdPartyMember_zS4utfqADdJj" title="Fair value of warrants"&gt;59&lt;/span&gt; respectively.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory>
    <SMX:ProceedFromIssuanceOfPrivatePlacement
      contextRef="From2024-09-112024-09-11"
      decimals="-3"
      id="Fact001989"
      unitRef="USD">5350000</SMX:ProceedFromIssuanceOfPrivatePlacement>
    <SMX:GrossProceedsOnEscrowAndPayablePercentage
      contextRef="From2024-09-112024-09-11"
      decimals="INF"
      id="Fact001991"
      unitRef="Pure">0.20</SMX:GrossProceedsOnEscrowAndPayablePercentage>
    <SMX:ProceedsFromEscrowOfWarrants
      contextRef="From2024-09-112024-09-11"
      decimals="-3"
      id="Fact001993"
      unitRef="USD">1072000</SMX:ProceedsFromEscrowOfWarrants>
    <SMX:AdjustmentsOfEscrowWarrants
      contextRef="From2024-09-112024-09-11"
      decimals="-3"
      id="Fact001995"
      unitRef="USD">1072000</SMX:AdjustmentsOfEscrowWarrants>
    <ifrs-full:FinanceCosts
      contextRef="From2024-09-112024-09-11"
      decimals="-3"
      id="Fact001997"
      unitRef="USD">4278000</ifrs-full:FinanceCosts>
    <ifrs-full:NumberOfSharesIssuedButNotFullyPaid
      contextRef="AsOf2024-09-11_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact001999"
      unitRef="Shares">187719</ifrs-full:NumberOfSharesIssuedButNotFullyPaid>
    <ifrs-full:NumberOfSharesIssuedButNotFullyPaid
      contextRef="AsOf2024-09-11_ifrs-full_OrdinarySharesMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact002001"
      unitRef="Shares">15</ifrs-full:NumberOfSharesIssuedButNotFullyPaid>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2024-09-112024-09-11_custom_TwoSeriesACommonWarrantsMember"
      decimals="INF"
      id="Fact002003"
      unitRef="USDPShares">28.5</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2024-09-112024-09-11_custom_TwoSeriesACommonWarrantsMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact002005"
      unitRef="USDPShares">348254</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2024-09-11_custom_SeriesBCommonWarrantsMember"
      decimals="INF"
      id="Fact002007"
      unitRef="USDPShares">28.5</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2024-09-11_custom_SeriesBCommonWarrantsMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact002009"
      unitRef="USDPShares">348254</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2024-09-11_custom_PreFundedUnitMember"
      decimals="INF"
      id="Fact002011"
      unitRef="USDPShares">28.49</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2024-09-11_custom_PreFundedUnitMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact002013"
      unitRef="USDPShares">348132</ifrs-full:ParValuePerShare>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2024-09-112024-09-11_custom_PreFundedWarrantMember"
      decimals="INF"
      id="Fact002015"
      unitRef="USDPShares">0.00285</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2024-09-112024-09-11_custom_PreFundedWarrantMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact002017"
      unitRef="USDPShares">34.8</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-09-11_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact002019"
      unitRef="Shares">55789</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-09-11_ifrs-full_OrdinarySharesMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact002021"
      unitRef="Shares">5</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-09-11_custom_PreFundedWarrantMember"
      decimals="INF"
      id="Fact002023"
      unitRef="Shares">131930</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-09-11_custom_PreFundedWarrantMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact002025"
      unitRef="Shares">11</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2024-09-112024-09-11_custom_SeriesACommonWarrantsMember"
      decimals="INF"
      id="Fact002027"
      unitRef="USDPShares">1</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2024-09-112024-09-11_custom_SeriesACommonWarrantsMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact002029"
      unitRef="USDPShares">12219</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-09-11_custom_SeriesACommonWarrantsMember"
      decimals="INF"
      id="Fact002031"
      unitRef="Shares">766210</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-09-11_custom_SeriesACommonWarrantsMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact002033"
      unitRef="Shares">63</ifrs-full:NumberOfSharesIssued>
    <SMX:AdjustmentOfExercisePrice
      contextRef="From2024-09-112024-09-11_custom_SeriesACommonWarrantsMember"
      decimals="INF"
      id="Fact002035"
      unitRef="USDPShares">13.9</SMX:AdjustmentOfExercisePrice>
    <SMX:AdjustmentOfExercisePrice
      contextRef="From2024-09-112024-09-11_custom_SeriesACommonWarrantsMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact002037"
      unitRef="USDPShares">169850</SMX:AdjustmentOfExercisePrice>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2024-09-112024-09-11_custom_SeriesBCommonWarrantsMember"
      decimals="INF"
      id="Fact002039"
      unitRef="USDPShares">0.00285</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2024-09-112024-09-11_custom_SeriesBCommonWarrantsMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact002041"
      unitRef="USDPShares">34.8</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-09-11_custom_SeriesBCommonWarrantsMember"
      decimals="INF"
      id="Fact002043"
      unitRef="Shares">195381</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-09-11_custom_SeriesBCommonWarrantsMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact002045"
      unitRef="Shares">16</ifrs-full:NumberOfSharesIssued>
    <SMX:FairValueOfWarrants
      contextRef="From2024-10-282024-10-28_custom_SeriesACommonWarrantsMember"
      decimals="-3"
      id="Fact002047"
      unitRef="USD">5845000</SMX:FairValueOfWarrants>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2024-10-282024-10-28_custom_SeriesACommonWarrantsMember"
      decimals="INF"
      id="Fact002049"
      unitRef="Pure">0.0411</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2024-10-282024-10-28_custom_SeriesACommonWarrantsMember"
      decimals="INF"
      id="Fact002051"
      unitRef="Pure">0.591</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2024-10-282024-10-28_custom_SeriesACommonWarrantsMember"
      decimals="INF"
      id="Fact002053"
      unitRef="Pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <SMX:DescriptionOfExpectedTermWarrants
      contextRef="From2024-10-282024-10-28_custom_SeriesACommonWarrantsMember"
      id="Fact002055">P5Y4M24D</SMX:DescriptionOfExpectedTermWarrants>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-12-31_custom_SeriesACommonWarrantsMember"
      decimals="INF"
      id="Fact002057"
      unitRef="Shares">277439</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-12-31_custom_SeriesACommonWarrantsMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact002059"
      unitRef="Shares">23</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-12-31_custom_SeriesACommonWarrantsMember"
      decimals="INF"
      id="Fact002061"
      unitRef="Shares">488762</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-12-31_custom_SeriesACommonWarrantsMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact002063"
      unitRef="Shares">40</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2025-12-31_custom_SeriesACommonWarrantsMember"
      decimals="-3"
      id="Fact002065"
      unitRef="USD">5000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2024-12-31_custom_SeriesACommonWarrantsMember"
      decimals="-3"
      id="Fact002067"
      unitRef="USD">1322000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2025-01-012025-12-31_custom_SeriesACommonWarrantsMember"
      decimals="INF"
      id="Fact002069"
      unitRef="Pure">0.03658</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2025-01-012025-12-31_custom_SeriesACommonWarrantsMember"
      decimals="INF"
      id="Fact002071"
      unitRef="Pure">1.6855</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2025-01-012025-12-31_custom_SeriesACommonWarrantsMember"
      decimals="INF"
      id="Fact002073"
      unitRef="Pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <SMX:DescriptionOfExpectedTermWarrants
      contextRef="From2025-01-012025-12-31_custom_SeriesACommonWarrantsMember"
      id="Fact002075">P4Y2M12D</SMX:DescriptionOfExpectedTermWarrants>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2024-01-012024-12-31_custom_SeriesACommonWarrantsMember"
      decimals="INF"
      id="Fact002077"
      unitRef="Pure">0.0438</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2024-01-012024-12-31_custom_SeriesACommonWarrantsMember"
      decimals="INF"
      id="Fact002079"
      unitRef="Pure">0.589</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2024-01-012024-12-31_custom_SeriesACommonWarrantsMember"
      decimals="INF"
      id="Fact002081"
      unitRef="Pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <SMX:DescriptionOfExpectedTermWarrants
      contextRef="From2024-01-012024-12-31_custom_SeriesACommonWarrantsMember"
      id="Fact002083">P5Y2M12D</SMX:DescriptionOfExpectedTermWarrants>
    <SMX:CashPlacementFeePercentage
      contextRef="From2025-01-012025-12-31_custom_PlacementAgentAgreementtMember"
      decimals="INF"
      id="Fact002085"
      unitRef="Pure">0.100</SMX:CashPlacementFeePercentage>
    <SMX:GrossProceedsOnCashProceedsPercentage
      contextRef="From2025-01-012025-12-31_custom_PlacementAgentAgreementtMember"
      decimals="INF"
      id="Fact002087"
      unitRef="Pure">0.03</SMX:GrossProceedsOnCashProceedsPercentage>
    <SMX:CashPlacementFeePercentage
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact002089"
      unitRef="Pure">0.020</SMX:CashPlacementFeePercentage>
    <SMX:TransactionCost
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact002091"
      unitRef="USD">1113000</SMX:TransactionCost>
    <SMX:CashPlacementFeePercentage
      contextRef="From2025-01-012025-12-31_custom_SeriesACommonWarrantsMember"
      decimals="INF"
      id="Fact002093"
      unitRef="Pure">0.03</SMX:CashPlacementFeePercentage>
    <SMX:GrossProceedsOnCashProceedsPercentage
      contextRef="From2025-01-012025-12-31_custom_SeriesACommonWarrantsMember"
      decimals="INF"
      id="Fact002095"
      unitRef="Pure">0.03</SMX:GrossProceedsOnCashProceedsPercentage>
    <SMX:ProvisionForFairValueOfFinancialLiabilityPercentage
      contextRef="From2025-01-012025-12-31_custom_SeriesACommonWarrantsMember"
      decimals="INF"
      id="Fact002097"
      unitRef="Pure">0.03</SMX:ProvisionForFairValueOfFinancialLiabilityPercentage>
    <SMX:ProvisionForFairValueOfFinancialLiabilityPercentage
      contextRef="From2024-10-282024-10-28_custom_ThirdPartyMember"
      decimals="INF"
      id="Fact002099"
      unitRef="Pure">0.03</SMX:ProvisionForFairValueOfFinancialLiabilityPercentage>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2024-10-282024-10-28_custom_ThirdPartyMember"
      decimals="INF"
      id="Fact002101"
      unitRef="Pure">0.0411</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2024-10-282024-10-28_custom_ThirdPartyMember"
      decimals="INF"
      id="Fact002103"
      unitRef="Pure">0.591</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2024-10-282024-10-28_custom_ThirdPartyMember"
      decimals="INF"
      id="Fact002105"
      unitRef="Pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <SMX:DescriptionOfExpectedTermWarrants
      contextRef="From2024-10-282024-10-28_custom_ThirdPartyMember"
      id="Fact002107">P5Y4M24D</SMX:DescriptionOfExpectedTermWarrants>
    <SMX:ProvisionForFairValueOfFinancialLiabilityPercentage
      contextRef="From2024-10-282024-10-28_custom_ThirdPartyMember"
      decimals="INF"
      id="Fact002109"
      unitRef="Pure">0.03</SMX:ProvisionForFairValueOfFinancialLiabilityPercentage>
    <SMX:FairValueOfWarrants
      contextRef="From2024-10-282024-10-28_custom_ThirdPartyMember"
      decimals="-3"
      id="Fact002111"
      unitRef="USD">76000</SMX:FairValueOfWarrants>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2025-01-012025-12-31_custom_ThirdPartyMember"
      decimals="INF"
      id="Fact002113"
      unitRef="Pure">0.03658</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2025-01-012025-12-31_custom_ThirdPartyMember"
      decimals="INF"
      id="Fact002115"
      unitRef="Pure">1.6855</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2025-01-012025-12-31_custom_ThirdPartyMember"
      decimals="INF"
      id="Fact002117"
      unitRef="Pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <SMX:DescriptionOfExpectedTermWarrants
      contextRef="From2025-01-012025-12-31_custom_ThirdPartyMember"
      id="Fact002119">P4Y2M12D</SMX:DescriptionOfExpectedTermWarrants>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2024-01-012024-12-31_custom_ThirdPartyMember"
      decimals="INF"
      id="Fact002121"
      unitRef="Pure">0.0438</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2024-01-012024-12-31_custom_ThirdPartyMember"
      decimals="INF"
      id="Fact002123"
      unitRef="Pure">0.589</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2024-01-012024-12-31_custom_ThirdPartyMember"
      decimals="INF"
      id="Fact002125"
      unitRef="Pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <SMX:DescriptionOfExpectedTermWarrants
      contextRef="From2024-01-012024-12-31_custom_ThirdPartyMember"
      id="Fact002127">P5Y2M12D</SMX:DescriptionOfExpectedTermWarrants>
    <SMX:ProvisionForFairValueOfFinancialLiabilityPercentage
      contextRef="From2025-01-012025-12-31_custom_ThirdPartyMember"
      decimals="INF"
      id="Fact002129"
      unitRef="Pure">0.03</SMX:ProvisionForFairValueOfFinancialLiabilityPercentage>
    <SMX:ProvisionForFairValueOfFinancialLiabilityPercentage
      contextRef="From2024-01-012024-12-31_custom_ThirdPartyMember"
      decimals="INF"
      id="Fact002131"
      unitRef="Pure">0.03</SMX:ProvisionForFairValueOfFinancialLiabilityPercentage>
    <SMX:FairValueOfWarrants
      contextRef="From2025-01-012025-12-31_custom_ThirdPartyMember"
      decimals="5"
      id="Fact002133"
      unitRef="USD">10000.00</SMX:FairValueOfWarrants>
    <SMX:FairValueOfWarrants
      contextRef="From2024-01-012024-12-31_custom_ThirdPartyMember"
      decimals="-3"
      id="Fact002135"
      unitRef="USD">59000</SMX:FairValueOfWarrants>
    <SMX:DisclosureOfShortTermLoanExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact002137">&lt;p id="xdx_80E_ecustom--DisclosureOfShortTermLoanExplanatory_zLuqg1u0NNg9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
12 - &lt;span id="xdx_829_zrcJ5Zwqx40d"&gt;SHORT TEARM LOAN&lt;/span&gt;:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -21.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 28, 2024, the Company entered into a Loan Agreement, dated as of December 27, 2024 (the &#x201c;&lt;b&gt;Abri Loan Agreement&lt;/b&gt;&#x201d;),
with Arbi Advisors Ltd. (&#x201c;Abri&#x201d;), pursuant to which the Company borrowed $&lt;span id="xdx_903_eifrs-full--Borrowings_iI_pn3n3_c20241228__ifrs-full--TypesOfContractsAxis__custom--LoanAgreementMember_zBKeq2uUwJH3" title="Borrowed amount"&gt;1,000&lt;/span&gt; from Abri. Pursuant to the Abri Loan Agreement,
the Company agrees to pay to Abri at the &lt;span id="xdx_903_eifrs-full--BorrowingsMaturity_c20241228__20241228__ifrs-full--TypesOfContractsAxis__custom--LoanAgreementMember_zAxqyJvVGKIf" title="Borrowed maturity"&gt;June 30, 2025&lt;/span&gt;, maturity date, $&lt;span id="xdx_900_eifrs-full--NotionalAmount_iI_pn3n3_c20241228__ifrs-full--TypesOfContractsAxis__custom--LoanAgreementMember_zE7ZSZ100V81" title="Original issue amount"&gt;1,400&lt;/span&gt;, which represents an original issue discount of &lt;span id="xdx_902_eifrs-full--BorrowingsInterestRate_iI_pid_dp_uPure_c20241228__ifrs-full--TypesOfContractsAxis__custom--LoanAgreementMember_zeUrWTtExEwl" title="Original issue discount percentage"&gt;28.577&lt;/span&gt;%,
plus interest on such amount at an absolute rate of &lt;span id="xdx_90B_eifrs-full--BorrowingsAdjustmentToInterestRateBasis_iI_pid_dp_uPure_c20241228__ifrs-full--TypesOfContractsAxis__custom--LoanAgreementMember_zYfFOugjpc2b" title="Interst absolute rate percentage"&gt;15&lt;/span&gt;%. During the period when any amounts under the Abri Loan Agreement are outstanding
and remain due and payable, the Company shall not issue any other form of debt instrument ranking senior or pari passu to or with the
obligations under the Abri Loan Agreement, whether in terms of payment or collateral, without the express prior written consent of Abri.
Additionally, during the period when any amounts under the Abri Loan Agreement are outstanding and remain due and payable, if the Company
undertakes, completes, agrees to complete, commits to complete, or otherwise sells any equity, or other securities fungible in any way
into equity, warrants, options, preferred shares, convertible preferred shares, or any other form of equity-related instrument of the
Company (a &#x201c;Financing&#x201d;), then the Company shall repay twenty percent (&lt;span id="xdx_908_ecustom--RepaymentOfFinancingPercentage_iI_pid_dp_uPure_c20241228__ifrs-full--TypesOfContractsAxis__custom--LoanAgreementMember_zN6KR8yXFR54" title="Financing repayment percentage"&gt;25.0&lt;/span&gt;%) of the then Loan Balance within three business
days from the closing date of the Financing (a &#x201c;Financing Repayment&#x201d;). A Financing Repayment shall not reduce or otherwise
diminish the amount due under the Abri Loan Agreement at the maturity of the loan, irrespective of the date of the Financing Repayment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Abri Loan Agreement contains customary Events of Default for transactions similar to the transactions contemplated by the Abri Loan Agreement.
In the event of an Event of Default, subject to a three-day cure period, the loan balance due plus any Refinancing Repayment that may
be due, then multiplied by &lt;span id="xdx_903_ecustom--DefaultPaymentPercentage_iI_pid_dp_uPure_c20241228__ifrs-full--TypesOfContractsAxis__custom--LoanAgreementMember_zCjZP8opsdm2" title="Default payment percentage"&gt;150&lt;/span&gt;%, shall become immediately due and payable by the Company to Abri (the &#x201c;Default Payment Amount&#x201d;).
The Default Payment Amount shall compound interest at a monthly rate of &lt;span id="xdx_903_ecustom--PercentageOfCompoundInterest_pid_dp_uPure_c20241228__20241228__ifrs-full--TypesOfContractsAxis__custom--LoanAgreementMember_zGqKVUE2St77" title="Compound interest percentage"&gt;5.0&lt;/span&gt;% from the date it becomes due and payable up and until the
date of payment. The Abri Loan Agreement contains representations and warranties made by each of the Company and Abri. As of 31 December
2024, the loan amount is $&lt;span id="xdx_908_eifrs-full--LoansReceived_iI_pn3n3_c20241231__ifrs-full--TypesOfContractsAxis__custom--LoanAgreementMember_zYLv8IHFMj7i" title="Loan amount"&gt;1,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
12 &#x2013; SHORT TEARM LOAN (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
2025, following the occurrence of an Event of Default under the Abri Loan Agreement, the outstanding loan balance and accumulated interest
was accelerated and increased by &lt;span id="xdx_90C_ecustom--AccumulatedInterestPercentage_pid_dp_uPure_c20250101__20251231__ifrs-full--TypesOfContractsAxis__custom--LoanAgreementMember_zNFqobWaU3S7" title="Accumulated interest percentage"&gt;150&lt;/span&gt;%, becoming immediately due and payable in accordance with the terms of the agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the second half of 2025, the Company repaid an aggregate amount of $&lt;span id="xdx_90F_eifrs-full--RepaymentsOfCurrentBorrowings_pn3n3_c20250701__20251231__ifrs-full--TypesOfContractsAxis__custom--LoanAgreementMember_zqykU7WGKDwb" title="Repaid to borrower"&gt;500&lt;/span&gt; in cash and entered into settlement agreement with Abri to convert
the remaining outstanding loan balance and the accumulated interest into ordinary shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with this settlement, the Company issued an aggregate of &lt;span id="xdx_90A_eifrs-full--NumberOfSharesIssued_iI_pid_c20251231__ifrs-full--TypesOfContractsAxis__custom--LoanAgreementMember_z5h45IEY9Asb" title="Number of shares issued"&gt;58,288&lt;/span&gt; ordinary shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2025, the Company has &lt;span id="xdx_90B_ecustom--RemainingObligationsLiability_iI_pn3n3_do_c20251231_zJAx5G9D9Hb6" title="Remaining obligations liability"&gt;no&lt;/span&gt; remaining obligations in respect of this liability.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</SMX:DisclosureOfShortTermLoanExplanatory>
    <ifrs-full:Borrowings
      contextRef="AsOf2024-12-28_custom_LoanAgreementMember"
      decimals="-3"
      id="Fact002139"
      unitRef="USD">1000000</ifrs-full:Borrowings>
    <ifrs-full:BorrowingsMaturity
      contextRef="From2024-12-282024-12-28_custom_LoanAgreementMember"
      id="Fact002141">June 30, 2025</ifrs-full:BorrowingsMaturity>
    <ifrs-full:NotionalAmount
      contextRef="AsOf2024-12-28_custom_LoanAgreementMember"
      decimals="-3"
      id="Fact002143"
      unitRef="USD">1400000</ifrs-full:NotionalAmount>
    <ifrs-full:BorrowingsInterestRate
      contextRef="AsOf2024-12-28_custom_LoanAgreementMember"
      decimals="INF"
      id="Fact002145"
      unitRef="Pure">0.28577</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:BorrowingsAdjustmentToInterestRateBasis
      contextRef="AsOf2024-12-28_custom_LoanAgreementMember"
      decimals="INF"
      id="Fact002147"
      unitRef="Pure">0.15</ifrs-full:BorrowingsAdjustmentToInterestRateBasis>
    <SMX:RepaymentOfFinancingPercentage
      contextRef="AsOf2024-12-28_custom_LoanAgreementMember"
      decimals="INF"
      id="Fact002149"
      unitRef="Pure">0.250</SMX:RepaymentOfFinancingPercentage>
    <SMX:DefaultPaymentPercentage
      contextRef="AsOf2024-12-28_custom_LoanAgreementMember"
      decimals="INF"
      id="Fact002151"
      unitRef="Pure">1.50</SMX:DefaultPaymentPercentage>
    <SMX:PercentageOfCompoundInterest
      contextRef="From2024-12-282024-12-28_custom_LoanAgreementMember"
      decimals="INF"
      id="Fact002153"
      unitRef="Pure">0.050</SMX:PercentageOfCompoundInterest>
    <ifrs-full:LoansReceived
      contextRef="AsOf2024-12-31_custom_LoanAgreementMember"
      decimals="-3"
      id="Fact002155"
      unitRef="USD">1000000</ifrs-full:LoansReceived>
    <SMX:AccumulatedInterestPercentage
      contextRef="From2025-01-012025-12-31_custom_LoanAgreementMember"
      decimals="INF"
      id="Fact002157"
      unitRef="Pure">1.50</SMX:AccumulatedInterestPercentage>
    <ifrs-full:RepaymentsOfCurrentBorrowings
      contextRef="From2025-07-012025-12-31_custom_LoanAgreementMember"
      decimals="-3"
      id="Fact002159"
      unitRef="USD">500000</ifrs-full:RepaymentsOfCurrentBorrowings>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-12-31_custom_LoanAgreementMember"
      decimals="INF"
      id="Fact002161"
      unitRef="Shares">58288</ifrs-full:NumberOfSharesIssued>
    <SMX:RemainingObligationsLiability
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002163"
      unitRef="USD">0</SMX:RemainingObligationsLiability>
    <ifrs-full:DisclosureOfLeasesExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact002165">&lt;p id="xdx_801_eifrs-full--DisclosureOfLeasesExplanatory_zgmf1WetoIZa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
13 - &lt;span id="xdx_823_zlQB76Kni064"&gt;LEASES&lt;/span&gt;:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -21.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group has lease contracts for office facilities (including a lab) and motor vehicles used in its operations. Leases of office and lab
facilities generally have lease terms of &lt;span id="xdx_905_ecustom--LeaseExpiration_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zMkOBOifGAJf" title="Lease expiration"&gt;12&lt;/span&gt; years; motor vehicles generally have lease terms of &lt;span id="xdx_901_ecustom--LeaseExpiration_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MotorVehiclesMember_zuc8DpEQ4jIa" title="Lease expiration"&gt;3&lt;/span&gt; years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_ecustom--DisclosureOfDetailedInformationAboutRightofuseAssetsExplanatory_zla3tjDUUyNa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Set
out below are the carrying amounts of right-of-use assets recognized and the movements during the period:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; display: none; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B7_zhuLmOKE7nml"&gt;SCHEDULE OF RIGHT OF USE ASSETS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BD_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--OfficeEquipmentMember_zT7hudzbw757" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Office and lab&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;facilities&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B6_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--MotorVehiclesMember_zcVVMduldSka" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Motor&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;vehicles&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B4_zi8Bu43qTR21" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_436_c20240101__20241231_eifrs-full--RightofuseAssets_iS_zakBE0tyj0C7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font-weight: bold"&gt;As of January 1, 2024&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;366&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;23&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;389&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--RightofuseAssetsEffectofForeignExchange_iN_di_z1fZyiRkAqIc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Foreign currency translation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2178"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--DepreciationRightofuseAssets_iN_di_zalhmiIttlml" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Depreciation expense&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(37&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(40&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20250101__20251231_eifrs-full--RightofuseAssets_iS_zz9hNn11M7ej" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;As of December 31, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;328&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;348&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43F_c20250101__20251231_eifrs-full--RightofuseAssets_iS_zcZRdP4d9gkc" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Right-of-use
    assets, beginning balance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;328&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;348&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--RightofuseAssetsEffectofForeignExchange_iN_di_zqn8FLz5Hkmd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Foreign currency translation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;49&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2194"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;49&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--DepreciationRightofuseAssets_iN_di_zgWfCEb4860a" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Depreciation expense&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(58&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(61&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43D_c20250101__20251231_eifrs-full--RightofuseAssets_iE_zcX5q7fSjav6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;As of December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;319&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;17&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;336&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43D_c20250101__20251231_eifrs-full--RightofuseAssets_iE_zCAGbqTO074g" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Right-of-use
    assets, ending balance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;319&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;17&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;336&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AB_z0DjxFxsJn4c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -21.3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_eifrs-full--DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory_zaQaAP1646W7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Information
on leases:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; display: none; text-align: justify"&gt;&lt;span id="xdx_8BD_zdSgDhkrYnqc"&gt;SCHEDULE OF INFORMATION ON LEASES&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_498_20250101__20251231_zJ4uAXO9wCcg" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20240101__20241231_zFNFW0iAoaki" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_zjusZk7IRzv6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Interest expense on lease liabilities&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;36&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;29&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--CashOutflowForLeases_pn3n3_z5fFoW3zYood" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total cash outflow for leases&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;86&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;79&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A3_zT0hIlYzyccg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
an analysis of maturity dates of lease liabilities, see Note 22 on liquidity risk.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfLeasesExplanatory>
    <SMX:LeaseExpiration
      contextRef="From2025-01-012025-12-31_ifrs-full_OfficeEquipmentMember"
      id="Fact002167">P12Y</SMX:LeaseExpiration>
    <SMX:LeaseExpiration
      contextRef="From2025-01-012025-12-31_ifrs-full_MotorVehiclesMember"
      id="Fact002169">P3Y</SMX:LeaseExpiration>
    <SMX:DisclosureOfDetailedInformationAboutRightofuseAssetsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact002171">&lt;p id="xdx_89B_ecustom--DisclosureOfDetailedInformationAboutRightofuseAssetsExplanatory_zla3tjDUUyNa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Set
out below are the carrying amounts of right-of-use assets recognized and the movements during the period:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; display: none; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B7_zhuLmOKE7nml"&gt;SCHEDULE OF RIGHT OF USE ASSETS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BD_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--OfficeEquipmentMember_zT7hudzbw757" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Office and lab&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;facilities&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B6_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--MotorVehiclesMember_zcVVMduldSka" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Motor&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;vehicles&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B4_zi8Bu43qTR21" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_436_c20240101__20241231_eifrs-full--RightofuseAssets_iS_zakBE0tyj0C7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font-weight: bold"&gt;As of January 1, 2024&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;366&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;23&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;389&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--RightofuseAssetsEffectofForeignExchange_iN_di_z1fZyiRkAqIc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Foreign currency translation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2178"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--DepreciationRightofuseAssets_iN_di_zalhmiIttlml" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Depreciation expense&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(37&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(40&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20250101__20251231_eifrs-full--RightofuseAssets_iS_zz9hNn11M7ej" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;As of December 31, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;328&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;348&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43F_c20250101__20251231_eifrs-full--RightofuseAssets_iS_zcZRdP4d9gkc" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Right-of-use
    assets, beginning balance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;328&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;348&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--RightofuseAssetsEffectofForeignExchange_iN_di_zqn8FLz5Hkmd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Foreign currency translation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;49&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2194"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;49&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--DepreciationRightofuseAssets_iN_di_zgWfCEb4860a" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Depreciation expense&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(58&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(61&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43D_c20250101__20251231_eifrs-full--RightofuseAssets_iE_zcX5q7fSjav6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;As of December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;319&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;17&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;336&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43D_c20250101__20251231_eifrs-full--RightofuseAssets_iE_zCAGbqTO074g" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Right-of-use
    assets, ending balance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;319&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;17&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;336&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</SMX:DisclosureOfDetailedInformationAboutRightofuseAssetsExplanatory>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2023-12-31_ifrs-full_OfficeEquipmentMember"
      decimals="-3"
      id="Fact002173"
      unitRef="USD">366000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2023-12-31_ifrs-full_MotorVehiclesMember"
      decimals="-3"
      id="Fact002174"
      unitRef="USD">23000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002175"
      unitRef="USD">389000</ifrs-full:RightofuseAssets>
    <SMX:RightofuseAssetsEffectofForeignExchange
      contextRef="From2024-01-012024-12-31_ifrs-full_OfficeEquipmentMember"
      decimals="-3"
      id="Fact002177"
      unitRef="USD">1000</SMX:RightofuseAssetsEffectofForeignExchange>
    <SMX:RightofuseAssetsEffectofForeignExchange
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact002179"
      unitRef="USD">1000</SMX:RightofuseAssetsEffectofForeignExchange>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="From2024-01-012024-12-31_ifrs-full_OfficeEquipmentMember"
      decimals="-3"
      id="Fact002181"
      unitRef="USD">37000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="From2024-01-012024-12-31_ifrs-full_MotorVehiclesMember"
      decimals="-3"
      id="Fact002182"
      unitRef="USD">3000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact002183"
      unitRef="USD">40000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2024-12-31_ifrs-full_OfficeEquipmentMember"
      decimals="-3"
      id="Fact002185"
      unitRef="USD">328000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2024-12-31_ifrs-full_MotorVehiclesMember"
      decimals="-3"
      id="Fact002186"
      unitRef="USD">20000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002187"
      unitRef="USD">348000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2024-12-31_ifrs-full_OfficeEquipmentMember"
      decimals="-3"
      id="Fact002189"
      unitRef="USD">328000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2024-12-31_ifrs-full_MotorVehiclesMember"
      decimals="-3"
      id="Fact002190"
      unitRef="USD">20000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002191"
      unitRef="USD">348000</ifrs-full:RightofuseAssets>
    <SMX:RightofuseAssetsEffectofForeignExchange
      contextRef="From2025-01-012025-12-31_ifrs-full_OfficeEquipmentMember"
      decimals="-3"
      id="Fact002193"
      unitRef="USD">-49000</SMX:RightofuseAssetsEffectofForeignExchange>
    <SMX:RightofuseAssetsEffectofForeignExchange
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact002195"
      unitRef="USD">-49000</SMX:RightofuseAssetsEffectofForeignExchange>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="From2025-01-012025-12-31_ifrs-full_OfficeEquipmentMember"
      decimals="-3"
      id="Fact002197"
      unitRef="USD">58000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="From2025-01-012025-12-31_ifrs-full_MotorVehiclesMember"
      decimals="-3"
      id="Fact002198"
      unitRef="USD">3000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact002199"
      unitRef="USD">61000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2025-12-31_ifrs-full_OfficeEquipmentMember"
      decimals="-3"
      id="Fact002201"
      unitRef="USD">319000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2025-12-31_ifrs-full_MotorVehiclesMember"
      decimals="-3"
      id="Fact002202"
      unitRef="USD">17000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002203"
      unitRef="USD">336000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2025-12-31_ifrs-full_OfficeEquipmentMember"
      decimals="-3"
      id="Fact002205"
      unitRef="USD">319000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2025-12-31_ifrs-full_MotorVehiclesMember"
      decimals="-3"
      id="Fact002206"
      unitRef="USD">17000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002207"
      unitRef="USD">336000</ifrs-full:RightofuseAssets>
    <ifrs-full:DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact002209">&lt;p id="xdx_894_eifrs-full--DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory_zaQaAP1646W7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Information
on leases:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; display: none; text-align: justify"&gt;&lt;span id="xdx_8BD_zdSgDhkrYnqc"&gt;SCHEDULE OF INFORMATION ON LEASES&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_498_20250101__20251231_zJ4uAXO9wCcg" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20240101__20241231_zFNFW0iAoaki" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_zjusZk7IRzv6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Interest expense on lease liabilities&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;36&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;29&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--CashOutflowForLeases_pn3n3_z5fFoW3zYood" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total cash outflow for leases&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;86&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;79&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ifrs-full:DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact002211"
      unitRef="USD">36000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact002212"
      unitRef="USD">29000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:CashOutflowForLeases
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact002214"
      unitRef="USD">86000</ifrs-full:CashOutflowForLeases>
    <ifrs-full:CashOutflowForLeases
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact002215"
      unitRef="USD">79000</ifrs-full:CashOutflowForLeases>
    <ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact002217">&lt;p id="xdx_808_eifrs-full--DisclosureOfTradeAndOtherPayablesExplanatory_zZuCGIOz5tJk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
14 - &lt;span id="xdx_82F_zgTodPVgcv5c"&gt;OTHER PAYABLES&lt;/span&gt;:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_ecustom--DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory_zVbnekoi8Xl4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; display: none"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B9_zdIvaTyIhsm1"&gt;&lt;span id="xdx_8B7_zJvvocSF7EIk"&gt;SCHEDULE OF OTHER PAYABLES&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20251231_z0tUpMPtCfLe" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20241231_zicy3KR3Y5l6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--CurrentExciseTaxPayables_iI_pn3n3_maTAOPzSMC_z0bz2wJQW9T1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: justify"&gt;Excise Tax&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;1,569&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;1,569&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--AccrualsClassifiedAsCurrent_iI_pn3n3_maTAOPzSMC_zyMvr2o3gQd9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Accrued expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,872&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,596&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--ShorttermEmployeeBenefitsAccruals_iI_pn3n3_maTAOPzSMC_zqAVdsxGy0V9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Employees, salaries and related liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;574&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,008&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--LiabilitiesForGrantsReceived_iI_pn3n3_maTAOPzSMC_zySxfZadqZq8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Liabilities for grants received (see also note 22)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;202&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;177&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--OtherCurrentPayables_iTI_pn3n3_mtTAOPzSMC_zqzinGnFdSvi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 1pt"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;4,217&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;4,350&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zn9cMaBzTy27" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 85%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory>
    <SMX:DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact002219">&lt;p id="xdx_89C_ecustom--DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory_zVbnekoi8Xl4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; display: none"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B9_zdIvaTyIhsm1"&gt;&lt;span id="xdx_8B7_zJvvocSF7EIk"&gt;SCHEDULE OF OTHER PAYABLES&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20251231_z0tUpMPtCfLe" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20241231_zicy3KR3Y5l6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--CurrentExciseTaxPayables_iI_pn3n3_maTAOPzSMC_z0bz2wJQW9T1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: justify"&gt;Excise Tax&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;1,569&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;1,569&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--AccrualsClassifiedAsCurrent_iI_pn3n3_maTAOPzSMC_zyMvr2o3gQd9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Accrued expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,872&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,596&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--ShorttermEmployeeBenefitsAccruals_iI_pn3n3_maTAOPzSMC_zqAVdsxGy0V9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Employees, salaries and related liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;574&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,008&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--LiabilitiesForGrantsReceived_iI_pn3n3_maTAOPzSMC_zySxfZadqZq8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Liabilities for grants received (see also note 22)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;202&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;177&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--OtherCurrentPayables_iTI_pn3n3_mtTAOPzSMC_zqzinGnFdSvi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 1pt"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;4,217&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;4,350&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</SMX:DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory>
    <ifrs-full:CurrentExciseTaxPayables
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002221"
      unitRef="USD">1569000</ifrs-full:CurrentExciseTaxPayables>
    <ifrs-full:CurrentExciseTaxPayables
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002222"
      unitRef="USD">1569000</ifrs-full:CurrentExciseTaxPayables>
    <ifrs-full:AccrualsClassifiedAsCurrent
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002224"
      unitRef="USD">1872000</ifrs-full:AccrualsClassifiedAsCurrent>
    <ifrs-full:AccrualsClassifiedAsCurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002225"
      unitRef="USD">1596000</ifrs-full:AccrualsClassifiedAsCurrent>
    <ifrs-full:ShorttermEmployeeBenefitsAccruals
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002227"
      unitRef="USD">574000</ifrs-full:ShorttermEmployeeBenefitsAccruals>
    <ifrs-full:ShorttermEmployeeBenefitsAccruals
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002228"
      unitRef="USD">1008000</ifrs-full:ShorttermEmployeeBenefitsAccruals>
    <SMX:LiabilitiesForGrantsReceived
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002230"
      unitRef="USD">202000</SMX:LiabilitiesForGrantsReceived>
    <SMX:LiabilitiesForGrantsReceived
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002231"
      unitRef="USD">177000</SMX:LiabilitiesForGrantsReceived>
    <ifrs-full:OtherCurrentPayables
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002233"
      unitRef="USD">4217000</ifrs-full:OtherCurrentPayables>
    <ifrs-full:OtherCurrentPayables
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002234"
      unitRef="USD">4350000</ifrs-full:OtherCurrentPayables>
    <ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact002236">&lt;p id="xdx_808_eifrs-full--DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_z8rkkyfVbegl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
15 - &lt;span id="xdx_821_zoHXg1jgt67h"&gt;SHAREHOLDERS&#x2019; EQUITY&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; padding-left: 10pt; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Share
    capital:&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eifrs-full--DisclosureOfClassesOfShareCapitalExplanatory_zov0z9egdX94" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; display: none"&gt;&lt;span id="xdx_8B6_zsjnYSfrI1Ha"&gt;SCHEDULE
OF SHARE CAPITAL&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" id="xdx_F6D_zY2qsES20MHa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Number of shares *&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Authorized&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Issued and&lt;br/&gt;
 outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Authorized&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Issued and&lt;br/&gt;
 outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%"&gt;Ordinary shares&lt;br/&gt; USD &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eifrs-full--ParValuePerShare_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z3bzz0nlOa3i" title="Par value per share"&gt;0.00000000012219451015625&lt;/span&gt; &lt;br/&gt;par value&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_fKg_____zjPYv66wRutb" style="width: 11%; text-align: right" title="Number of shares authorized"&gt;817,549,003,406,601,232,640&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_fKg_____z4XPD9R70Xha" style="width: 11%; text-align: right" title="Number of shares issued and outstanding"&gt;1,795,943&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_fKg_____zp43yVEjetfb" style="width: 11%; text-align: right" title="Number of shares authorized"&gt;1,392&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_fKg_____zDIiVG5phyva" style="width: 11%; text-align: right" title="Number of shares issued and outstanding"&gt;95&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Preferred shares &lt;br/&gt; USD &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eifrs-full--ParValuePerShare_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_zjy1TQ0G14Zj" title="Par value per share"&gt;0.0001&lt;/span&gt; par value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_fKg_____zKB98gVHwua9" style="text-align: right" title="Number of shares authorized"&gt;200,000,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_fKg_____zYwGBZEZiHfj" style="text-align: right" title="Number of shares issued and outstanding"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2254"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_fKg_____zwzJzDumdnna" style="text-align: right" title="Number of shares authorized"&gt;200,000,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_fKg_____zKWmlcFjj6Se" style="text-align: right" title="Number of shares issued and outstanding"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2258"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Deferred shares &lt;br/&gt; Euro &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eifrs-full--ParValuePerShare_iI_pid_uEuroPerShare_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--DeferredSharesMember_zeBEgJvyDrQb" title="Par value per share"&gt;1&lt;/span&gt; par value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--DeferredSharesMember_fKg_____zSGj9PKfSFUj" style="text-align: right" title="Number of shares authorized"&gt;25,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--DeferredSharesMember_fKg_____zBqd5oWPEOY1" style="text-align: right" title="Number of shares issued and outstanding"&gt;25,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--DeferredSharesMember_fKg_____zzGTQWLRaiLh" style="text-align: right" title="Number of shares authorized"&gt;25,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--DeferredSharesMember_fKg_____z6qEobNxySk3" style="text-align: right" title="Number of shares issued and outstanding"&gt;25,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;New Deferred shares &lt;br/&gt; USD &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eifrs-full--ParValuePerShare_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--NewDeferredSharesMember_zu0LaiRttWbj" title="Par value per share"&gt;0.00000000000001&lt;/span&gt; par value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--NewDeferredSharesMember_fKg_____zU93c8FIJ6r6" style="text-align: right" title="Number of shares authorized"&gt;7,999,999,999,999,982,413,677&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--NewDeferredSharesMember_fKg_____zqr9sTv6b92d" style="text-align: right" title="Number of shares issued and outstanding"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2274"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--NewDeferredSharesMember_fKg_____zqVmQOHua5dc" style="text-align: right" title="Number of shares authorized"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2276"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--NewDeferredSharesMember_fKg_____zGsT8xTlawsa" style="text-align: right" title="Number of shares issued and outstanding"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2278"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F0F_z6Ylts6kwIYc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F11_z63X6OiiSEI3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The share and per
share information in these financial statements reflects the &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20240715__20240715_zhFKFrr5MK4i" title="Reverse share splits, description"&gt;1-for-75&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20250115__20250115_zotQoNzkkUG8" title="Reverse share splits, description"&gt;1-for-28.5&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20250616__20250616_zybItfAHUDmi" title="Reverse share splits, description"&gt;1-for-4.1&lt;/span&gt; &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20250807__20250807_zdQGltGg8gB5" title="Reverse share splits, description"&gt;1-for-7&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20251023__20251023_znXlqU2WVZE5" title="Reverse share splits, description"&gt;1-for-10.89958&lt;/span&gt; , &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20251118__20251118_zGWhCwPiW5hi" title="Reverse share splits, description"&gt;1-for-8&lt;/span&gt; and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20260217__20260217__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventsMember_zEDpyXcjoTVl" title="Reverse share splits, description"&gt;1:4.8828125&lt;/span&gt;
reverse share splits became effective on July 15, 2024, January 15, 2025, June 16, 2025, August 7, 2025, October 23, 2025, November 18,
2025 and February 17, 2026 respectively, of the Company&#x2019;s issued and outstanding Ordinary Shares (the &#x201c;Reverse Stock Splits&#x201d;).
See also Note 1.F- 1.K and 26.3.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8AF_z6wpy8S04nM3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Ordinary
shares&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Ordinary
shares entitle the holder to participate in dividends and the proceeds on the winding up of the Company in proportion to the number of
and amounts paid on the shares held. The fully paid ordinary shares have a par value per share of $ &lt;span id="xdx_900_eifrs-full--ParValuePerShare_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zfJvhEKZZyL8" title="Par value per share"&gt;0.00000000012219451015625&lt;/span&gt; and the
Company does not have a limited amount of authorised capital.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;New
Deferred shares&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_ecustom--DescriptionOfImpactOfNewDeferredShares_c20250101__20251231_zXrCRjjmaIcl" title="New deferred shares description"&gt;The
new deferred shares of $&lt;span id="xdx_904_eifrs-full--ParValuePerShare_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--NewDeferredSharesMember_zMeh0jDbKfN" title="Par value per share"&gt;0.00000000000001&lt;/span&gt; par value with the following rights: (i) each new deferred share shall not entitle the holder
thereof to receive notice, attend or vote at general meetings of the Company; (ii) each New Deferred Share shall not entitle the holder
thereof to participate in any dividends declared or paid by the Company; and (iii) on a return of capital on a winding up or otherwise,
each New Deferred Share shall entitle the holder thereof to receive an amount of US$0.00000000000001 on each deferred share after an
amount of $1,000,000,000 has been paid in respect of each ordinary share.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Preferred
shares&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Preferred
shares of a nominal value of $&lt;span id="xdx_90B_eifrs-full--ParValuePerShare_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_zri4dMVjhqO6" title="Par value per share"&gt;0.0001&lt;/span&gt; with such designation, rights and preferences as may be determined from time to time by the Company&#x2019;s
Board of Directors.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 85%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands, except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
15 - SHAREHOLDERS&#x2019; EQUITY (CONT.)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Deferred
shares Euro 1 par value&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Immediately
prior to consummation of the Business Combination pursuant to the BCA and the SID, the Company had issued and paid-up share capital of
(i) &#x20ac;&lt;span id="xdx_90D_eifrs-full--NumberOfSharesIssued_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--DeferredSharesMember_z0xADUXKjKP5" title="Number of shares authorized"&gt;25,000&lt;/span&gt; representing &lt;span id="xdx_90B_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--DeferredSharesMember_zcKZwHjM0Rq2" title="Number of shares authorized"&gt;25,000&lt;/span&gt; deferred shares of &#x20ac;&lt;span id="xdx_902_eifrs-full--ParValuePerShare_iI_pid_uEuroPerShare_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--DeferredSharesMember_zHPFiROFOb0d" title="Par value per share"&gt;1.00&lt;/span&gt; each and (ii) $&lt;span id="xdx_907_eifrs-full--ParValuePerShare_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--DeferredSharesMember_zsZpABx3e875" title="Par value per share"&gt;0.0001&lt;/span&gt; representing one Ordinary Share of $&lt;span id="xdx_90F_eifrs-full--ParValuePerShare_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--IssuedCapitalMember_zjH4Diil33Q7" title="Par value per share"&gt;0.0001&lt;/span&gt; each
in the capital of the Company, in order to satisfy statutory capitalization requirements for all Irish public limited companies.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Changes
    in Share capital&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25.1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;During
2024&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25.1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            January 4, 2024, the Company issued &lt;span id="xdx_905_eifrs-full--NumberOfSharesIssued_iI_pid_c20240104__ifrs-full--TypesOfContractsAxis__custom--ServiceProviderAgreementsMember_ziOmHPmCltDk" title="Number of shares issued"&gt;47&lt;/span&gt; ordinary shares (&lt;span id="xdx_905_eifrs-full--NumberOfSharesIssued_iI_pid_dxL_c20240104__ifrs-full--TypesOfContractsAxis__custom--ServiceProviderAgreementsMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zdg8n2qobGS" title="Number of shares issued::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2315"&gt;nil&lt;/span&gt;&lt;/span&gt; after reverse stock splits) to
                                            a service provider in connection with certain investor relations services.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
                                            to Letter Agreement with Yorkville signed on February 2, 2024, the Company issued during
                                            the first quarter of 2024, &lt;span id="xdx_901_eifrs-full--NumberOfSharesIssued_iI_pid_c20240331__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zpzwckeHojy6"&gt;1,251&lt;/span&gt; ordinary shares (&lt;span id="xdx_900_eifrs-full--NumberOfSharesIssued_iI_pid_dxL_c20240331__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zzJHJOyBcJBk" title="::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2317"&gt;nil&lt;/span&gt;&lt;/span&gt; after reverse stock splits) for an
                                            aggregate of $&lt;span id="xdx_905_eifrs-full--ProceedsFromIssueOfOrdinaryShares_pn3n3_c20240101__20240331__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z8Egom0k2mAf"&gt;527&lt;/span&gt; net proceeds and in addition in June 21, 2024 the investor exercised the
                                            &lt;span id="xdx_90B_ecustom--WarrantsExercised_iI_pid_c20240621__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zBL77yLXhbwc" title="Warrants exercised"&gt;117&lt;/span&gt; warrants (&lt;span id="xdx_90F_ecustom--WarrantsExercised_iI_pid_dxL_c20240621__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zUsBL1HredG3" title="Warrants issued::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2322"&gt;nil&lt;/span&gt;&lt;/span&gt; after reverse stock splits) into &lt;span id="xdx_906_eifrs-full--NumberOfSharesIssued_iI_pid_c20240621__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zKGOwxZbBA4h" title="Number of shares issued"&gt;117&lt;/span&gt; ordinary shares (&lt;span id="xdx_90D_eifrs-full--NumberOfSharesIssued_iI_pid_dxL_c20240621__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_z79WuFH7oL0e" title="Number of shares issued::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2326"&gt;nil&lt;/span&gt;&lt;/span&gt; after reverse
                                            stock splits) at an exercise price of $&lt;span id="xdx_905_ecustom--ExercisePriceOfWarrants_pid_c20240621__20240621__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zFCLCPgkP2Xa" title="Warrant exercise price"&gt;4.7025&lt;/span&gt; ($&lt;span id="xdx_905_ecustom--ExercisePriceOfWarrants_pid_c20240621__20240621__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zWwn54ecuBFg" title="Warrant exercise price"&gt;57,460&lt;/span&gt; after reverse stock splits) per warrant.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            February 1, 2024, the Company issued &lt;span id="xdx_907_eifrs-full--NumberOfSharesIssued_iI_pid_c20240201__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zHCnAFKNobw3" title="Number of shares issued"&gt;234&lt;/span&gt; ordinary shares (&lt;span id="xdx_906_eifrs-full--NumberOfSharesIssued_iI_pid_dxL_c20240201__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zd5FjGho7u76" title="Number of shares issued::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2334"&gt;nil&lt;/span&gt;&lt;/span&gt; after reverse stock splits)
                                            to EF Hutton pursuant to their agreement as an underwriter.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            February 20, 2024, the Company completed an underwritten public offering of &lt;span id="xdx_908_eifrs-full--NumberOfSharesIssued_iI_pid_c20240220__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__custom--OrdinarySharesAndPrefundedWarrantsMember_z5W8DvNuc47i" title="Number of shares issued"&gt;5,672&lt;/span&gt; Ordinary
                                            Shares and pre-funded warrants (&lt;span id="xdx_904_eifrs-full--NumberOfSharesIssued_iI_pid_dxL_c20240220__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__custom--OrdinarySharesAndPrefundedWarrantsMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_z3ldP8Zu4dL2" title="Number of shares issued::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2338"&gt;nil&lt;/span&gt;&lt;/span&gt; after reverse stock splits) at $&lt;span id="xdx_907_eifrs-full--ParValuePerShare_iI_pid_c20240220__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__custom--OrdinarySharesAndPrefundedWarrantsMember_zUtFtFcSmj4f" title="Number of shares issued"&gt;513&lt;/span&gt; ($&lt;span id="xdx_900_eifrs-full--ParValuePerShare_iI_pid_c20240220__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__custom--OrdinarySharesAndPrefundedWarrantsMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zPEy2ZPyfpx8" title="Number of shares issued"&gt;6,268,574&lt;/span&gt; after
                                            reverse stock splits) per share, generating gross proceeds of approximately $&lt;span id="xdx_902_eifrs-full--ProceedsFromIssuingShares_pn4n6_c20240220__20240220__ifrs-full--TypesOfContractsAxis__custom--OrdinarySharesAndPrefundedWarrantsMember__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember_zwelt1ZEIC72" title="Gross proceeds from issuance"&gt;2.91&lt;/span&gt; million.
                                            The offering included a provision for the issuance of pre-funded warrants, convertible on
                                            a &lt;span id="xdx_90D_ecustom--PreFundedWarrantsConvertibleDescription_pid_c20240220__20240220__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__custom--PrefundedWarrantsMember_zHUeg6ERBRn1" title="Pre funded warrants convertible description"&gt;1-for-1&lt;/span&gt; basis into Ordinary Shares at a price of $&lt;span id="xdx_906_ecustom--PreFundedWarrantsConvertibleAmount_pn3n3_c20240220__20240220__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__custom--PrefundedWarrantsMember_zMfwDbBjVVAh" title="Conversion amount"&gt;508&lt;/span&gt; ($&lt;span id="xdx_902_ecustom--PreFundedWarrantsConvertibleAmount_pid_c20240220__20240220__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember__ifrs-full--ClassesOfShareCapitalAxis__custom--PrefundedWarrantsMember__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember_zgea5kmsMyP3"&gt;6,207,480&lt;/span&gt; after reverse stock splits)
                                            per share, to prevent any purchaser from exceeding &lt;span id="xdx_900_ecustom--BeneficialOwnershipPercentage_iI_pid_dp_c20240220__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__custom--PrefundedWarrantsMember_zmW4dJ84SDZi" title="Beneficial ownership percentage"&gt;4.99&lt;/span&gt;% beneficial ownership. After deducting
                                            discounts, commissions, and offering expenses, net proceeds amounted to approximately $&lt;span id="xdx_90A_eifrs-full--ProceedsFromIssuingOtherEquityInstruments_pn4n6_c20240220__20240220__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__custom--PrefundedWarrantsMember_z6iliwlVjjXi" title="Net proceeds"&gt;2.69&lt;/span&gt;
                                            million. The Company paid the underwriter a cash fee of &lt;span id="xdx_906_ecustom--UnderwriterCashFeePercentage_iI_pid_dp_c20240220__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__custom--PrefundedWarrantsMember_zTWBUA0aIRU3" title="Underwriter a cash fee percentage"&gt;2.5&lt;/span&gt;% of the gross proceeds, alongside
                                            $&lt;span id="xdx_90A_ecustom--UnderwriterCashFeeGrossProceedsAmount_pn3n3_c20240220__20240220__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__custom--PrefundedWarrantsMember_zQ3Q3z7b5Cuh" title="Underwriter cash fee gross proceeds amount"&gt;100&lt;/span&gt; in expenses. The pre-funded warrants met the fix for fix criteria and were classified
                                            as equity instrument.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2024, the Company issued &lt;span id="xdx_90F_eifrs-full--NumberOfSharesIssued_iI_pid_c20241231__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zPa5QodMxKwh" title="Number of shares issued"&gt;1,620&lt;/span&gt; ordinary shares at a subscription price per share of $&lt;span id="xdx_90A_eifrs-full--ParValuePerShare_iI_pid_c20241231__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z2VKfysXNDR4" title="Number of shares issued"&gt;513&lt;/span&gt; ($&lt;span id="xdx_90E_eifrs-full--ParValuePerShare_iI_pid_c20241231__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zsV5wvmV9Xl3" title="Number of shares issued"&gt;6,268,57&lt;/span&gt;4 after reverse stock
splits) and &lt;span id="xdx_90F_eifrs-full--NumberOfSharesIssued_iI_pn3n3_c20241231__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__custom--PrefundedWarrantsMember_zeGsE0VAFmU" title="Number of shares issued"&gt;4,052&lt;/span&gt; ordinary shares due to Pre-Funded Warrants (&lt;span id="xdx_90C_eifrs-full--NumberOfSharesIssued_iI_pn3n3_dxL_c20241231__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__custom--PrefundedWarrantsMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_z7Pr4MQ1HNx5" title="Number of shares issued::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2367"&gt;nil&lt;/span&gt;&lt;/span&gt; after reverse stock splits) exercise at a price per Pre-Funded Warrant
of $&lt;span id="xdx_90C_ecustom--PreFundedWarrantsConvertibleAmount_pn3n3_c20240101__20241231__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__custom--PrefundedWarrantsMember_zAkomkNHDdn7" title="Conversion amount"&gt;508&lt;/span&gt; ($&lt;span id="xdx_90F_ecustom--PreFundedWarrantsConvertibleAmount_pid_c20240101__20241231__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember__ifrs-full--ClassesOfShareCapitalAxis__custom--PrefundedWarrantsMember__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember_zigDXQ2aHqJ3"&gt;6,207,480&lt;/span&gt; after reverse stock splits).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25.1pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
                                            to a private placement binding term sheet dated February 28, 2024, the Company issued &lt;span id="xdx_904_ecustom--NumberOfWarrantsIssued_c20240228__20240228__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InvestorsMember_zCvVtkPGZU1h" title="Number of warrants"&gt;100,000&lt;/span&gt;
                                            (&lt;span id="xdx_906_ecustom--NumberOfWarrantsIssued_c20240228__20240228__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InvestorsMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zj9SOrG6ucTk" title="Number of warrants"&gt;8&lt;/span&gt; after reverse stock splits) warrants to the investor with an exercise price of $&lt;span id="xdx_902_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20240228__20240228__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InvestorsMember_zgzBz2vsKsb3" title="Exercise price of share"&gt;0.05&lt;/span&gt; ($&lt;span id="xdx_901_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20240228__20240228__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InvestorsMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_z0jMnq9m1ST4" title="Exercise price of share"&gt;610&lt;/span&gt;
                                            after reverse stock splits) per share.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
                                            2024, Alpha converted $&lt;span id="xdx_901_ecustom--NumberOfValueConverted_iI_pn5n6_c20241231__ifrs-full--BorrowingsByNameAxis__custom--ConvertiblePromissoryNoteMember_zydib3Nz0WC1" title="Number of value converted"&gt;2.3&lt;/span&gt; million of convertible promissory note and accrued interest into
                                            an aggregate of &lt;span id="xdx_908_eifrs-full--NumberOfSharesIssued_iI_pid_c20241231__ifrs-full--BorrowingsByNameAxis__custom--ConvertiblePromissoryNoteMember_zdNo0gPnoh8j" title="Number of shares issued"&gt;640&lt;/span&gt; (&lt;span id="xdx_90C_eifrs-full--NumberOfSharesIssued_iI_pid_dxL_c20241231__ifrs-full--BorrowingsByNameAxis__custom--ConvertiblePromissoryNoteMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zI0tPGxPrqU6" title="Number of shares issued::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2384"&gt;nil&lt;/span&gt;&lt;/span&gt; after reverse stock splits) Ordinary Shares and exercised &lt;span id="xdx_901_ecustom--WarrantsExercised_iI_pid_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InvestorsMember__ifrs-full--ComponentsOfEquityAxis__custom--WarrantAMember_zIgg7S8oaKX5" title="Warrants exercised"&gt;1,838&lt;/span&gt;
                                            (&lt;span id="xdx_90D_ecustom--WarrantsExercised_iI_pid_dxL_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InvestorsMember__ifrs-full--ComponentsOfEquityAxis__custom--WarrantAMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zCQP5QcLOnG6" title="Warrants exercised::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2388"&gt;nil&lt;/span&gt;&lt;/span&gt; after reverse stock splits) Warrant A (see also note 7.B).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
                                                                                                                            &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            April 11, 2024, pursuant to a Securities Purchase Agreement with Alpha, the Company issued
                                            &lt;span id="xdx_90F_ecustom--NumberOfWarrantsIssued_pid_c20240411__20240411__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zj0FfFvncZHg" title="Number of warrants"&gt;5,532&lt;/span&gt; (&lt;span id="xdx_907_ecustom--NumberOfWarrantsIssued_pid_dxL_c20240411__20240411__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zyxTRi7Nmj5j" title="Number of warrants::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2392"&gt;nil&lt;/span&gt;&lt;/span&gt; after reverse stock splits) warrants for a &lt;span id="xdx_905_ecustom--WarrantsTerm_dtY_c20240411__20240411__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zltkoHmB9GJa" title="Warrants term"&gt;5.5&lt;/span&gt; years period with an exercise price
                                            of $&lt;span id="xdx_90C_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20240411__20240411__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zycxLynh2DW5" title="Exercise price of share"&gt;336&lt;/span&gt; ($&lt;span id="xdx_905_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20240411__20240411__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zbvofyc1OFxi" title="Exercise price of share"&gt;4,105,732&lt;/span&gt; after reverse stock splits) per warrant. In addition, pursuant to a Warrant
                                            Amendment and Inducement Letter, Alpha exercised his outstanding &#x201c;B&#x201d; warrants
                                            to purchase &lt;span id="xdx_906_ecustom--NumberOfWarrantsIssued_pid_c20240411__20240411__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OrdinarySharesMember_zCjS6rjJ6d4" title="Number of warrants"&gt;1,225&lt;/span&gt; (&lt;span id="xdx_902_ecustom--NumberOfWarrantsIssued_pid_dxL_c20240411__20240411__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OrdinarySharesMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zfIj6HxNyeJ7" title="Number of warrants::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2402"&gt;nil&lt;/span&gt;&lt;/span&gt; after reverse stock splits) Ordinary Shares. The Existing Warrants
                                            were issued to Alpha as of September 6, 2023 and had a fixed exercise price of $&lt;span id="xdx_901_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230906__20230906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zNs8DbYVpcLg" title="Exercise price of share"&gt;3,501&lt;/span&gt; ($&lt;span id="xdx_902_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230906__20230906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zVmkJvqlErJ3" title="Exercise price of share"&gt;42,780,297&lt;/span&gt;
                                            after reverse stock splits) per share. Pursuant to the Inducement Letter, Alpha agreed to
                                            exercise for cash the existing warrants in full at a reduced exercise price of $&lt;span id="xdx_900_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230906__20230906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zwjsE3tIjmRa" title="Exercise price of share"&gt;4.7025&lt;/span&gt; ($&lt;span id="xdx_90C_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230906__20230906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zu1kLIyla0l6" title="Exercise price of share"&gt;57,460&lt;/span&gt;
                                            after reverse stock splits) per share.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
                                                                                                                            &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25.1pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 85%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands, except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
15 - SHAREHOLDERS&#x2019; EQUITY (CONT.)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 42.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Alpha
converted approximately $&lt;span id="xdx_900_ecustom--NumberOfValueConverted_iI_pn3n3_c20241231_zdXgHA4LXgC5" title="Number of value converted"&gt;2,110&lt;/span&gt; of the principal amount into &lt;span id="xdx_90D_ecustom--NumberOfWarrantsIssued_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OrdinarySharesMember_zvrPrQkHON68" title="Number of warrants"&gt;464,424&lt;/span&gt; (&lt;span id="xdx_900_ecustom--NumberOfWarrantsIssued_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OrdinarySharesMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zDVYO2gDJyu" title="Number of warrants"&gt;38&lt;/span&gt; after reverse stock splits) ordinary shares. As of December 31,
2024, Alpha exercised all the warrants pursuant to a cashless mechanism into &lt;span id="xdx_909_ecustom--NumberOfWarrantsIssued_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--WarrantsMember_zVRgNtMfdGZ9" title="Number of warrants"&gt;5,387&lt;/span&gt; (&lt;span id="xdx_90E_ecustom--NumberOfWarrantsIssued_pid_dxL_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--WarrantsMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zgzMtT2JK25g" title="Number of warrants::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2420"&gt;nil&lt;/span&gt;&lt;/span&gt; after reverse stock splits) Ordinary Shares.
(see also note 7.D)&lt;b&gt;.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
                                            the twelve-month period ended December 31, 2024, all the Cashless Warrants were fully exercised
                                            in cashless and converted into &lt;span id="xdx_90A_ecustom--NumberOfSharesConverted_iI_pid_c20241231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OrdinarySharesMember_zsNXJq0Koohe" title="Number of value converted"&gt;472&lt;/span&gt; (&lt;span id="xdx_905_ecustom--NumberOfSharesConverted_iI_pid_dxL_c20241231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OrdinarySharesMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_z7A5rwM8QL4h" title="Number of value converted::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2424"&gt;nil&lt;/span&gt;&lt;/span&gt; after reverse stock splits) ordinary shares. In addition,
                                            the Company issued another &lt;span id="xdx_905_eifrs-full--NumberOfSharesIssued_iI_pid_c20241231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OrdinarySharesMember_zCqlBEn6Fjk7" title="Number of shares issued"&gt;290&lt;/span&gt; (&lt;span id="xdx_90D_eifrs-full--NumberOfSharesIssued_iI_pid_dxL_c20241231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OrdinarySharesMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_z3tUJkF4LdZ9" title="Number of shares issued::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2428"&gt;nil&lt;/span&gt;&lt;/span&gt; after reverse stock splits) ordinary shares according
                                            to an amendment to the agreement with certain former debtholders. (see note 8)&lt;b&gt;.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
                                            April 2024, a service provider exercised in a cashless transaction all its warrants and the
                                            Company issued &lt;span id="xdx_905_ecustom--NumberOfSharesConverted_iI_pid_c20240430__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OrdinarySharesMember_zGrwhfsk8Pwj" title="Number of value converted"&gt;54&lt;/span&gt; (&lt;span id="xdx_901_ecustom--NumberOfSharesConverted_iI_pid_dxL_c20240430__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OrdinarySharesMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_znPYR95i4zTe" title="Number of value converted::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2432"&gt;nil&lt;/span&gt;&lt;/span&gt; after reverse stock splits) ordinary shares. In addition, the Company
                                            issued another &lt;span id="xdx_901_eifrs-full--NumberOfSharesIssued_iI_pid_c20240430__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OrdinarySharesMember_zmyoKVuSmxo9" title="Number of shares issued"&gt;32&lt;/span&gt; (&lt;span id="xdx_903_eifrs-full--NumberOfSharesIssued_iI_pid_dxL_c20240430__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OrdinarySharesMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zYFswYrNfJOj" title="Number of shares issued::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2436"&gt;nil&lt;/span&gt;&lt;/span&gt; after reverse stock splits) ordinary shares according to an amendment
                                            to the agreement with her.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            April 24, 2024, the Company issued to Alpha &lt;span id="xdx_90E_eifrs-full--NumberOfSharesIssued_iI_pid_c20240424__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InvestorsMember_zsgfcngC6A72" title="Number of shares issued"&gt;1,275&lt;/span&gt; (&lt;span id="xdx_903_eifrs-full--NumberOfSharesIssued_iI_pid_dxL_c20240424__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InvestorsMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zaaRcb9aMTB6" title="Number of shares issued::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2440"&gt;nil&lt;/span&gt;&lt;/span&gt; after reverse stock splits) Ordinary
                                            Shares as a &lt;span id="xdx_901_ecustom--CommitmentFeePercentage_iI_pid_dp_c20250424__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InvestorsMember_zh8J5V80f1zl" title="Commitment fee percentage"&gt;1.5&lt;/span&gt;% commitment fee under the SPA signed on April 19, 2024 (see note 9).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
                                            the second quarter of 2024, the Company converted $&lt;span id="xdx_90B_eifrs-full--NetDebt_iI_pn3n3_c20240630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zikHpMK4IWVj" title="Debt"&gt;569&lt;/span&gt; of debt into &lt;span id="xdx_909_eifrs-full--NumberOfSharesIssued_iI_pid_c20240630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zCDYtzSv7pFl" title="Ordinary shares"&gt;1,494&lt;/span&gt; (&lt;span id="xdx_900_eifrs-full--NumberOfSharesIssued_iI_pid_dxL_c20240630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zYt1w6HJuQ64" title="Ordinary shares::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2448"&gt;nil&lt;/span&gt;&lt;/span&gt; after reverse
                                            stock splits) ordinary shares.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            June 27, 2024, the Company converted $&lt;span id="xdx_904_eifrs-full--NetDebt_iI_pn3n3_c20240627__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z3jEucapPCC3" title="Debt"&gt;119&lt;/span&gt; debt to &lt;span id="xdx_90C_eifrs-full--NumberOfSharesIssuedAndFullyPaid_iI_pid_c20240627__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zEJaeW5Nv9m4" title="Ordinary shares issued upon conversion"&gt;410&lt;/span&gt; (&lt;span id="xdx_900_eifrs-full--NumberOfSharesIssuedAndFullyPaid_iI_pid_dxL_c20240627__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zl2FwdaPZLKf" title="Ordinary shares issued upon conversion::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2454"&gt;nil&lt;/span&gt;&lt;/span&gt; after reverse stock splits) ordinary
                                            shares and issued &lt;span id="xdx_903_ecustom--NumberOfWarrantsIssued_pid_c20240627__20240627_zaw1ofEhMLCd" title="Number of warrants"&gt;32&lt;/span&gt; (&lt;span id="xdx_900_ecustom--NumberOfWarrantsIssued_pid_dxL_c20240627__20240627__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_z90XT8uMOHn7" title="Number of warrants::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2458"&gt;nil&lt;/span&gt;&lt;/span&gt; after reverse stock splits) warrants at an exercise price of $&lt;span id="xdx_904_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20240627__20240627_zvkYIW4uCY7d" title="Exercise price of share"&gt;4.7025&lt;/span&gt;
                                            ($&lt;span id="xdx_904_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20240627__20240627__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zjJvjgVrjekc" title="Exercise price of share"&gt;57,460&lt;/span&gt; after reverse stock splits) per warrant.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            July 10, 2024, the Company entered into a Letter of Intent (LOI) with PMB. Under the LOI,
                                            the Company restructured $&lt;span id="xdx_90F_eifrs-full--NetDebt_iI_pn5n6_c20240710_zDRASg8tLR47"&gt;1.3&lt;/span&gt; million of its debt to PMB (see note 7.E). Subsequently, the
                                            Company entered into definitive agreements reflecting the terms of the LOI. PMB exchanged
                                            its shares in TrueGold, for &lt;span id="xdx_90B_ecustom--IssueOfConvertibleShares_pid_c20240710__20240710_zS4blR5EX2d2" title="Issue of convertible shares"&gt;1,022&lt;/span&gt; (&lt;span id="xdx_907_ecustom--IssueOfConvertibleShares_pid_dxL_c20240710__20240710__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zvpv834ilSKe" title="Issue of convertible shares::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2467"&gt;nil&lt;/span&gt;&lt;/span&gt; after reverse stock splits) Company shares. The Company
                                            also issued &lt;span id="xdx_906_eifrs-full--NumberOfSharesIssued_iI_pid_c20240710_z6RLLsoyL3ck"&gt;1,818&lt;/span&gt; (&lt;span id="xdx_908_eifrs-full--NumberOfSharesIssued_iI_pid_dxL_c20240710__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zTwTdDxPLTZa" title="::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2469"&gt;nil&lt;/span&gt;&lt;/span&gt; after reverse stock splits) shares as consideration for PMB&#x2019;s
                                            waivers and releases related to the debt.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            July 19, 2024, pursuant to a Securities Purchase Agreement, the Company issued to Alpha &lt;span id="xdx_90C_ecustom--NumberOfWarrantsIssued_pid_c20240719__20240719__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zJPvHhJ4dsBc" title="Number of warrants"&gt;7,317&lt;/span&gt;
                                            (&lt;span id="xdx_901_ecustom--NumberOfWarrantsIssued_pid_dxL_c20240719__20240719__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zxyoroliFvfl" title="Number of warrants::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2473"&gt;nil&lt;/span&gt;&lt;/span&gt; after reverse stock splits) warrants for a &lt;span id="xdx_902_ecustom--WarrantsTerm_dtY_c20240719__20240719__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zZuOVNmwAfQh" title="Warrants term"&gt;5.5&lt;/span&gt; years period with an exercise price of
                                            $&lt;span id="xdx_90C_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20240719__20240719__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zr18Quspos3c" title="Exercise price of share"&gt;178&lt;/span&gt; ($&lt;span id="xdx_90E_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20240719__20240719__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zx2oMdYHNMSa" title="Exercise price of share"&gt;2,175,058&lt;/span&gt; after reverse stock splits) per warrant. The warrants also may be exercised
                                            pursuant to a cashless mechanism. As of December 31, 2024, all of the warrants were exercised
                                            into &lt;span id="xdx_903_ecustom--NumberOfSharesConverted_iI_pid_c20241231__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__ifrs-full--WarrantsMember_z0iCqfYKik1i" title="Number of shares converted"&gt;7,188&lt;/span&gt; (&lt;span id="xdx_909_ecustom--NumberOfSharesConverted_iI_pid_dxL_c20241231__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__ifrs-full--WarrantsMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zdKkAFFoU1Mh" title="Number of shares converted::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2483"&gt;nil&lt;/span&gt;&lt;/span&gt; after reverse stock splits) ordinary shares. (see note 7.F).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;15.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            September 11, 2024, pursuant to a Securities Purchase Agreement, the Company issued to investors
                                            an aggregate of &lt;span id="xdx_900_eifrs-full--NumberOfSharesIssued_iI_pid_c20240911__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InvestorsMember_zIDzg9dvu1rj" title="Number of shares issued"&gt;55,789&lt;/span&gt; (&lt;span id="xdx_90E_eifrs-full--NumberOfSharesIssued_iI_pid_c20240911__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InvestorsMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zJDiXPIztlx9" title="Number of shares issued"&gt;4&lt;/span&gt; after reverse stock splits) ordinary shares, &lt;span id="xdx_902_eifrs-full--NumberOfSharesIssued_iI_pid_c20240911__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InvestorsMember__ifrs-full--ClassesOfShareCapitalAxis__custom--PreFundedWarrantMember_zr4iy3UXOz3e" title="Number of shares issued"&gt;131,930&lt;/span&gt; (&lt;span id="xdx_909_eifrs-full--NumberOfSharesIssued_iI_pid_c20240911__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InvestorsMember__ifrs-full--ClassesOfShareCapitalAxis__custom--PreFundedWarrantMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zs8gqFx68zK1" title="Number of shares issued"&gt;10&lt;/span&gt; after
                                            reverse stock splits) Pre-Funded Warrants and &lt;span id="xdx_90D_eifrs-full--NumberOfSharesIssued_iI_pid_c20240911__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InvestorsMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesACommonWarrantsMember_zMIp3BERti6k" title="Number of shares issued"&gt;375,439&lt;/span&gt; (&lt;span id="xdx_901_eifrs-full--NumberOfSharesIssued_iI_pid_c20240911__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InvestorsMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesACommonWarrantsMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zxShOenSs0Ui" title="Number of shares issued"&gt;30&lt;/span&gt; after reverse stock splits) series
                                            A common warrants. On October 28, 2024, pursuant to the terms of the transaction, the Company
                                            further issued &lt;span id="xdx_90F_eifrs-full--NumberOfSharesIssued_iI_pid_c20241028__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InvestorsMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesBCommonWarrantsMember_zXqr1DzYbNXl" title="Number of shares issued"&gt;195,381&lt;/span&gt; (&lt;span id="xdx_902_eifrs-full--NumberOfSharesIssued_iI_pid_c20241028__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InvestorsMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesBCommonWarrantsMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_z4X7wvdy1lzc" title="Number of shares issued"&gt;15&lt;/span&gt; after reverse stock splits) Series B Common Warrants and an additional
                                            &lt;span id="xdx_902_eifrs-full--NumberOfSharesIssued_iI_pid_c20241028__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InvestorsMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesACommonWarrantsMember_zfEYUIcsFxqh" title="Number of shares issued"&gt;390,763&lt;/span&gt; (&lt;span id="xdx_907_eifrs-full--NumberOfSharesIssued_iI_pid_c20241028__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InvestorsMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesACommonWarrantsMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_z5jij8OhtUOi" title="Number of shares issued"&gt;31&lt;/span&gt;after reverse stock splits) Series A Common Warrant.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 42.05pt; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of 31 December 2024, the investors exercised all of Pre-Funded Warrants and Series B Common Warrants, and &lt;span id="xdx_90C_eifrs-full--NumberOfSharesIssued_iI_pid_c20241231__ifrs-full--ComponentsOfEquityAxis__custom--SeriesACommonWarrantsMember_zEY6WRijlDea" title="Number of shares issued"&gt;277,439&lt;/span&gt; (&lt;span id="xdx_901_eifrs-full--NumberOfSharesIssued_iI_pid_c20241231__ifrs-full--ComponentsOfEquityAxis__custom--SeriesACommonWarrantsMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zXGxbd7KF7Uc" title="Number of shares issued"&gt;22&lt;/span&gt; after reverse stock
splits) of the Series A Common Warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 42.05pt; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2024, the outstanding Series A Common Warrant totalled &lt;span id="xdx_90E_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20241231__ifrs-full--ComponentsOfEquityAxis__custom--SeriesACommonWarrantsMember_zPm6Wv09v72e" title="Number of shares outstanding"&gt;488,762&lt;/span&gt; (&lt;span id="xdx_906_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20241231__ifrs-full--ComponentsOfEquityAxis__custom--SeriesACommonWarrantsMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zenlw4sWncyf" title="Number of shares outstanding"&gt;39&lt;/span&gt; after reverse stock splits) at an exercise price of
$&lt;span id="xdx_900_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--SeriesACommonWarrantsMember_zGwoEagPPA27" title="Warrants exercise price, per share"&gt;13.96&lt;/span&gt; ($&lt;span id="xdx_902_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--SeriesACommonWarrantsMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_z7STYNscmgLj" title="Warrants exercise price, per share"&gt;170,584&lt;/span&gt; after reverse stock splits). (see note 11).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25.1pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;16.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            September 16, 2024, an investor converted $&lt;span id="xdx_90C_ecustom--NumberOfValueConverted_iI_pn3n3_c20240916_z2ROehULsMl4" title="Number of value converted"&gt;23&lt;/span&gt; of its convertible security of the Company
                                            into &lt;span id="xdx_90E_eifrs-full--NumberOfSharesIssued_iI_pid_c20240916_zkkcGqMzlRH7" title="Number of shares issued"&gt;793&lt;/span&gt; (&lt;span id="xdx_908_eifrs-full--NumberOfSharesIssued_iI_pid_dxL_c20240916__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_z4cYjWsPjY6d" title="Number of shares issued::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2521"&gt;nil&lt;/span&gt;&lt;/span&gt; after reverse stock splits) ordinary shares. (see note 8.C).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;17.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
                                            September 2024, a service provider exercised options into &lt;span id="xdx_909_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_pid_uShares_c20240901__20240930_zk6Sh3j75tZ9" title="Number of options exercised"&gt;48&lt;/span&gt; (&lt;span id="xdx_905_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_pid_dxL_uShares_c20240901__20240930__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zRp2w3gMDeUk" title="Number of options exercised::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2525"&gt;nil&lt;/span&gt;&lt;/span&gt; after reverse stock splits)
                                            ordinary shares in cashless exercise.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 42.05pt; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 85%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands, except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
15 - SHAREHOLDERS&#x2019; EQUITY (CONT.)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;During
2025&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(*)
The amounts of ordinary shares and per share data, warrants, RSU, conversion price and exercise prices are after giving effect of all
the reverse stock splits that occurred during as of the date of these financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
                                            the year ending December 31, 2025, the investor converted all the principal amount of Alpha
                                            April Note and Alpha July Note into &lt;span id="xdx_900_ecustom--NumberOfSharesConverted_iI_pid_c20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OrdinarySharesMember__ifrs-full--BorrowingsByNameAxis__custom--AlphaAprilNoteMember_zqYTexrUiaD2" title="Number of shares converted"&gt;49&lt;/span&gt; and &lt;span id="xdx_908_ecustom--NumberOfSharesConverted_iI_pid_c20241231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OrdinarySharesMember__ifrs-full--BorrowingsByNameAxis__custom--AlphaJulyNoteMember_zH1PRjQaYuOe" title="Number of shares converted"&gt;31&lt;/span&gt; ordinary shares respectively, as a result of
                                            the issuance the issued capital and additional paid in capital increased in the amount of
                                            $&lt;span id="xdx_908_ecustom--NumberOfValueConverted_iI_pid_c20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OrdinarySharesMember_zCNJbaO2pnU4" title="Number of value converted"&gt;3,204&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
                                            the year ending December 31, 2025, the Company issued &lt;span id="xdx_90E_eifrs-full--NumberOfSharesIssued_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InvestorsMember_zjfXMoCQ6BTd"&gt;125,817&lt;/span&gt; ordinary shares and RSU to
                                            certain investors at a cost of $&lt;span id="xdx_90E_eifrs-full--FinanceCosts_pn3n3_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InvestorsMember_zwt7gAFFXJm3" title="Finance expenes"&gt;7,811&lt;/span&gt; recorded as finance expenses.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
                                            the year ending December 31, 2025, as part of the RBW May agreement the Company issued &lt;span id="xdx_907_eifrs-full--NumberOfSharesIssued_iI_pid_c20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--WarrantsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UnderwritersMember_zEVUqrZiMi52"&gt;224&lt;/span&gt;
                                            warrants underwriters. The warrants granted to the underwriters are classified as equity-settled
                                            share-based payments under IFRS 2 and are measured at fair value at the grant date. The total
                                            amount recognized in the additional paid in capital in respect of these warrants fair value
                                            amounted to $&lt;span id="xdx_909_ecustom--FairValueOfWarrants_pn3n3_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--WarrantsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UnderwritersMember_z3ci515Xg9l5" title="Fair value of warrants"&gt;2,718&lt;/span&gt;. (see Note 7.I).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2025, pursuant to the agreement all the promissory notes were fully converted into &lt;span id="xdx_902_ecustom--NumberOfSharesConverted_iI_pid_c20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OrdinarySharesMember__ifrs-full--BorrowingsByNameAxis__custom--PromissoryNotesMember_zYqRSfAoCSRi" title="Number of shares converted"&gt;1,949&lt;/span&gt; ordinary shares. As a result
of the issuance the issued capital and additional paid in capital increased in the amount of $&lt;span id="xdx_907_ecustom--NumberOfValueConverted_iI_pn3n3_c20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OrdinarySharesMember__ifrs-full--BorrowingsByNameAxis__custom--PromissoryNotesMember_zmBP28MPhc77" title="Number of value converted"&gt;9,668&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
                                            of December 31, 2025, pursuant to the RBW August agreement $&lt;span id="xdx_902_eifrs-full--Borrowings_iI_pn3n3_c20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OrdinarySharesMember__ifrs-full--BorrowingsByNameAxis__custom--PromissoryNotesMember__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_zaE8wUiWbeg9" title="Principal amount"&gt;13,750&lt;/span&gt; of the principal amount
                                            of the promissory notes were converted into &lt;span id="xdx_902_ecustom--NumberOfSharesConverted_iI_pid_c20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OrdinarySharesMember__ifrs-full--BorrowingsByNameAxis__custom--PromissoryNotesMember__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_znEDw3jvzod8" title="Number of shares converted"&gt;66,794&lt;/span&gt; ordinary shares. As a result of the issuance
                                            the issued capital and additional paid in capital increased in the amount of $&lt;span id="xdx_905_ecustom--NumberOfValueConverted_iI_pn3n3_c20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OrdinarySharesMember__ifrs-full--BorrowingsByNameAxis__custom--PromissoryNotesMember__ifrs-full--TypesOfContractsAxis__custom--RBWAugustAgreementMember_ziUMEyXNaaFf" title="Number of value converted"&gt;16,176&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
                                            of December 31, 2025, pursuant to the RBW December agreement the $&lt;span id="xdx_90A_eifrs-full--Borrowings_iI_pn3n3_c20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OrdinarySharesMember__ifrs-full--BorrowingsByNameAxis__custom--PromissoryNotesMember__ifrs-full--TypesOfContractsAxis__custom--RBWDecemberAgreementMember_zpMCde1sJbW5" title="Principal amount"&gt;11,984&lt;/span&gt; of the principal
                                            amount of the promissory notes were converted into &lt;span id="xdx_90D_ecustom--NumberOfSharesConverted_iI_pid_c20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OrdinarySharesMember__ifrs-full--BorrowingsByNameAxis__custom--PromissoryNotesMember__ifrs-full--TypesOfContractsAxis__custom--RBWDecemberAgreementMember_zChUGtfkCl2i" title="Number of shares converted"&gt;168,852&lt;/span&gt; ordinary shares. As a result of
                                            the issuance the issued capital and additional paid in capital increased in the amount of
                                            $&lt;span id="xdx_908_ecustom--NumberOfValueConverted_iI_pn3n3_c20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OrdinarySharesMember__ifrs-full--BorrowingsByNameAxis__custom--PromissoryNotesMember__ifrs-full--TypesOfContractsAxis__custom--RBWDecemberAgreementMember_zmFuJN0tygx4" title="Number of value converted"&gt;14,098&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
                                            the year ending December 31, 2025, as part of the Target SEPA agreement the Company issued
                                            &lt;span id="xdx_90D_eifrs-full--NumberOfSharesIssued_iI_pid_c20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OrdinarySharesMember__ifrs-full--TypesOfContractsAxis__custom--TargetSEPAAgreementMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InvestorsMember_zdv7AVGBTYn" title="Number of shares issued"&gt;10,505&lt;/span&gt; ordinary shares to the investor. The fair value of this issuance was recorded as facility
                                            fee financial expenses in the amount of $&lt;span id="xdx_901_eifrs-full--IssueOfEquity_pn3n3_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OrdinarySharesMember__ifrs-full--TypesOfContractsAxis__custom--TargetSEPAAgreementMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InvestorsMember_ztYDVZqAhjt7" title="Number of shares issued, value"&gt;2,639&lt;/span&gt; against additional paid in capital (see Note
                                            11)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
                                            the year ending December 31, 2025, the company signed settlement agreement with Abri. According
                                            to the settlement agreement the Company paid to the borrower $&lt;span id="xdx_908_ecustom--RepaymentOfShorttermLoan_pn3n3_c20250101__20251231__ifrs-full--TypesOfContractsAxis__custom--SettlementAgreementMember_zsN6BpjZIVO1" title="Paid to borrower"&gt;500&lt;/span&gt; and converted the remaining
                                            debt amount into &lt;span id="xdx_906_eifrs-full--NumberOfSharesIssued_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--TypesOfContractsAxis__custom--SettlementAgreementMember_zUNEgZjqe1xe" title="Number of shares issued"&gt;58,288&lt;/span&gt; ordinary shares. As a result of the issuance the issued capital and
                                            additional paid in capital increased in the amount of $&lt;span id="xdx_90E_eifrs-full--IssueOfEquity_pn3n3_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--TypesOfContractsAxis__custom--SettlementAgreementMember_zT5jfjofQWld" title="Number of shares issued, value"&gt;4,134&lt;/span&gt; (see Note 12).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25.1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands, except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
15 - SHAREHOLDERS&#x2019; EQUITY (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Share-Base
    Compensation:&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
June 2018, Security Matters PTY Ltd. adopted a Share Option Plan (the &#x201c;Plan&#x201d;) to provide an incentive to retain, in the employment
or service or directorship of the Group and provide the ability to attract new employees, directors or consultants whose services are
considered valuable. The persons eligible to participate in the Share Option Plan include employees, directors and consultants of Security
Matters PTY Ltd. or any subsidiary. On March 7, 2023, as part of the SPAC transaction, these options were exercised on a cashless basis
and then after replaced with the Company&#x2019;s shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;During
2024:&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25.1pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            January 31, 2024, the Company granted &lt;span id="xdx_90A_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pid_uShares_c20240131__20240131__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceProvidersMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zXsUd4iby8y7" title="Number of RSUs granted"&gt;702&lt;/span&gt; RSUs (&lt;span id="xdx_908_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pid_dxL_uShares_c20240131__20240131__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceProvidersMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zhFFcie4N9Cb" title="Number of RSUs granted::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2567"&gt;nil&lt;/span&gt;&lt;/span&gt; after revers stock splits) to employees,
                                            directors and service providers. The company measured the fair value of the RSU&#x2019;s according
                                            to the quote share price at the grant day. &lt;span id="xdx_90E_ecustom--DescriptionOfVestingPeriod_uShares_c20240131__20240131__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceProvidersMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_z62ONOtwU6V3" title="Description of vesting period"&gt;The RSUs shall vest monthly in equal instalments
                                            over 18 months beginning on the anniversary of the grant date&lt;/span&gt;, with an acceleration clause
                                            that was effective within the year 2024. As of December 31,2024 the related share-based expenses
                                            were $&lt;span id="xdx_905_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceProvidersMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zi9YZrVc7Kg8" title="Share-based expenses"&gt;585&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            July 21, 2024, the Company granted &lt;span id="xdx_906_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pid_uShares_c20240721__20240721__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AdvisorMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zRsSo1gjGmP4" title="Number of RSUs granted"&gt;241&lt;/span&gt; RSUs (&lt;span id="xdx_90F_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pid_dxL_uShares_c20240721__20240721__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AdvisorMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zNiTLpxDFiv6" title="Number of RSUs granted::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2575"&gt;nil&lt;/span&gt;&lt;/span&gt; after revers stock splits) to an advisor.
                                            The company measured the fair value of the RSU&#x2019;s according to the quote share price
                                            at the grant day. &lt;span id="xdx_90E_ecustom--DescriptionOfVestingPeriod_uShares_c20240721__20240721__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AdvisorMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zuAmBSd2FXE5" title="Description of vesting period"&gt;The RSUs shall vest monthly in equal instalment until December 20, 2024&lt;/span&gt;.
                                            According to the vesting schedule all the related share-based expenses recognized as of December
                                            31, 2024, and totalled to $&lt;span id="xdx_909_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AdvisorMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zej6444bKpUe" title="Share-based expenses"&gt;43&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            August 29, 2024, the Company amended its 2022 Incentive Equity Plan, to increase the number
                                            of authorized Ordinary Shares under the Incentive Plan to &lt;span id="xdx_902_ecustom--NumberOfInstrumentsAuthorizedInSharebasedPaymentArrangement_iI_c20240829__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember_zLx01xV2Rww3" title="Number of authorized ordinary shares"&gt;53,500&lt;/span&gt; (&lt;span id="xdx_902_ecustom--NumberOfInstrumentsAuthorizedInSharebasedPaymentArrangement_iI_c20240829__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zzp4E4BdXHC6" title="Number of authorized ordinary shares"&gt;4&lt;/span&gt; after reverse stock splits)
                                            As a Foreign Private Issuer, Nasdaq Rule 5615(a)(3) allows the Company to rely on home country
                                            corporate governance practices in lieu of certain of the rules in the Nasdaq Rule 5600 Series
                                            and Rule 5250(d) and, accordingly, the Company so elected to approve the amendment without
                                            stockholder approval.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            August 29, 2024, the Company granted an aggregate of &lt;span id="xdx_90A_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pid_uShares_c20240829__20240829__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesExecutiveOfficersAndDirectorsMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zcuXr5hQdS6f" title="Number of RSUs granted"&gt;14,430&lt;/span&gt; fully vested RSUs (&lt;span id="xdx_90E_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pid_dxL_uShares_c20240829__20240829__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesExecutiveOfficersAndDirectorsMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_ztAW7ZXdOh66" title="Number of RSUs granted::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2587"&gt;nil&lt;/span&gt;&lt;/span&gt; after
                                            reverse stock splits) to its employees, executive officers and directors, and to certain
                                            consultants and advisors of the Company. The company measured the fair value of the RSU&#x2019;s
                                            according to the quote share price at the grant day. According to the vesting schedule all
                                            the related share-based expenses recognized as of December 31, 2024, and totalled to $&lt;span id="xdx_903_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_pn3n3_c20240829__20240829__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesExecutiveOfficersAndDirectorsMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zdIBiSPZbjCb" title="Share-based expenses"&gt;1,176&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
                                            the year ended December 31, 2024, the Company granted &lt;span id="xdx_90C_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_pid_uShares_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesAndServiceProvidersMember_zu8kl446lMNh" title="Number of options granted"&gt;23,951&lt;/span&gt; fully vested options (&lt;span id="xdx_909_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_pid_uShares_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesAndServiceProvidersMember__ifrs-full--ReservesWithinEquityAxis__custom--AfterReverseStockSplitMember_zNyXLKipvxwk" title="Number of options granted"&gt;2&lt;/span&gt; after
                                            reverse stock splits) with &lt;span id="xdx_906_ecustom--DescriptionOfVestingPeriod_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesAndServiceProvidersMember_zpNlHCNMyg94" title="Vesting period description"&gt;expiration date of 4 years&lt;/span&gt; from the grant date to employees and
                                            service providers. The related share-based expenses that were recognized in the year ended
                                            December 31, 2024, amounted to $&lt;span id="xdx_909_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesAndServiceProvidersMember_zCtfcAJrLAvd" title="Share-based expenses"&gt;874&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25.1pt; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
options were valued using the Black-Scholes pricing model. The main inputs which were used are:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 60.55pt; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;risk-free
                                            rate: &lt;span id="xdx_90E_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20240101__20241231__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_zYLijtgMPysc" title="Risk-free rate"&gt;3.82&lt;/span&gt;%;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;expected
                                            volatility: &lt;span id="xdx_904_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20240101__20241231__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_z4kL7p3YhCXa" title="Expected volatility"&gt;71.56&lt;/span&gt;%;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;expected
                                            term: up to &lt;span id="xdx_90E_ecustom--DescriptionOfExpectedTermWarrants_dtY_c20240101__20241231__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_zhmd1Hvjjcwi" title="Expected term"&gt;2.5&lt;/span&gt; years; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;expected
                                            dividend yield: &lt;span id="xdx_909_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20240101__20241231__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_zjJoifSOWRhb" title="Expected dividend yield"&gt;0&lt;/span&gt;%.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
                                            of December 31, 2024, the company recorded according to previous RSUs grants that occurred
                                            during 2023 related share-based expenses of $&lt;span id="xdx_90C_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_pn3n3_c20240101__20241231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_z8jx5nTWFWql" title="Share-based expenses"&gt;979&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands, except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 54.6pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
15 - SHAREHOLDERS&#x2019; EQUITY (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;During
2025:&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25.1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            February 24, 2025, the Company amended its 2022 Incentive Equity Plan (&#x201c;2022 Incentive
                                            Equity Plan&#x201d;) to increase the number of authorized Ordinary Shares under the 2022 Incentive
                                            Equity Plan to &lt;span id="xdx_904_ecustom--NumberOfInstrumentsAuthorizedInSharebasedPaymentArrangement_iI_pid_c20250224__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember_z0oKaLNXiaB8" title="Number of authorized ordinary shares"&gt;186&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Thereafter,
                                            the Company granted an aggregate of &lt;span id="xdx_90B_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pid_uShares_c20250224__20250224__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExecutiveOfficersAndDirectorsCertainConsultantsAndAdvisorsMember_zbgTcbDMwym5" title="Number of RSUs granted"&gt;143&lt;/span&gt; RSUs to its executive officers and directors, certain
                                            consultants, employees and advisors. The company measured the fair value of the RSU&#x2019;s
                                            according to the quote share price at the grant day. &lt;span id="xdx_901_ecustom--DescriptionOfVestingPeriod_pid_c20250224__20250224__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExecutiveOfficersAndDirectorsCertainConsultantsAndAdvisorsMember_zWMLBdllApo" title="Vesting period description"&gt;The RSUs shall fully vest until December
                                            31, 2025&lt;/span&gt;. According to the vesting schedule all the related share-based expenses recognized
                                            in the period and totalled to $&lt;span id="xdx_907_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_pn3n3_c20250224__20250224__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExecutiveOfficersAndDirectorsCertainConsultantsAndAdvisorsMember_zaDh24TpEhij" title="Share-based expenses"&gt;4,322&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
                                            Company also granted &lt;span id="xdx_905_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_pid_uShares_c20250224__20250224__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsCertainConsultantsAndAdvisorsMember_zUfLBjreS9J8" title="Number of options granted"&gt;44&lt;/span&gt; options to its directors, certain consultants, and advisors. &lt;span id="xdx_902_ecustom--DescriptionOfVestingPeriod_pid_c20250224__20250224__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsCertainConsultantsAndAdvisorsMember_zWAjPCVLANh" title="Vesting period description"&gt;The
                                            options shall fully vest until December 31, 2025&lt;/span&gt;. According to the vesting schedule all the
                                            related share-based expenses recognized in the period and totalled to $&lt;span id="xdx_90D_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_pn3n3_c20250224__20250224__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsCertainConsultantsAndAdvisorsMember_zpQAVxJeXcw8" title="Share-based expenses"&gt;631&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25.1pt; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
options were valued using the Black-Scholes pricing model. The main inputs which were used are:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;risk-free
                                            rate: &lt;span id="xdx_908_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20250224__20250224__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_zDuzobhMpojg" title="Risk-free rate"&gt;4.14&lt;/span&gt;%.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;expected
                                            volatility: &lt;span id="xdx_900_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20250224__20250224__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_zKo2o3oU0bTg" title="Expected volatility"&gt;74.69&lt;/span&gt;%;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;expected
                                            term: up to &lt;span id="xdx_90E_ecustom--DescriptionOfExpectedTermWarrants_dtY_c20250224__20250224__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_z6Kwgu7iEhG5" title="Expected term"&gt;2.5&lt;/span&gt; years; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;expected
                                            dividend yield: &lt;span id="xdx_90D_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20250224__20250224__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_zG1EFISk9Nt2" title="Expected dividend yield"&gt;0&lt;/span&gt;%.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            March 17, 2025, the Company amended the 2022 Incentive Equity Plan, to further increase the
                                            number of authorized Ordinary Shares under the 2022 Incentive Equity Plan to &lt;span id="xdx_905_ecustom--NumberOfInstrumentsAuthorizedInSharebasedPaymentArrangement_iI_pid_c20250317__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember_zl7rq7ULeqfl" title="Number of authorized ordinary shares"&gt;207&lt;/span&gt;. Thereafter,
                                            the Company granted &lt;span id="xdx_908_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_pid_uShares_c20250317__20250317__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CertainConsultantsMember_z0nWaad0h3o" title="Number of options granted"&gt;11&lt;/span&gt; stock options to certain consultants of the Company. &lt;span id="xdx_90F_ecustom--DescriptionOfVestingPeriod_c20250317__20250317__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsCertainConsultantsAndAdvisorsMember_zv1UqsLJhFl7" title="Vesting period description"&gt;The options shall
                                            fully vest until December 31, 2025.&lt;/span&gt; According to the vesting schedule all the related share-based
                                            expenses recognized in the period and totalled to $&lt;span id="xdx_90F_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_pn3n3_c20250317__20250317__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsCertainConsultantsAndAdvisorsMember_zfEf98GFLJv3" title="Share-based expenses"&gt;140&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25.1pt; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
options were valued using the Black-Scholes pricing model. The main inputs which were used are:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;risk-free
                                            rate: &lt;span id="xdx_90D_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20250317__20250317__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_zrBfwLzKu9D4" title="Risk-free rate"&gt;4.05&lt;/span&gt;%.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;expected
                                            volatility: &lt;span id="xdx_902_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20250317__20250317__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_zTc7kiDfpyqj" title="Expected volatility"&gt;75.58&lt;/span&gt;%.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;expected
                                            term: up to &lt;span id="xdx_908_ecustom--DescriptionOfExpectedTermWarrants_dtY_c20250317__20250317__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_zBI3UzYL1h0e" title="Expected term"&gt;2.5&lt;/span&gt; years; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;expected
                                            dividend yield: &lt;span id="xdx_90F_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20250317__20250317__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_zh3o9iKE2jra" title="Expected dividend yield"&gt;0&lt;/span&gt;%.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25.1pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            June 17, 2025, the Company amended its 2022 Incentive Equity Plan, as amended, to increase
                                            the number of authorized Ordinary Shares under the 2022 Incentive Equity Plan to &lt;span id="xdx_900_ecustom--NumberOfInstrumentsAuthorizedInSharebasedPaymentArrangement_iI_pid_c20250617__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember_zbd0Abe266ei" title="Number of authorized ordinary shares"&gt;1,432&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Thereafter,
                                            the Company granted an aggregate of &lt;span id="xdx_909_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pid_uShares_c20250617__20250617__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExecutiveOfficersAndDirectorsCertainConsultantsAndAdvisorsMember_ziA0oaXIJOL4" title="Number of RSUs granted"&gt;721&lt;/span&gt; RSUs to its executive officers and directors, certain
                                            consultants, employees and advisors. The company measured the fair value of the RSU&#x2019;s
                                            according to the quote share price at the grant day. &lt;span id="xdx_904_ecustom--DescriptionOfVestingPeriod_pid_c20250617__20250617__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExecutiveOfficersAndDirectorsCertainConsultantsAndAdvisorsMember_zhvRdeDuHBvk" title="Vesting period description"&gt;The RSUs shall fully vest until December
                                            31, 2025.&lt;/span&gt; According to the vesting schedule all the related share-based expenses recognized
                                            in the period and totalled to $&lt;span id="xdx_900_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_pn3n3_c20250617__20250617__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExecutiveOfficersAndDirectorsCertainConsultantsAndAdvisorsMember_zxZzDwaibvP5" title="Share-based expenses"&gt;9,924&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
                                            Company also granted &lt;span id="xdx_903_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_pid_uShares_c20250617__20250617__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsCertainConsultantsAndAdvisorsMember_zN5KZglYc6C" title="Number of options granted"&gt;448&lt;/span&gt; options to its directors, certain consultants, and advisors. &lt;span id="xdx_904_ecustom--DescriptionOfVestingPeriod_pid_c20250617__20250617__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsCertainConsultantsAndAdvisorsMember_ziZyBpuUwPk1" title="Vesting period description"&gt;The
                                            options shall fully vest until December 31, 2025.&lt;/span&gt; According to the vesting schedule all the
                                            related share-based expenses recognized in the period and totalled to $&lt;span id="xdx_90B_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_pn3n3_c20250617__20250617__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsCertainConsultantsAndAdvisorsMember_z4U2qoIVSmUl" title="Share-based expenses"&gt;2,911&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25.1pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
options were valued using the Black-Scholes pricing model. The main inputs which were used are:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;risk-free
                                            rate: &lt;span id="xdx_90A_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20250617__20250617__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_zE4Y5R5xQKUe" title="Risk-free rate"&gt;3.92&lt;/span&gt;%.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;expected
                                            volatility: &lt;span id="xdx_90E_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20250617__20250617__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_z5ZTrLK0CP0f" title="Expected volatility"&gt;74.23&lt;/span&gt;%.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;expected
                                            term: up to &lt;span id="xdx_901_ecustom--DescriptionOfExpectedTermWarrants_dtY_c20250617__20250617__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_zvNkGH8RqY0b" title="Expected term"&gt;2.5&lt;/span&gt; years.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and
                                            expected dividend yield: &lt;span id="xdx_908_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20250617__20250617__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_zAmNiXAdwbc7" title="Expected dividend yield"&gt;0&lt;/span&gt;%.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 60.55pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands, except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
15 - SHAREHOLDERS&#x2019; EQUITY (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            July 3, 2025, the Company amended its 2022 Incentive Equity Plan, as amended, to increase
                                            the number of authorized Ordinary Shares under the 2022 Incentive Equity Plan to &lt;span id="xdx_90E_ecustom--NumberOfInstrumentsAuthorizedInSharebasedPaymentArrangement_iI_pid_c20250703__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember_zNJMDB6DN5e3" title="Number of authorized ordinary shares"&gt;1,563&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Thereafter,
                                            the Company granted an aggregate of &lt;span id="xdx_909_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pid_uShares_c20250703__20250703__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExecutiveOfficersAndDirectorsCertainConsultantsAndAdvisorsMember_zwEAOmy4VPng" title="Number of RSUs granted"&gt;128&lt;/span&gt; RSUs to its executive officers and directors, certain
                                            consultants, employees and advisors. The company measured the fair value of the RSU&#x2019;s
                                            according to the quote share price at the grant day. &lt;span id="xdx_906_ecustom--DescriptionOfVestingPeriod_pid_c20250703__20250703__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExecutiveOfficersAndDirectorsCertainConsultantsAndAdvisorsMember_zmldhyA4yMD9" title="Vesting period description"&gt;The RSUs shall fully vest until December
                                            31, 2025.&lt;/span&gt; According to the vesting schedule all the related share-based expenses recognized
                                            in the period and totalled to $&lt;span id="xdx_904_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_pn3n3_c20250703__20250703__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExecutiveOfficersAndDirectorsCertainConsultantsAndAdvisorsMember_zTpUXHyNSww" title="Share-based expenses"&gt;1,727&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
                                            Company also granted &lt;span id="xdx_909_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_pid_uShares_c20250703__20250703__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsCertainConsultantsAndAdvisorsMember_zde2k9bg4EBe" title="Number of options granted"&gt;12&lt;/span&gt; options to its directors, certain consultants, and advisors. &lt;span id="xdx_908_ecustom--DescriptionOfVestingPeriod_pid_c20250703__20250703__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsCertainConsultantsAndAdvisorsMember_zLu1QNoj65y3" title="Vesting period description"&gt;The
                                            options shall fully vest until December 31, 2025.&lt;/span&gt; According to the vesting schedule all the
                                            related share-based expenses recognized in the period and totalled to $&lt;span id="xdx_902_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_pn3n3_c20250703__20250703__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsCertainConsultantsAndAdvisorsMember_zvAfncEJoEv4" title="Share-based expenses"&gt;119&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25.1pt; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
options were valued using the Black-Scholes pricing model. The main inputs which were used are:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;risk-free
                                            rate: &lt;span id="xdx_905_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20250703__20250703__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_zcto3hP4O4b" title="Risk-free rate"&gt;3.86&lt;/span&gt;%.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;expected
                                            volatility: &lt;span id="xdx_90F_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20250703__20250703__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_zYyLjetHq5hg" title="Expected volatility"&gt;142&lt;/span&gt;%.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;expected
                                            term: up to &lt;span id="xdx_90C_ecustom--DescriptionOfExpectedTermWarrants_dtY_c20250703__20250703__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_zF9f5WGE0SR1" title="Expected term"&gt;2.5&lt;/span&gt; years.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and
                                            expected dividend yield: &lt;span id="xdx_907_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20250703__20250703__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_zLUMUCbUIpX2" title="Expected dividend yield"&gt;0&lt;/span&gt;%.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 60.55pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            August 26, 2025, the Company amended its 2022 Incentive Equity Plan, to increase the number
                                            of authorized Ordinary Shares under the 2022 Incentive Equity Plan to &lt;span id="xdx_90D_ecustom--NumberOfInstrumentsAuthorizedInSharebasedPaymentArrangement_iI_pid_c20250826__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember_z4ZnSesOlpOh" title="Number of authorized ordinary shares"&gt;18,309&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Thereafter,
                                            the Company granted an aggregate of &lt;span id="xdx_901_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pid_uShares_c20250826__20250826__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExecutiveOfficersAndDirectorsCertainConsultantsAndAdvisorsMember_zSf221IPqKf1" title="Number of RSUs granted"&gt;12,566&lt;/span&gt; RSUs to its executive officers and directors,
                                            certain consultants, employees and advisors. The company measured the fair value of the RSU&#x2019;s
                                            according to the quote share price at the grant day. &lt;span id="xdx_90A_ecustom--DescriptionOfVestingPeriod_pid_c20250826__20250826__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExecutiveOfficersAndDirectorsCertainConsultantsAndAdvisorsMember_zPfYVmWdHTA1" title="Vesting period description"&gt;The RSUs shall fully vest until December
                                            31, 2025.&lt;/span&gt; According to the vesting schedule all the related share-based expenses recognized
                                            in the period and totalled to $&lt;span id="xdx_903_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_pn3n3_c20250826__20250826__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExecutiveOfficersAndDirectorsCertainConsultantsAndAdvisorsMember_zEdlh18X1yGg" title="Share-based expenses"&gt;20,773&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
                                            Company also granted &lt;span id="xdx_90A_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_pid_uShares_c20250826__20250826__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsCertainConsultantsAndAdvisorsMember_zp3mYfIWCMKh" title="Number of options granted"&gt;3,758&lt;/span&gt; options to its directors, certain consultants, and advisors. &lt;span id="xdx_908_ecustom--DescriptionOfVestingPeriod_pid_c20250826__20250826__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsCertainConsultantsAndAdvisorsMember_zSPZzlbPUkD6" title="Vesting period description"&gt;The
                                            options shall fully vest until December 31, 2025.&lt;/span&gt; According to the vesting schedule all the
                                            related share-based expenses recognized in the period and totalled to $&lt;span id="xdx_907_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_pn3n3_c20250826__20250826__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsCertainConsultantsAndAdvisorsMember_zyVEOTbub5hj" title="Share-based expenses"&gt;4,896&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25.1pt; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
options were valued using the Black-Scholes pricing model. The main inputs which were used are:&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;risk-free
                                            rate: &lt;span id="xdx_90B_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20250826__20250826__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_zknE5NTouKd8" title="Risk-free rate"&gt;3.62&lt;/span&gt;%.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;expected
                                            volatility: &lt;span id="xdx_901_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20250826__20250826__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_zrT24WKSKbih" title="Expected volatility"&gt;144&lt;/span&gt;%.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;expected
                                            term: up to &lt;span id="xdx_90F_ecustom--DescriptionOfExpectedTermWarrants_dtY_c20250826__20250826__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_z72O1ZVxUBzj" title="Expected term"&gt;2.5&lt;/span&gt; years.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and
                                            expected dividend yield: &lt;span id="xdx_903_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20250826__20250826__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_zTWM3Tv1IoDi" title="Expected dividend yield"&gt;0&lt;/span&gt;%.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25.1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            September 4, 2025, the Company amended its 2022 Incentive Equity Plan to increase the number
                                            of authorized Ordinary Shares under the 2022 Incentive Equity Plan to &lt;span id="xdx_906_ecustom--NumberOfInstrumentsAuthorizedInSharebasedPaymentArrangement_iI_pid_c20250904__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember_zOeaLyFINU7k" title="Number of authorized ordinary shares"&gt;25,708&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Thereafter,
                                            the Company granted an aggregate of &lt;span id="xdx_90E_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pid_uShares_c20250904__20250904__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExecutiveOfficersAndDirectorsCertainConsultantsAndAdvisorsMember_zIySvktCsU14" title="Number of RSUs granted"&gt;4,110&lt;/span&gt; RSUs to its executive officers and directors. The
                                            company measured the fair value of the RSU&#x2019;s according to the quote share price at
                                            the grant day. &lt;span id="xdx_901_ecustom--DescriptionOfVestingPeriod_pid_c20250904__20250904__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExecutiveOfficersAndDirectorsCertainConsultantsAndAdvisorsMember_z3euCelQ8SEh" title="Vesting period description"&gt;The RSUs shall fully vest until December 31, 2025.&lt;/span&gt; According to the vesting
                                            schedule all the related share-based expenses recognized in the period and totalled to $&lt;span id="xdx_90F_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_pn3n3_c20250904__20250904__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExecutiveOfficersAndDirectorsCertainConsultantsAndAdvisorsMember_zNytcwLyrf42" title="Share-based expenses"&gt;2,642&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
                                            Company also granted &lt;span id="xdx_900_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_pid_uShares_c20250904__20250904__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsMember_z8IP58YtUQW7" title="Number of options granted"&gt;3,288&lt;/span&gt; options to its directors. &lt;span id="xdx_90D_ecustom--DescriptionOfVestingPeriod_pid_c20250904__20250904__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsMember_zjwJIJfxDByj" title="Vesting period description"&gt;The options shall fully vest until December
                                            31, 2025&lt;/span&gt;. According to the vesting schedule all the related share-based expenses recognized
                                            in the period and totalled to $&lt;span id="xdx_90C_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_pn3n3_c20250904__20250904__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsMember_zPOkfNSGFI2j" title="Share-based expenses"&gt;&lt;span id="xdx_90E_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_pn3n3_c20250904__20250904__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExecutiveOfficersAndDirectorsCertainConsultantsEmployeesAndAdvisorsMember_zZberPwUtYCj" title="Share-based expenses"&gt;1,428&lt;/span&gt;&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25.1pt; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
options were valued using the Black-Scholes pricing model. The main inputs which were used are:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;risk-free
                                            rate: &lt;span id="xdx_903_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20250904__20250904__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_z1vgQESVqfx2" title="Risk-free rate"&gt;3.57&lt;/span&gt;%.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;expected
                                            volatility: &lt;span id="xdx_902_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20250904__20250904__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_zLTkbXraStEj" title="Expected volatility"&gt;147&lt;/span&gt;%.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;expected
                                            term: up to &lt;span id="xdx_904_ecustom--DescriptionOfExpectedTermWarrants_dtY_c20250904__20250904__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_zLpnIBp2AIhb" title="Expected term"&gt;2.5&lt;/span&gt; years.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and
                                            expected dividend yield: &lt;span id="xdx_90E_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20250904__20250904__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_zNSHqdQlRw2c" title="Expected dividend yield"&gt;0&lt;/span&gt;%.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands, except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
15 - SHAREHOLDERS&#x2019; EQUITY (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25.1pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            October 29, 2025, the Company further amended its Incentive Plan to increase the number of
                                            authorized Ordinary Shares under the Incentive Plan to &lt;span id="xdx_90F_ecustom--NumberOfInstrumentsAuthorizedInSharebasedPaymentArrangement_iI_pid_c20251029__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember_zWOBE7hAkmYg" title="Number of authorized ordinary shares"&gt;233,324&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Thereafter,
                                            the Company granted an aggregate of &lt;span id="xdx_905_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pid_uShares_c20251029__20251029__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExecutiveOfficersAndDirectorsCertainConsultantsEmployeesAndAdvisorsMember_zYSE7XMnMyXc" title="Number of RSUs granted"&gt;150,272&lt;/span&gt; RSUs to its executive officers and directors,
                                            certain consultants, employees and advisors. The company measured the fair value of the RSU&#x2019;s
                                            according to the quote share price at the grant day. &lt;span id="xdx_90F_ecustom--DescriptionOfVestingPeriod_pid_c20251029__20251029__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExecutiveOfficersAndDirectorsCertainConsultantsEmployeesAndAdvisorsMember_zmoeMj8H5pMl" title="Vesting period description"&gt;The RSUs shall fully vest until December
                                            31, 2025.&lt;/span&gt; According to the vesting schedule all the related share-based expenses recognized
                                            in the period and totalled to $&lt;span id="xdx_909_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_pn3n3_c20251029__20251029__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExecutiveOfficersAndDirectorsCertainConsultantsEmployeesAndAdvisorsMember_zgoaYyxJdRC7" title="Share-based expenses"&gt;17,316&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
                                            Company also granted &lt;span id="xdx_903_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_pid_uShares_c20251029__20251029__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsCertainConsultantsAndAdvisorsMember_z7SoXi5570u4" title="Number of options granted"&gt;52,480&lt;/span&gt; options to its directors, certain consultants, and advisors.
                                            &lt;span id="xdx_90A_ecustom--DescriptionOfVestingPeriod_pid_c20251029__20251029__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsCertainConsultantsAndAdvisorsMember_zgymeMlPaTN9" title="Vesting period description"&gt;The options shall fully vest until December 31, 2025.&lt;/span&gt; According to the vesting schedule all
                                            the related share-based expenses recognized in the period and totalled to $&lt;span id="xdx_90F_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_pn3n3_c20251029__20251029__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsCertainConsultantsAndAdvisorsMember_zHeR751hESl5" title="Share-based expenses"&gt;4,817&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25.1pt; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
options were valued using the Black-Scholes pricing model. The main inputs which were used are:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;risk-free
                                            rate: &lt;span id="xdx_90B_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20251029__20251029__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_zM6U3eomMz98" title="Risk-free rate"&gt;3.6&lt;/span&gt;%.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;expected
                                            volatility: &lt;span id="xdx_90F_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20251029__20251029__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_z4edinOgxeVl" title="Expected volatility"&gt;142&lt;/span&gt;%.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;expected
                                            term: up to &lt;span id="xdx_903_ecustom--DescriptionOfExpectedTermWarrants_dtY_c20251029__20251029__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_z3H364pZQXD1" title="Expected term"&gt;2.5&lt;/span&gt; years.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and
                                            expected dividend yield: &lt;span id="xdx_90C_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20251029__20251029__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_z1x7oic6X3uf" title="Expected dividend yield"&gt;0&lt;/span&gt;%.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25.1pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            November 21, 2025, the Company further amended its 2022 Incentive Equity Plan to increase
                                            the number of authorized Ordinary Shares under the Incentive Plan to &lt;span id="xdx_904_ecustom--NumberOfInstrumentsAuthorizedInSharebasedPaymentArrangement_iI_pid_c20251121__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember_zjNu5DgiKjg7" title="Number of authorized ordinary shares"&gt;2,442,092&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Thereafter,
                                            the Company granted an aggregate of &lt;span id="xdx_90C_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pid_uShares_c20251121__20251121__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExecutiveOfficersAndDirectorsCertainConsultantsEmployeesAndAdvisorsMember_zj9cyRni80w" title="Number of RSUs granted"&gt;1,360,896&lt;/span&gt; RSUs to its executive officers and directors,
                                            certain consultants, employees and advisors. The company measured the fair value of the RSU&#x2019;s
                                            according to the quote share price at the grant day. &lt;span id="xdx_900_ecustom--DescriptionOfVestingPeriod_pid_c20251121__20251121__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExecutiveOfficersAndDirectorsCertainConsultantsEmployeesAndAdvisorsMember_zAxAEogwdbRf" title="Vesting period description"&gt;The RSUs shall fully vest until December
                                            31, 2025&lt;/span&gt;. According to the vesting schedule all the related share-based expenses recognized
                                            in the period and totalled to $&lt;span id="xdx_905_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_pn3n3_c20251121__20251121__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExecutiveOfficersAndDirectorsCertainConsultantsEmployeesAndAdvisorsMember_z7c8TdbXj361" title="Share-based expenses"&gt;28,175&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
                                            Company also granted &lt;span id="xdx_90C_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_pid_uShares_c20251121__20251121__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsCertainConsultantsAndAdvisorsMember_zDNfIwF0hz4d" title="Number of options granted"&gt;808,960&lt;/span&gt; options to its directors, certain consultants, and advisors.
                                            &lt;span id="xdx_907_ecustom--DescriptionOfVestingPeriod_pid_c20251121__20251121__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsCertainConsultantsAndAdvisorsMember_zh3VWD14OXDb" title="Vesting period description"&gt;The options shall fully vest until December 31, 2025&lt;/span&gt;. According to the vesting schedule all
                                            the related share-based expenses recognized in the period and totalled to $&lt;span id="xdx_90C_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_pn3n3_c20251121__20251121__ifrs-full--TypesOfContractsAxis__custom--TwoThousandTwentyTwoIncentiveEquityPlanMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsCertainConsultantsAndAdvisorsMember_z7ZfaQRfCoIe" title="Share-based expenses"&gt;13,975&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25.1pt; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
options were valued using the Black-Scholes pricing model. The main inputs which were used are:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 42.55pt"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;risk-free
                                            rate: &lt;span id="xdx_90F_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20251121__20251121__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_zcR42sSqa6j4" title="Risk-free rate"&gt;3.56&lt;/span&gt;%.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 42.55pt"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;expected
                                            volatility: &lt;span id="xdx_909_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20251121__20251121__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_zFZVZh7p4dn6" title="Expected volatility"&gt;142&lt;/span&gt;%.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 42.55pt"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;expected
                                            term: up to &lt;span id="xdx_90A_ecustom--DescriptionOfExpectedTermWarrants_dtY_c20251121__20251121__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_zjeITtQWHhT" title="Expected term"&gt;2.5&lt;/span&gt; years.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 42.55pt"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and
                                            expected dividend yield: &lt;span id="xdx_90A_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20251121__20251121__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_zJrZd1Uhi3z" title="Expected dividend yield"&gt;0&lt;/span&gt;%.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 60.55pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
                                            of December 31, 2025, the company recorded according to previous RSUs and options grants
                                            that occurred during 2023-2024 related share-based expenses of $&lt;span id="xdx_908_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_pn3n3_c20250101__20251231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_z6zOcTB12WH1" title="Share-based expenses"&gt;409&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
related share-based expenses that were recognized in the year ended December 31, 2025, amounted to $&lt;span id="xdx_90D_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_pn3n3_c20250101__20251231_zt2wsnOqTlYb" title="Share-based expenses"&gt;114,205&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands, except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
15 - SHAREHOLDERS&#x2019; EQUITY (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Summary
of the status of the Company&#x2019;s Share Option Plan granted to employees, directors, advisors and service providers and changes during
the relevant period are presented below&lt;b&gt;:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;RSUs
granted to employees, directors and service providers:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_ecustom--DisclosureOfRestrictedStockUnitExplanatory_zOs6YbaYFkW7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; display: none"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B5_zUISHMyylrGi"&gt;SCHEDULE OF RESTRICTED STOCK UNIT&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31, 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31, 2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Outstanding at the beginning of the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pid_uShares_c20250101__20251231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceProvidersMember_fKg_____zLjqAJJmqs7b" title="Number of outstanding, Beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2787"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pid_uShares_c20240101__20241231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceProvidersMember_fKg_____zAbzW1xIRAM3" title="Number of outstanding, Beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2789"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 60%"&gt;Granted&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pid_uShares_c20250101__20251231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceProvidersMember_zABedSQveUD8" style="width: 16%; text-align: right" title="Number of outstanding, Granted"&gt;1,528,836&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pid_uShares_c20240101__20241231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceProvidersMember_zzjFs8zPrrTk" style="width: 16%; text-align: right" title="Number of outstanding, Granted"&gt;1&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Vested&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pid_di_uShares_c20250101__20251231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceProvidersMember_z2BwIUcZqCy2" style="text-align: right" title="Number of outstanding, Vested"&gt;(1,528,832&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pid_di_uShares_c20240101__20241231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceProvidersMember_zhqnccIb0Kcd" style="text-align: right" title="Number of outstanding, Vested"&gt;(1&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Forfeited&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_iN_pid_di_uShares_c20250101__20251231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceProvidersMember_zTQVHq9nTBH2" style="border-bottom: Black 1pt solid; text-align: right" title="Number of outstanding, Forfeited"&gt;(4&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;span id="xdx_906_eifrs-full--NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_iN_pid_di_uShares_c20240101__20241231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceProvidersMember_fKg_____zoQKYVV7jmI7" title="Number of outstanding, Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2801"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Outstanding at the end of year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pid_uShares_c20250101__20251231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceProvidersMember_z1Y9wbajHkil" style="border-bottom: Black 1pt solid; text-align: right" title="Number of outstanding, Ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2803"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pid_uShares_c20240101__20241231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceProvidersMember_fKg_____zGlZzVAwXvAk" title="Number of outstanding, Ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2805"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F03_z0npetdkxj0f" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F17_zarYozArrL8k" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Nil after reverse
stock split&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A9_zXfmcVdW69Ml" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Options
granted to employees, directors, advisors and service providers:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_eifrs-full--DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_ze4gr04TnvNh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; display: none"&gt;&lt;span id="xdx_8B2_ze0UGk58A0Ig"&gt;SCHEDULE OF SHARE OPTION GRANTED&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: -28.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31, 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31, 2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Number&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;of options&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;br/&gt;
average&lt;br/&gt;
Exercise&lt;br/&gt;
 price (USD$)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Number&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;of options&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;br/&gt;
average&lt;br/&gt;
Exercise&lt;br/&gt;
 price (USD$)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Outstanding at beginning of year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_uUSD_c20250101__20251231_fKg_____zEcjaj2dp5fj" title="Number of options outstanding, Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2810"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20250101__20251231_za4tAOyZXej3" style="text-align: right" title="Weighted average exercise price outstanding, Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2812"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_uUSD_c20240101__20241231_fKg_____zFK8bvX5B5B" title="Number of options outstanding, Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2814"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20240101__20241231_zRfMqWh8ak04" style="text-align: right" title="Weighted average exercise price outstanding, Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2816"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 40%; padding-bottom: 1pt"&gt;Issue of options&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uShares_c20250101__20251231_zRvMdB1MwuR8" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Number of issue of options"&gt;869,001&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pid_c20250101__20251231_zUbrdEXdkzTf" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Weighted average exercise price, issued of options"&gt;183,639&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uUSD_c20240101__20241231_fKg_____zl9z95NghIug" title="Number of Issue of options"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2822"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pid_c20240101__20241231_zdssPfi7STia" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Weighted average exercise price, issued of options"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2824"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Outstanding at the end of year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_uShares_c20250101__20251231_zHqWe6y1b6Z2" style="border-bottom: Black 1pt solid; text-align: right" title="Number of options outstanding, Ending balance"&gt;869,001&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_c20250101__20251231_zaq6SPASsILc" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price outstanding, Ending balance"&gt;183,639&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_uUSD_c20240101__20241231_fKg_____zYWGP9r6o2pb" title="Number of options outstanding, Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2830"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_c20240101__20241231_zGFOFLMwCSjb" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price outstanding, Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2832"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Exercisable options&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iE_pid_uShares_c20250101__20251231_zHBaYGKxUjjb" style="border-bottom: Black 1pt solid; text-align: right" title="Number of options, Exercisable"&gt;869,001&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_iE_pid_c20250101__20251231_zkITq0Sv5Pie" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, Exercisable"&gt;183,639&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iE_pid_uUSD_c20240101__20241231_fKg_____zsXG2cvngkOd" title="Number of options, Exercisable"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2838"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_iE_pid_c20240101__20241231_zxBeDuF1POK8" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, Exercisable"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2840"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F06_zMXAlsdwG2Jb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1B_zHOdQty6NC98" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Nil after reverse
stock split&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A4_z2iCBqEXQaMb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory>
    <ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact002238">&lt;p id="xdx_893_eifrs-full--DisclosureOfClassesOfShareCapitalExplanatory_zov0z9egdX94" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; display: none"&gt;&lt;span id="xdx_8B6_zsjnYSfrI1Ha"&gt;SCHEDULE
OF SHARE CAPITAL&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" id="xdx_F6D_zY2qsES20MHa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Number of shares *&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Authorized&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Issued and&lt;br/&gt;
 outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Authorized&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Issued and&lt;br/&gt;
 outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%"&gt;Ordinary shares&lt;br/&gt; USD &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eifrs-full--ParValuePerShare_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z3bzz0nlOa3i" title="Par value per share"&gt;0.00000000012219451015625&lt;/span&gt; &lt;br/&gt;par value&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_fKg_____zjPYv66wRutb" style="width: 11%; text-align: right" title="Number of shares authorized"&gt;817,549,003,406,601,232,640&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_fKg_____z4XPD9R70Xha" style="width: 11%; text-align: right" title="Number of shares issued and outstanding"&gt;1,795,943&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_fKg_____zp43yVEjetfb" style="width: 11%; text-align: right" title="Number of shares authorized"&gt;1,392&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_fKg_____zDIiVG5phyva" style="width: 11%; text-align: right" title="Number of shares issued and outstanding"&gt;95&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Preferred shares &lt;br/&gt; USD &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eifrs-full--ParValuePerShare_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_zjy1TQ0G14Zj" title="Par value per share"&gt;0.0001&lt;/span&gt; par value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_fKg_____zKB98gVHwua9" style="text-align: right" title="Number of shares authorized"&gt;200,000,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_fKg_____zYwGBZEZiHfj" style="text-align: right" title="Number of shares issued and outstanding"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2254"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_fKg_____zwzJzDumdnna" style="text-align: right" title="Number of shares authorized"&gt;200,000,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_fKg_____zKWmlcFjj6Se" style="text-align: right" title="Number of shares issued and outstanding"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2258"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Deferred shares &lt;br/&gt; Euro &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eifrs-full--ParValuePerShare_iI_pid_uEuroPerShare_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--DeferredSharesMember_zeBEgJvyDrQb" title="Par value per share"&gt;1&lt;/span&gt; par value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--DeferredSharesMember_fKg_____zSGj9PKfSFUj" style="text-align: right" title="Number of shares authorized"&gt;25,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--DeferredSharesMember_fKg_____zBqd5oWPEOY1" style="text-align: right" title="Number of shares issued and outstanding"&gt;25,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--DeferredSharesMember_fKg_____zzGTQWLRaiLh" style="text-align: right" title="Number of shares authorized"&gt;25,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--DeferredSharesMember_fKg_____z6qEobNxySk3" style="text-align: right" title="Number of shares issued and outstanding"&gt;25,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;New Deferred shares &lt;br/&gt; USD &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eifrs-full--ParValuePerShare_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--NewDeferredSharesMember_zu0LaiRttWbj" title="Par value per share"&gt;0.00000000000001&lt;/span&gt; par value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--NewDeferredSharesMember_fKg_____zU93c8FIJ6r6" style="text-align: right" title="Number of shares authorized"&gt;7,999,999,999,999,982,413,677&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--NewDeferredSharesMember_fKg_____zqr9sTv6b92d" style="text-align: right" title="Number of shares issued and outstanding"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2274"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--NewDeferredSharesMember_fKg_____zqVmQOHua5dc" style="text-align: right" title="Number of shares authorized"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2276"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--NewDeferredSharesMember_fKg_____zGsT8xTlawsa" style="text-align: right" title="Number of shares issued and outstanding"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2278"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F0F_z6Ylts6kwIYc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F11_z63X6OiiSEI3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The share and per
share information in these financial statements reflects the &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20240715__20240715_zhFKFrr5MK4i" title="Reverse share splits, description"&gt;1-for-75&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20250115__20250115_zotQoNzkkUG8" title="Reverse share splits, description"&gt;1-for-28.5&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20250616__20250616_zybItfAHUDmi" title="Reverse share splits, description"&gt;1-for-4.1&lt;/span&gt; &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20250807__20250807_zdQGltGg8gB5" title="Reverse share splits, description"&gt;1-for-7&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20251023__20251023_znXlqU2WVZE5" title="Reverse share splits, description"&gt;1-for-10.89958&lt;/span&gt; , &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20251118__20251118_zGWhCwPiW5hi" title="Reverse share splits, description"&gt;1-for-8&lt;/span&gt; and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20260217__20260217__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventsMember_zEDpyXcjoTVl" title="Reverse share splits, description"&gt;1:4.8828125&lt;/span&gt;
reverse share splits became effective on July 15, 2024, January 15, 2025, June 16, 2025, August 7, 2025, October 23, 2025, November 18,
2025 and February 17, 2026 respectively, of the Company&#x2019;s issued and outstanding Ordinary Shares (the &#x201c;Reverse Stock Splits&#x201d;).
See also Note 1.F- 1.K and 26.3.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2025-12-31_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact002240"
      unitRef="USDPShares">0.00000000012219451015625</ifrs-full:ParValuePerShare>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="AsOf2025-12-31_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact002242"
      unitRef="Shares">817549003406601232640</ifrs-full:NumberOfSharesAuthorised>
    <SMX:NumberOfSharesIssuedAndOutstanding
      contextRef="AsOf2025-12-31_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact002244"
      unitRef="Shares">1795943</SMX:NumberOfSharesIssuedAndOutstanding>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="AsOf2024-12-31_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact002246"
      unitRef="Shares">1392</ifrs-full:NumberOfSharesAuthorised>
    <SMX:NumberOfSharesIssuedAndOutstanding
      contextRef="AsOf2024-12-31_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact002248"
      unitRef="Shares">95</SMX:NumberOfSharesIssuedAndOutstanding>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2025-12-31_ifrs-full_PreferenceSharesMember"
      decimals="INF"
      id="Fact002250"
      unitRef="USDPShares">0.0001</ifrs-full:ParValuePerShare>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="AsOf2025-12-31_ifrs-full_PreferenceSharesMember"
      decimals="INF"
      id="Fact002252"
      unitRef="Shares">200000000000</ifrs-full:NumberOfSharesAuthorised>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="AsOf2024-12-31_ifrs-full_PreferenceSharesMember"
      decimals="INF"
      id="Fact002256"
      unitRef="Shares">200000000000</ifrs-full:NumberOfSharesAuthorised>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2025-12-31_custom_DeferredSharesMember"
      decimals="INF"
      id="Fact002260"
      unitRef="EuroPerShare">1</ifrs-full:ParValuePerShare>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="AsOf2025-12-31_custom_DeferredSharesMember"
      decimals="INF"
      id="Fact002262"
      unitRef="Shares">25000</ifrs-full:NumberOfSharesAuthorised>
    <SMX:NumberOfSharesIssuedAndOutstanding
      contextRef="AsOf2025-12-31_custom_DeferredSharesMember"
      decimals="INF"
      id="Fact002264"
      unitRef="Shares">25000</SMX:NumberOfSharesIssuedAndOutstanding>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="AsOf2024-12-31_custom_DeferredSharesMember"
      decimals="INF"
      id="Fact002266"
      unitRef="Shares">25000</ifrs-full:NumberOfSharesAuthorised>
    <SMX:NumberOfSharesIssuedAndOutstanding
      contextRef="AsOf2024-12-31_custom_DeferredSharesMember"
      decimals="INF"
      id="Fact002268"
      unitRef="Shares">25000</SMX:NumberOfSharesIssuedAndOutstanding>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2025-12-31_custom_NewDeferredSharesMember"
      decimals="INF"
      id="Fact002270"
      unitRef="USDPShares">0.00000000000001</ifrs-full:ParValuePerShare>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="AsOf2025-12-31_custom_NewDeferredSharesMember"
      decimals="INF"
      id="Fact002272"
      unitRef="Shares">7999999999999982413677</ifrs-full:NumberOfSharesAuthorised>
    <SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding contextRef="From2024-07-152024-07-15" id="Fact002281">1-for-75</SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding>
    <SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding contextRef="From2025-01-152025-01-15" id="Fact002283">1-for-28.5</SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding>
    <SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding contextRef="From2025-06-162025-06-16" id="Fact002285">1-for-4.1</SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding>
    <SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding contextRef="From2025-08-072025-08-07" id="Fact002287">1-for-7</SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding>
    <SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding contextRef="From2025-10-232025-10-23" id="Fact002289">1-for-10.89958</SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding>
    <SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding contextRef="From2025-11-182025-11-18" id="Fact002291">1-for-8</SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding>
    <SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding
      contextRef="From2026-02-172026-02-17_custom_NonadjustingEventsMember"
      id="Fact002293">1:4.8828125</SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2025-12-31_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact002295"
      unitRef="USDPShares">0.00000000012219451015625</ifrs-full:ParValuePerShare>
    <SMX:DescriptionOfImpactOfNewDeferredShares contextRef="From2025-01-01to2025-12-31" id="Fact002297">The
new deferred shares of $0.00000000000001 par value with the following rights: (i) each new deferred share shall not entitle the holder
thereof to receive notice, attend or vote at general meetings of the Company; (ii) each New Deferred Share shall not entitle the holder
thereof to participate in any dividends declared or paid by the Company; and (iii) on a return of capital on a winding up or otherwise,
each New Deferred Share shall entitle the holder thereof to receive an amount of US$0.00000000000001 on each deferred share after an
amount of $1,000,000,000 has been paid in respect of each ordinary share.</SMX:DescriptionOfImpactOfNewDeferredShares>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2025-12-31_custom_NewDeferredSharesMember"
      decimals="INF"
      id="Fact002299"
      unitRef="USDPShares">0.00000000000001</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2025-12-31_ifrs-full_PreferenceSharesMember"
      decimals="INF"
      id="Fact002301"
      unitRef="USDPShares">0.0001</ifrs-full:ParValuePerShare>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-12-31_custom_DeferredSharesMember"
      decimals="INF"
      id="Fact002303"
      unitRef="Shares">25000</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="AsOf2025-12-31_custom_DeferredSharesMember"
      decimals="INF"
      id="Fact002305"
      unitRef="Shares">25000</ifrs-full:NumberOfSharesAuthorised>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2025-12-31_custom_DeferredSharesMember"
      decimals="INF"
      id="Fact002307"
      unitRef="EuroPerShare">1.00</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2025-12-31_custom_DeferredSharesMember"
      decimals="INF"
      id="Fact002309"
      unitRef="USDPShares">0.0001</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2025-12-31_ifrs-full_IssuedCapitalMember"
      decimals="INF"
      id="Fact002311"
      unitRef="USDPShares">0.0001</ifrs-full:ParValuePerShare>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-01-04_custom_ServiceProviderAgreementsMember"
      decimals="INF"
      id="Fact002313"
      unitRef="Shares">47</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-03-31_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact002316"
      unitRef="Shares">1251</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:ProceedsFromIssueOfOrdinaryShares
      contextRef="From2024-01-012024-03-31_ifrs-full_OrdinarySharesMember"
      decimals="-3"
      id="Fact002318"
      unitRef="USD">527000</ifrs-full:ProceedsFromIssueOfOrdinaryShares>
    <SMX:WarrantsExercised
      contextRef="AsOf2024-06-21_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact002320"
      unitRef="Shares">117</SMX:WarrantsExercised>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-06-21_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact002324"
      unitRef="Shares">117</ifrs-full:NumberOfSharesIssued>
    <SMX:ExercisePriceOfWarrants
      contextRef="From2024-06-212024-06-21_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact002328"
      unitRef="USDPShares">4.7025</SMX:ExercisePriceOfWarrants>
    <SMX:ExercisePriceOfWarrants
      contextRef="From2024-06-212024-06-21_ifrs-full_WarrantsMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact002330"
      unitRef="USDPShares">57460</SMX:ExercisePriceOfWarrants>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-02-01_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact002332"
      unitRef="Shares">234</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-02-20_custom_UnderwritingAgreementMember_custom_OrdinarySharesAndPrefundedWarrantsMember"
      decimals="INF"
      id="Fact002336"
      unitRef="Shares">5672</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2024-02-20_custom_UnderwritingAgreementMember_custom_OrdinarySharesAndPrefundedWarrantsMember"
      decimals="INF"
      id="Fact002340"
      unitRef="USDPShares">513</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2024-02-20_custom_UnderwritingAgreementMember_custom_OrdinarySharesAndPrefundedWarrantsMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact002342"
      unitRef="USDPShares">6268574</ifrs-full:ParValuePerShare>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="From2024-02-202024-02-20_custom_UnderwritingAgreementMember"
      decimals="-4"
      id="Fact002344"
      unitRef="USD">2910000</ifrs-full:ProceedsFromIssuingShares>
    <SMX:PreFundedWarrantsConvertibleDescription
      contextRef="From2024-02-202024-02-20_custom_UnderwritingAgreementMember_custom_PrefundedWarrantsMember"
      id="Fact002346">1-for-1</SMX:PreFundedWarrantsConvertibleDescription>
    <SMX:PreFundedWarrantsConvertibleAmount
      contextRef="From2024-02-202024-02-20_custom_UnderwritingAgreementMember_custom_PrefundedWarrantsMember"
      decimals="-3"
      id="Fact002348"
      unitRef="USD">508000</SMX:PreFundedWarrantsConvertibleAmount>
    <SMX:PreFundedWarrantsConvertibleAmount
      contextRef="From2024-02-202024-02-20_custom_AfterReverseStockSplitMember_custom_PrefundedWarrantsMember_custom_UnderwritingAgreementMember"
      decimals="INF"
      id="Fact002349"
      unitRef="USD">6207480</SMX:PreFundedWarrantsConvertibleAmount>
    <SMX:BeneficialOwnershipPercentage
      contextRef="AsOf2024-02-20_custom_UnderwritingAgreementMember_custom_PrefundedWarrantsMember"
      decimals="INF"
      id="Fact002351"
      unitRef="Pure">0.0499</SMX:BeneficialOwnershipPercentage>
    <ifrs-full:ProceedsFromIssuingOtherEquityInstruments
      contextRef="From2024-02-202024-02-20_custom_UnderwritingAgreementMember_custom_PrefundedWarrantsMember"
      decimals="-4"
      id="Fact002353"
      unitRef="USD">2690000</ifrs-full:ProceedsFromIssuingOtherEquityInstruments>
    <SMX:UnderwriterCashFeePercentage
      contextRef="AsOf2024-02-20_custom_UnderwritingAgreementMember_custom_PrefundedWarrantsMember"
      decimals="INF"
      id="Fact002355"
      unitRef="Pure">0.025</SMX:UnderwriterCashFeePercentage>
    <SMX:UnderwriterCashFeeGrossProceedsAmount
      contextRef="From2024-02-202024-02-20_custom_UnderwritingAgreementMember_custom_PrefundedWarrantsMember"
      decimals="-3"
      id="Fact002357"
      unitRef="USD">100000</SMX:UnderwriterCashFeeGrossProceedsAmount>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-12-31_custom_UnderwritingAgreementMember_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact002359"
      unitRef="Shares">1620</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2024-12-31_custom_UnderwritingAgreementMember_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact002361"
      unitRef="USDPShares">513</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2024-12-31_custom_UnderwritingAgreementMember_ifrs-full_OrdinarySharesMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact002363"
      unitRef="USDPShares">6268.57</ifrs-full:ParValuePerShare>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-12-31_custom_UnderwritingAgreementMember_custom_PrefundedWarrantsMember"
      decimals="-3"
      id="Fact002365"
      unitRef="Shares">4052000</ifrs-full:NumberOfSharesIssued>
    <SMX:PreFundedWarrantsConvertibleAmount
      contextRef="From2024-01-012024-12-31_custom_UnderwritingAgreementMember_custom_PrefundedWarrantsMember"
      decimals="-3"
      id="Fact002369"
      unitRef="USD">508000</SMX:PreFundedWarrantsConvertibleAmount>
    <SMX:PreFundedWarrantsConvertibleAmount
      contextRef="From2024-01-012024-12-31_custom_AfterReverseStockSplitMember_custom_PrefundedWarrantsMember_custom_UnderwritingAgreementMember"
      decimals="INF"
      id="Fact002370"
      unitRef="USD">6207480</SMX:PreFundedWarrantsConvertibleAmount>
    <SMX:NumberOfWarrantsIssued
      contextRef="From2024-02-282024-02-28_custom_InvestorsMember"
      decimals="-3"
      id="Fact002372"
      unitRef="Shares">100000000</SMX:NumberOfWarrantsIssued>
    <SMX:NumberOfWarrantsIssued
      contextRef="From2024-02-282024-02-28_custom_InvestorsMember_custom_AfterReverseStockSplitMember"
      decimals="-3"
      id="Fact002374"
      unitRef="Shares">8000</SMX:NumberOfWarrantsIssued>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2024-02-282024-02-28_custom_InvestorsMember"
      decimals="INF"
      id="Fact002376"
      unitRef="USDPShares">0.05</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2024-02-282024-02-28_custom_InvestorsMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact002378"
      unitRef="USDPShares">610</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <SMX:NumberOfValueConverted
      contextRef="AsOf2024-12-31_custom_ConvertiblePromissoryNoteMember"
      decimals="-5"
      id="Fact002380"
      unitRef="USD">2300000</SMX:NumberOfValueConverted>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-12-31_custom_ConvertiblePromissoryNoteMember"
      decimals="INF"
      id="Fact002382"
      unitRef="Shares">640</ifrs-full:NumberOfSharesIssued>
    <SMX:WarrantsExercised
      contextRef="AsOf2024-12-31_custom_InvestorsMember_custom_WarrantAMember"
      decimals="INF"
      id="Fact002386"
      unitRef="Shares">1838</SMX:WarrantsExercised>
    <SMX:NumberOfWarrantsIssued
      contextRef="From2024-04-112024-04-11_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact002390"
      unitRef="Shares">5532</SMX:NumberOfWarrantsIssued>
    <SMX:WarrantsTerm
      contextRef="From2024-04-112024-04-11_custom_SecuritiesPurchaseAgreementMember"
      id="Fact002394">P5Y6M</SMX:WarrantsTerm>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2024-04-112024-04-11_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact002396"
      unitRef="USDPShares">336</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2024-04-112024-04-11_custom_SecuritiesPurchaseAgreementMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact002398"
      unitRef="USDPShares">4105732</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <SMX:NumberOfWarrantsIssued
      contextRef="From2024-04-112024-04-11_custom_SecuritiesPurchaseAgreementMember_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact002400"
      unitRef="Shares">1225</SMX:NumberOfWarrantsIssued>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2023-09-062023-09-06_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact002404"
      unitRef="USDPShares">3501</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2023-09-062023-09-06_custom_SecuritiesPurchaseAgreementMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact002406"
      unitRef="USDPShares">42780297</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2023-09-062023-09-06_custom_SecuritiesPurchaseAgreementMember_ifrs-full_BottomOfRangeMember"
      decimals="INF"
      id="Fact002408"
      unitRef="USDPShares">4.7025</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2023-09-062023-09-06_custom_SecuritiesPurchaseAgreementMember_ifrs-full_BottomOfRangeMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact002410"
      unitRef="USDPShares">57460</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <SMX:NumberOfValueConverted
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002412"
      unitRef="USD">2110000</SMX:NumberOfValueConverted>
    <SMX:NumberOfWarrantsIssued
      contextRef="From2024-01-012024-12-31_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact002414"
      unitRef="Shares">464424</SMX:NumberOfWarrantsIssued>
    <SMX:NumberOfWarrantsIssued
      contextRef="From2024-01-012024-12-31_ifrs-full_OrdinarySharesMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact002416"
      unitRef="Shares">38</SMX:NumberOfWarrantsIssued>
    <SMX:NumberOfWarrantsIssued
      contextRef="From2024-01-012024-12-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact002418"
      unitRef="Shares">5387</SMX:NumberOfWarrantsIssued>
    <SMX:NumberOfSharesConverted
      contextRef="AsOf2024-12-31_ifrs-full_OrdinarySharesMember18019968"
      decimals="INF"
      id="Fact002422"
      unitRef="Shares">472</SMX:NumberOfSharesConverted>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-12-31_ifrs-full_OrdinarySharesMember18019968"
      decimals="INF"
      id="Fact002426"
      unitRef="Shares">290</ifrs-full:NumberOfSharesIssued>
    <SMX:NumberOfSharesConverted
      contextRef="AsOf2024-04-30_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact002430"
      unitRef="Shares">54</SMX:NumberOfSharesConverted>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-04-30_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact002434"
      unitRef="Shares">32</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-04-24_custom_InvestorsMember"
      decimals="INF"
      id="Fact002438"
      unitRef="Shares">1275</ifrs-full:NumberOfSharesIssued>
    <SMX:CommitmentFeePercentage
      contextRef="AsOf2025-04-24_custom_InvestorsMember"
      decimals="INF"
      id="Fact002442"
      unitRef="Pure">0.015</SMX:CommitmentFeePercentage>
    <ifrs-full:NetDebt
      contextRef="AsOf2024-06-30_ifrs-full_OrdinarySharesMember"
      decimals="-3"
      id="Fact002444"
      unitRef="USD">569000</ifrs-full:NetDebt>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-06-30_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact002446"
      unitRef="Shares">1494</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NetDebt
      contextRef="AsOf2024-06-27_ifrs-full_OrdinarySharesMember"
      decimals="-3"
      id="Fact002450"
      unitRef="USD">119000</ifrs-full:NetDebt>
    <ifrs-full:NumberOfSharesIssuedAndFullyPaid
      contextRef="AsOf2024-06-27_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact002452"
      unitRef="Shares">410</ifrs-full:NumberOfSharesIssuedAndFullyPaid>
    <SMX:NumberOfWarrantsIssued
      contextRef="From2024-06-272024-06-27"
      decimals="INF"
      id="Fact002456"
      unitRef="Shares">32</SMX:NumberOfWarrantsIssued>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2024-06-272024-06-27"
      decimals="INF"
      id="Fact002460"
      unitRef="USDPShares">4.7025</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2024-06-272024-06-27_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact002462"
      unitRef="USDPShares">57460</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:NetDebt
      contextRef="AsOf2024-07-10"
      decimals="-5"
      id="Fact002463"
      unitRef="USD">1300000</ifrs-full:NetDebt>
    <SMX:IssueOfConvertibleShares
      contextRef="From2024-07-102024-07-10"
      decimals="INF"
      id="Fact002465"
      unitRef="Shares">1022</SMX:IssueOfConvertibleShares>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-07-10"
      decimals="INF"
      id="Fact002468"
      unitRef="Shares">1818</ifrs-full:NumberOfSharesIssued>
    <SMX:NumberOfWarrantsIssued
      contextRef="From2024-07-192024-07-19_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact002471"
      unitRef="Shares">7317</SMX:NumberOfWarrantsIssued>
    <SMX:WarrantsTerm
      contextRef="From2024-07-192024-07-19_custom_SecuritiesPurchaseAgreementMember"
      id="Fact002475">P5Y6M</SMX:WarrantsTerm>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2024-07-192024-07-19_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact002477"
      unitRef="USDPShares">178</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2024-07-192024-07-19_custom_SecuritiesPurchaseAgreementMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact002479"
      unitRef="USDPShares">2175058</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <SMX:NumberOfSharesConverted
      contextRef="AsOf2024-12-31_custom_SecuritiesPurchaseAgreementMember_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact002481"
      unitRef="Shares">7188</SMX:NumberOfSharesConverted>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-09-11_custom_InvestorsMember"
      decimals="INF"
      id="Fact002485"
      unitRef="Shares">55789</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-09-11_custom_InvestorsMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact002487"
      unitRef="Shares">4</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-09-11_custom_InvestorsMember_custom_PreFundedWarrantMember"
      decimals="INF"
      id="Fact002489"
      unitRef="Shares">131930</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-09-11_custom_InvestorsMember_custom_PreFundedWarrantMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact002491"
      unitRef="Shares">10</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-09-11_custom_InvestorsMember_custom_SeriesACommonWarrantsMember"
      decimals="INF"
      id="Fact002493"
      unitRef="Shares">375439</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-09-11_custom_InvestorsMember_custom_SeriesACommonWarrantsMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact002495"
      unitRef="Shares">30</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-10-28_custom_InvestorsMember_custom_SeriesBCommonWarrantsMember"
      decimals="INF"
      id="Fact002497"
      unitRef="Shares">195381</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-10-28_custom_InvestorsMember_custom_SeriesBCommonWarrantsMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact002499"
      unitRef="Shares">15</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-10-28_custom_InvestorsMember_custom_SeriesACommonWarrantsMember"
      decimals="INF"
      id="Fact002501"
      unitRef="Shares">390763</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-10-28_custom_InvestorsMember_custom_SeriesACommonWarrantsMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact002503"
      unitRef="Shares">31</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-12-31_custom_SeriesACommonWarrantsMember18020578"
      decimals="INF"
      id="Fact002505"
      unitRef="Shares">277439</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-12-31_custom_SeriesACommonWarrantsMember_custom_AfterReverseStockSplitMember18020593"
      decimals="INF"
      id="Fact002507"
      unitRef="Shares">22</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesACommonWarrantsMember18020578"
      decimals="INF"
      id="Fact002509"
      unitRef="Shares">488762</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesACommonWarrantsMember_custom_AfterReverseStockSplitMember18020593"
      decimals="INF"
      id="Fact002511"
      unitRef="Shares">39</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019
      contextRef="From2024-01-012024-12-31_custom_SeriesACommonWarrantsMember18020812"
      decimals="INF"
      id="Fact002513"
      unitRef="USDPShares">13.96</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019
      contextRef="From2024-01-012024-12-31_custom_SeriesACommonWarrantsMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact002515"
      unitRef="USDPShares">170584</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019>
    <SMX:NumberOfValueConverted
      contextRef="AsOf2024-09-16"
      decimals="-3"
      id="Fact002517"
      unitRef="USD">23000</SMX:NumberOfValueConverted>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-09-16"
      decimals="INF"
      id="Fact002519"
      unitRef="Shares">793</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="From2024-09-012024-09-30"
      decimals="INF"
      id="Fact002523"
      unitRef="Shares">48</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <SMX:NumberOfSharesConverted
      contextRef="AsOf2025-12-31_ifrs-full_OrdinarySharesMember_custom_AlphaAprilNoteMember"
      decimals="INF"
      id="Fact002527"
      unitRef="Shares">49</SMX:NumberOfSharesConverted>
    <SMX:NumberOfSharesConverted
      contextRef="AsOf2024-12-31_ifrs-full_OrdinarySharesMember_custom_AlphaJulyNoteMember"
      decimals="INF"
      id="Fact002529"
      unitRef="Shares">31</SMX:NumberOfSharesConverted>
    <SMX:NumberOfValueConverted
      contextRef="AsOf2025-12-31_ifrs-full_OrdinarySharesMember18020906"
      decimals="INF"
      id="Fact002531"
      unitRef="USD">3204</SMX:NumberOfValueConverted>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-12-31_ifrs-full_OrdinarySharesMember_custom_InvestorsMember"
      decimals="INF"
      id="Fact002532"
      unitRef="Shares">125817</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:FinanceCosts
      contextRef="From2025-01-012025-12-31_ifrs-full_OrdinarySharesMember_custom_InvestorsMember"
      decimals="-3"
      id="Fact002534"
      unitRef="USD">7811000</ifrs-full:FinanceCosts>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-12-31_ifrs-full_WarrantsMember_custom_UnderwritersMember"
      decimals="INF"
      id="Fact002535"
      unitRef="Shares">224</ifrs-full:NumberOfSharesIssued>
    <SMX:FairValueOfWarrants
      contextRef="From2025-01-012025-12-31_ifrs-full_WarrantsMember_custom_UnderwritersMember"
      decimals="-3"
      id="Fact002537"
      unitRef="USD">2718000</SMX:FairValueOfWarrants>
    <SMX:NumberOfSharesConverted
      contextRef="AsOf2025-12-31_ifrs-full_OrdinarySharesMember_custom_PromissoryNotesMember"
      decimals="INF"
      id="Fact002539"
      unitRef="Shares">1949</SMX:NumberOfSharesConverted>
    <SMX:NumberOfValueConverted
      contextRef="AsOf2025-12-31_ifrs-full_OrdinarySharesMember_custom_PromissoryNotesMember"
      decimals="-3"
      id="Fact002541"
      unitRef="USD">9668000</SMX:NumberOfValueConverted>
    <ifrs-full:Borrowings
      contextRef="AsOf2025-12-31_ifrs-full_OrdinarySharesMember_custom_PromissoryNotesMember_custom_RBWAugustAgreementMember"
      decimals="-3"
      id="Fact002543"
      unitRef="USD">13750000</ifrs-full:Borrowings>
    <SMX:NumberOfSharesConverted
      contextRef="AsOf2025-12-31_ifrs-full_OrdinarySharesMember_custom_PromissoryNotesMember_custom_RBWAugustAgreementMember"
      decimals="INF"
      id="Fact002545"
      unitRef="Shares">66794</SMX:NumberOfSharesConverted>
    <SMX:NumberOfValueConverted
      contextRef="AsOf2025-12-31_ifrs-full_OrdinarySharesMember_custom_PromissoryNotesMember_custom_RBWAugustAgreementMember"
      decimals="-3"
      id="Fact002547"
      unitRef="USD">16176000</SMX:NumberOfValueConverted>
    <ifrs-full:Borrowings
      contextRef="AsOf2025-12-31_ifrs-full_OrdinarySharesMember_custom_PromissoryNotesMember_custom_RBWDecemberAgreementMember"
      decimals="-3"
      id="Fact002549"
      unitRef="USD">11984000</ifrs-full:Borrowings>
    <SMX:NumberOfSharesConverted
      contextRef="AsOf2025-12-31_ifrs-full_OrdinarySharesMember_custom_PromissoryNotesMember_custom_RBWDecemberAgreementMember"
      decimals="INF"
      id="Fact002551"
      unitRef="Shares">168852</SMX:NumberOfSharesConverted>
    <SMX:NumberOfValueConverted
      contextRef="AsOf2025-12-31_ifrs-full_OrdinarySharesMember_custom_PromissoryNotesMember_custom_RBWDecemberAgreementMember"
      decimals="-3"
      id="Fact002553"
      unitRef="USD">14098000</SMX:NumberOfValueConverted>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-12-31_ifrs-full_OrdinarySharesMember_custom_TargetSEPAAgreementMember_custom_InvestorsMember"
      decimals="INF"
      id="Fact002555"
      unitRef="Shares">10505</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:IssueOfEquity
      contextRef="From2025-01-012025-12-31_ifrs-full_OrdinarySharesMember_custom_TargetSEPAAgreementMember_custom_InvestorsMember"
      decimals="-3"
      id="Fact002557"
      unitRef="USD">2639000</ifrs-full:IssueOfEquity>
    <SMX:RepaymentOfShorttermLoan
      contextRef="From2025-01-012025-12-31_custom_SettlementAgreementMember"
      decimals="-3"
      id="Fact002559"
      unitRef="USD">500000</SMX:RepaymentOfShorttermLoan>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-12-31_ifrs-full_OrdinarySharesMember_custom_SettlementAgreementMember"
      decimals="INF"
      id="Fact002561"
      unitRef="Shares">58288</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:IssueOfEquity
      contextRef="From2025-01-012025-12-31_ifrs-full_OrdinarySharesMember_custom_SettlementAgreementMember"
      decimals="-3"
      id="Fact002563"
      unitRef="USD">4134000</ifrs-full:IssueOfEquity>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="From2024-01-312024-01-31_custom_EmployeesDirectorsAndServiceProvidersMember_ifrs-full_RestrictedShareUnitsMember"
      decimals="INF"
      id="Fact002565"
      unitRef="Shares">702</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <SMX:DescriptionOfVestingPeriod
      contextRef="From2024-01-312024-01-31_custom_EmployeesDirectorsAndServiceProvidersMember_ifrs-full_RestrictedShareUnitsMember"
      id="Fact002569">The RSUs shall vest monthly in equal instalments
                                            over 18 months beginning on the anniversary of the grant date</SMX:DescriptionOfVestingPeriod>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="From2024-01-012024-12-31_custom_EmployeesDirectorsAndServiceProvidersMember_ifrs-full_RestrictedShareUnitsMember"
      decimals="-3"
      id="Fact002571"
      unitRef="USD">585000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="From2024-07-212024-07-21_custom_AdvisorMember_ifrs-full_RestrictedShareUnitsMember"
      decimals="INF"
      id="Fact002573"
      unitRef="Shares">241</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <SMX:DescriptionOfVestingPeriod
      contextRef="From2024-07-212024-07-21_custom_AdvisorMember_ifrs-full_RestrictedShareUnitsMember"
      id="Fact002577">The RSUs shall vest monthly in equal instalment until December 20, 2024</SMX:DescriptionOfVestingPeriod>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="From2024-01-012024-12-31_custom_AdvisorMember_ifrs-full_RestrictedShareUnitsMember"
      decimals="-3"
      id="Fact002579"
      unitRef="USD">43000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <SMX:NumberOfInstrumentsAuthorizedInSharebasedPaymentArrangement
      contextRef="AsOf2024-08-29_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember"
      decimals="-3"
      id="Fact002581"
      unitRef="Shares">53500000</SMX:NumberOfInstrumentsAuthorizedInSharebasedPaymentArrangement>
    <SMX:NumberOfInstrumentsAuthorizedInSharebasedPaymentArrangement
      contextRef="AsOf2024-08-29_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_AfterReverseStockSplitMember"
      decimals="-3"
      id="Fact002583"
      unitRef="Shares">4000</SMX:NumberOfInstrumentsAuthorizedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="From2024-08-292024-08-29_custom_EmployeesExecutiveOfficersAndDirectorsMember_ifrs-full_RestrictedShareUnitsMember"
      decimals="INF"
      id="Fact002585"
      unitRef="Shares">14430</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="From2024-08-292024-08-29_custom_EmployeesExecutiveOfficersAndDirectorsMember_ifrs-full_RestrictedShareUnitsMember"
      decimals="-3"
      id="Fact002589"
      unitRef="USD">1176000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="From2024-01-012024-12-31_custom_EmployeesAndServiceProvidersMember"
      decimals="INF"
      id="Fact002591"
      unitRef="Shares">23951</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="From2024-01-012024-12-31_custom_EmployeesAndServiceProvidersMember_custom_AfterReverseStockSplitMember"
      decimals="INF"
      id="Fact002593"
      unitRef="Shares">2</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <SMX:DescriptionOfVestingPeriod
      contextRef="From2024-01-012024-12-31_custom_EmployeesAndServiceProvidersMember"
      id="Fact002595">expiration date of 4 years</SMX:DescriptionOfVestingPeriod>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="From2024-01-012024-12-31_custom_EmployeesAndServiceProvidersMember"
      decimals="-3"
      id="Fact002597"
      unitRef="USD">874000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2024-01-012024-12-31_custom_BlackScholesPricingModelMember"
      decimals="INF"
      id="Fact002599"
      unitRef="Pure">0.0382</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2024-01-012024-12-31_custom_BlackScholesPricingModelMember"
      decimals="INF"
      id="Fact002601"
      unitRef="Pure">0.7156</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <SMX:DescriptionOfExpectedTermWarrants
      contextRef="From2024-01-012024-12-31_custom_BlackScholesPricingModelMember"
      id="Fact002603">P2Y6M</SMX:DescriptionOfExpectedTermWarrants>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2024-01-012024-12-31_custom_BlackScholesPricingModelMember"
      decimals="INF"
      id="Fact002605"
      unitRef="Pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="From2024-01-012024-12-31_ifrs-full_RestrictedShareUnitsMember"
      decimals="-3"
      id="Fact002607"
      unitRef="USD">979000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <SMX:NumberOfInstrumentsAuthorizedInSharebasedPaymentArrangement
      contextRef="AsOf2025-02-24_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember"
      decimals="INF"
      id="Fact002609"
      unitRef="Shares">186</SMX:NumberOfInstrumentsAuthorizedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="From2025-02-242025-02-24_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_ExecutiveOfficersAndDirectorsCertainConsultantsAndAdvisorsMember"
      decimals="INF"
      id="Fact002611"
      unitRef="Shares">143</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <SMX:DescriptionOfVestingPeriod
      contextRef="From2025-02-242025-02-24_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_ExecutiveOfficersAndDirectorsCertainConsultantsAndAdvisorsMember"
      id="Fact002613">The RSUs shall fully vest until December
                                            31, 2025</SMX:DescriptionOfVestingPeriod>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="From2025-02-242025-02-24_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_ExecutiveOfficersAndDirectorsCertainConsultantsAndAdvisorsMember"
      decimals="-3"
      id="Fact002615"
      unitRef="USD">4322000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="From2025-02-242025-02-24_custom_DirectorsCertainConsultantsAndAdvisorsMember"
      decimals="INF"
      id="Fact002617"
      unitRef="Shares">44</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <SMX:DescriptionOfVestingPeriod
      contextRef="From2025-02-242025-02-24_custom_DirectorsCertainConsultantsAndAdvisorsMember"
      id="Fact002619">The
                                            options shall fully vest until December 31, 2025</SMX:DescriptionOfVestingPeriod>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="From2025-02-242025-02-24_custom_DirectorsCertainConsultantsAndAdvisorsMember"
      decimals="-3"
      id="Fact002621"
      unitRef="USD">631000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2025-02-242025-02-24_custom_BlackScholesPricingModelMember"
      decimals="INF"
      id="Fact002623"
      unitRef="Pure">0.0414</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2025-02-242025-02-24_custom_BlackScholesPricingModelMember"
      decimals="INF"
      id="Fact002625"
      unitRef="Pure">0.7469</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <SMX:DescriptionOfExpectedTermWarrants
      contextRef="From2025-02-242025-02-24_custom_BlackScholesPricingModelMember"
      id="Fact002627">P2Y6M</SMX:DescriptionOfExpectedTermWarrants>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2025-02-242025-02-24_custom_BlackScholesPricingModelMember"
      decimals="INF"
      id="Fact002629"
      unitRef="Pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <SMX:NumberOfInstrumentsAuthorizedInSharebasedPaymentArrangement
      contextRef="AsOf2025-03-17_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember"
      decimals="INF"
      id="Fact002631"
      unitRef="Shares">207</SMX:NumberOfInstrumentsAuthorizedInSharebasedPaymentArrangement>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="From2025-03-172025-03-17_custom_CertainConsultantsMember"
      decimals="INF"
      id="Fact002633"
      unitRef="Shares">11</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <SMX:DescriptionOfVestingPeriod
      contextRef="From2025-03-172025-03-17_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_DirectorsCertainConsultantsAndAdvisorsMember"
      id="Fact002635">The options shall
                                            fully vest until December 31, 2025.</SMX:DescriptionOfVestingPeriod>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="From2025-03-172025-03-17_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_DirectorsCertainConsultantsAndAdvisorsMember"
      decimals="-3"
      id="Fact002637"
      unitRef="USD">140000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2025-03-172025-03-17_custom_BlackScholesPricingModelMember"
      decimals="INF"
      id="Fact002639"
      unitRef="Pure">0.0405</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2025-03-172025-03-17_custom_BlackScholesPricingModelMember"
      decimals="INF"
      id="Fact002641"
      unitRef="Pure">0.7558</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <SMX:DescriptionOfExpectedTermWarrants
      contextRef="From2025-03-172025-03-17_custom_BlackScholesPricingModelMember"
      id="Fact002643">P2Y6M</SMX:DescriptionOfExpectedTermWarrants>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2025-03-172025-03-17_custom_BlackScholesPricingModelMember"
      decimals="INF"
      id="Fact002645"
      unitRef="Pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <SMX:NumberOfInstrumentsAuthorizedInSharebasedPaymentArrangement
      contextRef="AsOf2025-06-17_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember"
      decimals="INF"
      id="Fact002647"
      unitRef="Shares">1432</SMX:NumberOfInstrumentsAuthorizedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="From2025-06-172025-06-17_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_ExecutiveOfficersAndDirectorsCertainConsultantsAndAdvisorsMember"
      decimals="INF"
      id="Fact002649"
      unitRef="Shares">721</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <SMX:DescriptionOfVestingPeriod
      contextRef="From2025-06-172025-06-17_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_ExecutiveOfficersAndDirectorsCertainConsultantsAndAdvisorsMember"
      id="Fact002651">The RSUs shall fully vest until December
                                            31, 2025.</SMX:DescriptionOfVestingPeriod>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="From2025-06-172025-06-17_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_ExecutiveOfficersAndDirectorsCertainConsultantsAndAdvisorsMember"
      decimals="-3"
      id="Fact002653"
      unitRef="USD">9924000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="From2025-06-172025-06-17_custom_DirectorsCertainConsultantsAndAdvisorsMember"
      decimals="INF"
      id="Fact002655"
      unitRef="Shares">448</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <SMX:DescriptionOfVestingPeriod
      contextRef="From2025-06-172025-06-17_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_DirectorsCertainConsultantsAndAdvisorsMember"
      id="Fact002657">The
                                            options shall fully vest until December 31, 2025.</SMX:DescriptionOfVestingPeriod>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="From2025-06-172025-06-17_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_DirectorsCertainConsultantsAndAdvisorsMember"
      decimals="-3"
      id="Fact002659"
      unitRef="USD">2911000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2025-06-172025-06-17_custom_BlackScholesPricingModelMember"
      decimals="INF"
      id="Fact002661"
      unitRef="Pure">0.0392</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2025-06-172025-06-17_custom_BlackScholesPricingModelMember"
      decimals="INF"
      id="Fact002663"
      unitRef="Pure">0.7423</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <SMX:DescriptionOfExpectedTermWarrants
      contextRef="From2025-06-172025-06-17_custom_BlackScholesPricingModelMember"
      id="Fact002665">P2Y6M</SMX:DescriptionOfExpectedTermWarrants>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2025-06-172025-06-17_custom_BlackScholesPricingModelMember"
      decimals="INF"
      id="Fact002667"
      unitRef="Pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <SMX:NumberOfInstrumentsAuthorizedInSharebasedPaymentArrangement
      contextRef="AsOf2025-07-03_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember"
      decimals="INF"
      id="Fact002669"
      unitRef="Shares">1563</SMX:NumberOfInstrumentsAuthorizedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="From2025-07-032025-07-03_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_ExecutiveOfficersAndDirectorsCertainConsultantsAndAdvisorsMember"
      decimals="INF"
      id="Fact002671"
      unitRef="Shares">128</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <SMX:DescriptionOfVestingPeriod
      contextRef="From2025-07-032025-07-03_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_ExecutiveOfficersAndDirectorsCertainConsultantsAndAdvisorsMember"
      id="Fact002673">The RSUs shall fully vest until December
                                            31, 2025.</SMX:DescriptionOfVestingPeriod>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="From2025-07-032025-07-03_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_ExecutiveOfficersAndDirectorsCertainConsultantsAndAdvisorsMember"
      decimals="-3"
      id="Fact002675"
      unitRef="USD">1727000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="From2025-07-032025-07-03_custom_DirectorsCertainConsultantsAndAdvisorsMember"
      decimals="INF"
      id="Fact002677"
      unitRef="Shares">12</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <SMX:DescriptionOfVestingPeriod
      contextRef="From2025-07-032025-07-03_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_DirectorsCertainConsultantsAndAdvisorsMember"
      id="Fact002679">The
                                            options shall fully vest until December 31, 2025.</SMX:DescriptionOfVestingPeriod>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="From2025-07-032025-07-03_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_DirectorsCertainConsultantsAndAdvisorsMember"
      decimals="-3"
      id="Fact002681"
      unitRef="USD">119000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2025-07-032025-07-03_custom_BlackScholesPricingModelMember"
      decimals="INF"
      id="Fact002683"
      unitRef="Pure">0.0386</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2025-07-032025-07-03_custom_BlackScholesPricingModelMember"
      decimals="INF"
      id="Fact002685"
      unitRef="Pure">1.42</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <SMX:DescriptionOfExpectedTermWarrants
      contextRef="From2025-07-032025-07-03_custom_BlackScholesPricingModelMember"
      id="Fact002687">P2Y6M</SMX:DescriptionOfExpectedTermWarrants>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2025-07-032025-07-03_custom_BlackScholesPricingModelMember"
      decimals="INF"
      id="Fact002689"
      unitRef="Pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <SMX:NumberOfInstrumentsAuthorizedInSharebasedPaymentArrangement
      contextRef="AsOf2025-08-26_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember"
      decimals="INF"
      id="Fact002691"
      unitRef="Shares">18309</SMX:NumberOfInstrumentsAuthorizedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="From2025-08-262025-08-26_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_ExecutiveOfficersAndDirectorsCertainConsultantsAndAdvisorsMember"
      decimals="INF"
      id="Fact002693"
      unitRef="Shares">12566</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <SMX:DescriptionOfVestingPeriod
      contextRef="From2025-08-262025-08-26_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_ExecutiveOfficersAndDirectorsCertainConsultantsAndAdvisorsMember"
      id="Fact002695">The RSUs shall fully vest until December
                                            31, 2025.</SMX:DescriptionOfVestingPeriod>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="From2025-08-262025-08-26_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_ExecutiveOfficersAndDirectorsCertainConsultantsAndAdvisorsMember"
      decimals="-3"
      id="Fact002697"
      unitRef="USD">20773000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="From2025-08-262025-08-26_custom_DirectorsCertainConsultantsAndAdvisorsMember"
      decimals="INF"
      id="Fact002699"
      unitRef="Shares">3758</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <SMX:DescriptionOfVestingPeriod
      contextRef="From2025-08-262025-08-26_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_DirectorsCertainConsultantsAndAdvisorsMember"
      id="Fact002701">The
                                            options shall fully vest until December 31, 2025.</SMX:DescriptionOfVestingPeriod>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="From2025-08-262025-08-26_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_DirectorsCertainConsultantsAndAdvisorsMember"
      decimals="-3"
      id="Fact002703"
      unitRef="USD">4896000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2025-08-262025-08-26_custom_BlackScholesPricingModelMember"
      decimals="INF"
      id="Fact002705"
      unitRef="Pure">0.0362</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2025-08-262025-08-26_custom_BlackScholesPricingModelMember"
      decimals="INF"
      id="Fact002707"
      unitRef="Pure">1.44</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <SMX:DescriptionOfExpectedTermWarrants
      contextRef="From2025-08-262025-08-26_custom_BlackScholesPricingModelMember"
      id="Fact002709">P2Y6M</SMX:DescriptionOfExpectedTermWarrants>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2025-08-262025-08-26_custom_BlackScholesPricingModelMember"
      decimals="INF"
      id="Fact002711"
      unitRef="Pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <SMX:NumberOfInstrumentsAuthorizedInSharebasedPaymentArrangement
      contextRef="AsOf2025-09-04_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember"
      decimals="INF"
      id="Fact002713"
      unitRef="Shares">25708</SMX:NumberOfInstrumentsAuthorizedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="From2025-09-042025-09-04_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_ExecutiveOfficersAndDirectorsCertainConsultantsAndAdvisorsMember"
      decimals="INF"
      id="Fact002715"
      unitRef="Shares">4110</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <SMX:DescriptionOfVestingPeriod
      contextRef="From2025-09-042025-09-04_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_ExecutiveOfficersAndDirectorsCertainConsultantsAndAdvisorsMember"
      id="Fact002717">The RSUs shall fully vest until December 31, 2025.</SMX:DescriptionOfVestingPeriod>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="From2025-09-042025-09-04_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_ExecutiveOfficersAndDirectorsCertainConsultantsAndAdvisorsMember"
      decimals="-3"
      id="Fact002719"
      unitRef="USD">2642000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="From2025-09-042025-09-04_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_DirectorsMember"
      decimals="INF"
      id="Fact002721"
      unitRef="Shares">3288</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <SMX:DescriptionOfVestingPeriod
      contextRef="From2025-09-042025-09-04_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_DirectorsMember"
      id="Fact002723">The options shall fully vest until December
                                            31, 2025</SMX:DescriptionOfVestingPeriod>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="From2025-09-042025-09-04_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_DirectorsMember"
      decimals="-3"
      id="Fact002725"
      unitRef="USD">1428000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="From2025-09-042025-09-04_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_ExecutiveOfficersAndDirectorsCertainConsultantsEmployeesAndAdvisorsMember"
      decimals="-3"
      id="Fact002727"
      unitRef="USD">1428000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2025-09-042025-09-04_custom_BlackScholesPricingModelMember"
      decimals="INF"
      id="Fact002729"
      unitRef="Pure">0.0357</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2025-09-042025-09-04_custom_BlackScholesPricingModelMember"
      decimals="INF"
      id="Fact002731"
      unitRef="Pure">1.47</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <SMX:DescriptionOfExpectedTermWarrants
      contextRef="From2025-09-042025-09-04_custom_BlackScholesPricingModelMember"
      id="Fact002733">P2Y6M</SMX:DescriptionOfExpectedTermWarrants>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2025-09-042025-09-04_custom_BlackScholesPricingModelMember"
      decimals="INF"
      id="Fact002735"
      unitRef="Pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <SMX:NumberOfInstrumentsAuthorizedInSharebasedPaymentArrangement
      contextRef="AsOf2025-10-29_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember"
      decimals="INF"
      id="Fact002737"
      unitRef="Shares">233324</SMX:NumberOfInstrumentsAuthorizedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="From2025-10-292025-10-29_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_ExecutiveOfficersAndDirectorsCertainConsultantsEmployeesAndAdvisorsMember"
      decimals="INF"
      id="Fact002739"
      unitRef="Shares">150272</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <SMX:DescriptionOfVestingPeriod
      contextRef="From2025-10-292025-10-29_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_ExecutiveOfficersAndDirectorsCertainConsultantsEmployeesAndAdvisorsMember"
      id="Fact002741">The RSUs shall fully vest until December
                                            31, 2025.</SMX:DescriptionOfVestingPeriod>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="From2025-10-292025-10-29_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_ExecutiveOfficersAndDirectorsCertainConsultantsEmployeesAndAdvisorsMember"
      decimals="-3"
      id="Fact002743"
      unitRef="USD">17316000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="From2025-10-292025-10-29_custom_DirectorsCertainConsultantsAndAdvisorsMember"
      decimals="INF"
      id="Fact002745"
      unitRef="Shares">52480</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <SMX:DescriptionOfVestingPeriod
      contextRef="From2025-10-292025-10-29_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_DirectorsCertainConsultantsAndAdvisorsMember"
      id="Fact002747">The options shall fully vest until December 31, 2025.</SMX:DescriptionOfVestingPeriod>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="From2025-10-292025-10-29_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_DirectorsCertainConsultantsAndAdvisorsMember"
      decimals="-3"
      id="Fact002749"
      unitRef="USD">4817000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2025-10-292025-10-29_custom_BlackScholesPricingModelMember"
      decimals="INF"
      id="Fact002751"
      unitRef="Pure">0.036</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2025-10-292025-10-29_custom_BlackScholesPricingModelMember"
      decimals="INF"
      id="Fact002753"
      unitRef="Pure">1.42</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <SMX:DescriptionOfExpectedTermWarrants
      contextRef="From2025-10-292025-10-29_custom_BlackScholesPricingModelMember"
      id="Fact002755">P2Y6M</SMX:DescriptionOfExpectedTermWarrants>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2025-10-292025-10-29_custom_BlackScholesPricingModelMember"
      decimals="INF"
      id="Fact002757"
      unitRef="Pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <SMX:NumberOfInstrumentsAuthorizedInSharebasedPaymentArrangement
      contextRef="AsOf2025-11-21_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember"
      decimals="INF"
      id="Fact002759"
      unitRef="Shares">2442092</SMX:NumberOfInstrumentsAuthorizedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="From2025-11-212025-11-21_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_ExecutiveOfficersAndDirectorsCertainConsultantsEmployeesAndAdvisorsMember"
      decimals="INF"
      id="Fact002761"
      unitRef="Shares">1360896</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <SMX:DescriptionOfVestingPeriod
      contextRef="From2025-11-212025-11-21_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_ExecutiveOfficersAndDirectorsCertainConsultantsEmployeesAndAdvisorsMember"
      id="Fact002763">The RSUs shall fully vest until December
                                            31, 2025</SMX:DescriptionOfVestingPeriod>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="From2025-11-212025-11-21_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_ExecutiveOfficersAndDirectorsCertainConsultantsEmployeesAndAdvisorsMember"
      decimals="-3"
      id="Fact002765"
      unitRef="USD">28175000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="From2025-11-212025-11-21_custom_DirectorsCertainConsultantsAndAdvisorsMember"
      decimals="INF"
      id="Fact002767"
      unitRef="Shares">808960</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <SMX:DescriptionOfVestingPeriod
      contextRef="From2025-11-212025-11-21_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_DirectorsCertainConsultantsAndAdvisorsMember"
      id="Fact002769">The options shall fully vest until December 31, 2025</SMX:DescriptionOfVestingPeriod>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="From2025-11-212025-11-21_custom_TwoThousandTwentyTwoIncentiveEquityPlanMember_custom_DirectorsCertainConsultantsAndAdvisorsMember"
      decimals="-3"
      id="Fact002771"
      unitRef="USD">13975000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2025-11-212025-11-21_custom_BlackScholesPricingModelMember"
      decimals="INF"
      id="Fact002773"
      unitRef="Pure">0.0356</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2025-11-212025-11-21_custom_BlackScholesPricingModelMember"
      decimals="INF"
      id="Fact002775"
      unitRef="Pure">1.42</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <SMX:DescriptionOfExpectedTermWarrants
      contextRef="From2025-11-212025-11-21_custom_BlackScholesPricingModelMember"
      id="Fact002777">P2Y6M</SMX:DescriptionOfExpectedTermWarrants>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2025-11-212025-11-21_custom_BlackScholesPricingModelMember"
      decimals="INF"
      id="Fact002779"
      unitRef="Pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="From2025-01-012025-12-31_ifrs-full_RestrictedShareUnitsMember"
      decimals="-3"
      id="Fact002781"
      unitRef="USD">409000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact002783"
      unitRef="USD">114205000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <SMX:DisclosureOfRestrictedStockUnitExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact002785">&lt;p id="xdx_89B_ecustom--DisclosureOfRestrictedStockUnitExplanatory_zOs6YbaYFkW7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; display: none"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B5_zUISHMyylrGi"&gt;SCHEDULE OF RESTRICTED STOCK UNIT&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31, 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31, 2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Outstanding at the beginning of the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pid_uShares_c20250101__20251231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceProvidersMember_fKg_____zLjqAJJmqs7b" title="Number of outstanding, Beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2787"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pid_uShares_c20240101__20241231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceProvidersMember_fKg_____zAbzW1xIRAM3" title="Number of outstanding, Beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2789"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 60%"&gt;Granted&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pid_uShares_c20250101__20251231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceProvidersMember_zABedSQveUD8" style="width: 16%; text-align: right" title="Number of outstanding, Granted"&gt;1,528,836&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pid_uShares_c20240101__20241231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceProvidersMember_zzjFs8zPrrTk" style="width: 16%; text-align: right" title="Number of outstanding, Granted"&gt;1&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Vested&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pid_di_uShares_c20250101__20251231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceProvidersMember_z2BwIUcZqCy2" style="text-align: right" title="Number of outstanding, Vested"&gt;(1,528,832&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pid_di_uShares_c20240101__20241231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceProvidersMember_zhqnccIb0Kcd" style="text-align: right" title="Number of outstanding, Vested"&gt;(1&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Forfeited&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_iN_pid_di_uShares_c20250101__20251231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceProvidersMember_zTQVHq9nTBH2" style="border-bottom: Black 1pt solid; text-align: right" title="Number of outstanding, Forfeited"&gt;(4&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;span id="xdx_906_eifrs-full--NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_iN_pid_di_uShares_c20240101__20241231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceProvidersMember_fKg_____zoQKYVV7jmI7" title="Number of outstanding, Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2801"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Outstanding at the end of year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pid_uShares_c20250101__20251231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceProvidersMember_z1Y9wbajHkil" style="border-bottom: Black 1pt solid; text-align: right" title="Number of outstanding, Ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2803"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pid_uShares_c20240101__20241231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceProvidersMember_fKg_____zGlZzVAwXvAk" title="Number of outstanding, Ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2805"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F03_z0npetdkxj0f" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F17_zarYozArrL8k" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Nil after reverse
stock split&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</SMX:DisclosureOfRestrictedStockUnitExplanatory>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="From2025-01-012025-12-31_ifrs-full_RestrictedShareUnitsMember_custom_EmployeesDirectorsAndServiceProvidersMember"
      decimals="INF"
      id="Fact002791"
      unitRef="Shares">1528836</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="From2024-01-012024-12-31_custom_EmployeesDirectorsAndServiceProvidersMember_ifrs-full_RestrictedShareUnitsMember"
      decimals="INF"
      id="Fact002793"
      unitRef="Shares">1</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_ifrs-full_RestrictedShareUnitsMember_custom_EmployeesDirectorsAndServiceProvidersMember"
      decimals="INF"
      id="Fact002795"
      unitRef="Shares">1528832</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_EmployeesDirectorsAndServiceProvidersMember_ifrs-full_RestrictedShareUnitsMember"
      decimals="INF"
      id="Fact002797"
      unitRef="Shares">1</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_ifrs-full_RestrictedShareUnitsMember_custom_EmployeesDirectorsAndServiceProvidersMember"
      decimals="INF"
      id="Fact002799"
      unitRef="Shares">4</ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact002808">&lt;p id="xdx_890_eifrs-full--DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_ze4gr04TnvNh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; display: none"&gt;&lt;span id="xdx_8B2_ze0UGk58A0Ig"&gt;SCHEDULE OF SHARE OPTION GRANTED&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: -28.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31, 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31, 2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Number&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;of options&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;br/&gt;
average&lt;br/&gt;
Exercise&lt;br/&gt;
 price (USD$)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Number&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;of options&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;br/&gt;
average&lt;br/&gt;
Exercise&lt;br/&gt;
 price (USD$)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Outstanding at beginning of year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_uUSD_c20250101__20251231_fKg_____zEcjaj2dp5fj" title="Number of options outstanding, Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2810"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20250101__20251231_za4tAOyZXej3" style="text-align: right" title="Weighted average exercise price outstanding, Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2812"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_uUSD_c20240101__20241231_fKg_____zFK8bvX5B5B" title="Number of options outstanding, Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2814"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20240101__20241231_zRfMqWh8ak04" style="text-align: right" title="Weighted average exercise price outstanding, Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2816"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 40%; padding-bottom: 1pt"&gt;Issue of options&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uShares_c20250101__20251231_zRvMdB1MwuR8" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Number of issue of options"&gt;869,001&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pid_c20250101__20251231_zUbrdEXdkzTf" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Weighted average exercise price, issued of options"&gt;183,639&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uUSD_c20240101__20241231_fKg_____zl9z95NghIug" title="Number of Issue of options"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2822"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pid_c20240101__20241231_zdssPfi7STia" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Weighted average exercise price, issued of options"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2824"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Outstanding at the end of year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_uShares_c20250101__20251231_zHqWe6y1b6Z2" style="border-bottom: Black 1pt solid; text-align: right" title="Number of options outstanding, Ending balance"&gt;869,001&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_c20250101__20251231_zaq6SPASsILc" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price outstanding, Ending balance"&gt;183,639&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_uUSD_c20240101__20241231_fKg_____zYWGP9r6o2pb" title="Number of options outstanding, Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2830"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_c20240101__20241231_zGFOFLMwCSjb" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price outstanding, Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2832"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Exercisable options&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iE_pid_uShares_c20250101__20251231_zHBaYGKxUjjb" style="border-bottom: Black 1pt solid; text-align: right" title="Number of options, Exercisable"&gt;869,001&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_iE_pid_c20250101__20251231_zkITq0Sv5Pie" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, Exercisable"&gt;183,639&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iE_pid_uUSD_c20240101__20241231_fKg_____zsXG2cvngkOd" title="Number of options, Exercisable"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2838"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_iE_pid_c20240101__20241231_zxBeDuF1POK8" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, Exercisable"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2840"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F06_zMXAlsdwG2Jb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1B_zHOdQty6NC98" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Nil after reverse
stock split&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact002818"
      unitRef="Shares">869001</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact002820"
      unitRef="USDPShares">183639</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact002826"
      unitRef="Shares">869001</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact002828"
      unitRef="USDPShares">183639</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact002834"
      unitRef="Shares">869001</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact002836"
      unitRef="USDPShares">183639</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact002843">&lt;p id="xdx_803_eifrs-full--DisclosureOfGeneralAndAdministrativeExpenseExplanatory_zvYdQd4Hh6E6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
16 - &lt;span id="xdx_824_zDcYjGev6OU8"&gt;GENERAL AND ADMINISTRATIVE EXPENSES&lt;/span&gt;:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_ecustom--DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory_zhbkjkYpev05" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; display: none"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B3_zdxOmlnBMx6j"&gt;SCHEDULE
OF GENERAL AND ADMINISTRATIVE EXPENSES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20250101__20251231_zcO5N1W1ML31" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20240101__20241231_zpoNRcF9zdF2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20230101__20231231_zeIisedl6EK2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEzHn4_zuyPuJPDiih" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%"&gt;Share based compensation&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;101,981&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;3,178&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,222&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--ProfessionalFeesExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEzHn4_zZuh1XpAEKfd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Professional services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,256&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,556&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;667&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--TransactionCost_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEzHn4_zDzX6FgoEzm" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Transaction cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,759&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,544&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,278&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--WagesAndSalaries_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEzHn4_zzJIt618uCN8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Wages and salaries related&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,198&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,217&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,348&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--TravelExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEzHn4_z07R8T6Zf0qg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Travel expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;604&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;350&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;611&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--ServicesExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEzHn4_zH2DqWesHIt" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Public company expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;597&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,959&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,128&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--InsuranceExpenses_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEzHn4_zNpNUkncD6l4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Insurance expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;490&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;675&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--RepairsAndMaintenanceExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEzHn4_z0bNwtXYPB9k" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Office and maintenance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;144&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;170&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;170&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--DepreciationAndAmortisationExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEzHn4_zXWAJ9g5tNx2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Depreciation and amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;27&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;30&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--OtherExpenseByNature_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEzHn4_zzFDnKsuUqCh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Other expenses&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;48&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;53&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;63&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--GeneralAndAdministrativeExpense_iT_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_mtGAAEzHn4_zVru10yY9cqf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;120,099&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;12,729&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;16,567&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_znEeVrXlC96f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands, except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory>
    <SMX:DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact002845">&lt;p id="xdx_899_ecustom--DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory_zhbkjkYpev05" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; display: none"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B3_zdxOmlnBMx6j"&gt;SCHEDULE
OF GENERAL AND ADMINISTRATIVE EXPENSES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20250101__20251231_zcO5N1W1ML31" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20240101__20241231_zpoNRcF9zdF2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20230101__20231231_zeIisedl6EK2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEzHn4_zuyPuJPDiih" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%"&gt;Share based compensation&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;101,981&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;3,178&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,222&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--ProfessionalFeesExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEzHn4_zZuh1XpAEKfd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Professional services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,256&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,556&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;667&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--TransactionCost_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEzHn4_zDzX6FgoEzm" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Transaction cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,759&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,544&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,278&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--WagesAndSalaries_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEzHn4_zzJIt618uCN8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Wages and salaries related&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,198&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,217&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,348&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--TravelExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEzHn4_z07R8T6Zf0qg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Travel expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;604&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;350&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;611&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--ServicesExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEzHn4_zH2DqWesHIt" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Public company expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;597&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,959&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,128&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--InsuranceExpenses_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEzHn4_zNpNUkncD6l4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Insurance expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;490&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;675&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--RepairsAndMaintenanceExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEzHn4_z0bNwtXYPB9k" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Office and maintenance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;144&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;170&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;170&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--DepreciationAndAmortisationExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEzHn4_zXWAJ9g5tNx2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Depreciation and amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;27&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;30&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--OtherExpenseByNature_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEzHn4_zzFDnKsuUqCh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Other expenses&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;48&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;53&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;63&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--GeneralAndAdministrativeExpense_iT_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_mtGAAEzHn4_zVru10yY9cqf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;120,099&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;12,729&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;16,567&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</SMX:DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="From2025-01-012025-12-31_custom_GeneralAndAdministrativeExpensesMember"
      decimals="-3"
      id="Fact002847"
      unitRef="USD">101981000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="From2024-01-012024-12-31_custom_GeneralAndAdministrativeExpensesMember"
      decimals="-3"
      id="Fact002848"
      unitRef="USD">3178000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="From2023-01-012023-12-31_custom_GeneralAndAdministrativeExpensesMember"
      decimals="-3"
      id="Fact002849"
      unitRef="USD">1222000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2025-01-012025-12-31_custom_GeneralAndAdministrativeExpensesMember"
      decimals="-3"
      id="Fact002851"
      unitRef="USD">12256000</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2024-01-012024-12-31_custom_GeneralAndAdministrativeExpensesMember"
      decimals="-3"
      id="Fact002852"
      unitRef="USD">2556000</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2023-01-012023-12-31_custom_GeneralAndAdministrativeExpensesMember"
      decimals="-3"
      id="Fact002853"
      unitRef="USD">667000</ifrs-full:ProfessionalFeesExpense>
    <SMX:TransactionCost
      contextRef="From2025-01-012025-12-31_custom_GeneralAndAdministrativeExpensesMember"
      decimals="-3"
      id="Fact002855"
      unitRef="USD">2759000</SMX:TransactionCost>
    <SMX:TransactionCost
      contextRef="From2024-01-012024-12-31_custom_GeneralAndAdministrativeExpensesMember"
      decimals="-3"
      id="Fact002856"
      unitRef="USD">2544000</SMX:TransactionCost>
    <SMX:TransactionCost
      contextRef="From2023-01-012023-12-31_custom_GeneralAndAdministrativeExpensesMember"
      decimals="-3"
      id="Fact002857"
      unitRef="USD">7278000</SMX:TransactionCost>
    <ifrs-full:WagesAndSalaries
      contextRef="From2025-01-012025-12-31_custom_GeneralAndAdministrativeExpensesMember"
      decimals="-3"
      id="Fact002859"
      unitRef="USD">1198000</ifrs-full:WagesAndSalaries>
    <ifrs-full:WagesAndSalaries
      contextRef="From2024-01-012024-12-31_custom_GeneralAndAdministrativeExpensesMember"
      decimals="-3"
      id="Fact002860"
      unitRef="USD">1217000</ifrs-full:WagesAndSalaries>
    <ifrs-full:WagesAndSalaries
      contextRef="From2023-01-012023-12-31_custom_GeneralAndAdministrativeExpensesMember"
      decimals="-3"
      id="Fact002861"
      unitRef="USD">1348000</ifrs-full:WagesAndSalaries>
    <ifrs-full:TravelExpense
      contextRef="From2025-01-012025-12-31_custom_GeneralAndAdministrativeExpensesMember"
      decimals="-3"
      id="Fact002863"
      unitRef="USD">604000</ifrs-full:TravelExpense>
    <ifrs-full:TravelExpense
      contextRef="From2024-01-012024-12-31_custom_GeneralAndAdministrativeExpensesMember"
      decimals="-3"
      id="Fact002864"
      unitRef="USD">350000</ifrs-full:TravelExpense>
    <ifrs-full:TravelExpense
      contextRef="From2023-01-012023-12-31_custom_GeneralAndAdministrativeExpensesMember"
      decimals="-3"
      id="Fact002865"
      unitRef="USD">611000</ifrs-full:TravelExpense>
    <ifrs-full:ServicesExpense
      contextRef="From2025-01-012025-12-31_custom_GeneralAndAdministrativeExpensesMember"
      decimals="-3"
      id="Fact002867"
      unitRef="USD">597000</ifrs-full:ServicesExpense>
    <ifrs-full:ServicesExpense
      contextRef="From2024-01-012024-12-31_custom_GeneralAndAdministrativeExpensesMember"
      decimals="-3"
      id="Fact002868"
      unitRef="USD">1959000</ifrs-full:ServicesExpense>
    <ifrs-full:ServicesExpense
      contextRef="From2023-01-012023-12-31_custom_GeneralAndAdministrativeExpensesMember"
      decimals="-3"
      id="Fact002869"
      unitRef="USD">5128000</ifrs-full:ServicesExpense>
    <SMX:InsuranceExpenses
      contextRef="From2025-01-012025-12-31_custom_GeneralAndAdministrativeExpensesMember"
      decimals="-3"
      id="Fact002871"
      unitRef="USD">490000</SMX:InsuranceExpenses>
    <SMX:InsuranceExpenses
      contextRef="From2024-01-012024-12-31_custom_GeneralAndAdministrativeExpensesMember"
      decimals="-3"
      id="Fact002872"
      unitRef="USD">675000</SMX:InsuranceExpenses>
    <SMX:InsuranceExpenses
      contextRef="From2023-01-012023-12-31_custom_GeneralAndAdministrativeExpensesMember"
      decimals="-3"
      id="Fact002873"
      unitRef="USD">50000</SMX:InsuranceExpenses>
    <ifrs-full:RepairsAndMaintenanceExpense
      contextRef="From2025-01-012025-12-31_custom_GeneralAndAdministrativeExpensesMember"
      decimals="-3"
      id="Fact002875"
      unitRef="USD">144000</ifrs-full:RepairsAndMaintenanceExpense>
    <ifrs-full:RepairsAndMaintenanceExpense
      contextRef="From2024-01-012024-12-31_custom_GeneralAndAdministrativeExpensesMember"
      decimals="-3"
      id="Fact002876"
      unitRef="USD">170000</ifrs-full:RepairsAndMaintenanceExpense>
    <ifrs-full:RepairsAndMaintenanceExpense
      contextRef="From2023-01-012023-12-31_custom_GeneralAndAdministrativeExpensesMember"
      decimals="-3"
      id="Fact002877"
      unitRef="USD">170000</ifrs-full:RepairsAndMaintenanceExpense>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="From2025-01-012025-12-31_custom_GeneralAndAdministrativeExpensesMember"
      decimals="-3"
      id="Fact002879"
      unitRef="USD">22000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="From2024-01-012024-12-31_custom_GeneralAndAdministrativeExpensesMember"
      decimals="-3"
      id="Fact002880"
      unitRef="USD">27000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="From2023-01-012023-12-31_custom_GeneralAndAdministrativeExpensesMember"
      decimals="-3"
      id="Fact002881"
      unitRef="USD">30000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:OtherExpenseByNature
      contextRef="From2025-01-012025-12-31_custom_GeneralAndAdministrativeExpensesMember"
      decimals="-3"
      id="Fact002883"
      unitRef="USD">48000</ifrs-full:OtherExpenseByNature>
    <ifrs-full:OtherExpenseByNature
      contextRef="From2024-01-012024-12-31_custom_GeneralAndAdministrativeExpensesMember"
      decimals="-3"
      id="Fact002884"
      unitRef="USD">53000</ifrs-full:OtherExpenseByNature>
    <ifrs-full:OtherExpenseByNature
      contextRef="From2023-01-012023-12-31_custom_GeneralAndAdministrativeExpensesMember"
      decimals="-3"
      id="Fact002885"
      unitRef="USD">63000</ifrs-full:OtherExpenseByNature>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="From2025-01-012025-12-31_custom_GeneralAndAdministrativeExpensesMember"
      decimals="-3"
      id="Fact002887"
      unitRef="USD">120099000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="From2024-01-012024-12-31_custom_GeneralAndAdministrativeExpensesMember"
      decimals="-3"
      id="Fact002888"
      unitRef="USD">12729000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="From2023-01-012023-12-31_custom_GeneralAndAdministrativeExpensesMember"
      decimals="-3"
      id="Fact002889"
      unitRef="USD">16567000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact002891">&lt;p id="xdx_806_eifrs-full--DisclosureOfResearchAndDevelopmentExpenseExplanatory_zrZghnEh54uk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
17 - &lt;span id="xdx_821_z89oof4fdwkh"&gt;RESEARCH AND DEVELOPMENT EXPENSES&lt;/span&gt;:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_ecustom--DisclosureOfDetailedInformationAboutResearchAndDevelopmentExpenseExplanatory_zWQc9HwBFix8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; display: none"&gt;&lt;span id="xdx_8B6_zEbudmfXD86d"&gt;SCHEDULE
OF RESEARCH AND DEVELOPMENT EXPENSE&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_493_20250101__20251231_zkg8bu4kmP3a" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20240101__20241231_zckh5tq32CSk" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20230101__20231231_zjusH6FmMhv4" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--AdjustmentsForSharebasedPayments_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzyBc_zv7cTRQBveuh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: justify"&gt;Share based compensation&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;9,614&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;403&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;447&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--EmployeeBenefitsExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzyBc_zNn7ZpeYYy6j" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Salaries and related expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,431&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,796&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,228&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--ResearchExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzyBc_z11fF0o8U807" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Materials and laboratory expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;338&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;434&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;223&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--SubcontractorsAndConsultants_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzyBc_zrxG9RUT248f" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Subcontractors and consultants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;211&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;135&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;344&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--DepreciationAndAmortisationExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzyBc_zw1r4HnW6ut7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Depreciation and amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;179&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;172&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;197&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--TravelExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzyBc_z32THs0nuCH7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Travel expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;87&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;260&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;87&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--FreightExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzyBc_zZhYH8mjfH7i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Freight expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;33&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--OtherExpenseByNature_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzyBc_zgMckpxWcjBl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Other expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--ReimbursementFromPaidPilotsAndProofOfConceptProjects_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzyBc_zhjjav5H1qT1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Reimbursement from paid pilots and proof of concept projects&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(650&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,154&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(858&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--ResearchAndDevelopmentExpense_iT_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_mtRADEzyBc_zqburXGZ2P67" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;11,228&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;3,059&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;2,711&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zqXC1o9nRYZ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory>
    <SMX:DisclosureOfDetailedInformationAboutResearchAndDevelopmentExpenseExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact002893">&lt;p id="xdx_895_ecustom--DisclosureOfDetailedInformationAboutResearchAndDevelopmentExpenseExplanatory_zWQc9HwBFix8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; display: none"&gt;&lt;span id="xdx_8B6_zEbudmfXD86d"&gt;SCHEDULE
OF RESEARCH AND DEVELOPMENT EXPENSE&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_493_20250101__20251231_zkg8bu4kmP3a" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20240101__20241231_zckh5tq32CSk" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20230101__20231231_zjusH6FmMhv4" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--AdjustmentsForSharebasedPayments_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzyBc_zv7cTRQBveuh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: justify"&gt;Share based compensation&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;9,614&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;403&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;447&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--EmployeeBenefitsExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzyBc_zNn7ZpeYYy6j" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Salaries and related expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,431&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,796&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,228&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--ResearchExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzyBc_z11fF0o8U807" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Materials and laboratory expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;338&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;434&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;223&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--SubcontractorsAndConsultants_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzyBc_zrxG9RUT248f" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Subcontractors and consultants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;211&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;135&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;344&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--DepreciationAndAmortisationExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzyBc_zw1r4HnW6ut7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Depreciation and amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;179&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;172&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;197&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--TravelExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzyBc_z32THs0nuCH7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Travel expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;87&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;260&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;87&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--FreightExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzyBc_zZhYH8mjfH7i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Freight expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;33&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--OtherExpenseByNature_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzyBc_zgMckpxWcjBl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Other expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--ReimbursementFromPaidPilotsAndProofOfConceptProjects_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzyBc_zhjjav5H1qT1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Reimbursement from paid pilots and proof of concept projects&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(650&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,154&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(858&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--ResearchAndDevelopmentExpense_iT_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_mtRADEzyBc_zqburXGZ2P67" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;11,228&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;3,059&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;2,711&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</SMX:DisclosureOfDetailedInformationAboutResearchAndDevelopmentExpenseExplanatory>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="From2025-01-012025-12-31_custom_ResearchAndDevelopmentExpensesMember"
      decimals="-3"
      id="Fact002895"
      unitRef="USD">9614000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="From2024-01-012024-12-31_custom_ResearchAndDevelopmentExpensesMember"
      decimals="-3"
      id="Fact002896"
      unitRef="USD">403000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="From2023-01-012023-12-31_custom_ResearchAndDevelopmentExpensesMember"
      decimals="-3"
      id="Fact002897"
      unitRef="USD">447000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:EmployeeBenefitsExpense
      contextRef="From2025-01-012025-12-31_custom_ResearchAndDevelopmentExpensesMember"
      decimals="-3"
      id="Fact002899"
      unitRef="USD">1431000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense
      contextRef="From2024-01-012024-12-31_custom_ResearchAndDevelopmentExpensesMember"
      decimals="-3"
      id="Fact002900"
      unitRef="USD">2796000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense
      contextRef="From2023-01-012023-12-31_custom_ResearchAndDevelopmentExpensesMember"
      decimals="-3"
      id="Fact002901"
      unitRef="USD">2228000</ifrs-full:EmployeeBenefitsExpense>
    <SMX:ResearchExpense
      contextRef="From2025-01-012025-12-31_custom_ResearchAndDevelopmentExpensesMember"
      decimals="-3"
      id="Fact002903"
      unitRef="USD">338000</SMX:ResearchExpense>
    <SMX:ResearchExpense
      contextRef="From2024-01-012024-12-31_custom_ResearchAndDevelopmentExpensesMember"
      decimals="-3"
      id="Fact002904"
      unitRef="USD">434000</SMX:ResearchExpense>
    <SMX:ResearchExpense
      contextRef="From2023-01-012023-12-31_custom_ResearchAndDevelopmentExpensesMember"
      decimals="-3"
      id="Fact002905"
      unitRef="USD">223000</SMX:ResearchExpense>
    <SMX:SubcontractorsAndConsultants
      contextRef="From2025-01-012025-12-31_custom_ResearchAndDevelopmentExpensesMember"
      decimals="-3"
      id="Fact002907"
      unitRef="USD">211000</SMX:SubcontractorsAndConsultants>
    <SMX:SubcontractorsAndConsultants
      contextRef="From2024-01-012024-12-31_custom_ResearchAndDevelopmentExpensesMember"
      decimals="-3"
      id="Fact002908"
      unitRef="USD">135000</SMX:SubcontractorsAndConsultants>
    <SMX:SubcontractorsAndConsultants
      contextRef="From2023-01-012023-12-31_custom_ResearchAndDevelopmentExpensesMember"
      decimals="-3"
      id="Fact002909"
      unitRef="USD">344000</SMX:SubcontractorsAndConsultants>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="From2025-01-012025-12-31_custom_ResearchAndDevelopmentExpensesMember"
      decimals="-3"
      id="Fact002911"
      unitRef="USD">179000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="From2024-01-012024-12-31_custom_ResearchAndDevelopmentExpensesMember"
      decimals="-3"
      id="Fact002912"
      unitRef="USD">172000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="From2023-01-012023-12-31_custom_ResearchAndDevelopmentExpensesMember"
      decimals="-3"
      id="Fact002913"
      unitRef="USD">197000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:TravelExpense
      contextRef="From2025-01-012025-12-31_custom_ResearchAndDevelopmentExpensesMember"
      decimals="-3"
      id="Fact002915"
      unitRef="USD">87000</ifrs-full:TravelExpense>
    <ifrs-full:TravelExpense
      contextRef="From2024-01-012024-12-31_custom_ResearchAndDevelopmentExpensesMember"
      decimals="-3"
      id="Fact002916"
      unitRef="USD">260000</ifrs-full:TravelExpense>
    <ifrs-full:TravelExpense
      contextRef="From2023-01-012023-12-31_custom_ResearchAndDevelopmentExpensesMember"
      decimals="-3"
      id="Fact002917"
      unitRef="USD">87000</ifrs-full:TravelExpense>
    <SMX:FreightExpense
      contextRef="From2025-01-012025-12-31_custom_ResearchAndDevelopmentExpensesMember"
      decimals="-3"
      id="Fact002919"
      unitRef="USD">7000</SMX:FreightExpense>
    <SMX:FreightExpense
      contextRef="From2024-01-012024-12-31_custom_ResearchAndDevelopmentExpensesMember"
      decimals="-3"
      id="Fact002920"
      unitRef="USD">8000</SMX:FreightExpense>
    <SMX:FreightExpense
      contextRef="From2023-01-012023-12-31_custom_ResearchAndDevelopmentExpensesMember"
      decimals="-3"
      id="Fact002921"
      unitRef="USD">33000</SMX:FreightExpense>
    <ifrs-full:OtherExpenseByNature
      contextRef="From2025-01-012025-12-31_custom_ResearchAndDevelopmentExpensesMember"
      decimals="-3"
      id="Fact002923"
      unitRef="USD">11000</ifrs-full:OtherExpenseByNature>
    <ifrs-full:OtherExpenseByNature
      contextRef="From2024-01-012024-12-31_custom_ResearchAndDevelopmentExpensesMember"
      decimals="-3"
      id="Fact002924"
      unitRef="USD">5000</ifrs-full:OtherExpenseByNature>
    <ifrs-full:OtherExpenseByNature
      contextRef="From2023-01-012023-12-31_custom_ResearchAndDevelopmentExpensesMember"
      decimals="-3"
      id="Fact002925"
      unitRef="USD">10000</ifrs-full:OtherExpenseByNature>
    <SMX:ReimbursementFromPaidPilotsAndProofOfConceptProjects
      contextRef="From2025-01-012025-12-31_custom_ResearchAndDevelopmentExpensesMember"
      decimals="-3"
      id="Fact002927"
      unitRef="USD">-650000</SMX:ReimbursementFromPaidPilotsAndProofOfConceptProjects>
    <SMX:ReimbursementFromPaidPilotsAndProofOfConceptProjects
      contextRef="From2024-01-012024-12-31_custom_ResearchAndDevelopmentExpensesMember"
      decimals="-3"
      id="Fact002928"
      unitRef="USD">-1154000</SMX:ReimbursementFromPaidPilotsAndProofOfConceptProjects>
    <SMX:ReimbursementFromPaidPilotsAndProofOfConceptProjects
      contextRef="From2023-01-012023-12-31_custom_ResearchAndDevelopmentExpensesMember"
      decimals="-3"
      id="Fact002929"
      unitRef="USD">-858000</SMX:ReimbursementFromPaidPilotsAndProofOfConceptProjects>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="From2025-01-012025-12-31_custom_ResearchAndDevelopmentExpensesMember"
      decimals="-3"
      id="Fact002931"
      unitRef="USD">11228000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="From2024-01-012024-12-31_custom_ResearchAndDevelopmentExpensesMember"
      decimals="-3"
      id="Fact002932"
      unitRef="USD">3059000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="From2023-01-012023-12-31_custom_ResearchAndDevelopmentExpensesMember"
      decimals="-3"
      id="Fact002933"
      unitRef="USD">2711000</ifrs-full:ResearchAndDevelopmentExpense>
    <SMX:DisclosureOfSellingAndMarketingExpensesExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact002935">&lt;p id="xdx_801_ecustom--DisclosureOfSellingAndMarketingExpensesExplanatory_z0UU10rZmFC8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
18 &#x2013; &lt;span id="xdx_82A_zX5KuhYsvCu5"&gt;SELLING AND MARKETING EXPENSES&lt;/span&gt;:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_ecustom--DisclosureOfDetailedInformationAboutSellingAndMarketingExpensesExplanatory_zaJ34QDoAhZa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; display: none"&gt;&lt;span id="xdx_8B1_zokBt5yonWb6"&gt;SCHEDULE
OF SELLING AND MARKETING EXPENSES&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_494_20250101__20251231_zbecezu0dNSa" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_494_20240101__20241231_ztFAgpvA5RAk" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_491_20230101__20231231_zdLxTCklPEV3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--AdjustmentsForSharebasedPayments_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--SellingAndMarketingExpensesMember_maSAMEzfCd_zKd6uh5gZ721" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%"&gt;Share based compensation&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;2,610&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;76&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;28&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--EmployeeBenefitsExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--SellingAndMarketingExpensesMember_maSAMEzfCd_zqYvgehqniQ9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Salaries and related expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,063&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;398&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;176&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--BusinessDevelopmentExpenses_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--SellingAndMarketingExpensesMember_maSAMEzfCd_zlvXXNdJn1b2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Business development&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;160&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2948"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2949"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--TravelExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--SellingAndMarketingExpensesMember_maSAMEzfCd_zAJurGI5MJQ6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Travel expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;144&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;24&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--MediaProductionExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--SellingAndMarketingExpensesMember_maSAMEzfCd_zssKtQ4aorLi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Marketing expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;120&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;507&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;433&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--OtherExpenseByNature_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--SellingAndMarketingExpensesMember_maSAMEzfCd_zABqQJUysH6i" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;15&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2961"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--SalesAndMarketingExpense_iT_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--SellingAndMarketingExpensesMember_mtSAMEzfCd_zssAAFavnpfl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;4,112&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;992&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;661&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_zVNQzdw7hqu4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 85%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands, except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</SMX:DisclosureOfSellingAndMarketingExpensesExplanatory>
    <SMX:DisclosureOfDetailedInformationAboutSellingAndMarketingExpensesExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact002937">&lt;p id="xdx_890_ecustom--DisclosureOfDetailedInformationAboutSellingAndMarketingExpensesExplanatory_zaJ34QDoAhZa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; display: none"&gt;&lt;span id="xdx_8B1_zokBt5yonWb6"&gt;SCHEDULE
OF SELLING AND MARKETING EXPENSES&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_494_20250101__20251231_zbecezu0dNSa" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_494_20240101__20241231_ztFAgpvA5RAk" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_491_20230101__20231231_zdLxTCklPEV3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--AdjustmentsForSharebasedPayments_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--SellingAndMarketingExpensesMember_maSAMEzfCd_zKd6uh5gZ721" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%"&gt;Share based compensation&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;2,610&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;76&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;28&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--EmployeeBenefitsExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--SellingAndMarketingExpensesMember_maSAMEzfCd_zqYvgehqniQ9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Salaries and related expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,063&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;398&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;176&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--BusinessDevelopmentExpenses_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--SellingAndMarketingExpensesMember_maSAMEzfCd_zlvXXNdJn1b2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Business development&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;160&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2948"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2949"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--TravelExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--SellingAndMarketingExpensesMember_maSAMEzfCd_zAJurGI5MJQ6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Travel expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;144&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;24&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--MediaProductionExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--SellingAndMarketingExpensesMember_maSAMEzfCd_zssKtQ4aorLi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Marketing expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;120&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;507&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;433&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--OtherExpenseByNature_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--SellingAndMarketingExpensesMember_maSAMEzfCd_zABqQJUysH6i" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;15&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2961"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--SalesAndMarketingExpense_iT_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--SellingAndMarketingExpensesMember_mtSAMEzfCd_zssAAFavnpfl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;4,112&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;992&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;661&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</SMX:DisclosureOfDetailedInformationAboutSellingAndMarketingExpensesExplanatory>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="From2025-01-012025-12-31_custom_SellingAndMarketingExpensesMember"
      decimals="-3"
      id="Fact002939"
      unitRef="USD">2610000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="From2024-01-012024-12-31_custom_SellingAndMarketingExpensesMember"
      decimals="-3"
      id="Fact002940"
      unitRef="USD">76000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="From2023-01-012023-12-31_custom_SellingAndMarketingExpensesMember"
      decimals="-3"
      id="Fact002941"
      unitRef="USD">28000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:EmployeeBenefitsExpense
      contextRef="From2025-01-012025-12-31_custom_SellingAndMarketingExpensesMember"
      decimals="-3"
      id="Fact002943"
      unitRef="USD">1063000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense
      contextRef="From2024-01-012024-12-31_custom_SellingAndMarketingExpensesMember"
      decimals="-3"
      id="Fact002944"
      unitRef="USD">398000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense
      contextRef="From2023-01-012023-12-31_custom_SellingAndMarketingExpensesMember"
      decimals="-3"
      id="Fact002945"
      unitRef="USD">176000</ifrs-full:EmployeeBenefitsExpense>
    <SMX:BusinessDevelopmentExpenses
      contextRef="From2025-01-012025-12-31_custom_SellingAndMarketingExpensesMember"
      decimals="-3"
      id="Fact002947"
      unitRef="USD">160000</SMX:BusinessDevelopmentExpenses>
    <ifrs-full:TravelExpense
      contextRef="From2025-01-012025-12-31_custom_SellingAndMarketingExpensesMember"
      decimals="-3"
      id="Fact002951"
      unitRef="USD">144000</ifrs-full:TravelExpense>
    <ifrs-full:TravelExpense
      contextRef="From2024-01-012024-12-31_custom_SellingAndMarketingExpensesMember"
      decimals="-3"
      id="Fact002952"
      unitRef="USD">8000</ifrs-full:TravelExpense>
    <ifrs-full:TravelExpense
      contextRef="From2023-01-012023-12-31_custom_SellingAndMarketingExpensesMember"
      decimals="-3"
      id="Fact002953"
      unitRef="USD">24000</ifrs-full:TravelExpense>
    <ifrs-full:MediaProductionExpense
      contextRef="From2025-01-012025-12-31_custom_SellingAndMarketingExpensesMember"
      decimals="-3"
      id="Fact002955"
      unitRef="USD">120000</ifrs-full:MediaProductionExpense>
    <ifrs-full:MediaProductionExpense
      contextRef="From2024-01-012024-12-31_custom_SellingAndMarketingExpensesMember"
      decimals="-3"
      id="Fact002956"
      unitRef="USD">507000</ifrs-full:MediaProductionExpense>
    <ifrs-full:MediaProductionExpense
      contextRef="From2023-01-012023-12-31_custom_SellingAndMarketingExpensesMember"
      decimals="-3"
      id="Fact002957"
      unitRef="USD">433000</ifrs-full:MediaProductionExpense>
    <ifrs-full:OtherExpenseByNature
      contextRef="From2025-01-012025-12-31_custom_SellingAndMarketingExpensesMember"
      decimals="-3"
      id="Fact002959"
      unitRef="USD">15000</ifrs-full:OtherExpenseByNature>
    <ifrs-full:OtherExpenseByNature
      contextRef="From2024-01-012024-12-31_custom_SellingAndMarketingExpensesMember"
      decimals="-3"
      id="Fact002960"
      unitRef="USD">3000</ifrs-full:OtherExpenseByNature>
    <ifrs-full:SalesAndMarketingExpense
      contextRef="From2025-01-012025-12-31_custom_SellingAndMarketingExpensesMember"
      decimals="-3"
      id="Fact002963"
      unitRef="USD">4112000</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:SalesAndMarketingExpense
      contextRef="From2024-01-012024-12-31_custom_SellingAndMarketingExpensesMember"
      decimals="-3"
      id="Fact002964"
      unitRef="USD">992000</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:SalesAndMarketingExpense
      contextRef="From2023-01-012023-12-31_custom_SellingAndMarketingExpensesMember"
      decimals="-3"
      id="Fact002965"
      unitRef="USD">661000</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:DisclosureOfIncomeTaxExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact002967">&lt;p id="xdx_802_eifrs-full--DisclosureOfIncomeTaxExplanatory_z975rVZcpb8g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
19 - &lt;span id="xdx_82E_zMtzUGnze693"&gt;TAXES ON INCOME&lt;/span&gt;:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Company is incorporated and domiciled in Ireland where the applicable tax rate is &lt;span id="xdx_90B_eifrs-full--ApplicableTaxRate_pid_dp_uPure_c20250101__20251231_zTtpYaqzFhub" title="Applicable tax rate"&gt;12.5&lt;/span&gt;%.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Theoretical
    tax:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_ecustom--DisclosureOfDetailedInformationAboutComponentsOfIncomeTaxExpenseExplanatory_ze52tbvFSpu" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; display: none; text-align: justify"&gt;&lt;span id="xdx_8BD_zsfbU2pi9rO5"&gt;SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20250101__20251231_zgfnqRK3xdBl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20240101__20241231_z12QTE8nuXF1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20230101__20231231_z1Y37zVWzDl8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: italic; text-align: left"&gt;Reconciliation of income tax at the statutory rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--ProfitLossBeforeTax_pn3n3_zAYRaaFp82Jh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 52%; text-align: left; padding-bottom: 1pt"&gt;Loss before income tax&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;(174,590&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;(35,401&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;(20,989&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--TaxExpenseIncomeAtApplicableTaxRate_pn3n3_maITECOzgxM_zfLQ5GsgSMz8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Theoretical tax rate of &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTVBPTkVOVFMgT0YgSU5DT01FIFRBWCBFWFBFTlNFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90B_eifrs-full--ApplicableTaxRate_pid_dp_uPure_c20250101__20251231_zTIPvx1bQN5l"&gt;12.5&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(21,824&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(4,425&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(2,624&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Tax
effect amounts which are not deductible/(taxable) in calculating taxable income:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20250101__20251231_zxk1oFnh31Xe" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20240101__20241231_zQ9qxgU2ncFe" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49D_20230101__20231231_z60UKjGtDokl" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eifrs-full--TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_pn3n3_maITECOzgxM_z5BRBcd09Jnh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Non-deductible expenditure and others&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;27,338&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;2,984&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;3,254&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--TaxExpenseBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense_pn3n3_maITECOzgxM_zIl4RHAJWkQ5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Unrecognized temporary differences and tax losses for which deferred tax weren&#x2019;t recognized&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(5,514&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,441&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(630&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--IncomeTaxExpenseContinuingOperations_iT_pn3n3_mtITECOzgxM_zRdfNA8Oplh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Income tax / (benefit)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2990"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2991"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2992"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zVNslYdwILD3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    of December 31, 2025, the Group has estimated carry forward tax losses of approximately $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTVBPTkVOVFMgT0YgSU5DT01FIFRBWCBFWFBFTlNFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eifrs-full--TaxEffectOfTaxLosses_pn3n3_c20250101__20251231_zVCVV81woHZj" title="Carry forward tax losses"&gt;124,336&lt;/span&gt; (2024: $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTVBPTkVOVFMgT0YgSU5DT01FIFRBWCBFWFBFTlNFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eifrs-full--TaxEffectOfTaxLosses_pn3n3_c20240101__20241231_zEh3KH2UsBWj" title="Carry forward tax losses"&gt;69,393&lt;/span&gt;, 2023: $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTVBPTkVOVFMgT0YgSU5DT01FIFRBWCBFWFBFTlNFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90F_eifrs-full--TaxEffectOfTaxLosses_pn3n3_c20230101__20231231_zb2IMxeTCb7g" title="Carry forward tax losses"&gt;45,095&lt;/span&gt;) which
    may be carried forward and offset against taxable income for an indefinite period in the future. The Group did not recognize deferred
    tax assets relating to carry forward losses in the financial statements because their utilization in the foreseeable future is not
    probable.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfIncomeTaxExplanatory>
    <ifrs-full:ApplicableTaxRate
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact002969"
      unitRef="Pure">0.125</ifrs-full:ApplicableTaxRate>
    <SMX:DisclosureOfDetailedInformationAboutComponentsOfIncomeTaxExpenseExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact002971">&lt;p id="xdx_890_ecustom--DisclosureOfDetailedInformationAboutComponentsOfIncomeTaxExpenseExplanatory_ze52tbvFSpu" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; display: none; text-align: justify"&gt;&lt;span id="xdx_8BD_zsfbU2pi9rO5"&gt;SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20250101__20251231_zgfnqRK3xdBl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20240101__20241231_z12QTE8nuXF1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20230101__20231231_z1Y37zVWzDl8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: italic; text-align: left"&gt;Reconciliation of income tax at the statutory rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--ProfitLossBeforeTax_pn3n3_zAYRaaFp82Jh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 52%; text-align: left; padding-bottom: 1pt"&gt;Loss before income tax&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;(174,590&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;(35,401&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;(20,989&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--TaxExpenseIncomeAtApplicableTaxRate_pn3n3_maITECOzgxM_zfLQ5GsgSMz8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Theoretical tax rate of &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTVBPTkVOVFMgT0YgSU5DT01FIFRBWCBFWFBFTlNFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90B_eifrs-full--ApplicableTaxRate_pid_dp_uPure_c20250101__20251231_zTIPvx1bQN5l"&gt;12.5&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(21,824&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(4,425&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(2,624&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Tax
effect amounts which are not deductible/(taxable) in calculating taxable income:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20250101__20251231_zxk1oFnh31Xe" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20240101__20241231_zQ9qxgU2ncFe" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49D_20230101__20231231_z60UKjGtDokl" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eifrs-full--TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_pn3n3_maITECOzgxM_z5BRBcd09Jnh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Non-deductible expenditure and others&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;27,338&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;2,984&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;3,254&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--TaxExpenseBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense_pn3n3_maITECOzgxM_zIl4RHAJWkQ5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Unrecognized temporary differences and tax losses for which deferred tax weren&#x2019;t recognized&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(5,514&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,441&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(630&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--IncomeTaxExpenseContinuingOperations_iT_pn3n3_mtITECOzgxM_zRdfNA8Oplh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Income tax / (benefit)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2990"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2991"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2992"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</SMX:DisclosureOfDetailedInformationAboutComponentsOfIncomeTaxExpenseExplanatory>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact002973"
      unitRef="USD">-174590000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact002974"
      unitRef="USD">-35401000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002975"
      unitRef="USD">-20989000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ApplicableTaxRate
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact002980"
      unitRef="Pure">0.125</ifrs-full:ApplicableTaxRate>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact002977"
      unitRef="USD">-21824000</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact002978"
      unitRef="USD">-4425000</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002979"
      unitRef="USD">-2624000</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact002982"
      unitRef="USD">27338000</ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss>
    <ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact002983"
      unitRef="USD">2984000</ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss>
    <ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002984"
      unitRef="USD">3254000</ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss>
    <SMX:TaxExpenseBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact002986"
      unitRef="USD">-5514000</SMX:TaxExpenseBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense>
    <SMX:TaxExpenseBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact002987"
      unitRef="USD">1441000</SMX:TaxExpenseBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense>
    <SMX:TaxExpenseBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002988"
      unitRef="USD">-630000</SMX:TaxExpenseBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense>
    <ifrs-full:TaxEffectOfTaxLosses
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact002994"
      unitRef="USD">124336000</ifrs-full:TaxEffectOfTaxLosses>
    <ifrs-full:TaxEffectOfTaxLosses
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact002996"
      unitRef="USD">69393000</ifrs-full:TaxEffectOfTaxLosses>
    <ifrs-full:TaxEffectOfTaxLosses
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002998"
      unitRef="USD">45095000</ifrs-full:TaxEffectOfTaxLosses>
    <ifrs-full:EarningsPerShareExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact003000">&lt;p id="xdx_802_eifrs-full--EarningsPerShareExplanatory_zbmOQjN0AZ3f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
20 - &lt;span id="xdx_821_zzZgWJ8WNWL6"&gt;LOSS PER SHARE&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eifrs-full--DisclosureOfEarningsPerShareExplanatory_zhXpqaEkgNH6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; display: none"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BB_zwoTNBFTsyWj"&gt;SCHEDULE
OF LOSS PER SHARE&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_494_20250101__20251231_zV5SwoitnHJd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20240101__20241231_zHpYvqfoIIOj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_490_20230101__20231231_zB7hefCunS4i" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2025&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2024&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--NetLossAttributableToOwners_pn3n3_z299OnmmboZ2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; padding-bottom: 1pt"&gt;Net loss attributable to the owners of the company&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; font-weight: bold; text-align: right"&gt;(169,177&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; font-weight: bold; text-align: right"&gt;(31,092&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; font-weight: bold; text-align: right"&gt;(20,914&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Basic and diluted loss per share (US$ in thousands)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_903_eifrs-full--BasicEarningsLossPerShare_pid_c20250101__20251231_fKDEp_zXonCAxAyqzl" title="Basic loss per share"&gt;&lt;span id="xdx_90A_eifrs-full--DilutedEarningsLossPerShare_pid_c20250101__20251231_fKDEp_zPIaKfB17fT2" title="Diluted loss per share"&gt;(37&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;sup&gt;(1)&lt;/sup&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--BasicEarningsLossPerShare_pid_c20240101__20241231_fKDEp_za6id19MjIpi" title="Basic loss per share"&gt;&lt;span id="xdx_90F_eifrs-full--DilutedEarningsLossPerShare_pid_c20240101__20241231_fKDEp_zgNbuputS979" title="Diluted loss per share"&gt;(138,537&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)(1)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--BasicEarningsLossPerShare_pid_c20230101__20231231_fKDEp_z2l1tBoH7Os8" title="Basic loss per share"&gt;&lt;span id="xdx_907_eifrs-full--DilutedEarningsLossPerShare_pid_c20230101__20231231_fKDEp_zJ68lGjnjpuh" title="Diluted loss per share"&gt;(9,272,541&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)(1)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Weighted average number of ordinary shares used in calculating basic and diluted loss per share&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--WeightedAverageShares_pid_c20250101__20251231_zLGn1TPn5c87" title="Weighted average number of ordinary shares used in calculating basic loss per share"&gt;&lt;span id="xdx_90B_eifrs-full--AdjustedWeightedAverageShares_pid_c20250101__20251231_ziVDkM6dAJ7" title="Weighted average number of ordinary shares used in calculating diluted loss per share"&gt;4,526&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--WeightedAverageShares_pid_c20240101__20241231_zOY2MG74hhf9" title="Weighted average number of ordinary shares used in calculating basic loss per share"&gt;&lt;span id="xdx_90A_eifrs-full--AdjustedWeightedAverageShares_pid_c20240101__20241231_z5QIMbKkyb5" title="Weighted average number of ordinary shares used in calculating diluted loss per share"&gt;0.22&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;span id="xdx_908_eifrs-full--WeightedAverageShares_pid_c20230101__20231231_fKg_____zOB9oyuxNMQd" title="Weighted average number of ordinary shares used in calculating basic loss per share"&gt;&lt;span id="xdx_907_eifrs-full--AdjustedWeightedAverageShares_pid_c20230101__20231231_fKg_____zHieIiZltLF7" title="Weighted average number of ordinary shares used in calculating diluted loss per share"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3028"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3030"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F01_zPDKexWtzGU6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1E_zuevpbDP3nwc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Nil after reverse
stock splits&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F01_zANXc4GoHmte" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F12_zsallsuV07uh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    share and per share information in these financial statements reflects the &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90B_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20240715__20240715_z0CNwZVbmrx4" title="Reverse share splits"&gt;1-for-75&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90C_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20250115__20250115_zfrRwxzmYUPf" title="Reverse share splits"&gt;1-for-28.5&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_900_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20250616__20250616_zr9dPgR7fJWd" title="Reverse share splits"&gt;1-for-4.1&lt;/span&gt; &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_906_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20250807__20250807_zTuvtHyG67Z2" title="Reverse share splits"&gt;1-for-7&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_905_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20251023__20251023_zezbqDGDvpG9" title="Reverse share splits"&gt;1-for-10.89958&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_903_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20251118__20251118_zZxBsN2Dj7Zb" title="Reverse share splits"&gt;1-for-8&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_907_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20260217__20260217_zC5EaCuLJKh5" title="Reverse share splits"&gt;1:4.8828125&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20260511__20260511_zp9QOExakI52" title="Reverse share splits"&gt;1-for-20&lt;/span&gt;
    and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90B_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20260601__20260601_zTTap3P3bpxd" title="Reverse share splits"&gt;1-for-2.285&lt;/span&gt;
    reverse share splits became effective on July 15, 2024, January 15, 2025, June 16, 2025, August 7, 2025, October 23, 2025, November
    18, 2025, February 17, 2026, May 11, 2026 and June 1, 2026, respectively, of the Company&#x2019;s issued and outstanding Ordinary Shares (the &#x201c;Reverse
    Stock Splits&#x201d;). See also Note 1. F-1.K and 26.3, 26.5 and 26.6.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A1_zstEnQC59gm1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
calculation of the basic and diluted loss per share for all past periods presented have been adjusted retrospectively based on the new
number of shares derived from the conversion ratio.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 85%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands, except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:EarningsPerShareExplanatory>
    <ifrs-full:DisclosureOfEarningsPerShareExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact003002">&lt;p id="xdx_89A_eifrs-full--DisclosureOfEarningsPerShareExplanatory_zhXpqaEkgNH6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; display: none"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BB_zwoTNBFTsyWj"&gt;SCHEDULE
OF LOSS PER SHARE&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_494_20250101__20251231_zV5SwoitnHJd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20240101__20241231_zHpYvqfoIIOj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_490_20230101__20231231_zB7hefCunS4i" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2025&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2024&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--NetLossAttributableToOwners_pn3n3_z299OnmmboZ2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; padding-bottom: 1pt"&gt;Net loss attributable to the owners of the company&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; font-weight: bold; text-align: right"&gt;(169,177&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; font-weight: bold; text-align: right"&gt;(31,092&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; font-weight: bold; text-align: right"&gt;(20,914&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Basic and diluted loss per share (US$ in thousands)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_903_eifrs-full--BasicEarningsLossPerShare_pid_c20250101__20251231_fKDEp_zXonCAxAyqzl" title="Basic loss per share"&gt;&lt;span id="xdx_90A_eifrs-full--DilutedEarningsLossPerShare_pid_c20250101__20251231_fKDEp_zPIaKfB17fT2" title="Diluted loss per share"&gt;(37&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;sup&gt;(1)&lt;/sup&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--BasicEarningsLossPerShare_pid_c20240101__20241231_fKDEp_za6id19MjIpi" title="Basic loss per share"&gt;&lt;span id="xdx_90F_eifrs-full--DilutedEarningsLossPerShare_pid_c20240101__20241231_fKDEp_zgNbuputS979" title="Diluted loss per share"&gt;(138,537&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)(1)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--BasicEarningsLossPerShare_pid_c20230101__20231231_fKDEp_z2l1tBoH7Os8" title="Basic loss per share"&gt;&lt;span id="xdx_907_eifrs-full--DilutedEarningsLossPerShare_pid_c20230101__20231231_fKDEp_zJ68lGjnjpuh" title="Diluted loss per share"&gt;(9,272,541&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)(1)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Weighted average number of ordinary shares used in calculating basic and diluted loss per share&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--WeightedAverageShares_pid_c20250101__20251231_zLGn1TPn5c87" title="Weighted average number of ordinary shares used in calculating basic loss per share"&gt;&lt;span id="xdx_90B_eifrs-full--AdjustedWeightedAverageShares_pid_c20250101__20251231_ziVDkM6dAJ7" title="Weighted average number of ordinary shares used in calculating diluted loss per share"&gt;4,526&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--WeightedAverageShares_pid_c20240101__20241231_zOY2MG74hhf9" title="Weighted average number of ordinary shares used in calculating basic loss per share"&gt;&lt;span id="xdx_90A_eifrs-full--AdjustedWeightedAverageShares_pid_c20240101__20241231_z5QIMbKkyb5" title="Weighted average number of ordinary shares used in calculating diluted loss per share"&gt;0.22&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;span id="xdx_908_eifrs-full--WeightedAverageShares_pid_c20230101__20231231_fKg_____zOB9oyuxNMQd" title="Weighted average number of ordinary shares used in calculating basic loss per share"&gt;&lt;span id="xdx_907_eifrs-full--AdjustedWeightedAverageShares_pid_c20230101__20231231_fKg_____zHieIiZltLF7" title="Weighted average number of ordinary shares used in calculating diluted loss per share"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3028"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3030"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F01_zPDKexWtzGU6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1E_zuevpbDP3nwc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Nil after reverse
stock splits&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F01_zANXc4GoHmte" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F12_zsallsuV07uh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    share and per share information in these financial statements reflects the &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90B_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20240715__20240715_z0CNwZVbmrx4" title="Reverse share splits"&gt;1-for-75&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90C_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20250115__20250115_zfrRwxzmYUPf" title="Reverse share splits"&gt;1-for-28.5&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_900_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20250616__20250616_zr9dPgR7fJWd" title="Reverse share splits"&gt;1-for-4.1&lt;/span&gt; &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_906_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20250807__20250807_zTuvtHyG67Z2" title="Reverse share splits"&gt;1-for-7&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_905_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20251023__20251023_zezbqDGDvpG9" title="Reverse share splits"&gt;1-for-10.89958&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_903_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20251118__20251118_zZxBsN2Dj7Zb" title="Reverse share splits"&gt;1-for-8&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_907_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20260217__20260217_zC5EaCuLJKh5" title="Reverse share splits"&gt;1:4.8828125&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20260511__20260511_zp9QOExakI52" title="Reverse share splits"&gt;1-for-20&lt;/span&gt;
    and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90B_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20260601__20260601_zTTap3P3bpxd" title="Reverse share splits"&gt;1-for-2.285&lt;/span&gt;
    reverse share splits became effective on July 15, 2024, January 15, 2025, June 16, 2025, August 7, 2025, October 23, 2025, November
    18, 2025, February 17, 2026, May 11, 2026 and June 1, 2026, respectively, of the Company&#x2019;s issued and outstanding Ordinary Shares (the &#x201c;Reverse
    Stock Splits&#x201d;). See also Note 1. F-1.K and 26.3, 26.5 and 26.6.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</ifrs-full:DisclosureOfEarningsPerShareExplanatory>
    <SMX:NetLossAttributableToOwners
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact003004"
      unitRef="USD">-169177000</SMX:NetLossAttributableToOwners>
    <SMX:NetLossAttributableToOwners
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact003005"
      unitRef="USD">-31092000</SMX:NetLossAttributableToOwners>
    <SMX:NetLossAttributableToOwners
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact003006"
      unitRef="USD">-20914000</SMX:NetLossAttributableToOwners>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact003008"
      unitRef="USDPShares">-37</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact003010"
      unitRef="USDPShares">-37</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact003012"
      unitRef="USDPShares">-138537</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact003014"
      unitRef="USDPShares">-138537</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact003016"
      unitRef="USDPShares">-9272541</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact003018"
      unitRef="USDPShares">-9272541</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:WeightedAverageShares
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact003020"
      unitRef="Shares">4526</ifrs-full:WeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact003022"
      unitRef="Shares">4526</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact003024"
      unitRef="Shares">0.22</ifrs-full:WeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact003026"
      unitRef="Shares">0.22</ifrs-full:AdjustedWeightedAverageShares>
    <SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding contextRef="From2024-07-152024-07-15" id="Fact003034">1-for-75</SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding>
    <SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding contextRef="From2025-01-152025-01-15" id="Fact003036">1-for-28.5</SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding>
    <SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding contextRef="From2025-06-162025-06-16" id="Fact003038">1-for-4.1</SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding>
    <SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding contextRef="From2025-08-072025-08-07" id="Fact003040">1-for-7</SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding>
    <SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding contextRef="From2025-10-232025-10-23" id="Fact003042">1-for-10.89958</SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding>
    <SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding contextRef="From2025-11-182025-11-18" id="Fact003044">1-for-8</SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding>
    <SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding contextRef="From2026-02-172026-02-17" id="Fact003046">1:4.8828125</SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding>
    <SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding contextRef="From2026-05-112026-05-11" id="Fact003048">1-for-20</SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding>
    <SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding contextRef="From2026-06-012026-06-01" id="Fact003050">1-for-2.285</SMX:DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding>
    <ifrs-full:DisclosureOfRelatedPartyExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact003052">&lt;p id="xdx_807_eifrs-full--DisclosureOfRelatedPartyExplanatory_zQpO54HihQ04" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
21 - &lt;span id="xdx_82A_zmRFiKwWnf78"&gt;RELATED PARTIES&lt;/span&gt;:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Key
Management Personnel Compensation and other related party transactions and balances:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
key management personnel, among others, include board members, CEO and CFO.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eifrs-full--DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_zxLF9Gipkp3j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
totals of remuneration paid to Key Management Personnel and related parties during the years are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; display: none"&gt;&lt;span id="xdx_8BF_zyGPdzydaKAf"&gt;SCHEDULE
OF KEY MANAGEMENT PERSONNEL&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;1. Transactions with related parties:&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20250101__20251231_zsMs8vPqODWb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20240101__20241231_zUhQRiH2YCfa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--KeyManagementPersonnelCompensationSharebasedPayment_pn3n3_maKMPCzFmg_z2L4VZRNv98l" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;Share based payments&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;51,293&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;2,675&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_maKMPCzFmg_zXdBlFXwuIzl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Short-term salary and fees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;629&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;661&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--RevaluationOfFinancialLiabilitiesAtFairValue_pn3n3_maKMPCzFmg_zV2N5GwQdCN8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Revaluation of financial liabilities at fair value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3062"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;344&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--KeyManagementPersonnelCompensationPaymentsForLegalServices_pn3n3_maKMPCzFmg_z9Ter3p0XAz4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Payments for legal services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3065"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;337&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--KeyManagementPersonnelCompensationPostemploymentBenefits_pn3n3_maKMPCzFmg_zi9fKGk6UTlc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Post-employment retirement benefits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;87&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;98&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--KeyManagementPersonnelCompensationNonmonetaryBenefits_pn3n3_maKMPCzFmg_zOMhjZOFeyXg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Non-monetary benefits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;38&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;41&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--KeyManagementPersonnelCompensation_iT_pn3n3_mtKMPCzFmg_zkcwIlhbd0vf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Key management personnel
    compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;52,047&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;4,156&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zM1Ubt9Hh2Xa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_ecustom--DisclosureOfDetailedInformationAboutBalanceWithRelatedPartiesExplanatory_znwSNs4mZfph" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; display: none"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B1_zFChL2nlqPkg"&gt;SCHEDULE
OF BALANCE WITH RELATED PARTIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;2. Balance with related parties:&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 32%; text-align: left"&gt;Key management&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 30%; text-align: left"&gt;Salary and related&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--AmountsPayableRelatedPartyTransactions_iNI_pn3n3_di_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--KeyManagementPersonnelOfEntityOrParentMember_zyJfA96vVQU8" style="width: 14%; text-align: right" title="Salary and related"&gt;(229&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--AmountsPayableRelatedPartyTransactions_iNI_pn3n3_di_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--KeyManagementPersonnelOfEntityOrParentMember_zbl7FA8jZ6Ib" style="width: 14%; text-align: right" title="Salary and related"&gt;(166&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Directors&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Consultant services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--OutstandingCommitmentsMadeByEntityRelatedPartyTransactions_iNI_pn3n3_di_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsMember_zHfHyo3PCb1l" style="text-align: right" title="Consultant services"&gt;(94&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--OutstandingCommitmentsMadeByEntityRelatedPartyTransactions_iNI_pn3n3_di_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsMember_zDupNZyCyBR8" style="text-align: right" title="Consultant services"&gt;(83&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Joint Ventures&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Investment in subsidiary&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--InvestmentsInSubsidiaries_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--JointVenturesMember_zrkwuxnyQOK" style="text-align: right" title="Investment in subsidiary"&gt;114&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--InvestmentsInSubsidiaries_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--JointVenturesMember_zirXV6QilwSc" style="text-align: right" title="Investment in subsidiary"&gt;105&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Joint Ventures&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Other receivables&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--OtherReceivables_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--JointVenturesMember_zv23lGJQ0mJb" style="border-bottom: Black 1pt solid; text-align: right" title="Other receivables"&gt;15&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--OtherReceivables_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--JointVenturesMember_zUzfVRcGZ3A8" style="border-bottom: Black 1pt solid; text-align: right" title="Other receivables"&gt;15&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--BalanceWithRelatedParties_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_zNK5gORElJfh" style="border-bottom: Black 1pt solid; text-align: right" title="Total"&gt;(194&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--BalanceWithRelatedParties_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_z6ygDqGMFCt" style="border-bottom: Black 1pt solid; text-align: right" title="Total"&gt;(129&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zVtqqz3FYjH" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 85%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands, except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfRelatedPartyExplanatory>
    <ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact003054">&lt;p id="xdx_897_eifrs-full--DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_zxLF9Gipkp3j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
totals of remuneration paid to Key Management Personnel and related parties during the years are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; display: none"&gt;&lt;span id="xdx_8BF_zyGPdzydaKAf"&gt;SCHEDULE
OF KEY MANAGEMENT PERSONNEL&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;1. Transactions with related parties:&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20250101__20251231_zsMs8vPqODWb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20240101__20241231_zUhQRiH2YCfa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--KeyManagementPersonnelCompensationSharebasedPayment_pn3n3_maKMPCzFmg_z2L4VZRNv98l" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;Share based payments&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;51,293&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;2,675&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_maKMPCzFmg_zXdBlFXwuIzl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Short-term salary and fees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;629&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;661&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--RevaluationOfFinancialLiabilitiesAtFairValue_pn3n3_maKMPCzFmg_zV2N5GwQdCN8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Revaluation of financial liabilities at fair value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3062"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;344&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--KeyManagementPersonnelCompensationPaymentsForLegalServices_pn3n3_maKMPCzFmg_z9Ter3p0XAz4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Payments for legal services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3065"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;337&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--KeyManagementPersonnelCompensationPostemploymentBenefits_pn3n3_maKMPCzFmg_zi9fKGk6UTlc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Post-employment retirement benefits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;87&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;98&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--KeyManagementPersonnelCompensationNonmonetaryBenefits_pn3n3_maKMPCzFmg_zOMhjZOFeyXg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Non-monetary benefits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;38&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;41&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--KeyManagementPersonnelCompensation_iT_pn3n3_mtKMPCzFmg_zkcwIlhbd0vf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Key management personnel
    compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;52,047&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;4,156&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact003056"
      unitRef="USD">51293000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact003057"
      unitRef="USD">2675000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact003059"
      unitRef="USD">629000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact003060"
      unitRef="USD">661000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <SMX:RevaluationOfFinancialLiabilitiesAtFairValue
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact003063"
      unitRef="USD">344000</SMX:RevaluationOfFinancialLiabilitiesAtFairValue>
    <SMX:KeyManagementPersonnelCompensationPaymentsForLegalServices
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact003066"
      unitRef="USD">337000</SMX:KeyManagementPersonnelCompensationPaymentsForLegalServices>
    <ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact003068"
      unitRef="USD">87000</ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact003069"
      unitRef="USD">98000</ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits>
    <SMX:KeyManagementPersonnelCompensationNonmonetaryBenefits
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact003071"
      unitRef="USD">38000</SMX:KeyManagementPersonnelCompensationNonmonetaryBenefits>
    <SMX:KeyManagementPersonnelCompensationNonmonetaryBenefits
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact003072"
      unitRef="USD">41000</SMX:KeyManagementPersonnelCompensationNonmonetaryBenefits>
    <ifrs-full:KeyManagementPersonnelCompensation
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact003074"
      unitRef="USD">52047000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact003075"
      unitRef="USD">4156000</ifrs-full:KeyManagementPersonnelCompensation>
    <SMX:DisclosureOfDetailedInformationAboutBalanceWithRelatedPartiesExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact003077">&lt;p id="xdx_899_ecustom--DisclosureOfDetailedInformationAboutBalanceWithRelatedPartiesExplanatory_znwSNs4mZfph" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; display: none"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B1_zFChL2nlqPkg"&gt;SCHEDULE
OF BALANCE WITH RELATED PARTIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;2. Balance with related parties:&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 32%; text-align: left"&gt;Key management&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 30%; text-align: left"&gt;Salary and related&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--AmountsPayableRelatedPartyTransactions_iNI_pn3n3_di_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--KeyManagementPersonnelOfEntityOrParentMember_zyJfA96vVQU8" style="width: 14%; text-align: right" title="Salary and related"&gt;(229&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--AmountsPayableRelatedPartyTransactions_iNI_pn3n3_di_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--KeyManagementPersonnelOfEntityOrParentMember_zbl7FA8jZ6Ib" style="width: 14%; text-align: right" title="Salary and related"&gt;(166&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Directors&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Consultant services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--OutstandingCommitmentsMadeByEntityRelatedPartyTransactions_iNI_pn3n3_di_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsMember_zHfHyo3PCb1l" style="text-align: right" title="Consultant services"&gt;(94&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--OutstandingCommitmentsMadeByEntityRelatedPartyTransactions_iNI_pn3n3_di_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsMember_zDupNZyCyBR8" style="text-align: right" title="Consultant services"&gt;(83&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Joint Ventures&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Investment in subsidiary&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--InvestmentsInSubsidiaries_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--JointVenturesMember_zrkwuxnyQOK" style="text-align: right" title="Investment in subsidiary"&gt;114&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--InvestmentsInSubsidiaries_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--JointVenturesMember_zirXV6QilwSc" style="text-align: right" title="Investment in subsidiary"&gt;105&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Joint Ventures&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Other receivables&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--OtherReceivables_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--JointVenturesMember_zv23lGJQ0mJb" style="border-bottom: Black 1pt solid; text-align: right" title="Other receivables"&gt;15&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--OtherReceivables_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--JointVenturesMember_zUzfVRcGZ3A8" style="border-bottom: Black 1pt solid; text-align: right" title="Other receivables"&gt;15&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--BalanceWithRelatedParties_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_zNK5gORElJfh" style="border-bottom: Black 1pt solid; text-align: right" title="Total"&gt;(194&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--BalanceWithRelatedParties_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_z6ygDqGMFCt" style="border-bottom: Black 1pt solid; text-align: right" title="Total"&gt;(129&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</SMX:DisclosureOfDetailedInformationAboutBalanceWithRelatedPartiesExplanatory>
    <ifrs-full:AmountsPayableRelatedPartyTransactions
      contextRef="AsOf2025-12-31_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember"
      decimals="-3"
      id="Fact003079"
      unitRef="USD">229000</ifrs-full:AmountsPayableRelatedPartyTransactions>
    <ifrs-full:AmountsPayableRelatedPartyTransactions
      contextRef="AsOf2024-12-31_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember"
      decimals="-3"
      id="Fact003081"
      unitRef="USD">166000</ifrs-full:AmountsPayableRelatedPartyTransactions>
    <ifrs-full:OutstandingCommitmentsMadeByEntityRelatedPartyTransactions
      contextRef="AsOf2025-12-31_custom_DirectorsMember"
      decimals="-3"
      id="Fact003083"
      unitRef="USD">94000</ifrs-full:OutstandingCommitmentsMadeByEntityRelatedPartyTransactions>
    <ifrs-full:OutstandingCommitmentsMadeByEntityRelatedPartyTransactions
      contextRef="AsOf2024-12-31_custom_DirectorsMember"
      decimals="-3"
      id="Fact003085"
      unitRef="USD">83000</ifrs-full:OutstandingCommitmentsMadeByEntityRelatedPartyTransactions>
    <ifrs-full:InvestmentsInSubsidiaries
      contextRef="AsOf2025-12-31_ifrs-full_JointVenturesMember"
      decimals="-3"
      id="Fact003087"
      unitRef="USD">114000</ifrs-full:InvestmentsInSubsidiaries>
    <ifrs-full:InvestmentsInSubsidiaries
      contextRef="AsOf2024-12-31_ifrs-full_JointVenturesMember"
      decimals="-3"
      id="Fact003089"
      unitRef="USD">105000</ifrs-full:InvestmentsInSubsidiaries>
    <ifrs-full:OtherReceivables
      contextRef="AsOf2025-12-31_ifrs-full_JointVenturesMember"
      decimals="-3"
      id="Fact003091"
      unitRef="USD">15000</ifrs-full:OtherReceivables>
    <ifrs-full:OtherReceivables
      contextRef="AsOf2024-12-31_ifrs-full_JointVenturesMember"
      decimals="-3"
      id="Fact003093"
      unitRef="USD">15000</ifrs-full:OtherReceivables>
    <SMX:BalanceWithRelatedParties
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember"
      decimals="-3"
      id="Fact003095"
      unitRef="USD">-194000</SMX:BalanceWithRelatedParties>
    <SMX:BalanceWithRelatedParties
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember"
      decimals="-3"
      id="Fact003097"
      unitRef="USD">-129000</SMX:BalanceWithRelatedParties>
    <ifrs-full:DisclosureOfGovernmentGrantsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact003099">&lt;p id="xdx_809_eifrs-full--DisclosureOfGovernmentGrantsExplanatory_zPJpjCJMouY2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
22 - &lt;span id="xdx_824_zb4p3bqsJ49h"&gt;GOVERNMENT GRANTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Government of Israel encourages research and development projects oriented towards products for export or projects which will otherwise
benefit the Israeli economy. This is conducted via the Israel Innovation Authority (IIA), which replaced the former Office of the Chief
Scientist (OCS). The Group has an approved project with the IIA under which it received a total of $&lt;span id="xdx_907_ecustom--ProceedsFromGovernmentGrantsReceived_pn3n3_c20250101__20251231_zWTQz3Pb7i68" title="Proceeds from government grants received"&gt;162&lt;/span&gt; in prior years. The Group is
subject to paying &lt;span id="xdx_90D_ecustom--PercentageOfRevenue_pid_dp_c20250101__20251231_zFd8ru3qAXg9" title="Percentage of revenue"&gt;3&lt;/span&gt;% of its relevant revenues until repayment of the entire grant. As of December 31, 2025, and 2024, the Group has &lt;span id="xdx_90A_ecustom--PaymentsForGovernmentGrants_pn3n3_do_c20250101__20251231_zY7GQqwjBoa9" title="Royalties paid"&gt;&lt;span id="xdx_906_ecustom--PaymentsForGovernmentGrants_pn3n3_do_c20240101__20241231_ztkyv6irvjWf" title="Royalties paid"&gt;no&lt;/span&gt;&lt;/span&gt;t
paid any royalties to IIA. The difference between the consideration received and the liability recognized at inception (present value)
was treated as a government grant according to IAS 20 and recognized as a reimbursement of research expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_897_ecustom--DisclosureOfDetailedInformationAboutGovernmentGrantsExplanatory_zImnEacJT3x2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; display: none; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BB_zBwAwAvmJXk3"&gt;SCHEDULE
OF GOVERNMENT GRANTS&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20251231_zQGVkchwJnPb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20241231_zw0wwekL8Eq2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--CurrentGovernmentGrants_iI_pn3n3_maGGzYoK_zFelXVs5uqJ5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-bottom: 1pt"&gt;Short term liability at year end&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 14%; text-align: right"&gt;202&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 14%; text-align: right"&gt;177&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--GovernmentGrants_iTI_pn3n3_mtGGzYoK_zitDcgMKNM2g" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;202&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;177&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_zcvx4x2NxLR2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfGovernmentGrantsExplanatory>
    <SMX:ProceedsFromGovernmentGrantsReceived
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact003101"
      unitRef="USD">162000</SMX:ProceedsFromGovernmentGrantsReceived>
    <SMX:PercentageOfRevenue
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact003103"
      unitRef="Pure">0.03</SMX:PercentageOfRevenue>
    <SMX:PaymentsForGovernmentGrants
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact003105"
      unitRef="USD">0</SMX:PaymentsForGovernmentGrants>
    <SMX:PaymentsForGovernmentGrants
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact003107"
      unitRef="USD">0</SMX:PaymentsForGovernmentGrants>
    <SMX:DisclosureOfDetailedInformationAboutGovernmentGrantsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact003109">&lt;p id="xdx_897_ecustom--DisclosureOfDetailedInformationAboutGovernmentGrantsExplanatory_zImnEacJT3x2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; display: none; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BB_zBwAwAvmJXk3"&gt;SCHEDULE
OF GOVERNMENT GRANTS&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20251231_zQGVkchwJnPb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20241231_zw0wwekL8Eq2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt;
 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--CurrentGovernmentGrants_iI_pn3n3_maGGzYoK_zFelXVs5uqJ5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-bottom: 1pt"&gt;Short term liability at year end&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 14%; text-align: right"&gt;202&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 14%; text-align: right"&gt;177&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--GovernmentGrants_iTI_pn3n3_mtGGzYoK_zitDcgMKNM2g" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;202&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;177&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</SMX:DisclosureOfDetailedInformationAboutGovernmentGrantsExplanatory>
    <ifrs-full:CurrentGovernmentGrants
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact003111"
      unitRef="USD">202000</ifrs-full:CurrentGovernmentGrants>
    <ifrs-full:CurrentGovernmentGrants
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact003112"
      unitRef="USD">177000</ifrs-full:CurrentGovernmentGrants>
    <ifrs-full:GovernmentGrants
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact003114"
      unitRef="USD">202000</ifrs-full:GovernmentGrants>
    <ifrs-full:GovernmentGrants
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact003115"
      unitRef="USD">177000</ifrs-full:GovernmentGrants>
    <ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact003117">&lt;p id="xdx_80F_eifrs-full--DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_zfyvFHPdb3ld" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
23 - &lt;span id="xdx_82F_zwK81kiMT4i6"&gt;COMMITMENTS AND CONTINGENT LIABILITIES&lt;/span&gt;:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
part of the Board&#x2019;s ongoing regulatory compliance process, the Board continues to monitor legal and regulatory developments and
their potential impact on the Company. Management is not aware of any contingencies that may have a significant impact on the financial
position of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
                                            January 2015, the Company entered an agreement with Isorad Ltd. (a company wholly owned by
                                            the State of Israel with rights to exclusively commercialize the Soreq Research Center technology
                                            for civilian uses), according to which the Company was granted technological license in return
                                            for future royalties based on &lt;span id="xdx_901_ecustom--PercentageOfRoyalty_iI_pid_dp_c20150131_zpGzoq2kNi9i" title="Percentage of royalty"&gt;2.2&lt;/span&gt;% of gross sales by the Company and its affiliates and after
                                            25 years the license becomes royalty-free. Upon the occurrence of an M&amp;amp;A event (as such
                                            event is defined in the agreement to include mergers, sale of all or substantially all the
                                            assets of ours and similar event), in the first M&amp;amp;A event, the Company is to pay a consideration
                                            equal to &lt;span id="xdx_909_ecustom--ContingentOfConsiderationPercentage_iI_pid_dp_c20150131_zGSUCUGpSDT9" title="Contingent of consideration percentage"&gt;1&lt;/span&gt;% of the amount received or transferred and in the second M&amp;amp;A event, a consideration
                                            equal to &lt;span id="xdx_901_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20150131_zkmywLv96cQf"&gt;2&lt;/span&gt;% of the amount received or transferred. This will not apply to any future offer
                                            of shares, merger or sale of assets thereafter.&lt;br/&gt;
                                            In January 2023, the Company signed an amendment to the agreement that determine the following:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)
for the BCA with Lionheart, Isorad was issued (a) &lt;span id="xdx_90A_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uShares_c20230101__20230131__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z6l3vOCHfLF7" title="Options issued to purchase shares"&gt;864,000&lt;/span&gt; options to purchase shares of the Company, the options were issued in January
2023 and valued using the Black-Scholes pricing model. The main assumptions which were used are: (1) risk-free rate: &lt;span id="xdx_900_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230101__20230131__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zKddv6BL5Sc6" title="Risk-free rate"&gt;3.42&lt;/span&gt;%; (2) expected
volatility: &lt;span id="xdx_90E_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230101__20230131__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zrUS6t9a53Za" title="Expected volatility"&gt;81.92&lt;/span&gt;%; (3) expected term: up to &lt;span id="xdx_90B_ecustom--DescriptionOfExpectedExpectedTermOptionsGranted_dtY_c20230101__20230131__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zcOCzU5VB1Tl" title="Expected term"&gt;3&lt;/span&gt; years; and (4) expected dividend yield: &lt;span id="xdx_905_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230101__20230131__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zFNEOLhCwCI" title="Expected dividend yield"&gt;0&lt;/span&gt;%;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of these options was $&lt;span id="xdx_908_eifrs-full--WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20230131__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zd1ULvriQQc7" title="Fair value of options"&gt;33&lt;/span&gt; and recognized as a technology license intellectual property.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)
Additionally, Isorad will be entitled to &lt;span id="xdx_902_ecustom--AddtionalEquityFundOfConvertiblePercent_iI_pid_dp_uPure_c20230131_znCi6hxZxUo9" title="Addtional equity fund of convertible percent"&gt;1&lt;/span&gt;% of any amount actually received against equity or other funding convertible into equity at
the closing of the transaction and until 13 months thereafter to be paid after reaching an aggregated received amount of &lt;span id="xdx_90D_eifrs-full--ConsiderationPaidReceived_pn6n6_c20230101__20230131_zNrw1ofnpOwg" title="Aggregated amount received"&gt;27&lt;/span&gt; million,
or at the end of such 13 months, the earlier thereof).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2025, and 2024, based on the funds the Company actually received during the 13 month period after the BCA, the Company
recognized a technology license intellectual property at the amount of $&lt;span id="xdx_90B_eifrs-full--IntangibleAssetsOtherThanGoodwillCarryingAmountOfRevaluedAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--TechnologyLicenseIntellectualPropertyMember_zUHSxkBm1udk" title="Assets value against liability"&gt;180&lt;/span&gt; and $&lt;span id="xdx_906_eifrs-full--IntangibleAssetsOtherThanGoodwillCarryingAmountOfRevaluedAssets_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--TechnologyLicenseIntellectualPropertyMember_zuKRwy0jyqjc" title="Assets value against liability"&gt;158&lt;/span&gt;, respectively against a liability. The change in
the provision derives from exchange rate differences.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3)
Exit fee - in the occurrence of the first M&amp;amp;A event (as such event is defined in such agreement to include mergers, sale of all or
substantially all the assets of the Company and similar event) after the closing of the BCA, the Company is to pay a cash amount equal
to &lt;span id="xdx_903_ecustom--ExitFeePercentage_iI_pid_dp_uPure_c20230131_zkhpvjHtShde" title="Exit fee percentage"&gt;1.5&lt;/span&gt;% of the amount received or transferred. This will not apply to any future offer of shares, merger or sale of assets thereafter.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 85%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands, except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
23 - COMMITMENTS AND CONTINGENT LIABILITIES (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;B.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;p style="text-indent: 0.5in; margin-left: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;On January 12,
                                                                                                                                                                                                                                     2024, the Company announced that it entered into a $&lt;span id="xdx_903_eifrs-full--ContractualCapitalCommitments_iI_pn6n6_c20240112__ifrs-full--TypesOfContractsAxis__custom--RAndITradingMember_z4UJoaar0dS" title="Contractual capital commitments"&gt;5&lt;/span&gt;
                                                                                                                                                                                                                                     million contract with R&amp;amp;I Trading of New York (&#x201c;R&amp;amp;I Trading&#x201d;). The intention of the agreement with R&amp;amp;I
                                                                                                                                                                                                                                     Trading was to provide a service on supply chain management to a NATO member state. Subsequent to June 30, 2024, R&amp;amp;I
                                                                                                                                                                                                                                     Trading sent a termination notice to the Company and a demand for arbitration with respect to disputed payment amounts under the contract.
                                                                                                                                                                                                                                     The Company believes the termination of the contract is unlawful and has demanded that R&amp;amp;I Trading honor its obligations
                                                                                                                                                                                                                                     under the contract. The Company further intends to defend any action, if and when commenced, vigorously.&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
                                                                                &lt;p style="text-indent: 0.5in; margin-left: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company is
                                                                                currently engaged in an arbitration process with R&amp;amp;I Trading. The statements of claim by the parties to the arbitration
                                                                                proceedings were filed on January 6, 2025. R&amp;amp;I Trading&#x2019;s statement of claim demands full restitution of the amounts paid
                                                                                by it under the agreement. The Company&#x2019;s statement of claim alleges that R&amp;amp;I Trading breached the agreement and has
                                                                                requested the arbitrator to grant relief for the division of remedies in the event that the Company is presented with further
                                                                                expenses by suppliers and employees that have not yet been included in its damage estimate. The Company also raised claims regarding
                                                                                loss of opportunities and requested declaratory relief in favor of the Company.&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="text-indent: 0.5in; margin-left: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;Prior to filing
the statement of claim, on December 26, 2024, the Company filed a motion for declaratory relief. On January 9, 2025, R&amp;amp;I Trading
responded to the motion. The Company had until January 23, 2025, to submit reply papers in connection with this motion practice.&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="text-indent: 0.5in; margin-left: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On March 6, 2025, the parties filed a request for the approval of a mutual procedural arrangement, under which, among other things, R&amp;amp;I Trading will file an affidavit stating that it is not using the Company&#x2019;s IP rights and has no intention of violating the Company&#x2019;s IP rights; the Company will withdraw the motion for a declaration and amend its statement of claim accordingly by March 30, 2025; the statements of defense will be filed by April 21, 2025; and the statements of reply will be filed by May 12, 2025.&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="text-indent: 0.5in; margin-left: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;On March 7, 2025, the arbitrator approved the request, and on March 23, 2025, R&amp;amp;I Trading filed its affidavit. On May 11, 2025, the
parties filed their statements of defense. On June 26, 2025, the parties filed their reply to the statement of defense. An arbitration
hearing was scheduled for July 21, 2025. The parties exchanged general affidavits of disclosure and requests for responses to questionnaires
and for disclosure of documents and R&amp;amp;I&#x2019;s request and the Company&#x2019;s response for deposit of a security to guarantee the
costs. On February 3, 2026, another preliminary arbitration hearing was held, at which it was determined that the Company was required
to file an update regarding its position on the mutual provision of security to secure the arbitrator&#x2019;s fees. The Company filed
its response to the arbitrator&#x2019;s request on February 10, 2026, and R&amp;amp;I Trading was ordered to file its response by March 5,
2026. The parties were ordered to file a joint notice advising whether they have reached agreements that render their mutual disputes
unnecessary to determine whether they maintain their respective applications for determination. By March 31, 2026, both parties are required
to file their responses to the other party&#x2019;s submission regarding the conduct of the preliminary proceedings and document disclosure
and are also required to file their respective lists of witnesses and experts. At this preliminary stage, it is not possible to assess
the chances of the Company&#x2019;s claim and the outcome of the arbitration proceedings.&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands, except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory>
    <SMX:PercentageOfRoyalty
      contextRef="AsOf2015-01-31"
      decimals="INF"
      id="Fact003119"
      unitRef="Pure">0.022</SMX:PercentageOfRoyalty>
    <SMX:ContingentOfConsiderationPercentage
      contextRef="AsOf2015-01-31"
      decimals="INF"
      id="Fact003121"
      unitRef="Pure">0.01</SMX:ContingentOfConsiderationPercentage>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2015-01-31"
      decimals="INF"
      id="Fact003122"
      unitRef="Pure">0.02</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-01-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact003124"
      unitRef="Shares">864000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-01-012023-01-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact003126"
      unitRef="Pure">0.0342</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2023-01-012023-01-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact003128"
      unitRef="Pure">0.8192</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <SMX:DescriptionOfExpectedExpectedTermOptionsGranted
      contextRef="From2023-01-012023-01-31_ifrs-full_ShareOptionsMember"
      id="Fact003130">P3Y</SMX:DescriptionOfExpectedExpectedTermOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-01-012023-01-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact003132"
      unitRef="Pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted
      contextRef="AsOf2023-01-31_ifrs-full_ShareOptionsMember"
      decimals="-3"
      id="Fact003134"
      unitRef="USD">33000</ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted>
    <SMX:AddtionalEquityFundOfConvertiblePercent
      contextRef="AsOf2023-01-31"
      decimals="INF"
      id="Fact003136"
      unitRef="Pure">0.01</SMX:AddtionalEquityFundOfConvertiblePercent>
    <ifrs-full:ConsiderationPaidReceived
      contextRef="From2023-01-012023-01-31"
      decimals="-6"
      id="Fact003138"
      unitRef="USD">27000000</ifrs-full:ConsiderationPaidReceived>
    <ifrs-full:IntangibleAssetsOtherThanGoodwillCarryingAmountOfRevaluedAssets
      contextRef="AsOf2025-12-31_custom_TechnologyLicenseIntellectualPropertyMember"
      decimals="-3"
      id="Fact003140"
      unitRef="USD">180000</ifrs-full:IntangibleAssetsOtherThanGoodwillCarryingAmountOfRevaluedAssets>
    <ifrs-full:IntangibleAssetsOtherThanGoodwillCarryingAmountOfRevaluedAssets
      contextRef="AsOf2024-12-31_custom_TechnologyLicenseIntellectualPropertyMember"
      decimals="-3"
      id="Fact003142"
      unitRef="USD">158000</ifrs-full:IntangibleAssetsOtherThanGoodwillCarryingAmountOfRevaluedAssets>
    <SMX:ExitFeePercentage
      contextRef="AsOf2023-01-31"
      decimals="INF"
      id="Fact003144"
      unitRef="Pure">0.015</SMX:ExitFeePercentage>
    <ifrs-full:ContractualCapitalCommitments
      contextRef="AsOf2024-01-12_custom_RAndITradingMember"
      decimals="-6"
      id="Fact003146"
      unitRef="USD">5000000</ifrs-full:ContractualCapitalCommitments>
    <SMX:DisclosureOfFinancialInstrumentAndRiskManagementExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact003148">&lt;p id="xdx_806_ecustom--DisclosureOfFinancialInstrumentAndRiskManagementExplanatory_zYtWxazLMABk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
24 - &lt;span id="xdx_828_z5zXtRt3Wzsj"&gt;FINANCIAL INSTRUMENTS AND RISK MANAGEMENT&lt;/span&gt;:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eifrs-full--DisclosureOfCreditRiskExposureExplanatory_zx7y9cCE3F9a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Composition
of the Group&#x2019;s financial assets and financial liabilities:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; display: none"&gt;&lt;span id="xdx_8BF_zpEviBcKXJi9"&gt;SCHEDULE
OF FINANCIAL ASSETS AND IMPACT OF CREDIT EXPOSURE&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_495_20251231_zkrkfsoQqJCa" style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20241231_zk63Cg01WCdi" style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--DisclosureOfFinancialAssetsAbstract_iB_zBVlnhtNQusa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Financial assets at amortized cost:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--CashAndCashEquivalents_i01I_hifrs-full--TypesOfRisksAxis__ifrs-full--CreditRiskMember_zu5o4iMbTJua" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 64%; text-align: justify"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;12,201&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;2,343&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--OtherCurrentAssets_i01I_hifrs-full--TypesOfRisksAxis__ifrs-full--CreditRiskMember_zcpvBuJUB47d" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Other current receivables&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;587&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,993&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--CurrentAssets_i01TI_hifrs-full--TypesOfRisksAxis__ifrs-full--CreditRiskMember_zMWxnmpMi22c" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Total financial assets&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;12,788&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,336&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AA_zKTBoMI9iFbi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_ecustom--DisclosureOfFinancialLiabilitiesRiskManagementExplanatory_zDkAaddJlwnh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; display: none; text-align: justify"&gt;&lt;span id="xdx_8B5_zwoR2VUWI3Hl"&gt;SCHEDULE OF FINANCIAL LIABILITIES
FAIR VALUE THROUGH PROFIT OR LOSS&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20251231_z7LYJxKxO4n8" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49D_20241231_zAqNXK52yy71" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossAbstract_iB_zHEmqdSpJ2pe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Financial liabilities at fair value through profit or loss:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLoss_i01I_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ShortTermLoanMember_zaFxjj2AAfU4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 64%; text-align: justify"&gt;Short term loan&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3169"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;1,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--ConvertibleNotes_i01I_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_zwsKQqW449x1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Convertible notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;365&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;391&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLoss_i01I_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleFeaturesMember_zK9Mzzf1lCCb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Convertible Features&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,207&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;791&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLoss_i01I_hifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--WarrantsMember_z8bmhbIGFF1d" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Warrants - derivative financial liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,384&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--BridgeLoansLiabilities_i01I_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember_z9e1q9xsKKxl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Bridge loans liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;453&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;902&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLoss_i01I_zBYlp9OzYmVl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Total financial liabilities at fair value through profit or loss&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,030&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,468&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--FinancialLiabilitiesAmortisedCostAbstract_iB_zUTwCHHStvD3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Financial liabilities at amortized cost:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLoss_i01I_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember_zCq312TIVPE3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Trade and other payables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,735&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13,605&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--FinancialLiabilitiesAtAmortisedCost_i01I_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_znRIx7WBGtZj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Convertible notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,723&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,469&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--FinancialLiabilitiesAtAmortisedCost_i01I_hifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zO0hbfern7Pf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Lease liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;424&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;418&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--FinancialLiabilitiesAtAmortisedCost_i01I_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember_zr1oPdRra8q3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Government grants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;202&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;177&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--FinancialLiabilitiesAtAmortisedCost_i01I_zxRGpWevVRe6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Total financial liabilities at amortized cost&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;18,084&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;16,669&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--FinancialLiabilities_iI_zbEWDB2eK8u2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Total financial liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;22,114&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;21,137&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zJSn2wvYmW09" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Financial
risk management objectives&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group&#x2019;s activities expose it to a variety of financial risks such as market risks (foreign currency risk), credit risk and liquidity
risk. The Company&#x2019;s management oversees the management of these risks, focusing on the unpredictability of financial markets and
seeks to minimize potential adverse effects on the financial performance of the Group. The Group uses different methods to monitor different
types of risk to which it is exposed. These methods include sensitivity analysis in the case of foreign exchange, ageing analysis for
credit risk and maturity analysis in respect of liquidity risk.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Market
risk&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Market
risk is the risk that the fair value of future cash flows of a financial instrument will fluctuate because of changes in market prices,
which in the group&#x2019;s case refers only to foreign currency risk. Financial instruments affected by this risk include, loans and
borrowings and short-term payables and receivables.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 85%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands, except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
24 - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Foreign
currency risk&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Currency
risk is the risk that the value of financial instruments will fluctuate due to changes in foreign exchange rates. Currency risk arises
when future commercial transactions and recognized assets and liabilities are denominated in a currency that is not the functional currency.
The Group is exposed to foreign exchange risk arising from currency exposure primarily with respect to the NIS and Euro.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2025, the Group has excess financial assets over financial liabilities in foreign currencies in relation to the SGD and
AED totalling approximately $&lt;span id="xdx_90E_eifrs-full--FinancialLiabilities_iI_pn3n3_uSGD_c20251231_z5yeumcEwSx7" title="Financial liabilities"&gt;151&lt;/span&gt;, and $&lt;span id="xdx_90B_eifrs-full--FinancialLiabilities_iI_pn3n3_uAED_c20251231_zhEhutDtrEi5" title="Financial liabilities"&gt;11&lt;/span&gt; respectively; also the Group has excess financial liabilities over financial assets in foreign
currencies in relation to the NIS and AUD totalling approximately $&lt;span id="xdx_906_eifrs-full--FinancialLiabilities_iI_pn3n3_uILS_c20251231_zYTmD8MuSGK4" title="Financial liabilities"&gt;2,188&lt;/span&gt; and $&lt;span id="xdx_907_eifrs-full--FinancialLiabilities_iI_pn3n3_uAUD_c20251231_zbVaMKuRxcBc" title="Financial liabilities"&gt;273&lt;/span&gt;. On December 31, 2024, the Group has excess financial
liabilities over financial assets in foreign currencies in relation to the NIS, AUD, SGD and EUR totalling approximately $&lt;span id="xdx_90F_eifrs-full--IncreaseDecreaseInFinancialAssets_pn3n3_uILS_c20240101__20241231_zysCbp0PzFNl" title="Financial assets"&gt;2,745&lt;/span&gt;, $&lt;span id="xdx_902_eifrs-full--IncreaseDecreaseInFinancialAssets_pn3n3_uAUD_c20240101__20241231_zv1z2zaJelJb" title="Financial assets"&gt;376&lt;/span&gt;,
$&lt;span id="xdx_90A_eifrs-full--IncreaseDecreaseInFinancialAssets_pn3n3_uSGD_c20240101__20241231_z9KCvFPBlgjc" title="Financial assets"&gt;103&lt;/span&gt; and $&lt;span id="xdx_909_eifrs-full--IncreaseDecreaseInFinancialAssets_pn3n3_uEuro_c20240101__20241231_zOuWTmaIVkYg" title="Financial assets"&gt;163&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Foreign
currency sensitivity analysis&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table demonstrates the sensitivity test to a reasonably possible change of 10% in NIS, AUD, SGD, EUR and AED and NIS exchange
rates against the USD, with all other variables held constant. The impact on the Group&#x2019;s net loss (tax effect is not relevant)
and equity is due to changes in the fair value of monetary assets and liabilities including non-designated foreign currency derivatives
and embedded derivatives. The Company&#x2019;s exposure to foreign currency changes for all other currencies is immaterial&lt;i&gt;.&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_ecustom--DisclosureOfSensitivityAnalysisForActuarialAssumptionExplanatory_zhA3dibD4nE7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;span id="xdx_8B1_zemN5z0CZIic" style="display: none"&gt;SCHEDULE
OF FOREIGN CURRENCY SENSITIVITY ANALYSIS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Change in &lt;br/&gt; NIS rate&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Effect on &lt;br/&gt; net loss&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;December 31, 2025&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--TaxRateEffectFromChangeInTaxRate_pid_dp_uPure_c20250101__20251231_zIhyBen6JVOj"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NetForeignExchangeLoss_pn3n3_uILS_c20250101__20251231_zw1L1w7Lpdaf"&gt;219&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;December 31, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--TaxRateEffectFromChangeInTaxRate_pid_dp_uPure_c20240101__20241231_ztgCaM16Jttk"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--NetForeignExchangeLoss_pn3n3_uILS_c20240101__20241231_z8uVhnM0b2p2"&gt;275&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Change in AUD rate&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Effect on net loss&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: justify"&gt;December 31, 2025&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--TaxRateEffectFromChangeInTaxRate_pid_dp_uPure_c20250101__20251231_zWPBKrWY9xra"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NetForeignExchangeLoss_pn3n3_uAUD_c20250101__20251231_zXEmB5JGFT37"&gt;27&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;December 31, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--TaxRateEffectFromChangeInTaxRate_pid_dp_uPure_c20240101__20241231_zFnBEs95MdL3"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--NetForeignExchangeLoss_pn3n3_uAUD_c20240101__20241231_zoW7Q6kWQenl"&gt;38&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Change in SGD rate&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Effect on net loss&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;December 31, 2025&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--TaxRateEffectFromChangeInTaxRate_pid_dp_uPure_c20250101__20251231_zi0Yd1EyTLbh"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--NetForeignExchangeLoss_pn3n3_uSGD_c20250101__20251231_zZ6BkqL6kU98"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;December 31, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--TaxRateEffectFromChangeInTaxRate_pid_dp_uPure_c20240101__20241231_zoerFxQLg6f4"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NetForeignExchangeLoss_pn3n3_uSGD_c20240101__20241231_zMbOF3bT5f54"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Change in EUR rate&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Effect on net loss&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;December 31, 2025&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--TaxRateEffectFromChangeInTaxRate_pid_dp_uPure_c20250101__20251231_z3x7uh4o9Kx7"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NetForeignExchangeLoss_pn3n3_uEuro_c20250101__20251231_zi0wh73UDlWb"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3238"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;December 31, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--TaxRateEffectFromChangeInTaxRate_pid_dp_uPure_c20240101__20241231_zozdHqFaFZf6" title="Change in rate"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NetForeignExchangeLoss_pn3n3_uEuro_c20240101__20241231_zZV7SOuBrUok"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Change in AED rate&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Effect on net loss&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;December 31, 2025&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--TaxRateEffectFromChangeInTaxRate_pid_dp_uPure_c20250101__20251231_z2XH6DIxQknc" title="Change in tax rate"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NetForeignExchangeLoss_pn3n3_uAED_c20250101__20251231_z8j8tZInprKc" title="Effect on net loss"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;December 31, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--TaxRateEffectFromChangeInTaxRate_pid_dp_uPure_c20240101__20241231_zVGcSTcCR4Fh" title="Change in tax rate"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--NetForeignExchangeLoss_pn3n3_uAED_c20240101__20241231_zb9ckmSjTwMh" title="Effect on net loss"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3249"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_zNVqtJm6Wi17" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 85%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands, except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
24 - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (CONT.):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Credit
risk&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Credit
risk is the risk that a counterparty will not meet its obligations as a customer or under a financial instrument leading to a loss to
the Group. The Group is exposed to credit risk from its operating activity (other receivables and cash balances). The Group&#x2019;s main
financial assets are cash and cash equivalents as well as other receivables and their carrying amounts represent the Group&#x2019;s maximum
exposure to credit risk. Credit risk from balances with banks and financial institutions is managed by the Group&#x2019;s management in
accordance with the Group&#x2019;s policy. Wherever possible and commercially practical, the Group holds cash with major financial institutions
in Israel and Australia which the Company&#x2019;s management regards as financially solid.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Liquidity
risk&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Liquidity
risk is the risk that an entity will encounter difficulty in meeting obligations associated with financial liabilities that are settled
by delivering cash or another financial asset. The Group has procedures to minimize such loss by maintaining sufficient cash and other
highly liquid current assets and by having available an adequate amount of committed credit facilities. As of the balance sheet date,
the Group has a positive working capital.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following tables detail the Group&#x2019;s remaining contractual maturity for its financial liabilities. The tables have been drawn up
based on the undiscounted cash flows of financial liabilities based on the earliest date on which the Group can be required to pay.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As
of December 31, 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_eifrs-full--DisclosureOfFinancialLiabilitiesExplanatory_zrjvAdUQRj34" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B2_zgSd6XagbKd8" style="display: none"&gt;SCHEDULE OF CONTRACTUAL MATURITY FOR  FINANCIAL LIABILITIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20251231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zSvrw27NhqDi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Less than&lt;br/&gt; one year&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember_z7jfB5BQuVt7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;1 to 2&lt;br/&gt; years&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember_zUbIWEZaWoS7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2 to 3&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;years&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember_zftSjywi8K16" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;3 to 4&lt;br/&gt; years&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember_zvwEBFIhgR6k" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;4 to 5&lt;br/&gt; years&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zXjpmUJ0WWO2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&amp;gt;5&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;years&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20251231_zcZPkEp7fLf8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--FinancialLiabilitiesUndiscountedCashFlows_iI_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember_zcotEprUBwl4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 23%; text-align: left"&gt;Trade and other payables&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;12,735&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3254"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3255"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3256"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3257"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3258"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;12,735&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--FinancialLiabilitiesUndiscountedCashFlows_iI_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ShortTermLoanMember_z3dj9MOIaSSa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Short term loan&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3261"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3262"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3263"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3264"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3265"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3266"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3267"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--FinancialLiabilitiesUndiscountedCashFlows_iI_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember_zeoUTmocZQe8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Bridge loans&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;453&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3270"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3271"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3272"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3273"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3274"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;453&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--FinancialLiabilitiesUndiscountedCashFlows_iI_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember_zCCnAKTFSoY8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Government grants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;202&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3278"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3279"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3280"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3281"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3282"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;202&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--FinancialLiabilitiesUndiscountedCashFlows_iI_hifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zXFVhHZ14e" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Lease liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;74&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;74&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;74&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;74&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;74&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;54&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;424&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--FinancialLiabilitiesUndiscountedCashFlows_iI_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_z0XXeSmT7X2f" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Convertible note&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,295&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3294"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3295"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3296"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3297"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3298"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,295&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--FinancialLiabilitiesUndiscountedCashFlows_iI_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--FinancialDerivativesMember_zhZvjC2GkDB6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Financial derivatives&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;5&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3302"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3303"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3304"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3305"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3306"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;5&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--FinancialLiabilitiesUndiscountedCashFlows_iI_zUDN4Y49bXMi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
    liabilities undiscounted cashflows&lt;/span&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;21,764&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;74&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;74&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;74&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;74&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;54&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;22,114&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As
of December 31, 2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20241231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zj2KnebNgQHd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Less than&lt;br/&gt; one year&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember_zD1aDOHmTPgi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;1 to 2&lt;br/&gt; years&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember_zOsGXaScD7oe" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2 to 3&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;years&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember_znSuYb873fg7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;3 to 4&lt;br/&gt; years&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember_zsVjXvC26cH5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;4 to 5&lt;br/&gt; years&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zkZcSICcUHi6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&amp;gt;5&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;years&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20241231_zcgpNMEEngp" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--FinancialLiabilitiesUndiscountedCashFlows_iI_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember_zyV08D08K4l8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 23%; text-align: left"&gt;Trade and other payables&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;13,605&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3318"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3319"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3320"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3321"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3322"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;13,605&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--FinancialLiabilitiesUndiscountedCashFlows_iI_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ShortTermLoanMember_zsx9piEgvpz5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Short term loan&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3326"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3327"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3328"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3329"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3330"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--FinancialLiabilitiesUndiscountedCashFlows_iI_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember_z1gDuqvolo7k" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Bridge loans&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;902&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3334"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3335"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3336"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3337"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3338"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;902&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--FinancialLiabilitiesUndiscountedCashFlows_iI_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember_zKv7k4q6hsXc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Government grants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;177&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3342"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3343"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3344"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3345"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3346"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;177&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--FinancialLiabilitiesUndiscountedCashFlows_iI_hifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zI604kRFCxD7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Lease liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;81&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;74&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;74&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;74&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;74&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;41&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;418&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--FinancialLiabilitiesUndiscountedCashFlows_iI_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_zHdClFBgYkVe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Convertible note&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,651&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3358"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3359"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3360"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3361"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3362"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,651&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--FinancialLiabilitiesUndiscountedCashFlows_iI_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--FinancialDerivativesMember_zlySyHcZy7Sk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Financial derivatives&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,384&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3366"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3367"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3368"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3369"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3370"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,384&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--FinancialLiabilitiesUndiscountedCashFlows_iI_z5uUjpV5etd7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
    liabilities undiscounted cashflows&lt;/span&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;20,800&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;74&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;74&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;74&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;74&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;41&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;21,137&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AC_z2hplU80jJkc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 85%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands, except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</SMX:DisclosureOfFinancialInstrumentAndRiskManagementExplanatory>
    <ifrs-full:DisclosureOfCreditRiskExposureExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact003150">&lt;p id="xdx_89D_eifrs-full--DisclosureOfCreditRiskExposureExplanatory_zx7y9cCE3F9a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Composition
of the Group&#x2019;s financial assets and financial liabilities:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; display: none"&gt;&lt;span id="xdx_8BF_zpEviBcKXJi9"&gt;SCHEDULE
OF FINANCIAL ASSETS AND IMPACT OF CREDIT EXPOSURE&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_495_20251231_zkrkfsoQqJCa" style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20241231_zk63Cg01WCdi" style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--DisclosureOfFinancialAssetsAbstract_iB_zBVlnhtNQusa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Financial assets at amortized cost:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--CashAndCashEquivalents_i01I_hifrs-full--TypesOfRisksAxis__ifrs-full--CreditRiskMember_zu5o4iMbTJua" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 64%; text-align: justify"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;12,201&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;2,343&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--OtherCurrentAssets_i01I_hifrs-full--TypesOfRisksAxis__ifrs-full--CreditRiskMember_zcpvBuJUB47d" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Other current receivables&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;587&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,993&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--CurrentAssets_i01TI_hifrs-full--TypesOfRisksAxis__ifrs-full--CreditRiskMember_zMWxnmpMi22c" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Total financial assets&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;12,788&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,336&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ifrs-full:DisclosureOfCreditRiskExposureExplanatory>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2025-12-31_ifrs-full_CreditRiskMember"
      decimals="-3"
      id="Fact003155"
      unitRef="USD">12201000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2024-12-31_ifrs-full_CreditRiskMember"
      decimals="-3"
      id="Fact003156"
      unitRef="USD">2343000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:OtherCurrentAssets
      contextRef="AsOf2025-12-31_ifrs-full_CreditRiskMember"
      decimals="-3"
      id="Fact003158"
      unitRef="USD">587000</ifrs-full:OtherCurrentAssets>
    <ifrs-full:OtherCurrentAssets
      contextRef="AsOf2024-12-31_ifrs-full_CreditRiskMember"
      decimals="-3"
      id="Fact003159"
      unitRef="USD">1993000</ifrs-full:OtherCurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2025-12-31_ifrs-full_CreditRiskMember"
      decimals="-3"
      id="Fact003161"
      unitRef="USD">12788000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2024-12-31_ifrs-full_CreditRiskMember"
      decimals="-3"
      id="Fact003162"
      unitRef="USD">4336000</ifrs-full:CurrentAssets>
    <SMX:DisclosureOfFinancialLiabilitiesRiskManagementExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact003164">&lt;p id="xdx_89C_ecustom--DisclosureOfFinancialLiabilitiesRiskManagementExplanatory_zDkAaddJlwnh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; display: none; text-align: justify"&gt;&lt;span id="xdx_8B5_zwoR2VUWI3Hl"&gt;SCHEDULE OF FINANCIAL LIABILITIES
FAIR VALUE THROUGH PROFIT OR LOSS&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20251231_z7LYJxKxO4n8" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49D_20241231_zAqNXK52yy71" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossAbstract_iB_zHEmqdSpJ2pe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Financial liabilities at fair value through profit or loss:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLoss_i01I_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ShortTermLoanMember_zaFxjj2AAfU4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 64%; text-align: justify"&gt;Short term loan&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3169"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;1,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--ConvertibleNotes_i01I_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_zwsKQqW449x1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Convertible notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;365&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;391&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLoss_i01I_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleFeaturesMember_zK9Mzzf1lCCb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Convertible Features&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,207&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;791&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLoss_i01I_hifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--WarrantsMember_z8bmhbIGFF1d" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Warrants - derivative financial liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,384&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--BridgeLoansLiabilities_i01I_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember_z9e1q9xsKKxl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Bridge loans liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;453&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;902&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLoss_i01I_zBYlp9OzYmVl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Total financial liabilities at fair value through profit or loss&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,030&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,468&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--FinancialLiabilitiesAmortisedCostAbstract_iB_zUTwCHHStvD3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Financial liabilities at amortized cost:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLoss_i01I_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember_zCq312TIVPE3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Trade and other payables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,735&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13,605&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--FinancialLiabilitiesAtAmortisedCost_i01I_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_znRIx7WBGtZj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Convertible notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,723&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,469&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--FinancialLiabilitiesAtAmortisedCost_i01I_hifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zO0hbfern7Pf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Lease liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;424&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;418&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--FinancialLiabilitiesAtAmortisedCost_i01I_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember_zr1oPdRra8q3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Government grants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;202&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;177&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--FinancialLiabilitiesAtAmortisedCost_i01I_zxRGpWevVRe6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Total financial liabilities at amortized cost&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;18,084&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;16,669&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--FinancialLiabilities_iI_zbEWDB2eK8u2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Total financial liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;22,114&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;21,137&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</SMX:DisclosureOfFinancialLiabilitiesRiskManagementExplanatory>
    <ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLoss
      contextRef="AsOf2024-12-31_custom_ShortTermLoanMember"
      decimals="-3"
      id="Fact003170"
      unitRef="USD">1000000</ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLoss>
    <SMX:ConvertibleNotes
      contextRef="AsOf2025-12-31_custom_ConvertibleNotesMember"
      decimals="-3"
      id="Fact003172"
      unitRef="USD">365000</SMX:ConvertibleNotes>
    <SMX:ConvertibleNotes
      contextRef="AsOf2024-12-31_custom_ConvertibleNotesMember"
      decimals="-3"
      id="Fact003173"
      unitRef="USD">391000</SMX:ConvertibleNotes>
    <ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLoss
      contextRef="AsOf2025-12-31_custom_ConvertibleFeaturesMember"
      decimals="-3"
      id="Fact003175"
      unitRef="USD">3207000</ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLoss>
    <ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLoss
      contextRef="AsOf2024-12-31_custom_ConvertibleFeaturesMember"
      decimals="-3"
      id="Fact003176"
      unitRef="USD">791000</ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLoss>
    <ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLoss
      contextRef="AsOf2025-12-31_ifrs-full_WarrantsMember"
      decimals="-3"
      id="Fact003178"
      unitRef="USD">5000</ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLoss>
    <ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLoss
      contextRef="AsOf2024-12-31_ifrs-full_WarrantsMember"
      decimals="-3"
      id="Fact003179"
      unitRef="USD">1384000</ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLoss>
    <SMX:BridgeLoansLiabilities
      contextRef="AsOf2025-12-31_custom_BridgeLoansMember"
      decimals="-3"
      id="Fact003181"
      unitRef="USD">453000</SMX:BridgeLoansLiabilities>
    <SMX:BridgeLoansLiabilities
      contextRef="AsOf2024-12-31_custom_BridgeLoansMember"
      decimals="-3"
      id="Fact003182"
      unitRef="USD">902000</SMX:BridgeLoansLiabilities>
    <ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLoss
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact003184"
      unitRef="USD">4030000</ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLoss>
    <ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLoss
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact003185"
      unitRef="USD">4468000</ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLoss>
    <ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLoss
      contextRef="AsOf2025-12-31_custom_TradeAndOtherPayablesMember"
      decimals="-3"
      id="Fact003190"
      unitRef="USD">12735000</ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLoss>
    <ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLoss
      contextRef="AsOf2024-12-31_custom_TradeAndOtherPayablesMember"
      decimals="-3"
      id="Fact003191"
      unitRef="USD">13605000</ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLoss>
    <ifrs-full:FinancialLiabilitiesAtAmortisedCost
      contextRef="AsOf2025-12-31_custom_ConvertibleNotesMember"
      decimals="-3"
      id="Fact003193"
      unitRef="USD">4723000</ifrs-full:FinancialLiabilitiesAtAmortisedCost>
    <ifrs-full:FinancialLiabilitiesAtAmortisedCost
      contextRef="AsOf2024-12-31_custom_ConvertibleNotesMember"
      decimals="-3"
      id="Fact003194"
      unitRef="USD">2469000</ifrs-full:FinancialLiabilitiesAtAmortisedCost>
    <ifrs-full:FinancialLiabilitiesAtAmortisedCost
      contextRef="AsOf2025-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact003196"
      unitRef="USD">424000</ifrs-full:FinancialLiabilitiesAtAmortisedCost>
    <ifrs-full:FinancialLiabilitiesAtAmortisedCost
      contextRef="AsOf2024-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact003197"
      unitRef="USD">418000</ifrs-full:FinancialLiabilitiesAtAmortisedCost>
    <ifrs-full:FinancialLiabilitiesAtAmortisedCost
      contextRef="AsOf2025-12-31_custom_GovernmentGrantsMember"
      decimals="-3"
      id="Fact003199"
      unitRef="USD">202000</ifrs-full:FinancialLiabilitiesAtAmortisedCost>
    <ifrs-full:FinancialLiabilitiesAtAmortisedCost
      contextRef="AsOf2024-12-31_custom_GovernmentGrantsMember"
      decimals="-3"
      id="Fact003200"
      unitRef="USD">177000</ifrs-full:FinancialLiabilitiesAtAmortisedCost>
    <ifrs-full:FinancialLiabilitiesAtAmortisedCost
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact003202"
      unitRef="USD">18084000</ifrs-full:FinancialLiabilitiesAtAmortisedCost>
    <ifrs-full:FinancialLiabilitiesAtAmortisedCost
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact003203"
      unitRef="USD">16669000</ifrs-full:FinancialLiabilitiesAtAmortisedCost>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact003205"
      unitRef="USD">22114000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact003206"
      unitRef="USD">21137000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact003208"
      unitRef="SGD">151000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact003210"
      unitRef="AED">11000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact003212"
      unitRef="ILS">2188000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact003214"
      unitRef="AUD">273000</ifrs-full:FinancialLiabilities>
    <ifrs-full:IncreaseDecreaseInFinancialAssets
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact003216"
      unitRef="ILS">2745000</ifrs-full:IncreaseDecreaseInFinancialAssets>
    <ifrs-full:IncreaseDecreaseInFinancialAssets
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact003218"
      unitRef="AUD">376000</ifrs-full:IncreaseDecreaseInFinancialAssets>
    <ifrs-full:IncreaseDecreaseInFinancialAssets
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact003220"
      unitRef="SGD">103000</ifrs-full:IncreaseDecreaseInFinancialAssets>
    <ifrs-full:IncreaseDecreaseInFinancialAssets
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact003222"
      unitRef="Euro">163000</ifrs-full:IncreaseDecreaseInFinancialAssets>
    <SMX:DisclosureOfSensitivityAnalysisForActuarialAssumptionExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact003224">&lt;p id="xdx_891_ecustom--DisclosureOfSensitivityAnalysisForActuarialAssumptionExplanatory_zhA3dibD4nE7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;span id="xdx_8B1_zemN5z0CZIic" style="display: none"&gt;SCHEDULE
OF FOREIGN CURRENCY SENSITIVITY ANALYSIS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Change in &lt;br/&gt; NIS rate&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Effect on &lt;br/&gt; net loss&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;December 31, 2025&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--TaxRateEffectFromChangeInTaxRate_pid_dp_uPure_c20250101__20251231_zIhyBen6JVOj"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NetForeignExchangeLoss_pn3n3_uILS_c20250101__20251231_zw1L1w7Lpdaf"&gt;219&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;December 31, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--TaxRateEffectFromChangeInTaxRate_pid_dp_uPure_c20240101__20241231_ztgCaM16Jttk"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--NetForeignExchangeLoss_pn3n3_uILS_c20240101__20241231_z8uVhnM0b2p2"&gt;275&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Change in AUD rate&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Effect on net loss&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: justify"&gt;December 31, 2025&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--TaxRateEffectFromChangeInTaxRate_pid_dp_uPure_c20250101__20251231_zWPBKrWY9xra"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NetForeignExchangeLoss_pn3n3_uAUD_c20250101__20251231_zXEmB5JGFT37"&gt;27&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;December 31, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--TaxRateEffectFromChangeInTaxRate_pid_dp_uPure_c20240101__20241231_zFnBEs95MdL3"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--NetForeignExchangeLoss_pn3n3_uAUD_c20240101__20241231_zoW7Q6kWQenl"&gt;38&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Change in SGD rate&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Effect on net loss&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;December 31, 2025&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--TaxRateEffectFromChangeInTaxRate_pid_dp_uPure_c20250101__20251231_zi0Yd1EyTLbh"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--NetForeignExchangeLoss_pn3n3_uSGD_c20250101__20251231_zZ6BkqL6kU98"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;December 31, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--TaxRateEffectFromChangeInTaxRate_pid_dp_uPure_c20240101__20241231_zoerFxQLg6f4"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NetForeignExchangeLoss_pn3n3_uSGD_c20240101__20241231_zMbOF3bT5f54"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Change in EUR rate&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Effect on net loss&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;December 31, 2025&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--TaxRateEffectFromChangeInTaxRate_pid_dp_uPure_c20250101__20251231_z3x7uh4o9Kx7"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NetForeignExchangeLoss_pn3n3_uEuro_c20250101__20251231_zi0wh73UDlWb"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3238"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;December 31, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--TaxRateEffectFromChangeInTaxRate_pid_dp_uPure_c20240101__20241231_zozdHqFaFZf6" title="Change in rate"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NetForeignExchangeLoss_pn3n3_uEuro_c20240101__20241231_zZV7SOuBrUok"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Change in AED rate&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Effect on net loss&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;December 31, 2025&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--TaxRateEffectFromChangeInTaxRate_pid_dp_uPure_c20250101__20251231_z2XH6DIxQknc" title="Change in tax rate"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NetForeignExchangeLoss_pn3n3_uAED_c20250101__20251231_z8j8tZInprKc" title="Effect on net loss"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;December 31, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--TaxRateEffectFromChangeInTaxRate_pid_dp_uPure_c20240101__20241231_zVGcSTcCR4Fh" title="Change in tax rate"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--NetForeignExchangeLoss_pn3n3_uAED_c20240101__20241231_zb9ckmSjTwMh" title="Effect on net loss"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3249"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</SMX:DisclosureOfSensitivityAnalysisForActuarialAssumptionExplanatory>
    <ifrs-full:TaxRateEffectFromChangeInTaxRate
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact003225"
      unitRef="Pure">0.10</ifrs-full:TaxRateEffectFromChangeInTaxRate>
    <ifrs-full:NetForeignExchangeLoss
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact003226"
      unitRef="ILS">219000</ifrs-full:NetForeignExchangeLoss>
    <ifrs-full:TaxRateEffectFromChangeInTaxRate
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact003227"
      unitRef="Pure">0.10</ifrs-full:TaxRateEffectFromChangeInTaxRate>
    <ifrs-full:NetForeignExchangeLoss
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact003228"
      unitRef="ILS">275000</ifrs-full:NetForeignExchangeLoss>
    <ifrs-full:TaxRateEffectFromChangeInTaxRate
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact003229"
      unitRef="Pure">0.10</ifrs-full:TaxRateEffectFromChangeInTaxRate>
    <ifrs-full:NetForeignExchangeLoss
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact003230"
      unitRef="AUD">27000</ifrs-full:NetForeignExchangeLoss>
    <ifrs-full:TaxRateEffectFromChangeInTaxRate
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact003231"
      unitRef="Pure">0.10</ifrs-full:TaxRateEffectFromChangeInTaxRate>
    <ifrs-full:NetForeignExchangeLoss
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact003232"
      unitRef="AUD">38000</ifrs-full:NetForeignExchangeLoss>
    <ifrs-full:TaxRateEffectFromChangeInTaxRate
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact003233"
      unitRef="Pure">0.10</ifrs-full:TaxRateEffectFromChangeInTaxRate>
    <ifrs-full:NetForeignExchangeLoss
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact003234"
      unitRef="SGD">15000</ifrs-full:NetForeignExchangeLoss>
    <ifrs-full:TaxRateEffectFromChangeInTaxRate
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact003235"
      unitRef="Pure">0.10</ifrs-full:TaxRateEffectFromChangeInTaxRate>
    <ifrs-full:NetForeignExchangeLoss
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact003236"
      unitRef="SGD">10000</ifrs-full:NetForeignExchangeLoss>
    <ifrs-full:TaxRateEffectFromChangeInTaxRate
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact003237"
      unitRef="Pure">0.10</ifrs-full:TaxRateEffectFromChangeInTaxRate>
    <ifrs-full:TaxRateEffectFromChangeInTaxRate
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact003240"
      unitRef="Pure">0.10</ifrs-full:TaxRateEffectFromChangeInTaxRate>
    <ifrs-full:NetForeignExchangeLoss
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact003241"
      unitRef="Euro">16000</ifrs-full:NetForeignExchangeLoss>
    <ifrs-full:TaxRateEffectFromChangeInTaxRate
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact003243"
      unitRef="Pure">0.10</ifrs-full:TaxRateEffectFromChangeInTaxRate>
    <ifrs-full:NetForeignExchangeLoss
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact003245"
      unitRef="AED">1000</ifrs-full:NetForeignExchangeLoss>
    <ifrs-full:TaxRateEffectFromChangeInTaxRate
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact003247"
      unitRef="Pure">0.10</ifrs-full:TaxRateEffectFromChangeInTaxRate>
    <ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact003251">&lt;p id="xdx_89E_eifrs-full--DisclosureOfFinancialLiabilitiesExplanatory_zrjvAdUQRj34" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B2_zgSd6XagbKd8" style="display: none"&gt;SCHEDULE OF CONTRACTUAL MATURITY FOR  FINANCIAL LIABILITIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20251231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zSvrw27NhqDi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Less than&lt;br/&gt; one year&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember_z7jfB5BQuVt7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;1 to 2&lt;br/&gt; years&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember_zUbIWEZaWoS7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2 to 3&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;years&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember_zftSjywi8K16" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;3 to 4&lt;br/&gt; years&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember_zvwEBFIhgR6k" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;4 to 5&lt;br/&gt; years&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zXjpmUJ0WWO2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&amp;gt;5&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;years&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20251231_zcZPkEp7fLf8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--FinancialLiabilitiesUndiscountedCashFlows_iI_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember_zcotEprUBwl4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 23%; text-align: left"&gt;Trade and other payables&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;12,735&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3254"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3255"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3256"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3257"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3258"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;12,735&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--FinancialLiabilitiesUndiscountedCashFlows_iI_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ShortTermLoanMember_z3dj9MOIaSSa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Short term loan&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3261"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3262"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3263"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3264"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3265"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3266"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3267"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--FinancialLiabilitiesUndiscountedCashFlows_iI_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember_zeoUTmocZQe8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Bridge loans&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;453&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3270"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3271"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3272"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3273"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3274"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;453&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--FinancialLiabilitiesUndiscountedCashFlows_iI_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember_zCCnAKTFSoY8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Government grants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;202&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3278"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3279"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3280"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3281"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3282"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;202&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--FinancialLiabilitiesUndiscountedCashFlows_iI_hifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zXFVhHZ14e" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Lease liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;74&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;74&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;74&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;74&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;74&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;54&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;424&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--FinancialLiabilitiesUndiscountedCashFlows_iI_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_z0XXeSmT7X2f" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Convertible note&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,295&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3294"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3295"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3296"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3297"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3298"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,295&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--FinancialLiabilitiesUndiscountedCashFlows_iI_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--FinancialDerivativesMember_zhZvjC2GkDB6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Financial derivatives&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;5&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3302"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3303"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3304"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3305"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3306"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;5&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--FinancialLiabilitiesUndiscountedCashFlows_iI_zUDN4Y49bXMi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
    liabilities undiscounted cashflows&lt;/span&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;21,764&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;74&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;74&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;74&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;74&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;54&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;22,114&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As
of December 31, 2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20241231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zj2KnebNgQHd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Less than&lt;br/&gt; one year&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember_zD1aDOHmTPgi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;1 to 2&lt;br/&gt; years&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember_zOsGXaScD7oe" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2 to 3&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;years&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember_znSuYb873fg7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;3 to 4&lt;br/&gt; years&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember_zsVjXvC26cH5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;4 to 5&lt;br/&gt; years&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zkZcSICcUHi6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&amp;gt;5&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;years&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20241231_zcgpNMEEngp" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--FinancialLiabilitiesUndiscountedCashFlows_iI_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember_zyV08D08K4l8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 23%; text-align: left"&gt;Trade and other payables&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;13,605&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3318"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3319"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3320"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3321"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3322"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;13,605&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--FinancialLiabilitiesUndiscountedCashFlows_iI_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ShortTermLoanMember_zsx9piEgvpz5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Short term loan&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3326"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3327"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3328"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3329"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3330"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--FinancialLiabilitiesUndiscountedCashFlows_iI_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember_z1gDuqvolo7k" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Bridge loans&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;902&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3334"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3335"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3336"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3337"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3338"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;902&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--FinancialLiabilitiesUndiscountedCashFlows_iI_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember_zKv7k4q6hsXc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Government grants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;177&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3342"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3343"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3344"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3345"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3346"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;177&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--FinancialLiabilitiesUndiscountedCashFlows_iI_hifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zI604kRFCxD7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Lease liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;81&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;74&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;74&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;74&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;74&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;41&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;418&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--FinancialLiabilitiesUndiscountedCashFlows_iI_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_zHdClFBgYkVe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Convertible note&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,651&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3358"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3359"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3360"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3361"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3362"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,651&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--FinancialLiabilitiesUndiscountedCashFlows_iI_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--FinancialDerivativesMember_zlySyHcZy7Sk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Financial derivatives&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,384&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3366"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3367"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3368"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3369"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3370"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,384&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--FinancialLiabilitiesUndiscountedCashFlows_iI_z5uUjpV5etd7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
    liabilities undiscounted cashflows&lt;/span&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;20,800&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;74&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;74&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;74&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;74&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;41&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;21,137&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_NotLaterThanOneYearMember_custom_TradeAndOtherPayablesMember"
      decimals="-3"
      id="Fact003253"
      unitRef="USD">12735000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_custom_TradeAndOtherPayablesMember"
      decimals="-3"
      id="Fact003259"
      unitRef="USD">12735000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_NotLaterThanOneYearMember_custom_BridgeLoansMember"
      decimals="-3"
      id="Fact003269"
      unitRef="USD">453000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_custom_BridgeLoansMember"
      decimals="-3"
      id="Fact003275"
      unitRef="USD">453000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_NotLaterThanOneYearMember_custom_GovernmentGrantsMember"
      decimals="-3"
      id="Fact003277"
      unitRef="USD">202000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_custom_GovernmentGrantsMember"
      decimals="-3"
      id="Fact003283"
      unitRef="USD">202000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_NotLaterThanOneYearMember_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact003285"
      unitRef="USD">74000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact003286"
      unitRef="USD">74000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact003287"
      unitRef="USD">74000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact003288"
      unitRef="USD">74000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact003289"
      unitRef="USD">74000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact003290"
      unitRef="USD">54000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact003291"
      unitRef="USD">424000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_NotLaterThanOneYearMember_custom_ConvertibleNotesMember"
      decimals="-3"
      id="Fact003293"
      unitRef="USD">8295000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_custom_ConvertibleNotesMember"
      decimals="-3"
      id="Fact003299"
      unitRef="USD">8295000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_NotLaterThanOneYearMember_custom_FinancialDerivativesMember"
      decimals="-3"
      id="Fact003301"
      unitRef="USD">5000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_custom_FinancialDerivativesMember"
      decimals="-3"
      id="Fact003307"
      unitRef="USD">5000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_NotLaterThanOneYearMember"
      decimals="-3"
      id="Fact003309"
      unitRef="USD">21764000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember"
      decimals="-3"
      id="Fact003310"
      unitRef="USD">74000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember"
      decimals="-3"
      id="Fact003311"
      unitRef="USD">74000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember"
      decimals="-3"
      id="Fact003312"
      unitRef="USD">74000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember"
      decimals="-3"
      id="Fact003313"
      unitRef="USD">74000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanFiveYearsMember"
      decimals="-3"
      id="Fact003314"
      unitRef="USD">54000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact003315"
      unitRef="USD">22114000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_NotLaterThanOneYearMember_custom_TradeAndOtherPayablesMember"
      decimals="-3"
      id="Fact003317"
      unitRef="USD">13605000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_custom_TradeAndOtherPayablesMember"
      decimals="-3"
      id="Fact003323"
      unitRef="USD">13605000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_NotLaterThanOneYearMember_custom_ShortTermLoanMember"
      decimals="-3"
      id="Fact003325"
      unitRef="USD">1000000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_custom_ShortTermLoanMember"
      decimals="-3"
      id="Fact003331"
      unitRef="USD">1000000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_NotLaterThanOneYearMember_custom_BridgeLoansMember"
      decimals="-3"
      id="Fact003333"
      unitRef="USD">902000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_custom_BridgeLoansMember"
      decimals="-3"
      id="Fact003339"
      unitRef="USD">902000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_NotLaterThanOneYearMember_custom_GovernmentGrantsMember"
      decimals="-3"
      id="Fact003341"
      unitRef="USD">177000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_custom_GovernmentGrantsMember"
      decimals="-3"
      id="Fact003347"
      unitRef="USD">177000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_NotLaterThanOneYearMember_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact003349"
      unitRef="USD">81000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact003350"
      unitRef="USD">74000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact003351"
      unitRef="USD">74000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact003352"
      unitRef="USD">74000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact003353"
      unitRef="USD">74000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact003354"
      unitRef="USD">41000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact003355"
      unitRef="USD">418000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_NotLaterThanOneYearMember_custom_ConvertibleNotesMember"
      decimals="-3"
      id="Fact003357"
      unitRef="USD">3651000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_custom_ConvertibleNotesMember"
      decimals="-3"
      id="Fact003363"
      unitRef="USD">3651000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_NotLaterThanOneYearMember_custom_FinancialDerivativesMember"
      decimals="-3"
      id="Fact003365"
      unitRef="USD">1384000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_custom_FinancialDerivativesMember"
      decimals="-3"
      id="Fact003371"
      unitRef="USD">1384000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_NotLaterThanOneYearMember"
      decimals="-3"
      id="Fact003373"
      unitRef="USD">20800000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember"
      decimals="-3"
      id="Fact003374"
      unitRef="USD">74000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember"
      decimals="-3"
      id="Fact003375"
      unitRef="USD">74000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember"
      decimals="-3"
      id="Fact003376"
      unitRef="USD">74000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember"
      decimals="-3"
      id="Fact003377"
      unitRef="USD">74000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanFiveYearsMember"
      decimals="-3"
      id="Fact003378"
      unitRef="USD">41000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <SMX:FinancialLiabilitiesUndiscountedCashFlows
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact003379"
      unitRef="USD">21137000</SMX:FinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:DisclosureOfFairValueMeasurementExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact003381">&lt;p id="xdx_802_eifrs-full--DisclosureOfFairValueMeasurementExplanatory_zsAw1dTtpKt1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
25 - &lt;span id="xdx_827_zqwxC2zfHMee"&gt;FAIR VALUE MEASUREMENT&lt;/span&gt;:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Fair
value hierarchy&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following tables detail the consolidated entity&#x2019;s assets and liabilities, measured or disclosed at fair value, using a three-level
hierarchy, based on the lowest level of input that is significant to the entire fair value measurement, being:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
1: Quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
3: Unobservable inputs for the asset or liability.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_eifrs-full--DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory_zFBtPtD4HEch" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;span id="xdx_8BD_zrus3IY2JNT9" style="display: none"&gt;SCHEDULE
OF UNOBSERVABLE FOR ASSETS OR LIABILITY&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;As of December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_zQvCnI0S24Ae" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zoHERPEnxmd" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zCc2TGjJatG6" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20251231_zwVA1f9sMAp1" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;US$ in thousands&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--SignificantUnobservableInputLiabilities_iI_pn3n3_uUSD_hifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_zaCO2jcmqXbk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Derivative financial liabilities&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3385"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3386"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;3,577&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;3,577&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--SignificantUnobservableInputLiabilities_iI_pn3n3_uUSD_z97ZMfkI61y9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Total&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3390"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3391"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,577&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,577&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;As of December 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_z5a5aBMcsh34" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zrJwPRY97IM4" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zlN0vHkN1GH7" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20241231_zknxeCvBg0Nh" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;US$ in thousands&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--SignificantUnobservableInputLiabilities_iI_pn3n3_uUSD_hifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_zSvmvQJFiKD4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Derivative financial liabilities&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3395"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3396"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;1,381&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;1,381&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--SignificantUnobservableInputLiabilities_iI_pn3n3_uUSD_hifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--WarrantsMember_zFe5I260Pi7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Tradable warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3401"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3402"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--SignificantUnobservableInputLiabilities_iI_pn3n3_uUSD_zb5kn851Mbja" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;Total&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3406"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,381&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,384&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8AC_zLDuNf3gugt8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 85%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SMX
                                            (SECURITY MATTERS) PUBLIC LIMITED COMPANY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
    TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(US$
    in thousands, except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"&gt;&lt;img alt="" src="financials_001.jpg" style="width: 28px; height: 30px"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfFairValueMeasurementExplanatory>
    <ifrs-full:DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact003383">&lt;p id="xdx_89F_eifrs-full--DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory_zFBtPtD4HEch" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;span id="xdx_8BD_zrus3IY2JNT9" style="display: none"&gt;SCHEDULE
OF UNOBSERVABLE FOR ASSETS OR LIABILITY&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;As of December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_zQvCnI0S24Ae" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zoHERPEnxmd" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zCc2TGjJatG6" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20251231_zwVA1f9sMAp1" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;US$ in thousands&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--SignificantUnobservableInputLiabilities_iI_pn3n3_uUSD_hifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_zaCO2jcmqXbk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Derivative financial liabilities&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3385"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3386"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;3,577&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;3,577&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--SignificantUnobservableInputLiabilities_iI_pn3n3_uUSD_z97ZMfkI61y9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Total&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3390"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3391"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,577&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,577&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;As of December 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_z5a5aBMcsh34" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zrJwPRY97IM4" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zlN0vHkN1GH7" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20241231_zknxeCvBg0Nh" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;US$ in thousands&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--SignificantUnobservableInputLiabilities_iI_pn3n3_uUSD_hifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_zSvmvQJFiKD4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Derivative financial liabilities&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3395"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3396"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;1,381&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;1,381&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--SignificantUnobservableInputLiabilities_iI_pn3n3_uUSD_hifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--WarrantsMember_zFe5I260Pi7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Tradable warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3401"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3402"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--SignificantUnobservableInputLiabilities_iI_pn3n3_uUSD_zb5kn851Mbja" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;Total&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3406"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,381&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,384&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</ifrs-full:DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_ifrs-full_DerivativesMember"
      decimals="-3"
      id="Fact003387"
      unitRef="USD">3577000</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_DerivativesMember"
      decimals="-3"
      id="Fact003388"
      unitRef="USD">3577000</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_Level3OfFairValueHierarchyMember"
      decimals="-3"
      id="Fact003392"
      unitRef="USD">3577000</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact003393"
      unitRef="USD">3577000</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_ifrs-full_DerivativesMember"
      decimals="-3"
      id="Fact003397"
      unitRef="USD">1381000</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_DerivativesMember"
      decimals="-3"
      id="Fact003398"
      unitRef="USD">1381000</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_Level1OfFairValueHierarchyMember_ifrs-full_WarrantsMember"
      decimals="-3"
      id="Fact003400"
      unitRef="USD">3000</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_WarrantsMember18031281"
      decimals="-3"
      id="Fact003403"
      unitRef="USD">3000</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_Level1OfFairValueHierarchyMember"
      decimals="-3"
      id="Fact003405"
      unitRef="USD">3000</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_Level3OfFairValueHierarchyMember"
      decimals="-3"
      id="Fact003407"
      unitRef="USD">1381000</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact003408"
      unitRef="USD">1384000</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact003410">&lt;p id="xdx_806_eifrs-full--DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_z0eGh9UUo4If" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
26 - &lt;span id="xdx_82A_zvAMzWLzkxcl"&gt;SUBSEQUENT EVENTS&lt;/span&gt;:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Since
the reporting date the following significant events have occurred:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;The fair value of the RBW December Note, amounting to
                                                                                                                                                                                                                                     $&lt;span id="xdx_90F_eifrs-full--Borrowings_iI_pid_c20251231_zPPbGOZR96zg"&gt;5,751 &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;as of December 31, 2025, was fully converted into &lt;span id="xdx_90B_eifrs-full--NumberOfSharesIssued_iI_pid_c20251231_zPHbUitJh1yf"&gt;83,194&lt;/span&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ordinary
                                                                                                                                                                                                                                     shares.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            February 5, 2026, the Company and the SEPA Investor entered into a Second Amendment to Standby
                                            Equity Purchase Agreement (the &#x201c;Amendment&#x201d;), which amends the terms of the Company&#x2019;s
                                            SEPA, dated as of December 1, 2025, as amended and supplemented by that Amendment and Addendum
                                            to the SEPA, dated as of December 9, 2025 (see Note 11).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25.1pt; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Amendment increased the size of the Commitment Amount under the Agreement from $&lt;span id="xdx_90A_ecustom--CommitmentAmount_c20260205__20260205__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zyjiILu2IxQi"&gt;100,000&lt;/span&gt;&lt;/span&gt;
&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;to $&lt;span id="xdx_90F_ecustom--CommitmentAmount_c20260205__20260205__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zAN1XKND0cvj"&gt;250,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.
As of the date of this report, the Company has drawn down $&lt;span id="xdx_90B_ecustom--CommitmentAmount_c20251209__20251209_zwR54mvX3uxe" title="Commitment amount"&gt;11,919&lt;/span&gt;&lt;/span&gt;
&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;from the Commitment Amount under the SEPA, before agent fees
of $&lt;span id="xdx_90E_eifrs-full--ProfessionalFeesExpense_pn3n3_c20260205__20260205__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zq6zH0dZgRBj"&gt;557&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
and has issued an aggregate of &lt;span id="xdx_907_eifrs-full--NumberOfSharesIssued_iI_pid_c20260205__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_z8eci701ct16"&gt;389,682&lt;/span&gt; (post reverse splits)&lt;/span&gt;
&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;of its ordinary shares to SEPA Investor as a result. The Company
intends to continue to draw down from the Commitment Amount from time to time pursuant to the terms and conditions of the SEPA, as amended
by the Amendment, and applicable law.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25.1pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
addition, RBW Capital Partners LLC (a division of Dawson James Securities, Inc.), the placement agent for the offerings pursuant to the
SEPA, as amended by the January 30, 2026, Amendment, has agreed that it will charge the Company a cash fee equal to &lt;span id="xdx_90A_eifrs-full--DescriptionOfConversionOfDebtToEquity_c20260205__20260205__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zCiMgHkHQR1" title="Debt description"&gt;(a) &lt;span id="xdx_90C_eifrs-full--DebtInstrumentsPercentageContributedToFairValueOfPlanAssets_iI_pid_dp_uPure_c20260205__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zK38WYD934Fd" title="Cash fee percentage"&gt;4&lt;/span&gt;% for the first
$&lt;span id="xdx_902_eifrs-full--ProceedsFromIssueOfBondsNotesAndDebentures_c20260205__20260205__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zOPhFTHyUQG5" title="Gross proceeds"&gt;20,000&lt;/span&gt; of aggregate gross cash proceeds that may be drawn down from the Commitment Amount, (b) 3% for the next $80,000 of aggregate
gross cash proceeds that may be drawn down from the Commitment Amount and (c) 2% for the last $150,000 of aggregate gross cash proceeds
that may be drawn down from the Commitment Amount.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25.1pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            February 17, 2026, after the balance sheet date, the Company&#x2019;s Ordinary Shares began
                                            trading on the Nasdaq Capital Market post-reverse stock split of 4.8828125:1 under the symbol
                                            &#x201c;SMX,&#x201d; with a new CUSIP number of G8267K406 and the new ISIN code IE000B5COQZ5.
                                            Approved by shareholders and Board of Directors on July 10, 2025, this reverse split consolidated
                                            every &lt;span id="xdx_90F_eifrs-full--NumberOfSharesIssued_iI_pid_c20260217__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_z1d5Fgk9bGgc" title="Number of shares issued"&gt;4.8828125&lt;/span&gt; shares into one new ordinary share and was aimed at meeting Nasdaq&#x2019;s
                                            minimum bid price requirement of $&lt;span id="xdx_90B_ecustom--BidPricePerShare_iI_pid_c20260217__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zJiGCPo17At7" title="Bid price"&gt;1.00&lt;/span&gt; per share, reducing the number of outstanding shares
                                            from approximately &lt;span id="xdx_900_eifrs-full--NumberOfSharesOutstanding_iI_pn4n6_c20260216__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zL47MJuMwunf" title="Number of outstanding shares"&gt;10.67&lt;/span&gt; million to approximately &lt;span id="xdx_90C_eifrs-full--NumberOfSharesOutstanding_iI_pn4n6_c20260217__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zDnEVC8pQXu8" title="Number of outstanding shares"&gt;2.18&lt;/span&gt; million. Fractional shares resulting
                                            from the split were aggregated and sold at market prices. Additionally, the par value of
                                            the ordinary shares will be increased from $&lt;span id="xdx_903_eifrs-full--ParValuePerShare_iI_pid_c20260217__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zcmy01mp6Jie" title="Par value per share"&gt;0.00000000002502543568&lt;/span&gt; to $&lt;span id="xdx_901_eifrs-full--ParValuePerShare_iI_pid_c20260217__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zcU0u1YQjHNj" title="Par value per share"&gt;0.00000000012219451015625&lt;/span&gt;
                                            per share. The Company&#x2019;s options, warrants, and convertible securities were adjusted
                                            proportionately, and the Public Limited Company Constitution was amended to reflect these
                                            changes. The Basic and diluted loss per share attributable to shareholders amount in these
                                            December 31, 2025, financial statements are presented post this reverse stock split.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            January 30, 2026, the Board of Directors approved a Shareholder Rights Agreement (the &#x201c;Rights
                                            Agreement&#x201d;) and authorized the issuance of one preferred share purchase right (a &#x201c;Right&#x201d;)
                                            for each outstanding Ordinary Share. The Rights were issued on March 2, 2026, to shareholders
                                            of record on that date, pursuant to the Rights Agreement dated February 13, 2026, between
                                            the Company and Continental Stock Transfer &amp;amp; Trust Company.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25.1pt; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Rights are intended to protect shareholders from coercive or unfair takeover tactics by imposing penalties on any person or group that
acquires &lt;span id="xdx_906_eifrs-full--DebtInstrumentsPercentageContributedToFairValueOfPlanAssets_iI_pid_dp_uPure_c20260130__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zQNlrLqFG8V1" title="Cash fee percentage"&gt;10&lt;/span&gt;% or more of the Company&#x2019;s Ordinary Shares without prior Board approval. Prior to a triggering event, the Rights trade
together with the Ordinary Shares. Upon a person or group becoming an &#x201c;Acquiring Person,&#x201d; each Right (other than those held
by the Acquiring Person) becomes exercisable to purchase one Series A Preferred Share for $&lt;span id="xdx_90E_eifrs-full--ParValuePerShare_iI_pid_c20260130__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zwBjn7riXANg" title="Series A preferred share"&gt;0.0001&lt;/span&gt;, carrying a liquidation preference
of $&lt;span id="xdx_903_eifrs-full--IssuedCapitalPreferenceShares_iI_pn6n6_c20260130__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zm6Uerh43O08" title="Liquidation preference value"&gt;250&lt;/span&gt; million and cumulative dividends of &lt;span id="xdx_90C_ecustom--DividendPercentage_pid_dp_uPure_c20260130__20260130__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zLctHbx5W9Yb" title="Dividend percentage"&gt;18.5&lt;/span&gt;% per annum. The Rights may also provide for the purchase of shares of an acquiring
company at a discount if the Company is acquired after the Rights become exercisable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5.
On May 11, 2026, after the balance sheet date, the Company&#x2019;s &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_ecustom--DescriptionOfReverseStockSplitsSignificantsChangeInSharesIssuedAndOutstanding_c20260511__20260511__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zyTsxjeFV5D6" title="Reverse share splits, description"&gt;Ordinary Shares began trading on the Nasdaq Capital Market post-reverse
stock split of 20:1 under the symbol &#x201c;SMX,&#x201d; with a new CUSIP number of G8267K190 and the new ISIN code IE0008D7EWV5. Approved
by shareholders and Board of Directors on July 10, 2025, this reverse split consolidated every 20 shares into one new ordinary share
and was aimed at meeting Nasdaq&#x2019;s minimum bid price requirement of $1.00 per share, reducing the number of outstanding shares from
approximately &lt;span id="xdx_90C_ecustom--NumberOfReducingNumberOfOutstandingShares_pn6n6_c20260510__20260510__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_z9C3ZlSkvlUg" title="Reducing the number of outstanding shares"&gt;12 &lt;/span&gt;million to approximately &lt;span id="xdx_908_ecustom--NumberOfReducingNumberOfOutstandingShares_c20260511__20260511__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zKkc55tuVd9" title="Reducing the number of outstanding shares"&gt;614&lt;/span&gt;. Fractional shares resulting from the split were aggregated and sold at market prices.
Additionally, the par value of the ordinary shares will be increased from $&lt;span id="xdx_909_eifrs-full--ParValuePerShare_iI_pid_c20260510__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zWLlIXHjrL6a" title="Series A preferred share"&gt;0.00000000012219451015625&lt;/span&gt;&#160; to $&lt;span id="xdx_90F_eifrs-full--ParValuePerShare_iI_pid_c20260511__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_z4wn1chchyab" title="Series A preferred share"&gt;0.000000002443890203125&lt;/span&gt;
per share&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6.
On June 1, 2026, after the balance sheet date, the Company&#x2019;s &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_ecustom--DescriptionOfReverseStockSplitsSignificantsChangeInSharesIssuedAndOutstanding_c20260601__20260601__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zuuwX3RLXYo5" title="Reverse share splits, description"&gt;Ordinary Shares began trading on the Nasdaq Capital Market post-reverse
stock split of 2.285:1 under the symbol &#x201c;SMX,&#x201d; with a new CUSIP number of G8267K216&#160;and the new ISIN code IE000CNLGHH1.
Approved by shareholders and Board of Directors on July 10, 2025, this reverse split consolidated every 2.285 shares into one new ordinary
share and was aimed at meeting Nasdaq&#x2019;s minimum bid price requirement of $1.00 per share, reducing the number of outstanding shares
from approximately &lt;span id="xdx_909_ecustom--NumberOfReducingNumberOfOutstandingShares_pn5n6_c20260531__20260531__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zu9M3yh47ud8" title="Reducing the number of outstanding shares"&gt;1.5&lt;/span&gt; million to approximately &lt;span id="xdx_909_ecustom--NumberOfReducingNumberOfOutstandingShares_c20260601__20260601__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_z1D0iSGjTzfe" title="Reducing the number of outstanding shares"&gt;650&lt;/span&gt;. Fractional shares resulting from the split were aggregated and sold at market prices.
Additionally, the par value of the ordinary shares will be increased from $&lt;span id="xdx_907_eifrs-full--ParValuePerShare_iI_pid_c20260531__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zmmGsvEVf047" title="Series A preferred share"&gt;0.000000002443890203125&lt;/span&gt;&#160;to $&lt;span id="xdx_905_eifrs-full--ParValuePerShare_iI_pid_c20260601__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zd4Fa9yVbVd8" title="Series A preferred share"&gt;0.00000000558603475&lt;/span&gt; per
share&lt;/span&gt;. &lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory>
    <ifrs-full:Borrowings
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact003411"
      unitRef="USD">5751</ifrs-full:Borrowings>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact003412"
      unitRef="Shares">83194</ifrs-full:NumberOfSharesIssued>
    <SMX:CommitmentAmount
      contextRef="From2026-02-052026-02-05_custom_NonadjustingEventMember_ifrs-full_BottomOfRangeMember"
      decimals="0"
      id="Fact003413"
      unitRef="USD">100000</SMX:CommitmentAmount>
    <SMX:CommitmentAmount
      contextRef="From2026-02-052026-02-05_custom_NonadjustingEventMember_ifrs-full_TopOfRangeMember"
      decimals="0"
      id="Fact003414"
      unitRef="USD">250000</SMX:CommitmentAmount>
    <SMX:CommitmentAmount
      contextRef="From2025-12-092025-12-09"
      decimals="0"
      id="Fact003416"
      unitRef="USD">11919</SMX:CommitmentAmount>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2026-02-052026-02-05_custom_NonadjustingEventMember_ifrs-full_BottomOfRangeMember"
      decimals="-3"
      id="Fact003417"
      unitRef="USD">557000</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2026-02-05_custom_NonadjustingEventMember"
      decimals="INF"
      id="Fact003418"
      unitRef="Shares">389682</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:DescriptionOfConversionOfDebtToEquity
      contextRef="From2026-02-052026-02-05_custom_NonadjustingEventMember"
      id="Fact003420">(a) 4% for the first
$20,000 of aggregate gross cash proceeds that may be drawn down from the Commitment Amount, (b) 3% for the next $80,000 of aggregate
gross cash proceeds that may be drawn down from the Commitment Amount and (c) 2% for the last $150,000 of aggregate gross cash proceeds
that may be drawn down from the Commitment Amount.</ifrs-full:DescriptionOfConversionOfDebtToEquity>
    <ifrs-full:DebtInstrumentsPercentageContributedToFairValueOfPlanAssets
      contextRef="AsOf2026-02-05_custom_NonadjustingEventMember"
      decimals="INF"
      id="Fact003422"
      unitRef="Pure">0.04</ifrs-full:DebtInstrumentsPercentageContributedToFairValueOfPlanAssets>
    <ifrs-full:ProceedsFromIssueOfBondsNotesAndDebentures
      contextRef="From2026-02-052026-02-05_custom_NonadjustingEventMember"
      decimals="0"
      id="Fact003424"
      unitRef="USD">20000</ifrs-full:ProceedsFromIssueOfBondsNotesAndDebentures>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2026-02-17_custom_NonadjustingEventMember"
      decimals="INF"
      id="Fact003426"
      unitRef="Shares">4.8828125</ifrs-full:NumberOfSharesIssued>
    <SMX:BidPricePerShare
      contextRef="AsOf2026-02-17_custom_NonadjustingEventMember"
      decimals="INF"
      id="Fact003428"
      unitRef="USDPShares">1.00</SMX:BidPricePerShare>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2026-02-16_custom_NonadjustingEventMember"
      decimals="-4"
      id="Fact003430"
      unitRef="Shares">10670000</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2026-02-17_custom_NonadjustingEventMember"
      decimals="-4"
      id="Fact003432"
      unitRef="Shares">2180000</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2026-02-17_custom_NonadjustingEventMember_ifrs-full_BottomOfRangeMember"
      decimals="INF"
      id="Fact003434"
      unitRef="USDPShares">0.00000000002502543568</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2026-02-17_custom_NonadjustingEventMember_ifrs-full_TopOfRangeMember"
      decimals="INF"
      id="Fact003436"
      unitRef="USDPShares">0.00000000012219451015625</ifrs-full:ParValuePerShare>
    <ifrs-full:DebtInstrumentsPercentageContributedToFairValueOfPlanAssets
      contextRef="AsOf2026-01-30_custom_NonadjustingEventMember"
      decimals="INF"
      id="Fact003438"
      unitRef="Pure">0.10</ifrs-full:DebtInstrumentsPercentageContributedToFairValueOfPlanAssets>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2026-01-30_custom_NonadjustingEventMember"
      decimals="INF"
      id="Fact003440"
      unitRef="USDPShares">0.0001</ifrs-full:ParValuePerShare>
    <ifrs-full:IssuedCapitalPreferenceShares
      contextRef="AsOf2026-01-30_custom_NonadjustingEventMember"
      decimals="-6"
      id="Fact003442"
      unitRef="USD">250000000</ifrs-full:IssuedCapitalPreferenceShares>
    <SMX:DividendPercentage
      contextRef="From2026-01-302026-01-30_custom_NonadjustingEventMember"
      decimals="INF"
      id="Fact003444"
      unitRef="Pure">0.185</SMX:DividendPercentage>
    <SMX:DescriptionOfReverseStockSplitsSignificantsChangeInSharesIssuedAndOutstanding
      contextRef="From2026-05-112026-05-11_custom_NonadjustingEventMember"
      id="Fact003446">Ordinary Shares began trading on the Nasdaq Capital Market post-reverse
stock split of 20:1 under the symbol &#x201c;SMX,&#x201d; with a new CUSIP number of G8267K190 and the new ISIN code IE0008D7EWV5. Approved
by shareholders and Board of Directors on July 10, 2025, this reverse split consolidated every 20 shares into one new ordinary share
and was aimed at meeting Nasdaq&#x2019;s minimum bid price requirement of $1.00 per share, reducing the number of outstanding shares from
approximately 12 million to approximately 614. Fractional shares resulting from the split were aggregated and sold at market prices.
Additionally, the par value of the ordinary shares will be increased from $0.00000000012219451015625&#160; to $0.000000002443890203125
per share</SMX:DescriptionOfReverseStockSplitsSignificantsChangeInSharesIssuedAndOutstanding>
    <SMX:NumberOfReducingNumberOfOutstandingShares
      contextRef="From2026-05-102026-05-10_custom_NonadjustingEventMember"
      decimals="-6"
      id="Fact003448"
      unitRef="Shares">12000000</SMX:NumberOfReducingNumberOfOutstandingShares>
    <SMX:NumberOfReducingNumberOfOutstandingShares
      contextRef="From2026-05-112026-05-11_custom_NonadjustingEventMember"
      decimals="INF"
      id="Fact003450"
      unitRef="Shares">614</SMX:NumberOfReducingNumberOfOutstandingShares>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2026-05-10_custom_NonadjustingEventMember"
      decimals="INF"
      id="Fact003452"
      unitRef="USDPShares">0.00000000012219451015625</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2026-05-11_custom_NonadjustingEventMember"
      decimals="INF"
      id="Fact003454"
      unitRef="USDPShares">0.000000002443890203125</ifrs-full:ParValuePerShare>
    <SMX:DescriptionOfReverseStockSplitsSignificantsChangeInSharesIssuedAndOutstanding
      contextRef="From2026-06-012026-06-01_custom_NonadjustingEventMember"
      id="Fact003456">Ordinary Shares began trading on the Nasdaq Capital Market post-reverse
stock split of 2.285:1 under the symbol &#x201c;SMX,&#x201d; with a new CUSIP number of G8267K216&#160;and the new ISIN code IE000CNLGHH1.
Approved by shareholders and Board of Directors on July 10, 2025, this reverse split consolidated every 2.285 shares into one new ordinary
share and was aimed at meeting Nasdaq&#x2019;s minimum bid price requirement of $1.00 per share, reducing the number of outstanding shares
from approximately 1.5 million to approximately 650. Fractional shares resulting from the split were aggregated and sold at market prices.
Additionally, the par value of the ordinary shares will be increased from $0.000000002443890203125&#160;to $0.00000000558603475 per
share</SMX:DescriptionOfReverseStockSplitsSignificantsChangeInSharesIssuedAndOutstanding>
    <SMX:NumberOfReducingNumberOfOutstandingShares
      contextRef="From2026-05-312026-05-31_custom_NonadjustingEventMember"
      decimals="-5"
      id="Fact003458"
      unitRef="Shares">1500000</SMX:NumberOfReducingNumberOfOutstandingShares>
    <SMX:NumberOfReducingNumberOfOutstandingShares
      contextRef="From2026-06-012026-06-01_custom_NonadjustingEventMember"
      decimals="INF"
      id="Fact003460"
      unitRef="Shares">650</SMX:NumberOfReducingNumberOfOutstandingShares>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2026-05-31_custom_NonadjustingEventMember"
      decimals="INF"
      id="Fact003462"
      unitRef="USDPShares">0.000000002443890203125</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2026-06-01_custom_NonadjustingEventMember"
      decimals="INF"
      id="Fact003464"
      unitRef="USDPShares">0.00000000558603475</ifrs-full:ParValuePerShare>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000209"
          xlink:label="Fact000209"
          xlink:type="locator"/>
        <link:footnote id="Footnote000220" xlink:label="Footnote000220" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The
    share and per share information in these financial statements reflects the <xhtml:span
  id="xdx_904_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20240715__20240715__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__ifrs-full--PotentialOrdinaryShareTransactionsMember_zKoOxW6M264"
  title="Description of reverse stock splits">1-for-75</xhtml:span>, <xhtml:span
  id="xdx_908_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20250115__20250115__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__ifrs-full--PotentialOrdinaryShareTransactionsMember_zOsbRV22ky5l"
  title="Description of reverse stock splits">1-for-28.5</xhtml:span>, <xhtml:span
  id="xdx_905_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20250616__20250616__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__ifrs-full--PotentialOrdinaryShareTransactionsMember_zaBAM0NJoD54"
  title="Description of reverse stock splits">1-for-4.1</xhtml:span><xhtml:span
  id="xdx_909_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20250807__20250807__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__ifrs-full--PotentialOrdinaryShareTransactionsMember_zR8gb8fE7Md"
  title="Description of reverse stock splits">1-for-7</xhtml:span>, <xhtml:span
  id="xdx_90F_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20251023__20251023__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__ifrs-full--PotentialOrdinaryShareTransactionsMember_zfaFGzPnfkB5"
  title="Description of reverse stock splits">1-for-10.89958</xhtml:span>, <xhtml:span
  id="xdx_90B_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20251118__20251118__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__ifrs-full--PotentialOrdinaryShareTransactionsMember_zF2U4ZcFNYK2"
  title="Description of reverse stock splits">1-for-8,</xhtml:span><xhtml:span
  id="xdx_909_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20260217__20260217__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__ifrs-full--PotentialOrdinaryShareTransactionsMember_z9v6vlQJ3zol"
  title="Description of reverse stock splits">1:4.8828125</xhtml:span>, <xhtml:span
  id="xdx_905_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20260511__20260511__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__ifrs-full--PotentialOrdinaryShareTransactionsMember_zTuFYRlfqb7"
  title="Description of reverse stock splits">1-for-20</xhtml:span> and <xhtml:span
  id="xdx_90B_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20260601__20260601__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__ifrs-full--PotentialOrdinaryShareTransactionsMember_zUH0FosuKi2f"
  title="Description of reverse stock splits">1-for-2.285</xhtml:span> reverse share splits became effective on July 15, 2024, January 15, 2025, June 16, 2025, August 7, 2025,
    October 23, 2025, November 18, 2025, February 17, 2026, May 11, 2026 and June 1, 2026, respectively, of the Company&#x2019;s issued and outstanding
    Ordinary Shares (the &#x201c;Reverse Stock Splits&#x201d;). See also Note 1.F- 1.K and 26.3, 26.5 and 26.6.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000209"
          xlink:to="Footnote000220"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000211"
          xlink:label="Fact000211"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000211"
          xlink:to="Footnote000220"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000213"
          xlink:label="Fact000213"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000213"
          xlink:to="Footnote000220"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000215"
          xlink:label="Fact000215"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000215"
          xlink:to="Footnote000220"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000217"
          xlink:label="Fact000217"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000217"
          xlink:to="Footnote000220"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000219"
          xlink:label="Fact000219"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000219"
          xlink:to="Footnote000220"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000818"
          xlink:label="Fact000818"
          xlink:type="locator"/>
        <link:footnote id="Footnote000824" xlink:label="Footnote000824" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">On
    March 26, 2025, the Company established a fully owned entity incorporated in Dubai Multi Commodities Centre Authority, United Arab
    Emirates.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000818"
          xlink:to="Footnote000824"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000819"
          xlink:label="Fact000819"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000819"
          xlink:to="Footnote000824"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0820"
          xlink:label="xdx2ixbrl0820"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0820"
          xlink:to="Footnote000824"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002242"
          xlink:label="Fact002242"
          xlink:type="locator"/>
        <link:footnote id="Footnote002279" xlink:label="Footnote002279" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The share and per
share information in these financial statements reflects the <xhtml:span
  class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"
  id="xdx_90F_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20240715__20240715_zhFKFrr5MK4i"
  title="Reverse share splits, description">1-for-75</xhtml:span>, <xhtml:span
  class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"
  id="xdx_902_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20250115__20250115_zotQoNzkkUG8"
  title="Reverse share splits, description">1-for-28.5</xhtml:span>, <xhtml:span
  class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"
  id="xdx_900_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20250616__20250616_zybItfAHUDmi"
  title="Reverse share splits, description">1-for-4.1</xhtml:span><xhtml:span
  class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"
  id="xdx_906_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20250807__20250807_zdQGltGg8gB5"
  title="Reverse share splits, description">1-for-7</xhtml:span>, <xhtml:span
  class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"
  id="xdx_90E_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20251023__20251023_znXlqU2WVZE5"
  title="Reverse share splits, description">1-for-10.89958</xhtml:span> , <xhtml:span
  class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"
  id="xdx_90A_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20251118__20251118_zGWhCwPiW5hi"
  title="Reverse share splits, description">1-for-8</xhtml:span> and <xhtml:span
  class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"
  id="xdx_90A_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20260217__20260217__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventsMember_zEDpyXcjoTVl"
  title="Reverse share splits, description">1:4.8828125</xhtml:span>
reverse share splits became effective on July 15, 2024, January 15, 2025, June 16, 2025, August 7, 2025, October 23, 2025, November 18,
2025 and February 17, 2026 respectively, of the Company&#x2019;s issued and outstanding Ordinary Shares (the &#x201c;Reverse Stock Splits&#x201d;).
See also Note 1.F- 1.K and 26.3.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002242"
          xlink:to="Footnote002279"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002244"
          xlink:label="Fact002244"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002244"
          xlink:to="Footnote002279"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002246"
          xlink:label="Fact002246"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002246"
          xlink:to="Footnote002279"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002248"
          xlink:label="Fact002248"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002248"
          xlink:to="Footnote002279"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002252"
          xlink:label="Fact002252"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002252"
          xlink:to="Footnote002279"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2254"
          xlink:label="xdx2ixbrl2254"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2254"
          xlink:to="Footnote002279"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002256"
          xlink:label="Fact002256"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002256"
          xlink:to="Footnote002279"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2258"
          xlink:label="xdx2ixbrl2258"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2258"
          xlink:to="Footnote002279"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002262"
          xlink:label="Fact002262"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002262"
          xlink:to="Footnote002279"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002264"
          xlink:label="Fact002264"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002264"
          xlink:to="Footnote002279"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002266"
          xlink:label="Fact002266"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002266"
          xlink:to="Footnote002279"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002268"
          xlink:label="Fact002268"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002268"
          xlink:to="Footnote002279"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002272"
          xlink:label="Fact002272"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002272"
          xlink:to="Footnote002279"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2274"
          xlink:label="xdx2ixbrl2274"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2274"
          xlink:to="Footnote002279"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2276"
          xlink:label="xdx2ixbrl2276"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2276"
          xlink:to="Footnote002279"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2278"
          xlink:label="xdx2ixbrl2278"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2278"
          xlink:to="Footnote002279"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2787"
          xlink:label="xdx2ixbrl2787"
          xlink:type="locator"/>
        <link:footnote id="Footnote002806" xlink:label="Footnote002806" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Nil after reverse
stock split</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2787"
          xlink:to="Footnote002806"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2789"
          xlink:label="xdx2ixbrl2789"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2789"
          xlink:to="Footnote002806"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2801"
          xlink:label="xdx2ixbrl2801"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2801"
          xlink:to="Footnote002806"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2805"
          xlink:label="xdx2ixbrl2805"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2805"
          xlink:to="Footnote002806"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2810"
          xlink:label="xdx2ixbrl2810"
          xlink:type="locator"/>
        <link:footnote id="Footnote002841" xlink:label="Footnote002841" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Nil after reverse
stock split</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2810"
          xlink:to="Footnote002841"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2814"
          xlink:label="xdx2ixbrl2814"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2814"
          xlink:to="Footnote002841"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2822"
          xlink:label="xdx2ixbrl2822"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2822"
          xlink:to="Footnote002841"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2830"
          xlink:label="xdx2ixbrl2830"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2830"
          xlink:to="Footnote002841"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2838"
          xlink:label="xdx2ixbrl2838"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2838"
          xlink:to="Footnote002841"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3028"
          xlink:label="xdx2ixbrl3028"
          xlink:type="locator"/>
        <link:footnote id="Footnote003031" xlink:label="Footnote003031" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Nil after reverse
stock splits</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3028"
          xlink:to="Footnote003031"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3030"
          xlink:label="xdx2ixbrl3030"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3030"
          xlink:to="Footnote003031"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003008"
          xlink:label="Fact003008"
          xlink:type="locator"/>
        <link:footnote id="Footnote003032" xlink:label="Footnote003032" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The
    share and per share information in these financial statements reflects the <xhtml:span
  class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"
  id="xdx_90B_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20240715__20240715_z0CNwZVbmrx4"
  title="Reverse share splits">1-for-75</xhtml:span>, <xhtml:span
  class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"
  id="xdx_90C_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20250115__20250115_zfrRwxzmYUPf"
  title="Reverse share splits">1-for-28.5</xhtml:span>, <xhtml:span
  class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"
  id="xdx_900_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20250616__20250616_zr9dPgR7fJWd"
  title="Reverse share splits">1-for-4.1</xhtml:span><xhtml:span
  class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"
  id="xdx_906_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20250807__20250807_zTuvtHyG67Z2"
  title="Reverse share splits">1-for-7</xhtml:span>, <xhtml:span
  class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"
  id="xdx_905_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20251023__20251023_zezbqDGDvpG9"
  title="Reverse share splits">1-for-10.89958</xhtml:span>, <xhtml:span
  class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"
  id="xdx_903_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20251118__20251118_zZxBsN2Dj7Zb"
  title="Reverse share splits">1-for-8</xhtml:span>, <xhtml:span
  class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"
  id="xdx_907_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20260217__20260217_zC5EaCuLJKh5"
  title="Reverse share splits">1:4.8828125</xhtml:span>, <xhtml:span
  class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"
  id="xdx_909_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20260511__20260511_zp9QOExakI52"
  title="Reverse share splits">1-for-20</xhtml:span>
    and <xhtml:span
  class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"
  id="xdx_90B_ecustom--DescriptionOfReverseStockSplitsSignificantChangeInSharesIssuedAndOutstanding_c20260601__20260601_zTTap3P3bpxd"
  title="Reverse share splits">1-for-2.285</xhtml:span>
    reverse share splits became effective on July 15, 2024, January 15, 2025, June 16, 2025, August 7, 2025, October 23, 2025, November
    18, 2025, February 17, 2026, May 11, 2026 and June 1, 2026, respectively, of the Company&#x2019;s issued and outstanding Ordinary Shares (the &#x201c;Reverse
    Stock Splits&#x201d;). See also Note 1. F-1.K and 26.3, 26.5 and 26.6.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003008"
          xlink:to="Footnote003032"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003010"
          xlink:label="Fact003010"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003010"
          xlink:to="Footnote003032"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003012"
          xlink:label="Fact003012"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003012"
          xlink:to="Footnote003032"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003014"
          xlink:label="Fact003014"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003014"
          xlink:to="Footnote003032"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003016"
          xlink:label="Fact003016"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003016"
          xlink:to="Footnote003032"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003018"
          xlink:label="Fact003018"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003018"
          xlink:to="Footnote003032"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
